PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	King, KM; Ghali, WA; Faris, PD; Curtis, MJ; Galbraith, PD; Graham, MM; Knudtson, ML				King, KM; Ghali, WA; Faris, PD; Curtis, MJ; Galbraith, PD; Graham, MM; Knudtson, ML			Sex differences in outcomes after cardiac catheterization - Effect modification by treatment strategy and time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-HOSPITAL MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; ARTERY-BYPASS-SURGERY; GENDER BIAS; WOMEN; DISEASE; REVASCULARIZATION; MEN	Context Studies comparing outcomes of cardiac care in women vs men yield various results, with some suggesting worse outcomes for women and others suggesting equivalent outcomes. Objective To determine whether extent of coronary disease, treatment strategy, and follow-up time influence the risk of death in women vs men among patients who have had cardiac catheterization. Design, Setting, and Patients We studied a large inception cohort by using detailed clinical data from a registry of 37401 patients undergoing cardiac catheterization in Alberta, Canada, from 1995-2000, with follow-up through December 31, 2001. Main Outcome Measures The risk of death for women vs men was assessed for all patients combined and then in analyses stratified by degree of coronary anatomic risk and by treatment strategy (no revascularization, percutaneous coronary intervention [PCI], coronary artery bypass graft [CABG] surgery). The latter analysis included a graphic assessment of the changing relative risk over time for women vs men. Results Women had higher 1-year mortality than men did (5.6% vs 4.6%; P<.001). However, stratified analyses demonstrated that sex differences in risk occurred only early after catheterization and were most apparent among patients undergoing revascularization. The early risk-adjusted relative risks for women vs men were elevated at 3.49 (95% confidence interval [CI], 1.95-6.24) for CABG surgery and 2.38 (95% CI, 1.48-3.83) for PCI on day 1 after catheterization, with a subsequent decrease in relative risk over time to equivalence in risk between sexes before 1 year. Conclusions Sex-based differences in death rates after cardiac catheterization are time- and treatment-specific. This finding may at least partially explain the discrepancies in results from earlier studies on sex differences in outcomes of cardiac care.	Univ Calgary, Fac Nursing, Calgary, AB T2N 1N, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB, Canada; Univ Alberta, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Calgary	King, KM (corresponding author), Univ Calgary, Fac Nursing, 2500 Univ Dr NW, Calgary, AB T2N 1N, Canada.	kingk@ucalgary.ca	Faris, Peter/AAJ-3436-2020	Faris, Peter/0000-0001-5208-817X				Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0; Abramson JL, 2003, AM J CARDIOL, V91, P968, DOI 10.1016/S0002-9149(03)00114-0; BELL MR, 1995, J AM COLL CARDIOL, V25, P1650, DOI 10.1016/0735-1097(95)00044-5; BICKELL NA, 1992, ANN INTERN MED, V116, P791, DOI 10.7326/0003-4819-116-10-791; CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055, DOI 10.1016/S0735-1097(85)80005-X; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; DASH H, 1977, BRIT HEART J, V39, P733; FLEMING RF, 1991, COUNTING PROCESSES S; Gan SC, 2000, NEW ENGL J MED, V343, P8, DOI 10.1056/NEJM200007063430102; Ghali WA, 2002, ANN INTERN MED, V136, P723, DOI 10.7326/0003-4819-136-10-200205210-00007; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; Graham MM, 2001, AM HEART J, V142, P254, DOI 10.1067/mhj.2001.116481; Hastie TJ, 1990, GEN ADDITIVE MODELS; Iezzoni LI, 1997, MED CARE, V35, P158, DOI 10.1097/00005650-199702000-00006; JELINSKI SE, IN PRESS CAN J CARDI; LEGATO MJ, 2000, J GEND SPEC MED  OCT, P15; Malenka DJ, 1996, CIRCULATION, V94, P99; Mehilli J, 2002, JAMA-J AM MED ASSOC, V287, P210, DOI 10.1001/jama.287.2.210; Miller TD, 2001, J AM COLL CARDIOL, V38, P690, DOI 10.1016/S0735-1097(01)01413-9; Mueller C, 2002, J AM COLL CARDIOL, V40, P245, DOI 10.1016/S0735-1097(02)01949-6; O'Rourke DJ, 2001, ANN THORAC SURG, V71, P507, DOI 10.1016/S0003-4975(00)02236-0; Rathore SS, 2001, JAMA-J AM MED ASSOC, V286, P2849, DOI 10.1001/jama.286.22.2849; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; SMITH LR, 1991, CIRCULATION, V84, P245; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133	27	54	56	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2004	291	10					1220	1225		10.1001/jama.291.10.1220	http://dx.doi.org/10.1001/jama.291.10.1220			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800XV	15010443	Bronze			2022-12-01	WOS:000220061900022
J	Pantell, RH; Newman, TB; Bernzweig, J; Bergman, DA; Takayama, JI; Segal, M; Finch, SA; Wasserman, RC				Pantell, RH; Newman, TB; Bernzweig, J; Bergman, DA; Takayama, JI; Segal, M; Finch, SA; Wasserman, RC			Management and outcomes of care of fever in early infancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERIOUS BACTERIAL-INFECTIONS; FEBRILE INFANTS; LOW-RISK; OUTPATIENT TREATMENT; PRACTICE GUIDELINES; AGE; CHILDREN; ILLNESS; YOUNGER; IDENTIFICATION	Context Fever in infants challenges clinicians in distinguishing between serious conditions, such as bacteremia or bacterial meningitis, and minor illnesses. To date, the practice patterns of office-based pediatricians in treating febrile infants and the clinical outcomes resulting from their care have not been systematically studied. Objectives To characterize the management and clinical outcomes of fever in infants, develop a clinical prediction model for the identification of bacteremia/bacterial meningitis, and compare the accuracy of various strategies. Design Prospective cohort study. Setting Offices of 573 practitioners from the Pediatric Research in Office Settings (PROS) network of the American Academy of Pediatrics in 44 states, the District of Columbia, and Puerto Rico. Patients Consecutive sample of 3066 infants aged 3 months or younger with temperatures of at least 38degreesC seen by PROS practitioners from February 28, 1995, through April 25, 1998. Main Outcome Measures Management strategies, illness frequency, and rates and accuracy of treating bacteremia/bacterial meningitis. Results The PROS clinicians hospitalized 36% of the infants, performed laboratory testing in 75%, and initially treated 57% with antibiotics. The majority (64%) were treated exclusively outside of the hospital. Bacteremia was detected in 1.8% of infants (2.4% of those tested) and bacterial meningitis in 0.5%. Well-appearing infants aged 25 days or older with fever of less than 38.6degreesC had a rate of 0.4% for bacteremia/bacterial meningitis. Frequency of other illnesses included urinary tract infection, 5.4%; otitis media, 12.2%; upper respiratory tract infection, 25.6%; bronchiolitis, 7.8%; and gastroenteritis, 7.2%. Practitioners followed current guidelines in 42% of episodes. However, in the initial visit, they treated 61 of the 63 cases of bacteremia/bacterial meningitis with antibiotics. Neither current guidelines nor the model developed in this study performed with greater accuracy than observed practitioner management. Conclusions Pediatric clinicians in the United States use individualized clinical judgment in treating febrile infants. In this study, relying on current clinical guidelines would not have improved care but would have resulted in more hospitalizations and laboratory testing.	Univ Calif San Francisco, Sch Med, Dept Pediat, Div Gen Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Stanford Med Ctr, Lucile Salter Packard Childrens Hosp, Stanford, CA USA; Amer Acad Pediat, Ctr Child Hlth Res, Dept Practice & Res, Pediat Res Off Settings, Elk Grove Village, IL USA; Vermont Coll Med, Dept Pediat, Burlington, VT USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Lucile Packard Children's Hospital (LPCH); Stanford University; American Academy of Pediatrics	Pantell, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, Div Gen Pediat, Box 0503, San Francisco, CA 94143 USA.	pantell@itsa.ucsf.edu	Wasserman, Richard/G-3775-2015		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006485] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS06485] Funding Source: Medline; PHS HHS [MCJ-177022] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANBAR RD, 1986, J PEDIATR-US, V109, P483, DOI 10.1016/S0022-3476(86)80122-6; Avner JR, 2002, EMERG MED CLIN N AM, V20, P49, DOI 10.1016/S0733-8627(03)00051-8; Bachur RG, 2001, PEDIATRICS, V108, P311, DOI 10.1542/peds.108.2.311; Baker MD, 1999, ARCH PEDIAT ADOL MED, V153, P508; BAKER MD, 1990, PEDIATRICS, V85, P1040; Baker MD, 1999, PEDIATRICS, V103, P627, DOI 10.1542/peds.103.3.627; BARAFF LJ, 1992, PEDIATR INFECT DIS J, V11, P257, DOI 10.1097/00006454-199204000-00001; BARAFF LJ, 1993, ANN EMERG MED, V22, P1198, DOI 10.1016/S0196-0644(05)80991-6; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; BASKIN MN, 1992, J PEDIATR-US, V120, P22, DOI 10.1016/S0022-3476(05)80591-8; BASKIN MN, 1993, PEDIATR ANN, V22, P462, DOI 10.3928/0090-4481-19930801-06; Bennett JE, 2000, ARCH PEDIAT ADOL MED, V154, P43; BRATTON L, 1977, J PEDIATR-US, V90, P703, DOI 10.1016/S0022-3476(77)81231-6; Breimann L, 1984, CLASSIFICATION REGRE; DAGAN R, 1988, J PEDIATR-US, V112, P355, DOI 10.1016/S0022-3476(88)80312-3; DAGAN R, 1985, J PEDIATR-US, V107, P855, DOI 10.1016/S0022-3476(85)80175-X; DEANGELIS C, 1983, AM J DIS CHILD, V137, P1146, DOI 10.1001/archpedi.1983.02140380006003; DEANGELIS C, 1983, AM J DIS CHILD, V137, P1150, DOI 10.1001/archpedi.1983.02140380010004; FEDER HM, 1980, CLIN PEDIATR, V19, P457, DOI 10.1177/000992288001900705; GOTOFF SP, 1970, J PEDIATR-US, V76, P142, DOI 10.1016/S0022-3476(70)80148-2; Herr SM, 2001, PEDIATRICS, V108, P866, DOI 10.1542/peds.108.4.866; JONES RG, 1993, PEDIATR INFECT DIS J, V12, P179, DOI 10.1097/00006454-199303000-00001; Kadish HA, 2000, CLIN PEDIATR, V39, P81, DOI 10.1177/000992280003900202; Kramer MS, 1997, PEDIATRICS, V100, P128, DOI 10.1542/peds.100.1.128; Kuppermann N, 2003, ARCH PEDIAT ADOL MED, V157, P508, DOI 10.1001/archpedi.157.6.508; MCCARTHY PL, 1981, PEDIATRICS, V67, P687; MCCARTHY PL, 1987, J PEDIATR-US, V110, P26, DOI 10.1016/S0022-3476(87)80282-2; Newman TB, 2002, ARCH PEDIAT ADOL MED, V156, P44, DOI 10.1001/archpedi.156.1.44; ROBERTS KB, 1977, JOHNS HOPKINS MED J, V141, P9; Segal M R, 1995, Stat Methods Med Res, V4, P219, DOI 10.1177/096228029500400304; YOUNG PC, 1995, PEDIATRICS, V95, P623	31	185	192	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2004	291	10					1203	1212		10.1001/jama.291.10.1203	http://dx.doi.org/10.1001/jama.291.10.1203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800XV	15010441	Bronze			2022-12-01	WOS:000220061900020
J	Gerber, DJ; Tonegawa, S				Gerber, DJ; Tonegawa, S			Psychotomimetic effects of drugs - A common pathway to schizophrenia?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE		MIT, Picower Ctr, Boston, MA USA	Massachusetts Institute of Technology (MIT)	Gerber, DJ (corresponding author), MIT, Picower Ctr, Boston, MA USA.							Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Ralph-Williams RJ, 2002, J NEUROSCI, V22, P9604; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681	4	8	8	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2004	350	10					1047	1048		10.1056/NEJMcibr033201	http://dx.doi.org/10.1056/NEJMcibr033201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780GH	14999118				2022-12-01	WOS:000189363600015
J	Votier, SC; Furness, RW; Bearhop, S; Crane, JE; Caldow, RWG; Catry, P; Ensor, K; Hamer, KC; Hudson, AV; Kalmbach, E; Klomp, NI; Pfeiffer, S; Phillips, RA; Prieto, I; Thompson, DR				Votier, SC; Furness, RW; Bearhop, S; Crane, JE; Caldow, RWG; Catry, P; Ensor, K; Hamer, KC; Hudson, AV; Kalmbach, E; Klomp, NI; Pfeiffer, S; Phillips, RA; Prieto, I; Thompson, DR			Changes in fisheries discard rates and seabird communities	NATURE			English	Article							SKUAS CATHARACTA-SKUA; GREAT SKUAS; NORTH-SEA; COMMERCIAL FISHERIES; FOOD AVAILABILITY; SHETLAND; PREDATION; KITTIWAKES; NUMBERS; ECOLOGY	It is clear that discards from commercial fisheries are a key food resource for many seabird species around the world(1-8). But predicting the response of seabird communities to changes in discard rates is problematic and requires historical data to elucidate the confounding effects of other, more 'natural' ecological processes. In the North Sea, declining stocks, changes in technical measures, changes in population structure(9) and the establishment of a recovery programme for cod (Gadus morhua(10)) will alter the amount of fish discarded. This region also supports internationally important populations of seabirds(11), some of which feed extensively, but facultatively, on discards, in particular on undersized haddock (Melanogrammus aeglefinus) and whiting (Merlangius merlangus)(1-3). Here we use long-term data sets from the northern North Sea to show that there is a direct link between discard availability and discard use by a generalist predator and scavenger-the great skua (Stercorarius skua). Reduced rates of discarding, particularly when coupled with reduced availability of small shoaling pelagic fish such as sandeel (Ammodytes marinus), result in an increase in predation by great skuas on other birds. This switching of prey by a facultative scavenger presents a potentially serious threat to some seabird communities.	Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Queens Univ Belfast, Sch Biol & Biochem, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland; Winfrith Newburgh, Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England; ISPA, Unidade Invest Ecoetol, Lisbon, Portugal; Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Groningen, Dept Anim Ecol, NL-9751 NN Haren, Netherlands; Charles Sturt Univ, Johnstone Ctr, Sch Environm & Informat Sci, Albury, NSW 2640, Australia; Univ Jena, Inst Ecol, D-07743 Jena, Germany; British Antarctic Survey, Cambridge CB3 0ET, England; Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	University of Glasgow; Queens University Belfast; UK Centre for Ecology & Hydrology (UKCEH); Instituto Superior Psicologia Aplicada (ISPA); University of Leeds; University of Groningen; Charles Sturt University; Friedrich Schiller University of Jena; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Votier, SC (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	s.votier@bio.gla.ac.uk; r.furness@bio.gla.ac.uk	Votier, Stephen C/G-2348-2014; Catry, Paulo/I-5408-2013; Bond, Alexander L/A-3786-2010; Bearhop, Stuart/G-3105-2012	Votier, Stephen C/0000-0002-0976-0167; Catry, Paulo/0000-0003-3000-0522; Bearhop, Stuart/0000-0002-5864-0129; Klomp, Nicholas/0000-0002-2367-0125				Alverson D.L., 1994, GLOBAL ASSESSMENT FI, V339; [Anonymous], 2002, 255 ICES; Arcos JM, 1996, COLON WATERBIRD, V19, P128, DOI 10.2307/1521817; Bearhop S, 2001, CONDOR, V103, P802, DOI 10.1650/0010-5422(2001)103[0802:AVIGSD]2.0.CO;2; Catry P, 1998, CONDOR, V100, P448, DOI 10.2307/1369710; CROXALL JP, 1991, BIRD POPULATION STUD, P272; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Furness RW, 2002, ICES J MAR SCI, V59, P261, DOI 10.1006/jmsc.2001.1155; FURNESS RW, 1981, J ZOOL, V195, P1, DOI 10.1111/j.1469-7998.1981.tb01890.x; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; H?rk?nen T., 1986, GUIDE OTOLITHS BONY, DOI 10.1017/S0025315400057131; HAMER KC, 1991, J ZOOL, V223, P175, DOI 10.1111/j.1469-7998.1991.tb04758.x; HARVEY P, 2001, SHETLAND BIRD REPORT, P99; Heubeck M, 1999, BIRD STUDY, V46, P48, DOI 10.1080/00063659909461114; HUDSON AV, 1989, IBIS, V131, P225, DOI 10.1111/j.1474-919X.1989.tb02765.x; Huppop O, 2000, MAR ECOL PROG SER, V194, P241, DOI 10.3354/meps194241; *ICES, 1998, ICES CM 1998 ASSESS, V7; *ICES, 2003, ICES ADV ZER CATCH C; KLOMP NI, 1992, J APPL ECOL, V29, P341, DOI 10.2307/2404503; Lloyd C, 1991, STATUS SEABIRDS BRIT; Oro D, 2002, ECOLOGY, V83, P2516; Oro D, 1996, MAR ECOL PROG SER, V132, P43, DOI 10.3354/meps132043; Phillips RA, 1999, J APPL ECOL, V36, P218, DOI 10.1046/j.1365-2664.1999.00391.x; Regehr HM, 1997, MAR ECOL PROG SER, V155, P249, DOI 10.3354/meps155249; Russell J, 1996, IBIS, V138, P791, DOI 10.1111/j.1474-919X.1996.tb08839.x; SNOW DW, 1998, BIRDS W PALEARCTIC C, V1; Stratoudakis Y, 1999, ICES J MAR SCI, V56, P592, DOI 10.1006/jmsc.1999.0500; THOMPSON KR, 1992, IBIS, V134, P11, DOI 10.1111/j.1474-919X.1992.tb07223.x; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z	29	194	210	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2004	427	6976					727	730		10.1038/nature02315	http://dx.doi.org/10.1038/nature02315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973483				2022-12-01	WOS:000189026000041
J	Hasegawa, K; Martin, F; Huang, GM; Tumas, D; Diehl, L; Chan, AC				Hasegawa, K; Martin, F; Huang, GM; Tumas, D; Diehl, L; Chan, AC			PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells	SCIENCE			English	Article							PROTEIN-KINASE P50(CSK); TRANSGENIC MICE; PTP-PEST; B-CELLS; RECEPTOR; MEMORY; THYMOCYTES; EXPRESSION; ANTIGEN; ASSOCIATION	Protein tyrosine kinases and phosphatases cooperate to regulate normal immune cell function. We examined the role of PEST domain - enriched tyrosine phosphatase ( PEP) in regulating T cell antigen - receptor function during thymocyte development and peripheral T cell differentiation. Although normal naive T cell functions were retained in pep-deficient mice, effector/memory T cells demonstrated enhanced activation of Lck. In turn, this resulted in increased expansion and function of the effector/memory T cell pool, which was also associated with spontaneous development of germinal centers and elevated serum antibody levels. These results revealed a central role for PEP in negatively regulating specific aspects of T cell development and function.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Chan, AC (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	acc@gene.com						Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; CHAN AC, 1994, J IMMUNOL, V152, P4758; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Mustelin T, 2003, IMMUNOL REV, V191, P139, DOI 10.1034/j.1600-065X.2003.00014.x; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ong ST, 1998, ONCOGENE, V16, P2333, DOI 10.1038/sj.onc.1201771; SHI YF, 1991, J IMMUNOL, V146, P3340	26	302	313	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					685	689		10.1126/science.1092138	http://dx.doi.org/10.1126/science.1092138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752163				2022-12-01	WOS:000188530800045
J	Lewis, BP; Shih, IH; Jones-Rhoades, MW; Bartel, DP; Burge, CB				Lewis, BP; Shih, IH; Jones-Rhoades, MW; Bartel, DP; Burge, CB			Prediction of mammalian microRNA targets	CELL			English	Article							C-ELEGANS; SMALL RNAS; IDENTIFICATION; COMPLEMENTARY; CONSERVATION; EXPRESSION; SEQUENCE; ENCODES; LIN-28; TIME	MicroRNAs (miRNAs) can play important gene regulatory roles in nematodes, insects, and plants by base-pairing to mRNAs to specify posttranscriptional repression of these messages. However, the mRNAs regulated by vertebrate miRNAs are all unknown. Here we predict more than 400 regulatory target genes for the conserved vertebrate miRNAs by identifying mRNAs with conserved pairing to the 5' region of the miRNA and evaluating the number and quality of these complementary sites. Rigorous tests using shuffled miRNA controls supported a majority of these predictions, with the fraction of false positives estimated at 31% for targets identified in human, mouse, and rat and 22% for targets identified in pufferfish as well as mammals. Eleven predicted targets (out of 15 tested) were supported experimentally using a HeLa cell reporter system. The predicted regulatory targets of mammalian miRNAs were enriched for genes involved in transcriptional regulation but also encompassed an unexpectedly broad range of other functions.	MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Bartel, DP (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu; cburge@mit.edu	Burge, Christopher B./AAH-2177-2020					Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Ashburner M, 2001, GENOME RES, V11, P1425; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BARTEL DP, 2004, IN PESS CELL; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dostie J, 2003, RNA, V9, P631; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; NUSSINOV R, 1981, J BIOL CHEM, V256, P8458; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	44	3992	4342	4	389	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					787	798		10.1016/S0092-8674(03)01018-3	http://dx.doi.org/10.1016/S0092-8674(03)01018-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697198	Bronze			2022-12-01	WOS:000187664700004
J	Walther, DJ; Peter, JU; Winter, S; Holtje, M; Paulmann, N; Grohmann, M; Vowinckel, J; Alamo-Bethencourt, V; Wilhelm, CS; Ahnert-Hilger, G; Bader, M				Walther, DJ; Peter, JU; Winter, S; Holtje, M; Paulmann, N; Grohmann, M; Vowinckel, J; Alamo-Bethencourt, V; Wilhelm, CS; Ahnert-Hilger, G; Bader, M			Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release	CELL			English	Article							VON-WILLEBRAND-FACTOR; SEROTONIN REUPTAKE INHIBITORS; TISSUE-TRANSGLUTAMINASE; INDUCED ACTIVATION; THROMBUS FORMATION; ENDOTHELIAL-CELLS; SH-SY5Y CELLS; RHO GTPASES; RAT; 5-HYDROXYTRYPTAMINE	Serotonin is a neurotransmitter in the central nervous system. In the periphery, serotonin functions as a ubiquitous hormone involved in vasoconstriction and platelet function. Serotonin is synthesized independently in peripheral tissues and neurons by two different rate-limiting tryptophan hydroxylase (TPH) isoenzymes. Here, we show that mice selectively deficient in peripheral TPH and serotonin exhibit impaired hemostasis, resulting in a reduced risk of thrombosis and thromboembolism, although the ultrastructure of the platelets is not affected. While the aggregation of serotonin-deficient platelets in vitro is apparently normal, their adhesion in vivo is reduced due to a blunted secretion of adhesive alpha-granular proteins. In elucidating the mechanism further, we demonstrate that serotonin is transamidated to small GTPases by transglutaminases during activation and aggregation of platelets, rendering these GTPases constitutively active. Our data provides evidence for a receptor-independent signaling mechanism, termed herein as "serotonylation," which leads to alpha-granule exocytosis from platelets.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Humbolt Univ Berlin, Inst Anat, Charite, D-10117 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Walther, DJ (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.		Bader, Michael/K-2124-2013	Holtje, Markus/0000-0003-3193-4140; Bader, Michael/0000-0003-4780-4164				Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; BARRADAS MA, 1983, BRIT J CLIN PHARMACO, V16, P459, DOI 10.1111/j.1365-2125.1983.tb02198.x; Bodie SL, 2001, BIOCHEM BIOPH RES CO, V287, P71, DOI 10.1006/bbrc.2001.5547; BUCZKO W, 1975, BRIT J PHARMACOL, V53, P563, DOI 10.1111/j.1476-5381.1975.tb07395.x; Case A, 2003, BIOCHEMISTRY-US, V42, P9466, DOI 10.1021/bi030084z; Citron BA, 2000, NEUROCHEM INT, V37, P337, DOI 10.1016/S0197-0186(00)00044-9; COHEN RA, 1983, SCIENCE, V221, P273, DOI 10.1126/science.6574604; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; DECLERCK F, 1984, AGENTS ACTIONS, V15, P627; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Eddahibi S, 2002, J LAB CLIN MED, V139, P194, DOI 10.1067/mlc.2002.122181; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI200112805; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; HOLLAND JM, 1976, P SOC EXP BIOL MED, V151, P32; Holtje M, 2003, J BIOL CHEM, V278, P15850, DOI 10.1074/jbc.M212816200; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Katayama T, 2000, CIRC RES, V86, P1031, DOI 10.1161/01.RES.86.10.1031; KILLAM AL, 1991, THROMB RES, V64, P331, DOI 10.1016/0049-3848(91)90004-G; Lee SK, 2000, J HISTOCHEM CYTOCHEM, V48, P1565, DOI 10.1177/002215540004801113; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; Maayani S, 2001, PLATELETS, V12, P279, DOI 10.1080/09537100120071004; Maayani S, 2001, PLATELETS, V12, P359; Maggio N, 2001, BRAIN RES BULL, V56, P173, DOI 10.1016/S0361-9230(01)00649-9; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; MOHAMMAD SF, 1975, AM J PATHOL, V79, P81; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Nishioka H, 2001, BIOCHEM BIOPH RES CO, V280, P970, DOI 10.1006/bbrc.2001.4237; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; PALMER DS, 1994, THROMB HAEMOSTASIS, V72, P132; PUSZKIN EG, 1985, J BIOL CHEM, V260, P6012; RAPPORT MM, 1948, SCIENCE, V108, P329, DOI 10.1126/science.108.2804.329; Schluter T, 1999, BIOCHEM PHARMACOL, V57, P1191, DOI 10.1016/S0006-2952(99)00011-8; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schmidt G, 1999, J BIOL CHEM, V274, P31875, DOI 10.1074/jbc.274.45.31875; Schoenwaelder SM, 2002, J BIOL CHEM, V277, P14738, DOI 10.1074/jbc.M200661200; Serafeim A, 2002, BLOOD, V99, P2545, DOI 10.1182/blood.V99.7.2545; Serebruany VL, 2001, PHARMACOL RES, V43, P453, DOI 10.1006/phrs.2001.0817; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; SIESS W, 1989, PHYSIOL REV, V69, P59; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Szasz R, 2002, BLOOD, V100, P2827, DOI 10.1182/blood-2002-02-0354; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Walther DJ, 1999, MOL BRAIN RES, V68, P55, DOI 10.1016/S0169-328X(99)00046-7; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197	51	347	356	3	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					851	862		10.1016/S0092-8674(03)01014-6	http://dx.doi.org/10.1016/S0092-8674(03)01014-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697203	Bronze			2022-12-01	WOS:000187664700009
J	Palmer, LE; Rabinowicz, PD; O'Shaughnessy, AL; Balija, VS; Nascimento, LU; Dike, S; de la Bastide, M; Martienssen, RA; McCombie, WR				Palmer, LE; Rabinowicz, PD; O'Shaughnessy, AL; Balija, VS; Nascimento, LU; Dike, S; de la Bastide, M; Martienssen, RA; McCombie, WR			Maize genome sequencing by methylation filtrations	SCIENCE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; DRAFT SEQUENCE; GENE; RETROTRANSPOSONS; REGIONS; PLANTS	Gene enrichment strategies offer an alternative to sequencing large and repetitive genomes such as that of maize. We report the generation and analysis of nearly 100,000 undermethylated (or methylation filtration) maize sequences. Comparison with the rice genome reveals that methylation filtration results in a more comprehensive representation of maize genes than those that result from expressed sequence tags or transposon insertion sites sequences. About 7% of the repetitive DNA is unmethylated and thus selected in our libraries, but potentially active transposons and unmethylated organelle genomes can be identified. Reverse transcription polymerase chain reaction can be used to finish the maize transcriptome.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org; mccombie@cshl.edu		McCombie, W. Richard/0000-0003-1899-0682	NCI NIH HHS [2 T32-CA09311-25] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009311] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ANTEQUERA F, 1988, EMBO J, V7, P2295, DOI 10.1002/j.1460-2075.1988.tb03072.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; CRESSE AD, 1995, GENETICS, V140, P315; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; FLAVELL RB, 1994, P NATL ACAD SCI USA, V91, P3490, DOI 10.1073/pnas.91.9.3490; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Lunde China F., 2003, Functional & Integrative Genomics, V3, P25; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; MAY BP, IN PRESS P NATL ACAD; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morishige DT, 2002, PLANT PHYSIOL, V130, P1614, DOI 10.1104/pp.012567; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rabinowicz PD, 2003, CURR OPIN PLANT BIOL, V6, P150, DOI 10.1016/S1369-5266(03)00008-6; Raizada MN, 2001, PLANT CELL, V13, P1587, DOI 10.1105/tpc.13.7.1587; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; *RIC CHROM 10 SEQ, 2003, SCIENCE NEW YORK NY, V0300; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; WALBOT V, 1990, PLANT MOL BIOL, V15, P121, DOI 10.1007/BF00017729; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan YN, 2003, PLANT J, V34, P249, DOI 10.1046/j.1365-313X.2003.01716.x	33	173	192	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2115	2117		10.1126/science.1091265	http://dx.doi.org/10.1126/science.1091265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684820				2022-12-01	WOS:000187385200042
J	Ziebland, S; Chapple, A; Dumelow, C; Evans, D; Prinjha, S; Rozmovits, L				Ziebland, S; Chapple, A; Dumelow, C; Evans, D; Prinjha, S; Rozmovits, L			How the internet affects patients' experience of cancer: a qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH INFORMATION; SEEKING; NEEDS; CARE	Objective To explore how men and women with cancer talk about using the internet. Design Qualitative study using semistructured interviews collected by maximum variation sampling. Setting Respondents recruited throughout the United Kingdom during 2001-2. Participants 175 men and women aged 19-83 years, with one of five cancers (prostate, testicular, breast, cervical, or bowel) diagnosed since 1992 and selected to include different stages of treatment and follow up. Results Internet use, either directly or via friend or family, was widespread and reported by patients at all stages of cancer care, from early investigations to follow up after treatment. Patients used the internet to find second opinions, seek support and experiential information from other patients, interpret symptoms, seek information about tests and treatments, help interpret consultations, identify questions for doctors, make anonymous private inquiries, and raise awareness of the cancer. Patients also used it to check their doctors' advice covertly and to develop an expertise in their cancer. This expertise, reflecting familiarity with computer technology and medical terms, enabled patients to present a new type of "social fitness." Conclusion Cancer patients used the internet for a wide range of information and support needs, many of which are unlikely to be met through conventional health care. Serious illness often undermines people's self image as a competent member of society. Cancer patients may use the internet to acquire expertise to display competence in the face of serious illness.	Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, DIPEx Res Grp, Oxford OX3 7LF, England	University of Oxford	Ziebland, S (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, DIPEx Res Grp, Oxford OX3 7LF, England.	Sue.ziebland@dphpc.ox.ac.uk		Ziebland, Sue/0000-0002-6496-4859; Prinjha, Suman/0000-0001-8299-6646				Cline RJW, 2001, HEALTH EDUC RES, V16, P671, DOI 10.1093/her/16.6.671; Coiera E, 1996, BMJ-BRIT MED J, V312, P3, DOI 10.1136/bmj.312.7022.3; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; EATON L, 2002, BMJ-BRIT MED J, V325, P989; Eng TR, 1998, JAMA-J AM MED ASSOC, V280, P1371, DOI 10.1001/jama.280.15.1371; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Goffman E, 1955, PSYCHIATR, V18, P213, DOI 10.1080/00332747.1955.11023008; GRAY JAM, 2002, RESOURCEFUL PATIENT; GROL R, 2001, EVIDENCE BASED PATIE; Hardey M, 1999, SOCIOL HEALTH ILL, V21, P820, DOI 10.1111/1467-9566.00185; Herxheimer A, 2000, LANCET, V355, P1540, DOI 10.1016/S0140-6736(00)02174-7; Jadad AR, 2003, BRIT MED J, V326, P1293, DOI 10.1136/bmj.326.7402.1293; Jenkins V, 2001, BRIT J CANCER, V84, P48, DOI 10.1054/bjoc.2000.1573; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Mead Nicola, 2003, J Health Serv Res Policy, V8, P33, DOI 10.1258/13558190360468209; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Radley A, 1996, SOCIOL HEALTH ILL, V18, P220, DOI 10.1111/1467-9566.ep10934984; Reeves PM, 2001, HEALTH EDUC RES, V16, P709, DOI 10.1093/her/16.6.709; ROZMOVITS L, IN PRESS PATIENT ED; Sharma U., 1999, NEW MED PLURALISM AL; Stevenson FA, 2003, SOC SCI MED, V57, P513, DOI 10.1016/S0277-9536(02)00377-5; Strauss A., 1998, BASICS QUALITATIVE R	24	296	299	4	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2004	328	7439					564	+		10.1136/bmj.328.7439.564	http://dx.doi.org/10.1136/bmj.328.7439.564			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801JI	15001506	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000220091800025
J	Ngai, J				Ngai, J			Science imitates art: The cloning of mice from olfactory sensory neurons	CELL			English	Editorial Material							EXPRESSION; MOUSE	The functional identity of an olfactory sensory neuron is defined by its expression of one odorant receptor from a large multigene family. The complexity of this process has led to speculation that DNA rearrangements are used to limit the expression of one receptor gene per cell. However, a recent report in Nature directly rules out irreversible DNA rearrangements as a mechanism for odorant receptor gene choice.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ngai, J (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.							Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chun J, 1999, CURR BIOL, V9, pR251, DOI 10.1016/S0960-9822(99)80156-0; EGGAN K, 2004, IN PRESS NATURE; Kratz E, 2002, TRENDS GENET, V18, P29, DOI 10.1016/S0168-9525(01)02579-3; Qasba P, 1998, J NEUROSCI, V18, P227; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398	10	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 5	2004	116	5					636	637		10.1016/S0092-8674(04)00212-0	http://dx.doi.org/10.1016/S0092-8674(04)00212-0			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006346	Bronze			2022-12-01	WOS:000221499700004
J	Juul, K; Tybjaerg-Hansen, A; Schnohr, P; Nordestgaard, BG				Juul, K; Tybjaerg-Hansen, A; Schnohr, P; Nordestgaard, BG			Factor V Leiden and the risk for venous thromboembolism in the adult Danish population	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; PULMONARY-EMBOLISM; G20210A MUTATION; PREVALENCE; GENE; PROTHROMBIN; RESISTANCE; ASSOCIATION; CARRIERS	Background: Odds ratios for venous thromboembolism (deep venous thrombosis and pulmonary embolism) derived from case-control studies range from 3 to 16 for heterozygotes compared with noncarriers and up to 79 for homozygotes compared with noncarriers. Objective: To estimate risks for venous thromboembolism in the adult Danish population according to factor V Leiden genotype. Design: Cohort study with 23 years of follow-up. Setting: Adult Danish population. Participants: 9253 randomly selected individuals. Measurements: Hospitalization and death from venous thromboembolism, factor V Leiden genotype, and additional thromboembolic risk factors. Results: Adjusted hazard ratios in heterozygotes; and homozygotes compared with noncarriers were 2.7 (95% CI, 1.8 to 3.8) and 18 (CI, 4.1 to 41) for venous thromboembolism overall, 2.4 (CI, 1.3 to 3.8) and 22 (CI, 0 to 60) for deep venous thrombosis, and 3.0 (CI, 1.7 to 4.9) and 11 (CI, 0 to 33) for pulmonary embolism. The lowest absolute 10-year risks for venous thromboembolism in factor V Leiden heterozygotes; and homozygotes-0.7% (CI, 0.5% to 1.0%) and 3% (CI, 1% to 8%)-were found in nonsmokers younger than 40 years of age with a body mass index below 25 kg/m(2); the corresponding highest risks-10% (Cl, 7% to 14%) and 51% (CI, 13% to 100%)-were found in smokers older than 60 years of age with a body mass index above 30 kg/m(2). Conclusions: Hazard ratios for venous thromboembolism in factor V Leiden heterozygotes and homozygotes compared with noncarriers in the adult Danish population were approximately 3 and 18, respectively. The simultaneous presence of smoking, obesity, and old age resulted in absolute 10-year thromboembolic risks of 10% in heterozygotes and 51% in homozygotes.	Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Nordestgaard, BG (corresponding author), Herlev Univ Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@herlevhosp.kbhamt.dk	Nordestgaard, Borge Gronne/ABF-1310-2020					Appleyard M., 1989, SCAND J SOC MED, V41, P1; Aznar J, 2000, HAEMATOLOGICA, V85, P1271; Bounameaux H, 2000, LANCET, V356, P182, DOI 10.1016/S0140-6736(00)02476-4; Cattaneo M, 1999, THROMB RES, V93, P1, DOI 10.1016/S0049-3848(98)00136-4; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; Chamouard P, 1999, GASTROENTEROLOGY, V116, P144, DOI 10.1016/S0016-5085(99)70238-6; de Moerloose P, 2000, BRIT J HAEMATOL, V110, P125, DOI 10.1046/j.1365-2141.2000.02039.x; Desmarais S, 1996, LANCET, V347, P1374, DOI 10.1016/S0140-6736(96)91013-2; Franco RF, 2001, HUM GENET, V109, P369, DOI 10.1007/s004390100593; Gaustadnes M, 1999, BLOOD COAGUL FIBRIN, V10, P251, DOI 10.1097/00001721-199907000-00006; Hille ETM, 1997, BLOOD, V89, P1963, DOI 10.1182/blood.V89.6.1963; JENSEN G, 1984, ACTA MED SCAND, P11; Juul K, 2002, BLOOD, V100, P3, DOI 10.1182/blood-2002-01-0111; Larsen TB, 1998, THROMB RES, V89, P211, DOI 10.1016/S0049-3848(98)00010-3; Leroyer C, 1997, CHEST, V111, P1603, DOI 10.1378/chest.111.6.1603; Manten B, 1996, THROMB HAEMOSTASIS, V76, P510; Margaglione M, 1998, ANN INTERN MED, V129, P89, DOI 10.7326/0003-4819-129-2-199807150-00003; Marinelli I, 1997, THROMB HAEMOSTASIS, V77, P440; Meyer G, 2001, AM J MED, V110, P12, DOI 10.1016/S0002-9343(00)00653-7; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Salomon O, 1999, ARTERIOSCL THROM VAS, V19, P511, DOI 10.1161/01.ATV.19.3.511; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Turkstra F, 1999, THROMB HAEMOSTASIS, V81, P345	27	139	141	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2004	140	5					330	337		10.7326/0003-4819-140-5-200403020-00008	http://dx.doi.org/10.7326/0003-4819-140-5-200403020-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	778NC	14996674				2022-12-01	WOS:000189246800002
J	Klaholz, BP; Myasnikov, AG; van Heel, M				Klaholz, BP; Myasnikov, AG; van Heel, M			Visualization of release factor 3 on the ribosome during termination of protein synthesis	NATURE			English	Article							ELONGATION-FACTOR-G; AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; FACTOR-TU; ANGSTROM RESOLUTION; CODON-RECOGNITION; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; 70S RIBOSOME; FACTOR RF3	Termination of protein synthesis by the ribosome requires two release factor (RF) classes. The class II RF3 is a GTPase that removes class I RFs (RF1 or RF2) from the ribosome after release of the nascent polypeptide(1-3). RF3 in the GDP state binds to the ribosomal class I RF complex, followed by an exchange of GDP for GTP and release of the class I RF. As GTP hydrolysis triggers release of RF3 (ref. 4), we trapped RF3 on Escherichia coli ribosomes using a nonhydrolysable GTP analogue. Here we show by cryo-electron microscopy that the complex can adopt two different conformational states. In 'state 1', RF3 is pre-bound to the ribosome, whereas in 'state 2' RF3 contacts the ribosome GTPase centre. The transfer RNA molecule translocates from the peptidyl site in state 1 to the exit site in state 2. This translocation is associated with a large conformational rearrangement of the ribosome. Because state 1 seems able to accommodate simultaneously both RF3 and RF2, whose position is known from previous studies(5,6), we can infer the release mechanism of class I RFs.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Univ Strasbourg 1, CNRS, INSERM,Dept Struct Biol & Gen, Inst Genet & Mol & Cellular Biol, F-67404 Illkirch Graffenstaden, France; Moscow MV Lomonosov State Univ, Dept Mol Biol, Belozersky Inst, Moscow 119899, Russia	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lomonosov Moscow State University	Klaholz, BP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.	klaholz@igbmc.u-strasbg.fr	Myasnikov, Alexander/T-4654-2018					Aevarsson A, 1995, J MOL EVOL, V41, P1096; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Grentzmann G, 1998, RNA, V4, P973, DOI 10.1017/S1355838298971576; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; ROSENTHAL PB, 2003, J MOL BIOL, V31, P721; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wilson DN, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P495; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	28	105	109	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2004	427	6977					862	865		10.1038/nature02332	http://dx.doi.org/10.1038/nature02332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985767				2022-12-01	WOS:000189207500045
J	Minelli, C; Abrams, KR; Sutton, AJ; Cooper, NJ				Minelli, C; Abrams, KR; Sutton, AJ; Cooper, NJ			Benefits and harms associated with hormone replacement therapy: clinical decision analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; ESTROGEN PLUS PROGESTIN; CORONARY-ARTERY DISEASE; UP HERS-II; POSTMENOPAUSAL WOMEN; ESTROGEN/PROGESTIN REPLACEMENT; BREAST-CANCER; COST-EFFECTIVENESS; ATRIAL-FIBRILLATION; RANDOMIZED TRIALS	Objective To evaluate harms and benefits associated with use of combined hormone replacement therapy (HRT) for five years in women with different baseline risks for breast cancer. Design Probabilistic clinical decision analysis. Setting Hypothetical population of white UK women aged 50 years with different baseline risks for breast cancer. Main outcome measure Gain or loss in quality adjusted life years (QALYs). Results Women free of menopausal symptoms showed a net harm from HRT use, which increased for increasing baseline risk of breast cancer. Those with a baseline risk of 1.2% would expect a loss in QALYs of 0.4 months (-0.03 QALYs, 95% credibility interval -0.05 to -0.01). The main analysis showed HRT to be on average beneficial in women with symptoms, with benefit decreasing with increasing baseline risk of breast cancer. The results were sensitive to the assumed value of quality of life with menopausal symptoms, therefore a contour plot was developed to show the probability of net harm for a range of different values and baseline risks. Conclusions HRT for primary prevention of chronic diseases in women without menopausal symptoms is unjustified. Perceived quality of life in women with symptoms should be taken into account when deciding on HRT. Thus, a decision analysis tailored to an individual woman is more appropriate in clinical practice than a population based approach.	Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 6TP, Leics, England	University of Leicester	Abrams, KR (corresponding author), Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 6TP, Leics, England.	keith.abrams@le.ac.uk	Abrams, Keith/AAA-2557-2020	Abrams, Keith/0000-0002-7557-1567; Sutton, Alexander/0000-0002-8934-9940				Armstrong K, 2001, OBSTET GYNECOL, V98, P996, DOI 10.1016/S0029-7844(01)01624-6; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Col NF, 1999, ARCH INTERN MED, V159, P1458, DOI 10.1001/archinte.159.13.1458; Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140; Daly E, 1996, MATURITAS, V23, P247, DOI 10.1016/0378-5122(95)00978-7; DALY E, 1993, BRIT MED J, V307, P836, DOI 10.1136/bmj.307.6908.836; EASTON DF, 1995, AM J HUM GENET, V56, P265; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gallus S, 2002, INT J CANCER, V99, P762, DOI 10.1002/ijc.10411; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Gold MR., 1996, COST EFFECTIVENESS H; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Hill DA, 2000, AM J OBSTET GYNECOL, V183, P1456, DOI 10.1067/mob.2000.108081; HILLNER BE, 1986, AM J MED, V80, P1115, DOI 10.1016/0002-9343(86)90674-1; Hlatky MA, 2002, JAMA-J AM MED ASSOC, V287, P591, DOI 10.1001/jama.287.5.591; Hogervorst E, 2000, NEUROSCIENCE, V101, P485, DOI 10.1016/S0306-4522(00)00410-3; HOGERVORST E, 2004, COCHRANE LIB; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; LETHABY A, 2004, COCHRANE LIB; MacLennan A, 2004, COCHRANE LIB; *MED HEALTHC PROD, REG AG US HORM REPL; *MED HEALTHC PROD, US HORM REPL THER PR; Melsop KA, 2003, AM HEART J, V145, P36, DOI 10.1067/mhj.2003.37; Miller J, 2002, ANN INTERN MED, V136, P680, DOI 10.7326/0003-4819-136-9-200205070-00011; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Neymark N, 1998, EUR J CANCER, V34, P1317, DOI 10.1016/S0959-8049(98)00074-4; *OFF NAT STAT, 2001, SOC TRENDS, V31, pCH7; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rymer J, 2003, BRIT MED J, V326, P322, DOI 10.1136/bmj.326.7384.322; Simon JA, 2001, ANN INTERN MED, V135, P493, DOI 10.7326/0003-4819-135-7-200110020-00008; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES, DOI [10.1002/0470092602, DOI 10.1002/0470092602]; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Sturdee DW, 2000, BRIT J OBSTET GYNAEC, V107, P1392, DOI 10.1111/j.1471-0528.2000.tb11654.x; SUTTON AJ, 2004, 0401 U LEIC DEP HLTH; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Thomson R, 2000, LANCET, V355, P956, DOI 10.1016/S0140-6736(00)90012-6; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Uhler ML, 2000, MENOPAUSE, V7, P162, DOI 10.1097/00042192-200007030-00006; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Weinstein M C, 1983, Obstet Gynecol Surv, V38, P445, DOI 10.1097/00006254-198308000-00001; WEINSTEIN MC, 1980, NEW ENGL J MED, V303, P308, DOI 10.1056/NEJM198008073030604; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; White C, 2002, BRIT MED J, V325, P987, DOI 10.1136/bmj.325.7371.987; WILKES HC, 1991, BRIT MED J, V302, P1317, DOI 10.1136/bmj.302.6788.1317; Zethraeus N, 1997, BRIT J OBSTET GYNAEC, V104, P1191, DOI 10.1111/j.1471-0528.1997.tb10945.x; Zethraeus N, 1999, INT J TECHNOL ASSESS, V15, P352, DOI 10.1017/S0266462399015275	55	36	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2004	328	7436					371	375		10.1136/bmj.328.7436.371	http://dx.doi.org/10.1136/bmj.328.7436.371			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775GA	14962874	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000189031300017
J	Pack, A; Shelley, JMG; Palme, H				Pack, A; Shelley, JMG; Palme, H			Chondrules with peculiar REE patterns: Implications for solar nebular condensation at high C/O	SCIENCE			English	Article							ALUMINUM-RICH INCLUSIONS; UNEQUILIBRATED ENSTATITE CHONDRITES; RARE-EARTH ELEMENTS; FRACTIONATION; CHEMISTRY; MINERALOGY; ORIGIN	Rare earth element (REE) data from two ordinary chondrite chondrules show distinct negative chondrite-normalized concentration anomalies of samarium, europium, and ytterbium. The peculiar patterns may be the result of REE gas/solid fractionation at an oxygen fugacity lower than has been assumed for the canonical solar nebula. We suggest that the two ordinary chondrite chondrules acquired the fractionated REE patterns by incorporation of highly reduced, ultrarefractory condensates in their precursors. This interpretation implies that high-temperature condensation processes occurred in nebular environments with a strong deficit in oxygen, such as regions with an enhanced carbon/oxygen ratio.	Univ Cologne, Inst Mineral & Geochem, D-50674 Cologne, Germany; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France	University of Cologne; Australian National University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Pack, A (corresponding author), Univ Cologne, Inst Mineral & Geochem, Zulpicher Str 49B, D-50674 Cologne, Germany.	apack@crpg.cnrs-nancy.fr		Pack, Andreas/0000-0002-2618-2768				ALEXANDER CMO, 1994, GEOCHIM COSMOCHIM AC, V58, P3451, DOI 10.1016/0016-7037(94)90098-1; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; [Anonymous], 1983, RARE EARTH ELEMENT G; Boynton W. V., 1980, LUNAR PLANET SCI, V11, P103; BOYNTON WV, 1975, GEOCHIM COSMOCHIM AC, V39, P569, DOI 10.1016/0016-7037(75)90003-4; CROZAZ G, 1995, GEOCHIM COSMOCHIM AC, V59, P3817, DOI 10.1016/0016-7037(95)00268-5; DAVIS AM, 1979, GEOCHIM COSMOCHIM AC, V43, P1611, DOI 10.1016/0016-7037(79)90181-9; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; El Goresy A, 2002, GEOCHIM COSMOCHIM AC, V66, P1459, DOI 10.1016/S0016-7037(01)00854-7; Fagan TJ, 2000, METEORIT PLANET SCI, V35, P771, DOI 10.1111/j.1945-5100.2000.tb01461.x; Grossman JN, 2002, METEORIT PLANET SCI, V37, P49, DOI 10.1111/j.1945-5100.2002.tb00795.x; GROSSMAN L, 1972, GEOCHIM COSMOCHIM AC, V36, P597, DOI 10.1016/0016-7037(72)90078-6; GROSSMAN L, 1988, NATURE, V334, P14; Guan YB, 2000, SCIENCE, V289, P1330, DOI 10.1126/science.289.5483.1330; Hsu WB, 1998, GEOCHIM COSMOCHIM AC, V62, P1993, DOI 10.1016/S0016-7037(98)00124-0; Jones R. H., 2000, Protostars and planets 4, P927; Krot A. N., 2000, Protostars and planets 4, P1019; KURAT G, 1984, EARTH PLANET SC LETT, V68, P43, DOI 10.1016/0012-821X(84)90139-0; LARIMER JW, 1979, GEOCHIM COSMOCHIM AC, V43, P1455, DOI 10.1016/0016-7037(79)90140-6; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; LODDERS K, 1993, EARTH PLANET SC LETT, V117, P125, DOI 10.1016/0012-821X(93)90122-P; Mason B., 1977, SMITHSONIAN CONTRIB, V19, P84; MCPHERSON GJ, 1988, METEORITES EARLY SOL, P746; MISAWA K, 1988, GEOCHIM COSMOCHIM AC, V52, P1699, DOI 10.1016/0016-7037(88)90238-4; MISAWA K, 1988, NATURE, V334, P47, DOI 10.1038/334047a0; Nakamura N., 1993, PRIMITIVE SOLAR NEBU, P409; Nakano H, 2003, ASTROPHYS J, V592, P1252, DOI 10.1086/375856; PACK A, IN PRESS GEOCHIM COS; PALME H, 1982, EARTH PLANET SC LETT, V61, P1, DOI 10.1016/0012-821X(82)90032-2; Simon SB, 2002, METEORIT PLANET SCI, V37, P533, DOI 10.1111/j.1945-5100.2002.tb00837.x; Varela ME, 2002, GEOCHIM COSMOCHIM AC, V66, P1663, DOI 10.1016/S0016-7037(01)00871-7	31	36	36	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2004	303	5660					997	1000		10.1126/science.1092906	http://dx.doi.org/10.1126/science.1092906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963326				2022-12-01	WOS:000188918000041
J	Buchbinder, R; Jolley, D				Buchbinder, R; Jolley, D			Population based intervention to change back pain beliefs: three year follow up population survey	BRITISH MEDICAL JOURNAL			English	Article									Cabrini Hosp, Dept Clin Epidemiol, Malvern, Vic 3144, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Malvern, Vic 3144, Australia; Deakin Univ, Sch Hlth Sci, Burwood, Vic 3125, Australia	Cabrini Health; Monash University; Deakin University	Buchbinder, R (corresponding author), Cabrini Hosp, Dept Clin Epidemiol, Suite 41,Cabrini Med Ctr,183 Wattletree Rd, Malvern, Vic 3144, Australia.	rachelle.buchbinder@med.monash.edu.au	Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933				Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Buchbinder R, 2003, PREVENTING MANAGING; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Symonds TL, 1995, SPINE, V20, P2738, DOI 10.1097/00007632-199512150-00016	5	85	88	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 7	2004	328	7435					321	321		10.1136/bmj.328.7435.321	http://dx.doi.org/10.1136/bmj.328.7435.321			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773ME	14764492	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000188926900019
J	Pace, ML; Cole, JJ; Carpenter, SR; Kitchell, JF; Hodgson, JR; Van de Bogert, MC; Bade, DL; Kritzberg, ES; Bastviken, D				Pace, ML; Cole, JJ; Carpenter, SR; Kitchell, JF; Hodgson, JR; Van de Bogert, MC; Bade, DL; Kritzberg, ES; Bastviken, D			Whole-lake carbon-13 additions reveal terrestrial support of aquatic food webs	NATURE			English	Article							ORGANIC-MATTER; GROWTH-RATE; CARBON; FRACTIONATION; ZOOPLANKTON; ENERGY; TRACE; FLOW	Ecosystems are supported by organic carbon from two distinct sources. Endogenous carbon is produced by photosynthesis within an ecosystem by autotrophic organisms. Exogenous carbon is produced elsewhere and transported into ecosystems. Consumers may use exogenous carbon with consequent influences on population dynamics, predator-prey relationships and ecosystem processes(1). For example, exogenous inputs provide resources that may enhance consumer abundance beyond levels supported by within-system primary production(2). Exogenous fluxes of organic carbon to ecosystems are often large, but this material is recalcitrant and difficult to assimilate, in contrast to endogenously produced organic matter, which is used more easily(3,4). Here we show, by the experimental manipulation of dissolved inorganic C-13 in two lakes, that internal primary production is insufficient to support the food webs of these ecosystems. Additions of NaH (CO3)-C-13 enriched the C-13 content of dissolved inorganic carbon, particulate organic carbon, zooplankton and fish. Dynamics of C-13 indicate that 40-55% of particulate organic carbon and 22-50% of zooplankton carbon are derived from terrestrial sources, showing that there is significant subsidy of these ecosystems by organic carbon produced outside their boundaries.	Inst Ecosyst Studies, Box AB, Millbrook, NY 12545 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; St Norbert Coll, Dept Biol, De Pere, WI 54115 USA; Lund Univ, Dept Ecol Limnol, S-22362 Lund, Sweden; Linkoping Univ, Dept Water & Environm Studies, SE-58183 Linkoping, Sweden	Cary Institute of Ecosystem Studies; University of Wisconsin System; University of Wisconsin Madison; Lund University; Linkoping University	Pace, ML (corresponding author), Inst Ecosyst Studies, Box AB, Millbrook, NY 12545 USA.	pacem@ecostudies.org	Cole, Jonathan Jay/G-4566-2011; Carpenter, Stephen/AAQ-6404-2020; Van de Bogert, Matthew/J-2616-2012	Cole, Jonathan Jay/0000-0003-4633-7402; Bastviken, David/0000-0003-0038-2152; Pace, Michael/0000-0001-5945-6131				[Anonymous], [No title captured]; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Bidigare RR, 1997, GLOBAL BIOGEOCHEM CY, V11, P279, DOI 10.1029/96GB03939; BIRGE EA, 1927, P AM PHILOS SOC, V66, P357; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Cole JJ, 1998, ECOSYSTEMS, V1, P310, DOI 10.1007/s100219900024; COLE JJ, 1990, LIMNOL OCEANOGR, V35, P1230, DOI 10.4319/lo.1990.35.6.1230; Cole JJ, 2002, LIMNOL OCEANOGR, V47, P1664, DOI 10.4319/lo.2002.47.6.1664; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; HESSEN DO, 1998, AQUATIC HUMIC SUBSTA, P285; Hilborn Ray, 1997, V28; Jones RI, 1999, OIKOS, V86, P97, DOI 10.2307/3546573; KALFF J, 2002, LIMNOLOGY INLAND WAT, P366; Kerner M, 2003, NATURE, V422, P150, DOI 10.1038/nature01469; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; PETERSON BJ, 1985, SCIENCE, V227, P1361, DOI 10.1126/science.227.4692.1361; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 1997, LIMNOL OCEANOGR, V42, P722, DOI 10.4319/lo.1997.42.4.0722; Roditi HA, 2000, NATURE, V407, P78, DOI 10.1038/35024069; Tranvik L.J., 1998, AQUATIC HUMIC SUBSTA, P259, DOI [DOI 10.1007/978-3-662-03736-2_11, 10.1007/978-3-662-03736-2_11]; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; WETZEL RG, 1995, FRESHWATER BIOL, V33, P83, DOI 10.1111/j.1365-2427.1995.tb00388.x	28	436	451	3	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					240	243		10.1038/nature02227	http://dx.doi.org/10.1038/nature02227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724637				2022-12-01	WOS:000188068100042
J	Klein, RF; Allard, J; Avnur, Z; Nikolcheva, T; Rotstein, D; Carlos, AS; Shea, M; Waters, RV; Belknap, JK; Peltz, G; Orwoll, ES				Klein, RF; Allard, J; Avnur, Z; Nikolcheva, T; Rotstein, D; Carlos, AS; Shea, M; Waters, RV; Belknap, JK; Peltz, G; Orwoll, ES			Regulation of bone mass in mice by the lipoxygenase gene Alox15	SCIENCE			English	Article							ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; MINERAL DENSITY; OXIDIZED LDL; 15-LIPOXYGENASE; EXPRESSION; DIFFERENTIATION; 5-LIPOXYGENASE; OSTEOPOROSIS; MACROPHAGES	The development of osteoporosis involves the interaction of multiple environmental and genetic factors. Through combined genetic and genomic approaches, we identified the lipoxygenase gene Alox15 as a negative regulator of peak bone mineral density in mice. Crossbreeding experiments with Alox15 knockout mice confirmed that 12/15-lipoxygenase plays a role in skeletal development. Pharmacologic inhibitors of this enzyme improved bone density and strength in two rodent models of osteoporosis. These results suggest that drugs targeting the 12/15-lipoxygenase pathway merit investigation as a therapy for osteoporosis.	Oregon Hlth & Sci Univ, Sch Med, Dept Med, Bone & Mineral Res Unit, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Sch Med, Dept Orthopaed & Rehabil, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Sch Med, Dept Behav Neurosci, Portland, OR 97239 USA; Vet Affairs Med Ctr, Portland, OR 97207 USA; Roche Palo Alto, Dept Genet & Gen, Palo Alto, CA 94303 USA; Roche Palo Alto, Dept Chem, Palo Alto, CA 94303 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Roche Holding; Roche Holding	Klein, RF (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Med, Bone & Mineral Res Unit, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.		Rotstein, David/K-6691-2019	Orwoll, Eric/0000-0002-8520-7355	NHGRI NIH HHS [HG02322] Funding Source: Medline; NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NIAMS NIH HHS [R01 AR044659, AR44659, R01 AR044659-08] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bonewald LF, 1997, ADV EXP MED BIOL, V433, P299; Cornicelli JA, 1999, CURR PHARM DESIGN, V5, P11; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Feng JW, 2000, J LIPID RES, V41, P688; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Huang QY, 2003, OSTEOPOROSIS INT, V14, P701, DOI 10.1007/s00198-003-1445-9; Inoue M, 2001, ARTERIOSCL THROM VAS, V21, P560, DOI 10.1161/01.ATV.21.4.560; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Klein RF, 2001, J BONE MINER RES, V16, P1953, DOI 10.1359/jbmr.2001.16.11.1953; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Montero A, 2000, EXP NEPHROL, V8, P14; Nosjean O, 2002, CELL SIGNAL, V14, P573, DOI 10.1016/S0898-6568(01)00281-9; Ogawa S, 1999, BIOCHEM BIOPH RES CO, V260, P122, DOI 10.1006/bbrc.1999.0896; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SHANNON VR, 1993, AM REV RESPIR DIS, V147, P1024, DOI 10.1164/ajrccm/147.4.1024; Shureiqi I, 2000, J NATL CANCER I, V92, P1136, DOI 10.1093/jnci/92.14.1136; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Traianedes K, 1998, ENDOCRINOLOGY, V139, P3178, DOI 10.1210/en.139.7.3178; Turek JJ, 2003, J NUTR BIOCHEM, V14, P24, DOI 10.1016/S0955-2863(02)00221-8	27	218	229	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					229	232		10.1126/science.1090985	http://dx.doi.org/10.1126/science.1090985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716014				2022-12-01	WOS:000187908500048
J	Teno, JM; Clarridge, BR; Casey, V; Welch, LC; Wetle, T; Shield, R; Mor, V				Teno, JM; Clarridge, BR; Casey, V; Welch, LC; Wetle, T; Shield, R; Mor, V			Family perspectives on end-of-life care at the last place of care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GOOD DEATH; QUALITY; STATEMENT; HOSPICE; PATIENT	Context Over the past century, nursing homes and hospitals increasingly have become the site of death, yet no national studies have examined the adequacy or quality of end-of-life care in institutional settings compared with deaths at home. Objective To evaluate the US dying experience at home and in institutional settings. Design, Setting, and Participants Mortality follow-back survey of family members or other knowledgeable informants representing 1578 decedents, with a 2-stage probability sample used to estimate end-of-life care outcomes for 1.97 million deaths from chronic illness in the United States in 2000. Informants were asked via telephone about the patient's experience at the last place of care at which the patient spent more than 48 hours. Main Outcome Measures Patient- and family-centered end-of-life care outcomes, including whether health care workers (1) provided the desired physical comfort and emotional support to the dying person, (2) supported shared decision making, (3) treated the dying person with respect, (4) attended to the emotional needs of the family, and (5) provided coordinated care. Results For 1059 of 1578 decedents (67.1%), the last place of care was an institution. Of 519 (32.9%) patients dying at home represented by this sample, 198 (38.2%) did not receive nursing services; 65 (12.5%) had home nursing services, and 256 (49.3%) had home hospice services. About one quarter of all patients with pain or dyspnea did not receive adequate treatment, and one quarter reported concerns with physician communication. More than one third of respondents cared for by a home health agency, nursing home, or hospital reported insufficient emotional support for the patient and/or 1 or more concerns with family emotional support, compared with about one fifth of those receiving home hospice services. Nursing home residents were less likely than those cared for in a hospital or by home hospice services to always have been treated with respect at the end of life (68.2% vs 79.6% and 96.2%, respectively). Family members of patients receiving hospice services were more satisfied with overall quality of care: 70.7% rated care as "excellent" compared with less than 50% of those dying in an institutional setting or with home health services (P<.001). Conclusions Many people dying in institutions have unmet needs for symptom amelioration, physician communication, emotional support, and being treated with respect. Family members of decedents who received care at home with hospice services were more likely to report a favorable dying experience.	Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; Brown Univ, Brown Med Sch, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA	Brown University; Brown University; University of Massachusetts System; University of Massachusetts Boston	Teno, JM (corresponding author), 2 Stimson Ave, Providence, RI 02912 USA.		Welch, Lisa Christine/GZK-6246-2022	Welch, Lisa/0000-0001-6269-9310				Addington-Hall J, 2001, J PAIN SYMPTOM MANAG, V22, P784, DOI 10.1016/S0885-3924(01)00330-X; Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Cochran W.G., 1963, SAMPLING TECHNIQUES; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Field MJ, 1997, APPROACHING DEATH IM; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Harrington C, 2000, GERONTOLOGIST, V40, P5; Higginson IJ, 2002, J PAIN SYMPTOM MANAG, V23, P96, DOI 10.1016/S0885-3924(01)00406-7; Kish L, 1965, SURVEY SAMPLING; Lynn J, 1997, J AM GERIATR SOC, V45, P526; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Singer PA, 2002, BMJ-BRIT MED J, V324, P1291, DOI 10.1136/bmj.324.7349.1291; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Teno JM, 1999, J PAIN SYMPTOM MANAG, V17, P109, DOI 10.1016/S0885-3924(98)00132-8; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; TENO JM, 2000, FACTS DYING POLICY R; Weitzen S, 2003, MED CARE, V41, P323, DOI 10.1097/00005650-200302000-00013; Zerzan J, 2000, JAMA-J AM MED ASSOC, V284, P2489, DOI 10.1001/jama.284.19.2489; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	21	1059	1069	5	125	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2004	291	1					88	93		10.1001/jama.291.1.88	http://dx.doi.org/10.1001/jama.291.1.88			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760LX	14709580	Bronze			2022-12-01	WOS:000187836000023
J	Soares, HP; Daniels, S; Kumar, A; Clarke, M; Scott, C; Swann, S; Djulbegovic, B				Soares, HP; Daniels, S; Kumar, A; Clarke, M; Scott, C; Swann, S; Djulbegovic, B			Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group	BRITISH MEDICAL JOURNAL			English	Article							CONSORT STATEMENT; QUALITY	Objective To determine whether poor reporting of, methods in randomised controlled trials reflects on poor methods. Design Observational study. Setting Reports of randomised controlled trials conducted by the Radiation Therapy Oncology Group since its establishment in 1968. Participants The Radiation Therapy Oncology Group. Outcome measures Content of reports compared with the design features described in the protocols for all randomised controlled trials. Results The methodological quality of 56 randomised controlled trials was better than reported. Adequate allocation concealment was achieved in all trials but reported in only 42% of papers. An intention to treat analysis was done in 83% of trials but reported in only 69% of papers. The sample size calculation was performed in 76% of the studies, but reported in only 16% of papers. End points were clearly defined and cc and beta errors were prespecified in 76% and 74% of the trials, respectively, but only reported in 10% of the papers. The one exception was the description of drop outs, where the frequency of reporting was similar to that contained in the original statistical files of the Radiation Therapy Oncology Group. Conclusions The reporting of methodological aspects of randomised controlled trials does not necessarily reflect the conduct of the trial. Reviewing research protocols and contacting trialists for more information may improve quality assessment.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Eastern Cooperat Oncol Grp, Tampa, FL 33612 USA; UK Cochrane Ctr, Oxford OX2 7LG, England; Radiat Therapy Oncol Grp, Stat Unit, Philadelphia, PA 19107 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Cochrane Centre; Radiation Therapy Oncology Group (RTOG)	Djulbegovic, B (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.		KUMAR, ASHOK/AAF-4055-2021; Djulbegovic, Benjamin/I-3661-2012; Kumar, Ambuj/I-4940-2012; Kumar, Ambuj/U-5268-2019	KUMAR, ASHOK/0000-0002-9244-0622; Djulbegovic, Benjamin/0000-0003-0671-1447; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044417] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS/NR44417-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CLARKE M, 2003, COCHRANE LIB; EGGER M, 2001, SYSTEMATIC REV HLTH; Godlee F, 2001, BMC NEWS VIEWS, V2; HERSON J, 1980, CONTROL CLIN TRIALS, V1, P101, DOI 10.1016/0197-2456(80)90013-6; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; *RAD THER ONC GROU, 2003, RTOG PROC MAN; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831	12	229	231	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2004	328	7430					22	24		10.1136/bmj.328.7430.22	http://dx.doi.org/10.1136/bmj.328.7430.22			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761QG	14703540	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000187919000016
J	Loutfy, MR; Blatt, LM; Siminovitch, KA; Ward, S; Wolff, B; Lho, H; Pham, DH; Deif, H; LaMere, EA; Chang, M; Kain, KC; Farcas, GA; Ferguson, P; Latchford, M; Levy, G; Dennis, JW; Lai, EKY; Fish, EN				Loutfy, MR; Blatt, LM; Siminovitch, KA; Ward, S; Wolff, B; Lho, H; Pham, DH; Deif, H; LaMere, EA; Chang, M; Kain, KC; Farcas, GA; Ferguson, P; Latchford, M; Levy, G; Dennis, JW; Lai, EKY; Fish, EN			Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome - A preliminary study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SARS; OUTBREAK; ALPHA; MANAGEMENT; MECHANISMS; RIBAVIRIN; EFFICACY; OUTCOMES; THERAPY; TORONTO	Context Severe acute respiratory syndrome (SARS) is anew clinical entity for which no effective therapeutic strategy has been developed. Objective To provide preliminary results on the potential therapeutic benefit and tolerability of interferon alfacon-1 plus corticosteroids for SARS. Design, Setting, and Patients Open-label study of 22 patients diagnosed as having probable SARS at North York General Hospital, Toronto, Ontario, between April 11 and May 30, 2003. Interventions Thirteen patients were treated with corticosteroids alone and 9 patients were treated with corticosteroids plus subcutaneous interferon alfacon-1. Main Outcome Measures Clinical parameters, including oxygen saturation and requirement, laboratory measures, and serial chest radiography results. Results Resolution of fever and lymphopenia were similar between the 2 treatment groups. Of the 13 patients treated with corticosteroids alone, 5 (38.5%) were transferred to the intensive care unit, 3 (23.1 %) required intubation and mechanical ventilation, and 1 (7.7%) died. Of the 9 patients in the interferon alfacon-1 treatment group, 3 (33.3 %) were transferred to the intensive care unit, 1 (11.1 %) required intubation and mechanical ventilation, and none died. The interferon alfacon-1 treatment group had a shorter time to 50% resolution of lung radiographic abnormalities (median time, 4 days vs 9 days; P=.001), had, better oxygen saturation (P=.02), resolved their need for supplemental oxygen more rapidly (median, 10 days vs 16 days; P=.02), had less of an increase in creatine kinase levels (P=.03), and showed a trend toward more rapid resolution of lactate dehydrogenase levels compared with the group receiving corticosteroids alone. Conclusions In this preliminary, uncontrolled study of patients with SARS, Use of interferon alfacon-1 plus corticosteroids was associated with reduced disease-associated impaired oxygen saturation, more rapid resolution of radiographic lung abnormalities, and lower levels of creatine kinase. These findings suggest that further investigation may be warranted to determine the role of interferon alfacon-1 as a therapeutic agent for the treatment of SARS.	Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; N York Gen Hosp, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Intermune Corp, Brisbane, CA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Fish, EN (corresponding author), Toronto Gen Res Inst, Div Cell & Mol Biol, Canadian Blood Serv Bldg,Room 424,67 Coll St, Toronto, ON M5G 2M1, Canada.	en.fish@utoronto.ca	Dennis, James/E-7268-2013; Siminovitch, Katherine/K-1475-2013	Kain, Kevin/0000-0001-6068-1272				Alton K., 1983, BIOL INTERFERON SYST, P119; Avendano M, 2003, CAN MED ASSOC J, V168, P1649; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Blatt LM, 1996, J INTERF CYTOK RES, V16, P489, DOI 10.1089/jir.1996.16.489; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; *CDCP, UPD INT US CAS DEF S; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; Cornberg M, 2001, Forum (Genova), V11, P154; Cotler SJ, 2003, J VIRAL HEPATITIS, V10, P43, DOI 10.1046/j.1365-2893.2003.00401.x; Friis RH, 1996, EPIDEMIOLOGY PUBLIC; Fujimori K, 2002, J GASTROENTEROL, V37, P40, DOI 10.1007/s535-002-8131-9; HIGGINS PG, 1983, ANTIMICROB AGENTS CH, V24, P713, DOI 10.1128/AAC.24.5.713; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Melian EB, 2001, DRUGS, V61, P1661, DOI 10.2165/00003495-200161110-00009; Nguyen MH, 2001, CURR OPIN INFECT DIS, V14, P593, DOI 10.1097/00001432-200110000-00014; Oba Y, 2003, NEW ENGL J MED, V348, P2034; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Pockros PJ, 2003, J VIRAL HEPATITIS, V10, P55, DOI 10.1046/j.1365-2893.2003.00402.x; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Soza A, 2002, HEPATOLOGY, V36, P1273, DOI 10.1053/jhep.2002.36502; SPERBER SJ, 1989, J INTERFERON RES, V9, P285, DOI 10.1089/jir.1989.9.285; TURNER RB, 1986, J INFECT DIS, V154, P443, DOI 10.1093/infdis/154.3.443; TYRRELL DAJ, 1986, J ANTIMICROB CHEMOTH, V18, P153, DOI 10.1093/jac/18.Supplement_B.153; *WHO, REV CAS DEF SARS; WHO, CUM NUMB REP PROB CA; Wu W, 2003, CHINESE MED J-PEKING, V116, P811	30	278	309	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2003	290	24					3222	3228		10.1001/jama.290.24.3222	http://dx.doi.org/10.1001/jama.290.24.3222			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756TR	14693875				2022-12-01	WOS:000187499300026
J	Kruger, M; Meyerdierks, A; Glockner, FO; Amann, R; Widdel, F; Kube, M; Reinhardt, R; Kahnt, R; Bocher, R; Thauer, RK; Shima, S				Kruger, M; Meyerdierks, A; Glockner, FO; Amann, R; Widdel, F; Kube, M; Reinhardt, R; Kahnt, R; Bocher, R; Thauer, RK; Shima, S			A conspicuous nickel protein in microbial mats that oxidize methane anaerobically	NATURE			English	Article							CORAL-LIKE STRUCTURES; MARINE-SEDIMENTS; BLACK-SEA; SULFATE REDUCTION; MCRA GENES; OXIDATION; BACTERIA; SEEPS; CONSORTIUM; ARCHAEA	Anaerobic oxidation of methane (AOM) in marine sediments is an important microbial process in the global carbon cycle and in control of greenhouse gas emission. The responsible organisms supposedly reverse the reactions of methanogenesis(1-8), but cultures providing biochemical proof of this have not been isolated. Here we searched for AOM-associated cell components in microbial mats from anoxic methane seeps in the Black Sea(9-11). These mats catalyse AOM rather than carry out methanogenesis. We extracted a prominent nickel compound displaying the same absorption spectrum as the nickel cofactor F(430) of methyl-coenzyme M reductase, the terminal enzyme of methanogenesis(12); however, the nickel compound exhibited a higher molecular mass than F430. The apparent variant of F430 was part of an abundant protein that was purified from the mat and that consists of three different subunits. Determined amino-terminal amino acid sequences matched a gene locus cloned from the mat. Sequence analyses revealed similarities to methyl-coenzyme M reductase from methanogenic archaea. The abundance of the nickel protein (7% of extracted proteins) in the mat suggests an important role in AOM.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Widdel, F (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	fwiddel@mpi-bremen.de; thauer@mailer.uni-marburg.de	Amann, Rudolf I/C-6534-2014	Amann, Rudolf I/0000-0002-0846-7372; Reinhardt, Richard/0000-0001-9376-2132				BARNES RO, 1976, GEOLOGY, V4, P297, DOI 10.1130/0091-7613(1976)4<297:MPACIA>2.0.CO;2; Bian LQ, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000112; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Elvert M, 1999, NATURWISSENSCHAFTEN, V86, P295, DOI 10.1007/s001140050619; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; Harder J, 1997, MAR GEOL, V137, P13, DOI 10.1016/S0025-3227(96)00075-8; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MARTENS CS, 1974, SCIENCE, V185, P1167, DOI 10.1126/science.185.4157.1167; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Niewohner C, 1998, GEOCHIM COSMOCHIM AC, V62, P455, DOI 10.1016/S0016-7037(98)00055-6; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pancost RD, 2001, GEOCHIM COSMOCHIM AC, V65, P1611, DOI 10.1016/S0016-7037(00)00562-7; Pimenov NV, 1997, MICROBIOLOGY+, V66, P354; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; REEBURGH W, 1976, EARTH PLANET SC LETT, V28, P345; Schbath S, 1997, J COMPUT BIOL, V4, P189, DOI 10.1089/cmb.1997.4.189; Sorensen KB, 2001, MICROBIAL ECOL, V42, P1; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Tourova TP, 2002, MICROBIOLOGY+, V71, P196, DOI 10.1023/A:1015102422144; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	30	256	274	5	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					878	881		10.1038/nature02207	http://dx.doi.org/10.1038/nature02207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685246				2022-12-01	WOS:000187342000068
J	Geisbert, TW; Hensley, LE; Jahrling, PB; Larsen, T; Geisbert, JB; Paragas, J; Young, HA; Fredeking, TM; Rote, WE; Vlasuk, GP				Geisbert, TW; Hensley, LE; Jahrling, PB; Larsen, T; Geisbert, JB; Paragas, J; Young, HA; Fredeking, TM; Rote, WE; Vlasuk, GP			Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys	LANCET			English	Article							ANTICOAGULANT PROTEIN C2; DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE FACTOR/FACTOR-VIIA; FACTOR VIIA/TISSUE FACTOR; FACTOR PATHWAY; IN-VITRO; ACTIVATION; MECHANISMS; RELEASE; COMPLEX	Background Infection with the Ebola virus induces overexpression of the procoagulant tissue factor in primate monocytes and macrophages, suggesting that inhibition of the tissue-factor pathway could ameliorate the effects of Ebola haemorrhagic fever. Here, we tested the notion that blockade of fVIIa/tissue factor is beneficial after infection with Ebola virus. Methods We used a rhesus macaque model of Ebola haemorrhagic fever, which produces near 100% mortality. We administered recombinant nematode anticoagulant protein c2 (rNAPc2), a potent inhibitor of tissue factor-initiated blood coagulation, to the macaques either 10 min (n=6) or 24 h (n=3) after a high-dose lethal injection of Ebola virus. Three animals served as untreated Ebola virus-positive controls. Historical controls were also used in some analyses. Findings Both treatment regimens prolonged survival time, with a 33% survival rate in each treatment group. Survivors are still alive and healthy after 9 months. All but one of the 17 controls died. The mean survival for the six rNAPc2-treated macaques that died was 11.7 days compared with 8.3 days for untreated controls (p=0.0184). rNAPc2 attenuated the coagulation response as evidenced by modulation of various important coagulation factors, including plasma D dimers, which were reduced in nearly all treated animals; less prominent fibrin deposits and intravascular thromboemboli were observed in tissues of some animals that succumbed to Ebola virus. Furthermore, rNAPc2 attenuated the proinflammatory response with lower plasma concentrations of interleukin 6 and monocyte chemoattractant protein-1 (MCP-1) noted in the treated than in the untreated macaques. Interpretation Post-exposure protection with rNAPc2 against Ebola virus in primates provides a new foundation for therapeutic regimens that target the disease process rather than viral replication.	USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; USA, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA; NCI, Cellular & Mol Immunol Sect, Expt Immunol Lab, FCRDC, Frederick, MD USA; Antibody Syst, Hurst, TX USA; Corvas Int, San Diego, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Geisbert, TW (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.		; Young, Howard/A-6350-2008	Larsen, Thomas/0000-0002-3609-9490; Young, Howard/0000-0002-3118-5111; Hensley, Lisa/0000-0003-1188-4342				Arai A, 2000, THROMB RES, V97, P153, DOI 10.1016/S0049-3848(99)00147-4; Bick RL, 1998, SEMIN THROMB HEMOST, V24, P3, DOI 10.1055/s-2007-994971; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; de Jonge E, 2003, CLIN DIAGN LAB IMMUN, V10, P495, DOI 10.1128/CDLI.10.3.495-497.2003; de Pont ACJM, 2002, BLOOD, V100, p487A; Funahara Y, 1983, Bibl Haematol, P201; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Huggins J, 1999, J INFECT DIS, V179, pS240, DOI 10.1086/514316; Huggins J.W., 1995, ANTIVIR RES, V26, pA301; Iversen N, 2000, BLOOD COAGUL FIBRIN, V11, P591, DOI 10.1097/00001721-200010000-00002; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Johnson K, 1998, J IMMUNOL, V160, P5130; Lee A, 2001, CIRCULATION, V104, P74, DOI 10.1161/hc2601.091386; McVey JH, 1999, BEST PRACT RES CL HA, V12, P361, DOI 10.1053/beha.1999.0030; Moons AHM, 2003, J AM COLL CARDIOL, V41, P2147, DOI 10.1016/S0735-1097(03)00478-9; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Vlasuk GP, 2002, TRENDS CARDIOVAS MED, V12, P325, DOI 10.1016/S1050-1738(02)00185-8	20	282	329	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1953	1958		10.1016/S0140-6736(03)15012-X	http://dx.doi.org/10.1016/S0140-6736(03)15012-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683653	Green Submitted			2022-12-01	WOS:000187210700006
J	Etminan, M; Hemmelgarn, B; Delaney, JAC; Suissa, S				Etminan, M; Hemmelgarn, B; Delaney, JAC; Suissa, S			Use of lithium and the risk of injurious motor vehicle crash in elderly adults: case-control study nested within a cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIPOLAR DISORDER		McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; Univ Calgary, Dept Med, Calgary, AB, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	McGill University; Royal Victoria Hospital; University of Calgary; University of Calgary	Suissa, S (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, 687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	Samy.suissa@dinepi.mcgill.ca	Delaney, Joseph A/J-8204-2019	Delaney, Joseph A/0000-0003-1771-1776				Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Hemmelgarn B, 1997, JAMA-J AM MED ASSOC, V278, P27, DOI 10.1001/jama.278.1.27; Honig A, 1999, INT CLIN PSYCHOPHARM, V14, P167, DOI 10.1097/00004850-199905030-00003; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Verster JC, 2003, PSYCHOPHARMACOLOGY, V169, P84, DOI 10.1007/s00213-003-1462-6	5	18	18	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2004	328	7439					558	559		10.1136/bmj.38002.514838.94	http://dx.doi.org/10.1136/bmj.38002.514838.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JI	14732760	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000220091800020
J	Vahtera, J; Kivimaki, M; Pentti, J; Linna, A; Virtanen, M; Virtanen, P; Ferrie, JE				Vahtera, J; Kivimaki, M; Pentti, J; Linna, A; Virtanen, M; Virtanen, P; Ferrie, JE			Organisational downsizing, sickness absence, and mortality: 10-town prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; HEALTH; WORK; EMPLOYEES; EMPLOYMENT; STRESS; RISK; MEN	Objective To examine whether downsizing, the reduction of personnel in organisations, is a predictor of increased sickness absence and mortality among employees. Design Prospective cohort study over 7.5 years of employees grouped into categories on the basis of reductions of personnel in their occupation and workplace: no downsizing (< 8% reduction), minor downsizing (8-18%), and major downsizing (> 18%). Setting Four towns in Finland. Participants 5909 male and 16 521 female municipal employees, aged 19-62 years, who kept their jobs. Main outcome measures Annual sickness absence rate based on employers' records before and after downsizing by employment contract; all cause and cause specific mortality obtained from the national mortality register. Results Major downsizing was associated with an increase in sickness absence (P for trend < 0.001) in permanent employees but not in temporary employees. The extent of downsizing was also associated with cardiovascular deaths (P for trend < 0.01) but not with deaths from other causes. Cardiovascular mortality was 2.0 (95% confidence interval 1.0 to 3.9) times higher after major downsizing than after no downsizing. Splitting the follow up period into two halves showed a 5.1 (1.4 to 19.3) times increase in cardiovascular mortality for major downsizing during the first four years after downsizing. The corresponding hazard ratio was 1.4 (0.6 to 3.1) during the second half of follow up. Conclusion Organisational downsizing may increase sickness absence and the risk of death from cardiovascular disease in employees who keep their jobs.	Finnish Inst Occupat Hlth, FIN-00250 Helsinki, Finland; Univ Tampere, Sch Med, FIN-33014 Tampere, Finland; UCL, Sch Med, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England	Finnish Institute of Occupational Health; Tampere University; University of London; University College London; UCL Medical School	Vahtera, J (corresponding author), Finnish Inst Occupat Hlth, Hameenkatu 10, FIN-20500 Turku, Finland.	jussi.vahtera@ttl.fi	Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012; Ferrie, Jane/AAZ-2009-2020	Kivimaki, Mika/0000-0002-4699-5627; 				Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Everson SA, 1997, BRIT MED J, V314, P553, DOI 10.1136/bmj.314.7080.553; FERRIE JE, 1997, J HEALTH PSYCHOL, V2, P273; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kivimaki M, 2001, ANXIETY STRESS COPIN, V14, P59, DOI 10.1080/10615800108248348; Lichtenstein P, 1998, PSYCHOL MED, V28, P635, DOI 10.1017/S0033291798006692; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; MCLEOD J, 2002, BMJ-BRIT MED J, V324, P1247; Melchior M, 2003, J EPIDEMIOL COMMUN H, V57, P285, DOI 10.1136/jech.57.4.285; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Quinlan M, 2001, INT J HEALTH SERV, V31, P335, DOI 10.2190/607H-TTV0-QCN6-YLT4; Smith GD, 1998, BMJ-BRIT MED J, V317, P1351, DOI 10.1136/bmj.317.7169.1351; Statistics Finland, 1987, CLASS OCC HDB, V14; Theorell T, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e9; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Virtanen M, 2003, OCCUP ENVIRON MED, V60, P948, DOI 10.1136/oem.60.12.948; Weiss NS, 2002, EPIDEMIOLOGY, V13, P6, DOI 10.1097/00001648-200201000-00003	23	231	236	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2004	328	7439					555	558		10.1136/bmj.37972.496262.0D	http://dx.doi.org/10.1136/bmj.37972.496262.0D			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JI	14980982	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000220091800019
J	Nguyen, AN; Zinner, E				Nguyen, AN; Zinner, E			Discovery of ancient silicate stardust in a meteorite	SCIENCE			English	Article							ASYMPTOTIC GIANT BRANCH; ISOTOPIC COMPOSITION; DEEP CIRCULATION; SOLAR-SYSTEM; RICH RIMS; STARS; DUST; CORUNDUM; GRAINS; NUCLEOSYNTHESIS	We have discovered nine presolar silicate grains from the carbonaceous chondrite Acfer 094. Their anomalous oxygen isotopic compositions indicate formation in the atmospheres of evolved stars. Two grains are identified as pyroxene, two as olivine, one as a glass with embedded metal and sulfides (GEMS), and one as an Al-rich silicate. One grain is enriched in Mg-26, which is attributed to the radioactive decay of Al-26 and provides information about mixing processes in the parent star. This discovery opens new means for studying stellar processes and conditions in various solar system environments.	Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Nguyen, AN (corresponding author), Washington Univ, Space Sci Lab, St Louis, MO 63130 USA.	nguyen@wustl.edu						Alexander CMO, 1999, ASTROPHYS J, V519, P222, DOI 10.1086/307340; ALEXANDER CMO, 2001, LUNAR PLANET SCI, V32, pA2191; Boothroyd AI, 1999, ASTROPHYS J, V510, P232, DOI 10.1086/306546; BOOTHROYD AI, 1995, ASTROPHYS J, V442, pL21, DOI 10.1086/187806; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; CANNON RC, 1995, NUCLEI COSMOS, V3, P469; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Choi BG, 1999, ASTROPHYS J, V522, pL133, DOI 10.1086/312239; Demyk K, 2000, ASTRON ASTROPHYS, V364, P170; FLOSS C, 2004, LUNAR PLANET SCI, V35, pA1281; FORESTINI M, 1991, ASTRON ASTROPHYS, V252, P597; HUA X, 1988, GEOCHIM COSMOCHIM AC, V52, P1389, DOI 10.1016/0016-7037(88)90210-4; HUTCHEON ID, 1994, ASTROPHYS J, V425, pL97, DOI 10.1086/187319; Karakas AI, 2003, PUBL ASTRON SOC AUST, V20, P279, DOI 10.1071/AS03010; Malfait K, 1998, ASTRON ASTROPHYS, V332, pL25; Messenger S, 2000, METEORIT PLANET SCI, V35, pA109; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Molster FJ, 1999, NATURE, V401, P563, DOI 10.1038/44085; Molster FJ, 2002, ASTRON ASTROPHYS, V382, P241, DOI 10.1051/0004-6361:20011552; MOSTEFAOUI S, 2004, LUNAR PLANET SCI, V35, pA1593; Mowlavi N, 2000, ASTRON ASTROPHYS, V361, P959; Nguyen A, 2003, PUBL ASTRON SOC AUST, V20, P382, DOI 10.1071/AS03030; Nittler L. R., 1996, THESIS WASHINGTON U; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; Nollett KM, 2003, ASTROPHYS J, V582, P1036, DOI 10.1086/344817; Tachibana S, 2003, METEORIT PLANET SCI, V38, P939, DOI 10.1111/j.1945-5100.2003.tb00289.x; Waelkens C, 1996, ASTRON ASTROPHYS, V315, pL245; WASSERBURG GJ, 1995, ASTROPHYS J, V447, pL37, DOI 10.1086/309555; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; WEINBRUCH S, 1990, METEORITICS, V25, P115, DOI 10.1111/j.1945-5100.1990.tb00983.x; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147; Zinner EK, 2005, TREATISE GEOCHEM, V1, P17	33	196	200	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1496	1499		10.1126/science.1094389	http://dx.doi.org/10.1126/science.1094389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001773				2022-12-01	WOS:000220000100035
J	Wild, C; Huettel, M; Klueter, A; Kremb, SG; Rasheed, MYM; Jorgensen, BB				Wild, C; Huettel, M; Klueter, A; Kremb, SG; Rasheed, MYM; Jorgensen, BB			Coral mucus functions as an energy carrier and particle trap in the reef ecosystem	NATURE			English	Article							WATER-MOVEMENT; ZOOXANTHELLAE; RESPIRATION; POPULATIONS; ECOLOGY; RELEASE	Zooxanthellae, endosymbiotic algae of reef-building corals, substantially contribute to the high gross primary production of coral reefs(1), but corals exude up to half of the carbon assimilated by their zooxanthellae as mucus(2,3). Here we show that released coral mucus efficiently traps organic matter from the water column and rapidly carries energy and nutrients to the reef lagoon sediment, which acts as a biocatalytic mineralizing filter. In the Great Barrier Reef, the dominant genus of hard corals, Acropora, exudes up to 4.8 litres of mucus per square metre of reef area per day. Between 56% and 80% of this mucus dissolves in the reef water, which is filtered through the lagoon sands. Here, coral mucus is degraded at a turnover rate of at least 7% per hour. Detached undissolved mucus traps suspended particles, increasing its initial organic carbon and nitrogen content by three orders of magnitude within 2 h. Tidal currents concentrate these mucus aggregates into the lagoon, where they rapidly settle. Coral mucus provides light energy harvested by the zooxanthellae and trapped particles to the heterotrophic reef community, thereby establishing a recycling loop that supports benthic life, while reducing loss of energy and nutrients from the reef ecosystem.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Australian Inst Marine Sci, Townsville, Qld 4810, Australia; Alfred Wegener Inst Polar & Marine Res, Dept Benth Ecosyst, D-27570 Bremerhaven, Germany; Yarmouk Univ, Aqaba, Jordan; Univ Jordan, Marine Sci Stn, Aqaba, Jordan	Max Planck Society; State University System of Florida; Florida State University; Australian Institute of Marine Science; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Yarmouk University; University of Jordan	Wild, C (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	cwild@mpi-bremen.de	Jorgensen, Bo B/C-2214-2013; Huettel, Markus/F-8940-2011	Jorgensen, Bo B/0000-0001-9398-8027; Huettel, Markus/0000-0003-4844-7525; Rasheed, Mohammed/0000-0002-6131-368X				BENSON AA, 1974, LIMNOL OCEANOGR, V19, P810, DOI 10.4319/lo.1974.19.5.0810; COLES SL, 1973, LIMNOL OCEANOGR, V18, P673, DOI 10.4319/lo.1973.18.4.0673; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; DAVIES PS, 1984, CORAL REEFS, V2, P181; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Ferrier-Pages C, 2000, AQUAT MICROB ECOL, V21, P203, DOI 10.3354/ame021203; GOREAU TF, 1979, SCI AM, V241, P124, DOI 10.1038/scientificamerican0879-124; HERNDL GJ, 1986, MAR BIOL, V90, P363, DOI 10.1007/BF00428560; HUETTEL M, 1992, MAR ECOL PROG SER, V82, P187, DOI 10.3354/meps082187; JOHANNES RE, 1967, LIMNOL OCEANOGR, V12, P189, DOI 10.4319/lo.1967.12.2.0189; KRUPP DA, 1984, PAC SCI, V38, P1; MARSDEN J, 1990, J EXP MAR BIOL ECOL, V137, P97; MARSHALL N, 1968, Marine Biology (Berlin), V2, P50, DOI 10.1007/BF00351638; MEIKLE P, 1988, MAR BIOL, V99, P187, DOI 10.1007/BF00391980; MORIARTY DJW, 1985, MAR BIOL, V85, P285, DOI 10.1007/BF00393249; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; OBERDORFER JA, 1986, CORAL REEFS, V5, P7, DOI 10.1007/BF00302165; PARNELL KE, 1986, CORAL REEFS, V5, P1, DOI 10.1007/BF00302164; RICHMAN S, 1975, LIMNOL OCEANOGR, V20, P918, DOI 10.4319/lo.1975.20.6.0918; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; RIEDL RJ, 1972, MAR BIOL, V13, P210, DOI 10.1007/BF00391379; Romaine S, 1997, MAR BIOL, V129, P175, DOI 10.1007/s002270050158; SCHUHMACHER H, 1977, P 3 INT COR REEF S M, P503; SHANKS AL, 1989, MAR BIOL, V101, P463, DOI 10.1007/BF00541648; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; VACELET E, 1991, HYDROBIOLOGIA, V211, P19, DOI 10.1007/BF00008613; Wild C, 2004, MAR ECOL PROG SER, V267, P159, DOI 10.3354/meps267159; WILKINSON CR, 1987, SEARCH, V18, P31	28	425	435	10	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	2004	428	6978					66	70		10.1038/nature02344	http://dx.doi.org/10.1038/nature02344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999280				2022-12-01	WOS:000189363800035
J	Lau, HC; Rogers, RD; Haggard, P; Passingham, RE				Lau, HC; Rogers, RD; Haggard, P; Passingham, RE			Attention to intention	SCIENCE			English	Article							EXTERNALLY TRIGGERED MOVEMENTS; CONSCIOUS INTENTION; PARKINSONS-DISEASE; PREFRONTAL CORTEX; VOLUNTARY; POTENTIALS; BRAIN; MODULATION; ACTIVATION; AWARENESS	Intention is central to the concept of voluntary action. Using functional magnetic resonance imaging, we compared conditions in which participants made self-paced actions and attended either to their intention to move or to the actual movement. When they attended to their intention rather than their movement, there was an enhancement of activity in the pre-supplementary motor area (pre-SMA). We also found activations in the right dorsal prefrontal cortex and left intraparietal cortex. Prefrontal activity, but not parietal activity, was more strongly coupled with activity in the pre-SMA. We conclude that activity in the pre-SMA reflects the representation of intention.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England; Univ Oxford, Dept Psychiat, Oxford, England; Univ Oxford, Ctr Clin Magnet Resonance Res, Oxford, England; UCL, Inst Congnit Neurosci, London WC1E 6BT, England; UCL, Dept Psychol, London WC1E 6BT, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of London; University College London	Lau, HC (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	chris.lau@psy.ox.ac.uk	Rogers, Robert/AAF-7621-2019; Haggard, Patrick/A-5081-2010	Rogers, Robert/0000-0001-5010-069X; Haggard, Patrick/0000-0001-7798-793X				Baars B. J., 1988, COGNITIVE THEORY CON; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; FRIED I, 1991, J NEUROSCI, V11, P3656; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; James W., 1890, PRINCIPLES PSYCHOL; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Joordens S, 2002, CONSCIOUS COGN, V11, P231, DOI 10.1006/ccog.2002.0559; KELLER I, 1990, ELECTROEN CLIN NEURO, V76, P351, DOI 10.1016/0013-4694(90)90036-J; Klein S, 2002, CONSCIOUS COGN, V11, P273, DOI 10.1006/ccog.2002.0557; LAU HC, IN PRESS NEUROIMAGE; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; PASSINGHAM RE, IN PRESS ATTENTION A; Pochon JB, 2001, CEREB CORTEX, V11, P260, DOI 10.1093/cercor/11.3.260; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reason J., 1990, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; THALER D, 1995, EXP BRAIN RES, V102, P445; Thoenissen D, 2002, J NEUROSCI, V22, P9024; Toni I, 2002, J COGNITIVE NEUROSCI, V14, P769, DOI 10.1162/08989290260138663	30	393	394	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1208	1210		10.1126/science.1090973	http://dx.doi.org/10.1126/science.1090973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976320				2022-12-01	WOS:000189074700051
J	Lin, BZ; Kolluri, SK; Lin, F; Liu, W; Han, YH; Cao, XH; Dawson, MI; Reed, JC; Zhang, XK				Lin, BZ; Kolluri, SK; Lin, F; Liu, W; Han, YH; Cao, XH; Dawson, MI; Reed, JC; Zhang, XK			Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3	CELL			English	Article							LUNG-CANCER CELLS; PROSTATE-CANCER; RECEPTOR TR3; CYTOCHROME-C; BH3 DOMAIN; APOPTOSIS; DEATH; BAX; PROTEIN; INDUCTION	The Bcl-2 family proteins are key regulators of apoptosis in human diseases and cancers. Though known to block apoptosis, Bcl-2 promotes cell death through an undefined mechanism. Here, we show that Bcl-2 interacts with orphan nuclear receptor Nur77 (also known as TR3), which is required for cancer cell apoptosis induced by many antineoplastic agents. The interaction is mediated by the N-terminal loop region of Bcl-2 and is required for Nur77 mitochondrial localization and apoptosis. Nur77 binding induces a Bcl-2 conformational change that exposes its BH3 domain, resulting in conversion of Bcl-2 from a protector to a killer. These findings establish the coupling of Nur77 nuclear receptor with the Bcl-2 apoptotic machinery and demonstrate that Bcl-2 can manifest opposing phenotypes, induced by interactions with proteins such as Nur77, suggesting novel strategies for regulating apoptosis in cancer and other diseases.	Burnham Inst, Ctr Canc, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham.org; xzhang@burnham.org			NCI NIH HHS [CA60988, CA87000] Funding Source: Medline; NIGMS NIH HHS [GM60554] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087000, R01CA060988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060554] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Holmes WF, 2003, J CELL BIOCHEM, V89, P262, DOI 10.1002/jcb.10505; Holmes WF, 2002, J BIOL CHEM, V277, P45408, DOI 10.1074/jbc.M204600200; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Lee JM, 2002, P NATL ACAD SCI USA, V99, P11878, DOI 10.1073/pnas.182552499; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liu S, 2002, WORLD J GASTROENTERO, V8, P446, DOI 10.3748/wjg.v8.i3.446; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Reed J C, 1996, Behring Inst Mitt, P72; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rodi DJ, 1999, J MOL BIOL, V285, P197, DOI 10.1006/jmbi.1998.2303; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Subramanian T, 2003, J CELL BIOCHEM, V89, P1102, DOI 10.1002/jcb.10573; TANAKA S, 1992, LEUKEMIA, V6, pS15; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; Uhlmann EJ, 1998, J BIOL CHEM, V273, P17926, DOI 10.1074/jbc.273.28.17926; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wilson AJ, 2003, CANCER RES, V63, P5401; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Xue D, 1997, NATURE, V390, P305, DOI 10.1038/36889; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang XK, 2002, ENDOCR-RELAT CANCER, V9, DOI 10.1677/erc.0.0090087	51	531	563	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					527	540		10.1016/S0092-8674(04)00162-X	http://dx.doi.org/10.1016/S0092-8674(04)00162-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980220	Bronze			2022-12-01	WOS:000189184200007
J	Fox, CS; Larson, MG; Leip, EP; Culleton, B; Wilson, PWF; Levy, D				Fox, CS; Larson, MG; Leip, EP; Culleton, B; Wilson, PWF; Levy, D			Predictors of new-onset kidney disease in a community-based population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; CORONARY HEART-DISEASE; BLOOD-PRESSURE CONTROL; 3RD NATIONAL-HEALTH; SERUM CREATININE; CARDIOVASCULAR OUTCOMES; CLINICAL EPIDEMIOLOGY; RISK-FACTORS; HYPERTENSION; PROGRESSION	Context Kidney disease is associated with an increased risk for the development of cardiovascular disease and end-stage renal disease; however, risk factors for kidney disease have not been well studied. Objective To identify predictors of the development of new-onset kidney disease. Design, Setting, and Participants A community-based, longitudinal cohort study of 2585 participants who attended both a baseline examination in 1978-1982 and a follow-up examination in 1998-2001, and who were free of kidney disease at baseline. Main Outcome Measures Kidney disease was assessed by the Modification of Diet in Renal Disease Study equation and defined by a glomerular filtration rate (GFR) in the fifth or lower percentile (less than or equal to59.25 mL/min per 1.73 m(2) in women, less than or equal to64.25 mL/min per 1.73 m(2) in men). Stepwise logistic regression was used to determine the impact of risk factors on the occurrence of new-onset kidney disease. Baseline and long-term, 12-year, averaged risk factor models were explored. Results At baseline, there were 1223 men and 1362 women, with a mean age of 43 years, who were free of preexisting kidney disease. After a mean follow-up of 18.5 years, 244 participants (9.4%) had developed kidney disease. In multivariable models, baseline age (odds ratio [OR], 2.36 per 10-year increment; 95% confidence interval [CI], 2.00-2.78), GFR (<90 mL/min per 1.73 m(2): OR, 3.01; 95% CI, 1.98-4.58; 90-119 mL/min per 1.73 m(2): OR, 1.84; 95% CI, 1.16-2.93), body mass index (OR, 1.23 per 1 SD; 95% CI, 1.08-1.41), diabetes (OR, 2.60; 95% CI, 1.44-4.70), and smoking (OR, 1.42; 95% CI, 1.06-1.91) were related to the development of kidney disease. In addition to baseline age and GFR, the long-term, averaged risk factors that were predictive of kidney disease included hypertension (OR, 1.57; 95% CI, 1.17-2.12), high-density lipoprotein cholesterol level (OR, 0.80 per 1 SD; 95% CI, 0.69-0.92), and diabetes (OR, 2.38; 95% CI, 1.45-3.92). Compared with a normal GFR (>= 120 mL/min per 1.73 m(2)), a mildly reduced GFR (<90 mL/min per 1.73 m(2)) predicted a 3-fold odds of progression to kidney disease (OR, 2.95; 95% CI, 1.94-4.49). Conclusions Established cardiovascular disease risk factors are associated with the development of new-onset kidney disease. Patients with a mildly reduced GFR should be monitored for progression to kidney disease.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Calgary, Foothills Hosp, Calgary, AB, Canada	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; University of Calgary	Fox, CS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	caroline@fram.nhlbi.nih.gov	Wilson, Peter W.F./J-2455-2016; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Bethesda, 2002, US REN DAT SYST USRD; Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Briganti EM, 2002, AM J KIDNEY DIS, V40, P704, DOI 10.1053/ajkd.2002.35677; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Culleton BF, 1999, ARCH INTERN MED, V159, P1785, DOI 10.1001/archinte.159.15.1785; CUPPLES LA, 1987, NIH PUBLICATION; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Iseki K, 1997, KIDNEY INT, V51, P850, DOI 10.1038/ki.1997.119; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PERNEGER TV, 1993, JAMA-J AM MED ASSOC, V269, P488, DOI 10.1001/jama.269.4.488; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Regalado M, 2000, AM J KIDNEY DIS, V35, P687, DOI 10.1016/S0272-6386(00)70017-5; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Samuelsson O, 1997, NEPHROL DIAL TRANSPL, V12, P1908, DOI 10.1093/ndt/12.9.1908; *SAS I INC, 2000, SAS STAT US GUID VER, P1901; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Young JH, 2002, J AM SOC NEPHROL, V13, P2776, DOI 10.1097/01.ASN.0000031805.09178.37	45	882	918	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2004	291	7					844	850		10.1001/jama.291.7.844	http://dx.doi.org/10.1001/jama.291.7.844			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TF	14970063	Bronze			2022-12-01	WOS:000189000400022
J	Pool, JA; Lobkovsky, E; Chirik, PJ				Pool, JA; Lobkovsky, E; Chirik, PJ			Hydrogenation and cleavage of dinitrogen to ammonia with a zirconium complex	NATURE			English	Article							DIHYDROGEN; ACTIVATION; REDUCTION; MOLECULE	Molecular nitrogen is relatively inert owing to the strength of its triple bond, nonpolarity and high ionization potential. As a result, the fixation of atmospheric nitrogen to ammonia under mild conditions has remained a challenge to chemists for more than a century. Although the Haber-Bosch process produces over 100 million tons of ammonia annually(1) for the chemical industry and agriculture(2), it requires high temperature and pressure, in addition to a catalyst(3), to induce the combination of hydrogen (H-2) and nitrogen (N-2). Coordination of molecular nitrogen to transition metal complexes can activate and even rupture the strong N-N bond(4) under mild conditions, with protonation yielding ammonia in stoichiometric(5) and even catalytic yields(6). But the assembly of N-H bonds directly from H-2 and N-2 remains challenging: adding H-2 to a metal-N-2 complex results in the formation of N-2 and metal-hydrogen bonds or, in the case of one zirconium complex(7), in formation of one N-H bond and a bridging hydride. Here we extend our work on zirconium complexes containing cyclopentadienyl ligands(8,9) and show that adjustment of the ligands allows direct observation of N-H bond formation from N-2 and H-2. Subsequent warming of the complex cleaves the N-N bond at 45degreesC, and continued hydrogenation at 85degreesC results in complete fixation to ammonia.	Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University	Chirik, PJ (corresponding author), Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA.	pc92@cornell.edu						Basch H, 1999, J AM CHEM SOC, V121, P5754, DOI 10.1021/ja984408w; Basch H, 2000, ORGANOMETALLICS, V19, P3393, DOI 10.1021/om000389z; Bielawa H, 2001, ANGEW CHEM INT EDIT, V40, P1061, DOI 10.1002/1521-3773(20010316)40:6<1061::AID-ANIE10610>3.0.CO;2-B; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chirik PJ, 2002, ANGEW CHEM INT EDIT, V41, P3463, DOI 10.1002/1521-3773(20020916)41:18<3463::AID-ANIE3463>3.0.CO;2-P; CUMMINS CC, 1988, J AM CHEM SOC, V110, P8731, DOI 10.1021/ja00234a044; Fryzuk MD, 2000, COORDIN CHEM REV, V200, P379, DOI 10.1016/S0010-8545(00)00264-2; Fryzuk MD, 2003, CHEM REC, V3, P2, DOI 10.1002/tcr.10044; Fryzuk MD, 1997, SCIENCE, V275, P1445, DOI 10.1126/science.275.5305.1445; Hidai M, 1999, COORDIN CHEM REV, V185-6, P99, DOI 10.1016/S0010-8545(98)00250-1; HILLHOUSE GL, 1984, J AM CHEM SOC, V106, P5472, DOI 10.1021/ja00331a015; JANIAK C, 1995, J ORGANOMET CHEM, V501, P219, DOI 10.1016/0022-328X(95)05647-8; MANRIQUEZ JM, 1978, J AM CHEM SOC, V100, P3078, DOI 10.1021/ja00478a020; MANRIQUEZ JM, 1974, J AM CHEM SOC, V96, P6229, DOI 10.1021/ja00826a071; Pool JA, 2003, J AM CHEM SOC, V125, P2241, DOI 10.1021/ja020960g; SANNER RD, 1976, J AM CHEM SOC, V98, P8351, DOI 10.1021/ja00442a007; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553; Smil V., 2001, ENRICHING THE EARTH; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326	19	448	455	12	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					527	530		10.1038/nature02274	http://dx.doi.org/10.1038/nature02274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	770KM	14765191				2022-12-01	WOS:000188721800037
J	Clement, G; Ahlberg, PE; Blieck, A; Blom, H; Clack, JA; Poty, E; Thorez, J; Janvier, P				Clement, G; Ahlberg, PE; Blieck, A; Blom, H; Clack, JA; Poty, E; Thorez, J; Janvier, P			Palaeogeography - Devonian tetrapod from western Europe	NATURE			English	Editorial Material									Museum Natl Hist Nat, CNRS, UMR 5143, F-75005 Paris, France; Nat Hist Museum, London SW7 5BD, England; Uppsala Univ, Dept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; USTL Sci Terre, CNRS, UMR 8014, F-59655 Villeneuve Dascq, France; Univ Cambridge, Museum Zool, Cambridge CB2 3EJ, England; Univ Liege, Dept Geol, B-4000 Liege 1, Belgium	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Natural History Museum London; Uppsala University; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; University of Cambridge; University of Liege	Clement, G (corresponding author), Museum Natl Hist Nat, CNRS, UMR 5143, F-75005 Paris, France.	janvier@mnhn.fr	Ahlberg, Per/E-8086-2013	Ahlberg, Per/0000-0001-9054-2900				Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; CLACK JA, 2002, GAINING GROUND; Coates Michael I., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P373; Daeschler EB, 1998, NATURE, V391, P133, DOI 10.1038/34317; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Lohest M., 1888, ANN SOC GEOL BELG, V15, P112; LUKSEVICS E, 2003, ICHTHYOLITH ISSUES S, V7, P1302; Thorez J., 1988, TIDE INFLUENCED SEDI, P389; Thorez J., 1977, MEDEDELINGEN RIJKS G, V28, P17; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a	11	52	54	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					412	413		10.1038/427412a	http://dx.doi.org/10.1038/427412a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749820				2022-12-01	WOS:000188470500032
J	Heath, PGT; Balfour, G; Weisner, AM; Efstratiou, A; Lamagni, TL; Tighe, H; O'Connell, LAF; Cafferkey, M; Verlander, NQ; Nicoll, A; McCartney, AC				Heath, PGT; Balfour, G; Weisner, AM; Efstratiou, A; Lamagni, TL; Tighe, H; O'Connell, LAF; Cafferkey, M; Verlander, NQ; Nicoll, A; McCartney, AC		PHLS GBS Working Grp	Group B streptococcal disease in UK and Irish infants younger than 90 days	LANCET			English	Article								The incidence, morbidity, and. mortality of group B streptococcal disease in the UK and Republic of Ireland are largely unknown. Between Feb 1, 2000, and Feb 28, 2001, we identified cases of invasive group B streptococcal disease in infants younger than 90 days through surveillance involving paediatricians, microbiologists, and parents. 568 cases were identified, equivalent to a total incidence of 0.72 per 1000 live-births (95% CI 0.66-0.78); the incidence for early-onset disease (n = 377) was 0.48 per 1000 (0.43-0.53), and for late-onset disease (n = 191) was 0.24 per 1000 (0.21-0.28). Risk factors were identifiable for 218 (58%) cases of early-onset disease. 53 infants died (overall 9.7%). We have established the minimum current burden of group B streptococcal disease in UK and Irish infants. This information will assist in the formulation of guidelines for prevention of this disease.	St George Hosp, Sch Med, Dept Child Hlth, Vaccine Inst, London SW17 0RE, England; Hlth Protect Agcy London, Ctr Communicable Dis Surveillance, London, England; Hlth Protect Agcy London, Cent Publ Hlth Lab, London, England; Hlth Protect Agcy London, Stat Unit, London, England; Rotunda Hosp, Dublin, Ireland; Royal Coll Surgeons Ireland, Dublin 2, Ireland	St Georges University London; Health Protection Agency; Health Protection Agency; Public Health England; Health Protection Agency; Royal College of Surgeons - Ireland	Heath, PGT (corresponding author), St George Hosp, Sch Med, Dept Child Hlth, Vaccine Inst, Cranmer Terrace, London SW17 0RE, England.	pheath@sghms.ac.uk	Lamagni, Theresa/I-4115-2019	Lamagni, Theresa/0000-0002-3965-8323; Heath, Paul/0000-0002-7540-7433				*BRIT PAED SURV UN, 2001, 15 ROYAL COLL PAED C; Luck S, 2003, LANCET, V361, P1953, DOI 10.1016/S0140-6736(03)13553-2; Mayon-White R T, 1985, Antibiot Chemother (1971), V35, P17; Nicoll A, 2000, ARCH DIS CHILD-FETAL, V82, pF207; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1	5	179	187	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 24	2004	363	9405					292	294		10.1016/S0140-6736(03)15389-5	http://dx.doi.org/10.1016/S0140-6736(03)15389-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766FQ	14751704				2022-12-01	WOS:000188361400013
J	Zhou, DP; Cantu, C; Sagiv, Y; Schrantz, N; Kulkarni, AB; Qi, XY; Mahuran, DJ; Morales, CR; Grabowski, GA; Benlagha, K; Savage, P; Bendelac, A; Teyton, L				Zhou, DP; Cantu, C; Sagiv, Y; Schrantz, N; Kulkarni, AB; Qi, XY; Mahuran, DJ; Morales, CR; Grabowski, GA; Benlagha, K; Savage, P; Bendelac, A; Teyton, L			Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins	SCIENCE			English	Article							ACTIVATOR PROTEIN; CYTOPLASMIC TAIL; T-CELLS; INTRACELLULAR TRAFFICKING; ALPHA-GALACTOSIDASE; NKT CELLS; MOLECULES; MOUSE; CD1B; SPECIFICITY	It is now established that CD1 molecules present lipid antigens to T cells, although it is not clear how the exchange of lipids between membrane compartments and the CD1 binding groove is assisted. We report that mice deficient in prosaposin, the precursor to a family of endosomal lipid transfer proteins (LTP), exhibit specific defects in CD1d-mediated antigen presentation and lack Valpha14 NKT cells. In vitro, saposins extracted monomeric lipids from membranes and from CD1, thereby promoting the loading as well as the editing of lipids on CD1. Transient complexes between CD1, lipid, and LTP suggested a "tug-of-war" model in which lipid exchange between CD1 and LTP is on the basis of their respective affinities for lipids. LTPs constitute a previously unknown link between lipid metabolism and immunity and are likely to exert a profound influence on the repertoire of self, tumor, and microbial lipid antigens.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Toronto, Dept Med & Pathobiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	University of Chicago; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cincinnati Children's Hospital Medical Center; University of Toronto; McGill University; Brigham Young University	Bendelac, A (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu; lteyton@scripps.edu	Benlagha, Kamel/I-5035-2016; Benlagha, Kamel/GLQ-8342-2022; Morales, Carlos R./H-1055-2011; Zhou, Dapeng/A-6446-2019; Savage, Paul B/HGB-3414-2022; zhou, dapeng/GXG-9715-2022; Savage, Paul B/E-1448-2011	Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; benlagha, kamel/0000-0002-3251-9195	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050867, R37AI038339, R01AI038339, P01AI053725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000698] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [10435] Funding Source: Medline; NIAID NIH HHS [R01 AI050867, R01 AI038339, AI50867, P01 AI053725, P01 AI53725, R37 AI038339, AI38339] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kase R, 1996, FEBS LETT, V393, P74, DOI 10.1016/0014-5793(96)00863-0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; QI XY, 1994, J BIOL CHEM, V269, P16746; RUECKERT DG, 1990, CHEM PHYS LIPIDS, V56, P1, DOI 10.1016/0009-3084(90)90083-4; Sakai N, 1996, J NEUROCHEM, V66, P1118, DOI 10.1046/j.1471-4159.1996.66031118.x; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Vogler C, 2001, PEDIATR RES, V49, P342, DOI 10.1203/00006450-200103000-00007; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; WU YY, 1994, J BIOL CHEM, V269, P16276; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	33	259	270	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					523	527		10.1126/science.1092009	http://dx.doi.org/10.1126/science.1092009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14684827	Green Accepted			2022-12-01	WOS:000188316400038
J	Kirichok, Y; Krapivinsky, G; Clapham, DE				Kirichok, Y; Krapivinsky, G; Clapham, DE			The mitochondrial calcium uniporter is a highly selective ion channel	NATURE			English	Article							RAT-LIVER MITOCHONDRIA; CA2+; TRANSPORT; MEMBRANE; TRANSLOCATION; MICRODOMAINS; INHIBITION; APOPTOSIS; CATIONS; COMPLEX	During intracellular Ca2+ signalling mitochondria accumulate significant amounts of Ca2+ from the cytosol(1,2). Mitochondrial Ca2+ uptake controls the rate of energy production(1,3,4), shapes the amplitude and spatio- temporal patterns of intracellular Ca2+ signals(1,5-8), and is instrumental to cell death(9,10). This Ca2+ uptake is undertaken by the mitochondrial Ca2+ uniporter ( MCU) located in the organelle's inner membrane(11,12). The uniporter passes Ca2+ down the electrochemical gradient maintained across this membrane without direct coupling to ATP hydrolysis or transport of other ions(11). Carriers are characterized by turnover numbers that are typically 1,000- fold lower than ion channels, and until now it has been unclear whether the MCU is a carrier or a channel(13). By patch- clamping the inner mitochondrial membrane, we identified a previously unknown Ca2+ selective ion channel sensitive to inhibitors of mitochondrial Ca2+ uptake. Our data indicate that this unique channel binds Ca2+ with extremely high affinity ( dissociation constant less than or equal to 2 nM), enabling high Ca2+ selectivity despite relatively low cytoplasmic Ca2+ concentrations. The channel is inwardly rectifying, making it especially effective for Ca2+ uptake into energized mitochondria. Thus, we conclude that the properties of the current mediated by this novel channel are those of the MCU.	Childrens Hosp, Howard Hughes Med Inst, Dept Cardiovasc Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Dept Cardiovasc Res, 320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Cannon B, 1979, Methods Enzymol, V55, P65; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; DRAHOTA Z, 1969, ARCH BIOCHEM BIOPHYS, V130, P267, DOI 10.1016/0003-9861(69)90033-2; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hille B., 2001, ION CHANNELS EXCITAB, V3; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; KOSTYUK PG, 1977, J PHYSIOL-LONDON, V270, P569, DOI 10.1113/jphysiol.1977.sp011969; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; TASHMUKH.BA, 1972, FEBS LETT, V28, P239, DOI 10.1016/0014-5793(72)80721-X; VAINIO H, 1970, EUR J BIOCHEM, V12, P387, DOI 10.1111/j.1432-1033.1970.tb00863.x; VINOGRADOV A, 1973, J BIOL CHEM, V248, P5527; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	30	984	1013	4	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					360	364		10.1038/nature02246	http://dx.doi.org/10.1038/nature02246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737170				2022-12-01	WOS:000188266200043
J	Wilson, RI; Turner, GC; Laurent, G				Wilson, RI; Turner, GC; Laurent, G			Transformation of olfactory representations in the Drosophila antennal lobe	SCIENCE			English	Article							PRESYNAPTIC INHIBITION; FLY BRAIN; NEURONS; MELANOGASTER; MECHANISMS; BULB; MAP; TRANSMISSION; GLOMERULI; REVEALS	Molecular genetics has revealed a precise stereotypy in the projection of primary olfactory sensory neurons onto secondary neurons. A major challenge is to understand how this mapping translates into odor responses in these second-order neurons. We investigated this question in Drosophila using whole-cell recordings in vivo. We observe that monomolecular odors generally elicit responses in large ensembles of antennal lobe neurons. Comparison of odor-evoked activity from afferents and postsynaptic neurons in the same glomerulus revealed that second-order neurons display broader tuning and more complex responses than their primary afferents. This indicates a major transformation of odor representations, implicating lateral interactions within the antennal lobe.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.		Wilson, Rachel/E-2227-2012; Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Wilson, Rachel/0000-0001-8573-9266; Turner, Glenn/0000-0002-5341-2784				Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1996, J NEUROSCI, V16, P3837; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Oertner TG, 2001, J NEUROPHYSIOL, V85, P439, DOI 10.1152/jn.2001.85.1.439; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	28	390	394	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					366	370		10.1126/science.1090782	http://dx.doi.org/10.1126/science.1090782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14684826				2022-12-01	WOS:000188111800042
J	Hanley, JA; Turner, E; Bellera, C; Teltsch, D				Hanley, JA; Turner, E; Bellera, C; Teltsch, D			How long did their hearts go on? A Titanic study	BRITISH MEDICAL JOURNAL			English	Article							JAZZ MUSICIANS		McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Math & Stat, Montreal, PQ H3A 1A2, Canada	McGill University; McGill University	Hanley, JA (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.			Bellera, Carine/0000-0001-7926-4671				[Anonymous], ENCY TITANICA; *NAT CTR HLTH STAT, 2002, NAT VITAL STAT REPOR, V51, P26; ROTHMAN KJ, 1992, AM J PUBLIC HEALTH, V82, P761, DOI 10.2105/AJPH.82.5.761; SPENCER FJ, 1991, AM J PUBLIC HEALTH, V81, P804, DOI 10.2105/AJPH.81.6.804-a; *U CA BERK M PLANC, HUM MORT DAT LIF TAB	5	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1457	1458		10.1136/bmj.327.7429.1457	http://dx.doi.org/10.1136/bmj.327.7429.1457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684648	Green Published, Green Accepted			2022-12-01	WOS:000187562700019
J	Whitelaw, CA; Barbazuk, WB; Pertea, G; Chan, AP; Cheung, F; Lee, Y; Zheng, L; van Heeringen, S; Karamycheva, S; Bennetzen, JL; SanMiguel, P; Lakey, N; Bedell, J; Yuan, Y; Budiman, MA; Resnick, A; Van Aken, S; Utterback, T; Riedmuller, S; Williams, M; Feldblyum, T; Schubert, K; Beachy, R; Fraser, CM; Quackenbush, J				Whitelaw, CA; Barbazuk, WB; Pertea, G; Chan, AP; Cheung, F; Lee, Y; Zheng, L; van Heeringen, S; Karamycheva, S; Bennetzen, JL; SanMiguel, P; Lakey, N; Bedell, J; Yuan, Y; Budiman, MA; Resnick, A; Van Aken, S; Utterback, T; Riedmuller, S; Williams, M; Feldblyum, T; Schubert, K; Beachy, R; Fraser, CM; Quackenbush, J			Enrichment of gene-coding sequences in maize by genome filtration	SCIENCE			English	Article							DNA; ORGANIZATION; ELEMENTS	Approximately 80% of the maize genome comprises highly repetitive sequences interspersed with single-copy, gene-rich sequences, and standard genome sequencing strategies are not readily adaptable to this type of genome. Methodologies that enrich for genic sequences might more rapidly generate useful results from complex genomes. Equivalent numbers of clones from maize selected by techniques called methylation filtering and High C(0)t selection were sequenced to generate similar to 200,000 reads ( approximately 132 megabases), which were assembled into contigs. Combination of the two techniques resulted in a sixfold reduction in the effective genome size and a fourfold increase in the gene identification rate in comparison to a nonenriched library.	Inst Genom Res TIGR, Rockville, MD 20850 USA; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Purdue Univ, Purdue Genom Core Facil, W Lafayette, IN 47907 USA; Orion Genom, St Louis, MO 63108 USA; J Craig Venter Sci fdn Joint Technol Ctr, Rockville, MD 20850 USA	J. Craig Venter Institute; Donald Danforth Plant Science Center; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; J. Craig Venter Institute	Barbazuk, WB (corresponding author), Inst Genom Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	BBarbazuk@danforthcenter.org; Johnq@tigr.org	Whitelaw, Catherine Ann/AAD-3716-2021; van Heeringen, Simon/Q-8530-2017; van Heeringen, Simon/H-4937-2012; Jones, Cathy/A-7135-2011; SanMiguel, Phillip J/I-2196-2015	van Heeringen, Simon/0000-0002-0411-3219; Jones, Cathy/0000-0003-2844-2161; SanMiguel, Phillip J/0000-0002-3742-9527; Barbazuk, William/0000-0002-0909-4563; Chan, Agnes/0000-0003-2373-9580; Fraser, Claire/0000-0003-1462-2428; Quackenbush, John/0000-0002-2702-5879				Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1976, P NATL ACAD SCI USA, V73, P415, DOI 10.1073/pnas.73.2.415; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; FREELING M, 1984, ANNU REV PLANT PHYS, V35, P277; GISH WR, 2003, WU BLAST 2 0; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; LANDER E S, 1988, Genomics, V2, P231; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; SPRINGER PS, 1994, P NATL ACAD SCI USA, V91, P863, DOI 10.1073/pnas.91.3.863; YUAN Y, 2003, PLANT J, V33, P1	18	166	195	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2118	2120		10.1126/science.1090047	http://dx.doi.org/10.1126/science.1090047			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684821				2022-12-01	WOS:000187385200043
J	Head, JW; Mustard, JF; Kreslavsky, MA; Milliken, RE; Marchant, DR				Head, JW; Mustard, JF; Kreslavsky, MA; Milliken, RE; Marchant, DR			Recent ice ages on Mars	NATURE			English	Article							MIOCENE GLACIER ICE; SURFACE GROUND ICE; CHAOTIC OBLIQUITY; NEAR-SURFACE; CLIMATE; ANTARCTICA; DEPOSITS; WATER; HYDROGEN; ODYSSEY	A key pacemaker of ice ages on the Earth is climatic forcing due to variations in planetary orbital parameters. Recent Mars exploration has revealed dusty, water-ice-rich mantling deposits that are layered, metres thick and latitude dependent, occurring in both hemispheres from mid-latitudes to the poles. Here we show evidence that these deposits formed during a geologically recent ice age that occurred from about 2.1 to 0.4 Myr ago. The deposits were emplaced symmetrically down to latitudes of similar to30degrees equivalent to Saudi Arabia and the southern United States on the Earth - in response to the changing stability of water ice and dust during variations in obliquity ( the angle between Mars' pole of rotation and the ecliptic plane) reaching 30 - 35degrees. Mars is at present in an 'interglacial' period, and the ice-rich deposits are undergoing reworking, degradation and retreat in response to the current instability of near-surface ice. Unlike the Earth, martian ice ages are characterized by warmer polar climates and enhanced equatorward transport of atmospheric water and dust to produce widespread smooth deposits down to mid-latitudes.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Kharkov Natl Univ, Astron Inst, UA-61077 Kharkov, Ukraine; Boston Univ, Dept Earth Sci, Boston, MA 02215 USA	Brown University; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Boston University	Head, JW (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Kreslavsky, Mikhail/J-3425-2013	Kreslavsky, Mikhail/0000-0002-1900-826X				Bockheim JG, 2002, S AFR J SCI, V98, P82; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CABROL NA, 2002, LUNAR PLANET SCI, V33; Carr MH, 2001, J GEOPHYS RES-PLANET, V106, P23571, DOI 10.1029/2000JE001316; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; CHRISTIEBLICK N, 1982, ICARUS, V50, P408; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; DIXON JC, 1992, BINGHAMPTON S GEOMOR, V22; Fanale F.P., 1992, MARS, P1135; FANALE FP, 1994, ICARUS, V111, P305, DOI 10.1006/icar.1994.1147; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FELDMAN WC, 2003, 6 INT MARS C; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hecht MH, 2002, ICARUS, V156, P373, DOI 10.1006/icar.2001.6794; IMBRIE J, 1982, ICARUS, V50, P408, DOI 10.1016/0019-1035(82)90132-4; Imbrie J., 1986, ICE AGES SOLVING MYS; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; Johnson JB, 2000, GEOPHYS RES LETT, V27, P2769, DOI 10.1029/1999GL011077; Kieffer H. H., 1992, MARS, P1180; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; KOSTAMA VP, 2003, LUNAR PLANET SCI, V34; Kreslavsky MA, 2000, J GEOPHYS RES-PLANET, V105, P26695, DOI 10.1029/2000JE001259; KRESLAVSKY MA, 2002, GEOPHYS RES LETT, V29; KRESLAVSKY MA, 2003, LUNAR PLANET SCI, V34; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Leovy C, 2001, NATURE, V412, P245, DOI 10.1038/35084192; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MANGOLD M, 2002, LUNAR PLANET SCI, V33; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MELLON MT, 2003, LUNAR PLANET SCI, V34; MILLIKEN RE, 2003, J GEOPHYS RES, V108; MISCHNA MA, 2003, J GEOPHYS RES, V108; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; RICHARDSON MI, 2003, LUNAR PLANET SCI, V34; RICHARDSON MI, 2002, J GEOPHYS RES, V107; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; Squyres S. W., 1992, MARS, P523; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; TANAKA KL, 1987, MISC INVEST SER US G; Thomas P., 1992, MARS, P767; TOKAR RL, 2002, GEOPHYS RES LETT, V29; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; Ward W. R., 1992, MARS, P298; Williams P, 1989, FROZEN EARTH; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	50	554	560	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					797	802		10.1038/nature02114	http://dx.doi.org/10.1038/nature02114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685228				2022-12-01	WOS:000187342000047
J	Goldman, AP; Cassidy, J; de Leval, M; Haynes, S; Brown, K; Whitmore, P; Cohen, G; Tsang, V; Elliott, M; Davison, A; Hamilton, L; Bolton, D; Wray, J; Hasan, A; Radley-Smith, R; Macrae, D; Smith, J				Goldman, AP; Cassidy, J; de Leval, M; Haynes, S; Brown, K; Whitmore, P; Cohen, G; Tsang, V; Elliott, M; Davison, A; Hamilton, L; Bolton, D; Wray, J; Hasan, A; Radley-Smith, R; Macrae, D; Smith, J			The waiting game: bridging to paediatric heart transplantation	LANCET			English	Article							MECHANICAL CIRCULATORY SUPPORT; VENTRICULAR ASSIST DEVICE; CLINICAL-EXPERIENCE; CHILDREN; CARDIOMYOPATHY; INFANTS; SYSTEM; VAD	Background Although mechanical circulatory support might not increase the number of adults surviving to transplantation, because of the shortage of donor organs, the situation might be different for children. Our aim was to assess the effect of mechanical assist devices to bridge children with end-stage cardiomyopathy to heart transplantation. Methods A 5-year retrospective review was undertaken with data from the UK paediatric transplant programme and from bridging to transplant done at two paediatric transplant centres in the UK. Findings Between Jan 1, 1998 and Dec 31, 2002, 22 children with end-stage cardiomyopathy, median age 5.7 years (range 1.2-17), were supported by a mechanical assist device as a bridge to first heart transplantation, with a 77% survival rate to hospital discharge. Nine were supported by a paracorporeal ventricular assist device, six received transplantation, five survived to discharge (55%), with one late death. 13 were supported by extra-corporeal membrane oxygenation, and 12 were transplanted and survived to discharge (92%) with one late death. With urgent listing, the median waiting time for a heart was 7.5 days (range 1.5-22 days). The correlation between the proportion of patients bridged to transplantation and the proportion of patients dying while on the transplant waiting list was r=-0.93, p=0.02. Interpretation Our findings lend support to the hypothesis that a national mechanical assist programme to bridge children to transplantation can minimise the number dying while on the heart transplant waiting list. In the context of urgent listing and a short waiting time, extra-corporeal membrane oxygenation seems to provide the safest form of support.	Great Ormond St Hosp Children, London WC1N 3JY, England; Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Royal Brompton & Harefield NHS Trust, London SW3 6NP, England; Childrens Hosp & Reg Med Ctr, Ctr Heart, Seattle, WA 98115 USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle Freeman Hospital; Newcastle University - UK; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Seattle Children's Hospital	Goldman, AP (corresponding author), Great Ormond St Hosp Children, Great Ormond St, London WC1N 3JY, England.		Macrae, Duncan/AAC-9564-2020	Brown, Katherine/0000-0002-0729-4959; Macrae, Duncan/0000-0002-7158-6585; SixNajn, Takashi/0000-0001-7521-1126; Wray, Jo/0000-0002-4769-1211				Daily BB, 1996, ANN THORAC SURG, V61, P437, DOI 10.1016/0003-4975(95)00991-4; Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540; DUNCAN B, 2002, J THORAC CARDIOV SUR, V117, P529; Duncan BW, 2001, J THORAC CARDIOV SUR, V122, P440, DOI 10.1067/mtc.2001.115243; Frazier OH, 2002, CIRCULATION, V105, P2855, DOI 10.1161/01.CIR.0000018167.47314.AF; Hetzer R, 1998, ANN THORAC SURG, V66, P1498, DOI 10.1016/S0003-4975(98)00914-X; Holman WL, 2002, ANN THORAC SURG, V73, P1489, DOI 10.1016/S0003-4975(02)03502-6; Hosenpud JD, 2000, J HEART LUNG TRANSPL, V19, P909, DOI 10.1016/S1053-2498(00)00138-8; Ibrahim AE, 2000, ANN THORAC SURG, V69, P186, DOI 10.1016/S0003-4975(99)01194-7; Kirshbom PM, 2002, J THORAC CARDIOV SUR, V123, P130, DOI 10.1067/mtc.2002.118504; Konertz W, 1997, ANN THORAC SURG, V63, P1138, DOI 10.1016/S0003-4975(97)00063-5; Levi D, 2002, J HEART LUNG TRANSPL, V21, P760, DOI 10.1016/S1053-2498(02)00386-8; Nield LE, 2000, CARDIOL YOUNG, V10, P358; Reinhartz O, 2001, J HEART LUNG TRANSPL, V20, P439, DOI 10.1016/S1053-2498(00)00236-9; Reinhartz O, 2002, ASAIO J, V48, P455, DOI 10.1097/00002480-200209000-00002	15	72	75	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1967	1970		10.1016/S0140-6736(03)15015-5	http://dx.doi.org/10.1016/S0140-6736(03)15015-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683656				2022-12-01	WOS:000187210700009
J	Beall, CM				Beall, CM			High-altitude adaptations	LANCET			English	Article									Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA	Case Western Reserve University	Beall, CM (corresponding author), Case Western Reserve Univ, Dept Anthropol, 238 Mather Mem Bldg,11220 Bellflower Rd, Cleveland, OH 44106 USA.			Beall, Cynthia/0000-0003-1462-8299				SEVERINGHAUS J, HIGH ALTITUDE MED BI	1	47	50	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S14	S15		10.1016/S0140-6736(03)15058-1	http://dx.doi.org/10.1016/S0140-6736(03)15058-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698112				2022-12-01	WOS:000187790200008
J	Thor, J				Thor, J			Realities of rodeo	LANCET			English	Article											Thor, J (corresponding author), 1200 N 36 St, Norfolk, NE 68701 USA.								0	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S52	S53		10.1016/S0140-6736(03)15077-5	http://dx.doi.org/10.1016/S0140-6736(03)15077-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698131				2022-12-01	WOS:000187790200027
J	Young, KV; Brodie, ED; Brodie, ED				Young, KV; Brodie, ED; Brodie, ED			How the horned lizard got its horns	SCIENCE			English	Editorial Material							SELECTION; STRENGTH		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA	Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University	Brodie, ED (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	edb3@bio.indiana.edu	Brodie, Edmund D/B-2335-2013	Young, Kevin/0000-0003-2590-2273				BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Bumpus H.C., 1899, BIOL LECT WOODS HOLE, P209; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; KIPLING R, 2002, JUST SO STORIES; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.2307/2408842, 10.1111/j.1558-5646.1983.tb00236.x]; YOSEF R, 1992, EVOL ECOL, V6, P527, DOI 10.1007/BF02270696	7	56	60	5	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					65	65		10.1126/science.1094790	http://dx.doi.org/10.1126/science.1094790			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15001716				2022-12-01	WOS:000220567900036
J	Plowe, CV; Kublin, PG; Dzinjalamala, FK; Kamwendo, DS; Mukadam, RAG; Chimpeni, P; Molyneux, ME; Taylor, TE				Plowe, CV; Kublin, PG; Dzinjalamala, FK; Kamwendo, DS; Mukadam, RAG; Chimpeni, P; Molyneux, ME; Taylor, TE			Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study	BRITISH MEDICAL JOURNAL			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROFOLATE-REDUCTASE; DIHYDROPTEROATE SYNTHASE; DRUG-RESISTANCE; AFRICA; CHLOROQUINE; MUTATIONS; THERAPY; FAILURE; POLICY	Objective To measure the efficacy of sulfadoxine-pyrimethamine treatment of falciparum malaria in Malawi from 1998 to 2002, after a change from chloroquine to sulfadoxine-pyrimethamine as first line treatment in that country in 1993. Design Prospective open label drug efficacy study. Setting Health centre in large peri-urban township adjacent to Blantyre, Malawi. Participants People presenting to a health centre with uncomplicated Plasmodium falciparum malaria. Main outcome measures Therapeutic efficacy and parasitological resistance to standard sulfadoxine-pyrimediamine treatment at 14 days and 28 days of follow up. Results Therapeutic efficacy remained stable, with adequate clinical response rates of 80% or higher throughout the five years of the study. Analysis of follow up to 28 days showed modest but significant trends towards diminishing clinical and parasitological efficacy over time within the study period. Conclusion Contrary to expectations, sulfadoxine-pyrimethamine has retained good efficacy after 10 years as the first line antimalarial drug in Malawi. African countries with very low chloroquine efficacy, high sulfadoxine-pyrimethamine efficacy, and no other immediately available alternatives may benefit from interim use of sulfadoxine-pyrimethamine while awaiting implementation of combination antimalarial treatments.	Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21044 USA; Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; Michigan State Univ, Coll Osteopath Med, Lansing, MI USA	University System of Maryland; University of Maryland Baltimore; University of Malawi; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine	Plowe, CV (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, 685 W Baltimore St,HSFI-480, Baltimore, MD 21044 USA.	cplowe@medicine.umaryland.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040539, R01AI044824] Funding Source: NIH RePORTER; NIAID NIH HHS [R29 AI-40539, R01-AI-44824] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bloland PB, 2000, B WORLD HEALTH ORGAN, V78, P1378; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Bloland PB, 2003, AM J TROP MED HYG, V68, P125, DOI 10.4269/ajtmh.2003.68.125; Bredenkamp BLF, 2001, SAMJ S AFR MED J, V91, P970; Cortese JF, 1998, MOL BIOCHEM PARASIT, V94, P205, DOI 10.1016/S0166-6851(98)00075-9; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; Plowe CV, 2001, AM J TROP MED HYG, V64, P242, DOI 10.4269/ajtmh.2001.64.242; Plowe CV, 1998, DRUG RESIST UPDATE, V1, P389, DOI 10.1016/S1368-7646(98)80014-9; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Sirawaraporn W, 1997, P NATL ACAD SCI USA, V94, P1124, DOI 10.1073/pnas.94.4.1124; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; *WHO DIV CONTR TRO, 1996, ASS THER EFF ANT DRU; World Health Organization (WHO), 1973, WHO TECHN REP SER, V529	16	70	70	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 6	2004	328	7439					545	+		10.1136/bmj.37977.653750.EE	http://dx.doi.org/10.1136/bmj.37977.653750.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JI	14757706	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000220091800016
J	Schett, G; Kiechl, S; Redlich, K; Oberhollenzer, F; Weger, S; Egger, G; Mayr, A; Jocher, J; Xu, QB; Pietschmann, P; Teitelbaum, S; Smolen, J; Willeit, J				Schett, G; Kiechl, S; Redlich, K; Oberhollenzer, F; Weger, S; Egger, G; Mayr, A; Jocher, J; Xu, QB; Pietschmann, P; Teitelbaum, S; Smolen, J; Willeit, J			Soluble RANKL and risk of nontraumatic fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; POSTMENOPAUSAL WOMEN; HIP FRACTURE; VERTEBRAL FRACTURE; BONE-DENSITY; ELDERLY-MEN; OSTEOPOROSIS; REGRESSION; ACTIVATION	Context The receptor activator of nuclear factor kappaB ligand (RANKL) is essential for osteoclast and, possibly, osteoblast activation and may represent a key link between bone formation and resorption. Objective To determine the relationship between serum level of RANKL and the risk of nontraumatic fracture. Design, Setting, and Participants As part of a prospective population-based study conducted in Bruneck, Italy, we recorded all fractures that occurred between 1990 and 2000 in 906 participants and classified them as traumatic (n=115) or nontraumatic (n=31). Serum levels of RANKL and osteoprotegerin and characteristics of bone metabolism and lifestyle were assessed in 1990 and at follow-up in 1995 and 2000. Main Outcome Measure Incident nontraumatic fracture by levels of RANKL. Results Levels of RANKL did not differ between sexes and were not related to age, menopausal status, lifestyle characteristics, or data from bone ultrasound at the heel. However, RANKL emerged as a significant predictor of nontraumatic fracture. in pooled logistic regression analysis, the relative risks of nontraumatic fracture in the lowest and middle vs highest tertile for RANKL were 10.0 (95% confidence interval [CI], 2.3-43.1) and 3.9 (95% CI, 0.8-19.0) (P<.001 for trend), respectively. Patients in the highest-tertile group had a low risk of fracture even in the presence of other predisposing factors, whereas women aged 60 years or older in the lowest tertile had a 5-year rate of nontraumatic fracture greater than 7%. Conclusions A low level of RANKL is an independent predictor of nontraumatic fracture. This finding is consistent with the hypothesis of an important role of RANKL in human bone turnover and if confirmed in future investigations may gain relevance for assessment of fracture risk.	Univ Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria; Univ Vienna, Dept Pathophysiol, Vienna, Austria; Univ Clin Innsbruck, Dept Neurol, Innsbruck, Austria; Bruneck Hosp, Dept Internal Med, Brunico, Italy; Bruneck Hosp, Dept Lab Med, Brunico, Italy; Bruneck Hosp, Dept Radiol, Brunico, Italy; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	University of Vienna; University of Vienna; Medical University of Innsbruck; St Georges University London; Washington University (WUSTL)	Schett, G (corresponding author), Univ Vienna, Dept Internal Med 3, Div Rheumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	georg.schett@akh-wien.ac.at		Teitelbaum, Steven/0000-0002-4054-6679				Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chapurlat RD, 2000, BONE, V27, P283, DOI 10.1016/S8756-3282(00)00325-2; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LAM J, 2001, J BONE MINER RES  S1, V16, P1053; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Mundy GR, 1999, PRIMER METABOLIC BON, P30, DOI DOI 10.1080/10255840802136150; Salmen T, 2000, J BONE MINER RES, V15, P2479, DOI 10.1359/jbmr.2000.15.12.2479; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SMITHBINDMAN R, 1991, J BONE MINER RES, V6, P25; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; WILCOSKY TC, 1985, J CHRON DIS, V38, P849, DOI 10.1016/0021-9681(85)90109-2; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; 2000, NIH CONSENS STATEMEN, V17, P1	28	127	134	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2004	291	9					1108	1113		10.1001/jama.291.9.1108	http://dx.doi.org/10.1001/jama.291.9.1108			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780AQ	14996780	Bronze			2022-12-01	WOS:000189348900028
J	Ruby, E; Henderson, B; McFall-Ngai, M				Ruby, E; Henderson, B; McFall-Ngai, M			Microbiology - We get by with a little help from our (little) friends	SCIENCE			English	Editorial Material									Univ Hawaii, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96813 USA; UCL, Cellular Microbiol Res Grp, London WC1X 8LD, England	University of Hawaii System; University of London; University College London	McFall-Ngai, M (corresponding author), Univ Hawaii, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96813 USA.	mcfallng@hawaii.edu						Blaser MJ, 2002, JNCI-J NATL CANCER I, V94, P1662; Darveau RP, 2003, ASM NEWS, V69, P186; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Relman DA, 2001, TRENDS MICROBIOL, V9, P206, DOI 10.1016/S0966-842X(01)02041-8; Whitfield J, 2003, NATURE, V423, P583, DOI 10.1038/423583a; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; 2003, INFLUENCE BENEFICIAL	8	50	50	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2004	303	5662					1305	1307		10.1126/science.1094662	http://dx.doi.org/10.1126/science.1094662			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988540				2022-12-01	WOS:000189238600026
J	Folkman, J; Kalluri, R				Folkman, J; Kalluri, R			Cancer without disease	NATURE			English	Editorial Material							ANGIOGENESIS		Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Ctr Matrix Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Folkman, J (corresponding author), Childrens Hosp, Dept Surg, Boston, MA 02115 USA.		Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X				BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Udagawa T, 2002, FASEB J, V16, P1361, DOI 10.1096/fj.01-0813com	5	396	419	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2004	427	6977					787	787		10.1038/427787a	http://dx.doi.org/10.1038/427787a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985739	Bronze			2022-12-01	WOS:000189207500019
J	King, M; Smith, G; Bartlett, A				King, M; Smith, G; Bartlett, A			Treatments of homosexuality in Britain since the 1950s - an oral history: the experience of professionals	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To investigate the experiences of professionals who administered and evaluated treatments for homosexuality in Britain since the 1950s. Design A nationwide study based on qualitative interviews. Participants 30 health professionals who developed and practised treatments for homosexuality Results A range of treatments were developed to make homosexuals into heterosexuals, the most common of which were behavioural interventions. Treatments were based on little evidence of effectiveness and were open to the criticism that legal or social pressures coerced patients. Treatments did not become mainstream within British mental health services. With hindsight, professionals realised that they had not appreciated the influence of social context on sexual behaviour. Most now regarded same sex attraction as compatible with psychological health, although a small minority considered that the option to try to become heterosexual should still be available to patients who desire it. Conclusions Social and political assumptions sometimes lie at the heart of what we regard as mental pathology and serve as a warning for future practice.	UCL Royal Free & Univ Coll Sch Med, Dept Mental Hlth Sci, London NW3 2PF, England; St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England	University of London; University College London; St Georges University London	King, M (corresponding author), UCL Royal Free & Univ Coll Sch Med, Dept Mental Hlth Sci, Royal Free Campus, London NW3 2PF, England.	m.king@rfc.ucl.ac.uk	bartlett, annie/I-6651-2013; King, Michael B/D-7477-2011	bartlett, annie/0000-0002-5498-7141; King, Michael B/0000-0003-4715-7171				King M, 1999, BRIT J PSYCHIAT, V175, P106, DOI 10.1192/bjp.175.2.106; Smith G, 2004, BMJ-BRIT MED J, V328, P427, DOI 10.1136/bmj.37984.442419.EE; Weeks J., 1990, COMING OUT HOMOSEXUA; Wolpe J., 1958, PSYCHOTHERAPY RECIPR	4	33	33	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2004	328	7437					429	432		10.1136/bmj.37984.496725.EE	http://dx.doi.org/10.1136/bmj.37984.496725.EE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777DV	14751921	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000189161000015
J	Thomas, SL; Wheeler, JG; Hall, AJ				Thomas, SL; Wheeler, JG; Hall, AJ			Case-control study of the effect of mechanical trauma on the risk of herpes zoster	BRITISH MEDICAL JOURNAL			English	Article							VARICELLA-ZOSTER; VIRUS		Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England	University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Thomas, SL (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	sara.thomas@lshtm.ac.uk						ARVIN AM, 1992, J INFECT DIS, V166, pS35, DOI 10.1093/infdis/166.Supplement_1.S35; BURKE BL, 1982, ARCH INTERN MED, V142, P291, DOI 10.1001/archinte.142.2.291; MORENS DM, 1980, ANN INTERN MED, V93, P414, DOI 10.7326/0003-4819-93-3-414; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9	5	52	55	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 21	2004	328	7437					439	440		10.1136/bmj.37991.511829.F7	http://dx.doi.org/10.1136/bmj.37991.511829.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777DV	14742350	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000189161000020
J	Cheng, Y; Zak, O; Alsen, P; Harrison, SC; Walz, T				Cheng, Y; Zak, O; Alsen, P; Harrison, SC; Walz, T			Structure of the human transferrin receptor-transferrin complex	CELL			English	Article							HEMOCHROMATOSIS PROTEIN HFE; INDUCED CONFORMATIONAL-CHANGE; IRON RELEASE; C-LOBE; CRYSTAL-STRUCTURE; MONOFERRIC-TRANSFERRINS; ELECTRON-MICROSCOPY; MUTATIONAL ANALYSIS; ERYTHROID-CELLS; LIGAND-BINDING	Iron, insoluble as free Fe3+ and toxic as free Fe2+, is distributed through the body as Fe3+ bound to transferrin (Tf) for delivery to cells by endocytosis of its complex with transferrin receptor (TfR). Although much is understood of the transferrin endocytotic cycle, little has been uncovered of the molecular details underlying the formation of the receptor-transferrin complex. Using cryo-electron microscopy, we have produced a density map of the TfR-Tf complex at subnanometer resolution. An atomic model, obtained by fitting crystal structures of diferric Tf and the receptor ectodomain into the map, shows that the Tf N-lobe is sandwiched between the membrane and the TfR ectodomain and that the C-lobe abuts the receptor helical domain. When Tf binds receptor, its N-lobe moves by about 9 Angstrom with respect to its C-lobe. The structure of TfR-Tf complex helps account for known differences in the iron-release properties of free and receptor bound Tf.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	twalz@hms.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Cheng, Yifan/0000-0001-9535-0369	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK15056] Funding Source: Medline; NIGMS NIH HHS [GM62580] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; Baker E., 1994, ADV INORG CHEM, P389, DOI [10.1016/S0898-8838(08)60176-2, DOI 10.1016/S0898-8838(08)60176-2]; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; BALDWIN DA, 1981, BIOCHEM BIOPH RES CO, V99, P1101, DOI 10.1016/0006-291X(81)90732-4; BALI PK, 1991, BIOCHEMISTRY-US, V30, P9947, DOI 10.1021/bi00105a019; BALI PK, 1991, BIOCHEMISTRY-US, V30, P324, DOI 10.1021/bi00216a003; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bomford A, 2002, LANCET, V360, P1673, DOI 10.1016/S0140-6736(02)11607-2; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Buchegger F, 1996, EUR J BIOCHEM, V235, P9, DOI 10.1111/j.1432-1033.1996.0009u.x; CHAHINE JMEH, 1995, EUR J BIOCHEM, V230, P1102, DOI 10.1111/j.1432-1033.1995.tb20661.x; CHAN LNL, 1992, J BIOL CHEM, V267, P8254; CHAN RYY, 1994, EUR J BIOCHEM, V220, P683, DOI 10.1111/j.1432-1033.1994.tb18669.x; Crichton R., 2001, INORGANIC BIOCH IRON; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Dubljevic V, 1999, BIOCHEM J, V341, P11, DOI 10.1042/0264-6021:3410011; EGAN TJ, 1992, INORG CHEM, V31, P1994, DOI 10.1021/ic00037a005; Enns C.A., 1996, BIOMEMBRANE, V4, P255, DOI [10.1016/S1874-5342(96)80012-2, DOI 10.1016/S1874-5342(96)80012-2]; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fuchs H, 1998, STRUCTURE, V6, P1235, DOI 10.1016/S0969-2126(98)00124-5; GIANNETTI AM, 2003, MECH MULTIPLE LIGAND; Grigorieff N, 2000, ACTA CRYSTALLOGR D, V56, P1270, DOI 10.1107/S0907444900009549; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Halbrooks PJ, 2003, BIOCHEMISTRY-US, V42, P3701, DOI 10.1021/bi027071q; Hall DR, 2002, ACTA CRYSTALLOGR D, V58, P70, DOI 10.1107/S0907444901017309; Jameson GB, 1998, ACTA CRYSTALLOGR D, V54, P1319, DOI 10.1107/S0907444998004417; Jeffrey PD, 1998, BIOCHEMISTRY-US, V37, P13978, DOI 10.1021/bi9812064; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; KRETCHMAR SA, 1988, INORG CHEM, V27, P1436, DOI 10.1021/ic00281a028; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; LIM BC, 1987, J COMP PHYSIOL B, V157, P363, DOI 10.1007/BF00693363; Liu RT, 2003, BIOCHEMISTRY-US, V42, P12447, DOI 10.1021/bi0352973; MacGillivray RTA, 1998, BIOCHEMISTRY-US, V37, P7919, DOI 10.1021/bi980355j; Mason A B, 1991, Protein Expr Purif, V2, P214, DOI 10.1016/1046-5928(91)90074-S; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Nick H, 2003, CURR MED CHEM, V10, P1065, DOI 10.2174/0929867033457610; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; RAO K, 1986, MOL CELL BIOL, V6, P236, DOI 10.1128/MCB.6.1.236; RAWAS A, 1989, J MOL BIOL, V208, P213, DOI 10.1016/0022-2836(89)90100-9; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; Wong JS, 2003, J IMMUNOL, V171, P867, DOI 10.4049/jimmunol.171.2.867; Zak O, 2003, BIOCHEMISTRY-US, V42, P12330, DOI 10.1021/bi034991f; Zak O, 2002, BIOCHEMISTRY-US, V41, P1647, DOI 10.1021/bi015868w; Zak O, 1997, BIOCHEMISTRY-US, V36, P11036, DOI 10.1021/bi970628v; ZAK O, 1994, J BIOL CHEM, V269, P7110	55	379	395	7	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					565	576		10.1016/S0092-8674(04)00130-8	http://dx.doi.org/10.1016/S0092-8674(04)00130-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980223	Bronze			2022-12-01	WOS:000189184200010
J	Liu, L; Yan, Y; Zeng, M; Zhang, J; Hanes, MA; Ahearn, G; McMahon, TJ; Dickfeld, T; Marshall, HE; Que, LG; Stamler, JS				Liu, L; Yan, Y; Zeng, M; Zhang, J; Hanes, MA; Ahearn, G; McMahon, TJ; Dickfeld, T; Marshall, HE; Que, LG; Stamler, JS			Essential roles of S-nitrosothiols in vascular horneostasis and endotoxic shock	CELL			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT FORMALDEHYDE DEHYDROGENASE; NITROSATIVE STRESS; ALCOHOL-DEHYDROGENASE; MICE LACKING; BLOOD-PRESSURE; ORGAN FAILURE; SEPTIC SHOCK; NITROSYLATION; SEPSIS	The current perspective of NO biology is formulated predominantly from studies of NO synthesis. The role of S-nitrosothiol (SNO) formation and turnover in governing NO-related bioactivity remains uncertain. We generated mice with a targeted gene deletion of S-nitrosoglutathione reductase (GSNOR), and show that they exhibit substantial increases in whole-cell S-nitrosylation, tissue damage, and mortality following endotoxic or bacterial challenge. Further, GSNOR(-/-) mice have increased basal levels of SNOs in red blood cells and are hypotensive under anesthesia. Thus, SNOs regulate innate immune and vascular function, and are cleared actively to ameliorate nitrosative stress. Nitrosylation of cysteine thiols is a critical mechanism of NO function in both health and disease.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Pulm, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Lab Anim Resources, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	staml001@mc.duke.edu	McMahon, Tim/K-3986-2012	McMahon, Tim/0000-0002-3404-3223; Stamler, Jonathan/0000-0002-6866-1572				Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; CIRILLO M, 1992, HYPERTENSION, V20, P319, DOI 10.1161/01.HYP.20.3.319; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Didion SP, 2002, CIRC RES, V91, P938, DOI 10.1161/01.RES.0000043280.65241.04; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Feihl F, 2001, PHARMACOL THERAPEUT, V91, P179, DOI 10.1016/S0163-7258(01)00155-3; Foglio MH, 1996, EUR J BIOCHEM, V237, P496, DOI 10.1111/j.1432-1033.1996.0496k.x; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Gonzalez-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hausladen A, 1999, METHOD ENZYMOL, V300, P389; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Jourd'heuil D, 2000, BIOCHEM BIOPH RES CO, V273, P22, DOI 10.1006/bbrc.2000.2892; Kirima K, 2003, AM J PHYSIOL-HEART C, V285, pH589, DOI 10.1152/ajpheart.01010.2002; Kluge I, 1997, J NEUROCHEM, V69, P2599; KNOWLES RG, 1990, BIOCHEM J, V270, P833, DOI 10.1042/bj2700833; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Laubach VE, 1998, AM J PHYSIOL-HEART C, V275, pH2211, DOI 10.1152/ajpheart.1998.275.6.H2211; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marshall HE, 2002, J BIOL CHEM, V277, P34223, DOI 10.1074/jbc.M201638200; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Milsom AB, 2002, DIABETOLOGIA, V45, P1515, DOI 10.1007/s00125-002-0956-9; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAKAZONO K, 1991, P NATL ACAD SCI USA, V88, P10045, DOI 10.1073/pnas.88.22.10045; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nicholson SC, 1999, J SURG RES, V86, P198, DOI 10.1006/jsre.1999.5715; Oberholzer A, 2000, J TRAUMA, V48, P932, DOI 10.1097/00005373-200005000-00019; Ortiz PA, 2003, AM J PHYSIOL-REG I, V284, pR628, DOI 10.1152/ajpregu.00401.2002; Ou JH, 1997, NITRIC OXIDE-BIOL CH, V1, P404, DOI 10.1006/niox.1997.0136; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rees DD, 1998, BRIT J PHARMACOL, V124, P540, DOI 10.1038/sj.bjp.0701815; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; Romeo AA, 2003, J AM CHEM SOC, V125, P14370, DOI 10.1021/ja0289752; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1999, CORONARY ARTERY DIS, V10, P273, DOI 10.1097/00019501-199907000-00001; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Travis MD, 1997, AM J PHYSIOL-HEART C, V273, pH1493, DOI 10.1152/ajpheart.1997.273.3.H1493; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Uotila L, 1997, ADV EXP MED BIOL, V414, P365; UOTILA L, 1989, GLUTATHIONE CHEM B A, P517; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Yang ZN, 1997, J MOL BIOL, V265, P330, DOI 10.1006/jmbi.1996.0731; Zaman K, 2001, BIOCHEM BIOPH RES CO, V284, P65, DOI 10.1006/bbrc.2001.4935; Zellweger R, 1997, CRIT CARE MED, V25, P106, DOI 10.1097/00003246-199701000-00021; Zunic G, 1999, J CHROMATOGR B, V727, P73, DOI 10.1016/S0378-4347(99)00054-7	68	445	475	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					617	628		10.1016/S0092-8674(04)00131-X	http://dx.doi.org/10.1016/S0092-8674(04)00131-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980227	Bronze			2022-12-01	WOS:000189184200014
J	Campbell, DE; Lynn, J; Louis, TA; Shugarman, LR				Campbell, DE; Lynn, J; Louis, TA; Shugarman, LR			Medicare program expenditures associated with hospice use	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL COMORBIDITY INDEX; COST SAVINGS; LAST YEAR; PROPENSITY SCORES; CARE; LIFE; END; PATTERNS; SERVICES; FAILURE	Background: Hospice providers contend that enrollment reduces the cost of the Medicare programs, but estimates of effects are dated, methodologically limited, and focused on persons with cancer. Objective: To estimate the effects of hospice care on Medicare program payments during the last year of life from 1996 to 1999 within cohorts defined by age and diagnosis. Design: Retrospective cohort. Setting: Deceased Medicare enrollees. Participants: Elderly Medicare fee-for-service beneficiaries who received 36 months of continuous Part A and B coverage before death during 1996 to 1999 (n = 245 326). Age- and condition-specific (cancer or noncancer and principal condition) cohorts were defined. Measurements: Medicare expenditures in the last year of life, as a total figure and by service type. The cost effects of hospice were estimated by using linear regression within the cohorts for hospice enrollees compared with nonenrollees after adjustment for propensity to use hospice, gender, race, enrollment in Medicaid, urban setting, duration of illness, comorbid conditions, low use of Medicare, nursing home residence, and year of death. Results: Adjusted mean expenditures were 4.0% higher overall among hospice enrollees than among nonenrollees. Adjusted mean expenditures were 1% lower for hospice enrollees with cancer than for patients with cancer who did not use hospice. Savings were highest (7% to 17%) among enrollees with lung cancer and other very aggressive types of cancer diagnosed in the last year of life. Expenditures for hospice enrollees without cancer were 11% higher than for nonenrollees, ranging from 20% to 44% for patients with dementia and 0% to 16% for those with chronic heart failure or failure of most other organ systems. Hospice-related savings decreased and relative costs increased with age. Conclusion: Hospice enrollment correlates with reduced Medicare expenditures among younger decedents with cancer but increased expenditures among decedents without cancer and those older than 84 years of age. Future studies should assess the effects of hospice on quality and on expenditures from all payment sources.	Washington Home Ctr Palliat Care Studies, Washington, DC 20016 USA; Med Outcomes Res & Evaluat Serv, Thetford, VT USA; RAND Corp, Santa Monica, CA 90407 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	RAND Corporation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lynn, J (corresponding author), Washington Home Ctr Palliat Care Studies, 4200 Wisconsin Ave,4th Floor, Washington, DC 20016 USA.	jlynn@rand.org						Banaszak-Holl J, 1996, Hosp J, V11, P1, DOI 10.1300/J011v11n03_01; BRANCH LG, 1995, GERONTOLOGIST, V35, P349, DOI 10.1093/geront/35.3.349; BROOKS CH, 1984, MED CARE, V22, P691, DOI 10.1097/00005650-198408000-00002; Byock I, 2000, CA-CANCER J CLIN, V50, P123, DOI 10.3322/canjclin.50.2.123; Christakis N A, 1998, Hosp J, V13, P71; Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; *COMM STAT PARTN I, 2001, HOSP CAR 1, P11; Connor S R, 1996, HMO Pract, V10, P20; Covinsky KE, 2003, J AM GERIATR SOC, V51, P492, DOI 10.1046/j.1532-5415.2003.51157.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; EMANUEL EJ, 1994, NEW ENGL J MED, V330, P540, DOI 10.1056/NEJM199402243300806; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; Emanuel EJ, 2002, ARCH INTERN MED, V162, P1722, DOI 10.1001/archinte.162.15.1722; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; Field MJ, 1997, APPROACHING DEATH IM; FOLEY DM, 2001, IMPROVING PALLIATIVE; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; GAGE B, 2000, SYNTHESIS ANAL MEDIC; GAGE B, 2003, MEDICARES HOSPICE BE; *GEN ACC OFF, 2000, GAOHEHS00182; Ghelfi Linda M., 1997, RURAL DEV PERSPECTIV, V12, P32; HARRINGTON C, 1993, GERONTOLOGIST, V33, P790, DOI 10.1093/geront/33.6.790; HOGAN C, 2000, MEDPAC PUBLICATION; HOYERT DL, 1999, DEATHS FINAL DATA 19, V47; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kane RL, 1996, J AM GERIATR SOC, V44, P545, DOI 10.1111/j.1532-5415.1996.tb01440.x; KANE RL, 1984, LANCET, V1, P890; KANE RL, 2001, HDB AGING SOCIAL SCI; KIDDER D, 1992, HEALTH SERV RES, V27, P195; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; Levinsky NG, 1999, J AM GERIATR SOC, V47, P553, DOI 10.1111/j.1532-5415.1999.tb02569.x; Levinsky NG, 2001, JAMA-J AM MED ASSOC, V286, P1349, DOI 10.1001/jama.286.11.1349; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynn J, 1997, New Horiz, V5, P56; Lynn J, 1996, Duquesne Law Rev, V35, P311; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; Lynn J, 1998, Hosp J, V13, P151; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; *MED PAYM ADV COMM, 2002, REP C ASS MED BEN; Medicare Payment Advisory Commission, 2002, REP C MED BEN ACC HO; MILLER GW, 2002, DELIVERING QUALITY C; MILLER SC, 2000, SYNTHESIS ANAL MEDIC; MOON M, 2003, MEDICARE END LIFE CA; MOR V, 1985, HEALTH SERV RES, V20, P407; *NAT HOSP ORG, 1995, AN COST SAV MED HOS; *NAT HOSP PALL CAR, 2001, HOSP HOSP PARTN PALL; *NAT PACE ASS, 2000, PACE PROF PROGR ALL; REIS LA, 2000, SEER STAT REV 1973 1; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schlesselman J.J., 1982, CASE CONTROL STUDIES; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Somogyi-Zalud E, 2000, J AM GERIATR SOC, V48, pS140, DOI 10.1111/j.1532-5415.2000.tb03123.x; SPECTOR WD, 1984, INQUIRY-J HEALTH CAR, V21, P328; WHITE AJ, 2000, EVALUATION PROGRAM A	60	102	104	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2004	140	4					269	277		10.7326/0003-4819-140-4-200402170-00009	http://dx.doi.org/10.7326/0003-4819-140-4-200402170-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774GA	14970150				2022-12-01	WOS:000188970400005
J	Pascual, A; Huang, KL; Neveu, J; Preat, T				Pascual, A; Huang, KL; Neveu, J; Preat, T			Brain asymmetry and long-term memory	NATURE			English	Editorial Material							DROSOPHILA		CNRS, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pascual, A (corresponding author), Hosp Univ Virgen del Rocio, Lab Invest Biomed, Seville 41013, Spain.	preat@iaf.cnrs-gif.fr	Pascual, Alberto P/E-9609-2015; IBIS, NEURONAL/O-9910-2015; Pascual, Alberto/L-2014-2019	Pascual, Alberto P/0000-0001-5459-6207; Pascual, Alberto/0000-0001-5459-6207; Preat, Thomas/0000-0001-9976-1763				Bradshaw JL., 1993, EVOLUTION LATERAL AS; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; GALABURDA AM, 1991, CIBA F SYMP, V162, P219; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Heisenberg M., 1994, FORTSCH ZOOL, V39, P30; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; NASSEL DR, 1982, CELL TISSUE RES, V226, P355; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033	10	133	138	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					605	606		10.1038/427605a	http://dx.doi.org/10.1038/427605a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961111				2022-12-01	WOS:000188875300031
J	Bingley, PJ; Williams, AJK; Norcross, AJ; Unsworth, DJ; Lock, RJ; Ness, AR; Jones, RW				Bingley, PJ; Williams, AJK; Norcross, AJ; Unsworth, DJ; Lock, RJ; Ness, AR; Jones, RW		Avon Longitudinal Study Parents Ch	Undiagnosed coeliac disease at age seven: population based prospective birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN		Univ Bristol, Southmead Hosp, Div Med, Bristol BS10 5NB, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Dept Immunol, Bristol BS10 5NB, Avon, England; Univ Bristol, Div Child Hlth, Unit Paediat & Perinatal Epidemiol, Bristol, Avon, England	Southmead Hospital; University of Bristol; North Bristol NHS Trust; Southmead Hospital; University of Bristol	Bingley, PJ (corresponding author), Univ Bristol, Southmead Hosp, Div Med, Bristol BS10 5NB, Avon, England.	polly.bingley@bristol.ac.uk	Williams, Alistair/E-7647-2013; Ness, Andy R/M-7612-2013	Ness, Andy R/0000-0003-3548-9523; Williams, Alistair/0000-0002-3615-3899				Bazzigaluppi E, 1999, J AUTOIMMUN, V12, P51, DOI 10.1006/jaut.1998.0253; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hawkes ND, 2000, EUR J GASTROEN HEPAT, V12, P345, DOI 10.1097/00042737-200012030-00013; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960	5	189	195	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 7	2004	328	7435					322	323		10.1136/bmj.328.7435.322	http://dx.doi.org/10.1136/bmj.328.7435.322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773ME	14764493	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000188926900020
J	Verdel, A; Jia, ST; Gerber, S; Sugiyama, T; Gygi, S; Grewal, SIS; Moazed, D				Verdel, A; Jia, ST; Gerber, S; Sugiyama, T; Gygi, S; Grewal, SIS; Moazed, D			RNAi-mediated targeting of heterochromatin by the RITS complex	SCIENCE			English	Article							H3 LYSINE-9 METHYLATION; FISSION YEAST; HISTONE H3; EPIGENETIC CONTROL; GENE; DNA; DOMAIN; TRANSCRIPTION; INTERFERENCE; TETRAHYMENA	RNA interference (RNAi) is a widespread silencing mechanism that acts at both the posttranscriptional and transcriptional levels. Here, we describe the purification of an RNAi effector complex termed RITS (RNA-induced initiation of transcriptional gene silencing) that is required for heterochromatin assembly in fission yeast. The RITS complex contains Ago1 ( the fission yeast Argonaute homolog), Chp1 ( a heterochromatin-associated chromodomain protein), and Tas3 ( a novel protein). In addition, the complex contains small RNAs that require the Dicer ribonuclease for their production. These small RNAs are homologous to centromeric repeats and are required for the localization of RITS to heterochromatic domains. The results suggest a mechanism for the role of the RNAi machinery and small RNAs in targeting of heterochromatin complexes and epigenetic gene silencing at specific chromosomal loci.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moazed, D (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov; danesh@hms.harvard.edu	Verdel, André/M-5201-2013	Sugiyama, Tomoyasu/0000-0001-5704-6606; VERDEL, Andre/0000-0001-6048-3794; Gerber, Scott/0000-0002-2964-5051	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM072805, R01 GM072805-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Doe CL, 1998, NUCLEIC ACIDS RES, V26, P4222, DOI 10.1093/nar/26.18.4222; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.3.CO;2-4; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Partridge JF, 2000, GENE DEV, V14, P783; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Thon G, 2000, GENETICS, V155, P551; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	25	919	1027	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					672	676		10.1126/science.1093686	http://dx.doi.org/10.1126/science.1093686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14704433	Green Accepted			2022-12-01	WOS:000188530800041
J	Dubrulle, J; Pourquie, O				Dubrulle, J; Pourquie, O			fgf8 mRNA decay establishes a gradient that couples axial elongation to patterning in the vertebrate embryo	NATURE			English	Article							SIGNALING CONTROLS; GENE; SEGMENTATION; REGIONS	Formation and patterning of the vertebrate embryo occur in a head-to-tail sequence. This progressive mode of body formation from the posterior end of the embryo requires a strict temporal coordination of tissue differentiation - a process involving fibroblast growth factor (FGF) signalling. Here we show that transcription of fgf8 messenger RNA is restricted to the growing posterior tip of the embryo. fgf8 mRNA is progressively degraded in the newly formed tissues, resulting in the formation of an mRNA gradient in the posterior part of the embryo. This fgf8 mRNA gradient is translated into a gradient of FGF8 protein, which correlates with graded phosphorylation of the kinase Akt, a downstream effector of FGF signalling. Such a mechanism provides an efficient means to monitor the timing of FGF signalling, coupling the differentiation of embryonic tissues to the posterior elongation of the embryo. In addition, this mechanism provides a novel model for morphogen gradient formation.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				Bertrand N, 2000, DEVELOPMENT, V127, P4837; Bottone FG, 2003, J BIOL CHEM, V278, P25790, DOI 10.1074/jbc.M301002200; CATALA M, 1995, MECH DEVELOP, V51, P51, DOI 10.1016/0925-4773(95)00350-A; Chellaiah A, 1999, J BIOL CHEM, V274, P34785, DOI 10.1074/jbc.274.49.34785; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Davis Gregory K., 1999, Trends in Cell Biology, V9, pM68, DOI 10.1016/S0962-8924(99)01663-3; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HYMAN RW, 1970, J MOL BIOL, V50, P421, DOI 10.1016/0022-2836(70)90202-0; Kulesa PM, 2002, SCIENCE, V298, P991, DOI 10.1126/science.1075544; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Sawada A, 2001, DEVELOPMENT, V128, P4873; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; STERN CD, 1988, DEVELOPMENT, V104, P231; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1	21	310	320	2	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					419	422		10.1038/nature02216	http://dx.doi.org/10.1038/nature02216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749824				2022-12-01	WOS:000188470500036
J	Staalsoe, T; Shulman, CE; Bulmer, JN; Kawuondo, K; Marsh, K; Hviid, L				Staalsoe, T; Shulman, CE; Bulmer, JN; Kawuondo, K; Marsh, K; Hviid, L			Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria	LANCET			English	Article							CHONDROITIN SULFATE-A; SUB-SAHARAN AFRICA; RED-CELL SURFACE; INFECTED ERYTHROCYTES; PLACENTAL INFECTION; BIRTH-WEIGHT; VAR GENE; ANTIBODIES; ADHESION; WOMEN	Background Pregnancy-associated malaria caused by Plasmodium falciparum adherence to chondroitin sulfate A in the placental intervillous space is a major cause of low birthweight and maternal anaemia in areas of endemic P falciparum transmission. Adhesion-blocking antibodies that specifically recognise parasite-encoded variant surface antigens (VSA) are associated with resistance to pregnancy-associated malaria. We looked for a possible relation between VSA-specific antibody concentrations, placental infection, and protection from low birthweight and maternal anaemia. Methods We used flow cytometry to measure VSA-specific IgG concentrations in plasma samples taken during child birth from 477 Kenyan women selected from a cohort of 910 women on the basis of HIV-1 status, gravidity, and placental histology. We measured VSA expressed by one placental P falciparum isolate and two isolates selected or not selected for chondroitin sulfate A adhesiveness in-vitro. Findings Concentrations of plasma IgG specific for VSA, expressed by chondroitin sulfate A-adhering parasites (VSA in pregnancy-associated malaria or vsa-pam), increased with gravidity and were associated with placental histological findings. Women with chronic pregnancy-associated malaria and low or absent VSA-PAM-specific IgG had lower haemoglobin values (reduced by 17 g/L; 95% CI 8.1-25.2) and delivered smaller babies (birthweight reduced by 0.26 kg; 0.10-0.55) than did corresponding women with high VSA-PAM-specific IgG. No such relation was shown for concentrations of IgG with specificity for non-pregnancy-associated malaria VSA. Interpretation VSA-PAM-specific IgG protects against low birthweight and maternal anaemia. Our data indicate an important mechanism of clinical protection against malaria and raise hope for the clinical effectiveness of a potential VSA-based vaccine against pregnancy-associated malaria.	Univ Copenhagen Hosp, Rigshosp, Ctr Med Parasitol, Dept Infect Dis, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Inst Med Microbiol & Immunol, Copenhagen, Denmark; London Sch Hyg & Trop Med, London WC1, England; Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; Univ Newcastle Upon Tyne, Royal Victoria Infirm, Dept Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; Newcastle University - UK	Hviid, L (corresponding author), Rigshosp, Dept Infect Dis M7641, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	lhcmp@rh.dk	Hviid, Lars/G-3705-2012	Hviid, Lars/0000-0002-1698-4927; Shulman, Caroline/0000-0002-7744-2101; Staalso, Trine/0000-0002-7259-9425				Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Beeson JG, 2002, TRENDS PARASITOL, V18, P145, DOI 10.1016/S1471-4922(01)02228-0; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GARNER P, 2003, COCHRANE LIB; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; NGUYENDINH P, 1988, LANCET, V2, P751; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ofori MF, 2003, INFECT IMMUN, V71, P1584, DOI 10.1128/IAI.71.3.1584-1586.2003; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Okoko BJ, 2003, ACTA TROP, V87, P193, DOI 10.1016/S0001-706X(03)00097-4; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2002, MOL BIOCHEM PARASIT, V122, P111, DOI 10.1016/S0166-6851(02)00080-4; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161	29	222	224	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2004	363	9405					283	289		10.1016/S0140-6736(03)15386-X	http://dx.doi.org/10.1016/S0140-6736(03)15386-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766FQ	14751701				2022-12-01	WOS:000188361400010
J	Leroy, EM; Rouquet, P; Formenty, P; Souquiere, S; Kilbourne, A; Froment, JM; Bermejo, M; Smit, S; Karesh, W; Swanepoel, R; Zaki, SR; Rollin, PE				Leroy, EM; Rouquet, P; Formenty, P; Souquiere, S; Kilbourne, A; Froment, JM; Bermejo, M; Smit, S; Karesh, W; Swanepoel, R; Zaki, SR; Rollin, PE			Multiple Ebola virus transmission events and rapid decline of central African wildlife	SCIENCE			English	Article							HEMORRHAGIC-FEVER; SEQUENCE-ANALYSIS; OUTBREAK; REEMERGENCE; CONGO	Several human and animal Ebola outbreaks have occurred over the past 4 years in Gabon and the Republic of Congo. The human outbreaks consisted of multiple simultaneous epidemics caused by different viral strains, and each epidemic resulted from the handling of a distinct gorilla, chimpanzee, or duiker carcass. These animal populations declined markedly during human Ebola outbreaks, apparently as a result of Ebola infection. Recovered carcasses were infected by a variety of Ebola strains, suggesting that Ebola outbreaks in great apes result from multiple virus introductions from the natural host. Surveillance of animal mortality may help to predict and prevent human Ebola outbreaks.	Ctr Int Rech Med Franceville, UR034, Inst Rech Dev, Franceville, Gabon; WHO, Dept Communicable Dis Surveillance & Response, Global Alert & Response Team, Geneva, Switzerland; Wildlife Conservat Soc, Bronx, NY 10460 USA; Programme Conservat & Utilisat Rat Ecosyst Forest, Libreville, Gabon; Natl Inst Communicable Dis, Special Pathogens Unit, ZA-2131 Johannesburg, South Africa; Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA	Institut de Recherche pour le Developpement (IRD); World Health Organization; Wildlife Conservation Society; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA	Leroy, EM (corresponding author), Ctr Int Rech Med Franceville, UR034, Inst Rech Dev, BP 769, Franceville, Gabon.	Eric.Leroy@ird.fr	LEROY, Eric M/I-4347-2016; Karesh, William/AAU-9084-2020	LEROY, Eric M/0000-0003-0022-0890; Karesh, William/0000-0001-6042-2860; Rollin, Pierre/0000-0002-4608-2641				[Anonymous], 2001, Wkly Epidemiol Rec, V76, P41; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Formenty P, 2003, Med Trop (Mars), V63, P291; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Leroy EM, 2000, J MED VIROL, V60, P463, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;463::AID-JMV15&gt;3.0.CO;2-M; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; LEROY EM, UNPUB; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Zaki SR, 1999, J INFECT DIS, V179, pS36, DOI 10.1086/514319	21	446	474	2	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					387	390		10.1126/science.1092528	http://dx.doi.org/10.1126/science.1092528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726594				2022-12-01	WOS:000188111800048
J	Lukowitz, W; Roeder, A; Parmenter, D; Somerville, C				Lukowitz, W; Roeder, A; Parmenter, D; Somerville, C			A MAPKK kinase gene regulates extra-embryonic cell fate in Arabidopsis	CELL			English	Article							BASAL PATTERN-FORMATION; GNOM ARF-GEF; EARLY EMBRYOGENESIS; PLANT CYTOKINESIS; INNATE IMMUNITY; AUXIN GRADIENTS; PROTEIN; EMBRYO; THALIANA; SUSPENSOR	The Arabidopsis zygote divides asymmetrically into an embryonic apical cell and a basal cell with mostly extra-embryonic fate. This fundamental asymmetry sets the stage for further embryonic development, but the events mediating it are poorly understood. We have identified a MAPKK kinase gene, named YODA, that promotes extra-embryonic cell fates in the basal lineage. In loss-of-function mutants, the zygote does not elongate properly, and the cells of the basal lineage are eventually incorporated into the embryo instead of differentiating the extra-embryonic suspensor. Gain-of-function alleles cause exaggerated growth of the suspensor and can suppress embryonic development to a degree where no recognizable proembryo is formed. Our results imply that a MAP kinase cascade acts as a molecular switch promoting extra-embryonic fate.	Stanford Univ, Carnegie Inst, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University; Stanford University	Somerville, C (corresponding author), Stanford Univ, Carnegie Inst, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	crs@stanford.edu	Somerville, Christopher R/A-4048-2009; Roeder, Adrienne/ABF-5334-2021	Somerville, Christopher R/0000-0003-4647-0094; Roeder, Adrienne/0000-0001-6685-2984				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asamizu E, 2000, DNA RES, V7, P175, DOI 10.1093/dnares/7.3.175; BERLETH T, 1993, DEVELOPMENT, V118, P575; Berleth T, 2002, ARABIDOPSIS BOOK; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DEVIC M, 1995, CR ACAD SCI III-VIE, V318, P121; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; HERNANDEZ LF, 1993, PLANT CELL, V5, P1725, DOI 10.1105/tpc.5.12.1725; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; MANSFIELD SG, 1991, CAN J BOT, V69, P447, DOI 10.1139/b91-062; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; MAYER U, 1993, DEVELOPMENT, V117, P149; MCELROY D, 1995, MOL BREEDING, V1, P27, DOI 10.1007/BF01682087; Nishihama R, 2001, GENE DEV, V15, P352, DOI 10.1101/gad.863701; Ptashne M, 2003, SCIENCE, V299, P1025, DOI 10.1126/science.1081519; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Soyano T, 2002, PHILOS T R SOC B, V357, P767, DOI 10.1098/rstb.2002.1094; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; VERNON DM, 1994, DEV BIOL, V165, P566, DOI 10.1006/dbio.1994.1276; Waizenegger I, 2000, CURR BIOL, V10, P1371, DOI 10.1016/S0960-9822(00)00775-2; WEBB MC, 1991, PLANTA, V184, P187, DOI [10.1007/BF01102418, 10.1007/BF00197947]; Weterings K, 2001, PLANT CELL, V13, P2409, DOI 10.1105/tpc.13.11.2409; YEUNG EC, 1993, PLANT CELL, V5, P1371, DOI 10.1105/tpc.5.10.1371; Zhang JZ, 1997, P NATL ACAD SCI USA, V94, P7349, DOI 10.1073/pnas.94.14.7349	39	286	307	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2004	116	1					109	119		10.1016/S0092-8674(03)01067-5	http://dx.doi.org/10.1016/S0092-8674(03)01067-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718171	Bronze			2022-12-01	WOS:000187960800013
J	Kandhai, MC; Reij, MW; Gorris, LGM; Guillaume-Gentil, O; van Schothorst, M				Kandhai, MC; Reij, MW; Gorris, LGM; Guillaume-Gentil, O; van Schothorst, M			Occurrence of Enterobacter sakazakii in food production environments and households	LANCET			English	Article							FORMULA	Enterobacter sakazakii occasionally causes illness in premature babies and neonates. Contamination of infant formulae during factory production or bottle preparation is implicated. Advice to health-care professionals focuses on bottle preparation, but the effectiveness of prevention depends on the degree of contamination and contamination sites, which are generally unknown. To keep contamination to a minimum in the finished product depends on knowledge of the occurrence of E sakazakii. We used a refined isolation and detection method to investigate the presence of this micro-organism in various food factories and households. Environmental samples from eight of nine food factories and from five of 16 households contained E sakazakii. The widespread nature of this microorganism needs to be taken into account when designing preventive control measures.	Univ Wageningen & Res Ctr, Food Microbiol Lab, NL-6700 EV Wageningen, Netherlands; Nestle Res Ctr, Qual & Safety Assurance Dept, CH-1000 Lausanne, Switzerland	Wageningen University & Research; Nestle SA	Kandhai, MC (corresponding author), Univ Wageningen & Res Ctr, Food Microbiol Lab, POB 8129, NL-6700 EV Wageningen, Netherlands.		Reij, Martine/F-3330-2011	Gorris, Leon/0000-0001-7275-6681				Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Leclercq A, 2002, APPL ENVIRON MICROB, V68, P1631, DOI 10.1128/AEM.68.4.1631-1638.2002; MUYTJENS HL, 1988, J CLIN MICROBIOL, V26, P743, DOI 10.1128/JCM.26.4.743-746.1988; MUYTJENS HL, 1990, PEDIATR INFECT DIS J, V9, P372, DOI 10.1097/00006454-199005000-00016; NazarowecWhite M, 1997, LETT APPL MICROBIOL, V24, P9, DOI 10.1046/j.1472-765X.1997.00328.x	5	242	257	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 3	2004	363	9402					39	40		10.1016/S0140-6736(03)15169-0	http://dx.doi.org/10.1016/S0140-6736(03)15169-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758YZ	14723994				2022-12-01	WOS:000187711300014
J	Randak, C; Welsh, MJ				Randak, C; Welsh, MJ			An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ATP-BINDING-CASSETTE; RECOMBINANT POLYPEPTIDE MODEL; CYSTIC-FIBROSIS; CRYSTAL-STRUCTURE; CHLORIDE CHANNELS; DOMAIN; SITE; MECHANISM; HYDROLYSIS	Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel in the ATP binding cassette (ABC) transporter family. Like other ABC transporters, it can hydrolyze ATP. Yet while ATP hydrolysis influences channel gating, it has long seemed puzzling that CFTR would require this reaction because anions flow passively through CFTR. Moreover, no other ion channel is known to require the large energy of ATP hydrolysis to gate. We found that CFTR also has adenylate kinase activity (ATP + AMP reversible arrow ADP + ADP) that regulates gating. When functioning as an adenylate kinase, CFTR showed positive cooperativity for ATP suggesting its two nucleotide binding domains may dimerize. Thus, channel activity could be regulated by two different enzymatic reactions, ATPase and adenylate kinase, that share a common ATP binding site in the second nucleotide binding domain. At physiologic nucleotide concentrations, adenylate kinase activity, rather than ATPase activity may control gating, and therefore involve little energy consumption.	Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Dept Phys & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu		Welsh, Michael/0000-0002-1646-6206; Randak, Christoph/0000-0003-3264-4137	NHLBI NIH HHS [HL29851-21, HL1234-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL029851, R01HL029851] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2002, J BIOL CHEM, V277, P2125, DOI 10.1074/jbc.M109539200; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BOZZI A, 1994, BIOCHEM MOL BIOL INT, V32, P95; BYEON IJL, 1995, BIOCHEMISTRY-US, V34, P3172, DOI 10.1021/bi00010a006; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Cotten JF, 1998, J BIOL CHEM, V273, P31873, DOI 10.1074/jbc.273.48.31873; Dassa E., 2003, ABC PROTEINS BACTERI, P3; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 1996, J BIOL CHEM, V271, P4858; DIEDERICHS K, 1990, BIOCHEMISTRY-US, V29, P8138, DOI 10.1021/bi00487a022; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; FELDHAUS P, 1975, EUR J BIOCHEM, V57, P197, DOI 10.1111/j.1432-1033.1975.tb02291.x; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; FONT B, 1980, BIOCHIM BIOPHYS ACTA, V611, P299, DOI 10.1016/0005-2744(80)90065-0; Fontanella L, 1999, ANAL BIOCHEM, V269, P353, DOI 10.1006/abio.1999.4042; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hanrahan JW, 2003, ABC PROTEINS BACTERI, P589; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Ishihara H, 1997, AM J PHYSIOL-CELL PH, V273, pC1278, DOI 10.1152/ajpcell.1997.273.4.C1278; ITO Y, 1980, EUR J BIOCHEM, V105, P85, DOI 10.1111/j.1432-1033.1980.tb04477.x; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kosloff M, 2003, J MOL BIOL, V331, P1157, DOI 10.1016/S0022-2836(03)00847-7; Levitzki A, 1976, Curr Top Cell Regul, V10, P1; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MALAISSE WJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P190, DOI 10.1016/0167-4889(87)90134-0; MENENDEZ M, 1985, BIOPHYS CHEM, V21, P249, DOI 10.1016/0301-4622(85)80012-0; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OKAJIMA T, 1993, J BIOCHEM-TOKYO, V114, P627, DOI 10.1093/oxfordjournals.jbchem.a124228; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OSBORNE L, 1992, HUM GENET, V89, P653, DOI 10.1007/BF00221957; Ostedgaard LS, 2002, P NATL ACAD SCI USA, V99, P3093, DOI 10.1073/pnas.261714599; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Randak C, 1997, FEBS LETT, V410, P180, DOI 10.1016/S0014-5793(97)00574-7; Randak C, 1999, BIOCHEM J, V340, P227, DOI 10.1042/0264-6021:3400227; Randak C, 1996, FEBS LETT, V398, P97, DOI 10.1016/S0014-5793(96)01217-3; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; SCHULTZ BD, 1995, J GEN PHYSIOL, V105, P329, DOI 10.1085/jgp.105.3.329; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; ZELEZNIKAR RJ, 1995, J BIOL CHEM, V270, P7311, DOI 10.1074/jbc.270.13.7311; Zeltwanger S, 1999, J GEN PHYSIOL, V113, P541, DOI 10.1085/jgp.113.4.541	75	50	52	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					837	850		10.1016/S0092-8674(03)00983-8	http://dx.doi.org/10.1016/S0092-8674(03)00983-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697202	Bronze			2022-12-01	WOS:000187664700008
J	Vargason, JM; Szittya, G; Burgyan, J; Hall, TMT				Vargason, JM; Szittya, G; Burgyan, J; Hall, TMT			Size selective recognition of siRNA by an RNA silencing suppressor	CELL			English	Article							BUSHY-STUNT-VIRUS; SHORT INTERFERING RNA; NICOTIANA-BENTHAMIANA; VIRAL SUPPRESSOR; PROTEIN; PLANTS; DNA; EXPRESSION; INDUCTION; SYSTEM	RNA silencing in plants likely exists as a defense mechanism against molecular parasites such as RNA viruses, retrotransposons, and transgenes. As a result, many plant viruses have adapted mechanisms to evade and suppress gene silencing. Tombusviruses express a 19 kDa protein (p19), which has been shown to suppress RNA silencing in vivo and bind silencing-generated and synthetic small interfering RNAs (siRNAs) in vitro. Here we report the 2.5 Angstrom crystal structure of p19 from the Carnation Italian ringspot virus (CIRV) bound to a 21 nt siRNA and demonstrate in biochemical and in vivo assays that CIRV p19 protein acts as a molecular caliper to specifically select siRNAs based on the length of the duplex region of the RNA.	NIEHS, Lab Struct Biol, NIH, Res Triangle Pk, NC 27709 USA; Plant Biol Inst, Agr Biotechnol Ctr, Godollo, Hungary	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hall, TMT (corresponding author), NIEHS, Lab Struct Biol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Hall, Traci/F-5849-2019; Szittya, Gyorgy/M-9199-2019; Burgyan, Jozsef/C-7511-2012; Szittya, Gyorgy/A-2905-2012	Hall, Traci/0000-0001-6166-3009; Szittya, Gyorgy/0000-0003-2040-2851; Szittya, Gyorgy/0000-0003-2040-2851	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050165, ZIAES050165] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Baulcombe D, 2002, TRENDS MICROBIOL, V10, P306, DOI 10.1016/S0966-842X(02)02387-9; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brunger A. T., 1992, NATURE, V355, P472; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgyan J, 1996, J GEN VIROL, V77, P1967, DOI 10.1099/0022-1317-77-8-1967; Chu M, 2000, VIROLOGY, V266, P79, DOI 10.1006/viro.1999.0071; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; DALMAY T, 1993, VIROLOGY, V194, P697, DOI 10.1006/viro.1993.1310; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL., 2002, PYMOL USERS MANUAL D; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hull R, 2002, MATTHEWS PLANT VIROL; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung J, 2001, PROTEIN SCI, V10, P1881, DOI 10.1110/ps.05801; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Qu F, 2002, MOL PLANT MICROBE IN, V15, P193, DOI 10.1094/MPMI.2002.15.3.193; SCHOLTHOF HB, 1995, PLANT CELL, V7, P1157, DOI 10.1105/tpc.7.8.1157; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2002, CURR OPIN PLANT BIOL, V5, P444, DOI 10.1016/S1369-5266(02)00291-1; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	66	426	463	3	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					799	811		10.1016/S0092-8674(03)00984-X	http://dx.doi.org/10.1016/S0092-8674(03)00984-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697199	Bronze, Green Submitted			2022-12-01	WOS:000187664700005
J	Stone, A				Stone, A			Audit of soap usage by a primary care team	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Canna Surg, Cardiff CF11 9EE, S Glam, Wales		Stone, A (corresponding author), Canna Surg, Cardiff CF11 9EE, S Glam, Wales.	alan_stone@btinternet.com						Cohen HA, 1998, INFECTION, V26, P49, DOI 10.1007/BF02768754; Cookson B, 1999, BRIT MED J, V318, P686; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Rotter ML, 1997, HYG MED, V22, P332, DOI DOI 10.1136/BMJ.319.7208.518	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2003	327	7429					1453	1454		10.1136/bmj.327.7429.1453	http://dx.doi.org/10.1136/bmj.327.7429.1453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684644	Green Published			2022-12-01	WOS:000187562700015
J	Wang, Z; Lin, HF				Wang, Z; Lin, HF			Nanos maintains germline stem cell self-renewal by preventing differentiation	SCIENCE			English	Article							DROSOPHILA; PUMILIO; GENE; TRANSCRIPTION; DIVISION; PROTEINS; ROLES; RNA	Despite much progress in understanding how extrinsic signaling regulates stem cell self-renewal, little is known about how cell-autonomous gene regulation controls this process. In Drosophila ovaries, germline stem cells (GSCs) divide asymmetrically to produce daughter GSCs and cystoblasts, the latter of which develop into germline cysts. Here, we show that removing the translational repressor Nanos from either GSCs or their precursors, the primordial germ cells (PGCs), causes both cell types to differentiate into germline cysts. Thus, Nanos is essential for both establishing and maintaining GSCs by preventing their precocious entry into oogenesis. These functions are likely achieved by repressing the translation of differentiation factors in PGCs and GSCs.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Lin, HF (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	h.lin@cellbio.duke.edu	Wang, Zhong/E-7897-2011; Wang, Zhong/J-3244-2019	Wang, Zhong/0000-0002-6307-0458	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033760] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33760] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Asaoka M, 1998, MECH DEVELOP, V78, P153, DOI 10.1016/S0925-4773(98)00164-6; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Bhat KM, 1999, GENETICS, V151, P1479; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; CHOU TB, 1992, GENETICS, V131, P643; Deshpande G, 1999, CELL, V99, P271, DOI 10.1016/S0092-8674(00)81658-X; Forbes A, 1998, DEVELOPMENT, V125, P679; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; KING RC, 1970, OVARIAN DEV DROSOPHI, P54; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; LIN H, 2004, STEM CELLS HDB, P57; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Lin HF, 1997, DEVELOPMENT, V124, P2463; Parisi M, 1999, GENETICS, V153, P235; POIRIE M, 1995, DEVELOPMENT, V121, P1867; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; WIESCHAUS E, 1979, DEV BIOL, V68, P29, DOI 10.1016/0012-1606(79)90241-0; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	25	183	197	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2016	2019		10.1126/science.1093983	http://dx.doi.org/10.1126/science.1093983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	14976263				2022-12-01	WOS:000220429800041
J	Gibbs, JL; Monro, JL; Cunningham, D; Rickards, A				Gibbs, JL; Monro, JL; Cunningham, D; Rickards, A			Survival after surgery or therapeutic catheterisation for congenital heart disease in children in the United Kingdom: analysis of the central cardiac audit database for 2000-1	BRITISH MEDICAL JOURNAL			English	Article							PERFORMANCE	Objectives To analyse simple national statistics and survival data collected in the central cardiac audit database after treatment for congenital heart disease and to provide long term comparative statistics for each contributing centre. Design Prospective, longitudinal, observational, national cohort survival study. Setting UK central cardiac audit database. Main outcome measures Survival at 30 days and one year after treatment in the year April 2006-March 200 1, assessed by using both volunteered life status and independently validated life status through the Office for National Statistics, using the patient's unique NHS number, or the general register offices of Scotland and Northern Ireland. Institutional results following a group of six benchmark operations and three benchmark catheterisation procedures. Results Since April 2000 data have been received from all 13 UK tertiary centres performing cardiac surgery or therapeutic cardiac catheterisation in children with congenital heart disease. Altogether 3666 surgical procedures and 1828 therapeutic catheterisations were performed. Central tracking of mortality identified 469 deaths, 194 occurring within, 30 days and 27 5 later. Forty two of the 194 deaths within 30 days were detected by central tracking but not by volunteered data. For surgery overall, survival at 30 days was 94.9%, falling to 91.2% at one year; this effect was most marked for infants. For therapeutic catheterisation survival at 30 days was 99.1%, falling to 98.1% at one year. Survival of individual centres or individual operators did not differ from the national average after benchmark procedures. Conclusions Independent data validation is essential for accurate survival analysis. One year survival gives a more realistic view of outcome than traditional perioperative mortality. Currently no detectable difference exists in survival between any of the 13 UK tertiary congenital heart disease centres, but confidence intervals for small centres are wide, limiting our power to detect underperformance from analysis of a single year's data. Appropriately resourced, focused national audit is capable of accurate data collection on which nationwide, long term quality control can be based.	Gen Infirm, Dept Pediat Cardiol, Cent Cardiac Audit Database, Leeds LS1 3EX, W Yorkshire, England; Southampton Gen Hosp, Soc Cardiothorac Surg England & Ireland, Southampton SO16 6YD, Hants, England; Royal Brompton Hosp, Cent Cardiac Audit Database, London SW3 6NP, England	Leeds General Infirmary; University of Southampton; Royal Brompton Hospital	Gibbs, JL (corresponding author), Gen Infirm, Dept Pediat Cardiol, Cent Cardiac Audit Database, Leeds LS1 3EX, W Yorkshire, England.	jgibbs@boltblue.com						Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; Franklin R C, 2000, Cardiol Young, V10 Suppl 1, P1; Gallivan S, 2001, EUR J CARDIO-THORAC, V20, P1214, DOI 10.1016/S1010-7940(01)01008-9; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Lacour-Gayet F, 2000, EUR J CARDIO-THORAC, V18, P128, DOI 10.1016/S1010-7940(00)00463-2; Mavroudis C, 2000, Ann Thorac Surg, V69, pS2; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nieminen HP, 2001, CIRCULATION, V104, P570, DOI 10.1161/hc3101.093968; Stark J, 2000, LANCET, V355, P1004, DOI 10.1016/S0140-6736(00)90001-1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	10	63	68	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 13	2004	328	7440					611	615		10.1136/bmj.38027.613403.F6	http://dx.doi.org/10.1136/bmj.38027.613403.F6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803CB	14982866	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000220208100017
J	Tuomilehto, J; Hu, G; Bidel, S; Lindstrom, J; Jousilahti, P				Tuomilehto, J; Hu, G; Bidel, S; Lindstrom, J; Jousilahti, P			Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; CHLOROGENIC ACID; CAFFEINE INTAKE; LEISURE-TIME; LIFE-STYLE; GREEN TEA; DISEASE	Context Only a few studies of coffee consumption and diabetes mellitus (DM) have been reported, even though coffee is the most consumed beverage in the world. Objective To determine the relationship between coffee consumption and the incidence of type 2 DM among Finnish individuals, who have the highest coffee consumption in the world. Design, Setting, and Participants A prospective study from combined surveys conducted in 1982, 1987, and 1992 of 6974 Finnish men and 7655 women aged 35 to 64 years without history of stroke, coronary heart disease, or DM at baseline, with 175682 person-years of follow-up. Coffee consumption and other study parameters were determined at baseline using standardized measurements. Main Outcome Measures Hazard ratios (HRs) for the incidence of type 2 DM were estimated for different levels of daily coffee consumption. Results During a mean follow-up of 12 years, there were 381 incident cases of type 2 DM. After adjustment for confounding factors (age, study year, body mass index, systolic blood pressure, education, occupational, commuting and leisure-time physical activity, alcohol and tea consumption, and smoking), the HRs of DM associated with the amount of coffee consumed daily (0-2, 3-4, 5-6, 7-9, greater than or equal to10 cups) were 1.00, 0.71 (95% confidence interval [CI], 0.48-1.05), 0.39 (95% CI, 0.25-0.60), 0.39 (95% CI, 0.20-0.74), and 0.21 (95% CI, 0.06-0.69) (P for trend <.001) in women, and 1.00, 0.73 (95% CI, 0.47-1.13), 0.70 (95% CI, 0.45-1.05), 0.67 (95% CI, 0.40-1.12), and 0.45 (95% CI, 0.25-0.81) (P for trend=.12) in men, respectively. In both sexes combined, the multivariate-adjusted inverse association was significant (P for trend <.001) and persisted when stratified by younger and older than 50 years; smokers and never smokers; healthy weight, overweight, and obese participants; alcohol drinker and nondrinker; and participants drinking filtered and nonfiltered coffee. Conclusion Coffee drinking has a graded inverse association with the risk of type 2 DM; however, the reasons for this risk reduction associated with coffee remain unclear.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Inst Biomed, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki	Tuomilehto, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	jaakko.tuomilehto@ktl.fi	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Lindstrom, Jaana/0000-0001-9255-020X				Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Andrade-Cetto A, 2001, J ETHNOPHARMACOL, V78, P145, DOI 10.1016/S0378-8741(01)00335-X; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; ARO A, 1990, COFFEE CORONARY HEAR, P71; Barbagallo Mario, 2003, Molecular Aspects of Medicine, V24, P39, DOI 10.1016/S0098-2997(02)00090-0; Curhan GC, 1998, ANN INTERN MED, V128, P534, DOI 10.7326/0003-4819-128-7-199804010-00003; del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q; Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975; Goodman-Gruen D, 2001, J NUTR, V131, P1202, DOI 10.1093/jn/131.4.1202; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Isogawa A, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12586-X; Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832; Leitzmann MF, 1999, JAMA-J AM MED ASSOC, V281, P2106, DOI 10.1001/jama.281.22.2106; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; NEWGARD CB, 1984, DIABETES, V33, P192, DOI 10.2337/diabetes.33.2.192; PAJAK A, 1988, World Health Statistics Quarterly, V41, P115; Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1; PAOLISSO G, 1990, DIABETOLOGIA, V33, P511, DOI 10.1007/BF00404136; PAOLISSO G, 1995, J CLIN ENDOCR METAB, V80, P1382, DOI 10.1210/jc.80.4.1382; PIETINEN P, 1990, INT J EPIDEMIOL, V19, P586, DOI 10.1093/ije/19.3.586; Pizziol A, 1998, EUR J CLIN NUTR, V52, P846, DOI 10.1038/sj.ejcn.1600657; Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4; ROBERTSON D, 1984, AM J MED, V77, P54, DOI 10.1016/0002-9343(84)90435-2; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; TUOMILEHTO J, 1990, BRIT MED J, V300, P642, DOI 10.1136/bmj.300.6725.642; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; *WHO STUD GROUP DI, 1985, WHO TECHN REP SER, V727; *WORLD RES I, EARTH TRENDS DAT TAB; Yoshioka K, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12585-8; YOUN JH, 1986, J BIOL CHEM, V261, P5960; Zeegers MPA, 2001, INT J EPIDEMIOL, V30, P353, DOI 10.1093/ije/30.2.353	44	206	222	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2004	291	10					1213	1219		10.1001/jama.291.10.1213	http://dx.doi.org/10.1001/jama.291.10.1213			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800XV	15010442	Bronze			2022-12-01	WOS:000220061900021
J	Dai, JY; Liu, J; Deng, YQ; Smith, TM; Lu, M				Dai, JY; Liu, J; Deng, YQ; Smith, TM; Lu, M			Structure and protein design of a human platelet function inhibitor	CELL			English	Article							MACROMOLECULAR STRUCTURES; EXPRESSION; THROMBOREGULATION; NUCLEOTIDASE; DIFFRACTION; REFINEMENT; HEMOSTASIS; PROPELLER; CLONING; BLOOD	Hematophagous arthropods secrete a salivary apyrase that inhibits platelet activation by catabolizing ADP released from damaged tissues and blood cells. We report the X-ray crystal structures of a human enzyme of the soluble apyrase family in its apo state and bound to a substrate analog. The structures reveal a nucleotide binding domain comprising a five-blade P propeller, binding determinants of the substrate and the active site, and an unusual calcium binding site with a potential regulatory function. Using a comparative structural biology approach, we were able to redesign the human apyrase so as to enhance its ADPase activity by more than 100-fold. The engineered enzyme is a potent inhibitor of platelet aggregation and may serve as the basis for the development of a new class of antithrombotic agents.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Wyeth Ayerst Res, Dept Cardiovasc & Metab Dis, Cambridge, MA 02140 USA	Cornell University; Pfizer	Lu, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	mlu@med.cornell.edu	Deng, Yiqun/K-7709-2013; Dai, Jiayin/C-6654-2012	Deng, Yiqun/0000-0002-6838-3779; Dai, Jiayin/0000-0003-4908-5597	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041461] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41461] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basanova AV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P143, DOI 10.1023/A:1013968618120; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Chen W, 2001, BIOCHEM BIOPH RES CO, V282, P90, DOI 10.1006/bbrc.2001.4555; Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189; Failer BU, 2002, J BIOL CHEM, V277, P36978, DOI 10.1074/jbc.M201656200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LUTHJE J, 1989, KLIN WOCHENSCHR, V67, P317, DOI 10.1007/BF01741386; MARCUS AJ, 1993, FASEB J, V7, P516, DOI 10.1096/fasebj.7.6.8472890; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Murphy DM, 2003, BIOCHEMISTRY-US, V42, P2412, DOI 10.1021/bi026763b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Smith TM, 2002, ARCH BIOCHEM BIOPHYS, V406, P105, DOI 10.1016/S0003-9861(02)00420-4; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vargas CM, 1998, J CLIN EPIDEMIOL, V51, P739, DOI 10.1016/S0895-4356(98)00047-X; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	25	46	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					649	659		10.1016/S0092-8674(04)00172-2	http://dx.doi.org/10.1016/S0092-8674(04)00172-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006348	Bronze			2022-12-01	WOS:000221499700006
J	Campo, R				Campo, R			Questions for an epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Campo, R (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2004	350	10					968	970		10.1056/NEJMp038236	http://dx.doi.org/10.1056/NEJMp038236			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780GH	14999108				2022-12-01	WOS:000189363600004
J	Ane, JM; Kiss, GB; Riely, BK; Penmetsa, RV; Oldroyd, GED; Ayax, C; Levy, J; Debelle, F; Baek, JM; Kalo, P; Rosenberg, C; Roe, BA; Long, SR; Denarie, J; Cook, DR				Ane, JM; Kiss, GB; Riely, BK; Penmetsa, RV; Oldroyd, GED; Ayax, C; Levy, J; Debelle, F; Baek, JM; Kalo, P; Rosenberg, C; Roe, BA; Long, SR; Denarie, J; Cook, DR			Medicago truncatula DMI1 required for bacterial and fungal symbioses in legumes	SCIENCE			English	Article							NOD FACTOR TRANSDUCTION; RECEPTOR KINASE GENE; MEDICAGO-TRUNCATULA; NODULATION; RECOGNITION	Legumes form symbiotic associations with both mycorrhizal fungi and nitrogen-fixing soil bacteria called rhizobia. Several of the plant genes required for transduction of rhizobial signals, the Nod factors, are also necessary for mycorrhizal symbiosis. Here, we describe the cloning and characterization of one such gene from the legume Medicago truncatula. The DMI1 ( does not make infections) gene encodes a novel protein with low global similarity to a ligand-gated cation channel domain of archaea. The protein is highly conserved in angiosperms and ancestral to land plants. We suggest that DMI1 represents an ancient plant-specific innovation, potentially enabling mycorrhizal associations.	Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; INRA, CNRS, UMR215, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; Agr Biotechnol Ctr, Inst Genet, H-2100 Godollo, Hungary; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Calif Davis, Coll Agr & Environm Sci, Gen Facil, Davis, CA 95616 USA; Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA	University of California System; University of California Davis; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Hungarian Academy of Sciences; Hungarian Biological Research Center; Stanford University; University of California System; University of California Davis; University of Oklahoma System; University of Oklahoma - Norman	Cook, DR (corresponding author), Univ Calif Davis, Dept Plant Pathol, 1 Shields Ave, Davis, CA 95616 USA.	drcook@ucdavis.edu	Kalo, Peter/A-3919-2012; levy, julien G./I-9904-2019; Oldroyd, Giles/ABD-8143-2021; Ané, Jean-Michel/G-5921-2010; Oldroyd, Giles/ABA-7501-2020	Kalo, Peter/0000-0002-0404-8904; levy, julien G./0000-0002-1422-2195; Oldroyd, Giles/0000-0002-5245-6355; Ané, Jean-Michel/0000-0002-3128-9439; 				Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Ane JM, 2002, MOL PLANT MICROBE IN, V15, P1108, DOI 10.1094/MPMI.2002.15.11.1108; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CHOI HK, IN PRESS GENETICS; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Doyle JJ, 1998, TRENDS PLANT SCI, V3, P473, DOI 10.1016/S1360-1385(98)01340-5; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Parniske M, 2003, NATURE, V425, P569, DOI 10.1038/425569a; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797	23	370	396	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1364	1367		10.1126/science.1092986	http://dx.doi.org/10.1126/science.1092986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14963334				2022-12-01	WOS:000189238600050
J	Floss, C; Stadermann, FJ; Bradley, J; Dai, ZR; Bajt, S; Graham, G				Floss, C; Stadermann, FJ; Bradley, J; Dai, ZR; Bajt, S; Graham, G			Carbon and nitrogen isotopic anomalies in an anhydrous interplanetary dust particle	SCIENCE			English	Article							MACROMOLECULAR ORGANIC-MATTER; FRACTIONATION; PRESOLAR; ORIGIN; IDENTIFICATION; ABUNDANCES; CHEMISTRY; GRAINS	Because hydrogen and nitrogen isotopic anomalies in interplanetary dust particles have been associated with carbonaceous material, the lack of similar anomalies in carbon has been a major conundrum. We report here the presence of a C-13 depletion associated with a N-15 enrichment in an anhydrous interplanetary dust particle. Our observations suggest that the anomalies are carried by heteroatomic organic compounds. Theoretical models indicate that low-temperature formation of organic compounds in cold interstellar molecular clouds can produce carbon and nitrogen fractionations, but it remains to be seen whether the specific effects observed here can be reproduced.	Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA	Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Floss, C (corresponding author), Washington Univ, Space Sci Lab, St Louis, MO 63130 USA.	floss@wustl.edu	Bajt, Sasa/G-2228-2010; Dai, Zurong/E-6732-2010; Bajt, Sasa/O-4695-2019; 1.4, ALS Beamline/I-1886-2014	Bajt, Sasa/0000-0002-7163-7602; Dai, Zurong/0000-0002-4209-8718				Aleon J, 2003, GEOCHIM COSMOCHIM AC, V67, P3773, DOI [10.1016/S0016-7037(03)00170-4, 10.1016/S0016-7037(00)00170-4]; ALEON J, 2002, LUNAR PLANET SCI, V33, P1397; ALEON J, 2003, LUNAR PLANET SCI, V34, P1308; Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; Arpigny C, 2003, SCIENCE, V301, P1522, DOI 10.1126/science.1086711; Bradley JP, 2005, TREATISE GEOCHEM, V1, P689; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; BRADLEY JP, 1986, SCIENCE, V231, P1542, DOI 10.1126/science.231.4745.1542; BROWNLEE DE, 2002, LPI, V33, P1786; BROWNLEE DE, 1994, AIP C P, V310, P5; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; FLOSS C, 2003, LUNAR PLANET SCI, V34, P1238; FLOSS C, 2002, LUNAR PLANET SCI, V33, P1350; FLYNN GJ, 2002, LUNAR PLANET SCI, V33, P1320; FOMENKOVA MN, 1994, GEOCHIM COSMOCHIM AC, V58, P4503, DOI 10.1016/0016-7037(94)90351-4; Fouchet T, 2000, ICARUS, V143, P223, DOI 10.1006/icar.1999.6255; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; Heaney PJ, 2001, AM MINERAL, V86, P1094; HOPPE P, 1995, GEOCHIM COSMOCHIM AC, V59, P4029, DOI 10.1016/0016-7037(95)00280-D; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; KELLER LP, 1997, LUNAR PLANET SCI C, V28, P707; LANGER WD, 1989, ASTROPHYS J SUPPL S, V69, P241, DOI 10.1086/191313; LANGER WD, 1984, ASTROPHYS J, V277, P581, DOI 10.1086/161730; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; MESSENGER S, 1997, AIP C P, V402, P545; MILLAR TJ, 1989, ASTROPHYS J, V340, P906, DOI 10.1086/167444; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; Sandford SA, 2001, METEORIT PLANET SCI, V36, P1117, DOI 10.1111/j.1945-5100.2001.tb01948.x; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; TIELENS AGG, 1998, AIP C P, V402, P523	33	94	97	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1355	1358		10.1126/science.1093283	http://dx.doi.org/10.1126/science.1093283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988560				2022-12-01	WOS:000189238600047
J	Accardi, A; Miller, C				Accardi, A; Miller, C			Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels	NATURE			English	Article							CHLORIDE CHANNEL; SEROTONIN TRANSPORTER; ESCHERICHIA-COLI; IONIC CURRENTS; RECONSTITUTION; MECHANISM; SOLUBILIZATION; SELECTIVITY; CONDUCTANCE; HYDROLYSIS	ClC Cl- channels make up a large molecular family, ubiquitous with respect to both organisms and cell types. In eukaryotes, these channels fulfill numerous biological roles requiring gated anion conductance, from regulating skeletal muscle excitability to facilitating endosomal acidification by (H+) ATPases. In prokaryotes, ClC functions are unknown except in Escherichia coli, where the ClC- ec1 protein promotes H+ extrusion activated in the extreme acid-resistance response common to enteric bacteria. Recently, the high-resolution structure of ClC- ec1 was solved by X-ray crystallography. This primal prokaryotic ClC structure has productively guided understanding of gating and anion permeation in the extensively studied eukaryotic ClC channels. We now show that this bacterial homologue is not an ion channel, but rather a H+-Cl- exchange transporter. As the same molecular architecture can support two fundamentally different transport mechanisms, it seems that the structural boundary separating channels and transporters is not as clear cut as generally thought.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu		Accardi, Alessio/0000-0002-6584-0102				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BIWERSI J, 1994, ANAL BIOCHEM, V219, P139, DOI 10.1006/abio.1994.1242; Chen MF, 2003, J GEN PHYSIOL, V122, P133, DOI 10.1085/jgp.200308844; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FOSTER DL, 1982, BIOCHEMISTRY-US, V21, P5634, DOI 10.1021/bi00265a038; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Lin CW, 2003, J GEN PHYSIOL, V122, P147, DOI 10.1085/jgp.200308845; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; MITCHELL P, 1965, NATURE, V208, P147, DOI 10.1038/208147a0; PUSCH M, 1994, BIOPHYS J, V66, P149, DOI 10.1016/S0006-3495(94)80753-2; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Robinson R.A., 1965, ELECTROLYTE SOLUTION, V2nd; SCHELLENBERG GD, 1982, BIOCHIM BIOPHYS ACTA, V690, P133, DOI 10.1016/0005-2736(82)90247-4; SHANI M, 1987, BIOCHIM BIOPHYS ACTA, V904, P13, DOI 10.1016/0005-2736(87)90081-2; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; WEINMAN EJ, 1988, J MEMBRANE BIOL, V101, P1, DOI 10.1007/BF01872814; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	35	495	512	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					803	807		10.1038/nature02314	http://dx.doi.org/10.1038/nature02314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985752				2022-12-01	WOS:000189207500030
J	Gladwin, MT; Sachdev, V; Jison, ML; Shizukuda, Y; Plehn, JF; Minter, K; Brown, B; Coles, WA; Nichols, JS; Ernst, I; Hunter, LA; Blackwelder, WC; Schechter, AN; Rodgers, GP; Castro, O; Ognibene, FP				Gladwin, MT; Sachdev, V; Jison, ML; Shizukuda, Y; Plehn, JF; Minter, K; Brown, B; Coles, WA; Nichols, JS; Ernst, I; Hunter, LA; Blackwelder, WC; Schechter, AN; Rodgers, GP; Castro, O; Ognibene, FP			Pulmonary hypertension as a risk factor for death in patients with sickle cell disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; RELATIVE HYPERTENSION; FETAL-HEMOGLOBIN; ENDOTHELIN-1; STROKE; ECHOCARDIOGRAPHY; PRESSURE; ARGININE; ANEMIA	BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.	NHLBI, Dept Crit Care Med, Ctr Clin, NIH, Bethesda, MD 20892 USA; NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Lab Chem Biol, NIH, Bethesda, MD 20892 USA; NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; Howard Univ, Coll Med, Dept Med, Div Cardiol, Washington, DC USA; Howard Univ, Coll Med, Ctr Sickle Cell Dis, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard University; Howard University	Gladwin, MT (corresponding author), NHLBI, Dept Crit Care Med, Ctr Clin, NIH, Bldg 10,Rm 7D-43,10 Ctr Dr, Bethesda, MD 20892 USA.	mgladwin@nih.gov		Schechter, Alan N/0000-0002-5235-9408	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK027001, Z01DK025093, ZIADK025093] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL001173, Z01CL001174] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER		Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Adedeji MO, 2001, ARCH PATHOL LAB MED, V125, P1436; Aessopos A, 2001, BLOOD, V97, P3411, DOI 10.1182/blood.V97.11.3411; Appleton CP, 1997, J AM SOC ECHOCARDIOG, V10, P271, DOI 10.1016/S0894-7317(97)70063-4; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; Atweh GF, 2001, CURR OPIN HEMATOL, V8, P123, DOI 10.1097/00062752-200103000-00010; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; Castro O, 1996, HEMATOL ONCOL CLIN N, V10, P1289, DOI 10.1016/S0889-8588(05)70401-9; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; CHOPRA HK, 1989, J AM COLL CARDIOL, V14, P1266, DOI 10.1016/0735-1097(89)90426-9; COLLINS FS, 1982, AM J MED, V73, P814, DOI 10.1016/0002-9343(82)90763-X; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Derchi G, 1999, AM HEART J, V138, P384, DOI 10.1016/S0002-8703(99)70129-8; Du ZD, 1997, AM HEART J, V134, P532, DOI 10.1016/S0002-8703(97)70091-7; Escoffery CT, 2002, FORENSIC SCI INT, V129, P116, DOI 10.1016/S0379-0738(02)00268-2; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; GRISARU D, 1990, CHEST, V98, P1138, DOI 10.1378/chest.98.5.1138; Hahalis G, 2002, EUR HEART J, V23, P147, DOI 10.1053/euhj.2001.2709; Hammerman SI, 1997, AM J RESP CRIT CARE, V156, P280, DOI 10.1164/ajrccm.156.1.9611085; Haque AK, 2002, HUM PATHOL, V33, P1037, DOI 10.1053/hupa.2002.128059; Hayag-Barin JE, 1998, AM J HEMATOL, V57, P82, DOI 10.1002/(SICI)1096-8652(199801)57:1<82::AID-AJH15>3.0.CO;2-B; HELLER PG, 1992, CHEST, V102, P642, DOI 10.1378/chest.102.2.642; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; LEWIS JF, 1984, CIRCULATION, V70, P425, DOI 10.1161/01.CIR.70.3.425; LIESNER RJ, 1993, J ROY SOC MED, V86, P484; Lin G, 2001, BIOCHEM BIOPH RES CO, V280, P824, DOI 10.1006/bbrc.2000.4167; Morris CR, 2003, AM J RESP CRIT CARE, V168, P63, DOI 10.1164/rccm.200208-967OC; Morris CR, 2000, J PEDIAT HEMATOL ONC, V22, P515, DOI 10.1097/00043426-200011000-00009; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Norris S L, 1992, J Assoc Acad Minor Phys, V3, P20; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pegelow CH, 1997, AM J MED, V102, P171; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1988, MEDICINE, V67, P66, DOI 10.1097/00005792-198801000-00005; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; RODGERS GP, 1993, AM J MED SCI, V305, P150, DOI 10.1097/00000441-199303000-00004; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SIMMONS BE, 1988, ARCH INTERN MED, V148, P1526, DOI 10.1001/archinte.148.7.1526; SUTTON LL, 1994, AM J CARDIOL, V74, P626, DOI 10.1016/0002-9149(94)90760-9; VANENK A, 1992, BRIT J OBSTET GYNAEC, V99, P162	43	891	916	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2004	350	9					886	895		10.1056/NEJMoa035477	http://dx.doi.org/10.1056/NEJMoa035477			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777UM	14985486				2022-12-01	WOS:000189197300007
J	Rentel, MC; Lecourieux, D; Ouaked, F; Usher, SL; Petersen, L; Okamoto, H; Knight, H; Peck, SC; Grierson, CS; Hirt, H; Knight, MR				Rentel, MC; Lecourieux, D; Ouaked, F; Usher, SL; Petersen, L; Okamoto, H; Knight, H; Peck, SC; Grierson, CS; Hirt, H; Knight, MR			OXI1 kinase is necessary for oxidative burst-mediated signalling in Arabidopsis	NATURE			English	Article							HYDROGEN-PEROXIDE; DEFENSE RESPONSE; PLANTS; TRANSFORMATION; PATHWAYS; GROWTH; GENES; ACCUMULATION; EXPRESSION; SYSTEMIN	Active oxygen species (AOS) generated in response to stimuli and during development can function as signalling molecules in eukaryotes, leading to specific downstream responses(1,2). In plants these include such diverse processes as coping with stress ( for example pathogen attack(3), wounding(4) and oxygen deprivation(5)), abscisic-acid-induced guard-cell closure(6), and cellular development ( for example root hair growth(7)). Despite the importance of signalling via AOS in eukaryotes, little is known about the protein components operating downstream of AOS that mediate any of these processes. Here we show that expression of an Arabidopsis thaliana gene (OXI1) encoding a serine/threonine kinase is induced in response to a wide range of H2O2-generating stimuli. OXI1 kinase activity is itself also induced by H2O2 in vivo. OXI1 is required for full activation of the mitogen-activated protein kinases ( MAPKs) MPK3 and MPK6 after treatment with AOS or elicitor and is necessary for at least two very different AOS-mediated processes: basal resistance to Peronospora parasitica infection, and root hair growth. Thus, OXI1 is an essential part of the signal transduction pathway linking oxidative burst signals to diverse downstream responses.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Cape Town, Dept Mol & Cell Biol, ZA-7701 Rondebosch, South Africa; Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Oxford; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Bristol; University of Cape Town; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Rentel, MC (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	mrentel@cmp.ucsf.edu; heribert.hirt@univie.ac.at	Okamoto, Haruko/AAG-9512-2021; Lecourieux, David/AAD-5429-2019; Hirt, Heribert/A-2061-2013; lecourieux, fatma/AAC-2039-2019	Okamoto, Haruko/0000-0001-5981-6571; lecourieux, fatma/0000-0003-1601-2500; Rentel, Maike/0000-0002-0964-4377; Knight, Heather/0000-0003-2047-6084; Knight, Marc/0000-0002-4830-8608	Biotechnology and Biological Sciences Research Council [G19475] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baxter-Burrell A, 2003, ANN BOT-LONDON, V91, P129, DOI 10.1093/aob/mcf119; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Borden S, 2002, PHYSIOL MOL PLANT P, V61, P227, DOI 10.1006/pmpp.2002.0435; Cardinale F, 2002, PLANT CELL, V14, P703, DOI 10.1105/tpc.010256; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/0300-5127:0290345; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Martin T, 1992, PLANT MOL BIOL REP, V10, P37, DOI 10.1007/BF02669263; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Oyama T, 2002, PLANT J, V30, P289, DOI 10.1046/j.1365-313X.2002.01290.x; Parker JS, 2000, PLANT CELL, V12, P1961, DOI 10.1105/tpc.12.10.1961; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; PIETRZAK M, 1986, NUCLEIC ACIDS RES, V14, P5857, DOI 10.1093/nar/14.14.5857; Samaj J, 2002, EMBO J, V21, P3296, DOI 10.1093/emboj/cdf349; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Weigel D., 2001, ARABIDOPSIS LAB MANU; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x	28	412	458	7	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					858	861		10.1038/nature02353	http://dx.doi.org/10.1038/nature02353			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985766				2022-12-01	WOS:000189207500044
J	Sathyanarayanan, S; Zheng, XZ; Xiao, R; Sehgal, A				Sathyanarayanan, S; Zheng, XZ; Xiao, R; Sehgal, A			Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2A	CELL			English	Article							KINASE-I-EPSILON; CIRCADIAN-CLOCK; DOUBLE-TIME; BETA-CATENIN; NUCLEAR ACCUMULATION; BEHAVIORAL RHYTHMS; SIGNALING PATHWAYS; NERVOUS-SYSTEM; GENE; 2A	The posttranscriptional mechanisms that control the cycling of circadian clock protein levels are not known. Here we demonstrate a role for protein phosphatase 2A (PP2A) in the cyclic expression of the PER protein. PP2A regulatory subunits TWS and WDB target PER and stabilize it in S2 cells. In adult fly heads, expression of tws cycles robustly under control of the circadian clock. Hypomorphic tws mutants show delayed accumulation of PER, while overexpression of tws in clock neurons produces shorter, weaker rhythms. Reduction of PP2A activity reduces PER expression in central clock neurons and results in long periods and arrhythmia. In addition, overexpression of the PP2A catalytic subunit results in loss of behavioral rhythms and constitutive nuclear expression of PER. PP2A also affects PER phosphorylation in vitro and in vivo. We propose that the posttranslational mechanisms that drive cycling of PER require the rhythmic expression of PP2A.	Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Mol & Cellular Biol Program, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu						Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; Ashmore LJ, 2003, J NEUROSCI, V23, P7810; Bao S, 2001, J NEUROSCI, V21, P7117, DOI 10.1523/JNEUROSCI.21-18-07117.2001; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616; Glossop NRJ, 2002, J CELL SCI, V115, P3369; Greaves S, 1999, GENETICS, V153, P1753; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannus M, 2002, DEVELOPMENT, V129, P3493; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kalderon D, 2002, TRENDS CELL BIOL, V12, P523, DOI 10.1016/S0962-8924(02)02388-7; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kins S, 2001, J BIOL CHEM, V276, P38193; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; MAYERJAEKEL RE, 1995, SEMIN CANCER BIOL, V6, P249, DOI 10.1006/scbi.1995.0032; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2607; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Perrimon N, 1996, GENETICS, V144, P1681; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shafer OT, 2002, J NEUROSCI, V22, P5946; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Snaith HA, 1996, J CELL SCI, V109, P3001; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Stempfl T, 2002, GENETICS, V160, P571; UEMURA T, 1993, GENE DEV, V7, P429, DOI 10.1101/gad.7.3.429; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	58	215	218	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					603	615		10.1016/S0092-8674(04)00128-X	http://dx.doi.org/10.1016/S0092-8674(04)00128-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980226	Bronze			2022-12-01	WOS:000189184200013
J	Brecht, M; Schneider, M; Sakmann, B; Margrie, TW				Brecht, M; Schneider, M; Sakmann, B; Margrie, TW			Whisker movements evoked by stimulation of single pyramidal cells in rat motor cortex	NATURE			English	Article							SOMATOSENSORY CORTEX; CORTICAL-NEURONS; FIRING PATTERNS; BARREL CORTEX; TRACT CELLS; REPRESENTATION; CATS; MICROSTIMULATION; ORGANIZATION; FACILITATION	Neuronal activity in the motor cortex is understood to be correlated with movements, but the impact of action potentials (APs) in single cortical neurons on the generation of movement has not been fully determined. Here we show that trains of APs in single pyramidal cells of rat motor cortex can evoke long sequences of small whisker movements. For layer-5 pyramids, we find that evoked rhythmic movements have a constant phase relative to the AP train, indicating that single layer-5 pyramids can reset the rhythm of whisker movements. Action potentials evoked in layer-6 pyramids can generate bursts of rhythmic whisking, with a variable phase of movements relative to the AP train. An increasing number of APs decreases the latency to onset of movement, whereas AP frequency determines movement direction and amplitude. We find that the efficacy of cortical APs in evoking whisker movements is not dependent on background cortical activity and is greatly enhanced in waking rats. We conclude that in vibrissae motor cortex sparse AP activity can evoke movements.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; UCL, Dept Physiol, Wolfson Inst Biomed Res, London WC1E 6BT, England	Max Planck Society; University of London; University College London	Brecht, M (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	brecht@mpimf-heidelberg.mpg.de		Brecht, Michael/0000-0002-5387-0953				Adrian ED, 1941, J PHYSIOL-LONDON, V100, P159, DOI 10.1113/jphysiol.1941.sp003932; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; ASANUMA H, 1967, J NEUROPHYSIOL, V30, P35, DOI 10.1152/jn.1967.30.1.35; ASANUMA H, 1968, J NEUROPHYSIOL, V31, P670, DOI 10.1152/jn.1968.31.5.670; ASANUMA H, 1971, BRAIN RES, V27, P97, DOI 10.1016/0006-8993(71)90374-X; Asanuma H., 1989, MOTOR CORTEX; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Bermejo R, 1996, SOMATOSENS MOT RES, V13, P225, DOI 10.3109/08990229609052578; BERMEJO R, 2001, SOC NEUR ABSTR; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; BUYS EJ, 1986, J PHYSIOL-LONDON, V381, P529, DOI 10.1113/jphysiol.1986.sp016342; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P786, DOI 10.1152/jn.1985.53.3.786; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; ECCLES JC, 1976, UNDERSTANDING BRAIN; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; FETZ EE, 1976, BRAIN RES, V114, P505, DOI 10.1016/0006-8993(76)90973-2; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P617, DOI 10.1113/jphysiol.1975.sp011034; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; LERMA J, 1985, ELECTROEN CLIN NEURO, V60, P46, DOI 10.1016/0013-4694(85)90950-2; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Phillips C.G., 1977, MONOGR PHYSL SOC, V34; Porter R, 1995, CORTICOSPINAL FUNCTI; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; Schwartz AB, 2001, CURR OPIN NEUROBIOL, V11, P701, DOI 10.1016/S0959-4388(01)00272-0; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; TIMOIARIA C, 1990, BRAZ J MED BIOL RES, V23, P617; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WOODY CD, 1973, J NEUROPHYSIOL, V36, P1104, DOI 10.1152/jn.1973.36.6.1104; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	45	247	253	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2004	427	6976					704	710		10.1038/nature02266	http://dx.doi.org/10.1038/nature02266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973477				2022-12-01	WOS:000189026000035
J	Bush, MB; Silman, MR; Urrego, DH				Bush, MB; Silman, MR; Urrego, DH			48,000 years of climate and forest change in a biodiversity hot spot	SCIENCE			English	Article							PRECIPITATION; RECORDS; HISTORY; ANDES	A continuous 48,000-year-long paleoecological record from Neotropical lower montane forest reveals a consistent forest presence and an ice-age cooling of similar to5degrees to 9degreesC. After 30,000 years of compositional stability, a steady turnover of species marks the 8000-year-long transition from ice-age to Holocene conditions. Although the changes were directional, the rates of community change were no different during this transitional period than in the preceding 30,000-year period of community stability. The warming rate of about 1degreesC per millennium during the Pleistocene-Holocene transition was an order of magnitude less than the projected changes for the 21st century.	Florida Inst Technol, Melbourne, FL 32901 USA; Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Florida Institute of Technology; Wake Forest University	Bush, MB (corresponding author), Florida Inst Technol, 150 W Univ Blvd, Melbourne, FL 32901 USA.	mbush@fit.edu; silmanmr@wfu.org	Urrego, Dunia/A-6545-2010	Bush, Mark/0000-0001-6894-8613; Urrego, Dunia H./0000-0001-7938-5529				Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Bush MB, 2000, QUATERNARY RES, V54, P132, DOI 10.1006/qres.2000.2138; Bush MB, 2002, J PALEOLIMNOL, V27, P341, DOI 10.1023/A:1016059415848; Cavelier J, 1997, J HYDROL, V193, P83, DOI 10.1016/S0022-1694(96)03151-4; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Colinvaux P.A., 1999, AMAZON POLLEN MANUAL; Colinvaux PA, 1997, QUATERNARY RES, V48, P69, DOI 10.1006/qres.1997.1908; Faegri K., 1989, TXB POLLEN ANAL, V4th ed.; GRABANDT RAJ, 1985, THESIS U AMSTERDAM; HANSEN BCS, 1995, QUATERNARY RES, V44, P216, DOI 10.1006/qres.1995.1066; Hooghiemstra H, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P35; Hubbell Stephen P., 2001, V32, pi; *INT PAN CLIM CHAN, 2001, IPCC SUMM POL CLIM C; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Paduano GM, 2003, PALAEOGEOGR PALAEOCL, V194, P259, DOI 10.1016/S0031-0182(03)00281-5; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Sandweiss DH, 1999, SCIENCE, V283, P499, DOI 10.1126/science.283.5401.499; Silverman BW., 2018, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Weng CY, 2004, J TROP ECOL, V20, P113, DOI 10.1017/S0266467403001068	23	225	232	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					827	829		10.1126/science.1090795	http://dx.doi.org/10.1126/science.1090795			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764876				2022-12-01	WOS:000188753800054
J	Kokoszka, JE; Waymire, KG; Levy, SE; Sligh, JE; Cal, JY; Jones, DP; MacGregor, GR; Wallace, DC				Kokoszka, JE; Waymire, KG; Levy, SE; Sligh, JE; Cal, JY; Jones, DP; MacGregor, GR; Wallace, DC			The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore	NATURE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; OXIDATIVE STRESS; CYCLOSPORINE-A; APOPTOSIS; HEPATOCYTES; EXPRESSION; GENES; ADP; AGE	A sudden increase in permeability of the inner mitochondrial membrane, the so-called mitochondrial permeability transition, is a common feature of apoptosis and is mediated by the mitochondrial permeability transition pore (mtPTP). It is thought that the mtPTP is a protein complex formed by the voltage-dependent anion channel, members of the pro- and antiapoptotic BAX-BCL2 protein family, cyclophilin D, and the adenine nucleotide (ADP/ATP) translocators (ANTs)(1,2). The latter exchange mitochondrial ATP for cytosolic ADP and have been implicated in cell death. To investigate the role of the ANTs in the mtPTP, we genetically inactivated the two isoforms of ANT(3-5) in mouse liver and analysed mtPTP activation in isolated mitochondria and the induction of cell death in hepatocytes. Mitochondria lacking ANT could still be induced to undergo permeability transition, resulting in release of cytochrome c. However, more Ca2+ than usual was required to activate the mtPTP, and the pore could no longer be regulated by ANT ligands. Moreover, hepatocytes without ANT remained competent to respond to various initiators of cell death. Therefore, ANTs are non-essential structural components of the mtPTP, although they do contribute to its regulation.	Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Emory University; Emory University; Emory University	Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.	dwallace@uci.edu		Levy, Shawn/0000-0002-1369-5740	NICHD NIH HHS [U01 HD045913-01, R01 HD036437-04, R01 HD036437-02, R01 HD036437-05, R01 HD036437-03] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036437, U01HD045913] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Ellison JW, 1996, GENOMICS, V36, P369, DOI 10.1006/geno.1996.0478; Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; LAPIDUS RG, 1994, J BIOL CHEM, V269, P18931; LEIST M, 1994, J IMMUNOL, V153, P1778; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; LUNARDI J, 1992, J BIOL CHEM, V267, P15267; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	20	851	881	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					461	465		10.1038/nature02229	http://dx.doi.org/10.1038/nature02229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749836	Green Accepted			2022-12-01	WOS:000188470500048
J	Dobberstein, B; Sinning, I				Dobberstein, B; Sinning, I			Surprising news from the PCC	SCIENCE			English	Editorial Material							PROTEIN-CONDUCTING CHANNEL; ENDOPLASMIC-RETICULUM; ER MEMBRANE; COMPLEX; TRANSLOCATION; INTEGRATION; TRANSPORT; BILAYER; SECYEG		Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dobberstein, B (corresponding author), Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany.		Sinning, Irmgard/A-2982-2010					Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Locher KP, 2003, SCIENCE, V301, P603, DOI 10.1126/science.1088621; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393	16	6	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					320	322		10.1126/science.1094664	http://dx.doi.org/10.1126/science.1094664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726579				2022-12-01	WOS:000188111800027
J	Makhnevych, T; Lusk, CP; Anderson, AM; Aitchison, JD; Wozniak, RW				Makhnevych, T; Lusk, CP; Anderson, AM; Aitchison, JD; Wozniak, RW			Cell cycle regulated transport controlled by alterations in the nuclear pore complex	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEOPORIN NUP153; PROTEOMIC ANALYSIS; IMPORT RECEPTOR; PROTEIN; YEAST; RAN; LOCALIZATION; BINDING; PHOSPHORYLATION	Eukaryotic cells have developed mechanisms for regulating the nuclear transport of macromolecules that control various cellular events including movement through defined stages of the cell cycle. In yeast cells, where the nuclear envelope remains intact throughout the cell cycle, these transport regulatory mechanisms must also function during mitosis. We have uncovered a mechanism for regulating transport that is controlled by M phase specific molecular rearrangements in the nuclear pore complex (NPC). These changes allow a transport inhibitory nucleoporin, Nup53p, to bind the karyopherin Kap121p specifically during mitosis, slowing its movement through the NPC and inducing cargo release. Yeast strains that possess defects in the function of Kap121p or the fidelity of the inhibitory pathway are delayed in mitosis. We propose that fluctuations in Kap121p transport mediated by the NPC contribute to controlling the subcellular distribution of molecules that direct progression through mitosis.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; Inst Syst Biol, Seattle, WA 98103 USA	University of Alberta; Institute for Systems Biology (ISB)	Aitchison, JD (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	jaitchison@systemsbiology.org; rick.wozniak@ualberta.ca		Lusk, C. Patrick/0000-0003-4703-0533				AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Asakawa K, 2002, GENETICS, V162, P1545; Basrai MA, 1996, MOL CELL BIOL, V16, P2838; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DELORME E, 1989, APPL ENVIRON MICROB, V55, P2242, DOI 10.1128/AEM.55.9.2242-2246.1989; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; FELDHERR CM, 1994, EXP CELL RES, V215, P206, DOI 10.1006/excr.1994.1333; FELDHERR CM, 1993, EXP CELL RES, V205, P179, DOI 10.1006/excr.1993.1073; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jensen S, 2002, CELL CYCLE, V1, P300, DOI 10.4161/cc.1.5.142; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kehlenbach RH, 2000, J BIOL CHEM, V275, P17848, DOI 10.1074/jbc.M001455200; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; NEHRBASS U, 1993, EUR J CELL BIOL, V62, P1; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1999, CURR BIOL, V9, P47, DOI 10.1016/S0960-9822(99)80046-3; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Sherman F., 1983, METHODS YEAST GENETI; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	57	122	128	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					813	823		10.1016/S0092-8674(03)00986-3	http://dx.doi.org/10.1016/S0092-8674(03)00986-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697200	Bronze			2022-12-01	WOS:000187664700006
J	Mitchell, AA				Mitchell, AA			Systematic identification of drugs that cause birth defects - A new opportunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACID; PREGNANCY		Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA	Boston University	Mitchell, AA (corresponding author), Boston Univ, Slone Epidemiol Ctr, 1010 Commonwealth Ave, Boston, MA 02215 USA.			Mitchell, Allen/0000-0003-0950-6799				Chambers CD, 2001, TERATOLOGY, V64, P252, DOI 10.1002/tera.1071; Hernandez-Diaz S, 2001, NEW ENGL J MED, V344, P934; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LENZ W, 1962, LANCET, V1, P45; MITCHELL AA, 1981, JAMA-J AM MED ASSOC, V245, P2311; MITCHELL AA, 2001, PHARMACOEPIDEM DR S, V10, pS341; MITCHELL AA, 2000, PHARMACOEPIDEM DR S, P595; ROBERT E, 1982, LANCET, V2, P937, DOI 10.1016/s0140-6736(82)90908-4; ROSA FW, 1991, NEW ENGL J MED, V324, P674, DOI 10.1056/NEJM199103073241006; Slone D, 1977, EPIDEMIOLOGICAL EVAL, P59; Werler MM, 2002, AM J EPIDEMIOL, V155, P26, DOI 10.1093/aje/155.1.26; Wilson JG, 1973, ENV BIRTH DEFECTS, P146; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32	14	88	96	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2003	349	26					2556	2559		10.1056/NEJMsb031395	http://dx.doi.org/10.1056/NEJMsb031395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757BT	14695418				2022-12-01	WOS:000187529500014
J	Abbott, A				Abbott, A			Membrane proteins - Channel voyager makes waves	NATURE			English	News Item							DEPENDENT K+ CHANNEL; X-RAY-STRUCTURE; POTASSIUM CHANNEL; MOLECULAR-BASIS; SELECTIVITY; CONDUCTION											Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	8	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					755	755		10.1038/426755a	http://dx.doi.org/10.1038/426755a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685197	Bronze			2022-12-01	WOS:000187342000018
J	Parker, AR; Welch, VL; Driver, D; Martini, N				Parker, AR; Welch, VL; Driver, D; Martini, N			Structural colour - Opal analogue discovered in a weevil	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	andrew.parker@zoo.ox.ac.uk						Ajgaonkar M, 2002, J OPT SOC AM B, V19, P1391, DOI 10.1364/JOSAB.19.001391; Blackwell J., 1984, P257; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Parker AR, 1998, J EXP BIOL, V201, P1307; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Parker AR, 2001, NATURE, V409, P36, DOI 10.1038/35051168; PHILIPSE AP, 1989, J MATER SCI LETT, V8, P1371, DOI 10.1007/BF00720190; Sanders J. V., 1971, MINERAL REC, V2, P261; SANDERS JV, 1964, NATURE, V204, P1151, DOI 10.1038/2041151a0; SCHULTZ T D, 1986, Bulletin of the Entomological Society of America, V32, P142	11	205	221	6	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					786	787		10.1038/426786a	http://dx.doi.org/10.1038/426786a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685223				2022-12-01	WOS:000187342000042
J	Thomson, KS; Sutton, M; Thomas, B				Thomson, KS; Sutton, M; Thomas, B			A larval Devonian lungfish	NATURE			English	Article								Perhaps the most enduring of puzzles in palaeontology has been the identity of Palaeospondylus gunni Traquair, a tiny (5-60-mm) vertebrate fossil from the Middle Devonian period (similar to385 Myr ago) of Scotland, first discovered in 1890 (refs 1 - 3). It is known principally from a single site (Achanarras Quarry, Caithness) where, paradoxically, it is extremely abundant, preserved in varved lacustrine deposits along with 13 other genera of fishes(4). Here we show that Palaeospondylus is the larval stage of a lungfish, most probably Dipterus valenciennesi Sedgwick and Murchison 1828 (ref. 5), and that development of the adult form requires a distinct metamorphosis. Palaeospondylus is the oldest known true larva of a vertebrate.	Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England	University of Oxford	Thomson, KS (corresponding author), Univ Oxford, Museum Nat Hist, Parks Rd, Oxford OX1 3PW, England.							Agassiz A., 1879, P AM ACAD ARTS SCI, V14, P65; BEMIS WE, 1987, J MORPHOL S, V1, P249; FOREY P., 1981, B BRIT MUS NAT HIST, V35, P131; FOX HAROLD, 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P470; Kerr JG, 1900, P CAMB PHILOS SOC, V10, P298; MOY-THOMAS J. A., 1940, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P391, DOI 10.1098/rstb.1940.0004; Rayner D. H., 1963, Proceedings of the Yorkshire Geological Society, V34, P117; SEDGWICK A, 1828, T GEOL SOC LOND, V3, P125; SOLLAS WJ, 1903, PHILOS T ROY SOC LON, V196, P267; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; SUTTON MD, 2000, PALEONT ELECT, V4, DOI ARTN 2; THOMSON KEITH STEWART, 1965, PROC ZOOL SOC LONDON, V145, P207; THOMSON KS, 1992, AM SCI, V80, P216; Traquair R. H., 1890, Annals of Natural History, V(6), P479; TREWIN N H, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P21	15	19	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					833	834		10.1038/nature02175	http://dx.doi.org/10.1038/nature02175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685237				2022-12-01	WOS:000187342000056
J	Bower, EA				Bower, EA			Use of amphetamines in the military environment	LANCET			English	Article									Naval Hosp Pensacola, Dept Internal Med, Pensacola, FL 32512 USA; USN, Med Corps, Washington, DC USA	United States Department of Defense; United States Navy	Bower, EA (corresponding author), Naval Hosp Pensacola, Dept Internal Med, 6000 W Highway 98, Pensacola, FL 32512 USA.								0	9	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S18	S19		10.1016/S0140-6736(03)15060-X	http://dx.doi.org/10.1016/S0140-6736(03)15060-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698114				2022-12-01	WOS:000187790200010
J	Dussutour, A; Fourcassie, V; Helbing, D; Deneubourg, JL				Dussutour, A; Fourcassie, V; Helbing, D; Deneubourg, JL			Optimal traffic organization in ants under crowded conditions	NATURE			English	Article							LEAF-CUTTING ANT; TRAILS; SPEED	Efficient transportation, a hot topic in nonlinear science(1), is essential for modern societies and the survival of biological species. Biological evolution has generated a rich variety of successful solutions(2), which have inspired engineers to design optimized artificial systems(3,4). Foraging ants, for example, form attractive trails that support the exploitation of initially unknown food sources in almost the minimum possible time(5,6). However, can this strategy cope with bottleneck situations, when interactions cause delays that reduce the overall flow? Here, we present an experimental study of ants confronted with two alternative routes. We find that pheromone-based attraction generates one trail at low densities, whereas at a high level of crowding, another trail is established before traffic volume is affected, which guarantees that an optimal rate of food return is maintained. This bifurcation phenomenon is explained by nonlinear modelling approach. Surprisingly, the underlying mechanism is based on inhibitory interactions. It points to capacity reserves, a limitation of the density-induced speed reduction, and a sufficient pheromone concentration for reliable trail perception. The balancing mechanism between cohesive and dispersive forces appears to be generic in natural, urban and transportation systems.	Univ Toulouse 3, CNRS, UMR 5169, Ctr Rech Cognit Anim, 118 Route Narbonne, F-31062 Toulouse 4, France; Free Univ Brussels, Ctr Etud Phenomenes Nonlineaires & Syst Complexe, B-1050 Brussels, Belgium; Tech Univ Dresden, Inst Econ & Traff, D-01062 Dresden, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Technische Universitat Dresden	Dussutour, A (corresponding author), Univ Toulouse 3, CNRS, UMR 5169, Ctr Rech Cognit Anim, 118 Route Narbonne, F-31062 Toulouse 4, France.		Helbing, Dirk/C-6114-2008; Fourcassié, Vincent/AAJ-9016-2020; Dussutour, Audrey/A-2399-2012	Fourcassie, Vincent/0000-0002-3605-6351; Dussutour, Audrey/0000-0002-1377-3550				BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Bonabeau E., 1999, NATURAL ARTIFICIAL S; Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001; Burd M, 2002, AM NAT, V159, P283, DOI 10.1086/338541; CALENBUHR V, 1992, J THEOR BIOL, V158, P395, DOI 10.1016/S0022-5193(05)80739-8; Camazine S., 2001, SELF ORG BIOL SYSTEM; Couzin ID, 2003, P ROY SOC B-BIOL SCI, V270, P139, DOI 10.1098/rspb.2002.2210; EDELSTEINKESHET L, 1995, BEHAV ECOL SOCIOBIOL, V36, P119, DOI 10.1007/s002650050132; ERLANDSSON J, 1995, MAR BIOL, V122, P87, DOI 10.1007/BF00349281; FEENER DH, 1990, BEHAV ECOL SOCIOBIOL, V49, P348; Fitzgerald T.D., 1995, TENT CATERPILLARS; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fujita M, 1999, SPATIAL EC CITIES RE; Galef BG, 1996, ANIM BEHAV, V51, P765, DOI 10.1006/anbe.1996.0081; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Helbing D, 1997, NATURE, V388, P47, DOI 10.1038/40353; Helbing D, 2002, EUROPHYS LETT, V60, P227, DOI 10.1209/epl/i2002-00342-y; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Holldobler B., 1990, pi; Krause J., 2002, LIVING GROUPS; Miura T, 1998, J INSECT BEHAV, V11, P179, DOI 10.1023/A:1021039722402; O'Toole DV, 1999, J THEOR BIOL, V198, P305, DOI 10.1006/jtbi.1999.0917; Parrish J. K., 1997, ANIMAL GROUPS 3 DIME; Pasteels J.M., 1987, Experientia Supplementum (Basel), V54, P155; SCHWEITZER E, 2003, BROWNIAN AGENTS ACTI; Traniello James F.A., 1995, P241; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0	28	198	213	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					70	73		10.1038/nature02345	http://dx.doi.org/10.1038/nature02345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999281	Green Submitted			2022-12-01	WOS:000189363800036
J	Bhargava, SK; Sachdev, HS; Fall, CHD; Osmond, C; Lakshmy, R; Barker, DJP; Biswas, SKD; Ramji, S; Prabhakaran, D; Reddy, KS				Bhargava, SK; Sachdev, HS; Fall, CHD; Osmond, C; Lakshmy, R; Barker, DJP; Biswas, SKD; Ramji, S; Prabhakaran, D; Reddy, KS			Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIABETES-MELLITUS; BIRTH-WEIGHT; GROWTH; FETAL; INDIA; PREVALENCE; RISK	BACKGROUND: The risk of type 2 diabetes mellitus is increased in people who have low birth weights and who subsequently become obese as adults. Whether their obesity originates in childhood and, if so, at what age are unknown. Understanding the origin of obesity may be especially important in developing countries, where type 2 diabetes is rapidly increasing yet public health messages still focus on reducing childhood ``undernutrition.'' METHODS: We evaluated glucose tolerance and plasma insulin concentrations in 1492 men and women 26 to 32 years of age who had been measured at birth and at intervals of three to six months throughout infancy, childhood, and adolescence in a prospective, population-based study. RESULTS: The prevalence of impaired glucose tolerance was 10.8 percent, and that of diabetes was 4.4 percent. Subjects with impaired glucose tolerance or diabetes typically had a low body-mass index up to the age of two years, followed by an early adiposity rebound (the age after infancy when body mass starts to rise) and an accelerated increase in body-mass index until adulthood. However, despite an increase in body-mass index between the ages of 2 and 12 years, none of these subjects were obese at the age of 12 years. The odds ratio for disease associated with an increase in the body-mass index of 1 SD from 2 to 12 years of age was 1.36 (95 percent confidence interval, 1.18 to 1.57; P<0.001). CONCLUSIONS: There is an association between thinness in infancy and the presence of impaired glucose tolerance or diabetes in young adulthood. Crossing into higher categories of body-mass index after the age of two years is also associated with these disorders.	Sunder Lal Jain Hosp, Dept Pediat, Delhi, India; Maulana Azad Med Coll, Dept Pediat, New Delhi, India; All India Inst Med Sci, Dept Cardiol, New Delhi, India; Indian Council Med Res, New Delhi, India; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton, Hants, England	Maulana Azad Medical College; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); University of Southampton	Sachdev, HS (corresponding author), E-6-12 Vasant Vihar, New Delhi 110057, India.	hpssachdev@hotmail.com	Robles-Sardin, Alma E/M-7714-2015; Prabhakaran, Dorairaj/B-4147-2011; Barker, David JP/A-5671-2013	Robles-Sardin, Alma E/0000-0003-2044-7793; Prabhakaran, Dorairaj/0000-0002-3172-834X; Sachdev, Harshpal Singh/0000-0002-4956-9391; Osmond, Clive/0000-0002-9054-4655; Fall, Caroline/0000-0003-4402-5552	British Heart Foundation [PG/05/046/18730] Funding Source: Medline; Medical Research Council [U.1475.00.004.00005.01(74245), MC_U147574245] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Delisle H, 2002, PROGRAMMING CHRONIC; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Fall CHD, 1998, DIABETIC MED, V15, P220, DOI 10.1002/(SICI)1096-9136(199803)15:3<220::AID-DIA544>3.3.CO;2-F; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; GHOSH S, 1979, LONGITUDINAL STUDY S; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; *HLTH COMM AUSTR, 2000, AS PAC PERSP RED OB, P18; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Pradeepa R, 2002, INDIAN J MED RES, V116, P121; Ramachandran A, 1997, DIABETOLOGIA, V40, P232, DOI 10.1007/s001250050668; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; SACHDEV HPS, 2003, NFI B, V24, P6; Wareham N J, 1995, Diabet Med, V12, P931; WHO, 1995, WHO TECH REP SER, V854, P329; *WHO CONS, 1999, WHONCDNCS992 WHO CON; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x	21	709	729	2	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2004	350	9					865	875		10.1056/NEJMoa035698	http://dx.doi.org/10.1056/NEJMoa035698			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777UM	14985484	Green Accepted			2022-12-01	WOS:000189197300005
J	Perissi, V; Aggarwal, A; Glass, CK; Rose, DW; Rosenfeld, MG				Perissi, V; Aggarwal, A; Glass, CK; Rose, DW; Rosenfeld, MG			A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors	CELL			English	Article							EMBRYONIC STEM-CELLS; UBIQUITIN-DEPENDENT PROTEOLYSIS; IN-VITRO DIFFERENTIATION; GENE-EXPRESSION; COMBINATORIAL CONTROL; COREPRESSOR COMPLEX; SMRT COREPRESSOR; PROTEASOME; DEGRADATION; PATHWAY	The mechanisms that control the precisely regulated switch from gene repression to gene activation represent a central question in mammalian development Here, we report that transcriptional activation mediated by liganded nuclear receptors unexpectedly requires the actions of two highly related F box/WD-40-containing factors, TBL1 and TBLR1, initially identified as components of an N-CoR corepressor complex. TBL1/TBLR1 serve as specific adaptors for the recruitment of the ubiquitin conjugating/19S proteasome complex, with TBLR1 selectively serving to mediate a required exchange of the nuclear receptor corepressors, N-CoR and SMRT, for coactivators upon ligand binding. Tbl1 gene deletion in embryonic stem cells severely impairs PPARgamma-induced adipogenic differentiation, indicating that TBL1 function is also biologically indispensable for specific nuclear receptor-mediated gene activation events. The role of TBLR1 and TBL1 in cofactor exchange appears to also operate for c-Jun and NFkappaB and is therefore likely to be prototypic of similar mechanisms for other signal-dependent transcription factors.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Mol Pathol Grad Program, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rose, DW (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dwrose@popmail.ucsd.edu; mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Perissi, Valentina/0000-0002-3716-0003	Telethon [484/B] Funding Source: Medline	Telethon(Fondazione Telethon)		Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Asahara H, 1999, MOL CELL BIOL, V19, P8219; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Bassi MT, 1999, AM J HUM GENET, V64, P1604, DOI 10.1086/302408; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DEAN M, 1986, MOL CELL BIOL, V6, P518, DOI 10.1128/MCB.6.2.518; Delage-Mourroux R, 2000, J BIOL CHEM, V275, P35848, DOI 10.1074/jbc.M001327200; Dennis AP, 2001, FRONT BIOSCI, V6, pD954, DOI 10.2741/Dennis; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Disteche CM, 1998, MAMM GENOME, V9, P1062, DOI 10.1007/s003359900926; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; FEMANDES I, 2003, MOL CELL, V11, P139; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Glass CK, 2000, GENE DEV, V14, P121; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4; Guenther MG, 2000, GENE DEV, V14, P1048; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jepsen K, 2002, J CELL SCI, V115, P689; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; KIPREOS ET, 2000, GENOME BIOL, P1; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li X, 2002, SCIENCE, V297, P1180; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Liu YY, 2002, ENDOCRINOLOGY, V143, P2664, DOI 10.1210/en.143.7.2664; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rosen ED, 2000, GENE DEV, V14, P1293; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sasik R, 2002, BIOINFORMATICS, V18, P1633, DOI 10.1093/bioinformatics/18.12.1633; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Weiss MJ, 1996, J CLIN INVEST, V97, P591, DOI 10.1172/JCI118454; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yan F, 2003, MOL ENDOCRINOL, V17, P1315, DOI 10.1210/me.2002-0209; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	71	436	447	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					511	526		10.1016/S0092-8674(04)00133-3	http://dx.doi.org/10.1016/S0092-8674(04)00133-3			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980219	Bronze			2022-12-01	WOS:000189184200006
J	Raftopoulou, M; Etienne-Manneville, S; Self, A; Nicholls, S; Hall, A				Raftopoulou, M; Etienne-Manneville, S; Self, A; Nicholls, S; Hall, A			Regulation of cell migration by the C2 domain of the tumor suppressor PTEN	SCIENCE			English	Article							PHOSPHOINOSITIDE 3-KINASE; PHOSPHATASE-ACTIVITY; SIGNALING PATHWAY; CATALYTIC DOMAIN; PHOSPHORYLATION; INHIBITION; ACTIVATION; DELETION; GROWTH; SIZE	PTEN is a tumor suppressor protein that dephosphorylates phosphatidylinositol 3,4,5 trisphosphate and antagonizes the phosphatidylinositol-3 kinase signaling pathway. We show here that PTEN can also inhibit cell migration through its C2 domain, independent of its lipid phosphatase activity. This activity depends on the protein phosphatase activity of PTEN and on dephosphorylation at a single residue, threonine(383). The ability of PTEN to control cell migration through its C2 domain is likely to be an important feature of its tumor suppressor activity.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Cell Biol Unit, Canc Res UK Oncogene & Signal Transduct Grp, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Huang H, 1999, DEVELOPMENT, V126, P5365; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000	22	261	284	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2004	303	5661					1179	1181		10.1126/science.1092089	http://dx.doi.org/10.1126/science.1092089			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976311				2022-12-01	WOS:000189074700042
J	Goldstone, AR; Callaghan, CJ; Mackay, J; Charman, S; Nashef, SAM				Goldstone, AR; Callaghan, CJ; Mackay, J; Charman, S; Nashef, SAM			Should surgeons take a break after an intraoperative death? Attitude survey and outcome evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To investigate attitudes of cardiac surgeons and anaesthetists towards working immediately after an intraoperative death and to establish whether an intraoperative death affects the outcome of subsequent surgery. Design Questionnaire on attitudes to working after an intraoperative death and matched cohort study. Setting UK adult cardiac surgery centres and regional cardiothoracic surgical centre. Participants 371 consultant cardiac surgeons and anaesthetists in the United Kingdom were asked to complete a questionnaire, and seven surgeons from one centre who continued to operate after intraoperative death. Main outcome measures Outcome for 233 patients operated on by a surgeon who had experienced an intraoperative death within the preceding 48 hours compared with outcome of 932 matched controls. Hospital mortality and length of stay as a surrogate for hospital morbidity. Results The questionnaire response rate was 76%. Around a quarter of surgeons and anaesthetists thought they should stop work after an intraoperative death and most wanted guidelines on this subject. Overall, there was no increased mortality in patients operated on in the 48 hours after an intraoperative death. However, mortality was higher if the preceding intraoperative death was in an emergency or high risk case. Survivors operated on within 48 hours after an intraoperative death had longer stay in intensive care (odds ratio 1.64, 95% confidence interval 1.08 to 2.52, P = 0.02) and longer stay in hospital (relative change 1.15, 1.03 to 1.24, P = 0.02). Conclusion Mortality is not increased in operations performed in the immediate aftermath of an intraoperative death, but survivors have longer stays in intensive care and on the hospital ward.	Papworth Hosp, Cambridge CB3 8RE, England; Univ Cambridge, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England; Univ Cambridge, Dept Surg, Cambridge CB2 2QQ, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	Papworth Hospital; University of Cambridge; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Nashef, SAM (corresponding author), Papworth Hosp, Cambridge CB3 8RE, England.	sam.nashef@papworth.nhs.uk						Briffa N, 2001, BRIT MED J, V323, P341, DOI 10.1136/bmj.323.7308.341/a; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; PARSONNET V, 1989, CIRCULATION, V79, P1; SEINFERT BC, 2001, BRIT MED J, V323, P341; Sheehan AV, 1999, FATAL ACCIDENTS SUDD; Smith IC, 2001, BMJ-BRIT MED J, V322, P896, DOI 10.1136/bmj.322.7291.896; *SOC CARD SURG GRE, 1999, NAT AD CARD SURG DAT; White SM, 2003, ANAESTHESIA, V58, P515, DOI 10.1046/j.1365-2044.2003.03241.x	8	32	33	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2004	328	7436					379	382		10.1136/bmj.37985.371343.EE	http://dx.doi.org/10.1136/bmj.37985.371343.EE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775GA	14734519	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-01	WOS:000189031300019
J	Fromme, JC; Banerjee, A; Huang, SJ; Verdine, GL				Fromme, JC; Banerjee, A; Huang, SJ; Verdine, GL			Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase	NATURE			English	Article							C-TERMINAL DOMAIN; SOMATIC G-C->T-A MUTATIONS; ESCHERICHIA-COLI MUTY; STEADY-STATE KINETICS; INHERITED VARIANTS; DUPLEX; RECOGNITION; MECHANISM; REPAIR; MYH	The genomes of aerobic organisms suffer chronic oxidation of guanine to the genotoxic product 8-oxoguanine (oxoG)(1). Replicative DNA polymerases misread oxoG residues and insert adenine instead of cytosine opposite the oxidized base. Both bases in the resulting A.oxoG mispair are mutagenic lesions, and both must undergo base-specific replacement to restore the original C.G pair. Doing so represents a formidable challenge to the DNA repair machinery, because adenine makes up roughly 25% of the bases in most genomes. The evolutionarily conserved enzyme adenine DNA glycosylase (called MutY in bacteria and hMYH in humans) initiates repair of A.oxoG to C.G by removing the inappropriately paired adenine base from the DNA backbone. A central issue concerning MutY function is the mechanism by which A.oxoG mispairs are targeted among the vast excess of A.T pairs. Here we report the use of disulphide crosslinking(2) to obtain high-resolution crystal structures of MutY-DNA lesion-recognition complexes. These structures reveal the basis for recognizing both lesions in the A.oxoG pair and for catalysing removal of the adenine base.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Harvard University	Verdine, GL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	verdine@chemistry.harvard.edu	Banerjee, Anirban/AAC-4286-2020	banerjee, anirban/0000-0003-1494-6801; Fromme, J. Christopher/0000-0002-8837-0473; Banerjee, Anirban/0000-0002-9314-2862	NCI NIH HHS [R01 CA100742] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Bernards AS, 2002, J BIOL CHEM, V277, P20960, DOI 10.1074/jbc.C200181200; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Chmiel NH, 2003, J MOL BIOL, V327, P431, DOI 10.1016/S0022-2836(03)00124-4; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Gogos A, 1996, BIOCHEMISTRY-US, V35, P16665, DOI 10.1021/bi960843w; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; Lin J, 1997, BIOCHEMISTRY-US, V36, P1199, DOI 10.1021/bi962619c; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Massiah MA, 2003, BIOCHEMISTRY-US, V42, P10140, DOI 10.1021/bi030105p; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Porello SL, 1996, J AM CHEM SOC, V118, P10684, DOI 10.1021/ja9602206; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Volk DE, 2000, BIOCHEMISTRY-US, V39, P7331, DOI 10.1021/bi000416p; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178	24	260	282	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					652	656		10.1038/nature02306	http://dx.doi.org/10.1038/nature02306			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961129				2022-12-01	WOS:000188875300046
J	Oaks, JL; Gilbert, M; Virani, MZ; Watson, RT; Meteyer, CU; Rideout, BA; Shivaprasad, HL; Ahmed, S; Chaudhry, MJI; Arshad, M; Mahmood, S; Ali, A; Khan, AA				Oaks, JL; Gilbert, M; Virani, MZ; Watson, RT; Meteyer, CU; Rideout, BA; Shivaprasad, HL; Ahmed, S; Chaudhry, MJI; Arshad, M; Mahmood, S; Ali, A; Khan, AA			Diclofenac residues as the cause of vulture population decline in Pakistan	NATURE			English	Article							POLYMERASE-CHAIN-REACTION; WEST NILE VIRUS; INFECTIOUS-BRONCHITIS; CHICKENS; DIFFERENTIATION; PATHOLOGY; MORTALITY	The Oriental white-backed vulture (OWBV; Gyps bengalensis) was once one of the most common raptors in the Indian subcontinent(1). A population decline of >95%, starting in the 1990s, was first noted at Keoladeo National Park, India(2). Since then, catastrophic declines, also involving Gyps indicus and Gyps tenuirostris, have continued to be reported across the subcontinent(3). Consequently these vultures are now listed as critically endangered by BirdLife International(4). In 2000, the Peregrine Fund initiated its Asian Vulture Crisis Project with the Ornithological Society of Pakistan, establishing study sites at 16 OWBV colonies in the Kasur, Khanewal and Muzaffargarh-Layyah Districts of Pakistan to measure mortality at over 2,400 active nest sites(5). Between 2000 and 2003, high annual adult and subadult mortality (5-86%) and resulting population declines (34-95%) (ref. 5 and M. G., manuscript in preparation) were associated with renal failure and visceral gout. Here, we provide results that directly correlate residues of the anti-inflammatory drug diclofenac with renal failure. Diclofenac residues and renal disease were reproduced experimentally in OWBVs by direct oral exposure and through feeding vultures diclofenac-treated livestock. We propose that residues of veterinary diclofenac are responsible for the OWBV decline.	Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; Peregrine Fund, Boise, ID 83709 USA; US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Univ Calif Davis, Fresno Branch, Calif Anim Hlth & Food Safety Lab Syst, Fresno, CA 93725 USA; Bahauddin Zakariya Univ, Inst Pure & Appl Biol, Div Zool, Multan, Pakistan	Washington State University; United States Department of the Interior; United States Geological Survey; Zoological Society of San Diego; University of California System; University of California Davis; Bahauddin Zakariya University	Oaks, JL (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	loaks@vetmed.wsu.edu	Arshad, Muhammad/K-7335-2019; Arshad, Muhammad/GXW-0743-2022	Arshad, Muhammad/0000-0001-5501-6956; Gilbert, Martin/0000-0002-9930-4383				Ali S., 1968, HDB BIRDS INDIA PAKI; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; BEYER W, 1996, ENV CONTAMINANTS WIL, pCH10; BirdLife International, 2001, THREAT BIRDS AS BIRD; Crespo R., 2003, DIS POULTRY, P1085; Cunningham AA, 2003, ANIM CONSERV, V6, P189, DOI 10.1017/S136794300300324X; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Docherty D.E., 1988, Journal of Tissue Culture Methods, V11, P165, DOI 10.1007/BF01404270; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GATOME CW, 2002, HAEMATOLOGY BLOOD BI; Gilbert M, 2002, BIRD CONSERV INT, V12, P311, DOI 10.1017/S0959270902002198; HENNY CJ, 1985, J WILDLIFE MANAGE, V49, P648, DOI 10.2307/3801689; HILL E F, 1982, Environmental Toxicology and Chemistry, V1, P27, DOI 10.1897/1552-8618(1982)1[27:APOBFM]2.0.CO;2; Johnson DJ, 2001, EMERG INFECT DIS, V7, P739; KWON HM, 1993, AVIAN DIS, V37, P194, DOI 10.2307/1591474; Langelier K.M., 1993, P231; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; McKellar QA, 1997, VET PARASITOL, V72, P413, DOI 10.1016/S0304-4017(97)00108-8; Mendenhall MK, 2000, J VET DIAGN INVEST, V12, P57, DOI 10.1177/104063870001200110; Mishra SK, 2002, INDIAN J ANIM SCI, V72, P283; MURRAY MD, 1993, ANNU REV PHARMACOL, V33, P434; NYS Y, 1983, CR ACAD SCI III-VIE, V296, P401; Pain DJ, 2003, CONSERV BIOL, V17, P661, DOI 10.1046/j.1523-1739.2003.01740.x; Paul-Murphy Joanne, 2001, Veterinary Clinics of North America Exotic Animal Practice, V4, P35; Prakash Vibhu, 1999, Journal of the Bombay Natural History Society, V96, P365; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; SWAYNE DE, 1994, VET PATHOL, V31, P237, DOI 10.1177/030098589403100211; Tixier C, 2003, ENVIRON SCI TECHNOL, V37, P1061, DOI 10.1021/es025834r; TODD PA, 1988, DRUGS, V35, P244, DOI 10.2165/00003495-198835030-00004; Ziegler AF, 2002, AVIAN DIS, V46, P847, DOI 10.1637/0005-2086(2002)046[0847:NIBIPC]2.0.CO;2	30	1060	1140	16	495	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					630	633		10.1038/nature02317	http://dx.doi.org/10.1038/nature02317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14745453				2022-12-01	WOS:000188875300040
J	Pal-Bhadra, M; Leibovitch, BA; Gandhi, SG; Rao, M; Bhadra, U; Birchler, JA; Elgin, SCR				Pal-Bhadra, M; Leibovitch, BA; Gandhi, SG; Rao, M; Bhadra, U; Birchler, JA; Elgin, SCR			Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery	SCIENCE			English	Article							PROTEIN-1 BINDS; GENE; METHYLATION; MELANOGASTER; REPEATS; DNA	Genes normally resident in euchromatic domains are silenced when packaged into heterochromatin, as exemplified in Drosophila melanogaster by position effect variegation (PEV). Loss-of-function mutations resulting in suppression of PEV have identified critical components of heterochromatin, including proteins HP1, HP2, and histone H3 lysine 9 methyltransferase. Here, we demonstrate that this silencing is dependent on the RNA interference machinery, using tandem mini-white arrays and white transgenes in heterochromatin to show loss of silencing as a result of mutations in piwi, aubergine, or spindle-E ( homeless), which encode RNAi components. These mutations result in reduction of H3 Lys(9) methylation and delocalization of HP1 and HP2, most dramatically in spindle-E mutants.	Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Ctr Cellular & Mol Biol, Funct Genom & Gene Silencing Grp, Hyderabad 500007, Andhra Pradesh, India	University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhadra, U (corresponding author), Univ Missouri, Div Biol Sci, 117 Tucker Hall, Columbia, MO 65211 USA.	utpal@ccmb.res.in; birchlerj@missouri.edu; selgin@biology.wustl.edu		Elgin, Sarah C. R./0000-0002-5176-2510; Gandhi, Sumit G./0000-0002-9759-1745; Leibovitch, Boris/0000-0001-6771-5906	NICHD NIH HHS [HD23844] Funding Source: Medline; NIGMS NIH HHS [GM68388] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068388] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Birchler James A., 2003, P23; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Fanti L, 1998, CHROMOSOMA, V107, P286, DOI 10.1007/s004120050310; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Mette MF, 1999, EMBO J, V18, P241, DOI 10.1093/emboj/18.1.241; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Shaffer CD, 2002, P NATL ACAD SCI USA, V99, P14332, DOI 10.1073/pnas.212458899; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Zhao T, 2000, J BIOL CHEM, V275, P28332; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	21	538	623	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					669	672		10.1126/science.1092653	http://dx.doi.org/10.1126/science.1092653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752161	Green Submitted			2022-12-01	WOS:000188530800040
J	Davis, BG				Davis, BG			Biochemistry - Mimicking posttranslational modifications of proteins	SCIENCE			English	Editorial Material							GLYCOSYLATION		Univ Oxford, Dept Chem, Dyson Perrins Lab, Oxford OX1 3QY, England	University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Dyson Perrins Lab, S Parks Rd, Oxford OX1 3QY, England.	ben.davis@chemistry.oxford.ac.uk	Davis, Benjamin G/C-5281-2011	Davis, Benjamin G/0000-0002-5056-407X	Biotechnology and Biological Sciences Research Council [EGA17763, BB/C510824/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bader B, 2000, NATURE, V403, P223, DOI 10.1038/35003249; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Davis BG, 2000, BIOORGAN MED CHEM, V8, P1527, DOI 10.1016/S0968-0896(00)00083-3; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; GAMBLIN DP, IN PRESS ANGEW CHEM; Haselbeck A, 2003, CURR MED RES OPIN, V19, P430, DOI 10.1185/030079903125002063; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Liu HT, 2003, J AM CHEM SOC, V125, P1702, DOI 10.1021/ja029433n; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077	16	94	103	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					480	482		10.1126/science.1093449	http://dx.doi.org/10.1126/science.1093449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739446				2022-12-01	WOS:000188316400024
J	Anderson, MC; Ochsner, KN; Kuhl, B; Cooper, J; Robertson, E; Gabrieli, SW; Glover, GH; Gabrieli, JDE				Anderson, MC; Ochsner, KN; Kuhl, B; Cooper, J; Robertson, E; Gabrieli, SW; Glover, GH; Gabrieli, JDE			Neural systems underlying the suppression of unwanted memories	SCIENCE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVATION; INHIBITION; RETRIEVAL; HIPPOCAMPUS; MECHANISMS; MONKEYS; HUMANS; AREAS; TASK	Over a century ago, Freud proposed that unwanted memories can be excluded from awareness, a process called repression. It is unknown, however, how repression occurs in the brain. We used functional magnetic resonance imaging to identify the neural systems involved in keeping unwanted memories out of awareness. Controlling unwanted memories was associated with increased dorsolateral prefrontal activation, reduced hippocampal activation, and impaired retention of those memories. Both prefrontal cortical and right hippocampal activations predicted the magnitude of forgetting. These results confirm the existence of an active forgetting process and establish a neurobiological model for guiding inquiry into motivated forgetting.	Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	University of Oregon; Stanford University; Stanford University	Anderson, MC (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	mcanders@darkwing.uoregon.edu	Gabrieli, John/AAJ-2869-2020	Anderson, Michael/0000-0001-9505-9299	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059940, R01MH062126] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59940, MH62126] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BJORK EL, 1997, INTENTIONAL FORGETTI, P103; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dougall AL, 1999, PSYCHOSOM MED, V61, P38, DOI 10.1097/00006842-199901000-00008; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Erdelyi MH, 2001, AM PSYCHOL, V56, P761, DOI 10.1037/0003-066X.56.9.761; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; FREUD S, 1966, STANDARD EDITION COM, V1, P117; Freyd J. J., 1996, BETRAYAL TRAUMA LOGI; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	30	654	682	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2004	303	5655					232	235		10.1126/science.1089504	http://dx.doi.org/10.1126/science.1089504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	761KT	14716015				2022-12-01	WOS:000187908500049
J	Donnay, F; Weil, L				Donnay, F; Weil, L			Obstetric fistula: the international response	LANCET			English	Article							NORTHERN NIGERIA; HEALTH		UN Populat Fund, Tech Support Div, Reprod Hlth Branch, New York, NY 10017 USA	United Nations Population Fund	Donnay, F (corresponding author), UN Populat Fund, Tech Support Div, Reprod Hlth Branch, New York, NY 10017 USA.							Bangser M, 1999, SAFE MOTHERHOOD INIT, P157; Buekens P, 2003, BRIT MED J, V326, P136, DOI 10.1136/bmj.326.7381.136; HARRISON KA, 1985, BRIT J OBSTET GYNAEC, V92, P1; Lopez A, 1998, HLTH DIMENSIONS SEX; MURPHY M, 1981, J BIOSOC SCI, V13, P139, DOI 10.1017/S0021932000013304; *UNFPA AMDD FIGO, 2001, M PREV TREATM OBST F; *UNFPA MIN HLTH GO, 2002, TANZ FIST SURV 2001; Wall LL, 2002, INCONTINENCE, 2ND EDITION, P893; *WHO, 1989, WHOFHE895 DIV FAM HL; *WHO UNFPA UNICEF, 1997, GUID MON US OBST SER	10	35	35	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 3	2004	363	9402					71	72		10.1016/S0140-6736(03)15177-X	http://dx.doi.org/10.1016/S0140-6736(03)15177-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758YZ	14724002				2022-12-01	WOS:000187711300031
J	Ni, XJ; Wang, YQ; Hu, YM; Li, CK				Ni, XJ; Wang, YQ; Hu, YM; Li, CK			A euprimate skull from the early Eocene of China	NATURE			English	Article							TRICHROMATIC VISION; EVOLUTION; OMOMYIDAE; PRIMATES; ADAPTATIONS; ORIENTATION; PATTERNS; BASIN	The debut of undoubted euprimates (primates of modern aspect(1,2)) was in the early Eocene, about 55 Myr ago. Since their first appearance, the earliest euprimates can be distinguished as Cantius, Donrussellia and Teilhardina(2-4). Nonetheless, the earliest euprimates are primarily known from isolated teeth or fragmentary jaws. Here we describe a partially preserved euprimate skull with nearly complete upper and lower dentition, which represents a new species of Teilhardina and constitutes the first discovery of the genus in Asia. The new species is from the upper section of Lingcha Formation, Hunan Province, China, with an estimated age of 54.97 Myr ago(5). Morphology and phylogeny analyses reveal that the new species is the most primitive species of Teilhardina, positioned near the root of euprimate radiation. This discovery of the earliest euprimate skull known to date casts new light on the debate(6-12) concerning the adaptive origin of euprimates, and suggests that the last common ancestor of euprimates was probably a small, diurnal, visually oriented predator.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; CUNY, Grad Sch & City Coll, Biol Program, New York, NY 10016 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH); City University of New York (CUNY) System	Ni, XJ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	ni_xj@263.net						Bloch JI, 2002, SCIENCE, V298, P1606, DOI 10.1126/science.1078249; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; BOWN TM, 1987, J PALEONTOL, V61, P1; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129-4; Covert HH, 1995, CREATURES OF THE DARK, P495; Fleagle J.G., 1999, PRIMATE ADAPTATION E; GINGERICH PD, 1981, J HUM EVOL, V10, P345, DOI 10.1016/S0047-2484(81)80057-7; GODINOT M, 1987, MUNCHNER GEOWISS ABH, V10, P237; Gunnell GF, 2002, CAM S BIO EVOL ANTHR, V33, P45; Heesy CP, 2001, J HUM EVOL, V40, P111, DOI 10.1006/jhev.2000.0447; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; KAY RF, 1977, J HUM EVOL, V6, P19, DOI 10.1016/S0047-2484(77)80040-7; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; Kirk EC, 2003, SCIENCE, V300; Li WH, 2000, AM J PHYS ANTHROPOL, P318; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Ravosa MJ, 2000, J HUM EVOL, V38, P667, DOI 10.1006/jhev.1999.0380; ROSE KD, 1991, P NATL ACAD SCI USA, V88, P98, DOI 10.1073/pnas.88.1.98; Rose Kenneth D., 1994, P1; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; Simons EL, 1972, PRIMATE EVOLUTION IN; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; Swofford D, 2000, PAUP PHYLOGENETIC AN; Szalay F.S., 1979, EVOLUTIONARY HIST PR; Tan Y, 1999, NATURE, V402, P36, DOI 10.1038/46947; WILLIAMS BA, 1994, AM J PHYS ANTHROPOL, V93, P323, DOI 10.1002/ajpa.1330930305	30	102	117	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					65	68		10.1038/nature02126	http://dx.doi.org/10.1038/nature02126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	758YP	14702085				2022-12-01	WOS:000187710000034
J	Nishiguchi, KM; Sandberg, MA; Kooijman, AC; Martemyanov, KA; Pott, JWR; Hagstrom, SA; Arshavsky, VY; Berson, EL; Dryja, TP				Nishiguchi, KM; Sandberg, MA; Kooijman, AC; Martemyanov, KA; Pott, JWR; Hagstrom, SA; Arshavsky, VY; Berson, EL; Dryja, TP			Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation	NATURE			English	Article							GTPASE-ACCELERATING PROTEIN; RETINITIS-PIGMENTOSA; MEMBRANE ANCHOR; EXPRESSION; ACTIVATION; ROD; ELECTRORETINOGRAPHY; PHOTOTRANSDUCTION; STANDARD; RECOVERY	The RGS proteins are GTPase activating proteins that accelerate the deactivation of G proteins in a variety of signalling pathways in eukaryotes(1-6). RGS9 deactivates the G proteins (transducins) in the rod and cone phototransduction cascades(7,8). It is anchored to photoreceptor membranes by the transmembrane protein R9AP (RGS9 anchor protein), which enhances RGS9 activity up to 70-fold(9-11). If RGS9 is absent or unable to interact with R9AP, there is a substantial delay in the recovery from light responses in mice(4,12,13). We identified five unrelated patients with recessive mutations in the genes encoding either RGS9 or R9AP who reported difficulty adapting to sudden changes in luminance levels mediated by cones. Standard visual acuity was normal to moderately subnormal, but the ability to see moving objects, especially with low-contrast, was severely reduced despite full visual fields; we have termed this condition bradyopsia. To our knowledge, these patients represent the first identified humans with a phenotype associated with reduced RGS activity in any organ.	Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA; Univ Groningen Hosp, Dept Ophthalmol, NL-9700 RB Groningen, Netherlands	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Groningen	Dryja, TP (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA.	Thaddeus_Dryja@meei.harvard.edu						ANDREASSON SOL, 1988, AM J OPHTHALMOL, V105, P500, DOI 10.1016/0002-9394(88)90241-3; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P58; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P77; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; KOOIJMAN AC, 1991, CLIN VISION SCI, V6, P379; KOOIJMAN AC, 1991, DOC OPHTHALMOL, V78, P245, DOI 10.1007/BF00165687; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Lyubarsky A, 2001, MOL VIS, V7, P71; MARMOR MF, 1989, DOC OPHTHALMOL, V73, P299, DOI 10.1007/BF00154485; MARMOR MF, 1995, DOC OPHTHALMOL, V89, P199, DOI 10.1007/BF01203373; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2002, J BIOL CHEM, V277, P32843, DOI 10.1074/jbc.M205170200; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Rahman Z, 1999, J NEUROSCI, V19, P2016; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Sandberg MA, 1999, INVEST OPHTH VIS SCI, V40, P2457; Sandberg MA, 1998, ARCH OPHTHALMOL-CHIC, V116, P867, DOI 10.1001/archopht.116.7.867; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5	27	122	129	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					75	78		10.1038/nature02170	http://dx.doi.org/10.1038/nature02170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702087				2022-12-01	WOS:000187710000037
J	Surkan, PJ; Stephansson, O; Dickman, PW; Cnattingius, S				Surkan, PJ; Stephansson, O; Dickman, PW; Cnattingius, S			Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAUTERINE GROWTH-RETARDATION; FETAL DEATH; PERINATAL-MORTALITY; POPULATION; WEIGHT; OUTCOMES; COHORT; DETERMINANTS; PREGNANCIES; ULTRASOUND	Background: Some causes of stillbirth may also lead to fetuses that are small for gestational age (have a low birth weight with respect to their gestational age) or are delivered preterm (before 37 weeks of gestation). It is not known whether the birth of a previous small-for-gestational-age or preterm infant increases the subsequent risk of stillbirth. Methods: We assessed the associations between previous adverse outcomes of pregnancy and the risk of stillbirth in a nationwide Swedish study of 410,021 women who delivered first and second consecutive singleton infants between 1983 and 1997. There were 1842 and 1062 stillbirths during the first and second pregnancies, respectively. Results: As compared with women whose first infant was born at term (37 weeks of gestation or more) and was not small for gestational age, women whose first infant was born at term or preterm and was small for gestational age had an increased risk of stillbirth during their second pregnancy. The odds ratios for subsequent stillbirth, after adjustment for covariates known to be associated with an increased risk of stillbirth, were 2.1 (95 percent confidence interval, 1.6 to 2.8) among women with a first infant who was born at term and was small for gestational age, 3.4 (95 percent confidence interval, 2.1 to 5.6) among women with a first infant who was moderately (32 to 36 weeks of gestation) preterm and small for gestational age, and 5.0 (95 percent confidence interval, 2.5 to 9.8) among women with a first infant who was very (before 32 weeks of gestation) preterm and was small for gestational age. The odds ratio for subsequent stillbirth among women with a first stillborn infant was 2.5 (95 percent confidence interval, 1.4 to 4.7), as compared with women whose first infant was not stillborn. The rates of stillbirth in second pregnancies ranged from 2.4 per 1000 births among women whose first infant was born at term and was not small for gestational age to 19.0 per 1000 births among women whose first child was very preterm and was small for gestational age. Conclusions: Delivery of a previous small-for-gestational-age infant is an important predictor of the subsequent risk of stillbirth, particularly if the infant was delivered preterm.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Surkan, PJ (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.		Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380; Stephansson, Olof/0000-0003-1528-4563				Ananth CV, 1999, JAMA-J AM MED ASSOC, V282, P1646, DOI 10.1001/jama.282.17.1646; BAKKETEIG LS, 1979, AM J OBSTET GYNECOL, V135, P1086, DOI 10.1016/0002-9378(79)90742-7; Barfield WD, 2002, SEMIN PERINATOL, V26, P17, DOI 10.1053/sper.2002.29850; BENIRSCHKE K, 1987, CLIN OBSTET GYNECOL, V30, P2814; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Cnattingius S, 2002, SEMIN PERINATOL, V26, P25, DOI 10.1053/sper.2002.29841; Emanuel I, 1997, AM J EPIDEMIOL, V146, P820; FREEMAN RK, 1985, AM J OBSTET GYNECOL, V151, P7, DOI 10.1016/0002-9378(85)90414-4; FRETTS RC, 1992, OBSTET GYNECOL, V79, P35; GARBACIAK JA, 1992, CLIN PERINATOL, V19, P275, DOI 10.1016/S0095-5108(18)30454-8; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; GENEST DR, 1992, OBSTET GYNECOL, V80, P575; Hershkovitz R, 2001, EUR J OBSTET GYN R B, V97, P141, DOI 10.1016/S0301-2115(00)00517-0; HOFFMAN HJ, 1984, CLIN OBSTET GYNECOL, V27, P539, DOI 10.1097/00003081-198409000-00004; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; KHOURY MJ, 1988, PEDIATRICS, V82, P83; KRAMER MS, 1987, PEDIATRICS, V80, P502; Lackman F, 2001, AM J OBSTET GYNECOL, V184, P946, DOI 10.1067/mob.2001.111719; Lindmark G, 1991, Acta Obstet Gynecol Scand, V70, P105, DOI 10.3109/00016349109006190; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Marsal K, 2002, CURR OPIN OBSTET GYN, V14, P127, DOI 10.1097/00001703-200204000-00005; Martin JA, 2002, SEMIN PERINATOL, V26, P3, DOI 10.1053/sper:2002.29834; MILLER HC, 1985, AM J OBSTET GYNECOL, V153, P20, DOI 10.1016/0002-9378(85)90583-6; Papiernik E, 1999, Matern Child Health J, V3, P63, DOI 10.1023/A:1021897125652; PATTERSON RM, 1986, OBSTET GYNECOL, V68, P464; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; Robson S, 2001, AUST NZ J OBSTET GYN, V41, P29, DOI 10.1111/j.1479-828X.2001.tb01290.x; SAMUELOFF A, 1993, J REPROD MED, V38, P883; SCHNEIDER J, 1973, Clinical Obstetrics and Gynecology, V16, P120, DOI 10.1097/00003081-197303000-00007; STEIN ZA, 1984, SEMIN PERINATOL, V8, P5; Stephansson O, 2001, INT J EPIDEMIOL, V30, P1296, DOI 10.1093/ije/30.6.1296; Stephansson O, 2003, OBSTET GYNECOL, V102, P101, DOI 10.1016/S0029-7844(03)00366-1; Tolockiene E, 2001, ACTA OBSTET GYN SCAN, V80, P511, DOI 10.1034/j.1600-0412.2001.080006511.x; Westergaard HB, 2001, ULTRASOUND OBST GYN, V17, P466, DOI 10.1046/j.1469-0705.2001.00415.x	35	119	127	1	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2004	350	8					777	785		10.1056/NEJMoa031587	http://dx.doi.org/10.1056/NEJMoa031587			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774VM	14973215				2022-12-01	WOS:000189006400006
J	Shih, WM; Quispe, JD; Joyce, GF				Shih, WM; Quispe, JD; Joyce, GF			A 1.7-kilobase single-stranded DNA that folds into a nanoscale octahedron	NATURE			English	Article							DOUBLE CROSSOVER MOLECULES; NUCLEIC-ACID JUNCTIONS; CONSTRUCTION; SPECIMENS; DESIGN; VIRUS; RNA	Molecular self-assembly offers a means of spontaneously forming complex and well-defined structures from simple components. The specific bonding between DNA base pairs has been used in this way to create DNA-based nanostructures and to direct the assembly of material on the subnanometre to micrometre scale(1,2). In principle, large-scale clonal production of suitable DNA sequences and the directed evolution of sequence lineages towards optimized behaviour(3) can be realized through exponential DNA amplification by polymerases. But known examples of three-dimensional geometric DNA objects(4-6) are not amenable to cloning because they contain topologies that prevent copying by polymerases(1,2,7). Here we report the design and synthesis of a 1,669-nucleotide, single-stranded DNA molecule that is readily amplified by polymerases and that, in the presence of five 40-mer synthetic oligodeoxynucleotides, folds into an octahedron structure by a simple denaturation-renaturation procedure. We use cryo-electron microscopy to show that the DNA strands fold successfully, with 12 struts or edges joined at six four-way junctions to form hollow octahedra approximately 22 nanometres in diameter. Because the base-pair sequence of individual struts is not repeated in a given octahedron(8,9), each strut is uniquely addressable by the appropriate sequence-specific DNA binder.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Shih, WM (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wmshih@scripps.edu						Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; DORENBECK A, 2000, THESIS U BOCHUM; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; FRANK J, 1990, Q REV BIOPHYS, V23, P281, DOI 10.1017/S0033583500005564; FRANK J, 1975, ULTRAMICROSCOPY, V1, P159, DOI 10.1016/S0304-3991(75)80020-9; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; LARSON SB, 1993, NATURE, V361, P179, DOI 10.1038/361179a0; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Sa-Ardyen P, 2003, BIOPHYS J, V84, P3829, DOI 10.1016/S0006-3495(03)75110-8; SEEMAN NC, 1991, DNA CELL BIOL, V10, P475, DOI 10.1089/dna.1991.10.475; SEEMAN NC, 1983, BIOPHYS J, V44, P201, DOI 10.1016/S0006-3495(83)84292-1; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 1998, ANNU REV BIOPH BIOM, V27, P225, DOI 10.1146/annurev.biophys.27.1.225; STEMMER WP, 1995, GENE, V64, P49; Tang L, 2001, NAT STRUCT BIOL, V8, P77, DOI 10.1038/83089; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zhang XP, 2002, J AM CHEM SOC, V124, P12940, DOI 10.1021/ja026973b; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006; ZUKER M, 2003, NUCLEIC ACIDS RES, V31, P1	23	772	817	5	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2004	427	6975					618	621		10.1038/nature02307	http://dx.doi.org/10.1038/nature02307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961116				2022-12-01	WOS:000188875300036
J	Bhowmick, NA; Chytil, A; Plieth, D; Gorska, AE; Dumont, N; Shappell, S; Washington, MK; Neilson, EG; Moses, HL				Bhowmick, NA; Chytil, A; Plieth, D; Gorska, AE; Dumont, N; Shappell, S; Washington, MK; Neilson, EG; Moses, HL			TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia	SCIENCE			English	Article							HEPATOCYTE GROWTH-FACTOR; TISSUE FIBROSIS; TUMOR-CELLS; C-MYC; EXPRESSION; ORGANS; MICE	Stromal cells can have a significant impact on the carcinogenic process in adjacent epithelia. The role of transforming growth factor-beta (TGF-beta) signaling in such epithelial-mesenchymal interactions was determined by conditional inactivation of the TGF-beta type II receptor gene in mouse fibroblasts (Tgfbr2(fspKO)). The loss of TGF-beta responsiveness in fibroblasts resulted in intraepithelial neoplasia in prostate and invasive squamous cell carcinoma of the forestomach, both associated with an increased abundance of stromal cells. Activation of paracrine hepatocyte growth factor (HGF) signaling was identified as one possible mechanism for stimulation of epithelial proliferation. Thus, TGF-beta signaling in fibroblasts modulates the growth and oncogenic potential of adjacent epithelia in selected tissues.	Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Moses, HL (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA.	hal.moses@vanderbilt.edu	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989	NATIONAL CANCER INSTITUTE [R01CA102162, R01CA085492, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046282] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485, CA85492, CA102162] Funding Source: Medline; NIAMS NIH HHS [AR41943] Funding Source: Medline; NIDDK NIH HHS [DK46282] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; COOPER M, 1977, CANCER RES, V37, P2544; CUNHA GR, 1985, CELL DIFFER DEV, V17, P137, DOI 10.1016/0045-6039(85)90481-6; HAYASHI N, 1991, CANCER RES, V51, P4924; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Iwano M, 2001, MOL THER, V3, P149, DOI 10.1006/mthe.2000.0251; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Nakamura T, 1997, CANCER RES, V57, P3305; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Sakurai H, 1997, AM J PHYSIOL-RENAL, V272, pF139, DOI 10.1152/ajprenal.1997.272.1.F139; SEGARINI PR, 1989, MOL ENDOCRINOL, V3, P261, DOI 10.1210/mend-3-2-261; Shima N, 1998, J CELL PHYSIOL, V177, P130, DOI 10.1002/(SICI)1097-4652(199810)177:1<130::AID-JCP14>3.3.CO;2-O; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Walter KA, 2002, MOL CELL BIOL, V22, P2703, DOI 10.1128/MCB.22.8.2703-2715.2002; Watanabe R, 2000, NTT REVIEW, V12, P65; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333	24	1085	1136	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					848	851		10.1126/science.1090922	http://dx.doi.org/10.1126/science.1090922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764882				2022-12-01	WOS:000188753800061
J	Kitajima, TS; Kawashima, SA; Watanabe, Y				Kitajima, TS; Kawashima, SA; Watanabe, Y			The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis	NATURE			English	Article							SISTER-CHROMATID COHESION; REDUCTIONAL CHROMOSOME SEGREGATION; FISSION YEAST BUB1; AXIAL ELEMENTS; SPINDLE; REC8; MEI-S332; HETEROCHROMATIN; RECOMBINATION; MICROTUBULES	Meiosis comprises a pair of specialized nuclear divisions that produce haploid germ cells. To accomplish this, sister chromatids must segregate together during the first meiotic division (meiosis I), which requires that sister chromatid cohesion persists at centromeres. The factors that protect centromeric cohesion during meiosis I have remained elusive. Here we identify Sgo1 (shugoshin), a protector of the centromeric cohesin Rec8 in fission yeast. We also identify a homologue of Sgo1 in budding yeast. We provide evidence that shugoshin is widely conserved among eukaryotes. Moreover, we identify Sgo2, a paralogue of shugoshin in fission yeast, which is required for faithful mitotic chromosome segregation. Localization of Sgo1 and Sgo2 at centromeres requires the kinase Bub1, identifying shugoshin as a crucial target for the kinetochore function of Bub1. These findings provide insights into the evolution of meiosis and kinetochore regulation during mitosis and meiosis.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Japan Sci & Technol Agcy, SORST, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	ywatanab@ims.u-tokyo.ac.jp	Kitajima, Tomoya/A-7049-2016; Kawashima, Shigehiro/Q-6937-2017	Kitajima, Tomoya/0000-0002-6486-7143; Watanabe, Yoshinori/0000-0002-5488-4812				Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Henikoff S, 1998, NUCLEIC ACIDS RES, V26, P309, DOI 10.1093/nar/26.1.309; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; LeBlanc HN, 1999, CHROMOSOMA, V108, P401, DOI 10.1007/s004120050392; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scanlan M J, 2001, Cancer Immun, V1, P4; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Stoop-Myer C, 1999, NAT CELL BIOL, V1, pE125, DOI 10.1038/12956; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamamoto Y, 2001, J TURBUL, V2, P1; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003	44	437	452	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					510	517		10.1038/nature02312	http://dx.doi.org/10.1038/nature02312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14730319				2022-12-01	WOS:000188721800033
J	Parkman, R				Parkman, R			Getting a handle on graft-versus-host disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							T-CELLS		Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Parkman, R (corresponding author), Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA.							Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Itoh M, 1999, J IMMUNOL, V162, P5317; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x	3	1	1	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2004	350	6					614	615		10.1056/NEJMcibr033175	http://dx.doi.org/10.1056/NEJMcibr033175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770FP	14762191				2022-12-01	WOS:000188712800016
J	Tsiavaliaris, G; Fujita-Becker, S; Manstein, DJ				Tsiavaliaris, G; Fujita-Becker, S; Manstein, DJ			Molecular engineering of a backwards-moving myosin motor	NATURE			English	Article							NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; CHARGE CHANGES; ATOMIC MODEL; LIGHT-CHAIN; F-ACTIN; DOMAIN; DICTYOSTELIUM; COMPLEX; MOVE	All members of the diverse myosin superfamily have a highly conserved globular motor domain that contains the actin- and nucleotide-binding sites and produces force and movement(1,2). The light-chain-binding domain connects the motor domain to a variety of functionally specialized tail domains and amplifies small structural changes in the motor domain through rotation of a lever arm(3,4). Myosins move on polarized actin filaments either forwards to the barbed (1) or backwards to the pointed (2) end(5,6). Here, we describe the engineering of an artificial backwards-moving myosin from three pre-existing molecular building blocks. These blocks are: a forward-moving class I myosin motor domain, a directional inverter formed by a four-helix bundle segment of human guanylate-binding protein-1 and an artificial lever arm formed by two alpha-actinin repeats. Our results prove that reverse-direction movement of myosins can be achieved simply by rotating the direction of the lever arm 180degrees.	Hannover Med Sch, Inst Biophys Chem, OE 4350, D-30623 Hannover, Germany; Max Planck Inst Med Res, Biophys Abt, D-69120 Heidelberg, Germany	Hannover Medical School; Max Planck Society	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE 4350, Carl Neuberg Str 1, D-30623 Hannover, Germany.	manstein@bpc.mh-hannover.de	Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147				Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Knetsch MLW, 1999, J BIOL CHEM, V274, P20133, DOI 10.1074/jbc.274.29.20133; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kull FJ, 2002, J CELL SCI, V115, P15; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; Ponomarev MA, 2000, BIOCHEMISTRY-US, V39, P4527, DOI 10.1021/bi992420a; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Van Dijk J, 1999, EUR J BIOCHEM, V260, P672, DOI 10.1046/j.1432-1327.1999.00172.x; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	30	89	89	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					558	561		10.1038/nature02303	http://dx.doi.org/10.1038/nature02303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765199				2022-12-01	WOS:000188721800045
J	Chan, AT; Giovannucci, EL; Schernhammer, ES; Colditz, GA; Hunter, DJ; Willett, WC; Fuchs, CS				Chan, AT; Giovannucci, EL; Schernhammer, ES; Colditz, GA; Hunter, DJ; Willett, WC; Fuchs, CS			A prospective study of aspirin use and the risk for colorectal adenoma	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	Digestive Disease Week Meeting/104th Annual Meeting of the American-Gastroenterological-Association	MAY 17-22, 2003	ORLANDO, FL	Amer Gastroenterol Assoc			NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LONG-TERM USE; COST-EFFECTIVENESS ANALYSIS; COLON-CANCER CELLS; NF-KAPPA-B; LARGE-BOWEL; RANDOMIZED-TRIAL; UNITED-STATES; PHYSICAL-ACTIVITY; REDUCED RISK	Background: Randomized, double-blind, placebo-controlled trials have established that regular aspirin use reduces the risk for recurrent colorectal adenoma. However, the effect of dose and duration of use, particularly in an average-risk population, is not well understood. Objective: To examine the influence of dose and duration of aspirin use in the primary prevention of colorectal adenoma. Design: Prospective cohort study. Setting: Nurses' Health Study. Participants: 27 077 women, 34 to 77 years of age, without a history of adenoma, cancer, inflammatory bowel disease, or familial polyposis, who underwent lower endoscopy between 1980 and 1998. Measurements: 1368 cases of confirmed distal colorectal adenoma were diagnosed between 1980 and 1998. Self-reported data on aspirin use were collected from biennial questionnaires. Results: After other risk factors for adenoma were adjusted, women who regularly used aspirin (greater than or equal to2 standard aspirin tablets/wk) had a multivariate relative risk for adenoma of 0.75 (95% Cl, 0.66 to 0.84) compared with nonregular users. Compared with women who denied any aspirin use, the multivariate relative risks for adenoma were 0.80 (Cl, 0.70 to 0.93) for women who used 0.5 to 1.5 standard tablets per week, 0.74 (Cl, 0.62 to 0.88) for those who used 2 to 5 tablets per week, 0.72 (Cl, 0.61 to 0.85) for those who used 6 to 14 tablets per week, and 0.49 (Cl, 0.36 to 0.65) for those who used more than 14 tablets per week (P<0.001 for trend). Similar dose-response relationships were found among regular short-term users (less than or equal to5 years; P<0.001) and long-term users (>5 years; P<0.001). In contrast, after adjustments were made for dose, increasing duration of aspirin use did not confer greater risk reduction (P>0.2). Conclusions: Regular, short-term use of aspirin is inversely associated with risk for colorectal adenoma. However, the greatest protective effect is evident at substantially higher doses (>14 tablets/wk) than those recommended for the prevention of cardiovascular disease. Before aspirin can be recommended for chemo-prevention in the general adult population, these results suggest the need for a more thorough evaluation of the risks and benefits of routine aspirin use at doses not previously considered.	Harvard Univ, Gastrointestinal Unit, Massachusetts Gen Hosp,Med Sch, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Chan, AT (corresponding author), Harvard Univ, Gastrointestinal Unit, Massachusetts Gen Hosp,Med Sch, Brigham & Womens Hosp,Dana Farber Canc Inst, 55 Fruit St,GRJ-722, Boston, MA 02114 USA.		Chan, Andrew T/P-8293-2014; Schernhammer, Eva S/L-7898-2018; Colditz, Graham/A-3963-2009	Chan, Andrew T/0000-0001-7284-6767; Schernhammer, Eva S/0000-0002-4337-9415; Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NCI NIH HHS [CA 87969, CA 55075] Funding Source: Medline; NHLBI NIH HHS [HL 34594] Funding Source: Medline; NIDDK NIH HHS [T32DK07191] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baier M, 2000, CANCER EPIDEM BIOMAR, V9, P229; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Breuer-Katschinski B, 2000, DIGESTION, V61, P129, DOI 10.1159/000007745; Chan AT, 2003, CANCER CAUSE CONTROL, V14, P413, DOI 10.1023/A:1024986220526; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chau I, 2002, NEW ENGL J MED, V346, P1085, DOI 10.1056/NEJM200204043461412; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P192, DOI 10.1093/jnci/86.3.192; Giovannucci E, 1996, CANCER CAUSE CONTROL, V7, P253, DOI 10.1007/BF00051301; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Grodstein F, 1998, ANN INTERN MED, V128, P705, DOI 10.7326/0003-4819-128-9-199805010-00001; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Imperiale TF, 2003, NEW ENGL J MED, V348, P879, DOI 10.1056/NEJMp030005; Iso H, 1999, STROKE, V30, P1764, DOI 10.1161/01.STR.30.9.1764; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Ladabaum U, 2001, ANN INTERN MED, V135, P769, DOI 10.7326/0003-4819-135-9-200111060-00007; LaVecchia C, 1997, BRIT J CANCER, V76, P675, DOI 10.1038/bjc.1997.444; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Martin C, 2002, GASTROENTEROLOGY, V123, P1770, DOI 10.1053/gast.2002.37053; MARTINEZ ME, 1995, CANCER EPIDEM BIOMAR, V4, P703; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Peleg II, 1996, DIGEST DIS SCI, V41, P1319, DOI 10.1007/BF02088554; RANSOHOFF DF, 1990, JAMA-J AM MED ASSOC, V264, P76, DOI 10.1001/jama.264.1.76; REX DK, 1995, AM J GASTROENTEROL, V90, P353; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Ruffin MT, 1997, JNCI-J NATL CANCER I, V89, P1152, DOI 10.1093/jnci/89.15.1152; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Shureiqi I, 2000, CANCER RES, V60, P6846; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; Suleiman S, 2002, GASTROENTEROLOGY, V122, P78, DOI 10.1053/gast.2002.29689; Tangrea JA, 2003, CANCER CAUSE CONTROL, V14, P403, DOI 10.1023/A:1024990617158; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Williams CS, 1997, J CLIN INVEST, V100, P1325, DOI 10.1172/JCI119651; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307	58	135	143	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2004	140	3					157	166		10.7326/0003-4819-140-3-200402030-00006	http://dx.doi.org/10.7326/0003-4819-140-3-200402030-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	770BZ	14757613				2022-12-01	WOS:000188704500001
J	Thompson, S; Neal, S; Clark, V				Thompson, S; Neal, S; Clark, V			Clinical risk management in obstetrics: eclampsia drills	BRITISH MEDICAL JOURNAL			English	Article							PERFORMANCE	Problem Infrequent presentation of patients with eclampsia, leading to staff inexperienced in the condition and untested emergency systems. Design "Fire drill" programme using on-site simulation of patients with eclampsia. Setting Tertiary referral obstetric unit. Key measures for improvement Successful implementation of measures to optimise management of eclampsia. Strategies for change Rapid activation of emergency team after one call, development and dissemination of evidence based protocol for eclampsia, strategically placed "eclampsia boxes," individual staff feedback and education. Effects of change Efficient and appropriate management of subsequent simulated patients. Lessons learnt On-site simulation can identify and correct potential deficiencies in the care of patients with eclampsia.	St George Hosp, Dept Anaesthet, Kogarah, NSW 2217, Australia; St Johns Hosp, Livingston EH54 6PP, Scotland; Royal Infirm Edinburgh NHS Trust, Edinburgh EH3 9YW, Midlothian, Scotland	St George Hospital; Royal Infirmary of Edinburgh; University of Edinburgh	Thompson, S (corresponding author), St George Hosp, Dept Anaesthet, Kogarah, NSW 2217, Australia.	sarahathompson@hotmail.com						BURKE C, 2003, CLIN RISK, V9, P103; CHOPRA V, 1994, BRIT J ANAESTH, V73, P293, DOI 10.1093/bja/73.3.293; Cro S, 2001, BR J MIDWIFERY, V9, P492; Department of Health, 2000, ORG MEM; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duley L, 1996, BRIT J OBSTET GYNAEC, V103, P103, DOI 10.1111/j.1471-0528.1996.tb09657.x; Gaba DM, 1998, ANESTHESIOLOGY, V89, P8, DOI 10.1097/00000542-199807000-00005; *NHS LIT AUTH, 2003, CLIN NEGL SCHEM TRUS; Patel R M, 1998, Acad Med, V73, P593, DOI 10.1097/00001888-199805000-00060; *ROYAL COLL OBST G, 1999, WHY MOTH DIE; *ROYAL COLL OBST G, MAN ECL; *ROYAL COLL OBST G, 1999, TOW SAF CHILDB; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P1049, DOI 10.1016/0002-9378(90)91123-T; Walpole R, 2002, CPD ANAESTHESIA, V4, P15	14	46	47	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 31	2004	328	7434					269	271		10.1136/bmj.328.7434.269	http://dx.doi.org/10.1136/bmj.328.7434.269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771LC	14751898	Green Published			2022-12-01	WOS:000188786000023
J	Park, JY; Su, YQ; Ariga, M; Law, E; Jin, SLC; Conti, M				Park, JY; Su, YQ; Ariga, M; Law, E; Jin, SLC; Conti, M			EGF-like growth factors as mediators of LH action in the ovulatory follicle	SCIENCE			English	Article							RECEPTOR LIGANDS; GRANULOSA-CELLS; CUMULUS CELLS; CYCLIC-AMP; OOCYTES; MATURATION; RAT; EXPRESSION; EXPANSION; PATHWAYS	Before ovulation in mammals, a cascade of events resembling an inflammatory and/or tissue remodeling process is triggered by luteinizing hormone (LH) in the ovarian follicle. Many LH effects, however, are thought to be indirect because of the restricted expression of its receptor. Here, we demonstrate that LH stimulation induces the transient and sequential expression of the epidermal growth factor (EGF) family members amphiregulin, epiregulin, and beta-cellulin. Incubation of follicles with these growth factors recapitulates the morphological and biochemical events triggered by LH, including cumulus expansion and oocyte maturation. Thus, these EGF-related growth factors are paracrine mediators that propagate the LH signal throughout the follicle.	Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Stanford, CA 94305 USA	Stanford University; Stanford University	Conti, M (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA.	marco.conti@stanford.edu	Su, You-Qiang/C-6160-2019; Law, Evelyn C/AAM-4083-2020	Su, You-Qiang/0000-0003-3537-6246; Law, Evelyn C/0000-0003-4683-7220	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD031398, R01HD020788] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20788, HD31398] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; DEKEL N, 1985, ENDOCRINOLOGY, V116, P406, DOI 10.1210/endo-116-1-406; EPPIG JJ, 1979, J EXP ZOOL, V209, P345, DOI 10.1002/jez.1402090216; Eppig John J., 1994, Seminars in Developmental Biology, V5, P51, DOI 10.1006/sedb.1994.1007; Espey LL, 2002, BIOL REPROD, V67, P1662, DOI 10.1095/biolreprod.102.005173; Goud PT, 1998, HUM REPROD, V13, P1638, DOI 10.1093/humrep/13.6.1638; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; HSU CJ, 1987, BIOCHEM BIOPH RES CO, V147, P242, DOI 10.1016/S0006-291X(87)80112-2; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Park J.C., UNPUB; Park JY, 2003, MOL ENDOCRINOL, V17, P1117, DOI 10.1210/me.2002-0435; PATHAK BG, 1995, GENOMICS, V28, P116, DOI 10.1006/geno.1995.1116; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Prochazka R, 2000, MOL REPROD DEV, V56, P63, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;63::AID-MRD8&gt;3.0.CO;2-D; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; Robert C, 2000, MOL REPROD DEV, V57, P167, DOI 10.1002/1098-2795(200010)57:2&lt;167::AID-MRD8&gt;3.0.CO;2-P; Salustri A, 1996, ZYGOTE, V4, P313, DOI 10.1017/S0967199400003312; Tirone E, 1997, J BIOL CHEM, V272, P4787, DOI 10.1074/jbc.272.8.4787; TSAFRIRI A, 1972, J REPROD FERTIL, V31, P39, DOI 10.1530/jrf.0.0310039; TSAFRIRI A, 1994, MOL BIOL FEMALE REPR, V1, P207; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	24	732	760	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					682	684		10.1126/science.1092463	http://dx.doi.org/10.1126/science.1092463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14726596				2022-12-01	WOS:000188530800044
J	Gibot, S; Cravoisy, A; Levy, B; Bene, MC; Faure, G; Bollaert, PE				Gibot, S; Cravoisy, A; Levy, B; Bene, MC; Faure, G; Bollaert, PE			Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; BRONCHOALVEOLAR LAVAGE; NOSOCOMIAL PNEUMONIA; CLINICAL JUDGMENT; ORGAN FAILURE; TREM-1; SEPSIS; SCORE; PROCALCITONIN; STRATEGIES	BACKGROUND: The diagnosis and treatment of bacterial pneumonia in patients who are receiving mechanical ventilation remain a difficult challenge. The triggering receptor expressed on myeloid cells (TREM-1) is a member of the immunoglobulin superfamily, and its expression on phagocytes is specifically up-regulated by microbial products. The presence of soluble TREM-1 (sTREM-1) in bronchoalveolar-lavage fluid from patients receiving mechanical ventilation may be an indicator of pneumonia. METHODS: We conducted a prospective study of 148 patients receiving mechanical ventilation in whom infectious pneumonia was suspected. A rapid immunoblot technique was used to measure sTREM-1 in bronchoalveolar-lavage fluid. Two independent intensivists who were unaware of the results of the sTREM-1 assay determined whether community-acquired pneumonia and ventilator-associated pneumonia were present or absent. RESULTS: The final diagnosis was community-acquired pneumonia in 38 patients, ventilator-associated pneumonia in 46 patients, and no pneumonia in 64 patients. The presence of sTREM-1 by itself was more accurate than any clinical findings or laboratory values in identifying the presence of bacterial or fungal pneumonia (likelihood ratio, 10.38; sensitivity, 98 percent; specificity, 90 percent). In multiple logistic-regression analysis, the presence of sTREM-1 was the strongest independent predictor of pneumonia (odds ratio, 41.5). CONCLUSIONS: In patients receiving mechanical ventilation, rapid detection of sTREM-1 in bronchoalveolar-lavage fluid may be useful in establishing or excluding the diagnosis of bacterial or fungal pneumonia.	Hop Cent, Serv Reanimat Med, F-54035 Nancy, France; Fac Med, Immunol Lab, Nancy, France	CHU de Nancy; Universite de Franche-Comte; Universite de Lorraine	Gibot, S (corresponding author), Hop Cent, Serv Reanimat Med, 29 Ave Marechal de Lattre de Tassigny, F-54035 Nancy, France.	s.gibot@chu-nancy.fr						Amyes SGB, 1998, CHEST, V113, p228S, DOI 10.1378/chest.113.3_Supplement.228S; Baker AM, 1996, AM J RESP CRIT CARE, V153, P343, DOI 10.1164/ajrccm.153.1.8542141; Birmingham MC, 1997, PHARMACOECONOMICS, V12, P637, DOI 10.2165/00019053-199712060-00004; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bonten MJM, 1997, AM J RESP CRIT CARE, V156, P1105, DOI 10.1164/ajrccm.156.4.9610002; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brunkhorst FM, 2002, CLIN MICROBIOL INFEC, V8, P93, DOI 10.1046/j.1469-0691.2002.00349.x; Campbell GD, 2000, CHEST, V117, p207S, DOI 10.1378/chest.117.4_suppl_2.207S; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cohen J, 2001, LANCET, V358, P776, DOI 10.1016/S0140-6736(01)06007-X; Duflo F, 2002, ANESTHESIOLOGY, V96, P74, DOI 10.1097/00000542-200201000-00018; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; FAGON JY, 1993, CHEST, V103, P547, DOI 10.1378/chest.103.2.547; FUKUSHIMA R, 1994, CRIT CARE MED, V22, P114, DOI 10.1097/00003246-199401000-00022; Helling TS, 1996, AM J SURG, V171, P570, DOI 10.1016/S0002-9610(96)00040-2; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; MEDURI GU, 1992, CHEST, V101, P500, DOI 10.1378/chest.101.2.500; Monton C, 1999, CRIT CARE MED, V27, P1745, DOI 10.1097/00003246-199909000-00008; Nathan C, 2001, NAT MED, V7, P530, DOI 10.1038/87846; PAPAZIAN L, 1995, AM J RESP CRIT CARE, V152, P1982, DOI 10.1164/ajrccm.152.6.8520766; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wu CL, 2003, CRIT CARE MED, V31, P812, DOI 10.1097/01.CCM.0000054865.47068.58; Wunderink RG, 1998, AM J RESP CRIT CARE, V157, P349	28	426	494	1	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2004	350	5					451	458		10.1056/NEJMoa031544	http://dx.doi.org/10.1056/NEJMoa031544			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	767QJ	14749453				2022-12-01	WOS:000188463900007
J	Itoh, H; Takahashi, A; Adachi, K; Noji, H; Yasuda, R; Yoshida, M; Kinosita, K				Itoh, H; Takahashi, A; Adachi, K; Noji, H; Yasuda, R; Yoshida, M; Kinosita, K			Mechanically driven ATP synthesis by F-1-ATPase	NATURE			English	Article							MOLECULAR MOTOR; SYNTHASE; F1-ATPASE; DIMETHYLSULFOXIDE; RESOLUTION; NUCLEOTIDE; ROTATION; BINDING; ENERGY; MYOSIN	ATP, the main biological energy currency, is synthesized from ADP and inorganic phosphate by ATP synthase in an energy-requiring reaction(1-3). The F-1 portion of ATP synthase, also known as F-1-ATPase, functions as a rotary molecular motor: in vitro its gamma-subunit rotates(4) against the surrounding alpha(3)beta(3) subunits(5), hydrolysing ATP in three separate catalytic sites on the beta-subunits. It is widely believed that reverse rotation of the gamma-subunit, driven by proton flow through the associated F-o portion of ATP synthase, leads to ATP synthesis in biological systems(1-3,6,7). Here we present direct evidence for the chemical synthesis of ATP driven by mechanical energy. We attached a magnetic bead to the gamma-subunit of isolated F-1 on a glass surface, and rotated the bead using electrical magnets. Rotation in the appropriate direction resulted in the appearance of ATP in the medium as detected by the luciferase-luciferin reaction. This shows that a vectorial force ( torque) working at one particular point on a protein machine can influence a chemical reaction occurring in physically remote catalytic sites, driving the reaction far from equilibrium.	Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; CREST, Creat & Applicat Soft Nanomachine Hyperfunct Mol, Tsukuba, Ibaraki 3002635, Japan; Hamamatsu Photon KK, Syst Div, Hamamatsu, Shizuoka 4313103, Japan; Okazaki Natl Res Inst, Ctr Integrat Biosci, Okazaki, Aichi 4448585, Japan; Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; ERATO ATP Syst, Yokohama, Kanagawa 2260026, Japan	Hamamatsu Photonics; Japan Science & Technology Agency (JST); Hamamatsu Photonics; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo; Cold Spring Harbor Laboratory; Japan Science & Technology Agency (JST)	Itoh, H (corresponding author), Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan.	hiritoh@hpk.trc-net.co.jp	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Freitag S, 1997, PROTEIN SCI, V6, P1157, DOI 10.1002/pro.5560060604; Hattori N, 2002, BIOSCI BIOTECH BIOCH, V66, P2587, DOI 10.1271/bbb.66.2587; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; MANNHERZ HG, 1974, EUR J BIOCHEM, V48, P287, DOI 10.1111/j.1432-1033.1974.tb03767.x; MCELROY WD, 1969, PHOTOCHEM PHOTOBIOL, V10, P153, DOI 10.1111/j.1751-1097.1969.tb05676.x; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OISHI N, 1994, BBA-BIOENERGETICS, V1185, P346, DOI 10.1016/0005-2728(94)90250-X; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; SAKAMOTO J, 1984, J BIOCHEM-TOKYO, V96, P483, DOI 10.1093/oxfordjournals.jbchem.a134860; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; WOLCOTT RG, 1974, BIOCHEM BIOPH RES CO, V57, P709, DOI 10.1016/0006-291X(74)90604-4; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; YOSHIDA M, 1983, BIOCHEM BIOPH RES CO, V114, P907, DOI 10.1016/0006-291X(83)90646-0; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	22	394	411	4	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2004	427	6973					465	468		10.1038/nature02212	http://dx.doi.org/10.1038/nature02212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749837				2022-12-01	WOS:000188470500049
J	Young, T; Brailsford, S; Connell, C; Davies, R; Harper, P; Klein, JH				Young, T; Brailsford, S; Connell, C; Davies, R; Harper, P; Klein, JH			Using industrial processes to improve patient care	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; SIMULATION		Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England; Univ Southampton, Sch Management, Southampton SO17 1BJ, Hants, England; Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; Univ Southampton, Sch Math, Southampton SO9 5NH, Hants, England	Brunel University; University of Southampton; University of Warwick; University of Southampton	Young, T (corresponding author), Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England.	terry.young@brunel.ac.uk		Harper, Paul/0000-0001-7894-4907; Brailsford, Sally/0000-0002-6665-8230; Young, Terry/0000-0001-9545-2269; Klein, Jonathan/0000-0002-5495-8738				BECKETT P, 2000, AEROSPACE INT    NOV, P12; CRAIGHEAD IB, 2001, BMJ; Davies R, 2002, DIABETIC MED, V19, P762, DOI 10.1046/j.1464-5491.2002.00773.x; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Fontan JE, 2003, PHARM WORLD SCI, V25, P112, DOI 10.1023/A:1024053514359; *GEN EL, WHAT 6 SIGMA; Goldratt E, 2000, GOAL; Harry M., 1999, 6 SIGMA BREAKTHROUGH; Jun JB, 1999, J OPER RES SOC, V50, P109, DOI 10.1057/palgrave.jors.2600669; *NHS, 2000, INP ADM BED MAN NHS, P9; PENDLETON D, 2002, BRIT MED J, V325, P1354; Smith J, 2001, BRIT MED J, V322, P1257, DOI 10.1136/bmj.322.7297.1257; WILCON T, 2001, BMJ; Wolstenholme E, 1999, SYST DYNAM REV, V15, P253, DOI 10.1002/(SICI)1099-1727(199923)15:3<253::AID-SDR172>3.3.CO;2-G; Womack J.P., 1996, LEAN THINKING	15	148	149	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 17	2004	328	7432					162	164		10.1136/bmj.328.7432.162	http://dx.doi.org/10.1136/bmj.328.7432.162			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765CQ	14726351	Green Published			2022-12-01	WOS:000188249900030
J	Chapados, BR; Hosfield, DJ; Han, S; Qiu, JZ; Yelent, B; Shen, BH; Tainer, JA				Chapados, BR; Hosfield, DJ; Han, S; Qiu, JZ; Yelent, B; Shen, BH; Tainer, JA			Structural basis for FEN-1 substrate specificity and PCNA-mediated activation in DNA replication and repair	CELL			English	Article							CELL NUCLEAR ANTIGEN; HUMAN FLAP ENDONUCLEASE-1; CRYSTAL-STRUCTURE; EXCISION-REPAIR; PYROCOCCUS-FURIOSUS; POLYMERASE-DELTA; SLIDING CLAMP; STRANDED-DNA; FACTOR-C; BINDING	Flap EndoNuclease-1 (FEN-1) and the processivity factor proliferating cell nuclear antigen (PCNA) are central to DNA replication and repair. To clarify the molecular basis of FEN-1 specificity and PCNA activation, we report here structures of FEN-1:DNA and PCNA: FEN-1-peptide complexes, along with fluorescence resonance energy transfer (FRET) and mutational results. FEN-1 binds the unpaired 3' DNA end (3' flap), opens and kinks the DNA, and promotes conformational closing of a flexible helical clamp to facilitate 5' cleavage specificity. Ordering of unstructured C-terminal regions in FEN-1 and PCNA creates an intermolecular beta sheet interface that directly links adjacent PCNA and DNA binding regions of FEN-1 and suggests how PCNA stimulates FEN-1 activity. The DNA and protein conformational changes, composite complex structures, FRET, and mutational results support enzyme-PCNA alignments and a kinked DNA pivot point that appear suitable to coordinate rotary handoffs of kinked DNA intermediates among enzymes localized by the three PCNA binding sites.	Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92122 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92122 USA; City Hope Natl Med Ctr, Div Mol Med, Duarte, CA 91010 USA; Beckman Res Inst, Duarte, CA 91010 USA	Scripps Research Institute; Scripps Research Institute; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Tainer, JA (corresponding author), Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92122 USA.	jat@scripps.edu	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020	Tainer, John/0000-0003-1659-2429; Shen, Binghui/0000-0002-4408-407X	NCI NIH HHS [P01 CA92584, CA081967] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; CLEGG RM, 1993, P NATL ACAD SCI USA, V90, P2994, DOI 10.1073/pnas.90.7.2994; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Henneke G, 2003, TRENDS BIOCHEM SCI, V28, P384, DOI 10.1016/S0968-0004(03)00138-5; Hosfield DJ, 1998, J BIOL CHEM, V273, P27154, DOI 10.1074/jbc.273.42.27154; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; JONSSON ZO, 1995, EMBO J, V14, P5745, DOI 10.1002/j.1460-2075.1995.tb00261.x; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kim CY, 2001, BIOCHEMISTRY-US, V40, P3208, DOI 10.1021/bi002100n; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; Matsumiya S, 2002, GENES CELLS, V7, P911, DOI 10.1046/j.1365-2443.2002.00572.x; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Mossi R, 1998, EUR J BIOCHEM, V254, P209, DOI 10.1046/j.1432-1327.1998.254209.x; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Qiu JZ, 2002, J BIOL CHEM, V277, P24659, DOI 10.1074/jbc.M111941200; Reynaldo LP, 2000, J MOL BIOL, V297, P511, DOI 10.1006/jmbi.2000.3573; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shen BH, 1998, TRENDS BIOCHEM SCI, V23, P171, DOI 10.1016/S0968-0004(98)01199-2; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x	50	226	233	28	227	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2004	116	1					39	50		10.1016/S0092-8674(03)01036-5	http://dx.doi.org/10.1016/S0092-8674(03)01036-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718165	Bronze			2022-12-01	WOS:000187960800007
J	Lakhani, SR				Lakhani, SR			Putting the brakes on cylindromatosis?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NF-KAPPA-B; CYLD		Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Royal Marsden Hosp, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Lakhani, SR (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.		Lakhani, Sunil R/I-1970-2018	Lakhani, Sunil R/0000-0003-4067-2760	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803	4	11	12	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2004	350	2					187	188		10.1056/NEJMcibr032650	http://dx.doi.org/10.1056/NEJMcibr032650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760WP	14711921				2022-12-01	WOS:000187858500017
J	Rothenberg, SP; da Costa, MP; Sequeira, JM; Cracco, J; Roberts, JL; Weedon, J; Quadros, EV				Rothenberg, SP; da Costa, MP; Sequeira, JM; Cracco, J; Roberts, JL; Weedon, J; Quadros, EV			Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BINDING-PROTEINS; FOLIC-ACID; CELLS; RISK; PURIFICATION; PREVENTION; ABORTION; VITAMIN; GENE; RAT	Background: In the absence of clinical folate deficiency, periconceptional supplementation with folic acid reduces a woman's risk of having an infant with a neural-tube defect. Since antiserum to folate receptors induces embryo resorption and malformations in rats, we hypothesized that autoantibodies against folate receptors in women may be associated with pregnancy complicated by a neural-tube defect. Methods: Serum from 12 women who were or had been pregnant with a fetus with a neural-tube defect and from 24 control women (20 with current or prior normal pregnancies and 4 who were nulligravid) was analyzed for autoantibodies by incubation with human placental folate receptors radiolabeled with [H-3]folic acid. The properties of these autoantibodies were characterized by incubating serum and the autoantibodies isolated from serum with placental membranes, ED27 cells, and KB cells, which express the folate receptors. Results: Serum from 9 of 12 women with a current or previous affected pregnancy (index subjects) and 2 of 20 control subjects contained autoantibodies against folate receptors (P<0.001). The autoantibodies blocked the binding of [H-3]folic acid to folate receptors on placental membranes and on ED27 and KB cells incubated at 4 &DEG;C and blocked the uptake of [H-3]folic acid by KB cells when incubated at 37 &DEG;C. Conclusions: Serum from women with a pregnancy complicated by a neural-tube defect contains autoantibodies that bind to folate receptors and can block the cellular uptake of folate. Further study is warranted to assess whether the observed association between maternal autoantibodies against folate receptors and neural-tube defects reflects a causal relation.	Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Obstet & Gynecol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Div Pediat Neurol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Ctr Comp Sci, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Rothenberg, SP (corresponding author), Suny Downstate Med Ctr, Dept Med, 450 Clarkson Ave,Box 20, Brooklyn, NY 11203 USA.							Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; Antony AC, 2000, TERATOLOGY, V62, P42, DOI 10.1002/1096-9926(200007)62:1&lt;42::AID-TERA9&gt;3.0.CO;2-U; Barber RC, 1998, AM J MED GENET, V76, P310, DOI 10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-T; Barber RC, 1998, AM J MED GENET, V79, P231; CARMI R, 1994, AM J MED GENET, V51, P93, DOI 10.1002/ajmg.1320510203; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; Cragan J D, 1995, MMWR CDC Surveill Summ, V44, P1; CUCKLE HS, 1983, PRENATAL DIAG, V3, P287, DOI 10.1002/pd.1970030404; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; da Costa M, 2003, BIRTH DEFECTS RES A, V67, P837, DOI 10.1002/bdra.10088; daCosta M, 1996, BBA-PROTEIN STRUCT M, V1292, P23, DOI 10.1016/0167-4838(95)00180-8; DANSKY LV, 1992, NEUROLOGY, V42, P32; De Marco P, 2000, AM J MED GENET, V95, P216, DOI 10.1002/1096-8628(20001127)95:3<216::AID-AJMG6>3.0.CO;2-F; EVANS DR, 1979, BRIT MED J, V1, P975, DOI 10.1136/bmj.1.6169.975; Finnell R H, 2000, Ann N Y Acad Sci, V919, P261; GILES C, 1966, J CLIN PATHOL, V19, P1, DOI 10.1136/jcp.19.1.1; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Kniss DA, 2002, PLACENTA, V23, P32, DOI 10.1053/plac.2001.0749; MCHUGH M, 1979, J BIOL CHEM, V254, P1312; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; SADASIVAN E, 1987, BIOCHIM BIOPHYS ACTA, V925, P36, DOI 10.1016/0304-4165(87)90145-0; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SELLER MJ, 1995, CLIN DYSMORPHOL, V4, P202; Triplett A, 2002, CHEM BIOL PTERIDINES, P637; WALD N, 1991, LANCET, V338, P131; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	27	148	161	1	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2004	350	2					134	142		10.1056/NEJMoa031145	http://dx.doi.org/10.1056/NEJMoa031145			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760WP	14711912				2022-12-01	WOS:000187858500007
J	Zhou, HL; Wertz, I; O'Rourke, K; Ultsch, M; Seshagiri, S; Eby, M; Xiao, W; Dixit, VM				Zhou, HL; Wertz, I; O'Rourke, K; Ultsch, M; Seshagiri, S; Eby, M; Xiao, W; Dixit, VM			Bcl10 activates the NF-kappa B pathway through ubiquitination of NEMO	NATURE			English	Article							CONJUGATING ENZYME COMPLEX; KINASE COMPLEX; MALT LYMPHOMA; IKK-GAMMA; GENE; CYLD	The NF-kappaB family of transcription factors is activated in response to many stimuli, including pro-inflammatory cytokines, environmental stresses and, in the case of B and T lymphocytes, by antigenic stimulation(1,2). Bcl10 is essential for NF-kappaB activation by T- and B-cell receptors. T and B lymphocytes from Bcl10-deficient mice fail to activate NF-kappaB in response to antigenreceptor stimulation and, as a consequence, are unable to proliferate(3). Bcl10 overexpression is sufficient to activate NF-kappaB, a process that requires the NF-kappaB essential modulator NEMO ( also known as IKK-gamma), which is the regulatory subunit of the IkappaB kinase complex(4). However, the cellular mechanism by which Bcl10 activates the NF-kappaB pathway remains unclear. Here we show that Bcl10 targets NEMO for lysine-63-linked ubiquitination. Notably, a mutant form of NEMO that cannot be ubiquitinated inhibited Bcl10-induced NF-kappaB activation. Paracaspase and a ubiquitin-conjugating enzyme (UBC13) were both required for Bcl10-induced NEMO ubiquitination and subsequent NF-kappaB activation. Furthermore, short interfering RNAs that reduced the expression of paracaspase and UBC13 abrogated the effects of Bcl10. Thus, the adaptor protein Bcl10 promotes activation of NF-kappaB transcription factors through paracaspase- and UBC13-dependent ubiquitination of NEMO.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Davis; University of Saskatchewan	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Seshagiri, Somasekar/0000-0003-4272-6443; Xiao, Wei/0000-0001-7568-0782				Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M., 1999, SCI SIGNAL TRANSDUCT, V5, P1; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Smahi A, 2000, NATURE, V405, P466; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	28	430	461	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					167	171		10.1038/nature02273	http://dx.doi.org/10.1038/nature02273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14695475				2022-12-01	WOS:000187863900038
J	Beaber, JW; Hochhut, B; Waldor, MK				Beaber, JW; Hochhut, B; Waldor, MK			SOS response promotes horizontal dissemination of antibiotic resistance genes	NATURE			English	Article							VIBRIO-CHOLERAE O139; INTEGRATING ELEMENTS; ESCHERICHIA-COLI; R391; PLASMIDS; SXT; DETERMINANTS	Mobile genetic elements have a crucial role in spreading antibiotic resistance genes among bacterial populations. Environmental and genetic factors that regulate conjugative transfer of antibiotic resistance genes in bacterial populations are largely unknown(1). Integrating conjugative elements (ICEs) are a diverse group of mobile elements that are transferred by means of cell-cell contact and integrate into the chromosome of the new host(2). SXT is a similar to100-kilobase ICE derived from Vibrio cholerae that encodes genes that confer resistance to chloramphenicol, sulphamethoxazole, trimethoprim and streptomycin(3). SXT-related elements were not detected in V. cholerae before 1993 but are now present in almost all clinical V. cholerae isolates from Asia(4). ICEs related to SXT are also present in several other bacterial species and encode a variety of antibiotic and heavy metal resistance genes(4-7). Here we show that SetR, an SXT encoded repressor, represses the expression of activators of SXT transfer. The 'SOS response' to DNA damage alleviates this repression, increasing the expression of genes necessary for SXT transfer and hence the frequency of transfer. SOS is induced by a variety of environmental factors and antibiotics, for example ciprofloxacin, and we show that ciprofloxacin induces SXT transfer as well. Thus, we present a mechanism by which therapeutic agents can promote the spread of antibiotic resistance genes.	Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA; Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts University; Howard Hughes Medical Institute	Waldor, MK (corresponding author), Tufts Univ, Sch Med, Dept Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	matthew.waldor@tufts.edu		Waldor, Matthew/0000-0003-1843-7000				Ausubel FA, 1990, CURRENT PROTOCOLS MO; Beaber JW, 2002, J BACTERIOL, V184, P4259, DOI 10.1128/JB.184.15.4259-4269.2002; Beaber JW, 2002, CELL MOL LIFE SCI, V59, P2065, DOI 10.1007/s000180200006; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; COETZEE JN, 1972, J GEN MICROBIOL, V72, P543, DOI 10.1099/00221287-72-3-543; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GIMBLE FS, 1985, J BACTERIOL, V162, P147, DOI 10.1128/JB.162.1.147-154.1985; Hochhut B, 2001, ANTIMICROB AGENTS CH, V45, P2991, DOI 10.1128/AAC.45.11.2991-3000.2001; Hochhut B, 2001, J BACTERIOL, V183, P1124, DOI 10.1128/JB.183.4.1124-1132.2001; Little John W., 1996, P453; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller J.H., 1992, SHORT COURSE BACTERI, P150; PETERS SE, 1991, MOL GEN GENET, V228, P294, DOI 10.1007/BF00282479; PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631; Ptashne M., 1992, A GENETIC SWITCH; SCHNEIDER K, 1986, GENE, V42, P37, DOI 10.1016/0378-1119(86)90148-4; SINGER M, 1989, MICROBIOL REV, V53, P1; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Zatyka M, 1998, FEMS MICROBIOL REV, V21, P291, DOI 10.1016/S0168-6445(97)00061-2	21	671	748	22	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					72	74		10.1038/nature02241	http://dx.doi.org/10.1038/nature02241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14688795				2022-12-01	WOS:000187710000036
J	Peres, CA; Baider, C; Zuidema, PA; Wadt, LHO; Kainer, KA; Gomes-Silva, DAP; Salomao, RP; Simoes, LL; Franciosi, ERN; Valverde, FC; Gribel, R; Shepard, GH; Kanashiro, M; Coventry, P; Yu, DW; Watkinson, AR; Freckleton, RP				Peres, CA; Baider, C; Zuidema, PA; Wadt, LHO; Kainer, KA; Gomes-Silva, DAP; Salomao, RP; Simoes, LL; Franciosi, ERN; Valverde, FC; Gribel, R; Shepard, GH; Kanashiro, M; Coventry, P; Yu, DW; Watkinson, AR; Freckleton, RP			Demographic threats to the sustainability of Brazil nut exploitation	SCIENCE			English	Article							BERTHOLLETIA-EXCELSA; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; TROPICAL PALM; EXTRACTION; TREE	A comparative analysis of 23 populations of the Brazil nut tree ( Bertholletia excelsa) across the Brazilian, Peruvian, and Bolivian Amazon shows that the history and intensity of Brazil nut exploitation are major determinants of population size structure. Populations subjected to persistent levels of harvest lack juvenile trees less than 60 centimeters in diameter at breast height; only populations with a history of either light or recent exploitation contain large numbers of juvenile trees. A harvesting model confirms that intensive exploitation levels over the past century are such that juvenile recruitment is insufficient to maintain populations over the long term. Without management, intensively harvested populations will succumb to a process of senescence and demographic collapse, threatening this cornerstone of the Amazonian extractive economy.	Univ E Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ Sao Paulo, Dept Ecol, BR-05508900 Sao Paulo, Brazil; PROMAB, Riberalta, Beni, Bolivia; Univ Utrecht, Dept Plant Ecol, NL-3508 TB Utrecht, Netherlands; EMBRAPA, Ctr Pesquisa Agroflorestal Acre, BR-69908970 Rio Branco, Acre, Brazil; Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; Univ Florida, Trop Conservat & Dev Program, Gainesville, FL 32611 USA; Museu Paraense Emilio Goeldi, Dept Bot, BR-66040170 Belem, Para, Brazil; ACCA, Proyecto Conservando Castanales, Puerto Maldonado, Madre De Dios, Peru; INPA, Dept Bot, BR-69083000 Manaus, Amazonas, Brazil; Embrapa Amazonia Oriental DFID, Projeto Dendrogene, BR-69095100 Belem, Para, Brazil; Mauritius Herbarium, MSIRI, Reduit, Mauritius	University of East Anglia; University of East Anglia; Universidade de Sao Paulo; Utrecht University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peres, CA (corresponding author), Univ E Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Watkinson, Andrew R/N-1649-2013; Freckleton, Rob P/B-6455-2013; Zuidema, Pieter A/C-8951-2009; Wadt, Lucia HO/M-1703-2013; Peres, Carlos Augusto/N-8275-2019; Baider, Claudia/C-2570-2009; Shepard, Glenn H./C-3667-2014; Shepard, Glenn/AAS-4059-2021; Peres, Carlos A./B-1276-2013; Yu, Douglas W./D-2536-2009; Gribel, Rogerio/C-5392-2013; SALOMÃO, RAFAEL/AAU-1306-2020; Peres, Carlos A./ABE-8361-2020	Zuidema, Pieter A/0000-0001-8100-1168; Baider, Claudia/0000-0002-2203-2076; Shepard, Glenn H./0000-0003-3195-8230; Shepard, Glenn/0000-0003-3195-8230; Peres, Carlos A./0000-0002-1588-8765; Yu, Douglas W./0000-0001-8551-5609; Gribel, Rogerio/0000-0002-0850-5578; SALOMÃO, RAFAEL/0000-0003-0947-0132; Peres, Carlos A./0000-0002-1588-8765; Wadt, Lucia/0000-0002-5018-7550; Freckleton, Robert/0000-0002-8338-864X				[Anonymous], FLORESTA AMAZONICA D; BAIDER C, 2000, DEMOGRAFIA ECOLOGIA; BOOT RGA, 1995, ECOL APPL, V5, P896, DOI 10.2307/2269340; CLAY JW, 1997, HARVESTING WILD SPEC, P246; Freckleton RP, 2003, J APPL ECOL, V40, P846, DOI 10.1046/j.1365-2664.2003.00842.x; HUBER J, 1910, B MUS PARAENSE HIST, V6, P781; *I BRAS GEOGR EST, 2002, PROD EXTR VEG SILV; *I NAC PESQ ESP, 2003, MON BRAZ AM FOR SAT; Matos DMS, 1999, ECOLOGY, V80, P2635, DOI 10.2307/177246; Nepstad D. C., 1992, Advances in Economic Botany, V9, P1; Peres CA, 1997, J TROP ECOL, V13, P69, DOI 10.1017/S0266467400010269; Peres CA, 1997, J TROP ECOL, V13, P595, DOI 10.1017/S0266467400010749; Peters C.M., 1994, SUSTAINABLE HARVEST; Pires JM, 1984, AMAZON LIMNOLOGY LAN, P581, DOI DOI 10.1007/978-94-009-6542-3; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018; ZUIDEMA PA, 2003, ECOLOGY MANAGEMENT B, V6	16	208	216	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2112	2114		10.1126/science.1091698	http://dx.doi.org/10.1126/science.1091698			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684819				2022-12-01	WOS:000187385200041
J	Khaldeeva, N; Hillis, SD; Voronin, E; Rakhmanova, A; Yakovlev, A; Jamieson, DJ; Ryder, RW				Khaldeeva, N; Hillis, SD; Voronin, E; Rakhmanova, A; Yakovlev, A; Jamieson, DJ; Ryder, RW			HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002	LANCET			English	Article								The effectiveness of rapid HIV-1 testing and nevirapine prophylaxis for HIV-Infected mothers without prenatal care has been shown. We found that from 1998 to 2002, HIV-1 seroprevalence in women giving birth in St Petersburg, Russia increased 100-fold: from 0.013% to 1.3% (p<0.0001). HIV-1 seroprevalence was 8% (114 of 1466) in women without prenatal care and 1% (376 of 37 645) in those with prenatal care (p<0.0001). All 376 HIV-1-infected women with, and 41% (47 of 114) of HIV-1-infected women without prenatal care received intrapartum antiretroviral therapy (p<0.0001). In women who were HIV-1 positive, 26% (30 of 114) of those without prenatal care and 4% (13 of 371) of those with prenatal care relinquished their infants to the custody of the state, compared with 10% (354 of 37 621) of HIV-1-negative women (p<0.0001).	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; St Petersburg Glaser Pediat AIDS Fdn Planning Gra, St Petersburg, Russia; City AIDS Ctr, St Petersburg, Russia; Republ Hosp Infect Dis, Clin AIDS Ctr, St Petersburg, Russia; City Hlth Comm, St Petersburg, Russia; Botkin Hosp, St Petersburg, Russia; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Hillis, SD (corresponding author), Ctr Dis Control & Prevent, Mailstop K-34,4770 Buford Hwy NE, Atlanta, GA 30341 USA.		Yakovlev, Alexey/H-2748-2015	Yakovlev, Alexey/0000-0003-4163-5769; Jamieson, Denise/0000-0003-2597-1201				*ALL RUSS CTR PUBL, 1998, WOM REPR HLTH SURV 1; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; *MENT DIS RIGHTS I, 1999, CHILDR RUSS I HUM RI; *UNAIDS JOINT UN P, 2002, CHILDR BRINK 2002 JO; *UNAIDS JOINT UN P, 2002, REP GLOB HIV AIDS EP	5	16	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1981	1982		10.1016/S0140-6736(03)15019-2	http://dx.doi.org/10.1016/S0140-6736(03)15019-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683660				2022-12-01	WOS:000187210700013
J	Brady, M				Brady, M			Health care in remote Australian Indigenous communities	LANCET			English	Article									Australian Natl Univ, Ctr Aboriginal Econ Policy Res, Canberra, ACT 0200, Australia	Australian National University	Brady, M (corresponding author), Australian Natl Univ, Ctr Aboriginal Econ Policy Res, Canberra, ACT 0200, Australia.								0	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S36	S37		10.1016/S0140-6736(03)15069-6	http://dx.doi.org/10.1016/S0140-6736(03)15069-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698123				2022-12-01	WOS:000187790200019
J	Kellis, M; Birren, BW; Lander, ES				Kellis, M; Birren, BW; Lander, ES			Proof and evolutionary analysis of ancient genome duplication in the yeast Saccharomyces cerevisiae	NATURE			English	Article							HEMIASCOMYCETOUS YEASTS; FUNCTIONAL HOMOLOG; GENE DUPLICATION; SEQUENCE; DIFFERENTIATION; PRESERVATION; EXPLORATION; EXPRESSION; MUTATIONS; ARACHNE	Whole-genome duplication followed by massive gene loss and specialization has long been postulated as a powerful mechanism of evolutionary innovation. Recently, it has become possible to test this notion by searching complete genome sequence for signs of ancient duplication. Here, we show that the yeast Saccharomyces cerevisiae arose from ancient whole-genome duplication, by sequencing and analysing Kluyveromyces waltii, a related yeast species that diverged before the duplication. The two genomes are related by a 1:2 mapping, with each region of K. waltii corresponding to two regions of S. cerevisiae, as expected for whole-genome duplication. This resolves the long-standing controversy on the ancestry of the yeast genome, and makes it possible to study the fate of duplicated genes directly. Strikingly, 95% of cases of accelerated evolution involve only one member of a gene pair, providing strong support for a specific model of evolution, and allowing us to distinguish ancestral and derived functions.	MIT, Broad Inst, Cambridge, MA 02138 USA; Harvard Univ, Cambridge, MA 02138 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Kellis, M (corresponding author), MIT, Broad Inst, Cambridge, MA 02138 USA.	manoli@mit.edu; lander@broad.mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630				BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Benard L, 1999, J VIROL, V73, P2893, DOI 10.1128/JVI.73.4.2893-2900.1999; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; Coissac E, 1997, MOL BIOL EVOL, V14, P1062, DOI 10.1093/oxfordjournals.molbev.a025712; Force A, 1999, GENETICS, V151, P1531; Friedman R, 2001, GENOME RES, V11, P373, DOI 10.1101/gr.155801; Gallardo MH, 1999, NATURE, V401, P341, DOI 10.1038/43815; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KELLIS M, IN PRESS J COMPUT BI; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; Llorente B, 2000, FEBS LETT, V487, P101, DOI 10.1016/S0014-5793(00)02289-4; Lorenz MC, 1998, GENETICS, V150, P1443; Lynch M, 2000, GENETICS, V154, P459; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; MELNICK L, 1993, J MOL BIOL, V233, P372, DOI 10.1006/jmbi.1993.1518; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pebusque MJ, 1998, MOL BIOL EVOL, V15, P1145, DOI 10.1093/oxfordjournals.molbev.a026022; Philippsen P, 1997, NATURE, V387, P93, DOI 10.1038/387s093; Piskur J, 2001, TRENDS GENET, V17, P302, DOI 10.1016/S0168-9525(01)02308-3; Sanz M, 2002, MOL MICROBIOL, V43, P1183, DOI 10.1046/j.1365-2958.2002.02812.x; Sarthy AV, 1998, YEAST, V14, P239, DOI 10.1002/(SICI)1097-0061(199802)14:3<239::AID-YEA219>3.0.CO;2-B; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099	45	1078	1117	1	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					617	624		10.1038/nature02424	http://dx.doi.org/10.1038/nature02424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15004568				2022-12-01	WOS:000220697200034
J	Brunet, A; Sweeney, LB; Sturgill, JF; Chua, KF; Greer, PL; Lin, YX; Tran, H; Ross, SE; Mostoslavsky, R; Cohen, HY; Hu, LS; Cheng, HL; Jedrychowski, MP; Gygi, SP; Sinclair, DA; Alt, FW; Greenberg, ME				Brunet, A; Sweeney, LB; Sturgill, JF; Chua, KF; Greer, PL; Lin, YX; Tran, H; Ross, SE; Mostoslavsky, R; Cohen, HY; Hu, LS; Cheng, HL; Jedrychowski, MP; Gygi, SP; Sinclair, DA; Alt, FW; Greenberg, ME			Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase	SCIENCE			English	Article							PROMOTES CELL-SURVIVAL; LIFE-SPAN EXTENSION; PROTEIN-KINASE B; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; CALORIE RESTRICTION; P53; LONGEVITY; NAD; PATHWAY	The Sir2 deacetylase modulates organismal life-span in various species. However, the molecular mechanisms by which Sir2 increases longevity are largely unknown. We show that in mammalian cells, the Sir2 homolog SIRT1 appears to control the cellular response to stress by regulating the FOXO family of Forkhead transcription factors, a family of proteins that function as sensors of the insulin signaling pathway and as regulators of organismal longevity. SIRT1 and the FOXO transcription factor FOXO3 formed a complex in cells in response to oxidative stress, and SIRT1 deacetylated FOXO3 in vitro and within cells. SIRT1 had a dual effect on FOXO3 function: SIRT1 increased FOXO3's ability to induce cell cycle arrest and resistance to oxidative stress but inhibited FOXO3's ability to induce cell death. Thus, one way in which members of the Sir2 family of proteins may increase organismal longevity is by tipping FOXO-dependent responses away from apoptosis and toward stress resistance.	Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,CBR,Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu		Cohen, Haim Y./0000-0002-6613-8710; Sweeney, Lora/0000-0001-9242-5601; Sinclair, David/0000-0002-9936-436X; /0000-0002-7002-1275	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035138] Funding Source: NIH RePORTER; NICHD NIH HHS [NIHP30-HD18655] Funding Source: Medline; NINDS NIH HHS [P01 NS35138-17] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BRUNET A, UNPUB; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Guarente L, 2000, GENE DEV, V14, P1021; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin Y. P., UNPUB; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X	28	2508	2649	7	301	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2011	2015		10.1126/science.1094637	http://dx.doi.org/10.1126/science.1094637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	14976264				2022-12-01	WOS:000220429800040
J	Cowan, CA; Klimanskaya, I; McMahon, J; Atienza, J; Witmyer, J; Zucker, JP; Wang, SP; Morton, CC; McMahon, AP; Powers, D; Melton, DA				Cowan, CA; Klimanskaya, I; McMahon, J; Atienza, J; Witmyer, J; Zucker, JP; Wang, SP; Morton, CC; McMahon, AP; Powers, D; Melton, DA			Derivation of embryonic stem-cell lines from human blastocysts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIFFERENTIATION		Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Boston IVF, Waltham, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Cowan, CA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.		Young, Richard A/F-6495-2012; McMahon, Andrew P/ABE-7520-2020	Young, Richard A/0000-0001-8855-8647; 				ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; EASTER SS, 1993, J NEUROSCI, V13, P285; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KLIMANSKAYA I, IN PRESS HDB EMBRYON; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; MACDONALD DJ, 1978, CLIN CHIM ACTA, V87, P367, DOI 10.1016/0009-8981(78)90180-8; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Skotheim RI, 2002, CANCER RES, V62, P2359; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Thomson JA, 1998, SCIENCE, V282, P1827	21	722	850	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 25	2004	350	13					1353	1356		10.1056/NEJMsr040330	http://dx.doi.org/10.1056/NEJMsr040330			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805VN	14999088	Bronze			2022-12-01	WOS:000220393900017
J	Bringmann, H; Skiniotis, G; Spilker, A; Kandels-Lewis, S; Vernos, I; Surrey, T				Bringmann, H; Skiniotis, G; Spilker, A; Kandels-Lewis, S; Vernos, I; Surrey, T			A kinesin-like motor inhibits microtubule dynamic instability	SCIENCE			English	Article							ORGANIZATION; KINETICS; DOMAIN; ROLES; FORMS; MODEL	The motility of molecular motors and the dynamic instability of microtubules are key dynamic processes for mitotic spindle assembly and function. We report here that one of the mitotic kinesins that localizes to chromosomes, Xklp1 from Xenopus laevis, could inhibit microtubule growth and shrinkage. This effect appeared to be mediated by a structural change in the microtubule lattice. We also found that Xklp1 could act as a fast, nonprocessive, plus end-directed molecular motor. The integration of the two properties, motility and inhibition of microtubule dynamics, in one molecule emphasizes the versatile properties of kinesin family members.	European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Struct & Computat Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	surrey@embl.de	Surrey, Thomas/AAC-4608-2021; Vernos, Isabelle/C-1687-2015	Vernos, Isabelle/0000-0003-1469-9214; Skiniotis, Georgios/0000-0003-0238-7846; Surrey, Thomas/0000-0001-9082-1870				BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; HACKNEY DD, 1995, BIOPHYS J, V68, pS267; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hackney DD, 1996, ANNU REV PHYSIOL, V58, P731; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Howard J., 2001, MECH MOTOR PROTEINS; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kallipolitou A, 2001, EMBO J, V20, P6226, DOI 10.1093/emboj/20.22.6226; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; MITCHISON TJ, 1988, ANNU REV CELL BIOL, V4, P527, DOI 10.1146/annurev.cb.04.110188.002523; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; Scholey J. M., 1993, METHODS CELL BIOL, V39; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; VERNOS I, UNPUB; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	31	118	119	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1519	1522		10.1126/science.1094838	http://dx.doi.org/10.1126/science.1094838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001780				2022-12-01	WOS:000220000100043
J	Janicki, SM; Tsukamoto, T; Salghetti, SE; Tansey, WP; Sachidanandam, R; Prasanth, KV; Ried, T; Shav-Tal, Y; Bertrand, E; Singer, RH; Spector, DL				Janicki, SM; Tsukamoto, T; Salghetti, SE; Tansey, WP; Sachidanandam, R; Prasanth, KV; Ried, T; Shav-Tal, Y; Bertrand, E; Singer, RH; Spector, DL			From silencing to gene expression: Real-time analysis in single cells	CELL			English	Article							POSITION-EFFECT VARIEGATION; FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; HETEROCHROMATIN PROTEIN-1 BINDS; HISTONE H3; RAPID EXCHANGE; LYSINE-9 METHYLATION; CHROMATIN-STRUCTURE; RNA; HP1; DROSOPHILA	We have developed an inducible system to visualize gene expression at the levels of DNA, RNA and protein in living cells. The system is composed of a 200 copy transgene array integrated into a euchromatic region of chromosome 1 in human U20S cells. The condensed array is heterochromatic as it is associated with HP1, histone H3 methylated at lysine 9, and several histone methyltransferases. Upon transcriptional induction, HP1alpha is depleted from the locus and the histone variant H3.3 is deposited suggesting that histone exchange is a mechanism through which heterochromatin is transformed into a transcriptionally active state. RNA levels at the transcription site increase immediately after the induction of transcription and the rate of synthesis slows over time. Using this system, we are able to correlate changes in chromatin structure with the progression of transcriptional activation allowing us to obtain a real-time integrative view of gene expression.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Utsunomiya Univ, Utsunomiya, Tochigi 321, Japan; NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; CNRS, Inst Genet Mol Montpellier, F-34293 Montpellier, France	Cold Spring Harbor Laboratory; Utsunomiya University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Spector, DL (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu	sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459; Shav-Tal, Yaron/0000-0002-8017-948X; bertrand, edouard/0000-0002-9642-7994	DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694, R01GM067728] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB002060] Funding Source: Medline; NIGMS NIH HHS [GM42694, R01 GM067728, R01 GM042694, GM067728] Funding Source: Medline	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; BECKETT D, 1988, J MOL BIOL, V204, P927, DOI 10.1016/0022-2836(88)90052-6; Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Calapez A, 2002, J CELL BIOL, V159, P795, DOI 10.1083/jcb.200203046; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Clegg NJ, 1998, GENOME, V41, P495, DOI 10.1139/gen-41-4-495; Dietzel S, 2001, NAT CELL BIOL, V3, P767, DOI 10.1038/35087089; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; Fanti L, 1998, CHROMOSOMA, V107, P286, DOI 10.1007/s004120050310; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HEARN MG, 1991, GENETICS, V128, P785; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; HUANG S, 1997, EUKARYOTIC MESSENGER, P33; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Janicki SM, 2003, CURR OPIN CELL BIOL, V15, P149, DOI 10.1016/S0955-0674(03)00012-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lau S, 1999, DEV DYNAM, V215, P126, DOI 10.1002/(SICI)1097-0177(199906)215:2<126::AID-DVDY5>3.3.CO;2-#; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Lu BY, 2000, GENETICS, V155, P699; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sabl JF, 1996, GENETICS, V142, P447; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cb.09.110193.001405; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugaya K, 2000, J CELL SCI, V113, P2679; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Zhao T, 2000, J BIOL CHEM, V275, P28332	83	531	550	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					683	698		10.1016/S0092-8674(04)00171-0	http://dx.doi.org/10.1016/S0092-8674(04)00171-0			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006351	Bronze, Green Accepted			2022-12-01	WOS:000221499700009
J	Milo, R; Itzkovitz, S; Kashtan, N; Levitt, R; Shen-Orr, S; Ayzenshtat, I; Sheffer, M; Alon, U				Milo, R; Itzkovitz, S; Kashtan, N; Levitt, R; Shen-Orr, S; Ayzenshtat, I; Sheffer, M; Alon, U			Superfamilies of evolved and designed networks	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; SMALL-WORLD; DYNAMICS; LOOP; MOTIFS	Complex biological, technological, and sociological networks can be of very different sizes and connectivities, making it difficult to compare their structures. Here we present an approach to systematically study similarity in the local structure of networks, based on the significance profile (SP) of small subgraphs in the network compared to randomized networks. We find several superfamilies of previously unrelated networks with very similar SPs. One superfamily, including transcription networks of microorganisms, represents "rate-limited" information-processing networks strongly constrained by the response time of their components. A distinct superfamily includes protein signaling, developmental genetic networks, and neuronal wiring. Additional superfamilies include power grids, protein-structure networks and geometric networks, World Wide Web links and social networks, and word-adjacency networks from different languages.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Milo, Hilla/C-8767-2016; Yang, Chen/G-1379-2010	Ayzenshtat, Inbal/0000-0001-8975-3938; Milo, Ron/0000-0003-1641-2299; Sheffer, Michal/0000-0001-5934-9950; Shen-Orr, Shai/0000-0002-6991-7736; Kashtan, Nadav/0000-0002-7475-1363				Allen J., 1995, NATURAL LANGUAGE UND; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berg J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.228701; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Eckmann JP, 2002, P NATL ACAD SCI USA, V99, P5825, DOI 10.1073/pnas.032093399; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Goh KI, 2002, P NATL ACAD SCI USA, V99, P12583, DOI 10.1073/pnas.202301299; HOLLAND PW, 1975, SOCIOL METHODOL, P1, DOI DOI 10.2307/270703; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; KASHTAN N, IN PRESS BIOINFORMAT; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	27	916	964	5	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1538	1542		10.1126/science.1089167	http://dx.doi.org/10.1126/science.1089167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001784				2022-12-01	WOS:000220000100049
J	Juarez, MT; Kui, JS; Thomas, J; Heller, BA; Timmermans, MCP				Juarez, MT; Kui, JS; Thomas, J; Heller, BA; Timmermans, MCP			microRNA-mediated repression of rolled leaf1 specifies maize leaf polarity	NATURE			English	Article							LATERAL ORGANS; GENE; ARABIDOPSIS; MERISTEM; IDENTITY; PROTEIN; ENCODES; PLANT	In both animals and plants, many developmentally important regulatory genes have complementary microRNAs (miRNAs), which suggests that these miRNAs constitute a class of developmental signalling molecules(1). Leaves of higher plants exhibit a varying degree of asymmetry along the adaxial/abaxial (upper/lower) axis. This asymmetry is specified through the polarized expression of class III homeodomain/leucine zipper (HD-ZIPIII) genes(2-4). In Arabidopsis, three such genes, PHABULOSA (PHB), PHAVOLUTA (PHV) and REVOLUTA (REV), are expressed throughout the incipient leaf, but become adaxially localized after primordium emergence. Downregulation of the HD-ZIPIII genes allows expression of the KANADI and YABBY genes, which specify abaxial fate(5-8). PHB, PHV and REV transcripts contain a complementary site for miRNA165 and miRNA166, which can direct their cleavage in vitro(9-11). Here we show that miRNA166 constitutes a highly conserved polarizing signal whose expression pattern spatially defines the expression domain of the maize hd-zipIII family member rolled leaf1 (rld1). Moreover, the progressively expanding expression pattern of miRNA166 during leaf development and its accumulation in phloem suggests that miRNA166 may form a movable signal that emanates from a signalling centre below the incipient leaf.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Timmermans, MCP (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	timmerma@cshl.org		Heller, Bradley/0000-0002-8487-9088; Juarez, Michelle/0000-0002-6910-0881				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BURR B, 1988, GENETICS, V118, P519; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Jackson D., 1991, MOL PLANT PATHOLOGY, P163; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Nelson JM, 2002, DEVELOPMENT, V129, P4581; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Ratcliffe OJ, 2000, PLANT CELL, V12, P315, DOI 10.1105/tpc.12.3.315; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SNOW M., 1959, NEW PHYTOL, V58, P188, DOI 10.1111/j.1469-8137.1959.tb05351.x; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Timmermans MCP, 1996, GENETICS, V143, P1771; Timmermans MCP, 1998, DEVELOPMENT, V125, P2813; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139	27	539	618	8	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					84	88		10.1038/nature02363	http://dx.doi.org/10.1038/nature02363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999285				2022-12-01	WOS:000189363800040
J	Callaway, RM; Thelen, GC; Rodriguez, A; Holben, WE				Callaway, RM; Thelen, GC; Rodriguez, A; Holben, WE			Soil biota and exotic plant invasion	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BIOLOGICAL-CONTROL; FEEDBACK; COMMUNITIES; PATHOGENS; GROWTH	Invasive plants are an economic problem and a threat to the conservation of natural systems. Escape from natural enemies might contribute to successful invasion(1), with most work emphasizing the role of insect herbivores(2-4); however, microbial pathogens are attracting increased attention(5). Soil biota in some invaded ecosystems may promote 'exotic' invasion(6-9), and plant-soil feedback processes are also important. Thus, relatively rare species native to North America consistently demonstrate negative feedbacks with soil microbes that promote biological diversity(10), whereas abundant exotic and native species demonstrate positive feedbacks that reduce biological diversity(10). Here we report that soil microbes from the home range of the invasive exotic plant Centaurea maculosa L. have stronger inhibitory effects on its growth than soil microbes from where the weed has invaded in North America. Centaurea and soil microbes participate in different plant-soil feedback processes at home compared with outside Centaurea's home range. In native European soils, Centaurea cultivates soil biota with increasingly negative effects on the weed's growth, possibly leading to its control. But in soils from North America, Centaurea cultivates soil biota with increasingly positive effects on itself, which may contribute to the success of this exotic species in North America.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Callaway, RM (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	ray.callaway@mso.umt.edu						ANGSPURGER CK, 1990, PESTS PATHOGENS PLAN, pCH3; Bais HP, 2002, PLANT PHYSIOL, V128, P1173, DOI 10.1104/pp.011019; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; BRUNDRETT M, 1991, ADV ECOL RES, V21, P171, DOI 10.1016/S0065-2504(08)60099-9; BURDON JJ, 1993, ANNU REV PHYTOPATHOL, V31, P305, DOI 10.1146/annurev.py.31.090193.001513; Callaway RM, 2001, ECOL LETT, V4, P429, DOI 10.1046/j.1461-0248.2001.00251.x; Crawley MJ, 1992, NATURAL ENEMIES POPU; CROWLEY DE, 1991, PLANT SOIL, V130, P179, DOI 10.1007/BF00011873; Eom AH, 2000, OECOLOGIA, V122, P435, DOI 10.1007/s004420050050; GOEDEN RD, 1999, HDB BIOL CONTROL, pCH34; Holah JC, 1999, J ECOL, V87, P598, DOI 10.1046/j.1365-2745.1999.00383.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Louda SM, 2003, ANNU REV ENTOMOL, V48, P365, DOI 10.1146/annurev.ento.48.060402.102800; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; McEvoy PB, 1999, ECOL APPL, V9, P387, DOI 10.1890/1051-0761(1999)009[0387:BCOPIR]2.0.CO;2; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; NEWSHAM KK, 1994, J ECOL, V82, P805, DOI 10.2307/2261445; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; StreitwolfEngel R, 1997, J ECOL, V85, P181, DOI 10.2307/2960650; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; VANDERPUTTEN WH, 1993, NATURE, V362, P53; YOUNG NR, 1983, GRASS FORAGE SCI, V38, P13, DOI 10.1111/j.1365-2494.1983.tb01615.x	28	660	745	31	581	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					731	733		10.1038/nature02322	http://dx.doi.org/10.1038/nature02322			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973484				2022-12-01	WOS:000189026000042
J	Sinha, DN; Gupta, PC; Pednekar, MS				Sinha, DN; Gupta, PC; Pednekar, MS			Use of tobacco products as dentifrice among adolescents in India: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; Sch Prevent Oncol, Patna 800001, Bihar, India; Tata Mem Hosp, Epidemiol Res Ctr, Bombay 400012, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Memorial Centre (TMC); Tata Memorial Hospital	Gupta, PC (corresponding author), Tata Inst Fundamental Res, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	pcgupta@tifr.res.in		Pednekar, Mangesh/0000-0001-6266-5356				BHONSLE RB, 1992, CONTROL TOBACCO RELA; Global Youth Tobacco Survey Collabor, 2003, J SCHOOL HEALTH, V73, P207; Simpson D, 1997, Tob Control, V6, P171; SINHA DN, IN PRESS INDIAN J CA; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252	5	17	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2004	328	7435					323	324		10.1136/bmj.328.7435.323	http://dx.doi.org/10.1136/bmj.328.7435.323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773ME	14764494	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000188926900021
J	Boots, M; Hudson, PJ; Sasaki, A				Boots, M; Hudson, PJ; Sasaki, A			Large shifts in pathogen virulence relate to host population structure	SCIENCE			English	Article							HEMORRHAGIC-DISEASE-VIRUS; EVOLUTION; EPIDEMIOLOGY; COEVOLUTION; PARASITES	Theory on the evolution of virulence generally predicts selection for an optimal level of virulence determined by trade-offs with transmission and/or recovery. Here we consider the evolution of pathogen virulence in hosts who acquire long-lived immunity and live in a spatially structured population. We show theoretically that large shifts in virulence may occur in pathogen populations as a result of a bistability in evolutionary dynamics caused by the local contact or social population structure of the host. This model provides an explanation for the rapid emergence of the highly virulent strains of rabbit hemorrhagic disease virus.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Penn State Univ, Dept Biol, Mueller Lab, University Pk, PA 16802 USA; Kyushu Univ, Math Biol Lab, Higashi Ku, Fukuoka 812, Japan	University of Sheffield; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kyushu University	Boots, M (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	m.boots@sheffield.ac.uk	Hudson, Peter/AAB-8080-2020	Hudson, Peter/0000-0003-0468-3403				ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Ellner SP, 2001, J THEOR BIOL, V210, P435, DOI 10.1006/jtbi.2001.2322; Haraguchi Y, 2000, J THEOR BIOL, V203, P85, DOI 10.1006/jtbi.1999.1065; LEVY E, 2003, NEW KILLER DIS; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; MOSS SJ, UNPUB; Moss SR, 2002, J GEN VIROL, V83, P2461, DOI 10.1099/0022-1317-83-10-2461; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; SCHROER R, 1995, IEEE AERO EL SYS MAG, V10, P3; White PJ, 2001, PHILOS T R SOC B, V356, P1087, DOI 10.1098/rstb.2001.0897	11	145	149	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2004	303	5659					842	844		10.1126/science.1088542	http://dx.doi.org/10.1126/science.1088542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764881				2022-12-01	WOS:000188753800059
J	Sagrista-Sauleda, J; Angel, J; Sanchez, A; Permanyer-Miralda, G; Soler-Soler, J				Sagrista-Sauleda, J; Angel, J; Sanchez, A; Permanyer-Miralda, G; Soler-Soler, J			Effusive-constrictive pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPECTRUM	BACKGROUND: Effusive-constrictive pericarditis is an uncommon pericardial syndrome characterized by concomitant tamponade, caused by tense pericardial effusion, and constriction, caused by the visceral pericardium. We conducted a prospective study of its clinical evolution and management. METHODS: From 1986 through 2001, all patients with effusive-constrictive pericarditis were prospectively evaluated. Combined pericardiocentesis and cardiac catheterization were performed in all patients, and pericardiectomy was performed in those with persistent constriction. Follow-up ranged from 1 month to 15 years (median, 7 years). RESULTS: A total of 1184 patients with pericarditis were evaluated, 218 of whom had tamponade. Of these 218, 190 underwent combined pericardiocentesis and catheterization. Fifteen of these patients had effusive-constrictive pericarditis and were included in the study. All patients presented with clinical tamponade; however, concomitant constriction was recognized in only seven patients. At catheterization, all patients had elevated intrapericardial pressure (median, 12 mm Hg; interquartile range, 7 to 18) and elevated right atrial and end-diastolic right and left ventricular pressures. After pericardiocentesis, the intrapericardial pressure decreased (median value, -5 mm Hg; interquartile range, -5 to 0), whereas right atrial and end-diastolic right and left ventricular pressures, although slightly reduced, remained elevated, with a dip-plateau morphology. The causes were diverse, and death was mainly related to the underlying disease. Pericardiectomy was required in seven patients, all of whom had involvement of the visceral pericardium. Three patients had spontaneous resolution. CONCLUSIONS: Effusive-constrictive pericarditis is an uncommon pericardial syndrome that may be missed in some patients who present with tamponade. Although evolution to persistent constriction is frequent, idiopathic cases may resolve spontaneously. In our opinion, extensive epicardiectomy is the procedure of choice in patients requiring surgery.	Hosp Gen Univ Vall Hebron, Serv Cardiol, Barcelona 08035, Spain	Hospital Universitari Vall d'Hebron	Sagrista-Sauleda, J (corresponding author), Hosp Gen Univ Vall Hebron, Serv Cardiol, C-P Vall Hebron 119-129, Barcelona 08035, Spain.							BURCHELL H B, 1954, J Lancet, V74, P465; CAMERON J, 1987, AM HEART J, V113, P354, DOI 10.1016/0002-8703(87)90278-X; DCRUZ IA, 1991, SOUTHERN MED J, V84, P1375, DOI 10.1097/00007611-199111000-00022; DOIG JC, 1991, BRIT HEART J, V65, P296; FOWLER N, 1978, AM HEART J, V96, P533, DOI 10.1016/0002-8703(78)90168-0; HANCOCK EW, 1971, CIRCULATION, V43, P183, DOI 10.1161/01.CIR.43.2.183; HIRATA K, 1991, JPN CIRC J, V55, P154, DOI 10.1253/jcj.55.154; HUGOHAMMAN CT, 1994, PEDIATR INFECT DIS J, V13, P13, DOI 10.1097/00006454-199401000-00004; Ling LH, 1999, CIRCULATION, V100, P1380, DOI 10.1161/01.CIR.100.13.1380; Oudiz R, 1995, J Am Soc Echocardiogr, V8, P947, DOI 10.1016/S0894-7317(05)80024-0; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; SAGRISTASAULEDA J, 1987, AM J CARDIOL, V59, P961, DOI 10.1016/0002-9149(87)91134-9; SATOH T, 1993, BRIT HEART J, V69, P563; SOLERSOLER J, 1990, DEV CARDIOVASC MED, V108, P217; SPODICK DH, 1968, DIS CHEST, V54, P62, DOI 10.1378/chest.54.1.62; Tanaka Kimihiro, 2002, J Cardiol, V39, P267; Tsang TSM, 2003, AM J CARDIOL, V91, P704, DOI 10.1016/S0002-9149(02)03408-2; WALSH TJ, 1982, J THORAC CARDIOV SUR, V83, P126; Woods T, 1999, CLIN CARDIOL, V22, P316, DOI 10.1002/clc.4960220414	19	153	157	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2004	350	5					469	475		10.1056/NEJMoa035630	http://dx.doi.org/10.1056/NEJMoa035630			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	767QJ	14749455				2022-12-01	WOS:000188463900009
J	Lewis, R; Dixon, J				Lewis, R; Dixon, J			Rethinking management of chronic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVING PRIMARY-CARE; CHRONIC ILLNESS; HEALTH-CARE		Kings Fund, Hlth Policy, London W1G 0AN, England		Lewis, R (corresponding author), Kings Fund, Hlth Policy, London W1G 0AN, England.	rlewis@kingsfund.org.uk						Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; British Medical Association, 2003, INV GEN PRACT NEW GE; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Collins C, 1999, HEALTH POLICY, V47, P69, DOI 10.1016/S0168-8510(99)00003-2; *DEP HLTH, 2002, IMPR EXP REF NEX 3 Y; Department of Foreign Affairs and Trade, 2003, GOV RESP HLTH SEL CO, V11, P13; Department of Health, 1998, INF HLTH INF STRAT M; Department of Health, 2001, EXP PAT NEW APPR CHR; Department of Health, 2002, REF NHS FIN FLOWS IN; LEWIS R, 2003, FUTURE DIRECTIONS PR; *NAT COAL HLTH CAR, 2002, CUR SYST; *NHS CONF, 2003, GMS CONTR NEG FACT S; RICHARDSON T, 2001, PERSONAL MED SERVICE; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; *RW JOHNS FDN, CHRON CAR MOD; Smith PC, 2002, HEALTH AFFAIR, V21, P103, DOI 10.1377/hlthaff.21.3.103; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64	19	75	77	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2004	328	7433					220	222		10.1136/bmj.328.7433.220	http://dx.doi.org/10.1136/bmj.328.7433.220			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	769LU	14739194	Green Published			2022-12-01	WOS:000188652200024
J	Matsuo, H; Chevallier, J; Mayran, N; Le Blanc, I; Ferguson, C; Faure, J; Blanc, NS; Matile, S; Dubochet, J; Sadoul, R; Parton, RG; Vilbois, F; Gruenberg, J				Matsuo, H; Chevallier, J; Mayran, N; Le Blanc, I; Ferguson, C; Faure, J; Blanc, NS; Matile, S; Dubochet, J; Sadoul, R; Parton, RG; Vilbois, F; Gruenberg, J			Role of LBPA and Alix in multivesicular liposome formation and endosome organization	SCIENCE			English	Article							PROTEIN; APOPTOSIS; VESICLES; EXOSOMES; PATHWAY; ACID; CELL	What are the components that control the assembly of subcellular organelles in eukaryotic cells? Although membranes can clearly be distorted by cytosolic factors, very little is known about the intrinsic mechanisms that control the biogenesis, shape, and organization of organellar membranes. Here, we found that the unconventional phospholipid lysobisphosphatidic acid (LBPA) could induce the formation of multivesicular liposomes that resembled the multivesicular endosomes that exist where this lipid is found in vivo. This process depended on the same pH gradient that exists across endosome membranes in vivo and was selectively controlled by Alix. In turn, Alix regulated the organization of LBPA-containing endosomes in vivo.	Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Organ Chem, CH-1211 Geneva 4, Switzerland; Univ Queensland, Ctr Microscopy & Microanal, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; Univ Grenoble 1, Hop A Michallon, Neurodegenerescence & Plast Inserm, F-38043 Grenoble 9, France; Univ Lausanne, Lab Anal Ultrastruct, CH-1015 Lausanne, Switzerland; Serono Pharmaceut Res Inst, CH-1228 Plan Les Ouates, Switzerland	University of Geneva; University of Geneva; University of Queensland; University of Queensland; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Lausanne	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch	Matile, Stefan/AFL-7826-2022; Parton, Robert G/C-5673-2009; Fauré, julien/AAJ-1845-2020	Matile, Stefan/0000-0002-8537-8349; Parton, Robert G/0000-0002-7494-5248; Fauré, julien/0000-0002-3660-9809; SADOUL, Remy/0000-0002-4763-0320				Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chevallier J, 2000, ORG LETT, V2, P1859, DOI 10.1021/ol0059246; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Cluett EB, 1996, J CELL SCI, V109, P2121; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dubochet J, 2001, MICRON, V32, P91, DOI 10.1016/S0968-4328(00)00026-3; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Galve-de Rochemonteix B, 2000, ARTERIOSCL THROM VAS, V20, P563; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tedesco MM, 1999, BIOORGAN MED CHEM, V7, P1373, DOI 10.1016/S0968-0896(99)00076-0; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WHITNEY JA, 1995, CELL, V83, P703	26	512	523	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					531	534		10.1126/science.1092425	http://dx.doi.org/10.1126/science.1092425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739459				2022-12-01	WOS:000188316400040
J	Wright, NMJ; Tompkins, CNE				Wright, NMJ; Tompkins, CNE			Supervised injecting centres	BRITISH MEDICAL JOURNAL			English	Article							DRUG-USERS; ROOMS		Ctr Res primary Care, Leeds LS2 9PL, W Yorkshire, England; NE Leeds Primary Care Trust, Leeds LS6 2HF, W Yorkshire, England	University of Leeds	Wright, NMJ (corresponding author), Ctr Res primary Care, Leeds LS2 9PL, W Yorkshire, England.							Buchanan J, 2000, DRUG-EDUC PREV POLIC, V7, P409, DOI 10.1080/713660130; Carlson RG, 2000, HUM ORGAN, V59, P325, DOI 10.17730/humo.59.3.w483t11p717473k6; *CONS ROOMS PROF S, 1999, GUID OP US CONS ROOM; De Jong W, 1999, INT J DRUG POLICY, V10, P99, DOI DOI 10.1016/S0955-3959(98)00072-73; European Monitoring Centre for Drugs and Drug Addiction, 2002, ANN REP STAT DRUGS P; Glantz LH, 1996, AM J PUBLIC HEALTH, V86, P1077, DOI 10.2105/AJPH.86.8_Pt_1.1077; *INT DROG, 1997, JAHR 1996; JACOB J, 1999, ENTSTEHUNG PRAXIS EI; *MSIC EV COMM, 2003, FIN REP EV REP SYDN; *NAT TREATM AG, INJ HER INJ METH POT; Stoever H, 2002, J DRUG ISSUES, V32, P597, DOI 10.1177/002204260203200217; Taylor A, 2000, J INFECTION, V40, P176, DOI 10.1053/jinf.2000.0647; van Ameijden EJC, 2001, J EPIDEMIOL COMMUN H, V55, P356, DOI 10.1136/jech.55.5.356; Yamey G, 2000, BRIT MED J, V320, P667	14	37	37	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 10	2004	328	7431					100	102		10.1136/bmj.328.7431.100	http://dx.doi.org/10.1136/bmj.328.7431.100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MP	14715606	Green Published			2022-12-01	WOS:000187976400022
J	Schoenbaum, SC; Bovbjerg, RR				Schoenbaum, SC; Bovbjerg, RR			Malpractice reform must include steps to prevent medical injury	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPROVE PATIENT SAFETY; ADVERSE EVENTS; ERRORS; RESPONSIBILITY; NEGLIGENCE; PHYSICIANS; QUALITY	In the current malpractice insurance crisis, physicians have focused their advocacy and energy primarily on rapidly increasing liability premiums; problems in access to care; and demands for legal reform, especially caps on damages. An even more important focus, however, is prevention of injury and improvement of patient safety. Physicians largely control patient care and can play a critical role in systematically reducing injury. Reforms should go beyond liability issues; they should also harness and enhance physicians' ability to act. More visible efforts by physicians to reduce harm, better communication with patients and others, and true evidence of improved patient safety should reduce patient anger and litigiousness. Individually and collectively, physicians can and should ensure that "doing no harm" comes first in the malpractice debate.	Commonwealth Fund, New York, NY 10021 USA; Urban Inst, Washington, DC 20037 USA	Commonwealth Fund; Urban Institute	Schoenbaum, SC (corresponding author), Commonwealth Fund, 1 E 75th St, New York, NY 10021 USA.	scs@cmwf.org						BERWICK DM, 2003, I HEALTHC IMPR 13 AN; BOVBJERG RR, 2003, PATIENT SAFETY JUST; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2003, ANN INTERN MED, V139, P267, DOI 10.7326/0003-4819-139-4-200308190-00009; Chassin MR, 1998, MILBANK Q, V76, P565, DOI 10.1111/1468-0009.00106; Classen DC, 2002, ACAD MED, V77, P963, DOI 10.1097/00001888-200210000-00007; CORRIGAN JM, FOSTERING RAPID ADV; DANZON PM, 1985, MED MALPRACTICE THEO; Davis K, 2002, ROOM IMPROVEMENT PAT; DOMINO KB, 2002, ASA NEWSLETTER, V66, P5; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; Goode LD, 2002, ACAD MED, V77, P947, DOI 10.1097/00001888-200210000-00004; HELLINGER FJ, 2003, IMPACT STATE LAWS LI; Institute of Medicine Committee on Quality of Health Care in America, 2000, ERR IS HUMAN BUILDIN; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; James B C, 1989, QA Rev, V1, P4; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; LOWES R, 2002, MED ECON, V13, P86; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mello MM, 2002, TEX LAW REV, V80, P1595; Miller RH, 2002, J HEALTH POLIT POLIC, V27, P401, DOI 10.1215/03616878-27-3-401; *NAT PAT SAF FDN, BIBLIOGRAPHY; *NEW JERS DEP BANK, 2003, MED MALPR PRE DAT SU; Pierce E C Jr, 1990, QRB Qual Rev Bull, V16, P61; PRAGER LO, 2000, AM MED NEWS     0612; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Silversin JB, 2000, LEADING PHYS CHANGE; STOLBERG SG, 2003, NY TIMES        0710; TAYLOR H, 2002, MOST DOCT REP FEAR M; *US C BUDG OFF, 2002, COST ESTIMATE HR 460; *US GEN ACC OFF, 2003, GAO03702; Wachter RM, 2002, ANN INTERN MED, V136, P850, DOI 10.7326/0003-4819-136-11-200206040-00015; Werner MJ, 1995, ANN INTERN MED, V122, P466, DOI 10.7326/0003-4819-122-6-199503150-00012; ZUCKERMAN S, 1990, INQUIRY-J HEALTH CAR, V27, P167	35	22	25	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2004	140	1					51	53		10.7326/0003-4819-140-1-200401060-00011	http://dx.doi.org/10.7326/0003-4819-140-1-200401060-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760VH	14706972				2022-12-01	WOS:000187855600007
J	Aarts, M; Iihara, K; Wei, WL; Xiong, ZG; Arundine, M; Cerwinski, W; MacDonald, JF; Tymianski, M				Aarts, M; Iihara, K; Wei, WL; Xiong, ZG; Arundine, M; Cerwinski, W; MacDonald, JF; Tymianski, M			A key role for TRPM7 channels in anoxic neuronal death	CELL			English	Article							METHYL-D-ASPARTATE; CORTICAL CELL-CULTURE; CATION CHANNEL; CALCIUM NEUROTOXICITY; RECEPTOR ACTIVATION; RNA INTERFERENCE; CLINICAL-TRIALS; BRAIN INJURY; NITRIC-OXIDE; ACUTE STROKE	Excitotoxicity in brain ischemia triggers neuronal death and neurological disability, and yet these are not prevented by antiexcitotoxic therapy (AET) in humans. Here, we show that in neurons subjected to prolonged oxygen glucose deprivation (OGD), AET unmasks a dominant death mechanism perpetuated by a Ca2+-permeable nonselective cation conductance (I-OGD). I-OGD was activated by reactive oxygen/nitrogen species (ROS), and permitted neuronal Ca2+ overload and further ROS production despite AET. I-OGD currents corresponded to those evoked in HEK-293 cells expressing the nonselective cation conductance TRPM7. In cortical neurons, blocking I-OGD or suppressing TRPM7 expression blocked TRPM7 currents, anoxic Ca-45(2+) up-take, ROS production, and anoxic death. TRPM7 suppression eliminated the need for AET to rescue anoxic neurons and permitted the survival of neurons previously destined to die from prolonged anoxia. Thus, excitotoxicity is a subset of a greater overall anoxic cell death mechanism, in which TRPM7 channels play a key role.	Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.		Aarts, Michelle/C-5766-2008	Aarts, Michelle/0000-0002-9171-0571; Tymianski, Mike/0000-0002-6311-9565	NINDS NIH HHS [NS 39060] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; CHOI DW, 1987, J NEUROSCI, V7, P357; Cullen BR, 2002, NAT IMMUNOL, V3, P597, DOI 10.1038/ni0702-597; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gao TM, 1998, NEUROSCIENCE, V87, P371, DOI 10.1016/S0306-4522(98)00150-X; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 1997, J CEREBR BLOOD F MET, V17, P455, DOI 10.1097/00004647-199704000-00011; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sensi SL, 1999, NEUROREPORT, V10, P1723, DOI 10.1097/00001756-199906030-00018; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018	43	612	646	2	69	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					863	877		10.1016/S0092-8674(03)01017-1	http://dx.doi.org/10.1016/S0092-8674(03)01017-1			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697204	Bronze			2022-12-01	WOS:000187664700010
J	Berry, KL; Bulow, HE; Hall, DH; Hobert, O				Berry, KL; Bulow, HE; Hall, DH; Hobert, O			A C-elegans CLIC-like protein required for intracellular tube formation and maintenance	SCIENCE			English	Article							CHLORIDE-ION CHANNEL; SECRETORY-EXCRETORY SYSTEM; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; ANION CHANNEL; CELL; NCC27; EXPRESSION; FAMILY; P64H1	The Caenorhabditis elegans excretory canal is composed of a single elongated and branched cell that is tunneled by an inner lumen of apical character. Loss of the exc-4 gene causes a cystic enlargement of this intracellular tube. exc-4 encodes a member of the chloride intracellular channel (CLIC) family of proteins. EXC-4 protein localizes to various tubular membranes in distinct cell types, including the lumenal membrane of the excretory tubes. A conserved 55 - amino acid domain enables EXC-4 translocation from the cytosol to the lumenal membrane. The tubular architecture of this membrane requires EXC-4 for both its formation and maintenance.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr C Elegans Anat, Dept Neurosci, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.			Berry, Katherine/0000-0002-2311-0734; Hobert, Oliver/0000-0002-7634-2854	NCRR NIH HHS [R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ashley RH, 2003, MOL MEMBR BIOL, V20, P1, DOI 10.1080/09687680210042746; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Proutski I, 2002, BIOCHEM BIOPH RES CO, V297, P317, DOI 10.1016/S0006-291X(02)02199-X; Tonini R, 2000, FASEB J, V14, P1171, DOI 10.1096/fasebj.14.9.1171; Tulk BM, 2000, J BIOL CHEM, V275, P26986; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200	23	124	129	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2134	2137		10.1126/science.1087667	http://dx.doi.org/10.1126/science.1087667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684823				2022-12-01	WOS:000187385200048
J	Paschen, SA; Waizenegger, T; Stan, T; Preuss, M; Cyrklaff, M; Hell, K; Rapaport, D; Neupert, W				Paschen, SA; Waizenegger, T; Stan, T; Preuss, M; Cyrklaff, M; Hell, K; Rapaport, D; Neupert, W			Evolutionary conservation of biogenesis of beta-barrel membrane proteins	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; TOM COMPLEX; IMPORT PORE; CHANNEL; COMPONENT; MACHINERY; RECEPTORS; YEAST	The outer membranes of mitochondria and chloroplasts are distinguished by the presence of beta-barrel membrane proteins(1,2). The outer membrane of Gram-negative bacteria also harbours beta-barrel proteins(3). In mitochondria these proteins fulfil a variety of functions such as transport of small molecules (porin/VDAC), translocation of proteins (Tom40) and regulation of mitochondrial morphology (Mdm10)(4-7). These proteins are encoded by the nucleus, synthesized in the cytosol, targeted to mitochondria as chaperone-bound species, recognized by the translocase of the outer membrane, and then inserted into the outer membrane where they assemble into functional oligomers(8-11). Whereas some knowledge has been accumulated on the pathways of insertion of proteins that span cellular membranes with alpha-helical segments, very little is known about how beta-barrel proteins are integrated into lipid bilayers and assembled into oligomeric structures(12). Here we describe a protein complex that is essential for the topogenesis of mitochondrial outer membrane beta-barrel proteins (TOB). We present evidence that important elements of the topogenesis of beta-barrel membrane proteins have been conserved during the evolution of mitochondria from endosymbiotic bacterial ancestors(13).	Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany; Max Planck Inst Biochem, Abt Mol Strukturbiol, D-82152 Martinsried, Germany	University of Munich; Max Planck Society	Neupert, W (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.							Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; Brachat A, 2000, YEAST, V16, P241, DOI 10.1002/(SICI)1097-0061(200002)16:3<241::AID-YEA517>3.0.CO;2-T; De Carlo S, 2002, J STRUCT BIOL, V138, P216, DOI 10.1016/S1047-8477(02)00035-7; Ellis RJ, 1996, FOLD DES, V1, pR9, DOI 10.1016/S1359-0278(96)00004-1; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Gabriel K, 2001, TRENDS BIOCHEM SCI, V26, P36, DOI 10.1016/S0968-0004(00)01684-4; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; Marcotte EM, 2000, P NATL ACAD SCI USA, V97, P12115, DOI 10.1073/pnas.220399497; Matouschek A, 2001, NAT STRUCT BIOL, V8, P284, DOI 10.1038/86140; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Paschen SA, 2001, IUBMB LIFE, V52, P101, DOI 10.1080/15216540152845894; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753	29	334	347	5	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					862	866		10.1038/nature02208	http://dx.doi.org/10.1038/nature02208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685243				2022-12-01	WOS:000187342000064
J	Basehoar, AD; Zanton, SJ; Pugh, BF				Basehoar, AD; Zanton, SJ; Pugh, BF			Identification and distinct regulation of yeast TATA box-containing genes	CELL			English	Article							PROMOTERS IN-VIVO; RNA-POLYMERASE-II; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; ENVIRONMENTAL-CHANGES; EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; GLOBAL REPRESSOR; DNA-SEQUENCES	Despite being one of the first eukaryotic transcriptional regulatory elements identified, the sequence of a native TATA box and its significance remain elusive. Applying criteria associated with TATA boxes we queried several Saccharomyces genomes and arrived at the consensus TATA(A/T)A(A/T)(A/G). Approximately 20% of yeast genes contain a TATA box. Strikingly, TATA box-containing genes are associated with responses to stress, are highly regulated, and preferentially utilize SAGA rather than TFIID when compared to TATA-less promoters. Transcriptional regulation in yeast appears to be mechanistically bipolar, possibly reflecting a need to balance inducible stress-related responses with constitutive housekeeping functions.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Grad Program Stat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu			NIGMS NIH HHS [R01 GM059055, GM059055] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; WONG JM, 1994, NUCLEIC ACIDS RES, V22, P1890, DOI 10.1093/nar/22.10.1890; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	57	480	495	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					699	709		10.1016/S0092-8674(04)00205-3	http://dx.doi.org/10.1016/S0092-8674(04)00205-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006352	Bronze			2022-12-01	WOS:000221499700010
J	Coull, JT; Vidal, F; Nazarian, B; Macar, F				Coull, JT; Vidal, F; Nazarian, B; Macar, F			Functional anatomy of the attentional modulation of time estimation	SCIENCE			English	Article							SUPPLEMENTARY MOTOR AREA; BRAIN ACTIVATION; NEURAL SYSTEMS; MOVEMENTS; CORTEX; FMRI; ORGANIZATION; INFORMATION; COMPONENTS; INTERVALS	Attention modulates our subjective perception of time. The less we attend to an event's duration, the shorter it seems to last. Attention to time or color stimulus attributes was modulated parametrically in an event-related functional magnetic resonance imaging study. Linear increases in task performance were accompanied by corresponding increases in brain activity. Increasing attention to time selectively increased activity in a corticostriatal network, including pre-supplementary motor area and right frontal operculum. Increasing attention to color selectively increased activity in area V4. By identifying areas whose activity was specifically modulated by attention to time, we have defined the core neuroanatomical substrates of timing behavior.	CNRS, Lab Neurobiol Cognit, F-13402 Marseille 20, France; IMNSSA, Toulon, France; CHU Timone, Ctr IRM Fonct Cerebrale, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Coull, JT (corresponding author), CNRS, Lab Neurobiol Cognit, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	jcoull@lnf.cnrs-mrs.fr	Coull, Jennifer T/M-4243-2015	Coull, Jennifer T/0000-0002-8790-5835				Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2003, COGNITIVE BRAIN RES, V17, P368, DOI 10.1016/S0926-6410(03)00138-1; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rao SM, 1997, J NEUROSCI, V17, P5528; Rushworth MFS, 1997, NEUROPSYCHOLOGIA, V35, P1261, DOI 10.1016/S0028-3932(97)00050-X; Schubotz RI, 2001, COGNITIVE BRAIN RES, V11, P97, DOI 10.1016/S0926-6410(00)00069-0; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; ZEKI S, 1991, J NEUROSCI, V11, P641	27	465	485	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2004	303	5663					1506	1508		10.1126/science.1091573	http://dx.doi.org/10.1126/science.1091573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001776				2022-12-01	WOS:000220000100038
J	Kaufmann, P; Bose, P; Prescher, A				Kaufmann, P; Bose, P; Prescher, A			New insights into the soft-tissue anatomy anterior to the patella	LANCET			English	Editorial Material									Univ Technol Aachen, Dept Anat, D-52057 Aachen, Germany	RWTH Aachen University	Kaufmann, P (corresponding author), Univ Technol Aachen, Dept Anat, D-52057 Aachen, Germany.	pkaufmann@ukaachen.de						Dye SF, 2003, J BONE JOINT SURG AM, V85A, P1012, DOI 10.2106/00004623-200306000-00005; Federative Committee on Anatomical Terminology, 1998, TERM AN; FENEIS H, 1982, ANATOMISCHES BILDWOR; Fick R, 1904, HDB ANATOMIE MECHANI; RAUBER A, 1987, ANATOMIE MENSCHEN, V1; SIEGLBAUER F, 1944, LEHRBUCH NORMALEN AN; [No title captured]; [No title captured]; [No title captured]	9	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2004	363	9409					586	586		10.1016/S0140-6736(04)15627-4	http://dx.doi.org/10.1016/S0140-6736(04)15627-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	776EZ	14987881				2022-12-01	WOS:000189104900005
J	Le May, N; Dubaele, S; De Santis, LP; Billecocq, A; Bouloy, M; Egly, JM				Le May, N; Dubaele, S; De Santis, LP; Billecocq, A; Bouloy, M; Egly, JM			TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus	CELL			English	Article							NONSTRUCTURAL PROTEIN NSS; RNA-POLYMERASE-II; INFECTED-CELLS; DNA-REPAIR; GENE; INHIBITION; INTERFERON; POLIOVIRUS; KINASE; XPD	The Rift Valley fever virus (RVFV) is the causative agent of fatal hemorrhagic fever in humans and acute hepatitis in ruminants. We found that infection by RVFV leads to a rapid and drastic suppression of host cellular RNA synthesis that parallels a decrease of the TFIIH transcription factor cellular concentration. Using yeast two hybrid system, recombinant technology, and confocal microscopy, we further demonstrated that the nonstructural viral NSs protein interacts with the p44 component of TFIIH to form nuclear filamentous structures that also contain XPB subunit of TFIIH. By competing with XPD, the natural partner of p44 within TFIIH, and sequestering p44 and XPB subunits, NSs prevents the assembly of TFIIH subunits, thus destabilizing the normal host cell life. These observations shed light on the mechanism utilized by RVFV to evade the host response.	Inst Pasteur, Unite Genet Mol Bunyavirides, F-75724 Paris 15, France; CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bouloy, M (corresponding author), Inst Pasteur, Unite Genet Mol Bunyavirides, 25 Rue Dr Roux, F-75724 Paris 15, France.	mbouloy@pasteur.fr; egly@titus.u-strasbg.fr	Le May, Nicolas/O-1275-2016; De Santis, Luca Proietti/A-4119-2015; Le May, Nicolas/R-4656-2019	De Santis, Luca Proietti/0000-0002-2715-9113; Le May, Nicolas/0000-0002-0172-8752				[Anonymous], 2000, Wkly Epidemiol Rec, V75, P370; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P392; BALTIMORE D, 1962, P NATL ACAD SCI USA, V48, P1383, DOI 10.1073/pnas.48.8.1383; BILLECOCQ A, 2003, 12 INT C NEG STRAND, P137; BISHOP DH, 1996, BUNYAVIRIDAE; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CRAWFORD N, 1981, CELL, V27, P555, DOI 10.1016/0092-8674(81)90397-4; DAHMUS ME, 1992, TRANSCRIPTIONAL REGU, P109; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; ELLIOTT RM, 2000, FAMILY BUNYAVIRIDAE, P614; Endrizzi MG, 2000, GENOME RES, V10, P1095, DOI 10.1101/gr.10.8.1095; Frit P, 1999, BIOCHIMIE, V81, P27, DOI 10.1016/S0300-9084(99)80035-2; GERARD M, 1991, J BIOL CHEM, V266, P20940; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; HE D, 2000, J CELL BIOL, V110, P569; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; Iben S, 2002, CELL, V109, P297, DOI 10.1016/S0092-8674(02)00729-8; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Santagati F, 2001, NUCLEIC ACIDS RES, V29, P1574, DOI 10.1093/nar/29.7.1574; SCHMALJOHN CAH, 2001, BUNYAVIRIDAE VIRUSES; STRUTHERS JK, 1982, J GEN VIROL, V60, P381, DOI 10.1099/0022-1317-60-2-381; SWANEPOEL R, 1977, J GEN VIROL, V34, P557, DOI 10.1099/0022-1317-34-3-557; THOMAS D, 2003, 12 INT C NEG STRAND, P127; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Yalamanchili P, 1996, J VIROL, V70, P2922, DOI 10.1128/JVI.70.5.2922-2929.1996; Yuan H, 1998, VIROLOGY, V251, P383, DOI 10.1006/viro.1998.9413; ZIMMERMAN E, 1963, VIROLOGY, V19, P400, DOI 10.1016/0042-6822(63)90080-1; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	45	231	237	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					541	550		10.1016/S0092-8674(04)00132-1	http://dx.doi.org/10.1016/S0092-8674(04)00132-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980221	Bronze			2022-12-01	WOS:000189184200008
J	Del Bene, F; Tessmar-Raible, K; Wittbrodt, J				Del Bene, F; Tessmar-Raible, K; Wittbrodt, J			Direct interaction of geminin and Six3 in eye development	NATURE			English	Article							DNA-REPLICATION; HOMEOBOX GENE; XENOPUS-LAEVIS; REPRESSION; HOMOLOG; OVEREXPRESSION; INHIBITION; EXPRESSION; ZEBRAFISH; BINDING	Organogenesis in vertebrates requires the tight control of cell proliferation and differentiation. The homeobox-containing transcription factor Six3 plays a pivotal role(1,2) in the proliferation of retinal precursor cells. In a yeast two-hybrid screen, we identified the DNA replication-inhibitor geminin as a partner of Six3. Geminin inhibits cell-cycle progression(3) by sequestering Cdt1 (refs 4, 5), the key component for the assembly of the pre-replication complex(6). Here, we show that Six3 efficiently competes with Cdt1 directly to bind to geminin, which reveals how Six3 can promote cell proliferation without transcription. In common with Six3 inactivation(2,7), overexpression of the geminin gene (Gem; also known as Gmn) in medaka (Oryzias latipes) induces specific forebrain and eye defects that are rescued by Six3. Conversely, loss of Gem (in common with gain of Six3 (ref. 1)) promotes retinal precursor-cell proliferation and results in expanded optic vesicles, markedly potentiating Six3 gain-of-function phenotypes. Our data indicate that the transcription factor Six3 and the replication-initiation inhibitor geminin act antagonistically to control the balance between proliferation and differentiation during early vertebrate eye development.	European Mol Biol Lab, Dev Biol Programme, D-69012 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Wittbrodt, J (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69012 Heidelberg, Germany.	Jochen.Wittbrodt@EMBL.de	del bene, filippo/D-1245-2010; Tessmar-Raible, Kristin/F-9642-2011; Wittbrodt, Joachim/D-4735-2014	del bene, filippo/0000-0001-8551-2846; Tessmar-Raible, Kristin/0000-0002-8038-1741; Wittbrodt, Joachim/0000-0001-8550-7377				Carl M, 2002, DEVELOPMENT, V129, P4057; Goudreau G, 2002, P NATL ACAD SCI USA, V99, P8719, DOI 10.1073/pnas.132195699; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Koster R, 1997, DEVELOPMENT, V124, P3147; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; LIANG J, 1995, J BIOL CHEM, V270, P25520, DOI 10.1074/jbc.270.43.25520; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; LUO L, 2000, NATURE, V427, P749; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Sato S, 2002, HUM MOL GENET, V11, P1045, DOI 10.1093/hmg/11.9.1045; Sawai S, 1997, MECH DEVELOP, V65, P175, DOI 10.1016/S0925-4773(97)00071-3; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tessmar K, 2002, MECH DEVELOP, V117, P103, DOI 10.1016/S0925-4773(02)00185-5; Toy J, 1998, P NATL ACAD SCI USA, V95, P10643, DOI 10.1073/pnas.95.18.10643; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302; Winkler S, 2000, DEVELOPMENT, V127, P1911; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zhu CQC, 2002, DEVELOPMENT, V129, P2835; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	25	202	208	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					745	749		10.1038/nature02292	http://dx.doi.org/10.1038/nature02292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973488				2022-12-01	WOS:000189026000046
J	Levine, RJ; Maynard, SE; Qian, C; Lim, KH; England, LJ; Yu, KF; Schisterman, EF; Thadhani, R; Sachs, BP; Epstein, FH; Sibai, BM; Sukhatme, VP; Karumanchi, SA				Levine, RJ; Maynard, SE; Qian, C; Lim, KH; England, LJ; Yu, KF; Schisterman, EF; Thadhani, R; Sachs, BP; Epstein, FH; Sibai, BM; Sukhatme, VP; Karumanchi, SA			Circulating angiogenic factors and the risk of preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RANDOMIZED-TRIAL; FACTOR RECEPTOR; SERUM LEVELS; 2ND-TRIMESTER; BEVACIZUMAB; EXPRESSION; CALCIUM; CANCER	Background: The cause of preeclampsia remains unclear. Limited data suggest that excess circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor (PlGF) and vascular endothelial growth factor (VEGF), may have a pathogenic role. Methods: We performed a nested case-control study within the Calcium for Preeclampsia Prevention trial, which involved healthy nulliparous women. Each woman with preeclampsia was matched to one normotensive control. A total of 120 pairs of women were randomly chosen. Serum concentrations of angiogenic factors (total sFlt-1, free PlGF, and free VEGF) were measured throughout pregnancy; there were a total of 655 serum specimens. The data were analyzed cross-sectionally within intervals of gestational age and according to the time before the onset of preeclampsia. Results: During the last two months of pregnancy in the normotensive controls, the level of sFlt-1 increased and the level of PlGF decreased. These changes occurred earlier and were more pronounced in the women in whom preeclampsia later developed. The sFlt-1 level increased beginning approximately five weeks before the onset of preeclampsia. At the onset of clinical disease, the mean serum level in the women with preeclampsia was 4382 pg per milliliter, as compared with 1643 pg per milliliter in controls with fetuses of similar gestational age (P<0.001). The PlGF levels were significantly lower in the women who later had preeclampsia than in the controls beginning at 13 to 16 weeks of gestation (mean, 90 pg per milliliter vs. 142 pg per milliliter, P=0.01), with the greatest difference occurring during the weeks before the onset of preeclampsia, coincident with the increase in the sFlt-1 level. Alterations in the levels of sFlt-1 and free PlGF were greater in women with an earlier onset of preeclampsia and in women in whom preeclampsia was associated with a small-for-gestational-age infant. Conclusions: Increased levels of sFlt-1 and reduced levels of PlGF predict the subsequent development of preeclampsia.	NICHHD, Div Epidemiol Stat & Prevent Res, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Allied Technol Grp, Rockville, MD USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Obstet, Boston, MA 02114 USA; Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University System of Ohio; University of Cincinnati	Levine, RJ (corresponding author), NICHHD, Div Epidemiol Stat & Prevent Res, Dept Hlth & Human Serv, Bldg 6100,Rm 7B03, Bethesda, MD 20892 USA.	levinerj@mail.nih.gov; sananth@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Sukhatme, Vikas/W-2776-2019	Schisterman, Enrique/0000-0003-3757-641X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000373] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000373, ZIAHD000864, Z01HD000864] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Holzgreve W, 1998, OBSTET GYNECOL, V91, P669, DOI 10.1016/S0029-7844(98)00068-4; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Page NM, 2000, NATURE, V405, P797, DOI 10.1038/35015579; Polliotti BM, 2003, OBSTET GYNECOL, V101, P1266, DOI 10.1016/S0029-7844(03)00338-7; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Strevens H, 2003, BJOG-INT J OBSTET GY, V110, P831, DOI 10.1111/j.1471-0528.2003.02162.x; Su YN, 2001, OBSTET GYNECOL, V97, P898, DOI 10.1016/S0029-7844(01)01341-2; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; THADHANI R, IN PRESS J CLIN ENDO; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Tjoa ML, 2001, OBSTET GYNECOL, V98, P600, DOI 10.1016/S0029-7844(01)01497-1; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Torry DS, 2003, J SOC GYNECOL INVEST, V10, P178, DOI 10.1016/S1071-5576(03)00048-0; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	25	2548	2699	6	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2004	350	7					672	683		10.1056/NEJMoa031884	http://dx.doi.org/10.1056/NEJMoa031884			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772YB	14764923				2022-12-01	WOS:000188869500008
J	Chopra, SS; Sotile, WM; Sotile, MO				Chopra, SS; Sotile, WM; Sotile, MO			Physician burnout	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							JOB-SATISFACTION; STRESS; MANAGEMENT; PREVENTION; RESIDENTS; CARE		Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Vanderbilt University; Wake Forest University; Tulane University	Chopra, SS (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.							Gabbe SG, 2002, AM J OBSTET GYNECOL, V186, P601, DOI 10.1067/mob.2002.122391; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; KELLER KL, 1989, ANN EMERG MED, V18, P42; Lloyd S, 1994, J Emerg Med, V12, P559; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; Michels PJ, 2003, ACAD MED, V78, P69, DOI 10.1097/00001888-200301000-00013; Mirvis D M, 1999, J Health Hum Serv Adm, V21, P390; Mirvis DM, 1999, J HEALTHC MANAG, V44, P353, DOI 10.1097/00115514-199909000-00007; RAFFERTY JP, 1986, J CLIN PSYCHOL, V42, P488, DOI 10.1002/1097-4679(198605)42:3<488::AID-JCLP2270420315>3.0.CO;2-S; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Thommasen HV, 2001, CAN FAM PHYSICIAN, V47, P737	13	75	78	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2004	291	5					633	633		10.1001/jama.291.5.633	http://dx.doi.org/10.1001/jama.291.5.633			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	769LC	14762045				2022-12-01	WOS:000188650700031
J	Shinoda-Tagawa, T; Leonard, R; Pontikas, J; McDonough, JE; Allen, D; Dreyer, PI				Shinoda-Tagawa, T; Leonard, R; Pontikas, J; McDonough, JE; Allen, D; Dreyer, PI			Resident-to-resident violent incidents in nursing homes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AGGRESSIVE-BEHAVIOR; PSYCHOSIS; VICTIMS	Context Little is known about nursing home residents' injuries that are inflicted by other residents. Objective To assess risk factors for violent injury to nursing home residents by other residents. Design, Setting, and Subjects. Case-control study using data from the Massachusetts Department of Public Health's Complaint and Incident Reporting System and from Minimum Data Set assessments for Massachusetts nursing home residents. Cases had an injury sustained from an incident with another nursing home resident between January 1, 2000, and December 31, 2000, which left visible evidence Oe, fracture, dislocation, bruise or hematoma, laceration, and reddened area) (median age, 81 years). Controls were randomly selected from all residents who had a Minimum Data Set assessment completed in 2000 (n = 101429) and no injury report (median age, 83 years). A total of 1994 controls were included in the analyses. Main Outcome Measures Injury type and risk of being injured by resident-to-resident aggressive physical behaviors based on the specific characteristics of the injured resident. Results During the first incident, 294 residents sustained fractures (n=39), dislocations (n=6), bruises or hematomas (n=105), lacerations (n=113), and reddened areas (n=31). Injured residents (cases) were more likely to be cognitively impaired, exhibit symptoms of wandering, be verbally abusive, and have socially inappropriate behavior than the controls. Residents who were classified as needing extensive assistance (adjusted odds ratio [AOR], 0.3; 95% confidence interval [CI], 0.2-0.6) and being severely dependent (AOR, 0.12; 95% Cl, 0.05-0.27) had a significant reduction in being injured. Residents in an Alzheimer disease unit were almost 3 times as likely to be injured than those living in other units (AOR, 3.2; 95% Cl, 1.4-7.5). Conclusions Injured residents were more likely, perhaps unknowingly, to "put themselves in harm's way," be verbally aggressive, and be cognitively impaired. Interventions to prevent these incidents should focus on the behavior of the injured persons.	Yale Univ, Sch Med, Div Geriatr, Dept Internal Med, New Haven, CT 06504 USA; Hlth Care All, Boston, MA USA; Massachusetts Dept Publ Hlth, Div Hlth Care Qual, Boston, MA USA; Harvard Injury Control Res Ctr, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Yale University; Massachusetts Department of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Leonard, R (corresponding author), Yale Univ, Sch Med, Div Geriatr, Dept Internal Med, 17B Tompkins,20 York St, New Haven, CT 06504 USA.	Ralph.Leonard@yale.edu						Brodaty H, 2001, INT J GERIATR PSYCH, V16, P504, DOI 10.1002/gps.382; BURSTON GR, 1975, BRIT MED J, V3, P592, DOI 10.1136/bmj.3.5983.592-a; Covington H, 2001, Holist Nurs Pract, V15, P59; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; *EX OFF ELD AFF, NURS HOM OMB PROGR; Feldt K S, 1998, J Gerontol Nurs, V24, P14; *GEN ACC OFF, 2002, 02312 GAO PUBL; *GEN ACC OFF, 2002, 02448T GAO PUBL; *GEN ACC OFF, 1999, HEHS9989 GAO PUBL; Gray MJ, 2002, J ANXIETY DISORD, V16, P299, DOI 10.1016/S0887-6185(02)00101-9; *I MED, 1990, MED STRAT QUAL ASS, V1; Ikegami N., 2002, MEASURING IMPROVING; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2001, IMPR QUAL LONG TERM; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Kolanowski A M, 1999, J Neurosci Nurs, V31, P278; Lam LCW, 1997, INT J GERIATR PSYCH, V12, P678, DOI 10.1002/(SICI)1099-1166(199706)12:6<678::AID-GPS610>3.0.CO;2-R; Lang AJ, 2002, DEPRESS ANXIETY, V16, P77, DOI 10.1002/da.10062; LOHR KN, 1990, MED STRATEGY QUALITY, V1; Lou MF, 2001, SCAND J CARING SCI, V15, P165, DOI 10.1046/j.1471-6712.2001.00021.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Morris JN., 2003, VALIDATION LONG TERM; NELSON HW, 1995, GERONTOLOGIST, V35, P509, DOI 10.1093/geront/35.4.509; Nishith P, 2002, BIOL PSYCHIAT, V51, P867, DOI 10.1016/S0006-3223(01)01346-4; PILLEMER K, 1989, GERONTOLOGIST, V29, P314, DOI 10.1093/geront/29.3.314; Price J. D., 2000, COCHRANE DB SYST REV, V4; Rapoport MJ, 2001, INT J GERIATR PSYCH, V16, P123, DOI 10.1002/1099-1166(200102)16:2<123::AID-GPS260>3.0.CO;2-1; Ray WA, 1997, JAMA-J AM MED ASSOC, V278, P557, DOI 10.1001/jama.278.7.557; RUDMAN D, 1993, HOSP COMMUNITY PSYCH, V44, P571; RUDMAN D, 1994, J GEN INTERN MED, V9, P261, DOI 10.1007/BF02599652; Ryden MB, 1999, ARCH PSYCHIAT NURS, V13, P170, DOI 10.1016/S0883-9417(99)80003-X; Schnelle JF, 1996, J AM GERIATR SOC, V44, P507, DOI 10.1111/j.1532-5415.1996.tb01434.x; Shah A, 2000, INT PSYCHOGERIATR, V12, P145, DOI 10.1017/S1041610200006281; TATARA T, 1990, ELDERLY ABUSE US ISS; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1207, DOI 10.1111/j.1532-5415.1995.tb07395.x; Wooldridge JM, 2000, INTRO ECONOMETRICS M	38	84	84	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2004	291	5					591	598		10.1001/jama.291.5.591	http://dx.doi.org/10.1001/jama.291.5.591			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	769LC	14762038	Bronze			2022-12-01	WOS:000188650700024
J	Silaruks, S; Thinkhamrop, B; Kiatchoosakun, S; Wongvipaporn, C; Tatsanavivat, P				Silaruks, S; Thinkhamrop, B; Kiatchoosakun, S; Wongvipaporn, C; Tatsanavivat, P			Resolution of left atrial thrombus after 6 months of anticoagulation in candidates for percutaneous transvenous mitral commissurotomy	ANNALS OF INTERNAL MEDICINE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WARFARIN; MECHANISM; VALVULOPLASTY; STENOSIS; THERAPY; VALVE; TERM	Background: Resolution of left atrial thrombus after long-term oral anticoagulation enhances safe percutaneous transvenous mitral commissurotomy (PTMC); however, the short-term benefit has not been defined. Objectives: To estimate the resolution rate of left atrial thrombus among PTMC candidates after 6 months of oral anticoagulation and to determine its main predictors. Design: Prospective cohort. Setting: Community-based university medical center. Patients: 219 PTMC candidates with thrombus demonstrated by multiplane transesophageal echocardiographic studies. Measurements: The primary,outcome was the status of the thrombus at the first 6-month follow-up; secondary measures were bleeding or thromboembolic complications. Results: Among 219 PTMC candidates with left atrial thrombus (mean age [+/-SD], 39.6 +/- 7.4 years [range, 19 to 62 years]), complete resolution of thrombus, with an overall disappearance rate of 24.2% (95% CI, 18.5% to 29.9%), was demonstrated in 53 patients who subsequently underwent successful PTMC. In another 166 patients, the thrombus size was reduced by 24% (P < 0.001). No thrombus resolution was observed in the 27 patients with a left atrial body thrombus. Eighteen patients had minor bleeding. The significant predictors of thrombus resolution were a New York Heart Association class of 2 or less, a left atrial appendage thrombus size of 1.6 cm(2) or less, a left atrial spontaneous echocardiographic contrast grade of 1 or less, and an international normalized ratio (INR) of at least 2.5. Patients with all of these predictors had a 94.4% chance of complete thrombus resolution (CI, 84.4% to 98.1%). Conclusions: After 6 months of oral anticoagulation, the left atrial thrombus disappeared in about a quarter of PTMC candidates so they could safely undergo PTMC. Less clinical severity, lower grading of the left atrial spontaneous echocardiographic contrast, a smaller thrombus, and a higher INR level predict thrombus resolution.	Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen 40002, Thailand	Khon Kaen University	Silaruks, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen 40002, Thailand.	sonsil@kku.ac.th	Silaruks, Songkwan/AAB-4166-2022					[Anonymous], 1998, Br J Haematol, V101, P374; CHEN CR, 1992, AM J CARDIOL, V70, P1445, DOI 10.1016/0002-9149(92)90297-C; *CRIT COMM NEW YOR, 1994, NOM CRIT DIAGN, P143; FATKIN D, 1994, J AM COLL CARDIOL, V23, P307, DOI 10.1016/0735-1097(94)90412-X; FEIGENBAUM H, 1986, ECHOCARDIOGR-J CARD, P592; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Hosmer D.W., 2000, WILEY PS TX, DOI 10.1002/0471722146; HUNG JS, 1991, AM J CARDIOL, V67, P854, DOI 10.1016/0002-9149(91)90619-V; HUNG JS, 1989, AM J CARDIOL, V64, P126; Kang DH, 1998, AM J CARDIOL, V81, P97, DOI 10.1016/S0002-9149(97)00858-8; KLEINBAUM DG, 1998, APPL REGRESSION ANAL, P330; Lin SL, 1999, CARDIOLOGY, V92, P145, DOI 10.1159/000006963; PALACIOS IF, 1989, CIRCULATION, V79, P573, DOI 10.1161/01.CIR.79.3.573; PYTLEWSKI G, 1994, AM HEART J, V128, P843, DOI 10.1016/0002-8703(94)90290-9; Silaruks S, 2002, J HEART VALVE DIS, V11, P346; Silaruks S, 2002, J AM COLL CARDIOL, V39, P886, DOI 10.1016/S0735-1097(02)01686-8; SOLOMON RE, 1992, CIRCULATION, V85, P448; TSAI LM, 1991, AM HEART J, V121, P1232, DOI 10.1016/0002-8703(91)90688-E; WILKINS GT, 1988, BRIT HEART J, V60, P299	20	14	19	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2004	140	2					101	105		10.7326/0003-4819-140-2-200401200-00010	http://dx.doi.org/10.7326/0003-4819-140-2-200401200-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764MY	14734332				2022-12-01	WOS:000188211700004
J	Pathan, N; Hemingway, CA; Alizadeh, AA; Stephens, AC; Boldrick, JC; Oragui, EE; McCabe, C; Welch, SB; Whitney, A; O'Gara, P; Nadel, S; Relman, DA; Harding, SE; Levin, M				Pathan, N; Hemingway, CA; Alizadeh, AA; Stephens, AC; Boldrick, JC; Oragui, EE; McCabe, C; Welch, SB; Whitney, A; O'Gara, P; Nadel, S; Relman, DA; Harding, SE; Levin, M			Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock	LANCET			English	Article							ADHESION MOLECULE EXPRESSION; INCREASING PROTEIN RBPI(21); NITRIC-OXIDE; PROINFLAMMATORY CYTOKINES; NEISSERIA-MENINGITIDIS; DEPRESSANT FACTOR; PLASMA-LEVELS; IN-VITRO; CHILDREN; SEVERITY	Background Myocardial failure has a central role in the complex pathophysiology of septic shock and contributes to organ failure and death. During the sepsis-induced inflammatory process, specific factors are released that depress myocardial contractile function. We aimed to identify these mediators of myocardial depression in meningococcal septic shock. Methods We combined gene-expression profiling with protein and cellular methods to identify a serum factor causing cardiac dysfunction in meningococcal septic shock. We identified genes that were significantly upregulated in blood after exposure to meningococci. We then selected for further analysis those genes whose protein products had properties of a myocardial depressant factor-specifically a 12-25 kDa heat-stable protein that is released into serum shortly after onset of meningococcal infection. Findings We identified 174 significantly upregulated genes in meningococcus-infected blood: six encoded proteins that were of the predicted size and had characteristics of a myocardial depressant factor. Of these, interleukin 6 caused significant myocardial depression in vitro. Removal of interleukin 6 from serum samples of patients with meningococcaemia and from supernatants of inflammatory cells stimulated by meningococci in vitro abolished the negative inotropic activity. Furthermore, concentrations in serum of interleukin 6 strongly predicted degree of myocardial dysfunction and severity of disease in children with meningococcal septic shock. Interpretation Interleukin 6 is a mediator of myocardial depression in meningococcal disease. This cytokine and its downstream mediators could be a target for future treatment strategies.	Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiac Med, London, England; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Imperial College London; Imperial College London; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Pathan, N (corresponding author), St Marys Hosp, Imperial Coll Sch Med, Dept Paediat, 2nd Floor,Med Sch Bldg, London W2 1PG, England.	n.pathan@imperial.ac.uk	Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Harding, Sian/0000-0002-3651-6354; Relman, David A./0000-0001-8331-1354; Levin, Michael/0000-0003-2767-6919; Pathan, Nazima/0000-0001-7656-9453				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], STANFORD MICROARRAY; BALLIGAND JL, 1993, J CLIN INVEST, V91, P2314, DOI 10.1172/JCI116461; BENNASSAYAG C, 1984, EUR J CLIN INVEST, V14, P288; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chan B, 1996, BIOTHERAPY, V9, P221, DOI 10.1007/BF02620735; EISEN M, MICROARRAYS ORG SOFT; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; GARDLUND B, 1995, J INFECT DIS, V172, P296, DOI 10.1093/infdis/172.1.296; Geppert A, 2002, CRIT CARE MED, V30, P1987, DOI 10.1097/00003246-200209000-00007; HAZELZET JA, 1994, INTENS CARE MED, V20, P371, DOI 10.1007/BF01720912; Hazelzet JA, 1996, THROMB HAEMOSTASIS, V76, P932; Heyderman RS, 1999, J INFECT DIS, V179, P1288, DOI 10.1086/314706; Hovels-Gurich HH, 2002, J THORAC CARDIOV SUR, V124, P811, DOI 10.1067/mtc.2002.122308; KINUGAWA K, 1994, CIRC RES, V75, P285, DOI 10.1161/01.RES.75.2.285; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; LIU CL, DATA PROCESSING TIME; MERCIER JC, 1988, CRIT CARE MED, V16, P27, DOI 10.1097/00003246-198801000-00006; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; Pathan N, 2002, CRIT CARE MED, V30, P2191, DOI 10.1097/00003246-200210000-00003; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; SAGHER U, 1986, CIRC SHOCK, V19, P319; Sugishita K, 1999, J MOL CELL CARDIOL, V31, P1457, DOI 10.1006/jmcc.1999.0989; THALINGE.AR, 1971, P SOC EXP BIOL MED, V136, P354; VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546	28	214	237	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 17	2004	363	9404					203	209		10.1016/S0140-6736(03)15326-3	http://dx.doi.org/10.1016/S0140-6736(03)15326-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765AG	14738793	Green Submitted			2022-12-01	WOS:000188243900010
J	Cheng, Z; Menees, TM				Cheng, Z; Menees, TM			RNA branching and debranching in the yeast retrovirus-like element Ty1	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; REVERSE TRANSCRIPTION; MESSENGER-RNA; ENDS; RETROTRANSPOSITION; AMPLIFICATION; GENOME; ENZYME	Ty elements of Saccharomyces cerevisiae are long terminal repeat (LTR) retroelements related to retroviruses. Normal levels of Ty1 transposition require Dbr1p, a cellular enzyme that cleaves 2'-5' RNA bonds. We show that Ty1 RNAs lacking identifiable 5' ends accumulate in virus-like particles (VLPs) in dbr1 mutants. Debranching this RNA in vitro with Dbr1p creates an uncapped version of the normal Ty1 RNA 5' end. We show that the 5' nucleotide (nt) of Ty1 RNA forms a 2'-5' bond with a nt near the 3' end of the same RNA, creating a lariat. The properties of the lariat suggest it forms by a novel mechanism and that branching and debranching may play roles in Ty1 reverse transcription at the minus-strand transfer step.	Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Menees, TM (corresponding author), Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA.							Berkhout B, 2002, J BIOL CHEM, V277, P19967, DOI 10.1074/jbc.M200950200; Boeke J. D., 1997, P343; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Cheng Z., UNPUB; Cristofari G, 2002, EMBO J, V21, P4368, DOI 10.1093/emboj/cdf436; ELDER RT, 1983, P NATL ACAD SCI-BIOL, V80, P2432, DOI 10.1073/pnas.80.9.2432; Frohman Michael A., 1995, P381; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Karst SM, 2000, BIOCHEM BIOPH RES CO, V268, P112, DOI 10.1006/bbrc.1999.2048; LORSCH JR, 1995, NUCLEIC ACIDS RES, V23, P2811, DOI 10.1093/nar/23.15.2811; MARUYAMA K, 1994, GENE, V138, P171; Mosch HU, 1997, GENETICS, V145, P671; Mules EH, 1998, J VIROL, V72, P6490, DOI 10.1128/JVI.72.8.6490-6503.1998; Ooi SL, 2001, METHOD ENZYMOL, V342, P233, DOI 10.1016/S0076-6879(01)42548-1; Salem LA, 2003, J VIROL, V77, P12795, DOI 10.1128/JVI.77.23.12795-12806.2003; Sandmeyer S.B., 2002, MOBILE DNA-UK, P663; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Vogel J, 1997, NUCLEIC ACIDS RES, V25, P2030, DOI 10.1093/nar/25.10.2030; VOLLOCH V, 1994, NUCLEIC ACIDS RES, V22, P2507, DOI 10.1093/nar/22.13.2507; Voytas DF, 2002, MOBILE DNA, P631, DOI DOI 10.1128/9781555817954.CH26	22	46	47	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					240	243		10.1126/science.1087023	http://dx.doi.org/10.1126/science.1087023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716018				2022-12-01	WOS:000187908500052
J	Bekker, A; Holland, HD; Wang, PL; Rumble, D; Stein, HJ; Hannah, JL; Coetzee, LL; Beukes, NJ				Bekker, A; Holland, HD; Wang, PL; Rumble, D; Stein, HJ; Hannah, JL; Coetzee, LL; Beukes, NJ			Dating the rise of atmospheric oxygen	NATURE			English	Article							MASS-INDEPENDENT SULFUR; TIMEBALL HILL FORMATION; SOUTH-AFRICA; TRANSVAAL SUPERGROUP; ARCHEAN ATMOSPHERE; IRON-FORMATION; AUSTRALIA; BASIN; FRACTIONATION; MICROPROBE	Several lines of geological and geochemical evidence indicate that the level of atmospheric oxygen was extremely low before 2.45 billion years (Gyr) ago, and that it had reached considerable levels by 2.22 Gyr ago. Here we present evidence that the rise of atmospheric oxygen had occurred by 2.32 Gyr ago. We found that syngenetic pyrite is present in organic-rich shales of the 2.32-Gyr-old Rooihoogte and Timeball Hill formations, South Africa. The range of the isotopic composition of sulphur in this pyrite is large and shows no evidence of mass-independent fractionation, indicating that atmospheric oxygen was present at significant levels ( that is, greater than 10(-5) times that of the present atmospheric level) during the deposition of these units. The presence of rounded pebbles of sideritic iron formation at the base of the Rooihoogte Formation and an extensive and thick ironstone layer consisting of haematitic pisolites and oolites in the upper Timeball Hill Formation indicate that atmospheric oxygen rose significantly, perhaps for the first time, during the deposition of the Rooihoogte and Timeball Hill formations. These units were deposited between what are probably the second and third of the three Palaeoproterozoic glacial events.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; Colorado State Univ, Dept Geosci, AIRIE Program, Ft Collins, CO 80523 USA; Rand Afrikaans Univ, Dept Geol, ZA-2006 Johannesburg, South Africa	Harvard University; Carnegie Institution for Science; Colorado State University; University of Johannesburg	Bekker, A (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	abekker@fas.harvard.edu	Rumble, Douglas/AAU-3930-2020; Hannah, Judith/AAE-5212-2020	Rumble, Douglas/0000-0002-7440-9189; WANG, PEI-LING/0000-0002-4392-3935; Bekker, Andrey/0000-0002-1154-0585				BAU M, 1998, MINERAL MAG A, V62, P127, DOI DOI 10.1180/MINMAG.1998.62A.1.67; Bekker A, 2001, AM J SCI, V301, P261, DOI 10.2475/ajs.301.3.261; BEKKER A, 2000, GEOL SOC AM ABSTR, V32, pA135; BEUKES NJ, 1990, PRECAMBRIAN RES, V47, P99, DOI 10.1016/0301-9268(90)90033-M; BEUKES NJ, 2002, GEOL SOC AM ABSTR, V34, P283; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; Chandler F.W., 1980, CAN GEOL SURV B, V311; Chandler FW., 1988, CARBONATE EVAPORITE, V3, P75, DOI 10.1007/BF03174414; CLEMMEY H, 1982, GEOLOGY, V10, P141, DOI 10.1130/0091-7613(1982)10<141:OITPAA>2.0.CO;2; Coetzee L.L., 2001, THESIS RAND AFRIKAAN; DIMROTH E, 1976, CAN J EARTH SCI, V13, P1161, DOI 10.1139/e76-119; El Tabakh M, 1999, GEOLOGY, V27, P871, DOI 10.1130/0091-7613(1999)027<0871:PAEMIW>2.3.CO;2; England GL, 2002, SEDIMENTOLOGY, V49, P1133, DOI 10.1046/j.1365-3091.2002.00479.x; ERIKSSON KA, 1973, J SEDIMENT PETROL, V43, P1046; Eriksson PG, 1998, SEDIMENT GEOL, V120, P319, DOI 10.1016/S0037-0738(98)00038-4; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Farquhar J., 2001, J GEOPHYS RES, V106, P1; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HANNAH JL, 2003, GEOCHIMICA COSMOCHIM, V67, pA34; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Hu GX, 2003, GEOCHIM COSMOCHIM AC, V67, P3101, DOI 10.1016/S0016-7037(02)00929-8; Klein C, 1992, PROTEROZOIC BIOSPHER, P147; MACGREGOR AM, 1927, S AFR J SCI, V23, P155; MARTINI JEJ, 1976, ECON GEOL, V71, P625, DOI 10.2113/gsecongeo.71.3.625; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Ohmoto H, 1996, GEOLOGY, V24, P1135, DOI 10.1130/0091-7613(1996)024<1135:EIPGPF>2.3.CO;2; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; PHILLIPS GN, 1987, GEOLOGY, V15, P1027, DOI 10.1130/0091-7613(1987)15<1027:PWTPMF>2.0.CO;2; Pickard AL, 2003, PRECAMBRIAN RES, V125, P275, DOI 10.1016/S0301-9268(03)00113-X; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; ROMERO AB, 2002, EOS S, V83, DOI UNSP B71A-0731; Roscoe S.M., 1996, GEOLOGY CANADIAN MIN, P10; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schieber J, 1999, PALAIOS, V14, P3, DOI 10.2307/3515357; Schweigart H., 1965, ECON GEOL, V60, P269; STRAUSS H, 2002, PRECAMBRIAN SEDIMENT, P67; Visser J.N.J., 1981, EARTHS PREPLEISTOCEN, P180; VISSER JNJ, 1971, ANN GEOLOGICAL SURVE, V9, P115; Wing BA, 2002, GEOCHIM COSMOCHIM AC, V66, pA840; YANG W, 2002, GEOL SOC AM ABSTR, V34, P381	44	930	991	15	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 8	2004	427	6970					117	120		10.1038/nature02260	http://dx.doi.org/10.1038/nature02260			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712267				2022-12-01	WOS:000187863900026
J	Hanashima, C; Li, SC; Shen, LJ; Lai, ES; Fishell, G				Hanashima, C; Li, SC; Shen, LJ; Lai, ES; Fishell, G			Foxg1 suppresses early cortical cell fate	SCIENCE			English	Article							CAJAL-RETZIUS CELLS; HELIX TRANSCRIPTION FACTOR; CEREBRAL-CORTEX; DEVELOPING NEOCORTEX; PROGENITOR CELLS; MESSENGER-RNA; RAT; EXPRESSION; PROTEIN; NEURONS	During mammalian cerebral corticogenesis, progenitor cells become progressively restricted in the types of neurons they can produce. The molecular mechanism that determines earlier versus later born neuron fate is unknown. We demonstrate here that the generation of the earliest born neurons, the Cajal-Retzius cells, is suppressed by the telencephalic transcription factor Foxg1. In Foxg1 null mutants, we observed an excess of Cajal-Retzius neuron production in the cortex. By conditionally inactivating Foxg1 in cortical progenitors that normally produce deep-layer cortical neurons, we demonstrate that Foxg1 is constitutively required to suppress Cajal-Retzius cell fate. Hence, the competence to generate the earliest born neurons during later cortical development is actively suppressed but not lost.	NYU, Med Ctr, Dev Genet Program, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA	New York University; New York University; Memorial Sloan Kettering Cancer Center; Cornell University	Lai, ES (corresponding author), NYU, Med Ctr, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	eseng_lai@merck.com; fishell@saturn.med.nyu.edu		Fishell, Gordon/0000-0002-9640-9278	NEI NIH HHS [EY11124] Funding Source: Medline; NICHD NIH HHS [HD29584] Funding Source: Medline; NINDS NIH HHS [NS32993, NS39007] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD029584, R01HD029584] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007, R01NS032993] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Brody T, 2002, DEVELOPMENT, V129, P3763; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Desai AR, 2000, DEVELOPMENT, V127, P2863; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; LI J, 1995, CANCER RES, V55, P5540; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Meyer G, 1998, J COMP NEUROL, V397, P493; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stumm RK, 2003, J NEUROSCI, V23, P5123; Sumi Y, 2002, NEUROSCI LETT, V320, P13, DOI 10.1016/S0304-3940(02)00011-3; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Valcanis H, 2003, J NEUROSCI, V23, P5113; WEISENHORN DMV, 1994, DEV BRAIN RES, V82, P293; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7	33	287	296	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					56	59		10.1126/science.1090674	http://dx.doi.org/10.1126/science.1090674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704420				2022-12-01	WOS:000187710600029
J	Abbott, A				Abbott, A			Neuroscience - Genomics on the brain	NATURE			English	News Item																		Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					757	757		10.1038/426757a	http://dx.doi.org/10.1038/426757a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685199	Bronze			2022-12-01	WOS:000187342000020
J	Hanada, K; Kumagai, K; Yasuda, S; Miura, Y; Kawano, M; Fukasawa, M; Nishijima, M				Hanada, K; Kumagai, K; Yasuda, S; Miura, Y; Kawano, M; Fukasawa, M; Nishijima, M			Molecular machinery for non-vesicular trafficking of ceramide	NATURE			English	Article							ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; SPHINGOMYELIN SYNTHESIS; BINDING PROTEIN; TRANSPORT; STAR; IDENTIFICATION; PHOSPHORYLATES; ACCUMULATION; RESISTANT	Synthesis and sorting of lipids are essential for membrane biogenesis; however, the mechanisms underlying the transport of membrane lipids remain little understood. Ceramide is synthesized at the endoplasmic reticulum and translocated to the Golgi compartment for conversion to sphingomyelin. The main pathway of ceramide transport to the Golgi is genetically impaired in a mammalian mutant cell line, LY-A. Here we identify CERT as the factor defective in LY-A cells. CERT, which is identical to a splicing variant of Goodpasture antigen-binding protein, is a cytoplasmic protein with a phosphatidylinositol-4-monophosphate- binding (PtdIns4P) domain and a putative domain for catalysing lipid transfer. In vitro assays show that this lipid-transfer-catalysing domain specifically extracts ceramide from phospholipid bilayers. CERT expressed in LY-A cells has an amino acid substitution that destroys its PtdIns4P-binding activity, thereby impairing its Golgi-targeting function. We conclude that CERT mediates the intracellular trafficking of ceramide in a non-vesicular manner.	Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hanak@nih.go.jp	Kumagai, Keigo/AAG-1385-2021	Hanada, Kentaro/0000-0003-1383-2781; YASUDA, Satoshi/0000-0002-1011-0815; Kumagai, Keigo/0000-0002-1663-2905; KAWANO-KAWADA, Miyuki/0000-0002-1168-9291				AKEROYD R, 1981, EUR J BIOCHEM, V114, P385, DOI 10.1111/j.1432-1033.1981.tb05158.x; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KASPER AM, 1981, BIOCHIM BIOPHYS ACTA, V664, P22, DOI 10.1016/0005-2760(81)90025-4; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Simon CG, 1999, BIOCHEMISTRY-US, V38, P14676, DOI 10.1021/bi991537w; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; VOELKER DR, 2002, BIOCH LIPIDS LIPOPRO, P449; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	40	780	802	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					803	809		10.1038/nature02188	http://dx.doi.org/10.1038/nature02188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685229				2022-12-01	WOS:000187342000048
J	Finger, C				Finger, C			Health care in indigenous populations: The Xingu Indian park	LANCET			English	Article											Finger, C (corresponding author), R Pascoat Vita 405,Apt 83, BR-05445000 Sao Paulo, Brazil.								0	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S38	S39		10.1016/S0140-6736(03)15070-2	http://dx.doi.org/10.1016/S0140-6736(03)15070-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698124				2022-12-01	WOS:000187790200020
J	Solforosi, L; Criado, JR; McGavern, DB; Wirz, S; Sanchez-Alavez, M; Sugama, S; DeGiorgio, LA; Volpe, BT; Wiseman, E; Abalos, G; Masliah, E; Gilden, D; Oldstone, MB; Conti, B; Williamson, RA				Solforosi, L; Criado, JR; McGavern, DB; Wirz, S; Sanchez-Alavez, M; Sugama, S; DeGiorgio, LA; Volpe, BT; Wiseman, E; Abalos, G; Masliah, E; Gilden, D; Oldstone, MB; Conti, B; Williamson, RA			Cross-linking cellular prion protein triggers neuronal apoptosis in vivo	SCIENCE			English	Article							DISEASE; ANTIBODIES; EXPRESSION	Neuronal death is a prominent, but poorly understood, pathological hallmark of prion disease. Notably, in the absence of the cellular prion protein (PrPC), the disease-associated isoform, PrPSc, appears not to be intrinsically neurotoxic, suggesting that PrPC itself may participate directly in the prion neurodegenerative cascade. Here, cross-linking PrPC in vivo with specific monoclonal antibodies was found to trigger rapid and extensive apoptosis in hippocampal and cerebellar neurons. These findings suggest that PrPC functions in the control of neuronal survival and provides a model to explore whether cross-linking of PrPC by oligomeric PrPSc can promote neuronal loss during prion infection.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Harold Dorris Neurol Res Ctr, La Jolla, CA 92037 USA; Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92037 USA; Univ Colorado, Dept Neurol, Denver, CO 80262 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Cornell University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Denver	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	anthony@scripps.edu	McGavern, Dorian/HCH-3601-2022; volpe, b/U-8409-2019	McGavern, Dorian/0000-0001-9568-545X; Volpe, Bruce/0000-0002-1098-1848; Sanchez-Alavez, Manuel/0000-0002-8164-8452; Conti, Bruno/0000-0002-9185-5201	NHLBI NIH HHS [HL63817] Funding Source: Medline; NIAID NIH HHS [AI09484] Funding Source: Medline; NIA NIH HHS [AG00080, AG04342] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009484, R01AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BURTON DR, 1987, MOL GENETICS IMMUNOG; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Farkas I, 2003, J IMMUNOL, V170, P5764, DOI 10.4049/jimmunol.170.11.5764; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Yu JX, 2002, J NEUROIMMUNOL, V123, P91, DOI 10.1016/S0165-5728(01)00483-0	14	284	300	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1514	1516		10.1126/science.1094273	http://dx.doi.org/10.1126/science.1094273			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	14752167				2022-12-01	WOS:000220000100041
J	Tomita, S; Fukata, M; Nicoll, RA; Bredt, DS				Tomita, S; Fukata, M; Nicoll, RA; Bredt, DS			Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses	SCIENCE			English	Article							SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; MOUSE STARGAZER; PHOSPHORYLATION; MECHANISMS; PSD-95; PROTEINS; INTERNALIZATION; TRANSMISSION; ACTIVATION	Activity-dependent plasticity in the brain arises in part from changes in the number of synaptic AMPA receptors. Synaptic trafficking of AMPA receptors is controlled by stargazin and homologous transmembrane AMPA receptor regulatory proteins (TARPs). We found that TARPs were stable at the plasma membrane, whereas AMPA receptors were internalized in a glutamate-regulated manner. Interaction with AMPA receptors involved both extra- and intracellular determinants of TARPs. Upon binding to glutamate, AMPA receptors detached from TARPs. This did not require ion flux or intracellular second messengers. This allosteric mechanism for AMPA receptor dissociation from TARPs may participate in glutamate-mediated internalization of receptors in synaptic plasticity.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	bredt@itsa.ucsf.edu	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806				Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Ziff EB, 1999, ANN NY ACAD SCI, V868, P465, DOI 10.1111/j.1749-6632.1999.tb11315.x	27	172	177	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1508	1511		10.1126/science.1090262	http://dx.doi.org/10.1126/science.1090262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001777				2022-12-01	WOS:000220000100039
J	Sumner, S; Hughes, WOH; Pedersen, JS; Boomsma, JJ				Sumner, S; Hughes, WOH; Pedersen, JS; Boomsma, JJ			Ant parasite queens revert to mating singly	NATURE			English	Editorial Material							SOCIAL HYMENOPTERA; TRANSITION; EVOLUTION; NUMBER		Univ Copenhagen, Dept Populat Biol, Inst Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen	Sumner, S (corresponding author), Smithsonian Trop Res Inst, Unit 0948, APO, AA 34002 USA.	jjboomsma@zi.ku.dk	Sumner, Seirian/E-6611-2011; Pedersen, Jes Søe/J-6337-2014; Boomsma, Jacobus J/M-2785-2014; Hughes, William OH/A-6957-2014	Pedersen, Jes Søe/0000-0002-4439-2638; Boomsma, Jacobus J/0000-0002-3598-1609; Hughes, William OH/0000-0003-0951-9768; Sumner, Seirian/0000-0003-0213-2018				Bekkevold D, 2000, J EVOLUTION BIOL, V13, P615, DOI 10.1046/j.1420-9101.2000.00201.x; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; Ortius-Lechner D, 2000, MOL ECOL, V9, P114, DOI 10.1046/j.1365-294x.2000.00764-5.x; Pedersen JS, 1999, MOL ECOL, V8, P577, DOI 10.1046/j.1365-294x.1999.00573.x; Simmons L.W., 2001, MG BEH ECOL; Sumner S, 2004, INSECT SOC, V51, P37, DOI 10.1007/s00040-003-0723-z; Sumner S, 2003, BEHAV ECOL SOCIOBIOL, V54, P256, DOI 10.1007/s00265-003-0633-0; Sumner S, 2003, P ROY SOC B-BIOL SCI, V270, P1315, DOI 10.1098/rspb.2003.2362; Villesen P, 2002, P ROY SOC B-BIOL SCI, V269, P1541, DOI 10.1098/rspb.2002.2044; Villesen P, 2002, MOL ECOL NOTES, V2, P320, DOI 10.1046/j.1471-8286.2002.00229.x	11	74	76	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					35	36		10.1038/428035a	http://dx.doi.org/10.1038/428035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999273				2022-12-01	WOS:000189363800026
J	Wertz, IE; O'Rourke, KM; Zhang, ZM; Dornan, D; Arnott, D; Deshaies, RJ; Dixit, VM				Wertz, IE; O'Rourke, KM; Zhang, ZM; Dornan, D; Arnott, D; Deshaies, RJ; Dixit, VM			Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase	SCIENCE			English	Article							COP9 SIGNALOSOME; GENE-EXPRESSION; ARABIDOPSIS; PHOTOMORPHOGENESIS; DEGRADATION; PROTEIN-1; INTERACTS; MOTIF; SCF	Arabidopsis thaliana De-etiolated-1 (AtDET1) is a highly conserved protein, with orthologs in vertebrate and invertebrate organisms. AtDET1 negatively regulates photomorphogenesis, but its biochemical mechanism and function in other species are unknown. We report that human DET1 (hDET1) promotes ubiquitination and degradation of the proto-oncogenic transcription factor c-Jun by assembling a multisubunit ubiquitin ligase containing DNA Damage Binding Protein-1 (DDB1), cullin 4A (CUL4A), Regulator of Cullins-1 (ROC1), and constitutively photomorphogenic-1. Ablation of any subunit by RNA interference stabilized c-Jun and increased c-Jun-activated transcription. These findings characterize a c-Jun ubiquitin ligase and define a specific function for hDET1 in mammalian cells.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Davis; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012; Deshaies, Raymond/B-8354-2014	dixit, vishva m/0000-0001-6983-0326; Deshaies, Raymond/0000-0002-3671-9354	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Hu JP, 2002, SCIENCE, V297, P405, DOI 10.1126/science.1073633; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; PEPPER A, 1994, CELL, V78, P109, DOI 10.1016/0092-8674(94)90577-0; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yi CL, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-30	25	292	304	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1371	1374		10.1126/science.1093549	http://dx.doi.org/10.1126/science.1093549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14739464				2022-12-01	WOS:000189238600052
J	Masip, L; Pan, JL; Haldar, S; Penner-Hahn, JE; DeLisa, MP; Georgiou, G; Bardwell, JCA; Collet, JF				Masip, L; Pan, JL; Haldar, S; Penner-Hahn, JE; DeLisa, MP; Georgiou, G; Bardwell, JCA; Collet, JF			An engineered pathway for the formation of protein disulfide bonds	SCIENCE			English	Article							IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; THIOREDOXIN; DESIGN	We have engineered a pathway for the formation of disulfide bonds. By imposing evolutionary pressure, we isolated mutations that changed thioredoxin, which is a monomeric disulfide reductase, into a [2Fe-2S] bridged dimer capable of catalyzing O-2-dependent sulfhydryl oxidation in vitro. Expression of the mutant protein in Escherichia coli with oxidizing cytoplasm and secretion via the Tat pathway restored disulfide bond formation in strains that lacked the complete periplasmic oxidative machinery (DsbA and DsbB). The evolution of [2Fe-2S] thioredoxin illustrates how mutations within an existing scaffold can add a cofactor and markedly change protein function.	Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA; Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Georgiou, G (corresponding author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu; jbardwel@umich.edu	Masip, Lluis/F-9919-2015; DeLisa, Matthew/AAE-7361-2019; Penner-Hahn, James/GYD-3750-2022; Collet, Jean Francois/F-2105-2010	Masip, Lluis/0000-0002-3938-4633; Penner-Hahn, James/0000-0003-0314-1274; DeLisa, Matthew/0000-0003-3226-1566; Collet, Jean-Francois/0000-0001-8069-7036	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038047, R01GM055090, R01GM064662, R29GM038047, R01GM057039] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR01633] Funding Source: Medline; NIGMS NIH HHS [GM-57039, GM-55090, GM-38047, GM-64662] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benson DE, 1998, BIOCHEMISTRY-US, V37, P7070, DOI 10.1021/bi980583d; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; JANOLINO VG, 1975, J BIOL CHEM, V250, P2532; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Lippard S.J, 1994, PRINCIPLES BIOINORGA, P115; MASIP L, UNPUB; Meyer J, 2001, FEBS LETT, V509, P1, DOI 10.1016/S0014-5793(01)03049-6; Mossner E, 1998, PROTEIN SCI, V7, P1233; Moulis JM, 1996, J BIOL INORG CHEM, V1, P2, DOI 10.1007/s007750050017; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Staples CR, 1996, BIOCHEMISTRY-US, V35, P11425, DOI 10.1021/bi961007p; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; [No title captured]	22	68	75	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1185	1189		10.1126/science.1092612	http://dx.doi.org/10.1126/science.1092612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976313				2022-12-01	WOS:000189074700044
J	Ozbudak, EM; Thattai, M; Lim, HN; Shraiman, BI; van Oudenaarden, A				Ozbudak, EM; Thattai, M; Lim, HN; Shraiman, BI; van Oudenaarden, A			Multistability in the lactose utilization network of Escherichia coli	NATURE			English	Article							POSITIVE FEEDBACK; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; TOGGLE SWITCH; SYSTEMS; BISTABILITY; REPRESSION; HYSTERESIS; BINARY	Multistability, the capacity to achieve multiple internal states in response to a single set of external inputs, is the defining characteristic of a switch. Biological switches are essential for the determination of cell fate in multicellular organisms(1), the regulation of cell-cycle oscillations during mitosis(2,3) and the maintenance of epigenetic traits in microbes(4). The multistability of several natural(1-6) and synthetic(7-9) systems has been attributed to positive feedback loops in their regulatory networks(10). However, feedback alone does not guarantee multistability. The phase diagram of a multistable system, a concise description of internal states as key parameters are varied, reveals the conditions required to produce a functional switch(11,12). Here we present the phase diagram of the bistable lactose utilization network of Escherichia coli(13). We use this phase diagram, coupled with a mathematical model of the network, to quantitatively investigate processes such as sugar uptake and transcriptional regulation in vivo. We then show how the hysteretic response of the wildtype system can be converted to an ultrasensitive graded response(14,15). The phase diagram thus serves as a sensitive probe of molecular interactions and as a powerful tool for rational network design.	MIT, Dept Phys, Cambridge, MA 02139 USA; Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; Rutgers State Univ, BioMAPS Inst, Piscataway, NJ 08854 USA	Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick; Rutgers State University New Brunswick	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Ozbudak, Ertugrul/0000-0003-2858-4696				Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blauwkamp TA, 2002, MOL MICROBIOL, V46, P203, DOI 10.1046/j.1365-2958.2002.03153.x; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Chung JD, 1996, CHEM ENG SCI, V51, P1509, DOI 10.1016/0009-2509(95)00306-1; COHN M, 1959, J BACTERIOL, V78, P601, DOI 10.1128/JB.78.5.601-612.1959; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; LOUIS M, SCI STKE; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Ma S. K., 1976, MODERN THEORY CRITIC; Muller-Hill B, 1996, LAC OPERON SHORT HIS, V1st; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Strogatz S. H, 1994, NONLINEAR DYNAMICS C, V1st; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Thattai M, 2003, BIOPHYS J, V85, P744, DOI 10.1016/S0006-3495(03)74517-2; Tyson J., 1978, PROG THEOR BIOL, V5, P1	30	734	746	4	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					737	740		10.1038/nature02298	http://dx.doi.org/10.1038/nature02298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973486				2022-12-01	WOS:000189026000044
J	Jiang, R; Manson, JE; Meigs, JB; Ma, J; Rifai, N; Hu, FB				Jiang, R; Manson, JE; Meigs, JB; Ma, J; Rifai, N; Hu, FB			Body iron stores in relation to risk of type 2 diabetes in apparently healthy women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERUM FERRITIN; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MELLITUS; HYPERINSULINEMIA; REPRODUCIBILITY; VALIDITY	Context Type 2 diabetes is a common manifestation of hemochromatosis, a disease of iron overload. However, it is not clear whether higher iron stores predict the development of type 2 diabetes in a healthy population. Objective To examine plasma ferritin concentration and the ratio of the concentrations of transferrin receptors to ferritin in relation to risk of type 2 diabetes. Design, Setting, and Participants Prospective nested case-control study within the Nurses' Health Study cohort. Of the 32826 women who provided blood samples during 1989-1990 and were free of diagnosed diabetes, cardiovascular disease, and cancer, 698 developed diabetes during 10 years of follow-up. The controls (n=716) were matched to cases on age, race, and fasting status; and on body mass index (BMI) for cases in the top BMI decile. Main Outcome Measure Incident cases of type 2 diabetes. Results Among cases, the mean (SD) concentration of ferritin was significantly higher (109 [1051 vs 71.5 [68.7] ng/mL for controls; P<.001 for difference) and the mean (SD) ratio of transferrin receptors to ferritin was significantly lower (102 [205] vs 141 [340], respectively; P=.01). In conditional logistic regression stratified on the matching factors and controlled for BMI and other diabetes risk factors, the multivariate relative risks [RRs] of incident type 2 diabetes across increasing quintiles of ferritin were 1.00, 1.09 (95% confidence interval [CI], 0.70-1.70),1.26 (95% Cl, 0.82-1.95),1.30 (95% Cl, 0.83-2.04), and 2.68 (95% Cl, 1.75-4.11) (P<.001 for trend). The RRs across increasing quintiles of transferrin receptors to ferritin ratio were 2.44 (95% Cl, 1.61-3.71), 1.00 (95% Cl, 0.64-1.56),1.13 (95% Cl, 0.73-1.74), 0.99 (95% Cl, 0.64-1.53), and 1.00 (P=.01 for trend). Further adjustment for an inflammatory marker (C-reactive protein) did not change the results appreciably. The associations persisted within strata defined by levels of BMI, menopausal status, alcohol consumption, and C-reactive protein. Conclusion Higher iron stores (reflected by an elevated ferritin concentration and a lower ratio of transferrin receptors to ferritin) are associated with an increased risk of type 2 diabetes in healthy women independent of known diabetes risk factors.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; Channing Labs, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Childrens Hosp, Med Ctr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Jiang, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	rjiang@hsph.harvard.edu	Meigs, James/P-3927-2019; Hu, Frank/C-1919-2013	Meigs, James/0000-0002-2439-2657; 	NATIONAL CANCER INSTITUTE [P01CA087969, R29CA078293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969, CA78293] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; CUTLER P, 1989, DIABETES, V38, P1207, DOI 10.2337/diabetes.38.10.1207; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; Hernandez C, 2000, MED CLIN-BARCELONA, V115, P21, DOI 10.1016/S0025-7753(00)71450-3; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hughes K, 1998, ATHEROSCLEROSIS, V136, P25, DOI 10.1016/S0021-9150(97)00180-9; KAYE TB, 1993, J DIABETES COMPLICAT, V7, P246, DOI 10.1016/0891-6632(93)90008-5; Kim NH, 2000, YONSEI MED J, V41, P387, DOI 10.3349/ymj.2000.41.3.387; KNULMAN MW, 2003, AM J EPIDEMIOL, V158, P144; Ma J, 2002, CLIN CHEM, V48, P601; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McCord JM, 1996, NUTR REV, V54, P85, DOI 10.1111/j.1753-4887.1996.tb03876.x; MERKEL PA, 1988, NEW ENGL J MED, V318, P809, DOI 10.1056/NEJM198803313181303; NIEDERAU C, 1984, DIABETOLOGIA, V26, P441; OBERLEY LW, 1988, FREE RADICAL BIO MED, V5, P113, DOI 10.1016/0891-5849(88)90036-6; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Tuomainen TP, 1997, DIABETES CARE, V20, P426, DOI 10.2337/diacare.20.3.426; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637	31	424	444	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2004	291	6					711	717		10.1001/jama.291.6.711	http://dx.doi.org/10.1001/jama.291.6.711			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AY	14871914	Bronze			2022-12-01	WOS:000188819200024
J	Ozanne, SE; Hales, CN				Ozanne, SE; Hales, CN			Lifespan - Catch-up growth and obesity in male mice	NATURE			English	Editorial Material							LONGEVITY; RATS		Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England	University of Cambridge	Ozanne, SE (corresponding author), Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England.	seo10@cam.ac.uk		Ozanne, Susan/0000-0001-8753-5144				Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Johnson PR, 1997, AM J CLIN NUTR, V66, P890, DOI 10.1093/ajcn/66.4.890; Petry CJ, 1997, CLIN SCI, V93, P147, DOI 10.1042/cs0930147; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682	6	427	432	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					411	412		10.1038/427411b	http://dx.doi.org/10.1038/427411b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749819				2022-12-01	WOS:000188470500031
J	Li, SM; Armstrong, CM; Bertin, N; Ge, H; Milstein, S; Boxem, M; Vidalain, PO; Han, JDJ; Chesneau, A; Hao, T; Goldberg, DS; Li, N; Martinez, M; Rual, JF; Lamesch, P; Xu, L; Tewari, M; Wong, SL; Zhang, LV; Berriz, GF; Jacotot, L; Vaglio, P; Reboul, J; Hirozane-Kishikawa, T; Li, QR; Gabel, HW; Elewa, A; Baumgartner, B; Rose, DJ; Yu, HY; Bosak, S; Sequerra, R; Fraser, A; Mango, SE; Saxton, WM; Strome, S; van den Heuvel, S; Piano, F; Vandenhaute, J; Sardet, C; Gerstein, M; Doucette-Stamm, L; Gunsalus, KC; Harper, JW; Cusick, ME; Roth, FP; Hill, DE; Vidal, M				Li, SM; Armstrong, CM; Bertin, N; Ge, H; Milstein, S; Boxem, M; Vidalain, PO; Han, JDJ; Chesneau, A; Hao, T; Goldberg, DS; Li, N; Martinez, M; Rual, JF; Lamesch, P; Xu, L; Tewari, M; Wong, SL; Zhang, LV; Berriz, GF; Jacotot, L; Vaglio, P; Reboul, J; Hirozane-Kishikawa, T; Li, QR; Gabel, HW; Elewa, A; Baumgartner, B; Rose, DJ; Yu, HY; Bosak, S; Sequerra, R; Fraser, A; Mango, SE; Saxton, WM; Strome, S; van den Heuvel, S; Piano, F; Vandenhaute, J; Sardet, C; Gerstein, M; Doucette-Stamm, L; Gunsalus, KC; Harper, JW; Cusick, ME; Roth, FP; Hill, DE; Vidal, M			A map of the interactome network of the metazoan C-elegans	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; GENOME; IDENTIFICATION; RESOURCE	To initiate studies on how protein-protein interaction (or "interactome") networks relate to multicellular functions, we have mapped a large fraction of the Caenorhabditis elegans interactome network. Starting with a subset of metazoan-specific proteins, more than 4000 interactions were identified from high-throughput, yeast two-hybrid (HT=Y2H) screens. Independent coaffinity purification assays experimentally validated the overall quality of this Y2H data set. Together with already described Y2H interactions and interologs predicted in silico, the current version of the Worm Interactome (WI5) map contains similar to5500 interactions. Topological and biological features of this interactome network, as well as its integration with phenome and transcriptome data sets, lead to numerous biological hypotheses.	Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Inst Genet Mol, CNRS, UMR 5535, F-34293 Montpellier 5, France; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Fac Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Belgium; Baylor Coll Med, Verna & Marrs Dept Biochem & Mol Biol, Program Cell & Mol Biol Biophys & Biol, Houston, TX 77030 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; NYU, Dept Biol, New York, NY 10003 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Harvard University; Harvard Medical School; Baylor College of Medicine; Indiana University System; Indiana University Bloomington; Yale University; Yale University; Wellcome Trust Sanger Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital; New York University	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Boxem, Mike/B-8857-2011; van den Heuvel, Sander J.L./B-8892-2011; Reboul, Jerome/P-9103-2016; Bertin, Nicolas/O-9602-2019; Vidalain, Pierre-Olivier/F-9778-2019; Hill, David E/B-6617-2011; Roth, Frederick P/H-6308-2011; Bertin, Nicolas/C-3025-2008	van den Heuvel, Sander J.L./0000-0001-9015-7463; Reboul, Jerome/0000-0002-5513-4546; Vidalain, Pierre-Olivier/0000-0003-3082-7407; Mango, Susan/0000-0002-2146-3237; Harper, Jeffrey/0000-0002-6944-7236; Vaglio, Philippe/0000-0003-2900-5596; Elewa, Ahmed/0000-0002-1988-7970; Rual, Jean-Francois/0000-0003-4465-8819; Roth, Frederick/0000-0002-6628-649X; Fraser, Andrew/0000-0001-9939-6014; Bertin, Nicolas/0000-0002-9835-9606	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NIGMS NIH HHS [R01 GM034059, R01 GM034059-18] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dozier C, 2001, DEV BIOL, V236, P289, DOI 10.1006/dbio.2001.0325; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; GE H, UNPUB; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Hanazawa M, 2001, P NATL ACAD SCI USA, V98, P8686, DOI 10.1073/pnas.141004698; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917	27	1299	1363	3	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					540	543		10.1126/science.1091403	http://dx.doi.org/10.1126/science.1091403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14704431	Green Accepted			2022-12-01	WOS:000188316400043
J	Verver, S; Warren, RM; Munch, Z; Richardson, M; van der Spuy, GD; Borgdorff, MW; Behr, MA; Beyers, N; van Helden, PD				Verver, S; Warren, RM; Munch, Z; Richardson, M; van der Spuy, GD; Borgdorff, MW; Behr, MA; Beyers, N; van Helden, PD			Proportion of tuberculosis transmission that takes place in households in a high-incidence area	LANCET			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; COMMUNITY	The prevalence of infection among household contacts of people with tuberculosis is high. This information frequently guides active case finding. We analysed DNA fingerprints of Mycobacterium tuberculosis from 765 tuberculosis patients in Ravensmead and Uitsig, adjacent suburbs of Cape Town, South Africa. In 129 households in which DNA fingerprints were available for more than one patient, we identified 313 patients, of whom 145 (46%) had a fingerprint pattern matching that of another member of the household. The proportion of transmission in the community that took place in the household was 19%, and therefore, in this high-incidence area, tuberculosis transmission occurs mainly outside the household.	Univ Stellenbosch, Dept Paediat & Child Hlth, Cape Town, South Africa; Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, Dept Biochem Med, Cape Town, South Africa; KNCV TB Fdn, The Hague, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; McGill Univ, Ctr Hlth, Dept Med, Div Infect Dis, Montreal, PQ, Canada	Stellenbosch University; Stellenbosch University; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; McGill University	Verver, S (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Cape Town, South Africa.	ververs@kncvtbc.nl	van der Spuy, Gian/AAY-7701-2020; Münch, Zahn/D-5193-2016	van der Spuy, Gian/0000-0002-9067-5903; Münch, Zahn/0000-0003-0691-7920; Warren, Robin/0000-0001-5741-7358				Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; Lockman S, 2001, J CLIN MICROBIOL, V39, P1042, DOI 10.1128/JCM.39.3.1042-1047.2001; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Warren RM, 2002, J CLIN MICROBIOL, V40, P1277, DOI 10.1128/JCM.40.4.1277-1282.2002	6	214	217	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 17	2004	363	9404					212	214		10.1016/S0140-6736(03)15332-9	http://dx.doi.org/10.1016/S0140-6736(03)15332-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765AG	14738796				2022-12-01	WOS:000188243900013
J	Dave, UP; Jenkins, NA; Copeland, NG				Dave, UP; Jenkins, NA; Copeland, NG			Gene therapy insertional mutagenesis insights	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LEUKEMIA		NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Copeland, NG (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA.				DIVISION OF BASIC SCIENCES - NCI [Z01BC010393] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887	7	200	211	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					333	333		10.1126/science.1091667	http://dx.doi.org/10.1126/science.1091667			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726584				2022-12-01	WOS:000188111800032
J	Mao, CB; Solis, DJ; Reiss, BD; Kottmann, ST; Sweeney, RY; Hayhurst, A; Georgiou, G; Iverson, B; Belcher, AM				Mao, CB; Solis, DJ; Reiss, BD; Kottmann, ST; Sweeney, RY; Hayhurst, A; Georgiou, G; Iverson, B; Belcher, AM			Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires	SCIENCE			English	Article							CRYSTAL-GROWTH; NANOPARTICLES; FEPT; BIOMINERALIZATION; NANOCRYSTALS; ORGANIZATION; SPECIFICITY; DYNAMICS; PEPTIDES; DISPLAY	We report a virus-based scaffold for the synthesis of single-crystal ZnS, CdS, and freestanding chemically ordered CoPt and FePt nanowires, with the means of modifying substrate specificity through standard biological methods. Peptides (selected through an evolutionary screening process) that exhibit control of composition, size, and phase during nanoparticle nucleation have been expressed on the highly ordered filamentous capsid of the M13 bacteriophage. The incorporation of specific, nucleating peptides into the generic scaffold of the M13 coat structure provides a viable template for the directed synthesis of semiconducting and magnetic materials. Removal of the viral template by means of annealing promoted oriented aggregation-based crystal growth, forming individual crystalline nanowires. The unique ability to interchange substrate-specific peptides into the linear self-assembled filamentous construct of the M13 virus introduces a material tunability that has not been seen in previous synthetic routes. Therefore, this system provides a genetic toolkit for growing and organizing nanowires from semiconducting and magnetic materials.	MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Dept Chem Engn, Austin, TX 78712 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.			Mao, Chuanbin/0000-0002-8142-3659; Hayhurst, Andrew/0000-0003-4612-8707				Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Barbas III C. F., 2001, PHAGE DISPLAY LAB MA; Barmak K, 2002, APPL PHYS LETT, V80, P4268, DOI 10.1063/1.1483924; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; de Picciotto R, 2001, NATURE, V411, P51, DOI 10.1038/35075009; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Dujardin E, 2003, NANO LETT, V3, P413, DOI 10.1021/nl034004o; Flynn CE, 2003, J MATER CHEM, V13, P2414, DOI 10.1039/b307593a; Gao CS, 1999, P NATL ACAD SCI USA, V96, P6025, DOI 10.1073/pnas.96.11.6025; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Huang YH, 2002, J APPL PHYS, V91, P6869, DOI 10.1063/1.1447524; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Luedtke WD, 1996, J PHYS CHEM-US, V100, P13323, DOI 10.1021/jp961721g; Malik P, 1997, NUCLEIC ACIDS RES, V25, P915, DOI 10.1093/nar/25.4.915; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; NAM K, 2003, IN PRESS NANO L 1216; Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X; Qadri SB, 1999, PHYS REV B, V60, P9191, DOI 10.1103/PhysRevB.60.9191; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; REISS BD, UNPUB; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Wang YW, 2002, CHEM PHYS LETT, V357, P314, DOI 10.1016/S0009-2614(02)00530-4; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Ye CH, 2002, J PHYS CHEM B, V106, P10338, DOI 10.1021/jp0255785; Yeadon M, 1998, APPL PHYS LETT, V73, P3208, DOI 10.1063/1.122720; Zhu HL, 1996, PHIL MAG LETT, V73, P27, DOI 10.1080/095008396181073	32	838	896	8	409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					213	217		10.1126/science.1092740	http://dx.doi.org/10.1126/science.1092740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716009				2022-12-01	WOS:000187908500043
J	Zhu, H; Zhu, JX; Lo, PS; Li, JM; Leung, KM; Rowlands, DK; Tsang, LL; Yu, MK; Jiang, JL; Lam, SY; Chung, YW; Zhou, ZM; Sha, JH; Chan, HC				Zhu, H; Zhu, JX; Lo, PS; Li, JM; Leung, KM; Rowlands, DK; Tsang, LL; Yu, MK; Jiang, JL; Lam, SY; Chung, YW; Zhou, ZM; Sha, JH; Chan, HC			Rescue of defective pancreatic secretion in cystic-fibrosis cells by suppression of a novel isoform of phospholipase C	LANCET			English	Article							CFTR CHLORIDE CHANNEL; PROTEIN-KINASE-C; DUCT CELLS; SURFACE EXPRESSION; ANION SECRETION; GENE; DELTA-F508-CFTR; PHOSPHORYLATION; MECHANISMS; MUTATION	Background Cystic fibrosis is caused by mutations in the gene encoding an ion-transport protein, the cystic-fibrosis transmembrane conductance regulator (CFTR). Defective secretion of anions is the primary cause of many of the clinical manifestations of cystic fibrosis, including pancreatic insufficiency. We aimed to identify a molecular mechanism from which a new method to circumvent defective pancreatic secretion could be derived. Methods Multiple-human-tissue RT-PCR and semiquantitative RT-PCR analyses were used to examine gene expression. An antisense technique was used in conjunction with radioimmunoassay, Fura-2 spectrofluorometry, immunohistochemistry, and the short-circuit current technique (Ussing chamber) for elucidation of gene function and its application in rescuing defective pancreatic secretion. Findings We cloned a newly identified gene, NYD-SP27, which has structural similarity to an isoform of phospholipase C. NYD-SP27 was expressed endogenously in human pancreatic-duct cells and upregulated in cystic fibrosis. Suppression of NYD-SP27, by transfection of its antisense into human cystic-fibrosis pancreatic-duct cells, resulted in augmentation of phospholipase-C-coupled calcium-ion release and protein kinase C activity, improvement in the amount of mutated CFTR reaching the plasma membrane, and restoration of cAMP-activated pancreatic anion secretion. Interpretation NYD-SP27 exerts an inhibitory effect on phospholipase-C-coupled processes that depend on calcium ions and protein kinase C, including CFTR trafficking and function. Its upregulation in pancreatic-duct cells may reveal a previously unsuspected defect in cystic fibrosis contributing to pancreatic insufficiency, and thus represents a new target for pharmacological intervention in cystic fibrosis.	Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; Nanjing Med Univ, Lab Reprod Med, Nanjing 210009, Peoples R China	Chinese University of Hong Kong; Nanjing Medical University	Chan, HC (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China.		Chan, Hsiao Chang/E-1507-2016	Rowlands, Dewi/0000-0001-5180-842X				ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Case R. M., 1993, P301; Chan HC, 1996, AM J PHYSIOL-CELL PH, V271, pC469, DOI 10.1152/ajpcell.1996.271.2.C469; Cheng HS, 1998, J MEMBRANE BIOL, V164, P155, DOI 10.1007/s002329900401; Cheng HS, 1999, BBA-BIOMEMBRANES, V1418, P31, DOI 10.1016/S0005-2736(99)00011-5; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Communi D, 2000, CELL SIGNAL, V12, P351, DOI 10.1016/S0898-6568(00)00083-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Estell K, 2003, MOL CELL BIOL, V23, P594, DOI 10.1128/MCB.23.2.594-606.2003; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; HADORN B, 1968, CAN MED ASSOC J, V98, P377; Maitra R, 2001, AM J PHYSIOL-CELL PH, V280, pC1031, DOI 10.1152/ajpcell.2001.280.5.C1031; Nousia-Arvanitakis S, 1999, J CLIN GASTROENTEROL, V29, P138, DOI 10.1097/00004836-199909000-00007; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1999, PHYSL REV S, V79, P109; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x; Walkowiak J, 2001, EUR J CLIN INVEST, V31, P796, DOI 10.1046/j.1365-2362.2001.00876.x; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WINPENNY JP, 1995, AM J PHYSIOL-CELL PH, V268, pC823, DOI 10.1152/ajpcell.1995.268.4.C823; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhou ZM, 2002, REPRODUCTION, V123, P227, DOI 10.1530/rep.0.1230227; Zsembery A, 2000, FASEB J, V14, P2345, DOI 10.1096/fj.99-0509com	26	15	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2059	2065		10.1016/S0140-6736(03)15100-8	http://dx.doi.org/10.1016/S0140-6736(03)15100-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697805				2022-12-01	WOS:000187429600010
J	Brake, JM; Daschner, MK; Luk, YY; Abbott, NL				Brake, JM; Daschner, MK; Luk, YY; Abbott, NL			Biomolecular interactions at phospholipid-decorated surfaces of liquid crystals	SCIENCE			English	Article							PORCINE PANCREAS; KINETIC-ANALYSIS; MONOLAYERS; MEMBRANES; STREPTAVIDIN; RECOGNITION; INTERFACE; CATALYSIS; BILAYERS; ZYMOGEN	The spontaneous assembly of phospholipids at planar interfaces between thermotropic liquid crystals and aqueous phases gives rise to patterned orientations of the liquid crystals that reflect the spatial and temporal organization of the phospholipids. Strong and weak specific-binding events involving proteins at these interfaces drive the reorganization of the phospholipids and trigger orientational transitions in the liquid crystals. Because these interfaces are fluid, processes involving the lateral organization of proteins ( such as the formation of protein- and phospholipid-rich domains) are also readily imaged by the orientational response of the liquid crystal, as are stereospecific enzymatic events. These results provide principles for label-free monitoring of aqueous streams for molecular and biomolecular species without the need for complex instrumentation.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, 1415 Engn Dr, Madison, WI 53706 USA.							BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; BONSEN PPM, 1972, BIOCHIM BIOPHYS ACTA, V270, P364, DOI 10.1016/0005-2760(72)90200-7; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; DAHMENLEVISON U, 1998, THIN SOLID FILMS, V616, P327; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DEHAAS GH, 1971, BIOCHIM BIOPHYS ACTA, V239, P252, DOI 10.1016/0005-2760(71)90171-8; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Gast AP, 1999, BIOMOL ENG, V16, P21, DOI 10.1016/S1050-3862(99)00045-5; GRAINGER DW, 1992, J CONTROL RELEASE, V19, P201, DOI 10.1016/0168-3659(92)90077-5; Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; HILTROP K, 1981, BER BUNSEN PHYS CHEM, V85, P582, DOI 10.1002/bbpc.19810850712; Hubbard JB, 1998, BIOPHYS CHEM, V75, P163, DOI 10.1016/S0301-4622(98)00199-9; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Ransac S, 1997, METHOD ENZYMOL, V286, P263; Rao NM, 1997, BIOPHYS J, V73, P3066, DOI 10.1016/S0006-3495(97)78334-6; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Song XD, 1999, ANAL CHEM, V71, P2097, DOI 10.1021/ac981145f; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Tanaka K, 2000, LANGMUIR, V16, P2665, DOI 10.1021/la9909244; Walker RA, 1997, LANGMUIR, V13, P3070, DOI 10.1021/la961007q; Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o; ZOGRAFI G, 1971, CHEM PHYS LIPIDS, V7, P185, DOI 10.1016/0009-3084(71)90001-6	25	521	540	9	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2094	2097		10.1126/science.1091749	http://dx.doi.org/10.1126/science.1091749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684814				2022-12-01	WOS:000187385200035
J	Lovelock, J				Lovelock, J			The living Earth	NATURE			English	Editorial Material							GAIA		Univ Oxford Green Coll, Oxford OX2 6HG, England	University of Oxford	Lovelock, J (corresponding author), Univ Oxford Green Coll, Woodstock Rd, Oxford OX2 6HG, England.							Hamilton WD, 1998, ETHOL ECOL EVOL, V10, P1, DOI 10.1080/08927014.1998.9522867; Kump Leo, 2004, EARTH SYSTEM; Lenton TM, 1998, NATURE, V394, P439, DOI 10.1038/28792; Lovelock J, 2000, AGES GAIA; Margulis L, 1999, SYMBIOTIC PLANET; SCHELLNHUBER HJ, 1998, EARTH SYSTEM ANAL IN; Turney Jon, 2003, LOVELOCK GAIA	7	67	70	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					769	770		10.1038/426769a	http://dx.doi.org/10.1038/426769a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685210				2022-12-01	WOS:000187342000030
J	Olsen, SJ; Chang, H; Cheung, TY; Tang, AF; Fisk, TL; Ooi, SP; Kuo, H; Jiang, DD; Chen, K; Lando, J; Hsu, K; Chen, T; Dowell, SF				Olsen, SJ; Chang, H; Cheung, TY; Tang, AF; Fisk, TL; Ooi, SP; Kuo, H; Jiang, DD; Chen, K; Lando, J; Hsu, K; Chen, T; Dowell, SF			Transmission of the severe acute respiratory syndrome on aircraft	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-FEATURES; SYNDROME SARS	BACKGROUND: The severe acute respiratory syndrome (SARS) spread rapidly around the world, largely because persons infected with the SARS-associated coronavirus (SARS-CoV) traveled on aircraft to distant cities. Although many infected persons traveled on commercial aircraft, the risk, if any, of in-flight transmission is unknown. METHODS: We attempted to interview passengers and crew members at least 10 days after they had taken one of three flights that transported a patient or patients with SARS. All index patients met the criteria of the World Health Organization for a probable case of SARS, and index or secondary cases were confirmed to be positive for SARS-CoV on reverse-transcriptase polymerase chain reaction or serologic testing. RESULTS: After one flight carrying a symptomatic person and 119 other persons, laboratory-confirmed SARS developed in 16 persons, 2 others were given diagnoses of probable SARS, and 4 were reported to have SARS but could not be interviewed. Among the 22 persons with illness, the mean time from the flight to the onset of symptoms was four days (range, two to eight), and there were no recognized exposures to patients with SARS before or after the flight. Illness in passengers was related to the physical proximity to the index patient, with illness reported in 8 of the 23 persons who were seated in the three rows in front of the index patient, as compared with 10 of the 88 persons who were seated elsewhere (relative risk, 3.1; 95 percent confidence interval, 1.4 to 6.9). In contrast, another flight carrying four symptomatic persons resulted in transmission to at most one other person, and no illness was documented in passengers on the flight that carried a person who had presymptomatic SARS. CONCLUSIONS: Transmission of SARS may occur on an aircraft when infected persons fly during the symptomatic phase of illness. Measures to reduce the risk of transmission are warranted.	Ctr Dis Control & Prevent, Int Emerging Infect Program, Nonthaburi, Thailand; Taiwan Ctr Dis Control, Dept Hlth, Taipei, Taiwan; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; Emory Univ, Sch Med, Atlanta, GA USA; Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Emory University; Ministry of Health-Singapore; Centers for Disease Control & Prevention - USA	Olsen, SJ (corresponding author), Ctr Dis Control & Prevent, Int Emerging Infect Program, Box 68,Amer Embassy, APO, AP 96546 USA.							[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P97; [Anonymous], 1995, MMWR-MORBID MORTAL W, V44, P137; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Booth CM, 2003, JAMA-J AM MED ASSOC, V290, P334; *CDCP, 2003, INT GUID CLEAN COMM; *CDCP, 2003, INT GUID SEV AC RESP; Demers RR, 2001, CHEST, V120, P1377, DOI 10.1378/chest.120.4.1377; GARNER JS, 1997, GUIDELINE ISOLATION; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; *IATA, 2003, DID YOU KNOW FACTS I; KAHN J, 2003, INT HERALD TRIBUNE T, V1, P4; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAKSHMANAN IAR, 2003, BOSTON GLOBE    0518; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Wenzel RP, 1996, NEW ENGL J MED, V334, P981, DOI 10.1056/NEJM199604113341509; WHO, 2003, WHO M REPORT; *WHO, 2003, UPD 59 REP GUANGX CH; *WHO, 2003, UPD 62 MOR 8000 CAS; World Health Organization, 2003, CAS DEF SURV SEV AC; World Health Organization, 2003, UPD 11 WHO REC NEW M; 2003, MMWR MORB MORTAL WKL, V52, P248; 2003, MMWR MORB MORTAL WKL, V52, P284; 2003, MMWR MORB MORTAL WKL, V52, P241; 1995, MMWR MORB MORTAL WKL, V44, P175; 2003, MMWR MORB MORTAL WKL, V52, P405	28	401	420	0	33	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2416	2422		10.1056/NEJMoa031349	http://dx.doi.org/10.1056/NEJMoa031349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681507	Bronze			2022-12-01	WOS:000187326200007
J	PETTIGREW, JD; WALLMAN, J; WILDSOET, CF				PETTIGREW, JD; WALLMAN, J; WILDSOET, CF			SACCADIC OSCILLATIONS FACILITATE OCULAR PERFUSION FROM THE AVIAN PECTEN	NATURE			English	Article									CUNY CITY COLL,DEPT BIOL,NEW YORK,NY 10031; QUEENSLAND UNIV TECHNOL,DEPT OPTOMETRY,BRISBANE 4001,AUSTRALIA	City University of New York (CUNY) System; City College of New York (CUNY); Queensland University of Technology (QUT)	PETTIGREW, JD (corresponding author), UNIV QUEENSLAND,VIS TOUCH & HEARING RES CTR,ST LUCIA,QLD 4067,AUSTRALIA.							Abelsdorff G., 1909, Archiv fuer Augenheilkunde Wiesbaden, V64; AMEMIYA T, 1982, GRAEF ARCH CLIN EXP, V219, P11, DOI 10.1007/BF02159972; BARLOW HB, 1972, NATURE-NEW BIOL, V236, P88, DOI 10.1038/newbio236088a0; BAWA SR, 1972, EXP EYE RES, V13, P92, DOI 10.1016/0014-4835(72)90129-7; BELL SM, 1975, PATHOLOGY, V7, P1; BRAEKEVELT CR, 1984, OPHTHALMOLOGICA, V189, P211, DOI 10.1159/000309412; DUKEELDER S, 1958, EYE EVOLUTION, V1, P362; LETELIER J C, 1987, Society for Neuroscience Abstracts, V13, P172; LETELIER J C, 1984, Society for Neuroscience Abstracts, V10, P912; Pettigrew J. D., 1978, ANIMAL MIGRATION NAV, P42; RAVIOLA E, 1967, AM J ANAT, V120, P427, DOI 10.1002/aja.1001200304; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; SEAMAN AR, 1973, EXPL EYE RES, V2, P163; TUCKER R, 1975, CELL TISSUE RES, V157, P457; WALLMAN J, 1985, J NEUROSCI, V5, P1418; WALLS GL, 1967, VERTEBRATE EYE ITS A, P648; WINGSTRAND KARL GEORG, 1965, BIOL SKR KONGELIGE DANSKE VIDENSKABERNES SELSK, V14, P1; [No title captured]	18	83	83	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 25	1990	343	6256					362	363		10.1038/343362a0	http://dx.doi.org/10.1038/343362a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK918	14756148				2022-12-01	WOS:A1990CK91800059
J	Nishimura, I; Yang, YF; Lu, BW				Nishimura, I; Yang, YF; Lu, BW			PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED-HELICAL-FILAMENT; C-ELEGANS PAR-1; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PROTEIN-KINASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; NEURONAL POLARITY; IN-VIVO	Multisite hyperphosphorylation of tau has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD). However, the phosphorylation events critical for tau toxicity and mechanisms regulating these events are largely unknown. Here we show that Drosophila PAR-1 kinase initiates tau toxicity by triggering a temporally ordered phosphorylation process. PAR-1 directly phosphorylates tau at S262 and S356. This phosphorylation event is a prerequisite for the action of downstream kinases, including glycogen synthase kinase 3 (GSK-3) and cyclin-dependent kinase-5 (Cdk5), to phosphorylate several other sites and generate disease-associated phospho-epitopes. The initiator role of PAR-1 is further underscored by the fact that mutating PAR-1 phosphorylation sites causes a much greater reduction of overall tau phosphorylation and toxicity than mutating S202, one of the downstream sites whose phosphorylation depends on prior PAR-1 action. These findings begin to differentiate the effects of various phosphorylation events on tau toxicity and provide potential therapeutic targets.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Lu, BW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	bingwei@stanford.edu		Lu, Bingwei/0000-0002-5807-7014				Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAND AH, 1993, DEVELOPMENT, V118, P401; Connell-Crowley L, 2000, CURR BIOL, V10, P599, DOI 10.1016/S0960-9822(00)00487-5; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Davies P, 2000, ANN NY ACAD SCI, V924, P8, DOI 10.1111/j.1749-6632.2000.tb05553.x; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Goedert M, 1998, PROG BRAIN RES, V117, P287; GOEDERT M, 1995, NEUROBIOL AGING, V16, P325, DOI 10.1016/0197-4580(95)00017-9; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jenkins SM, 2000, J NEUROCHEM, V74, P1463, DOI 10.1046/j.1471-4159.2000.0741463.x; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Liu JH, 2002, ASIAN J SOC PSYCHOL, V5, P3, DOI 10.1111/1467-839X.00091; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mandelkow E, 1999, NATURE, V402, P588, DOI 10.1038/45095; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; MORENO FJ, 1995, FEBS LETT, V372, P65, DOI 10.1016/0014-5793(95)00934-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	53	247	256	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					671	682		10.1016/S0092-8674(04)00170-9	http://dx.doi.org/10.1016/S0092-8674(04)00170-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006350	Bronze			2022-12-01	WOS:000221499700008
J	Woolhead, CA; McCormick, PJ; Johnson, AE				Woolhead, CA; McCormick, PJ; Johnson, AE			Nascent membrane and secretory proteins differ in FRET-detected folding far inside the ribosome and in their exposure to ribosomal proteins	CELL			English	Article							FLUORESCENCE ENERGY-TRANSFER; ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL RECOGNITION PARTICLE; ER MEMBRANE; TRANSLOCON PORE; ANGSTROM RESOLUTION; ORIENTATION FACTOR; STRUCTURAL BASIS; TRANSFER-RNA; TUNNEL	Fluorescence resonance energy transfer measurements reveal that a transmembrane sequence within a nascent membrane protein folds into a compact conformation near the peptidyltransferase center and remains folded as the sequence moves through a membrane bound ribosome into the translocon. This compact conformation is compatible with an alpha helix because nearly the same energy transfer efficiency was observed when the transmembrane sequence was integrated into the lipid bilayer. Since the transmembrane sequence unfolds upon emerging from a free ribosome, this nascent chain folding is ribosome induced and stabilized. In contrast, a nascent secretory protein is in an extended conformation in the exit tunnel. Furthermore, two ribosomal proteins photo-crosslink to nascent membrane but not secretory proteins. These interactions coincide with the previously described sequential closing and opening of the two ends of the aqueous translocon pore, thereby suggesting that ribosomal recognition of nascent chain folding controls the operational mode of the translocon at the ER membrane.	Texas A&M Univ, Syst Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA.	aejohnson@tamu.edu	Johnson, Arthur E/G-3457-2012; McCormick, Peter/E-7387-2012	McCormick, Peter/0000-0002-2225-5181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 26494] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; HILLEL Z, 1976, BIOCHEMISTRY-US, V15, P2105, DOI 10.1021/bi00655a012; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JOHNSON AE, 1976, BIOCHEMISTRY-US, V15, P569, DOI 10.1021/bi00648a018; JOHNSON AE, 1982, J MOL BIOL, V156, P113, DOI 10.1016/0022-2836(82)90462-4; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WATSON BS, 1995, BIOCHEMISTRY-US, V34, P7904, DOI 10.1021/bi00024a015; WEBER G, 1957, T FARADAY SOC, V53, P646, DOI 10.1039/tf9575300646; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; WU PG, 1992, BIOCHEMISTRY-US, V31, P7939, DOI 10.1021/bi00149a027; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	37	302	307	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					725	736		10.1016/S0092-8674(04)00169-2	http://dx.doi.org/10.1016/S0092-8674(04)00169-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006354	Bronze			2022-12-01	WOS:000221499700012
J	Harker, N; Montgomery, A; Fahey, T				Harker, N; Montgomery, A; Fahey, T			Interactive case report - Treating nausea and vomiting during pregnancy: case outcome	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Dean Lane Family Practice, Bristol, Avon, England; Univ Bristol, Div Primary Hlth Care, Bristol BS8 1TH, Avon, England	University of Bristol	Fahey, T (corresponding author), Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland.	t.p.fahey@dundee.ac.uk	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; Montgomery, Alan/0000-0003-0450-1606				Jewell D, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000145; Jewell David, 2003, Clin Evid, P1561; Magee LA, 1996, BRIT J OBSTET GYNAEC, V103, P478, DOI 10.1111/j.1471-0528.1996.tb09779.x; Niebyl JR, 2002, AM J OBSTET GYNECOL, V186, pS253, DOI 10.1067/mob.2002.122595; Ranzini Angela, 2001, Obstetrics and Gynecology, V97, p46S, DOI 10.1016/S0029-7844(01)01255-8	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2004	328	7438					503	503		10.1136/bmj.328.7438.503	http://dx.doi.org/10.1136/bmj.328.7438.503			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800BC	14988187	Green Published			2022-12-01	WOS:000220002900028
J	Shimojima, M; Miyazawa, T; Ikeda, Y; McMonagle, EL; Haining, H; Akashi, H; Takeuchi, Y; Hosie, MJ; Willett, BJ				Shimojima, M; Miyazawa, T; Ikeda, Y; McMonagle, EL; Haining, H; Akashi, H; Takeuchi, Y; Hosie, MJ; Willett, BJ			Use of CD134 as a primary receptor by the feline immunodeficiency virus	SCIENCE			English	Article							ACTIVATED RAT; SHARED USAGE; CXCR4; EXPRESSION; INFECTION; OX40; MOLECULE; TROPISM; ANTIGEN; LIGAND	Feline immunodeficiency virus (FIV) induces a disease similar to acquired immunodeficiency syndrome (AIDS) in cats, yet in contrast to human immunodeficiency virus (HIV), CD4 is not the viral receptor. We identified a primary receptor for FIV as CD134 (OX40), a T cell activation antigen and costimulatory molecule. CD134 expression promotes viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Infection is CXCR4-dependent, analogous to infection with X4 strains of HIV. Thus, despite the evolutionary divergence of the feline and human lentiviruses, both viruses use receptors that target the virus to a subset of cells that are pivotal to the acquired immune response.	Univ Glasgow, Inst Comparat Med, Retrovirus Res Lab, Glasgow G61 1QH, Lanark, Scotland; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; Obihiro Univ Agr & Vet Med, Dept Vet Publ Hlth, Obihiro, Hokkaido 0808555, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; UCL, Windeyer Inst Med Sci, Dept Immunol & Mol Pathol, London W1T 4JF, England	University of Glasgow; University of Tokyo; Obihiro University of Agriculture & Veterinary Medicine; Japan Science & Technology Agency (JST); University of London; University College London	Willett, BJ (corresponding author), Univ Glasgow, Inst Comparat Med, Retrovirus Res Lab, Glasgow G61 1QH, Lanark, Scotland.	b.willett@vet.gla.ac.uk	Willett, Brian J/F-3396-2011	Miyazawa, Takayuki/0000-0003-1938-9661	NIAID NIH HHS [R01 AI49765-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049765] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlShamkhani A, 1996, EUR J IMMUNOL, V26, P1695, DOI 10.1002/eji.1830260805; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; Dean GA, 1996, J VIROL, V70, P5165, DOI 10.1128/JVI.70.8.5165-5169.1996; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; DURKOP H, 1995, BRIT J HAEMATOL, V91, P927, DOI 10.1111/j.1365-2141.1995.tb05413.x; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; Gramaglia I, 1998, J IMMUNOL, V161, P6510; HOSIE MJ, 1992, VET IMMUNOL IMMUNOP, V35, P191, DOI 10.1016/0165-2427(92)90131-9; Hosie MJ, 1998, J VIROL, V72, P2097, DOI 10.1128/JVI.72.3.2097-2104.1998; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lerner DL, 2000, J VIROL, V74, P1854, DOI 10.1128/JVI.74.4.1854-1863.2000; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; MIYAZAWA T, 1989, ARCH VIROL, V108, P131, DOI 10.1007/BF01313750; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PEDERSEN NC, 1993, RETROVIRIDAE, V2, pCH3; Richardson J, 1999, J VIROL, V73, P3661, DOI 10.1128/JVI.73.5.3661-3671.1999; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; Shimojimaa M, 2003, ANAL BIOCHEM, V315, P138, DOI 10.1016/S0003-2697(02)00708-X; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; Willett BJ, 1998, J VIROL, V72, P6475, DOI 10.1128/JVI.72.8.6475-6481.1998; Willett BJ, 1997, J VIROL, V71, P6407, DOI 10.1128/JVI.71.9.6407-6415.1997; Willett BJ, 2003, J VIROL, V77, P709, DOI 10.1128/JVI.77.1.709-712.2003; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681	29	143	150	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1192	1195		10.1126/science.1092124	http://dx.doi.org/10.1126/science.1092124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976315	Green Accepted			2022-12-01	WOS:000189074700046
J	Rothwell, N				Rothwell, N			One more thing... How an extra control experiment led to a change of research field.	NATURE			English	Editorial Material									Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Rothwell, N (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.								0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 19	2004	427	6976					683	683		10.1038/427683a	http://dx.doi.org/10.1038/427683a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973460				2022-12-01	WOS:000189026000020
J	Salomon, JA; Tandon, A; Murray, CJL				Salomon, JA; Tandon, A; Murray, CJL		World Hlth Survey Pilot Study Coll	Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; LIMITATIONS; MORBIDITY	Objective To examine differences in expectations for health using "anchoring vignettes," which describe fixed levels of health on dimensions such as mobility. Design Cross sectional survey of adults living in the community. Setting China, Myanmar, Sri Lanka, Pakistan, Turkey, and United Arab Emirates. Participants 3012 men and women aged 18 years and older (self ratings); subsample of 406 (vignette ratings). Main outcome measures Self rated mobility levels and ratings of hypothetical vignettes using the same questions and response categories. Results Consistent rankings of vignettes are evidence that vignettes are understood in similar ways in different settings, and internal consistency of orderings on two mobility questions indicates good comprehension. Variation in vignette ratings across age groups suggests that expectations for mobility decline with age. Comparison of responses to two different mobility questions supports the assumption that individual ratings of hypothetical vignettes relate to expectations for health in similar ways as self assessments. Conclusions Anchoring vignettes could provide a powerful tool for understanding and adjusting for the influence of different health expectations on self ratings of health. Incorporating anchoring vignettes in surveys can improve the comparability of self reported measures.	Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Cambridge, MA 02138 USA; Harvard Univ, Global Hlth Iniat, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Salomon, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 9 Bow St, Cambridge, MA 02138 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009	Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Freedman VA, 1998, AM J PUBLIC HEALTH, V88, P1457, DOI 10.2105/AJPH.88.10.1457; Garratt AN, 2002, BMJ-BRIT MED J, V324, P1417, DOI 10.1136/bmj.324.7351.1417; Goldie J, 2002, MED EDUC, V36, P489, DOI 10.1046/j.1365-2923.2002.01176.x; GROUT W, 2000, J HLTH EC, V19, P103; Herskovits MJ, 1950, SOUTHWEST J ANTHROP, V6, P32, DOI 10.1086/soutjanth.6.1.3628688; Hughes R, 2002, J ADV NURS, V37, P382, DOI 10.1046/j.1365-2648.2002.02100.x; Kelly WF, 2002, CHEST, V121, P957, DOI 10.1378/chest.121.3.957; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; King G, 2003, AM POLIT SCI REV, V97, P567, DOI 10.1017/S0003055403000881; KING G, 2004, IN PRESS AM POLIT SC, V98; Koedoot CG, 2002, J CLIN ONCOL, V20, P3658, DOI 10.1200/JCO.2002.12.012; Mathers C., 1998, MEASURING PROGR IS L, P125; Montague J. A., 1951, INTRO PROJECTIVE TEC; MURRAY CJL, 1992, POPUL DEV REV, V18, P481, DOI 10.2307/1973655; Murray CJL, 2002, SUMMARY MEASURES POP; Rossi P. H., 1982, MEASURING SOCIAL JUD; Sadana R, 2002, SUMMARY MEASURES POP; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Shibuya K, 2002, BRIT MED J, V324, P16, DOI 10.1136/bmj.324.7328.16; TANDON A, 2003, HLTH SYSTEMS PERFORM, P727; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; WALSTER E, 1966, J PERS SOC PSYCHOL, V3, P73, DOI 10.1037/h0022733; WHO, WORLD HLTH SURV; Wolfe R, 2002, J ROY STAT SOC C-APP, V51, P245, DOI 10.1111/1467-9876.00267	27	229	235	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2004	328	7434					258	261		10.1136/bmj.37963.691632.44	http://dx.doi.org/10.1136/bmj.37963.691632.44			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771LC	14742348	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000188786000020
J	Scotland, RW; Sanderson, MJ				Scotland, RW; Sanderson, MJ			The significance of few versus many in the tree of life	SCIENCE			English	Article							DIVERSIFICATION RATES		Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	University of Oxford; University of California System; University of California Davis	Scotland, RW (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	robert.scotland@plants.ox.ac.uk						Cardillo M, 2003, J EVOLUTION BIOL, V16, P282, DOI 10.1046/j.1420-9101.2003.00513.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Sims HJ, 2003, EVOLUTION, V57, P460, DOI 10.1111/j.0014-3820.2003.tb01538.x; Willis JC, 1922, NATURE, V109, P177, DOI 10.1038/109177a0; [No title captured]	6	54	56	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 30	2004	303	5658					643	643		10.1126/science.1091483	http://dx.doi.org/10.1126/science.1091483			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752153				2022-12-01	WOS:000188530800031
J	Yoo, AS; Bais, C; Greenwald, I				Yoo, AS; Bais, C; Greenwald, I			Crosstalk between the EGFR and LIN-12/Notch pathways in C-elegans vulval development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NOTCH; INDUCTION; RECEPTOR; PROTEIN	The Caenorhabditis elegans vulva is an important paradigm for cell-cell interactions in animal development. The fates of six vulval precursor cells are patterned through the action of the epidermal growth factor receptor - mitogen-activated protein kinase (EGFR-MAPK) inductive signaling pathway, which specifies the 1degrees fate, and the LIN-12/Notch lateral signaling pathway, which specifies the 2degrees fate. Here, we provide evidence that the inductive signal is spatially graded and initially activates the EGFR-MAPK pathway in the prospective 2degrees cells. Subsequently, this effect is counteracted by the expression of multiple new negative regulators of the EGFR-MAPK pathway, under direct transcriptional control of the LIN-12-mediated lateral signal.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Greenwald, I (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St,Room 720, New York, NY 10032 USA.	greenwald@cancercenter.columbia.edu		Yoo, Andrew/0000-0002-0304-3247	NATIONAL CANCER INSTITUTE [R01CA095389] Funding Source: NIH RePORTER; NCI NIH HHS [CA095389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beitel GJ, 1995, GENE DEV, V9, P3149, DOI 10.1101/gad.9.24.3149; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Chen N, UNPUB; Christensen S, 1996, DEVELOPMENT, V122, P1373; GARRIGA G, COMMUNICATION; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Greenwald Iva, 1997, Cold Spring Harbor Monograph Series, V33, P519; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; KOGA M, 1995, DEVELOPMENT, V121, P2655; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Liu J, 1999, GENETICS, V153, P1257; Maillard I, 2003, CANCER CELL, V3, P203, DOI 10.1016/S1535-6108(03)00052-7; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	24	198	223	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					663	666		10.1126/science.1091639	http://dx.doi.org/10.1126/science.1091639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752159				2022-12-01	WOS:000188530800038
J	Emerson, JJ; Kaessmann, H; Betran, E; Long, MY				Emerson, JJ; Kaessmann, H; Betran, E; Long, MY			Extensive gene traffic on the mammalian X chromosome	SCIENCE			English	Article							HUMAN Y-CHROMOSOME; HUMAN GENOME; SEX-CHROMOSOMES; EVOLUTION; EXPRESSION; INACTIVATION; DROSOPHILA; SEQUENCE; TESTIS; IDENTIFICATION	Mammalian sex chromosomes have undergone profound changes since evolving from ancestral autosomes. By examining retroposed genes in the human and mouse genomes, we demonstrate that, during evolution, the mammalian X chromosome has generated and recruited a disproportionately high number of functional retroposed genes, whereas the autosomes experienced lower gene turnover. Most autosomal copies originating from X-linked genes exhibited testis-biased expression. Such export is incompatible with mutational bias and is likely driven by natural selection to attain male germline function. However, the excess recruitment is consistent with a combination of both natural selection and mutational bias.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Lausanne, BEP, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Texas, Dept Biol, Arlington, TX 76019 USA	University of Chicago; University of Lausanne; University of Texas System; University of Texas Arlington	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	mlong@uchicago.edu	Emerson, J.J./D-8955-2011; Kaessmann, Henrik/B-4989-2013	Kaessmann, Henrik/0000-0001-7563-839X; Betran, Esther/0000-0002-4742-7963; Emerson, James/0000-0001-9474-0891	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065429] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-065429-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Betran E, 2002, MOL BIOL EVOL, V19, P654, DOI 10.1093/oxfordjournals.molbev.a004124; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Dass B, 2001, J BIOL CHEM, V276, P8044, DOI 10.1074/jbc.M009091200; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Fujii T, 2002, EMBO REP, V3, P367, DOI 10.1093/embo-reports/kvf073; Graves JAM, 2002, CYTOGENET GENOME RES, V96, P161, DOI 10.1159/000063022; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; Lercher MJ, 2003, MOL BIOL EVOL, V20, P1113, DOI 10.1093/molbev/msg131; Lewin B., 2000, GENES; MCCARREY JR, 1994, BIOSCIENCE, V44, P20, DOI 10.2307/1312402; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Strichman-Almashanu LZ, 2003, GENOME RES, V13, P800, DOI 10.1101/gr.893803; TAIRA M, 1990, J BIOL CHEM, V265, P16491; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WICHMAN HA, 1992, GENETICA, V86, P287, DOI 10.1007/BF00133727; Wu CI, 2003, TRENDS GENET, V19, P243, DOI 10.1016/S0168-9525(03)00058-1; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	35	308	314	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					537	540		10.1126/science.1090042	http://dx.doi.org/10.1126/science.1090042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739461				2022-12-01	WOS:000188316400042
J	de Nadal, E; Zapater, M; Alepuz, PM; Sumoy, L; Mas, G; Posas, F				de Nadal, E; Zapater, M; Alepuz, PM; Sumoy, L; Mas, G; Posas, F			The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes	NATURE			English	Article							OSMOTIC-STRESS; KINASE HOG1; YEAST; TRANSCRIPTION; ACETYLATION; OSMOSTRESS	Regulation of gene expression by mitogen- activated protein kinases ( MAPKs) is essential for proper cell adaptation to extracellular stimuli. Exposure of yeast cells to high osmolarity results in rapid activation of the MAPK Hog1, which coordinates the transcriptional programme required for cell survival on osmostress(1). The mechanisms by which Hog1 and MAPKs in general regulate gene expression are not completely understood, although Hog1 can modify some transcription factors(2). Here we propose that Hog1 induces gene expression by a mechanism that involves recruiting a specific histone deacetylase complex to the promoters of genes regulated by osmostress. Cells lacking the Rpd3 - Sin3 histone deacetylase complex are sensitive to high osmolarity and show compromised expression of osmostress genes. Hog1 interacts physically with Rpd3 in vivo and in vitro and, on stress, targets the deacetylase to specific osmostress-responsive genes. Binding of the Rpd3 - Sin3 complex to specific promoters leads to histone deacetylation, entry of RNA polymerase II and induction of gene expression. Together, our data indicate that targeting of the Rpd3 histone deacetylase to osmo-responsive promoters by the MAPK Hog1 is required to induce gene expression on stress.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; CRG, E-08003 Barcelona, Spain	Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Posas, F (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain.	francesc.posas@upf.edu	Posas, Francesc/K-1364-2013; de Nadal, Eulàlia/J-8178-2014; Sumoy, Lauro/AGZ-3186-2022; Alepuz, Paula/F-7849-2016; Sumoy, Lauro/K-1680-2013	Posas, Francesc/0000-0002-4164-7076; de Nadal, Eulàlia/0000-0003-0039-5607; Sumoy, Lauro/0000-0003-0005-4618; Alepuz, Paula/0000-0003-1472-2373; Sumoy, Lauro/0000-0003-0005-4618				Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790	16	242	250	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2004	427	6972					370	374		10.1038/nature02258	http://dx.doi.org/10.1038/nature02258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737171				2022-12-01	WOS:000188266200045
J	Berkovitch, F; Nicolet, Y; Wan, JT; Jarrett, JT; Drennan, CL				Berkovitch, F; Nicolet, Y; Wan, JT; Jarrett, JT; Drennan, CL			Crystal structure of biotin synthase, an S-adenosylmethionine-dependent radical enzyme	SCIENCE			English	Article							LYASE ACTIVATING ENZYME; IRON-SULFUR CENTER; CLUSTER BINDING-SITES; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; <4FE-4S>(2+) CLUSTER; 4FE-4S CLUSTERS; COENZYME B-12; IN-VITRO; MOSSBAUER	The crystal structure of biotin synthase from Escherichia coli in complex with S-adenosyl-L-methionine and dethiobiotin has been determined to 3.4 angstrom resolution. This structure addresses how "AdoMet radical" or "radical SAM" enzymes use Fe4S4 clusters and S-adenosyl-L-methionine to generate organic radicals. Biotin synthase catalyzes the radical-mediated insertion of sulfur into dethiobiotin to form biotin. The structure places the substrates between the Fe4S4 cluster, essential for radical generation, and the Fe2S2 cluster, postulated to be the source of sulfur, with both clusters in unprecedented coordination environments.	MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; University of Pennsylvania	Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.		Yvain, Nicolet/AAP-9763-2020	Yvain, Nicolet/0000-0002-4189-7067; Jarrett, Joseph/0000-0002-3737-7464	NIGMS NIH HHS [R01 GM059175, R01-GM59175, R01-GM65337, T32-GM07229] Funding Source: Medline; NINDS NIH HHS [NSLS X25] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059175, R01GM065337, T32GM007229] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoki S, 2002, J AM CHEM SOC, V124, P5256, DOI 10.1021/ja020029y; Baranska M, 2002, J INORG BIOCHEM, V92, P112, DOI 10.1016/S0162-0134(02)00485-3; Benda R, 2002, BIOCHEMISTRY-US, V41, P15000, DOI 10.1021/bi026590q; Bui BTS, 2003, BIOCHEMISTRY-US, V42, P8791, DOI 10.1021/bi034426c; Bui BTS, 1998, FEBS LETT, V440, P226, DOI 10.1016/S0014-5793(98)01464-1; Bui BTS, 1999, FEBS LETT, V459, P411, DOI 10.1016/S0014-5793(99)01300-9; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Cosper MM, 2003, PROTEIN SCI, V12, P1573, DOI 10.1110/ps.0302203; Cosper MM, 2002, FEBS LETT, V529, P332, DOI 10.1016/S0014-5793(02)03390-2; Cosper MM, 2002, J AM CHEM SOC, V124, P14006, DOI 10.1021/ja0283044; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Duin EC, 1997, BIOCHEMISTRY-US, V36, P11811, DOI 10.1021/bi9706430; Escalettes F, 1999, J AM CHEM SOC, V121, P3571, DOI 10.1021/ja9811748; Fairlie DP, 1997, INORG CHEM, V36, P1020, DOI 10.1021/ic961138e; FREY PA, 1993, FASEB J, V7, P662, DOI 10.1096/fasebj.7.8.8500691; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2000, ARCH BIOCHEM BIOPHYS, V382, P6, DOI 10.1006/abbi.2000.2010; Hewitson KS, 2000, FEBS LETT, V466, P372, DOI 10.1016/S0014-5793(00)01101-7; Hewitson KS, 2002, J BIOL INORG CHEM, V7, P83, DOI 10.1007/s007750100268; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ollagnier-de Choudens S, 2000, BIOCHEMISTRY-US, V39, P4165, DOI 10.1021/bi992090u; Ollagnier-de Choudens S, 2002, J BIOL CHEM, V277, P13449, DOI 10.1074/jbc.M111324200; Ollagnier-de-Choudens S, 2002, FEBS LETT, V532, P465, DOI 10.1016/S0014-5793(02)03733-X; Ollagnier-de-Choudens S, 2002, BIOCHEMISTRY-US, V41, P9145, DOI 10.1021/bi0122011; Padovani D, 2001, BIOCHEMISTRY-US, V40, P6713, DOI 10.1021/bi002936q; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Sanyal I, 1996, ARCH BIOCHEM BIOPHYS, V326, P48, DOI 10.1006/abbi.1996.0045; SANYAL I, 1994, BIOCHEMISTRY-US, V33, P3625, DOI 10.1021/bi00178a020; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Ugulava NB, 2000, BIOCHEMISTRY-US, V39, P5206, DOI 10.1021/bi9926227; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Ugulava NB, 2002, J AM CHEM SOC, V124, P9050, DOI 10.1021/ja027004j; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8352, DOI 10.1021/bi010463x; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s	41	322	330	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					76	79		10.1126/science.1088493	http://dx.doi.org/10.1126/science.1088493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704425	Green Accepted			2022-12-01	WOS:000187710600036
J	Kerr, D				Kerr, D			Of Struldbruggs, sugar, and gatekeepers: a tale of our times	BRITISH MEDICAL JOURNAL			English	Article							PEOPLE; CARE; RISK		Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England		Kerr, D (corresponding author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.							Armitage M, 2002, CLIN MED, V2, P331, DOI 10.7861/clinmedicine.2-4-331; Basile JN, 2002, BMJ-BRIT MED J, V325, P917, DOI 10.1136/bmj.325.7370.917; Evans JMM, 2002, DIABETIC MED, V19, P685, DOI 10.1046/j.1464-5491.2002.00749.x; GRANKS P, 1992, NEW ENGL J MED, V327, P424; Gregg EW, 2002, BRIT MED J, V325, P916, DOI 10.1136/bmj.325.7370.916; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; Hampton JR, 2002, AGE AGEING, V31, P3, DOI 10.1093/ageing/31.1.3; McGouran RCM, 2002, CLIN MED, V2, P43, DOI 10.7861/clinmedicine.2-1-43; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SWIFT J, GULLIVERS TRAVELS 3, pCH10; Trewby PN, 2002, CLIN MED, V2, P527, DOI 10.7861/clinmedicine.2-6-527; WILSON AN, 2002, DAILY TELEGRAPH 0127; Winocour PH, 2002, BMJ-BRIT MED J, V324, P1577, DOI 10.1136/bmj.324.7353.1577	14	1	1	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1451	1453		10.1136/bmj.327.7429.1451	http://dx.doi.org/10.1136/bmj.327.7429.1451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684643	Green Published, Green Submitted			2022-12-01	WOS:000187562700014
J	Wechsler, A; Brafman, A; Shafir, M; Heverin, M; Gottlieb, H; Damari, G; Gozlan-Kelner, S; Spivak, I; Moshkin, O; Fridman, E; Becker, Y; Skaliter, R; Einat, P; Faerman, A; Bjorkhem, I; Feinstein, E				Wechsler, A; Brafman, A; Shafir, M; Heverin, M; Gottlieb, H; Damari, G; Gozlan-Kelner, S; Spivak, I; Moshkin, O; Fridman, E; Becker, Y; Skaliter, R; Einat, P; Faerman, A; Bjorkhem, I; Feinstein, E			Generation of viable cholesterol-free mice	SCIENCE			English	Article							MOUSE MODEL; STEROL		Quark Biotech Inc, Cleveland, OH 44106 USA; H3 30 Huddinge Univ Hosp, Karolinska Inst, Div Clin Chem, Dept Med Lab Sci & Technol, SE-14186 Huddinge, Sweden; Chaim Sheba Med Ctr, Sackler Sch Med, Dept Pathol, IL-52621 Tel Hashomer, Israel	Karolinska Institutet; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Feinstein, E (corresponding author), Quark Biotech Inc, 10265 Carnegie Ave, Cleveland, OH 44106 USA.	elenaf@qbi.co.il	Heverin, Maura B/J-4101-2012	Bjorkhem, Ingemar/0000-0002-0575-9425; Fridman, Eddie/0000-0002-0317-7085				Andersson H. C., 2000, Journal of Inherited Metabolic Disease, V23, P200; Chevy F, 2002, J LIPID RES, V43, P1192, DOI 10.1194/jlr.M200082-JLR200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI12103; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; Herz J, 1999, J NUTR, V129, p473S, DOI 10.1093/jn/129.2.473S; ROTHBLAT GH, 1970, SCIENCE, V169, P880, DOI 10.1126/science.169.3948.880; Singh SK, 2003, REPROD TOXICOL, V17, P37, DOI 10.1016/S0890-6238(02)00075-8; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555	8	144	147	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2087	2087		10.1126/science.1090776	http://dx.doi.org/10.1126/science.1090776			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684813				2022-12-01	WOS:000187385200033
J	McCulloch, SD; Kokoska, RJ; Masutani, C; Iwai, S; Hanaoka, F; Kunkel, TA				McCulloch, SD; Kokoska, RJ; Masutani, C; Iwai, S; Hanaoka, F; Kunkel, TA			Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity	NATURE			English	Article							LESION-BYPASS; XERODERMA-PIGMENTOSUM; CRYSTAL-STRUCTURE; ERROR-PRONE; POL-ETA; YEAST; SITE; GENE; SPECIFICITY; MUTAGENESIS	Human DNA polymerase eta (Pol eta) modulates susceptibility to skin cancer by promoting DNA synthesis past sunlight-induced cyclobutane pyrimidine dimers that escape nucleotide excision repair (NER)(1,2). Here we have determined the efficiency and fidelity of dimer bypass. We show that Pol eta copies thymine dimers and the flanking bases with higher processivity than it copies undamaged DNA, and then switches to less processive synthesis. This ability of Pol eta to sense the dimer location as synthesis proceeds may facilitate polymerase switching before and after lesion bypass. Pol eta bypasses a dimer with low fidelity and with higher error rates at the 3' thymine than at the 5' thymine. A similar bias is seen with Sulfolobus solfataricus DNA polymerase 4, which forms a Watson-Crick base pair at the 3' thymine of a dimer but a Hoogsteen base pair at the 5' thymine (ref. 3). Ultraviolet-induced mutagenesis is also higher at the 3' base of dipyrimidine sequences(4-6). Thus, in normal people and particularly in individuals with NER-defective xeroderma pigmentosum who accumulate dimers, errors made by Pol eta uring dimer bypass could contribute to mutagenesis and skin cancer.	NIEHS, Genet Mol Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, DHHS, Res Triangle Pk, NC 27709 USA; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Engn Sci, Div Chem, Osaka 5608531, Japan; RIKEN, Discovery Res Inst, Wako, Saitama 3510198, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Osaka University; Japan Science & Technology Agency (JST); Osaka University; RIKEN	Kunkel, TA (corresponding author), NIEHS, Genet Mol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Masutani, Chikahide/I-6160-2014	Kunkel, Thomas A./0000-0002-9900-1788; Masutani, Chikahide/0000-0002-8600-8227	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, ZIAES065070] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARMSTRONG JD, 1990, P NATL ACAD SCI USA, V87, P9005, DOI 10.1073/pnas.87.22.9005; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; DUMAZ N, 1994, MUTAT RES, V307, P375, DOI 10.1016/0027-5107(94)90311-5; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P544; HSIA HC, 1989, J MOL BIOL, V205, P103, DOI 10.1016/0022-2836(89)90368-9; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; MURATA T, 1990, NUCLEIC ACIDS RES, V18, P7279, DOI 10.1093/nar/18.24.7279; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; ODAY CL, 1992, NUCLEIC ACIDS RES, V20, P5403, DOI 10.1093/nar/20.20.5403; Ohashi E, 2000, GENE DEV, V14, P1589; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; SHCHERBAKOVA PV, 2003, SCI AGING KNOWL 0226; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Washington MT, 2003, P NATL ACAD SCI USA, V100, P12093, DOI 10.1073/pnas.2134223100; Zhang H, 2002, NUCLEIC ACIDS RES, V30, P1262, DOI 10.1093/nar/30.5.1262; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	28	209	214	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					97	100		10.1038/nature02352	http://dx.doi.org/10.1038/nature02352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999287				2022-12-01	WOS:000189363800043
J	Young, BA; Gruber, TM; Gross, CA				Young, BA; Gruber, TM; Gross, CA			Minimal machinery of RNA polymerase holoenzyme sufficient for promoter melting	SCIENCE			English	Article							SINGLE-STRANDED-DNA; OPEN COMPLEX; TRANSCRIPTION INITIATION; STRUCTURAL ORGANIZATION; ANGSTROM RESOLUTION; SIGMA FACTORS; AMINO-ACIDS; SUBUNIT; BINDING; RECOGNITION	We determined the minimal portion of Escherichia coli RNA polymerase ( RNAP) holoenzyme able to accomplish promoter melting, the crucial step in transcription initiation that provides RNAP access to the template strand. Upon duplex DNA binding, the N terminus of the beta' subunit ( amino acids 1 to 314) and amino acids 94 to 507 of the sigma subunit, together comprising less than one-fifth of RNAP holoenzyme, were able to melt an extended - 10 promoter in a reaction remarkably similar to that of authentic holoenzyme. Our results support the model that capture of nontemplate bases extruded from the DNA helix underlies the melting process.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gross, CA (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.	cgross@cgl.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057755] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 57755] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Dombroski AJ, 1997, J BIOL CHEM, V272, P3487; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fenton MS, 2001, P NATL ACAD SCI USA, V98, P9020, DOI 10.1073/pnas.161085798; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Lilley, 1997, NUCL ACIDS MOL BIOL, P41, DOI 10.1007/978-3-642-60691-5_4; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Minakhin L, 2003, J BIOL CHEM, V278, P29710, DOI 10.1074/jbc.M304906200; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tsujikawa L, 2002, BIOCHEMISTRY-US, V41, P15334, DOI 10.1021/bi026539m; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1	20	66	68	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1382	1384		10.1126/science.1092462	http://dx.doi.org/10.1126/science.1092462			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988563				2022-12-01	WOS:000189238600055
J	Kaul, P; Newby, LK; Fu, YL; Mark, DB; Califf, RM; Topol, EJ; Aylward, P; Granger, CB; Van de Werf, F; Armstrong, PW				Kaul, P; Newby, LK; Fu, YL; Mark, DB; Califf, RM; Topol, EJ; Aylward, P; Granger, CB; Van de Werf, F; Armstrong, PW		VIGOUR Grp	International differences in evolution of early discharge after acute myocardial infarction	LANCET			English	Article							RISK STRATIFICATION; COST-EFFECTIVENESS; THROMBOLYSIS; ANGIOPLASTY; SAFETY; TRIAGE	Background Early discharge of low-risk patients with acute myocardial infarction is feasible and can be achieved at no additional risk of adverse events. We aimed to identify the extent to which countries have taken advantage of the opportunity for early discharge. Methods The study population consisted of 54 174 patients enrolled in GUSTO-I, GUSTO-III, and ASSENT-2 studies (enrolment period 1990-98) in the USA, Canada, Australia, New Zealand, Belgium, France, Germany, Spain, and Poland. We identified patients with uncomplicated acute myocardial infarction who were eligible for early discharge on the basis of previously established criteria, and assessed the extent to which these patients were discharged early-defined as discharged alive within 4 days of admission. The economic consequences (defined as potentially unnecessary hospital days consumed per 100 patients enrolled) were also investigated. Findings Patients in all European countries had significantly longer stays than did those from. non-European countries. Over the study period, the number of eligible patients discharged on or before day 4 increased in the USA, Canada, Australia, and New Zealand. Despite this increase, no more than 40% of patients who were eligible for early discharge were actually discharged early. The rate of early discharge of eligible patients was consistently low (<2%) in Belgium, France, Germany, Spain, and Poland. In ASSENT-2, which is the most recent trial in this study, the number of potentially unnecessary hospital days (per 100 patients enrolled) ranged from 65 in New Zealand to 839 in Germany. Interpretation Despite more than a decade of research, there is still a lot of variation between countries in international length-of-stay patterns in acute myocardial infarction. The potential for more efficient discharge of low-risk patients exists in all countries investigated, but was especially evident in the European countries included in the study (Belgium, France, Germany, Spain, and Poland).	Univ Alberta, Edmonton, AB T6G 2B7, Canada; Duke Clin Res Inst, Durham, NC USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Flinders Med Ctr, Adelaide, SA, Australia; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium	University of Alberta; Duke University; Cleveland Clinic Foundation; Flinders Medical Centre; KU Leuven; University Hospital Leuven	Kaul, P (corresponding author), Univ Alberta, 7221 Aberhart Ctr I, Edmonton, AB T6G 2B7, Canada.	pkaul@ualberta.ca	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291; Van de Werf, Frans/0000-0001-9479-7767; Aylward, Philip/0000-0002-5358-8552; Armstrong, Paul/0000-0002-0460-3445; Kaul, Padma/0000-0003-2239-3944; Mark, Daniel/0000-0001-6340-8087; Topol, Eric/0000-0002-1478-4729				DIXON A, 2002, HLTH CARE SYSTEMS 8; Every NR, 1996, J AM COLL CARDIOL, V28, P287, DOI 10.1016/0735-1097(96)00168-4; Fu YL, 2001, CIRCULATION, V104, P2653, DOI 10.1161/hc4701.099731; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; HARPUR JE, 1971, LANCET, V2, P1331; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; MARK DB, 1991, CIRCULATION, V83, P1186, DOI 10.1161/01.CIR.83.4.1186; Morrow DA, 2001, LANCET, V358, P1571, DOI 10.1016/S0140-6736(01)06649-1; Newby LK, 1996, J AM COLL CARDIOL, V27, P625; Newby LK, 2000, NEW ENGL J MED, V342, P749, DOI 10.1056/NEJM200003163421101; Ohman EM, 1999, AM J CARDIOL, V84, P1281, DOI 10.1016/S0002-9149(99)00558-5; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SANZ G, 1993, J AM COLL CARDIOL, V22, P1795, DOI 10.1016/0735-1097(93)90759-T; Snijders T., 1999, MULTILEVEL ANAL INTR; Stubbs P, 1996, CIRCULATION, V94, P1291, DOI 10.1161/01.CIR.94.6.1291; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TOPOL EJ, 1988, NEW ENGL J MED, V318, P1083, DOI 10.1056/NEJM198804283181702; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8	21	51	51	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2004	363	9408					511	517		10.1016/S0140-6736(04)15536-0	http://dx.doi.org/10.1016/S0140-6736(04)15536-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TA	14975612				2022-12-01	WOS:000188999900007
J	Lin, L; Spoor, MS; Gerth, AJ; Brody, SL; Peng, SL				Lin, L; Spoor, MS; Gerth, AJ; Brody, SL; Peng, SL			Modulation of Th1 activation and inflammation by the NF-kappa B repressor Foxj1	SCIENCE			English	Article							T-CELL; TRANSCRIPTION FACTORS; EXPRESSION; INDUCTION; REGULATOR; FAMILY; FOXP3; ALPHA; MICE	Forkhead transcription factors play key roles in the regulation of immune responses. Here, we identify a role for one member of this family, Foxj1, in the regulation of T cell activation and autoreactivity. Foxj1 deficiency resulted in multiorgan systemic inflammation, exaggerated Th1 cytokine production, and T cell proliferation in autologous mixed lymphocyte reactions. Foxj1 suppressed NF-kappaB transcription activity in vitro, and Foxj1-deficient T cells possessed increased NF-kappaB activity in vivo, correlating with the ability of Foxj1 to regulate IkappaB proteins, particularly IkappaBbeta. Thus, Foxj1 likely modulates inflammatory reactions and prevents autoimmunity by antagonizing proinflammatory transcriptional activities. These results suggest a potentially general role for forkhead genes in the enforcement of lymphocyte quiescence.	Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Peng, SL (corresponding author), Washington Univ, Sch Med, Div Rheumatol, 660 S Euclid Ave, St Louis, MO 63110 USA.	speng@im.wustl.edu	Peng, Stanford/S-6723-2019	Peng, Stanford/0000-0001-7445-2542	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063988, R01HL056244, R29HL056244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001803, R01AI057471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56244, HL63988] Funding Source: Medline; NIAID NIH HHS [AI057471, AI01803] Funding Source: Medline; NIDDK NIH HHS [DK52574] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Burgos P, 2000, J RHEUMATOL, V27, P116; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kaestner KH, 2000, GENE DEV, V14, P142; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LIN LL, UNPUB; Liu JJ, 2002, J IMMUNOL, V169, P581, DOI 10.4049/jimmunol.169.1.581; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Vallabhapurapu S, 2001, EUR J IMMUNOL, V31, P2612, DOI 10.1002/1521-4141(200109)31:9<2612::AID-IMMU2612>3.0.CO;2-C	22	112	123	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1017	1020		10.1126/science.1093889	http://dx.doi.org/10.1126/science.1093889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963332				2022-12-01	WOS:000188918000047
J	Shin, C; Feng, Y; Manley, JL				Shin, C; Feng, Y; Manley, JL			Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock	NATURE			English	Article							HELA-CELLS; NUCLEAR RIBONUCLEOPROTEINS; PROTEIN-PROTEIN; SR PROTEINS; ASF/SF2; STRESS; PHOSPHORYLATION; INACTIVATION; RECOGNITION; INHIBITION	The cellular response to stresses such as heat shock involves changes in gene expression(1). It is well known that the splicing of messenger RNA precursors is generally repressed on heat shock(2,3), but the factors responsible have not been identified(4-8). SRp38 is an SR protein splicing factor(9,10) that functions as a general repressor of splicing. It is activated by dephosphorylation and required for splicing repression in M-phase cells(11). Here we show that SRp38 is also dephosphorylated on heat shock and that this dephosphorylation correlates with splicing inhibition. Notably, depletion of SRp38 from heat-shocked cell extracts derepresses splicing, and adding back dephosphorylated SRp38 specifically restores inhibition. We further show that dephosphorylated SRp38 interacts with a U1 small nuclear ribonucleoprotein particle (snRNP) protein, and that this interaction interferes with 5'-splice-site recognition by the U1 snRNP. Finally, SRp38-deficient DT40 cells show an altered cell-cycle profile consistent with a mitotic defect; they are also temperature sensitive and defective in recovery after heat shock. SRp38 thus plays a crucial role in cell survival under stress conditions by inhibiting the splicing machinery.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu		Manley, James/0000-0002-8341-1459				ARRIGO AP, 1981, MOL GEN GENET, V184, P73, DOI 10.1007/BF00271198; BOND U, 1988, EMBO J, V7, P3509, DOI 10.1002/j.1460-2075.1988.tb03227.x; Bond U, 2000, INT J BIOCHEM CELL B, V32, P643, DOI 10.1016/S1357-2725(00)00008-X; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Dubois MF, 1999, NUCLEIC ACIDS RES, V27, P1338, DOI 10.1093/nar/27.5.1338; Fukagawa T, 2001, NUCLEIC ACIDS RES, V29, P3796, DOI 10.1093/nar/29.18.3796; Gattoni R, 1996, NUCLEIC ACIDS RES, V24, P2535, DOI 10.1093/nar/24.13.2535; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; HALL KB, 1992, P NATL ACAD SCI USA, V89, P10969, DOI 10.1073/pnas.89.22.10969; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Labourier E, 1999, GENE DEV, V13, P740, DOI 10.1101/gad.13.6.740; Mahe D, 1997, J BIOL CHEM, V272, P1827, DOI 10.1074/jbc.272.3.1827; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; SHUKLA RR, 1990, J BIOL CHEM, V265, P20377; UTANS U, 1992, GENE DEV, V6, P631, DOI 10.1101/gad.6.4.631; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; VOGEL JL, 1995, CURR BIOL, V5, P306, DOI 10.1016/S0960-9822(95)00061-3; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; YOST HJ, 1990, TRENDS GENET, V6, P223, DOI 10.1016/0168-9525(90)90183-7; YOST HJ, 1986, CELL, V45, P185, DOI 10.1016/0092-8674(86)90382-X	25	169	179	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					553	558		10.1038/nature02288	http://dx.doi.org/10.1038/nature02288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765198				2022-12-01	WOS:000188721800044
J	Yildiz, A; Tomishige, M; Vale, RD; Selvin, PR				Yildiz, A; Tomishige, M; Vale, RD; Selvin, PR			Kinesin walks hand-over-hand	SCIENCE			English	Article							MYOSIN-V; MOTOR; MOTILITY; MOVEMENT; BINDING	Kinesin is a processive motor that takes 8.3-nm center-of-mass steps along microtubules for each adenosine triphosphate hydrolyzed. Whether kinesin moves by a "hand-over-hand" or an "inchworm" model has been controversial. We have labeled a single head of the kinesin dimer with a Cy3 fluorophore and localized the position of the dye to within 2 nm before and after a step. We observed that single kinesin heads take steps of 17.3 +/- 3.3 nm. A kinetic analysis of the dwell times between steps shows that the 17-nm steps alternate with 0-nm steps. These results strongly support a hand-over-hand mechanism, and not an inchworm mechanism. In addition, our results suggest that kinesin is bound by both heads to the microtubule while it waits for adenosine triphosphate in between steps.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Selvin, PR (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	selvin@uiuc.edu	Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X	NIAMS NIH HHS [AR42895, AR44420] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895, R29AR044420, R01AR044420] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; Bartko AP, 1999, J PHYS CHEM B, V103, P11237, DOI 10.1021/jp993364q; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	20	691	722	5	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					676	678		10.1126/science.1093753	http://dx.doi.org/10.1126/science.1093753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14684828				2022-12-01	WOS:000188530800042
J	Moody, DB; Young, DC; Cheng, TY; Rosat, JP; Roura-mir, C; O'Connor, PB; Zajonc, DM; Walz, A; Miller, MJ; Levery, SB; Wilson, IA; Costello, CE; Brenner, MB				Moody, DB; Young, DC; Cheng, TY; Rosat, JP; Roura-mir, C; O'Connor, PB; Zajonc, DM; Walz, A; Miller, MJ; Levery, SB; Wilson, IA; Costello, CE; Brenner, MB			T cell activation by lipopeptide antigens	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; IRON ACQUISITION; LYMPHOCYTES-T; RECOGNITION; INFECTION; ANGSTROM; COMPLEX; CD1; RECEPTOR	Unlike major histocompatibility proteins, which bind peptides, CD1 proteins display lipid antigens to T cells. Here, we report that CD1a presents a family of previously unknown lipopeptides from Mycobacterium tuberculosis, named didehydroxymycobactins because of their structural relation to mycobactin siderophores. T cell activation was mediated by the alphabeta T cell receptors and was specific for structure of the acyl and peptidic components of these antigens. These studies identify a means of intracellular pathogen detection and identify lipopeptides as a biochemical class of antigens for T cells, which, like conventional peptides, have a potential for marked structural diversity.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Mass Spectrometry Resource, Boston, MA 02115 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; Univ New Hampshire, Dept Chem, Durham, NH 03834 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; University of Notre Dame; University System Of New Hampshire; University of New Hampshire; Scripps Research Institute; Scripps Research Institute	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Smith Bldg Room 514,1 Jimmy Fund Way, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu	Roura-Mir, Carme/D-4538-2013; OConnor, Peter/C-2117-2009	Roura-Mir, Carme/0000-0003-0514-337X; OConnor, Peter/0000-0002-6588-6274; Costello, Catherine/0000-0003-1594-5122	NCI NIH HHS [CA58896] Funding Source: Medline; NCRR NIH HHS [P20 RR16459, P41-RR10888, S10-RR10493] Funding Source: Medline; NIAID NIH HHS [AI30988, AI50216] Funding Source: Medline; NIAMS NIH HHS [AR48632] Funding Source: Medline; NIGMS NIH HHS [GM62116, GM25845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888, P20RR016459, S10RR010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030988, R01AI050216, R21AI050216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025845, U54GM062116] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; FITHIAN E, 1981, P NATL ACAD SCI-BIOL, V78, P2541, DOI 10.1073/pnas.78.4.2541; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Honey K, 2002, NAT IMMUNOL, V3, P1069, DOI 10.1038/ni844; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MOODY DC, UNPUB; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rosat JP, 1999, J IMMUNOL, V162, P366; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; SNOW GA, 1970, BACTERIOL REV, V34, P99, DOI 10.1128/MMBR.34.2.99-125.1970; Stenger S, 1998, J IMMUNOL, V161, P3582; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Tsukamoto M, 1997, J ANTIBIOT, V50, P815, DOI 10.7164/antibiotics.50.815; Vergne AF, 2000, NAT PROD REP, V17, P99, DOI 10.1039/a809397k; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	35	209	216	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					527	531		10.1126/science.1089353	http://dx.doi.org/10.1126/science.1089353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739458				2022-12-01	WOS:000188316400039
J	Matloubian, M; Lo, CG; Cinamon, G; Lesneski, MJ; Xu, Y; Brinkmann, V; Allende, ML; Proia, RL; Cyster, JG				Matloubian, M; Lo, CG; Cinamon, G; Lesneski, MJ; Xu, Y; Brinkmann, V; Allende, ML; Proia, RL; Cyster, JG			Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; THYMOCYTE EMIGRATION; SPHINGOSINE-1-PHOSPHATE; MATURATION; FTY720; IMMUNOSUPPRESSANT; RESPONSIVENESS; KINASE	Adaptive immunity depends on T- cell exit from the thymus and T and B cells travelling between secondary lymphoid organs to survey for antigens. After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown. An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate ( S1P) receptors(1-4). However, the role of S1P receptors in normal immune cell trafficking is unclear. Here we show that in mice whose haematopoietic cells lack a single S1P receptor ( S1P(1); also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus. Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph. Adoptive cell transfer experiments establish an intrinsic requirement for S1P(1) in T and B cells for lymphoid organ egress. Furthermore, S1P(1)- dependent chemotactic responsiveness is strongly upregulated in T- cell development before exit from the thymus, whereas S1P(1) is downregulated during peripheral lymphocyte activation, and this is associated with retention in lymphoid organs. We find that FTY720 treatment downregulates S1P(1), creating a temporary pharmacological S1P(1)- null state in lymphocytes, providing an explanation for the mechanism of FTY720- induced lymphocyte sequestration. These findings establish that S1P(1) is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu	Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Caligan TB, 2000, ANAL BIOCHEM, V281, P36, DOI 10.1006/abio.2000.4555; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Chiba K, 1998, J IMMUNOL, V160, P5037; Chu P, 2003, J BIOL, V2, P211; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; Graessley W. W, 1974, ADV POLYM SCI, V16, P1; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hla T, 2001, PROSTAG OTH LIPID M, V64, P135, DOI 10.1016/S0090-6980(01)00109-5; Idzko M, 2002, FASEB J, V16, P625, DOI 10.1096/fj.01-0625fje; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; LUCAS B, 1994, J IMMUNOL, V153, P53; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; PARROTT DMV, 1971, CLIN EXP IMMUNOL, V8, P663; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O	24	1934	2027	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2004	427	6972					355	360		10.1038/nature02284	http://dx.doi.org/10.1038/nature02284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737169				2022-12-01	WOS:000188266200042
J	Checkley, W; Gilman, RH; Black, RE; Epstein, LD; Cabrera, L; Sterling, CR; Moulton, LH				Checkley, W; Gilman, RH; Black, RE; Epstein, LD; Cabrera, L; Sterling, CR; Moulton, LH			Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community	LANCET			English	Article							NUTRITIONAL-STATUS; RURAL BANGLADESH; YOUNG-CHILDREN; ENVIRONMENTAL SANITATION; DEVELOPING-COUNTRIES; DIARRHEAL DISEASES; INFANT-MORTALITY; GROWTH; DETERMINANTS; INFECTION	Background Inadequate water and sanitation adversely affect the health of children in developing countries. We aimed to assess the effects of water and sanitation on childhood health in a birth cohort of Peruvian children. Methods We followed up children once a day for diarrhoea and once a month for anthropometry, and obtained data for household water and sanitation at baseline. Findings At 24 months of age, children with the worst conditions for water source, water storage, and sanitation were 1.0 cm (95% CI 0.1-0.8) shorter and had 54% (-1 to 240) more diarrhoeal episodes than did those with the best conditions. Children from households with small storage containers had 28% (1-63) more diarrhoeal episodes than did children from households with large containers. Lack of adequate sewage disposal explained a height deficit of 0.9 cm (0.2-1.7) at 24 months of age. Better water source alone did not accomplish full health benefits. In 24-month-old children from households with a water connection, those in households without adequate sewage disposal and with small storage containers were 1.8 cm (0.1-3.6) shorter than children in households with sewage and with large storage containers. Interpretation Our findings show that nutritional status is a useful endpoint for water and sanitation interventions and underscores the need to improve sanitation in developing countries. Improved and more reliable water sources should discourage water storage at risk of becoming contaminated, decrease diarrhoeal incidence, and improve linear growth in children.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; Proyectos Informat Salud Med & Agr, Lima, Peru; Catholic Univ Chile, Dept Estadist, Santiago, Chile; Univ Arizona, Dept Vet Sci, Tucson, AZ 85721 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pontificia Universidad Catolica de Chile; University of Arizona	Checkley, W (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St W5515, Baltimore, MD 21205 USA.	wcheckle@jhsph.edu		Moulton, Lawrence/0000-0001-7041-7387; Black, Robert/0000-0001-9926-7984; Checkley, William/0000-0003-1106-8812	NICHD NIH HHS [F31-HD08488] Funding Source: Medline; PHS HHS [U01-A135894] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD008488] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; ANDRIANZEN BT, 1974, ARCH ENVIRON HEALTH, V28, P312; ARROWOOD MJ, 1997, CRYPTOSPORIDIUM CRYP, P43; AZIZ KMA, 1990, T ROY SOC TROP MED H, V84, P433, DOI 10.1016/0035-9203(90)90353-G; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Checkley W, 1997, AM J EPIDEMIOL, V145, P156, DOI 10.1093/oxfordjournals.aje.a009086; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Checkley W, 2002, J PEDIATR-US, V140, P210, DOI 10.1067/mpd.2002.121820; CHRISTIANSEN N, 1975, BRIT J PREV SOC MED, V29, P121; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1988, AM J PUBLIC HEALTH, V78, P1451, DOI 10.2105/AJPH.78.11.1451; ESREY SA, 1986, EPIDEMIOL REV, V8, P117, DOI 10.1093/oxfordjournals.epirev.a036290; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608, DOI 10.1093/oxfordjournals.aje.a008791; GILMAN RH, 1993, AM J PUBLIC HEALTH, V83, P1554, DOI 10.2105/AJPH.83.11.1554; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5; HASAN KZ, 1989, EUR J CLIN NUTR, V43, P837; HENRY FI, 1981, T ROY SOC TROP MED H, V75, P507, DOI 10.1016/0035-9203(81)90187-5; HERBERT J R, 1984, Tropical and Geographical Medicine, V36, P375; Herbert JR., 1985, B WORLD HEALTH ORGAN, V63, P143; HUTTLY S R A, 1990, World Health Statistics Quarterly, V43, P118; Huttly SRA, 1997, B WORLD HEALTH ORGAN, V75, P163; HUTTLY SRA, 1990, T ROY SOC TROP MED H, V84, P316, DOI 10.1016/0035-9203(90)90300-4; Jonnalagadda Padmaja R., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P789; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LINDSKOG U, 1987, HUM NUTR-CLIN NUTR, V41C, P409; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; MINTZ ED, 1996, JAMA-J AM MED ASSOC, V273, P948; Moulton LH, 1997, INT J EPIDEMIOL, V26, P1334, DOI 10.1093/ije/26.6.1334; Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590; PICKERING H, 1985, SOC SCI MED, V21, P121, DOI 10.1016/0277-9536(85)90080-2; PRESTON SH, 1978, POP STUD-J DEMOG, V32, P275, DOI 10.2307/2173562; RAHMAN M, 1985, LANCET, V2, P28, DOI 10.1016/S0140-6736(85)90068-6; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; TOMKINS AM, 1978, T ROY SOC TROP MED H, V72, P239, DOI 10.1016/0035-9203(78)90201-8; VANPOPPEL, 1997, HLTH TRANSIT REV, V7, P113; VICTORA CG, 1988, INT J EPIDEMIOL, V17, P651, DOI 10.1093/ije/17.3.651; *WHO, 1992, WHOCWS9212; YEAGER BAC, 1991, J DIARRHOEAL DIS RES, V9, P186	41	163	174	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2004	363	9403					112	118		10.1016/S0140-6736(03)15261-0	http://dx.doi.org/10.1016/S0140-6736(03)15261-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761WV	14726164				2022-12-01	WOS:000187939200008
J	Sung, SB; Amasino, RM				Sung, SB; Amasino, RM			Vernalization in Arabidopsis thaliana is mediated by the PHD finger protein VIN3	NATURE			English	Article							FLOWERING-LOCUS-C; DNA METHYLATION; MOLECULAR-BASIS; FRIGIDA; GENE; MUTATIONS; PHENOTYPE; REPRESSOR; ACTS	In biennials and winter annuals, flowering is typically blocked in the first growing season. Exposure to the prolonged cold of winter, through a process called vernalization, is required to alleviate this block and permit flowering in the second growing season(1). In winter-annual types of Arabidopsis thaliana, a flowering repressor, FLOWERING LOCUS C (FLC), is expressed at levels that inhibit flowering in the first growing season(2). Vernalization promotes flowering by causing a repression of FLC that is mitotically stable after return to warmgrowing conditions(2). Here we identify a gene with a function in the measurement of the duration of cold exposure and in the establishment of the vernalized state. We show that this silencing involves changes in the modification of histones in FLC chromatin.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Amasino, RM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	amasino@biochem.wisc.edu	Sung, Sibum/AAM-6500-2020					BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; LANG A, 1947, Z NATURFORSCH B, V2, P444, DOI 10.1515/znb-1947-11-1212; Lang A, 1965, ENCY PLANT PHYSL, P1371, DOI DOI 10.1007/978-3-642-50088-6_39; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Michaels SD, 2000, PLANT CELL ENVIRON, V23, P1145, DOI 10.1046/j.1365-3040.2000.00643.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Micheals SD, 1999, DEV GENET, V25, P194, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;194::AID-DVG2&gt;3.0.CO;2-2; Reyes JC, 2002, PLANT PHYSIOL, V130, P1090, DOI 10.1104/pp.006791; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WELLENSIEK SJ, 1962, NATURE, V195, P307, DOI 10.1038/195307a0	30	624	697	7	164	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					159	164		10.1038/nature02195	http://dx.doi.org/10.1038/nature02195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712276				2022-12-01	WOS:000187863900036
J	Pitulko, VV; Nikolsky, PA; Girya, EY; Basilyan, AE; Tumskoy, VE; Koulakov, SA; Astakhov, SN; Pavlova, EY; Anisimov, MA				Pitulko, VV; Nikolsky, PA; Girya, EY; Basilyan, AE; Tumskoy, VE; Koulakov, SA; Astakhov, SN; Pavlova, EY; Anisimov, MA			The Yana RHS site: Humans in the Arctic before the Last Glacial Maximum	SCIENCE			English	Article							COLONIZATION; PLEISTOCENE	A newly discovered Paleolithic site on the Yana River, Siberia, at 71degreesN, lies well above the Arctic circle and dates to 27,000 radiocarbon years before present, during glacial times. This age is twice that of other known human occupations in any Arctic region. Artifacts at the site include a rare rhinoceros foreshaft, other mammoth foreshafts, and a wide variety of tools and flakes. This site shows that people adapted to this harsh, high-latitude, Late Pleistocene environment much earlier than previously thought.	Russian Acad Sci, Inst Hist Mat Culture, St Petersburg 191186, Russia; Russian Acad Sci, Inst Geol, Moscow 119017, Russia; Moscow MV Lomonosov State Univ, Fac Geog, Geol Res Lab N, Moscow 119992, Russia; Arctic & Antarctic Res Inst, St Petersburg 199397, Russia	Russian Academy of Sciences; Institute for the History of Material Culture, Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; Lomonosov Moscow State University; Arctic & Antarctic Research Institute	Pitulko, VV (corresponding author), Russian Acad Sci, Inst Hist Mat Culture, 18 Dvortsovaya Nab St, St Petersburg 191186, Russia.	archeo@archeo.ru	Nikolskiy, Pavel A/C-5041-2012; Girya, Evgeniy/AAC-5774-2020; Pitulko, Vladimir/N-4009-2019; Pitulko, Vladimir/E-2200-2015; Astakhov, Sergej/AAC-5889-2020; Pavlova, Elena/AAA-3291-2019; Tumskoy, Vladimir E./Y-5682-2018	Pitulko, Vladimir/0000-0001-5672-2756; Astakhov, Sergej/0000-0001-9266-3001; Tumskoy, Vladimir E./0000-0002-1462-1444; Pavlova, Elena/0000-0002-3010-6290				ANDERSON PM, 2001, QUATERNARY SCI REV, V20, P99; Bradley B., 1995, TRAVAIL USAGE IVOIRE, P114; Dunbar J., 1989, BONE MODIFICATION, P473; DUNBUR J, 1991, HALF MILE RISE TIMES, V1, P10; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Hoffecker JF, 2003, EVOL ANTHROPOL, V12, P34, DOI 10.1002/evan.10103; Kaplina T.N., 1982, IZVESTIYA SSSR P SSS, V2, P84; KARTASHOVA GG, 1983, VESTN MOSK U GEOGR, V6, P37; LAUKHIN SA, 1991, INQUA INT S STRAT CO, P133; MIKHALEV V, 1992, ARCHAEOLOGICAL RES Y, P47; MOCHANOV YA, 1977, EARLY STAGES HUMAN O; PAVLIDIS YA, 1992, SHELF MIROVOGO OKEAN; Pitul'ko V, 2001, QUATERNARY SCI REV, V20, P267, DOI 10.1016/S0277-3791(00)00117-7; Scherbakova N.M., 1980, NOVOYE ARKHEOLOGII Y, P62; SULERZHITSKY L, 1997, CRYOSPHERA EARTH, V1, P27; VANGHENHEIM EA, SPECIES IDENTIFICATI; Vereschagin N. K., 1972, SOVETSKAYA ARKHEOLOG, V3, P332; WEST FH, 1996, AM BEGINNINGS	20	206	220	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					52	56		10.1126/science.1085219	http://dx.doi.org/10.1126/science.1085219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704419				2022-12-01	WOS:000187710600028
J	Raxworthy, CJ; Martinez-Meyer, E; Horning, N; Nussbaum, RA; Schneider, GE; Ortega-Huerta, MA; Peterson, AT				Raxworthy, CJ; Martinez-Meyer, E; Horning, N; Nussbaum, RA; Schneider, GE; Ortega-Huerta, MA; Peterson, AT			Predicting distributions of known and unknown reptile species in Madagascar	NATURE			English	Article							BIODIVERSITY HOTSPOTS; FUTURE	Despite the importance of tropical biodiversity(1), informative species distributional data are seldom available for biogeographical study or setting conservation priorities(2,3). Modelling ecological niche distributions of species offers a potential soluion(4-7); however, the utility of old locality data from museums, and of more recent remotely sensed satellite data, remains poorly explored, especially for rapidly changing tropical landscapes. Using 29 modern data sets of environmental land coverage and 621 chameleon occurrence localities from Madagascar ( historical and recent), here we demonstrate a significant ability of our niche models in predicting species distribution. At 11 recently inventoried sites, highest predictive success (85.1%) was obtained for models based only on modern occurrence data (74.7% and 82.8% predictive success, respectively, for pre-1978 and all data combined). Notably, these models also identified three intersecting areas of over-prediction that recently yielded seven chameleon species new to science. We conclude that ecological niche modelling using recent locality records and readily available environmental coverage data provides informative biogeographical data for poorly known tropical landscapes, and offers innovative potential for the discovery of unknown distributional areas and unknown species.	Amer Museum Nat Hist, New York, NY 10024 USA; Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	American Museum of Natural History (AMNH); Universidad Nacional Autonoma de Mexico; University of Michigan System; University of Michigan; University of Kansas; University of Kansas	Raxworthy, CJ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	rax@amnh.org	Peterson, A. Townsend/I-5697-2013; Martinez-Meyer, Enrique/B-1464-2008	Peterson, A. Townsend/0000-0003-0243-2379; Martinez-Meyer, Enrique/0000-0003-1184-9264				Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andreone F, 2001, ITAL J ZOOL, V68, P235, DOI 10.1080/11250000109356414; ANGAP (Association nationale pour la Gestion des Aires protegees), 2001, PLAN GEST RES NAT AI; Brygoo E. R., 1971, Faune de Madagascar, V33, P1; Brygoo E.-R., 1978, Faune de Madagascar, V47, P1; Crisci JV, 2001, J BIOGEOGR, V28, P157, DOI 10.1046/j.1365-2699.2001.00523.x; *ESRI, 1997, ARCATLAS; Goodman S.M., 1998, AKONNY ALA, V24, P19; GOODMAN S. M., 2002, AKONNY ALA, V28, P1; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Martinez-Meyer E., 2002, THESIS U KANSAS; Mayaux P, 2000, INT J REMOTE SENS, V21, P3139, DOI 10.1080/01431160050145018; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELSON R, 1993, INT J REMOTE SENS, V14, P1463, DOI 10.1080/01431169308953981; New M., 1997, 1961 1990 MEAN MONTH; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P617; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; RAKOTOMALALA D, 2001, RECH DEV SERIE SCI B, V17, P133; Rakotomalala Domoina, 2002, Boissiera, V59, P339; Raselimanana A.P., 1998, RECHERCHES DEV SB, V13, P43; RASELIMANANA AP, 1998, RECHERCHES DEV SB, V14, P183; Rasolonandrasana AP, 1999, RECHERCHES POUR LE D, V15; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2	30	381	418	6	121	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					837	841		10.1038/nature02205	http://dx.doi.org/10.1038/nature02205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685238	Green Published			2022-12-01	WOS:000187342000058
J	Dewar, H; Tanaka, K; Nasmyth, K; Tanaka, TU				Dewar, H; Tanaka, K; Nasmyth, K; Tanaka, TU			Tension between two kinetochores suffices for their bi-orientation on the mitotic spindle	NATURE			English	Article							DNA TOPOISOMERASE-II; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; AURORA-B; MICROTUBULE ATTACHMENT; PRECOCIOUS SEPARATION; PROTEIN-KINASE; MITOSIS; INCENP	The movement of sister chromatids to opposite spindle poles during anaphase depends on the prior capture of sister kinetochores by microtubules with opposing orientations (amphitelic attachment or bi-orientation)(1). In addition to proteins necessary for the kinetochore-microtubule attachment, bi-orientation requires the Ipl1 (Aurora B in animal cells) protein kinase(2-7) and tethering of sister chromatids by cohesin(8,9). Syntelic attachments, in which sister kinetochores attach to microtubules with the same orientation, must be either 'avoided' or 'corrected'. Avoidance might be facilitated by the juxtaposition of sister kinetochores such that they face in opposite directions; kinetochore geometry is therefore deemed important. Error correction, by contrast, is thought to stem from the stabilization of kinetochore-spindle pole connections by tension in microtubules, kinetochores, or the surrounding chromatin arising from amphitelic but not syntelic attachment(10,11). The tension model predicts that any type of connection between two kinetochores suffices for efficient bi-orientation. Here we show that the two kinetochores of engineered, unreplicated dicentric chromosomes in Saccharomyces cerevisiae bi-orient efficiently, implying that sister kinetochore geometry is dispensable for bi-orientation. We also show that Ipl1 facilitates bi-orientation by promoting the turnover of kinetochore-spindle pole connections in a tension-dependent manner.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Dundee; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Tanaka, TU (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	Tanaka, Tomoyuki U/A-4775-2008; Tanaka, Kozo/Y-6566-2018	Nasmyth, Kim/0000-0001-7030-4403; Tanaka, Kozo/0000-0001-6086-2858; Tanaka, Tomoyuki/0000-0002-9886-5947				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; HEGEMANN JH, 1993, BIOESSAYS, V15, P451, DOI 10.1002/bies.950150704; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; MATSUZAKI H, 1990, J BACTERIOL, V172, P610, DOI 10.1128/jb.172.2.610-618.1990; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Thrower DA, 2001, MOL BIOL CELL, V12, P2800, DOI 10.1091/mbc.12.9.2800; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	31	151	154	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					93	97		10.1038/nature02328	http://dx.doi.org/10.1038/nature02328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14961024				2022-12-01	WOS:000189363800042
J	Chan, SWL; Zilberman, D; Xie, ZX; Johansen, LK; Carrington, JC; Jacobsen, SE				Chan, SWL; Zilberman, D; Xie, ZX; Johansen, LK; Carrington, JC; Jacobsen, SE			RNA silencing genes control de novo DNA methylation	SCIENCE			English	Article							DRM		Univ Calif Los Angeles, Dept MCD Biol, Los Angeles, CA 90095 USA; Oregon State Univ, CGRB, Corvallis, OR 97331 USA; Oregon State Univ, Bot Plant Pathol Dept, Corvallis, OR 97331 USA	University of California System; University of California Los Angeles; Oregon State University; Oregon State University	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept MCD Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Carrington, James C/A-4656-2012	Carrington, James C/0000-0003-3572-129X; Zilberman, Daniel/0000-0002-0123-8649; Xie, Zhixin/0000-0002-6191-5170	NIGMS NIH HHS [GM60398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; XIE Z, IN PRESS PLOS BIOL; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	8	412	453	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1336	1336		10.1126/science.1095989	http://dx.doi.org/10.1126/science.1095989			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988555				2022-12-01	WOS:000189238600041
J	Song, YM; Sung, JH; Lawlor, DA; Smith, GD; Shin, YS; Ebrahim, S				Song, YM; Sung, JH; Lawlor, DA; Smith, GD; Shin, YS; Ebrahim, S			Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; CHOLESTEROL		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; Kangweon Natl Univ, Coll Med, Dept Prevent Med, Chunchon, Kangwon Do, South Korea; Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea	University of Bristol; Sungkyunkwan University (SKKU); Samsung Medical Center; Kangwon National University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Ebrahim, S (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	shah.ebrahim@bristol.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				Lawlor DA, 2002, LANCET, V360, P1818, DOI 10.1016/S0140-6736(02)11769-7; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; McCarron P, 2001, BMJ-BRIT MED J, V322, P885, DOI 10.1136/bmj.322.7291.885; Rodgers A, 1998, LANCET, V352, P1801; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272	5	38	41	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2004	328	7435					324	325		10.1136/bmj.328.7435.324	http://dx.doi.org/10.1136/bmj.328.7435.324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773ME	14764495	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000188926900022
J	Hardy, J; Francis, KP; DeBoer, M; Chu, P; Gibbs, K; Contag, CH				Hardy, J; Francis, KP; DeBoer, M; Chu, P; Gibbs, K; Contag, CH			Extracellular replication of Listeria monocytogenes in the murine gall bladder	SCIENCE			English	Article							INFECTIONS	The bacterium Listeria monocytogenes can cause a life-threatening systemic illness in humans. Despite decades of progress in animal models of listeriosis, much remains unknown about the processes of infection and colonization. Here, we report that L. monocytogenes can replicate in the murine gall bladder and provide evidence that its replication there is extracellular and intraluminal. In vivo bioluminescence imaging was employed to determine the location of the infection over time in live animals, revealing strong signals from the gall bladder over a period of several days, in diseased as well as asymptomatic animals. The data suggest that L. monocytogenes may be carried in the human gall bladder.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Xenogen Corp, Alameda, CA 94501 USA	Stanford University; Stanford University; Stanford University	Contag, CH (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	ccontag@cmgm.stanford.edu	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022; Hardy, Jonathan/AAO-9306-2020	Hamblin, Michael R/0000-0001-6431-4605; Gibbs, Karine/0000-0002-1246-6401; Contag, Christopher/0000-0002-1011-8278	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037543] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD37543] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRIONES V, 1992, AM J VET RES, V53, P191; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Crum Nancy F, 2002, Curr Gastroenterol Rep, V4, P287, DOI 10.1007/s11894-002-0078-z; Dramsi S, 2002, J CELL BIOL, V156, P943, DOI 10.1083/jcb.200202121; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; GORDON S, 1986, J INFECT DIS, V154, P918, DOI 10.1093/infdis/154.5.918; HARDY JG, UNPUB; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Smith GA, 1997, TRENDS MICROBIOL, V5, P272, DOI 10.1016/S0966-842X(97)01048-2	16	184	200	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					851	853		10.1126/science.1092712	http://dx.doi.org/10.1126/science.1092712			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764883				2022-12-01	WOS:000188753800062
J	Zimdahl, H; Nyakatura, G; Brandt, P; Schulz, H; Hummel, O; Fartmann, B; Brett, D; Droege, M; Monti, J; Lee, YA; Sun, YY; Zhao, SY; Winter, EE; Ponting, CP; Chen, Y; Kasprzyk, A; Birney, E; Ganten, D; Hubner, N				Zimdahl, H; Nyakatura, G; Brandt, P; Schulz, H; Hummel, O; Fartmann, B; Brett, D; Droege, M; Monti, J; Lee, YA; Sun, YY; Zhao, SY; Winter, EE; Ponting, CP; Chen, Y; Kasprzyk, A; Birney, E; Ganten, D; Hubner, N			A SNP map of the rat genome generated from cDNA sequences	SCIENCE			English	Article									Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; MWG, D-85560 Ebersberg, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Inst Genom Res, Rockville, MD 20850 USA; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; European Bioinformat Inst, EMBL, Cambridge CB10 1SD, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; J. Craig Venter Institute; University of Oxford; European Molecular Biology Laboratory (EMBL)	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	nhuebner@mdc-berlin.de	Ponting, Chris/AAV-2621-2021	Birney, Ewan/0000-0001-8314-8497; Ponting, Chris/0000-0003-0202-7816				Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252	5	44	46	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					807	807		10.1126/science.1092427	http://dx.doi.org/10.1126/science.1092427			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764869				2022-12-01	WOS:000188753800047
J	Rost, S; Fregin, A; Ivaskevicius, V; Conzelmann, E; Hortnagel, K; Pelz, HJ; Lappegard, K; Seifried, E; Scharrer, I; Tuddenham, EGD; Muller, CR; Strom, TM; Oldenburg, J				Rost, S; Fregin, A; Ivaskevicius, V; Conzelmann, E; Hortnagel, K; Pelz, HJ; Lappegard, K; Seifried, E; Scharrer, I; Tuddenham, EGD; Muller, CR; Strom, TM; Oldenburg, J			Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2	NATURE			English	Article							VITAMIN-K 2,3-EPOXIDE; GAMMA-GLUTAMYL CARBOXYLASE; ENDOPLASMIC-RETICULUM; EPOXIDE-REDUCTASE; RAT-LIVER; IDENTIFICATION; PROTHROMBIN; METABOLISM; COMPLEX; LOCUS	Coumarin derivatives such as warfarin represent the therapy of choice for the long-term treatment and prevention of thromboembolic events. Coumarins target blood coagulation by inhibiting the vitamin K epoxide reductase multiprotein complex (VKOR)(1). This complex recycles vitamin K 2,3-epoxide to vitamin K hydroquinone, a cofactor that is essential for the post-translational gamma-carboxylation of several blood coagulation factors(2,3). Despite extensive efforts, the components of the VKOR complex have not been identified(4-8). The complex has been proposed to be involved in two heritable human diseases: combined deficiency of vitamin-K-dependent clotting factors type 2 (VKCFD2; Online Mendelian Inheritance in Man (OMIM) 607473), and resistance to coumarin-type anticoagulant drugs (warfarin resistance, WR; OMIM 122700). Here we identify, by using linkage information from three species, the gene vitamin K epoxide reductase complex subunit 1 (VKORC1), which encodes a small transmembrane protein of the endoplasmic reticulum. VKORC1 contains missense mutations in both human disorders and in a warfarin-resistant rat strain. Overexpression of wildtype VKORC1, but not VKORC1 carrying the VKCFD2 mutation, leads to a marked increase in VKOR activity, which is sensitive to warfarin inhibition.	Univ Wurzburg, Biozentrum, Dept Human Genet, D-97074 Wurzburg, Germany; GSF, Natl Res Ctr, Inst Human Genet, D-85764 Munich, Germany; Univ Frankfurt, DRK Blood Donor Serv, Inst Transfus Med & Immune Haematol, D-60526 Frankfurt, Germany; Univ Wurzburg, Biozentrum, Dept Physiol Chem 2, D-97074 Wurzburg, Germany; Fed Biol Res Ctr Agr & Forestry, Inst Nematol & Vertebrate Res, D-48161 Munster, Germany; Nordland Hosp, Dept Med, N-8092 Bodo, Norway; Univ Frankfurt, Ctr Internal Med, D-60528 Frankfurt, Germany; Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; University of Wurzburg; Goethe University Frankfurt; Imperial College London; Technical University of Munich	Oldenburg, J (corresponding author), Univ Wurzburg, Biozentrum, Dept Human Genet, D-97074 Wurzburg, Germany.	joldenburg@bsdhessen.de	Scharrer, Inge/N-2999-2013; Tuddenham, Edward/AAS-6196-2020; Oldenburg, Johannes/ABB-7817-2020	Tuddenham, Edward/0000-0001-8955-2909; Oldenburg, Johannes/0000-0002-1585-4100				Bandyopadhyay PK, 2002, P NATL ACAD SCI USA, V99, P1264, DOI 10.1073/pnas.022637099; Begent LA, 2001, J PHARM PHARMACOL, V53, P481, DOI 10.1211/0022357011775776; Cain D, 1997, J BIOL CHEM, V272, P29068, DOI 10.1074/jbc.272.46.29068; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; FASCO MJ, 1983, J BIOL CHEM, V258, P4372; Fregin A, 2002, BLOOD, V100, P3229, DOI 10.1182/blood-2002-03-0698; GREAVES JH, 1967, NATURE, V215, P877, DOI 10.1038/215877a0; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kohn MH, 1999, MAMM GENOME, V10, P696, DOI 10.1007/s003359901073; LEE JJ, 1984, BIOCHEMISTRY-US, V23, P2246, DOI 10.1021/bi00305a024; Li T, 2000, J BIOL CHEM, V275, P18291, DOI 10.1074/jbc.M001790200; MARTIN AD, 1979, LAB ANIM, V13, P209, DOI 10.1258/002367779780937852; NELSESTUEN GL, 1974, J BIOL CHEM, V249, P6347; Oldenburg J, 2000, THROMB HAEMOSTASIS, V84, P937; Presnell SR, 2002, THROMB HAEMOSTASIS, V87, P937, DOI 10.1055/s-0037-1613115; Romero EE, 1998, EXP CELL RES, V243, P334, DOI 10.1006/excr.1998.4151; STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730; Suttie J W, 1987, Adv Exp Med Biol, V214, P3; THIJSSEN HH, 2001, ADV VERTEBRATE PEST, P181; WALLACE ME, 1976, J HYG-CAMBRIDGE, V76, P173, DOI 10.1017/S0022172400055078; WALLIN R, 1985, J CLIN INVEST, V76, P1879, DOI 10.1172/JCI112182; Wallin R, 2001, FASEB J, V15, P2542, DOI 10.1096/fj.01-0337fje	23	888	965	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					537	541		10.1038/nature02214	http://dx.doi.org/10.1038/nature02214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765194				2022-12-01	WOS:000188721800040
J	Dawkins, MS; Donnelly, CA; Jones, TA				Dawkins, MS; Donnelly, CA; Jones, TA			Chicken welfare is influenced more by housing conditions than by stocking density	NATURE			English	Article							FOOT-PAD DERMATITIS; BROILER-CHICKENS; LEG WEAKNESS; PERFORMANCE; PREVALENCE; BEHAVIOR	Intensive broiler ( meat) chicken production now exceeds 800 million birds each year in the United Kingdom and 2 x 10(10) birds worldwide(1), but it attracts accusations of poor welfare(2,3). The European Union is currently adopting standards for broilers aimed at a chief welfare concern - namely, overcrowding - by limiting maximum ' stocking density' ( bird weight per unit area). It is not clear, however, whether this will genuinely improve bird welfare because evidence is contradictory(4-10). Here we report on broiler welfare in relation to the European Union proposals through a large- scale study ( 2.7 million birds) with the unprecedented cooperation of ten major broiler producers in an experimental manipulation of stocking density under a range of commercial conditions. Producer companies stocked birds to five different final densities, but otherwise followed company practice, which we recorded in addition to temperature, humidity, litter and air quality. We assessed welfare through mortality, physiology, behaviour and health, with an emphasis on leg health and walking ability. Our results show that differences among producers in the environment that they provide for chickens have more impact on welfare than has stocking density itself.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Dawkins, MS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	marian.dawkins@zoo.ox.ac.uk		Donnelly, Christl/0000-0002-0195-2463				BAGSHAW CS, 2001, BROILER WELFARE REV; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; COCKREM JF, 1994, BRIT POULTRY SCI, V35, P433, DOI 10.1080/00071669408417708; DAWKINS MS, 2001, COPING CHALLENGE WEL, P63; Dehnhard M, 2003, GEN COMP ENDOCR, V131, P345, DOI 10.1016/S0016-6480(03)00033-9; Ekstrand C, 1998, BRIT POULTRY SCI, V39, P318, DOI 10.1080/00071669888845; Farm Animal Welfare Council, 1992, REP WELF BROIL CHICK; Feddes JJR, 2002, POULTRY SCI, V81, P774, DOI 10.1093/ps/81.6.774; Gordon S. H., 2001, British Poultry Science, V42, pS118; GRASHORN M, 1991, ARCH GEFLUGELKD, V55, P84; Hall AL, 2001, ANIM WELFARE, V10, P23; Heier BT, 2002, PREV VET MED, V53, P147, DOI 10.1016/S0167-5877(01)00266-5; KEMP C, 2002, ROSS BROILER MANAGEM, V36; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kestin SC, 2001, VET REC, V148, P195, DOI 10.1136/vr.148.7.195; Kristensen HH, 2000, WORLD POULTRY SCI J, V56, P235, DOI 10.1079/WPS20000018; Martrenchar A, 2002, PREV VET MED, V52, P213, DOI 10.1016/S0167-5877(01)00259-8; McLean JA, 2002, ANIM WELFARE, V11, P55; Mendl M, 2001, NATURE, V410, P31, DOI 10.1038/35065194; Reiter K, 1998, ARCH GEFLUGELKD, V62, P145; *ROYAL SOC PREV CR, 1995, RSPCS WELF STAND CHI; Scientific Committee on Animal Health and Animal Welfare, 2000, WELF CHICK KEPT MEAT; Sorensen P, 2000, POULTRY SCI, V79, P864, DOI 10.1093/ps/79.6.864; STEVENSON P, 1995, WELFARE BROILER CHIC; Webster J, 1994, ANIMAL WELFARE COOL; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; Whitehead CC, 2002, WORLD POULTRY SCI J, V58, P349, DOI 10.1079/WPS20020027	28	399	429	4	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					342	344		10.1038/nature02226	http://dx.doi.org/10.1038/nature02226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737165				2022-12-01	WOS:000188266200038
J	Fedoriw, AM; Stein, P; Svoboda, P; Schultz, RM; Bartolomei, MS				Fedoriw, AM; Stein, P; Svoboda, P; Schultz, RM; Bartolomei, MS			Transgenic RNAi reveals essential function for CTCF in H19 gene imprinting	SCIENCE			English	Article							DNA METHYLATION; H19/IGF2 LOCUS; CONTROL REGION; MOUSE OOCYTES; CPG ISLAND; INSULATOR; IGF2; EXPRESSION; PROMOTER; PARENT	The imprinted regulation of H19 and Insulin-like growth factor 2 expression involves binding of the vertebrate insulator protein, CCCTC binding factor (CTCF), to the maternally hypomethylated differentially methylated domain (DMD). How this hypomethylated state is maintained during oogenesis and the role of CTCF, if any, in this process are not understood. With the use of a transgenic RNA interference (RNAi)-based approach to generate oocytes with reduced amounts of CTCF protein, we found increased methylation of the H19 DMD and decreased developmental competence of CTCF-deficient oocytes. Our results suggest that CTCF protects the H19 DMD from de novo methylation during oocyte growth and is required for normal preimplantation development.	Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bartolomei, MS (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.		Stein, Paula/ABE-9388-2020; Svoboda, Petr/G-3890-2012	Stein, Paula/0000-0002-2040-4593; Svoboda, Petr/0000-0002-4370-3705	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516, R01HD042026] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-42026, T32 HD-07516] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; FEDORIW AM, UNPUB; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Kaffer CR, 2000, GENE DEV, V14, P1908; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Thorvaldsen JL, 2000, SCIENCE, V288, P2145, DOI 10.1126/science.288.5474.2145; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	25	217	228	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					238	240		10.1126/science.1090934	http://dx.doi.org/10.1126/science.1090934			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716017				2022-12-01	WOS:000187908500051
J	Pilmanis, AA				Pilmanis, AA			Physiological hazards of flight at high altitude	LANCET			English	Article									USAF, Res Lab, AFRL HEPR, Brooks AFB, TX 78235 USA	United States Department of Defense; United States Air Force	Pilmanis, AA (corresponding author), 309 Driftwind, San Antonio, TX 78239 USA.								0	6	6	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S16	S17		10.1016/S0140-6736(03)15059-3	http://dx.doi.org/10.1016/S0140-6736(03)15059-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698113	Green Submitted, Bronze			2022-12-01	WOS:000187790200009
J	Webb, P				Webb, P			Can famine relief meet health and hunger goals simultaneously?	LANCET			English	Article									UN, World Food Programme, I-00148 Rome, Italy; Tufts Univ, Friedman Sch Nutr Sci & Policy, Food Policy & Appl Nutr Programme, Boston, MA 02111 USA	Tufts University	Webb, P (corresponding author), UN, World Food Programme, Via GC Viola 68-70,Parco Medici, I-00148 Rome, Italy.		Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354				DEWAAL A, 2003, NEW VARIANT FAMINE H; Sen A, 1981, POVERTY FAMINES	2	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S40	S41		10.1016/S0140-6736(03)15071-4	http://dx.doi.org/10.1016/S0140-6736(03)15071-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698125				2022-12-01	WOS:000187790200021
J	Fonseca, DM; Keyghobadi, N; Malcolm, CA; Mehmet, C; Schaffner, F; Mogi, M; Fleischer, RC; Wilkerson, RC				Fonseca, DM; Keyghobadi, N; Malcolm, CA; Mehmet, C; Schaffner, F; Mogi, M; Fleischer, RC; Wilkerson, RC			Emerging vectors in the Culex pipiens complex	SCIENCE			English	Article							WEST-NILE-VIRUS; NEW-YORK-CITY; MOSQUITOS; CULICIDAE; DIPTERA; QUINQUEFASCIATUS; POPULATIONS; INFECTION; BIRDS	In the Old World, some mosquitoes in the Culex pipiens complex are excellent enzootic vectors of West Nile virus, circulating the virus among birds, whereas others bite mainly humans and other mammals. Here we show that, in northern Europe, such forms differing in behavior and physiology have unique microsatellite fingerprints with no evidence of gene flow between them, as would be expected from distinct species. In the United States, however, hybrids between these forms are ubiquitous. Such hybrids between human-biters and bird-biters may be the bridge vectors contributing to the unprecedented severity and range of the West Nile virus epidemic in North America.	Smithsonian Inst, Natl Museum Nat Hist, Genet Program, Washington, DC 20008 USA; Walter Reed Army Inst Res, Dept Entomol, Div Communicable Dis & Immunol, Silver Spring, MD 20910 USA; Univ London, Queen Mary, Sch Biol Sci, London E1 4NS, England; Adege, Entente Interdept Demousticat Mediterranee, F-34184 Montpellier 4, France; Saga Med Sch, Dept Microbiol, Div Parasitol, Saga 8498501, Japan	Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of London; Queen Mary University London; Saga University	Fonseca, DM (corresponding author), Acad Nat Sci Philadelphia, 1900 Benjamin Franklin Pkwy, Philadelphia, PA 19103 USA.	fonseca@acnatsci.org	Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100; Schaffner, Francis/0000-0001-9166-7617	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063258] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM063258] Funding Source: Medline; ODCDC CDC HHS [U50/CCU220532] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ODCDC CDC HHS		BARR AR, 1957, AM J TROP MED HYG, V6, P153, DOI 10.4269/ajtmh.1957.6.153; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; Byrne K, 1999, HEREDITY, V82, P7, DOI 10.1038/sj.hdy.6884120; Cavalli-Sforza LL, 1995, GREAT HUMAN DIASPORA; CHEVILLON C, 1995, GENET RES, V66, P147, DOI 10.1017/S0016672300034492; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Crook P D, 2002, Commun Dis Public Health, V5, P138; De Zulueta J., 1994, Parassitologia (Rome), V36, P7; Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640; DRUMMOND F. H., 1951, The Culex pipiens Complex in Australia., P369; Fonseca DM, 1998, MOL ECOL, V7, P1617; Guillemaud T, 1997, P ROY SOC B-BIOL SCI, V264, P245, DOI 10.1098/rspb.1997.0035; HARBACH RE, 1985, P ENTOMOL SOC WASH, V87, P1; HARBACH RE, 1984, P ENTOMOL SOC WASH, V86, P521; Hayes CG, 2001, ANN NY ACAD SCI, V951, P25; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x; Knight K. L., 1978, CATALOG MOSQUITOES S, V6; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; MATTINGLY P. F., 1951, TRANS ROY ENT SOC LONDON, V102, P331; Nasci RS, 2001, EMERG INFECT DIS, V7, P742; Pritchard JK, 2000, GENETICS, V155, P945; Richards A. G. jr., 1941, Entomological News Philadelphia, V52, P211; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Spielman A, 2001, ANN NY ACAD SCI, V951, P220; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Urbanelli S, 1997, J MED ENTOMOL, V34, P116, DOI 10.1093/jmedent/34.2.116; Urbanelli S., 1981, EC ATT 1 C NAZ ZAR, P305; Vinagradova E. B., 2000, CULEX PIPIENS PIPIEN; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	31	344	362	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2004	303	5663					1535	1538		10.1126/science.1094247	http://dx.doi.org/10.1126/science.1094247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001783				2022-12-01	WOS:000220000100048
J	Tyson, GW; Chapman, J; Hugenholtz, P; Allen, EE; Ram, RJ; Richardson, PM; Solovyev, VV; Rubin, EM; Rokhsar, DS; Banfield, JF				Tyson, GW; Chapman, J; Hugenholtz, P; Allen, EE; Ram, RJ; Richardson, PM; Solovyev, VV; Rubin, EM; Rokhsar, DS; Banfield, JF			Community structure and metabolism through reconstruction of microbial genomes from the environment	NATURE			English	Article							IN-SITU DETECTION; MINE DRAINAGE; PHYLOGENETIC IDENTIFICATION; THIOBACILLUS-FERROOXIDANS; LEPTOSPIRILLUM; DIVERSITY; RUSTICYANIN; SEQUENCES; BACTERIA; OXIDASE	Microbial communities are vital in the functioning of all ecosystems; however, most microorganisms are uncultivated, and their roles in natural systems are unclear. Here, using random shotgun sequencing of DNA from a natural acidophilic biofilm, we report reconstruction of near-complete genomes of Leptospirillum group II and Ferroplasma type II, and partial recovery of three other genomes. This was possible because the biofilm was dominated by a small number of species populations and the frequency of genomic rearrangements and gene insertions or deletions was relatively low. Because each sequence read came from a different individual, we could determine that single-nucleotide polymorphisms are the predominant form of heterogeneity at the strain level. The Leptospirillum group II genome had remarkably few nucleotide polymorphisms, despite the existence of low-abundance variants. The Ferroplasma type II genome seems to be a composite from three ancestral strains that have undergone homologous recombination to form a large population of mosaic genomes. Analysis of the gene complement for each organism revealed the pathways for carbon and nitrogen fixation and energy generation, and provided insights into survival strategies in an extreme environment.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jill@eps.berkeley.edu	Hugenholtz, Philip/AAD-9138-2019; Hugenholtz, Philip/G-9608-2011; Tyson, Gene W/C-6558-2013; WU, TAKLON/A-2827-2010; Solovyev, Victor/C-4614-2013	Hugenholtz, Philip/0000-0001-5386-7925; Hugenholtz, Philip/0000-0001-5386-7925; Tyson, Gene W/0000-0001-8559-9427; Solovyev, Victor/0000-0001-8885-493X; Banfield, Jill/0000-0001-8203-8771; Rokhsar, Daniel/0000-0002-8704-2224				Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; ACUNA J, 1992, FEMS MICROBIOL LETT, V96, P37, DOI 10.1016/0378-1097(92)90453-U; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amils R, 1998, BIOCHIMIE, V80, P911, DOI 10.1016/S0300-9084(00)88888-4; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; BLAKE R, 1992, GEOMICROBIOL J, V10, P173, DOI 10.1080/01490459209377919; BLAKE RC, 1994, BIOCHEMISTRY-US, V33, P9220, DOI 10.1021/bi00197a025; Bond PL, 2000, APPL ENVIRON MICROB, V66, P4962, DOI 10.1128/AEM.66.11.4962-4971.2000; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Bond PL, 2001, MICROBIAL ECOL, V41, P149; Branscomb E, 2002, J BACTERIOL, V184, P6406, DOI 10.1128/JB.184.23.6406-6409.2002; Coram NJ, 2002, APPL ENVIRON MICROB, V68, P838, DOI 10.1128/AEM.68.2.838-845.2002; Dewdney AK, 2000, BIOL BULL-US, V198, P152, DOI 10.2307/1542811; Edwards KJ, 1999, APPL ENVIRON MICROB, V65, P3627; Edwards KJ, 2000, CHEM GEOL, V169, P383, DOI 10.1016/S0009-2541(00)00216-3; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Hugenholtz P, 2002, GENOME BIOL, V3; Komorowski L, 2002, BIOL CHEM, V383, P1791, DOI 10.1515/BC.2002.200; Koonin EV, 1996, CURR OPIN GENET DEV, V6, P757, DOI 10.1016/S0959-437X(96)80032-3; MACALADY JL, UNPUB EXTREMOPHILES; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Makarova KS, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-115; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Parro V, 2003, P NATL ACAD SCI USA, V100, P7883, DOI 10.1073/pnas.1230487100; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; SILVERMAN M. P., 1964, Advances in Applied Microbiology, V6, P153, DOI 10.1016/S0065-2164(08)70626-9; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yamanaka T, 1995, FEMS MICROBIOL REV, V17, P401	42	1494	1611	13	567	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					37	43		10.1038/nature02340	http://dx.doi.org/10.1038/nature02340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14961025				2022-12-01	WOS:000189363800028
J	Neil, HAW; Hammond, T; Mant, D; Humphries, SE				Neil, HAW; Hammond, T; Mant, D; Humphries, SE			Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002	BRITISH MEDICAL JOURNAL			English	Article									Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7HJ, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Hlth Care, Oxford OX3 7LF, England; UCL Royal Free & UCL Med Sch, British Heart Fdn Lab, Ctr Cardiovasc Genet, London WC1E 6JJ, England	University of Oxford; University of Oxford; University of London; University College London	Neil, HAW (corresponding author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7HJ, England.	andrew.neil@wolfson.ox.ac.uk	Humphries, Stephen E/C-5075-2008; Mant, David CA/C-7763-2009	Humphries, Stephen E/0000-0002-8221-6547				Mayor S, 2001, BRIT MED J, V323, P1021, DOI 10.1136/bmj.323.7320.1021; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; NEIL HAW, 1991, BRIT MED J, V302, P891, DOI 10.1136/bmj.302.6781.891; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476	5	21	22	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 28	2004	328	7438					500	501		10.1136/bmj.328.7438.500	http://dx.doi.org/10.1136/bmj.328.7438.500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800BC	14988185	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000220002900026
J	Cattin, MF; Bersier, LF; Banasek-Richter, C; Baltensperger, R; Gabriel, JP				Cattin, MF; Bersier, LF; Banasek-Richter, C; Baltensperger, R; Gabriel, JP			Phylogenetic constraints and adaptation explain food-web structure	NATURE			English	Article							CONNECTANCE; STABILITY; PATTERNS	Food webs are descriptions of who eats whom in an ecosystem. Although extremely complex and variable, their structure possesses basic regularities(1-6). A fascinating question is to find a simple model capturing the underlying processes behind these repeatable patterns. Until now, two models have been devised for the description of trophic interactions within a natural community(7,8). Both are essentially based on the concept of ecological niche, with the consumers organized along a single niche dimension; for example, prey size(8,9). Unfortunately, they fail to describe adequately recent and high-quality data. Here, we propose a new model built on the hypothesis that any species' diet is the consequence of phylogenetic constraints and adaptation. Simple rules incorporating both concepts yield food webs whose structure is very close to real data. Consumers are organized in groups forming a nested hierarchy, which better reflects the complexity and multidimensionality of most natural systems.	Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; Swiss Fed Inst Technol, Dept Math, Chair Stat, CH-1015 Lausanne, Switzerland; Univ Fribourg, Dept Math, CH-1700 Fribourg, Switzerland	University of Neuchatel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Fribourg	Bersier, LF (corresponding author), Univ Neuchatel, Inst Zool, Rue Emile Argand 11,CP2, CH-2007 Neuchatel, Switzerland.	louis-felix.bersier@unine.ch	Bersier, Louis-Félix/G-8018-2011	Bersier, Louis-Félix/0000-0001-9552-8032				BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Bersier LF, 1997, P NATL ACAD SCI USA, V94, P1247, DOI 10.1073/pnas.94.4.1247; Cohen J., 1978, FOOD WEBS NICHE SPAC; Cohen J., 1990, COMMUNITY FOOD WEBS; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P449, DOI 10.1098/rspb.1985.0043; COUSINS SH, 1985, CAN B FISH AQUAT SCI, V213, P76; DEANGELIS DL, 1975, ECOLOGY, V56, P238; Diamond J.M., 1975, P342; GARDNER MR, 1970, NATURE, V228, P784, DOI 10.1038/228784a0; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Jaccard P., 1908, B SOCIETE VAUDOISE S, V44, P223, DOI [DOI 10.5169/SEALS-268384, 10.5169/seals-268384Nutzungsbedingungen]; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; LAWTON JH, 1988, TRENDS ECOL EVOL, V3, P242, DOI 10.1016/0169-5347(88)90167-X; Legendre P., 1998, NUMERICAL ECOLOGY, V2nd; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; May RM, 1974, SYST MAN CYBERN, DOI 10.2307/j.ctvs32rq4; Pimm S.L., 1982, FOOD WEBS; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Price PW, 2003, MACROEVOLUTIONARY TH; Solow AR, 1998, ECOLOGY, V79, P2013, DOI 10.1890/0012-9658(1998)079[2013:OLSIFW]2.0.CO;2; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Sugihara G., 1982, THESIS PRINCETON U P; SUGIHARA G, 1984, POPULATION BIOL, P83; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	29	262	272	3	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					835	839		10.1038/nature02327	http://dx.doi.org/10.1038/nature02327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985761	Green Published			2022-12-01	WOS:000189207500039
J	Peiris, JSM; Yu, WC; Leung, CW; Cheung, CY; Ng, WF; Nicholls, JM; Ng, TK; Chan, KH; Lai, ST; Lim, WL; Yuen, KY; Guan, Y				Peiris, JSM; Yu, WC; Leung, CW; Cheung, CY; Ng, WF; Nicholls, JM; Ng, TK; Chan, KH; Lai, ST; Lim, WL; Yuen, KY; Guan, Y			Re-emergence of fatal human influenza A subtype H5N1 disease	LANCET			English	Article							VIRUS	Human disease associated with influenza A subtype H5N1 re-emerged in January, 2003, for the first time since an outbreak in Hong Kong in 1997. Patients with H5N1 disease had unusually high serum concentrations of chemokines (eg, interferon induced protein-10 [IP-10] and monokine induced by interferon gamma [MIG]). Taken together with a previous report that H5N1 influenza viruses induce large amounts of proinflammatory cytokines from macrophage cultures in vitro, our findings suggest that cytokine dysfunction contributes to the pathogenesis of H5N1 disease. Development of vaccines against influenza A (H5N1) virus should be made a priority.	Univ Hong Kong, Dept Pathol & Microbiol, Pokfulam, Hong Kong, Peoples R China; Queen Mary Hosp, Pokfulam, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Intens Care, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Govt Virus Unit, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Peiris, JSM (corresponding author), Univ Hong Kong, Dept Pathol & Microbiol, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Yuen, Kwok Yung/C-4465-2009; Chan, Kwok Hung/ABD-5399-2021; Cheung, Chung Yan/C-4233-2009; Nicholls, John Malcolm/C-4375-2009	Yuen, Kwok-yung/0000-0002-2083-1552; Guan, Yi/0000-0001-6057-9243; Nicholls, John Malcolm/0000-0001-7217-7444	NIAID NIH HHS [N01AI95357, AI95357] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; World Health Organization, CONF HUM CAS AV INFL; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	6	596	684	0	73	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2004	363	9409					617	619		10.1016/S0140-6736(04)15595-5	http://dx.doi.org/10.1016/S0140-6736(04)15595-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	776EZ	14987888	Green Published, Bronze			2022-12-01	WOS:000189104900012
J	De Tomaso, AW; Weissman, IL				De Tomaso, AW; Weissman, IL			Evolution of a protochordate allorecognition locus	SCIENCE			English	Article							SYSTEM		Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	De Tomaso, AW (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	tdet@stanford.edu			NIAID NIH HHS [R01 AI041588, AI10332, AI41588] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARDEN B, 1982, P NATL ACAD SCI-BIOL, V79, P2342, DOI 10.1073/pnas.79.7.2342; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 2002, MAR ECOL PROG SER, V243, P93, DOI 10.3354/meps243093; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5	7	26	26	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					977	977		10.1126/science.1094952	http://dx.doi.org/10.1126/science.1094952			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963321				2022-12-01	WOS:000188918000035
J	Lee, HY; Kleber, M; Hari, L; Brault, V; Suter, U; Taketo, MM; Kemler, R; Sommer, L				Lee, HY; Kleber, M; Hari, L; Brault, V; Suter, U; Taketo, MM; Kemler, R; Sommer, L			Instructive role of Wnt/beta-catenin in sensory fate specification in neural crest stem cells	SCIENCE			English	Article							BETA-CATENIN; PRECURSORS; LINEAGE; SOX10; GROWTH; TRUNK; GENE; CNS	Wnt signaling has recently emerged as a key factor in controlling stem cell expansion. In contrast, we show here that Wnt/beta-catenin signal activation in emigrating neural crest stem cells (NCSCs) has little effect on the population size and instead regulates fate decisions. Sustained beta-catenin activity in neural crest cells promotes the formation of sensory neural cells in vivo at the expense of virtually all other neural crest derivatives. Moreover, Wnt1 is able to instruct early NCSCs (eNCSCs) to adopt a sensory neuronal fate in a beta-catenin-dependent manner. Thus, the role of Wnt/beta-catenin in stem cells is cell-type dependent.	ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; Max Planck Inst Immunbiol, Dept Mol Embryol, D-79108 Freiburg, Germany; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Kyoto University	Sommer, L (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland.	lukas.sommer@cell.biol.ethz.ch	Suter, Ueli/A-1624-2010	Brault, Veronique/0000-0002-1418-5849				BAROFFIO A, 1991, DEVELOPMENT, V112, P301; Brault V, 2001, DEVELOPMENT, V128, P1253; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; FRANK E, 1991, DEVELOPMENT, V111, P895; FRASER SE, 1991, DEVELOPMENT, V112, P913; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Le Douarin N.M., 1999, NEURAL CREST; Megason SG, 2002, DEVELOPMENT, V129, P2087; NODEN DM, 1993, J NEUROBIOL, V24, P248, DOI 10.1002/neu.480240210; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SIEBERBLUM M, 1989, SCIENCE, V243, P1608, DOI 10.1126/science.2564699; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	29	333	361	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1020	1023		10.1126/science.1091611	http://dx.doi.org/10.1126/science.1091611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14716020				2022-12-01	WOS:000188918000048
J	Mira, MT; Alcais, A; Van Thuc, N; Moraes, MO; Di Flumeri, C; Thai, VH; Phuong, MC; Huong, NT; Ba, NN; Khoa, PX; Sarno, EN; Alter, A; Montpetit, A; Moraes, ME; Moraes, JR; Dore, C; Gallant, CJ; Lepage, P; Verner, A; van de Vosse, E; Hudson, TJ; Abel, L; Schurr, E				Mira, MT; Alcais, A; Van Thuc, N; Moraes, MO; Di Flumeri, C; Thai, VH; Phuong, MC; Huong, NT; Ba, NN; Khoa, PX; Sarno, EN; Alter, A; Montpetit, A; Moraes, ME; Moraes, JR; Dore, C; Gallant, CJ; Lepage, P; Verner, A; van de Vosse, E; Hudson, TJ; Abel, L; Schurr, E			Susceptibility to leprosy is associated with PARK2 and PACRG	NATURE			English	Article								Leprosy is caused by Mycobacterium leprae and affects about 700,000 individuals each year(1). It has long been thought that leprosy has a strong genetic component(2), and recently we mapped a leprosy susceptibility locus to chromosome 6 region q25-q26 (ref. 3). Here we investigate this region further by using a systematic association scan of the chromosomal interval most likely to harbour this leprosy susceptibility locus. In 197 Vietnamese families we found a significant association between leprosy and 17 markers located in a block of approx. 80 kilobases overlapping the 5' regulatory region shared by the Parkinson's disease gene PARK2 and the co-regulated gene PACRG. Possession of as few as two of the 17 risk alleles was highly predictive of leprosy. This was confirmed in a sample of 975 unrelated leprosy cases and controls from Brazil in whom the same alleles were strongly associated with leprosy. Variants in the regulatory region shared by PARK2 and PACRG therefore act as common risk factors for leprosy.	McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; Univ Catolica Parana, Ctr Ciencias Biol & Saude, BR-80215901 Curitiba, Parana, Brazil; Univ Paris 05, Fac Med Necker, INSERM, U550,Lab Genet Humaine Malad Infect, F-75015 Paris, France; Hosp Dermatovenereol, Ho Chi Minh City, Vietnam; Fiocruz MS, Inst Oswaldo Cruz, Dept Trop Med, Leprosy Lab, BR-20221903 Rio De Janeiro, Brazil; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Minist Saude, Inst Nacl Canc, Lab Imunogenet, BR-20230130 Rio De Janeiro, Brazil; Leiden Univ, Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands	McGill University; McGill University; McGill University; McGill University; Pontificia Universidade Catolica do Parana; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz; McGill University; National Cancer Institute (Inca); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Abel, L (corresponding author), Univ Paris 05, Fac Med Necker, INSERM, U550,Lab Genet Humaine Malad Infect, F-75015 Paris, France.	abel@necker.fr; erwin@igloo.epi.mcgill.ca	van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009; Moraes, Milton/AFF-1842-2022; Mira, Marcelo T/B-5046-2010; Peng, Bo/A-6920-2009; Moraes, Milton Ozório/G-9753-2011; Abel, Laurent/H-8888-2017; Alcais, Alexandre/J-5882-2017	van de Vosse, Esther/0000-0001-5199-3426; Mira, Marcelo T/0000-0002-8087-9400; Peng, Bo/0000-0001-8225-2284; Moraes, Milton Ozório/0000-0003-2653-0037; Abel, Laurent/0000-0001-7016-6493; Alcais, Alexandre/0000-0002-1012-2226; Nunes Sarno, Euzenir/0000-0003-0129-2159				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis J, 1999, GENETICS, V151, P373; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Imai Y, 2003, J BIOL CHEM, V278, P51901, DOI 10.1074/jbc.M309655200; Jacobson RR, 1999, LANCET, V353, P655, DOI 10.1016/S0140-6736(98)06322-3; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; THOMSON G, 1995, AM J HUM GENET, V57, P487; West AB, 2003, J MOL BIOL, V326, P11, DOI 10.1016/S0022-2836(02)01376-1; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P1	18	357	369	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					636	640		10.1038/nature02326	http://dx.doi.org/10.1038/nature02326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14737177				2022-12-01	WOS:000188875300042
J	Tian, XL; Kadaba, R; You, SA; Liu, MG; Timura, AA; Yang, L; Chen, QY; Szafranski, P; Rao, SQ; Wu, L; Housman, DE; DiCorleto, PE; Driscoll, DJ; Borrow, J; Wang, Q				Tian, XL; Kadaba, R; You, SA; Liu, MG; Timura, AA; Yang, L; Chen, QY; Szafranski, P; Rao, SQ; Wu, L; Housman, DE; DiCorleto, PE; Driscoll, DJ; Borrow, J; Wang, Q			Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome	NATURE			English	Article							BLOOD-VESSEL FORMATION; GROWTH; TWEAK; TRANSLOCATION; MECHANISMS; RECEPTOR; DOMAINS; MEMBER; BINDS; CELLS	Angiogenic factors are critical to the initiation of angiogenesis and maintenance of the vascular network(1). Here we use human genetics as an approach to identify an angiogenic factor, VG5Q, and further define two genetic defects of VG5Q in patients with the vascular disease Klippel-Trenaunay syndrome (KTS)(2,3). One mutation is chromosomal translocation t(5;11), which increases VG5Q transcription. The second is mutation E133K identified in five KTS patients, but not in 200 matched controls. VG5Q protein acts as a potent angiogenic factor in promoting angiogenesis, and suppression of VG5Q expression inhibits vessel formation. E133K is a functional mutation that substantially enhances the angiogenic effect of VG5Q. VG5Q shows strong expression in blood vessels and is secreted as vessel formation is initiated. VG5Q can bind to endothelial cells and promote cell proliferation, suggesting that it may act in an autocrine fashion. We also demonstrate a direct interaction of VG5Q with another secreted angiogenic factor, TWEAK (also known as TNFSF12)(4,5). These results define VG5Q as an angiogenic factor, establish VG5Q as a susceptibility gene for KTS, and show that increased angiogenesis is a molecular pathogenic mechanism of KTS.	Cleveland Clin Fdn, Dept Mol Cardiol, Ctr Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China; Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Mayo Clin & Mayo Fdn, Div Pediat Cardiol, Rochester, MN 55905 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Fudan University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Baylor College of Medicine; Massachusetts Institute of Technology (MIT); Mayo Clinic	Wang, Q (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, Ctr Mol Genet, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org		Rao, Shaoqi/0000-0001-7809-3700; Szafranski, Przemyslaw/0000-0002-3886-2971	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251, R01HL065630] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL066251, R01 HL065630] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BASKERVILLE PA, 1985, ANN SURG, V202, P624, DOI 10.1097/00000658-198511000-00015; Berry SA, 1998, AM J MED GENET, V79, P319, DOI 10.1002/(SICI)1096-8628(19981002)79:4<319::AID-AJMG15>3.3.CO;2-A; Buschmann I, 1999, NEWS PHYSIOL SCI, V14, P121; Calvert JT, 1999, HUM MOL GENET, V8, P1279, DOI 10.1093/hmg/8.7.1279; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Fan C, 2003, J Med Genet, V40, pe29, DOI 10.1136/jmg.40.3.e29; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; HAPPLE R, 1993, BRIT J DERMATOL, V128, P465, DOI 10.1111/j.1365-2133.1993.tb00214.x; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; JACKSON CL, 1996, CURRENT PROTOCOLS HU; Jacob AG, 1998, MAYO CLIN PROC, V73, P28; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shriver MD, 1997, AM J HUM GENET, V60, P957; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 2001, CYTOGENET CELL GENET, V95, P183, DOI 10.1159/000059343; WHELAN AJ, 1995, AM J MED GENET, V59, P492, DOI 10.1002/ajmg.1320590416; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	30	212	235	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					640	645		10.1038/nature02320	http://dx.doi.org/10.1038/nature02320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961121	Green Accepted			2022-12-01	WOS:000188875300043
J	Wang, M; Vijayraghavan, S; Goldman-Rakic, PS				Wang, M; Vijayraghavan, S; Goldman-Rakic, PS			Selective D2 receptor actions on the functional circuitry of working memory	SCIENCE			English	Article							PREFRONTAL CORTEX; NEURONS; NUCLEUS; MODULATION; RACLOPRIDE; ACCUMBENS; AGONIST; MONKEYS; FIELDS; MICE	Prefrontal neurons engaged by working memory tasks express a sequence of phasic and tonic activations linked to a train of sensory, mnemonic, and response-related events. Here, we report that the dopamine D2 receptor selectively modulates the neural activities associated with memory-guided saccades in oculomotor delayed-response tasks yet has little or no effect on the persistent mnemonic-related activity, which is instead modulated by D1 receptors. This associates the D2 receptor with a specific component of working memory circuitry and fractionates the modulatory effects of D1 and D2 receptors on the neural machinery of a cognitive process.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University	Wang, M (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.	min.wang@yale.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789, P50MH044866] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH068789, P50 MH44866] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson CM, 2002, AM J PSYCHIAT, V159, P1322, DOI 10.1176/appi.ajp.159.8.1322; ARNSTEN AFT, 1995, J NEUROSCI, V15, P3429; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BROOKS DJ, 1992, ANN NEUROL, V31, P184, DOI 10.1002/ana.410310209; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; FEINBERG I, 1978, SCHIZOPHRENIA BULL, V4, P636, DOI 10.1093/schbul/4.4.636; FRITH C, 1995, LANCET, V346, P615, DOI 10.1016/S0140-6736(95)91441-2; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; KIM R, 1976, J COMP NEUROL, V169, P263, DOI 10.1002/cne.901690302; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Lidow MS, 1998, SYNAPSE, V28, P10, DOI 10.1002/(SICI)1098-2396(199801)28:1<10::AID-SYN2>3.0.CO;2-F; LUCIANA M, 1992, J COGNITIVE NEUROSCI, V4, P58, DOI 10.1162/jocn.1992.4.1.58; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Tanibuchi I, 2003, J NEUROPHYSIOL, V89, P1067, DOI 10.1152/jn.00207.2002; Tran AH, 2002, P NATL ACAD SCI USA, V99, P8986, DOI 10.1073/pnas.132284599; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; WANG M, UNPUB; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	30	241	248	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2004	303	5659					853	856		10.1126/science.1091162	http://dx.doi.org/10.1126/science.1091162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764884				2022-12-01	WOS:000188753800063
J	Cyranoski, D				Cyranoski, D			Lack of infrastructure hampers virus monitoring	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2004	427	6974					472	472						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14770450				2022-12-01	WOS:000188721800004
J	Dennis, C				Dennis, C			Mixed messages	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 5	2004	427	6974					473	473						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14768651				2022-12-01	WOS:000188721800005
J	Heeschen, C; Dimmeler, S; Fichtlscherer, S; Hamm, CW; Berger, J; Simoons, ML; Zeiher, AM				Heeschen, C; Dimmeler, S; Fichtlscherer, S; Hamm, CW; Berger, J; Simoons, ML; Zeiher, AM		CAPTURE Investigators	Prognostic value of placental growth factor in patients with acute chest pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; ACUTE CORONARY SYNDROMES; UNSTABLE ANGINA; TROPONIN-T; ELEVATED LEVELS; MORTALITY; REVASCULARIZATION; STRATIFICATION; INTERLEUKIN-6; ANGIOGENESIS	Context Experimental data suggest that placental growth factor (PIGF), a member of the vascular endothelial growth factor family, acts as a primary inflammatory instigator of atherosclerotic plaque instability and thus may be useful as a risk-predicting biomarker in patients with acute coronary syndromes (ACS). Objective To determine whether blood levels of PIGF predict risk for death or non-fatal myocardial infarction in patients with acute chest pain. Design, Setting, and Patients Measurement of PIGF levels as well as levels of markers of myocardial necrosis (troponin T [TnT]), platelet activation (soluble CD40 ligand [sCD40L]) and inflammation (high-sensitivity C-reactive protein [hsCRP]) in an inception cohort of 547 patients with angiographically validated ACS participating in the CAPTURE (c7E3 Fab Anti-Platelet Therapy in Unstable Refractory Angina) trial and in a heterogeneous cohort of 626 patients presenting with acute chest pain to an emergency department in Germany between December 1996 and March 1999. Main Outcome Measure Risk for death or non-fatal myocardial infarction after 30 days. Results Inpatients with ACS, elevated PIG F levels (>27.0 ng/L; 40.8% of patients) indicated a markedly increased risk of events at 30 days (14.8% vs 4.9%; unadjusted hazard ratio [HR], 3.34; 95% confidence interval [CI], 1.79-6.24; P<.001). In a multivariable model, elevated levels of TnT (HR, 1.83; 95% CI, 1.05-3.86; P=.03), sCD40L (HR, 2.65; 95% CI, 1.41-4.99; P=.002), and PIGF (HR, 3.03; 95% CI, 1.54-5.95; P<.001) were independent predictors, while elevated hsCRP level was not (HR, 0.98; 95% CI, 0.53-1.98; P=.94). In patients with acute chest pain, elevated levels of PIGF predicted risk (21.2% vs 5.3%) (unadjusted: HR, 4.80; 95% CI, 2.81-8.21; P<.001; adjusted: HR, 3.00; 95% Cl, 1.68-5.38; P<.001). Patients negative for all 3 markers (TnT, sCD40L, and PIGF) were at very low cardiac risk Q days: no event; 30 days: 2.1% event rate). Conclusions Plasma PIGF levels may be an independent biomarker of adverse outcome in patients with suspected ACS. A single initial measurement of plasma PIGF appears to extend the predictive and prognostic information gained from traditional inflammatory markers.	Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; Kerckhoff Heart Ctr, Bad Nauheim, Germany; Univ Hamburg, Inst Math & Comp Sci Med, Hamburg, Germany; Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands	Goethe University Frankfurt; Kerckhoff Clinic; University of Hamburg; Erasmus University Rotterdam; Erasmus MC	Heeschen, C (corresponding author), Goethe Univ Frankfurt, Dept Cardiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	c.heeschen@em.uni-frankfurt.de	Hamm, Christian W./I-3155-2017; Guba, Markus/M-4309-2019	Hamm, Christian W./0000-0001-6763-4161; Dimmeler, Stefanie/0000-0002-1045-2436; Heeschen, Christopher/0000-0002-1158-8554				Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G; Biasucci L M, 2001, Ital Heart J, V2, P164; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Cao YH, 1996, J CLIN INVEST, V98, P2507, DOI 10.1172/JCI119069; *CAPTURE INV, 1997, LANCET, V350, P744; COX DR, 1972, J R STAT SOC B, V34, P187; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Hamm CW, 2000, CIRCULATION, V102, P118, DOI 10.1161/01.CIR.102.1.118; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Heeschen C, 2000, J AM COLL CARDIOL, V35, P1535, DOI 10.1016/S0735-1097(00)00581-7; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heeschen C, 2003, CIRCULATION, V107, P524, DOI 10.1161/01.CIR.0000048183.37648.1A; Khaliq A, 1999, LAB INVEST, V79, P151; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Liuzzo G, 1996, CIRCULATION, V94, P2373, DOI 10.1161/01.CIR.94.10.2373; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Pepys M B, 2001, Ital Heart J, V2, P804; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Simoons ML, 1997, LANCET, V349, P1429; Toss H, 1997, CIRCULATION, V96, P4204	30	123	151	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2004	291	4					435	441		10.1001/jama.291.4.435	http://dx.doi.org/10.1001/jama.291.4.435			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	767EF	14747500	Bronze			2022-12-01	WOS:000188426700028
J	Soinio, M; Marniemi, J; Laakso, M; Lehto, S; Ronnemaa, T				Soinio, M; Marniemi, J; Laakso, M; Lehto, S; Ronnemaa, T			Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							PROTEIN-C ACTIVATION; RISK-FACTOR; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; VASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; JAPANESE PATIENTS; FOLLOW-UP; HYPERHOMOCYSTEINEMIA	Background: High plasma homocysteine level has been associated with increased risk for coronary heart disease (CHD) events in nondiabetic individuals, especially in those with previously diagnosed CHD. In persons with type 2 diabetes mellitus, the association between homocysteine level and cardiovascular disease may be stronger than that in nondiabetic individuals, but no large prospective studies have examined the relationship between homocysteine level and CHD mortality in persons with type 2 diabetes. Objective: To investigate whether moderately elevated plasma homocysteine levels are independently related to increased incidence of fatal and nonfatal CHD events in persons with type 2 diabetes. Design: Prospective study. Setting: Finnish sample of patients with type 2 diabetes. Patients: 462 men and 368 women who were 45 to 64 years of age at baseline. Measurements: Coronary heart disease mortality and incidence of nonfatal myocardial infarction during the 7-year follow-up. Results: Participants with plasma homocysteine levels of 15 mumol/L or more at baseline had a higher risk for CHD death than those with plasma homocysteine levels less than 15 mumol/L (26.1% and 13.5%, respectively; P = 0.005). The risks for all CHID events were 36.2% and 22.6%, respectively (P = 0.011). In Cox regression analyses, elevated plasma homocysteine level was significantly associated with CHD mortality (P < 0.001) and all CHID events (P = 0.002) even after adjustment for confounding variables, including creatinine clearance. In participants without myocardial infarction at baseline, moderate hyperhomocysteinemia was also associated with CHD mortality and all CHD events in univariate (P < 0.001 and P = 0.006, respectively) and multivariate Cox regression analyses (P < 0.001 and P = 0.004, respectively). Conclusions: in this large cohort of patients with type 2 diabetes, plasma homocysteine level was a strong and independent risk factor for CHD events.	Turku Univ, FIN-20520 Turku, Finland; Social Insurance Inst Finland, Turku, Finland; Univ Kuopio, FIN-70211 Kuopio, Finland	University of Turku; University of Eastern Finland	Soinio, M (corresponding author), Turku Univ, Cent Hosp, Dept Med, POB 52, FIN-20521 Turku, Finland.	minna.soinio@tyks.fi		Lehto, Seppo/0000-0003-0414-5285				Al-Obaidi MK, 2000, CIRCULATION, V101, P372, DOI 10.1161/01.CIR.101.4.372; ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; ARAKI A, 1993, ATHEROSCLEROSIS, V103, P149, DOI 10.1016/0021-9150(93)90258-V; Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Evans RW, 1997, ARTERIOSCL THROM VAS, V17, P1947, DOI 10.1161/01.ATV.17.10.1947; Friedman AN, 2001, J AM SOC NEPHROL, V12, P2181, DOI 10.1681/ASN.V12102181; Hoogeveen EK, 1998, ARTERIOSCL THROM VAS, V18, P133, DOI 10.1161/01.ATV.18.1.133; Hoogeveen EK, 2000, CIRCULATION, V101, P1506, DOI 10.1161/01.CIR.101.13.1506; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Kark JD, 1999, LANCET, V353, P1936, DOI 10.1016/S0140-6736(98)05381-1; Khajurla A, 2000, BLOOD, V96, P966, DOI 10.1182/blood.V96.3.966.015k12_966_972; Knekt P, 2001, ARCH INTERN MED, V161, P1589, DOI 10.1001/archinte.161.13.1589; KOSTNER GM, 1976, CLIN CHEM, V22, P695; LAAKSO M, 1988, DIABETES CARE, V11, P449, DOI 10.2337/diacare.11.6.449; LENTZ SR, 1991, J CLIN INVEST, V88, P1906, DOI 10.1172/JCI115514; Li H, 2002, CIRCULATION, V105, P1037, DOI 10.1161/hc0902.104713; Majors A, 1997, ARTERIOSCL THROM VAS, V17, P2074, DOI 10.1161/01.ATV.17.10.2074; MALINOW MR, 1993, CIRCULATION, V87, P1107, DOI 10.1161/01.CIR.87.4.1107; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Munshi MN, 1996, METABOLISM, V45, P133, DOI 10.1016/S0026-0495(96)90211-5; Nurk E, 2002, ARCH INTERN MED, V162, P1374, DOI 10.1001/archinte.162.12.1374; Okada E, 1999, DIABETES CARE, V22, P484, DOI 10.2337/diacare.22.3.484; Omland T, 2000, ARCH INTERN MED, V160, P1834, DOI 10.1001/archinte.160.12.1834; RODGERS GM, 1990, BLOOD, V75, P895; Rose G.A., 1982, CARDIOVASCULAR SURVE; SAMPSON MJ, 1992, DIABETES CARE, V15, P609, DOI 10.2337/diacare.15.5.609; Smulders YM, 1999, DIABETES CARE, V22, P125, DOI 10.2337/diacare.22.1.125; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; Stehouwer CDA, 1999, KIDNEY INT, V55, P308, DOI 10.1046/j.1523-1755.1999.00256.x; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Tawakol A, 1997, CIRCULATION, V95, P1119; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; Voutilainen S, 1999, ARTERIOSCL THROM VAS, V19, P1263, DOI 10.1161/01.ATV.19.5.1263; Voutilainen S, 1998, ANN MED, V30, P300, DOI 10.3109/07853899809005859; *WHO, 1983, WHOMNC821; Woo KS, 1997, CIRCULATION, V96, P2542, DOI 10.1161/01.CIR.96.8.2542	41	104	121	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2004	140	2					94	100		10.7326/0003-4819-140-2-200401200-00009	http://dx.doi.org/10.7326/0003-4819-140-2-200401200-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764MY	14734331				2022-12-01	WOS:000188211700003
J	Cioli, D; Liberti, P				Cioli, D; Liberti, P			Schistosoma japonicum: modern tools for an ancient disease	LANCET			English	Editorial Material									Inst Cell Biol, I-00016 Monterotondo, Rome, Italy		Cioli, D (corresponding author), Inst Cell Biol, I-00016 Monterotondo, Rome, Italy.	dcioli@ibc.cnr.it						Bilharz T., 1852, Z WISS ZOOL ABT A, V4, P53; Christopherson JB, 1918, LANCET, V2, P325; CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7; DEELDER AM, 1990, LANCET, V335, P724, DOI 10.1016/0140-6736(90)90838-V; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Ruffer M A, 1910, Br Med J, V1, P16; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; WHO, 2002, WHO TECH REP SER	9	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 17	2004	363	9404					180	181		10.1016/S0140-6736(03)15366-4	http://dx.doi.org/10.1016/S0140-6736(03)15366-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765AG	14738785				2022-12-01	WOS:000188243900002
J	Young, J; De Geest, S; Spirig, R; Flepp, M; Rickenbach, M; Furrer, H; Bernasconi, E; Hirschel, B; Telenti, A; Vernazza, P; Battegay, M; Bucher, HC				Young, J; De Geest, S; Spirig, R; Flepp, M; Rickenbach, M; Furrer, H; Bernasconi, E; Hirschel, B; Telenti, A; Vernazza, P; Battegay, M; Bucher, HC		Swiss HIV Cohort Study Grp	Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study	BRITISH MEDICAL JOURNAL			English	Article							SOCIAL SUPPORT; MYOCARDIAL-INFARCTION; ALAMEDA COUNTY; MORTALITY; MEN; HEALTH; ASSOCIATION; DEPRESSION; POPULATION; ADHERENCE	Objectives To explore the association between a stable partnership and clinical outcome in HIV infected patients receiving highly active antiretroviral therapy (HAART). Design Prospective cohort study of adults with HIV (Swiss HIV cohort study). Setting Seven outpatient clinics throughout Switzerland. Participants The 3736. patients in the cohort who started HAART before 2002 (median age 36 years, 29% female, median follow up 3.6 years). Main outcome measures Time to AIDS or death (primary endpoint), death alone, increases in CD4 cell count of at least 50 and 100 above baseline, optimal viral suppression (a viral load below 400 copies/ml), and viral rebound. Results During follow up 2985 (80%) participants reported a stable partnership on at least one occasion. When starting HAART, 52% (545/1042) of participants reported a stable partnership; after five years of follow up 46% (190/412) of participants reported a stable partnership. In an analysis stratified by previous antiretroviral therapy and clinical stage when starting HAART (US Centers for Disease Control and Prevention group A, B, or C), the adjusted hazard ratio for progression to AIDS or death was 0.79 (95% confidence interval 0.63 to 0.98) for participants with a stable partnership compared with those without. Adjusted hazards ratios for other endpoints were 0.59 (0.44 to 0.79) for progression to death, 1.15 (1.06 to 1.24) for an increase in CD4 cells of 100 counts/mul or more, and 1.06 (0.98 to 1.14) for optimal viral suppression. Conclusions A stable partnership is associated with a slower rate of progression to AIDS or death in HIV infected patients receiving HAART.	Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Infect Dis & Hosp Hyg, CH-4031 Basel, Switzerland; Univ Basel, Inst Nursing Sci, Basel, Switzerland; Univ Zurich, Div Infect Dis, Zurich, Switzerland; Univ Lausanne, Swiss HIV Cohort Study, Ctr Data, Lausanne, Switzerland; Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; Osped Civ, Ambulattorio Malattie Infett, Lugano, Switzerland; Hop Univ Geneve, Div Malad Infect, Geneva, Switzerland; CHU Vaudois, Div Malad Infect, Lausanne, Switzerland; Cantonal Hosp St Gall, Div Internal Med, St Gallen, Switzerland	University of Basel; University of Basel; University of Basel; University of Zurich; University of Lausanne; University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital St. Gallen	Bucher, HC (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol, Hebelstr 10, CH-4031 Basel, Switzerland.		De Geest, Sabina M/F-7724-2010; VALLET, Yannick/F-9979-2011; Furrer, Hansjakob/G-6768-2013	Furrer, Hansjakob/0000-0002-1375-3146; Young, Jim/0000-0002-4314-3007; De Geest, Sabina/0000-0001-6596-7237				ANCELLEPARK R, 1993, LANCET, V341, P441, DOI 10.1016/0140-6736(93)93040-8; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; FrasureSmith N, 1997, LANCET, V350, P473, DOI 10.1016/S0140-6736(97)02142-9; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; HANSON BS, 1989, AM J EPIDEMIOL, V130, P100, DOI 10.1093/oxfordjournals.aje.a115301; Ingram KM, 1999, AIDS CARE, V11, P313, DOI 10.1080/09540129947947; Johnson JG, 2001, J CONSULT CLIN PSYCH, V69, P1056, DOI 10.1037//0022-006X.69.6.1056; Kimberly JA, 1999, AIDS EDUC PREV, V11, P465; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Leserman J, 2000, AM J PSYCHIAT, V157, P1221, DOI 10.1176/appi.ajp.157.8.1221; LEVINE C, 1990, MILBANK Q, V68, P33, DOI 10.2307/3350175; PageShafer K, 1996, ANN EPIDEMIOL, V6, P420, DOI 10.1016/S1047-2797(96)00064-6; Penninx BWJH, 1997, AM J EPIDEMIOL, V146, P510, DOI 10.1093/oxfordjournals.aje.a009305; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SEEMAN TE, 1987, AM J EPIDEMIOL, V126, P714, DOI 10.1093/oxfordjournals.aje.a114711; Spire B, 2002, SOC SCI MED, V54, P1481, DOI 10.1016/S0277-9536(01)00125-3; THEORELL T, 1995, PSYCHOSOM MED, V57, P32, DOI 10.1097/00006842-199501000-00005; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520	25	34	39	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2004	328	7430					15	18B		10.1136/bmj.328.7430.15	http://dx.doi.org/10.1136/bmj.328.7430.15			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761QG	14703538	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000187919000014
J	Humeau, Y; Shaban, H; Bissiere, S; Luthi, A				Humeau, Y; Shaban, H; Bissiere, S; Luthi, A			Presynaptic induction of heterosynaptic associative plasticity in the mammalian brain	NATURE			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; SYNAPTIC TRANSMISSION; BASOLATERAL AMYGDALA; NMDA RECEPTORS; DEPRESSION; RAT; LOCALIZATION; CORTEX; MEMORY	The induction of associative synaptic plasticity in the mammalian central nervous system classically depends on coincident presynaptic and postsynaptic activity(1,2). According to this principle, associative homosynaptic long-term potentiation (LTP) of excitatory synaptic transmission can be induced only if synaptic release occurs during postsynaptic depolarization(1,2). In contrast, heterosynaptic plasticity in mammals is considered to rely on activity-independent, non-associative processes(3-8). Here we describe a novel mechanism underlying the induction of associative LTP in the lateral amygdala ( LA). Simultaneous activation of converging cortical and thalamic afferents specifically induced associative, N-methyl-D-aspartate (NMDA)-receptor-dependent LTP at cortical, but not at thalamic, inputs. Surprisingly, the induction of associative LTP at cortical inputs was completely independent of postsynaptic activity, including depolarization, postsynaptic NMDA receptor activation or an increase in postsynaptic Ca2+ concentration, and did not require network activity. LTP expression was mediated by a persistent increase in the presynaptic probability of release at cortical afferents. Our study shows the presynaptic induction and expression of heterosynaptic and associative synaptic plasticity on simultaneous activity of converging afferents. Our data indicate that input specificity of associative LTP can be determined exclusively by presynaptic properties.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Luthi, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Shaban, Hamdy/ABD-5617-2021; shaban, Hamdy/C-1939-2014	Shaban, Hamdy/0000-0003-3760-6113; shaban, Hamdy/0000-0003-3760-6113				ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Farb CR, 1999, SYNAPSE, V33, P218, DOI 10.1002/(SICI)1098-2396(19990901)33:3<218::AID-SYN6>3.0.CO;2-1; GRACY KN, 1995, J COMP NEUROL, V362, P71, DOI 10.1002/cne.903620105; GUSTAFSSON B, 1990, SEMIN NEUROSCI, V2, P321; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2002, J NEUROSCI, V22, P7968; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McDonald AJ, 1996, NEUROSCIENCE, V75, P407, DOI 10.1016/0306-4522(96)00269-2; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tsukamoto M, 2003, J PHYSIOL-LONDON, V546, P665, DOI 10.1113/jphysiol.2002.033803; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Weisskopf MG, 1999, J NEUROSCI, V19, P10512	30	199	201	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					841	845		10.1038/nature02194	http://dx.doi.org/10.1038/nature02194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685239				2022-12-01	WOS:000187342000059
J	Schiermeier, Q				Schiermeier, Q			Climate change - The long road from Kyoto	NATURE			English	News Item																		Christensen JH, 2003, NATURE, V421, P805, DOI 10.1038/421805a; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333	3	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					756	756		10.1038/426756a	http://dx.doi.org/10.1038/426756a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685198	Bronze			2022-12-01	WOS:000187342000019
J	Dobbins, IG; Schnyer, DM; Verfaellie, M; Schacter, DL				Dobbins, IG; Schnyer, DM; Verfaellie, M; Schacter, DL			Cortical activity reductions during repetition priming can result from rapid response learning	NATURE			English	Article							INFERIOR PREFRONTAL CORTEX; FUSIFORM CORTEX; IMPLICIT MEMORY; FUNCTIONAL MRI; MECHANISMS; SPECIFICITY; RETRIEVAL; BRAIN; TASKS	Recent observation of objects speeds up their subsequent identification and classification(1,2). This common form of learning, known as repetition priming, can operate in the absence of explicit memory for earlier experiences(3,4), and functional neuroimaging has shown that object classification improved in this way is accompanied by 'neural priming' ( reduced neural activity) in prefrontal, fusiform and other cortical regions(5-10). These observations have led to suggestions that cortical representations of items undergo 'tuning', whereby neurons encoding irrelevant information respond less as a given object is observed repeatedly(10), thereby facilitating future availability of pertinent object knowledge. Here we provide experimental support for an alternative hypothesis, in which reduced cortical activity occurs because subjects rapidly learn their previous responses(11). After a primed object classification ( such as 'bigger than a shoebox'), cue reversal ('smaller than a shoebox') greatly slowed performance and completely eliminated neural priming in fusiform cortex, which suggests that these cortical item representations were no more available for primed objects than they were for new objects. In contrast, prefrontal cortex activity tracked behavioural priming and predicted the degree to which cue reversal would slow down object classification - highlighting the role of the prefrontal cortex in executive control.	Duke Univ, Durham, NC 27708 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Boston VA Healthcare Syst, Memory Disorders Res Ctr, Boston, MA 02118 USA; MGH MIT HMS, Athinoua A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Duke University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University	Dobbins, IG (corresponding author), Duke Univ, Durham, NC 27708 USA.	ian.dobbins@duke.edu	Schnyer, David/ABD-6372-2021	Schnyer, David/0000-0002-7472-2853; Schacter, Daniel/0000-0002-2460-6061; Verfaellie, Mieke/0000-0001-5535-4584				BUCKNER RL, 1995, J NEUROSCI, V15, P12; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DEMB JB, 1995, J NEUROSCI, V15, P5870; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; HAYMAN CAG, 1989, J EXP PSYCHOL LEARN, V15, P941, DOI 10.1037/0278-7393.15.5.941; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; LOGAN GD, 1990, COGNITIVE PSYCHOL, V22, P1, DOI 10.1016/0010-0285(90)90002-L; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SCHACTER DL, 1985, MEMORY SYSTEMS BRAIN, P351; Simons JS, 2003, NEUROIMAGE, V19, P613, DOI 10.1016/S1053-8119(03)00096-X; SQUIRE LR, 1992, J EXP PSYCHOL LEARN, V18, P106, DOI 10.1037/0278-7393.18.1.106; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; TOTH JP, 1996, IMPLICIT COGNITION, P41; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VRIEZEN ER, 1995, J EXP PSYCHOL LEARN, V21, P933, DOI 10.1037/0278-7393.21.4.933; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	25	242	245	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2004	428	6980					316	319		10.1038/nature02400	http://dx.doi.org/10.1038/nature02400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803SG	14990968				2022-12-01	WOS:000220250200043
J	Hien, TT; Liem, NT; Dung, NT; San, LT; Mai, PP; Chau, NVV; Suu, PT; Dong, VC; Mai, LTQ; Thi, NT; Khoa, DB; Phat, LP; Truong, NT; Long, HT; Tung, CV; Giang, LT; Tho, ND; Nga, LH; Tien, NTK; San, LH; Tuan, LV; Dolecek, C; Thanh, TT; de Jong, M; Schultsz, C; Cheng, P; Lim, W; Horby, P; Farrar, J				Hien, TT; Liem, NT; Dung, NT; San, LT; Mai, PP; Chau, NVV; Suu, PT; Dong, VC; Mai, LTQ; Thi, NT; Khoa, DB; Phat, LP; Truong, NT; Long, HT; Tung, CV; Giang, LT; Tho, ND; Nga, LH; Tien, NTK; San, LH; Tuan, LV; Dolecek, C; Thanh, TT; de Jong, M; Schultsz, C; Cheng, P; Lim, W; Horby, P; Farrar, J		World Hlth Org Int Avian Influenza	Avian influenza A (H5N1) in 10 patients in Vietnam.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HONG-KONG; INFECTION; VIRUS; DISEASE; RISK	Background: Recent outbreaks of avian influenza A (H5N1) in poultry throughout Asia have had major economic and health repercussions. Human infections with this virus were identified in Vietnam in January 2004. Methods: We report the clinical features and preliminary epidemiologic findings among 10 patients with confirmed cases of avian influenza A (H5N1) who presented to hospitals in Ho Chi Minh City and Hanoi, Vietnam, in December 2003 and January 2004. Results: In all 10 cases, the diagnosis of influenza A (H5N1) was confirmed by means of viral culture or reverse transcriptase-polymerase chain reaction with primers specific for H5 and N1. None of the 10 patients (mean age, 13.7 years) had preexisting medical conditions. Nine of them had a clear history of direct contact with poultry (median time before onset of illness, three days). All patients presented with fever (temperature, 38.5 to 40.0degreesC), <LF>respiratory symptoms, and clinically significant lymphopenia (median lymphocyte count, 700 per cubic millimeter). The median platelet count was 75,500 per cubic millimeter. Seven patients had diarrhea. In all patients, there were marked abnormalities on chest radiography. There was no definitive evidence of human-to-human transmission. Eight patients died, one patient has recovered, and one is recovering. Conclusions: Influenza A (H5N1) infection, characterized by fever, respiratory symptoms, and lymphopenia, carries a high risk of death. Although in all 10 cases the infection appears to have been acquired directly from infected poultry, the potential exists for genetic reassortment with human influenzaviruses and the evolution of human-to-human transmission. Containment of influenza A (H5N1) in poultry throughout Asia is therefore urgently required.	Hosp Trop Dis, Ho Chi Minh City, Vietnam; Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; Pediat Hosp Number Two, Ho Chi Minh City, Vietnam; Hlth Serv Ho Chi Minh City, Ho Chi Minh City, Vietnam; Inst Pasteur, Ho Chi Minh City, Vietnam; Prevent Med Ctr, Ho Chi Minh City, Vietnam; Natl Pediat Hosp, Hanoi, Vietnam; Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; Dept Hlth, Govt Virus Unit, Hong Kong, Hong Kong, Peoples R China; WHO, Vietnam Off, Hanoi, Vietnam	National Institute of Hygiene & Epidemiology (NIHE); World Health Organization	Farrar, J (corresponding author), Hosp Trop Dis, 190 Ben Ham Tu,Quan 5, Ho Chi Minh City, Vietnam.	jeremyjf@hcm.vnn.vn	Horby, Peter/D-1585-2013; Farrar, Jeremy J./HGA-7610-2022	Tran Tan, Thanh/0000-0002-8096-7750; Farrar, Jeremy/0000-0002-2700-623X; Horby, Peter/0000-0002-9822-1586				Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; van Kolfschooten F, 2003, LANCET, V361, P1444, DOI 10.1016/S0140-6736(03)13156-X; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	10	648	723	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2004	350	12					1179	1188		10.1056/NEJMoa040419	http://dx.doi.org/10.1056/NEJMoa040419			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803PG	14985470				2022-12-01	WOS:000220242400005
J	Odom, DT; Zizlsperger, N; Gordon, DB; Bell, GW; Rinaldi, NJ; Murray, HL; Volkert, TL; Schreiber, J; Rolfe, PA; Gifford, DK; Fraenkel, E; Bell, GI; Young, RA				Odom, DT; Zizlsperger, N; Gordon, DB; Bell, GW; Rinaldi, NJ; Murray, HL; Volkert, TL; Schreiber, J; Rolfe, PA; Gifford, DK; Fraenkel, E; Bell, GI; Young, RA			Control of pancreas and liver gene expression by HNF transcription factors	SCIENCE			English	Article							BETA-CELL FUNCTION; DIABETES-MELLITUS; HNF-4-ALPHA GENE; DIFFERENTIATION; SPECIFICATION; HEPATOCYTES; UPSTREAM; NETWORKS; COMPLEX; YOUNG/	The transcriptional regulatory networks that specify and maintain human tissue diversity are largely uncharted. To gain insight into this circuitry, we used chromatin immunoprecipitation combined with promoter microarrays to identify systematically the genes occupied by the transcriptional regulators HNF1alpha, HNF4alpha, and HNF6, together with RNA polymerase II, in human liver and pancreatic islets. We identified tissue-specific regulatory circuits formed by HNF1alpha, HNF4alpha, and HNF6 with other transcription factors, revealing how these factors function as master regulators of hepatocyte and islet transcription. Our results suggest how misregulation of HNF4alpha can contribute to type 2 diabetes.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Comp Sci Lab, Cambridge, MA 02139 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Chicago; University of Chicago; University of Chicago	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Rinaldi, Nicola J/J-5858-2017; Young, Richard A/F-6495-2012	Rinaldi, Nicola J/0000-0002-0358-0747; Young, Richard A/0000-0001-8855-8647; Fraenkel, Ernest/0000-0001-9249-8181; Odom, Duncan/0000-0001-6201-5599	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092310] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002668-01, R01 HG002668] Funding Source: Medline; NIDDK NIH HHS [N01-DK-9-2310] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, NUCL RECEPTORS GENET; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bort R, 2002, NAT GENET, V32, P85, DOI 10.1038/ng0902-85; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Ferrer J, 2002, DIABETES, V51, P2355, DOI 10.2337/diabetes.51.8.2355; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAI E, 1991, TRENDS BIOCHEM SCI, V16, P427, DOI 10.1016/0968-0004(91)90169-V; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LOVEGREGORY L, IN PRESS DIABETES; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Shih DQ, 2001, P NATL ACAD SCI USA, V98, P14189, DOI 10.1073/pnas.251558998; SILANDER K, IN PRESS DIABETES; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhu Q, 2003, DIABETOLOGIA, V46, P567, DOI 10.1007/s00125-003-1067-y	29	1019	1100	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2004	303	5662					1378	1381		10.1126/science.1089769	http://dx.doi.org/10.1126/science.1089769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988562	Green Accepted			2022-12-01	WOS:000189238600054
J	Carli, P; Orliaguet, G				Carli, P; Orliaguet, G			Severe traumatic brain injury in children	LANCET			English	Editorial Material							SEVERE HEAD-INJURIES; CEREBRAL BLOOD-FLOW; BLUNT TRAUMA; PEDIATRIC-PATIENTS; HYPOTENSION; INTUBATION; MANAGEMENT; GUIDELINES; SURVIVAL; CARE		Hop Necker Enfants Malad, Dept Anesthesie & Reanimat Chirurg, F-75743 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Carli, P (corresponding author), Hop Necker Enfants Malad, Dept Anesthesie & Reanimat Chirurg, F-75743 Paris, France.	pCarli.samu@invivo.edu		Orliaguet, Gilles/0000-0003-0930-2251				Azocar F, 2003, J BEHAV HEALTH SER R, V30, P109, DOI 10.1007/BF02287816; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Meyer PG, 2000, PAEDIATR ANAESTH, V10, P253, DOI 10.1046/j.1460-9592.2000.00496.x; Orliaguet G, 2001, INTENS CARE MED, V27, P743, DOI 10.1007/s001340100905; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Suominen P, 1998, INJURY, V29, P425; Suominen P, 1998, J PEDIATR SURG, V33, P1388, DOI 10.1016/S0022-3468(98)90014-8	17	8	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2004	363	9409					584	585		10.1016/S0140-6736(04)15626-2	http://dx.doi.org/10.1016/S0140-6736(04)15626-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	776EZ	14987880				2022-12-01	WOS:000189104900004
J	Pizzarello, S; Weber, AL				Pizzarello, S; Weber, AL			Prebiotic amino acids as asymmetric catalysts	SCIENCE			English	Article							NUCLEIC-ACID; ORIGIN		Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA	Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Pizzarello, S (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.							BADA JL, 1987, BIOSYSTEMS, V20, P21, DOI 10.1016/0303-2647(87)90016-5; Notz W, 2000, J AM CHEM SOC, V122, P7386, DOI 10.1021/ja001460v; Orgel L, 2000, SCIENCE, V290, P1306, DOI 10.1126/science.290.5495.1306; Pizzarello S, 2003, GEOCHIM COSMOCHIM AC, V67, P1589, DOI 10.1016/S0016-7037(02)01283-8; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Thomas P. J., 1997, COMETS ORIGIN EVOLUT; Weber AL, 2001, ORIGINS LIFE EVOL B, V31, P71, DOI 10.1023/A:1006750423942	7	274	277	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2004	303	5661					1151	1151		10.1126/science.1093057	http://dx.doi.org/10.1126/science.1093057			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976304				2022-12-01	WOS:000189074700034
J	Sharma, P; Varma, R; Sarasij, RC; Ira; Gousset, K; Krishnamoorthy, G; Rao, M; Mayor, S				Sharma, P; Varma, R; Sarasij, RC; Ira; Gousset, K; Krishnamoorthy, G; Rao, M; Mayor, S			Nanoscale organization of multiple GPI-anchored proteins in living cell membranes	CELL			English	Article							LIPID RAFTS; CHOLESTEROL DEPLETION; FRET MICROSCOPY; DOMAINS; MICRODOMAINS; SURFACE; RESOLUTION; MOLECULES; DYNAMICS; CAVEOLAE	Cholesterol and sphingolipid-enriched "rafts" have long been proposed as platforms for the sorting of specific membrane components including glycosylphosphatidylinositol-anchored proteins (GPI-APs), however, their existence and physical properties have been controversial. Here, we investigate the size of lipid-dependent organization of GPI-APs in live cells, using homo and hetero-FRET-based experiments combined with theoretical modeling. These studies reveal an unexpected organization wherein cell surface GPI-APs are present as monomers and a smaller fraction (20%-40%) as nanoscale (<5 nm) cholesterol-sensitive clusters. These clusters are composed of at most four molecules and accommodate diverse GPI-AP species; crosslinking GPI-APs segregates them from preexisting GPI-AP clusters and prevents endocytosis of the crosslinked species via a GPI-AP-selective pinocytic pathway. In conjunction with an analysis of the statistical distribution of the clusters, these observations suggest a mechanism for functional lipid-dependent clustering of GPI-APs.	Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; Raman Res Inst, Bangalore 560080, Karnataka, India; Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI); Tata Institute of Fundamental Research (TIFR)	Rao, M (corresponding author), Natl Ctr Biol Sci TIFR, UAS GKVK Campus,GKVK PO, Bangalore 560065, Karnataka, India.	madan@rri.res.in	Probodh, Ira/G-7725-2012; Gousset, Karine/ADS-3249-2022; Varma, Rajat/I-1209-2012; Rao, Madan/E-2927-2012	Probodh, Ira/0000-0002-9346-9726; Gousset, Karine/0000-0002-0988-2332; Varma, Rajat/0000-0001-5131-0402; 				Agranovich V. M., 1982, ELECT EXCITATION ENE; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Clayton AHA, 2002, BIOPHYS J, V83, P1631, DOI 10.1016/S0006-3495(02)73932-5; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Edidin M, 2001, TRENDS CELL BIOL, V11, P492, DOI 10.1016/S0962-8924(01)02139-0; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Krishnan RV, 2001, J FLUORESC, V11, P211, DOI 10.1023/A:1012201201651; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; Lakshmikanth GS, 1999, BIOPHYS J, V77, P1100, DOI 10.1016/S0006-3495(99)76960-2; MATSUE H, 1992, P NATL ACAD SCI USA, V89, P6006, DOI 10.1073/pnas.89.13.6006; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Subczynski WK, 2003, BBA-BIOMEMBRANES, V1610, P231, DOI 10.1016/S0005-2736(03)00021-X; TANAKA F, 1979, PHOTOCHEM PHOTOBIOL, V29, P1091, DOI 10.1111/j.1751-1097.1979.tb07825.x; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zurzolo C, 2003, EMBO REP, V4, P1117, DOI 10.1038/sj.embor.7400032	46	666	680	2	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					577	589		10.1016/S0092-8674(04)00167-9	http://dx.doi.org/10.1016/S0092-8674(04)00167-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980224	Bronze			2022-12-01	WOS:000189184200011
J	Singer, T; Seymour, B; O'Doherty, J; Kaube, H; Dolan, RJ; Frith, CD				Singer, T; Seymour, B; O'Doherty, J; Kaube, H; Dolan, RJ; Frith, CD			Empathy for pain involves the affective but not sensory components of pain	SCIENCE			English	Article							HUMAN CINGULATE CORTEX; BRAIN RESPONSES; PHYSIOLOGICAL CONDITION; INSULAR CORTEX; NEURAL SYSTEMS; FMRI; INTEROCEPTION; METAANALYSIS; ACTIVATION; HUMANS	Our ability to have an experience of another's pain is characteristic of empathy. Using functional imaging, we assessed brain activity while volunteers experienced a painful stimulus and compared it to that elicited when they observed a signal indicating that their loved one-present in the same room-was receiving a similar pain stimulus. Bilateral anterior insula (AI), rostral anterior cingulate cortex (ACC), brainstem, and cerebellum were activated when subjects received pain and also by a signal that a loved one experienced pain. AI and ACC activation correlated with individual empathy scores. Activity in the posterior insula/secondary somatosensory cortex, the sensorimotor cortex (SI/MI), and the caudal ACC was specific to receiving pain. Thus, a neural response in AI and rostral ACC, activated in common for "self" and "other" conditions, suggests that the neural substrate for empathic experience does not involve the entire "pain matrix." We conclude that only that part of the pain network associated with its affective qualities, but not its sensory qualities, mediates empathy.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3AR, England; UCL, Inst Neurol, Headache Grp, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Singer, T (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3AR, England.	t.singer@fil.ion.ucl.ac.uk	O'Doherty, John P/F-1204-2013; Frith, Chris D/A-2171-2009; Girault, Johann/B-2430-2012	Frith, Chris D/0000-0002-8665-0690; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Bingel U, 2003, NEUROIMAGE, V18, P740, DOI 10.1016/S1053-8119(02)00033-2; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Brooks JCW, 2002, NEUROIMAGE, V15, P293, DOI 10.1006/nimg.2001.0974; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Churchland PS, 2002, SCIENCE, V296, P308, DOI 10.1126/science.1070564; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DAMASIO AR, 1994, DESCARTES ERROR; Davis KD, 2000, NEUROL RES, V22, P313; Davis MH, 1980, JSAS CATALOG SELECTE, V10, P85; Decety J, 2003, NEUROPSYCHOLOGIA, V41, P127, DOI 10.1016/S0028-3932(02)00143-4; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; LANGER SK, 1988, ESSAY HUMAN FEELINGS; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816	38	2489	2569	15	603	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2004	303	5661					1157	1162		10.1126/science.1093535	http://dx.doi.org/10.1126/science.1093535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	775RP	14976305	Green Submitted			2022-12-01	WOS:000189074700036
J	Loscalzo, J				Loscalzo, J			Ozone - From environmental pollutant to atherogenic determinant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOW-DENSITY LIPOPROTEIN; DEGRADATION		Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Loscalzo, J (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.		Loscalzo, Joseph/ABD-8980-2021					GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2003, SCIENCE, V302, P1053, DOI 10.1126/science.1089525; Wentworth P, 2003, P NATL ACAD SCI USA, V100, P1490, DOI 10.1073/pnas.0437831100	5	12	14	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2004	350	8					834	835		10.1056/NEJMcibr033352	http://dx.doi.org/10.1056/NEJMcibr033352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774VM	14973208				2022-12-01	WOS:000189006400014
J	Toelle, BG; Ng, K; Belousova, E; Salome, CM; Peat, JK; Marks, GB				Toelle, BG; Ng, K; Belousova, E; Salome, CM; Peat, JK; Marks, GB			Prevalence of asthma and allergy in schoolchildren in Belmont, Australia: three cross sectional surveys over 20 years	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN		Univ Sydney, Woolcock Inst Med Res, Camperdown, NSW 2050, Australia; Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney	Toelle, BG (corresponding author), Univ Sydney, Woolcock Inst Med Res, Box M77,Missenden Rd PO, Camperdown, NSW 2050, Australia.	bgt@woolcock.org.au	Toelle, Brett G/B-1531-2008; Marks, Guy B./F-5058-2013	Toelle, Brett G/0000-0002-7375-0019; Marks, Guy B./0000-0002-8976-8053				BRITTON WJ, 1986, INT J EPIDEMIOL, V15, P202, DOI 10.1093/ije/15.2.202; DEMARCO R, 1994, EUR RESPIR J, V7, P2139, DOI 10.1183/09031936.94.07122139; DRANE JW, 1991, AM J EPIDEMIOL, V134, P908, DOI 10.1093/oxfordjournals.aje.a116165; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; PEAT JK, 1994, BMJ-BRIT MED J, V308, P1591, DOI 10.1136/bmj.308.6944.1591	5	103	107	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 14	2004	328	7436					386	387		10.1136/bmj.328.7436.386	http://dx.doi.org/10.1136/bmj.328.7436.386			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775GA	14962876	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000189031300025
J	Mak, W; Nesterova, TB; de Napoles, M; Appanah, R; Yamanaka, S; Otte, AP; Brockdorff, N				Mak, W; Nesterova, TB; de Napoles, M; Appanah, R; Yamanaka, S; Otte, AP; Brockdorff, N			Reactivation of the paternal X chromosome in early mouse embryos	SCIENCE			English	Article							LINKED GENES; HISTONE H3; INACTIVATION; MAINTENANCE; METHYLATION; PLURIPOTENCY; EXPRESSION; NANOG; CELL	It is generally accepted that paternally imprinted X inactivation occurs exclusively in extraembryonic lineages of mouse embryos, whereas cells of the embryo proper, derived from the inner cell mass (ICM), undergo only random X inactivation. Here we show that imprinted X inactivation, in fact, occurs in all cells of early embryos and that the paternal X is then selectively reactivated in cells allocated to the ICM. This contrasts with more differentiated cell types where X inactivation is highly stable and generally irreversible. Our observations illustrate that an important component of genome plasticity in early development is the capacity to reverse heritable gene silencing decisions.	Hammersmith Hosp, ICSM, MRC, Clin Sci Ctr,X Inactivat Grp, London W12 0NN, England; Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Lab Anim Mol Technol, Nara 6300192, Japan; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands	Imperial College London; Nara Institute of Science & Technology; University of Amsterdam	Brockdorff, N (corresponding author), Hammersmith Hosp, ICSM, MRC, Clin Sci Ctr,X Inactivat Grp, London W12 0NN, England.	neil.brockdorff@csc.mrc.ac.uk	Mak, Winifred/AAN-1971-2021	Nesterova, Tatyana/0000-0001-7740-4386; Brockdorff, Neil/0000-0003-4838-2653				BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; GARDNER RL, 1971, NATURE, V231, P385, DOI 10.1038/231385a0; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; LATHAM KE, 1995, DEV GENET, V17, P212, DOI 10.1002/dvg.1020170306; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAGI N, 1978, CYTOGENET CELL GENET, V20, P240, DOI 10.1159/000130856; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	19	403	415	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					666	669		10.1126/science.1092674	http://dx.doi.org/10.1126/science.1092674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752160				2022-12-01	WOS:000188530800039
J	Poupon, R; Poupon, RE				Poupon, R; Poupon, RE			Retrovirus infection as a trigger for primary biliary cirrhosis?	LANCET			English	Editorial Material							MAMMARY-TUMOR VIRUS; BREAST-CANCER; IMMUNE-SYSTEM; IDENTIFICATION		Hop St Antoine, Assistance Publ Hop Paris, Serv Hepatol, F-75571 Paris 12, France; Fac Med Necker Enfants Malad, INSERM, U370, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Poupon, R (corresponding author), Hop St Antoine, Assistance Publ Hop Paris, Serv Hepatol, F-75571 Paris 12, France.	raoul.poupon@sat.ap-hop-paris.fr						Czarneski J, 2003, IMMUNOL RES, V27, P469, DOI 10.1385/IR:27:2-3:469; Etkind P, 2000, CLIN CANCER RES, V6, P1273; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Liu BR, 2001, CANCER RES, V61, P1754; Otten LA, 2002, TRENDS MICROBIOL, V10, P303, DOI 10.1016/S0966-842X(02)02385-5; Poupon R.E., 1996, HEPATOLOGY TXB LIVER, Vthird, P1329; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213; VANDEWATER J, 1993, J CLIN INVEST, V91, P2653, DOI 10.1172/JCI116504; Xu LZ, 2003, P NATL ACAD SCI USA, V100, P8454, DOI 10.1073/pnas.1433063100	10	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 24	2004	363	9405					260	261		10.1016/S0140-6736(03)15418-9	http://dx.doi.org/10.1016/S0140-6736(03)15418-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766FQ	14751695				2022-12-01	WOS:000188361400004
J	Kadokura, H; Tian, HP; Zander, T; Bardwell, JCA; Beckwith, J				Kadokura, H; Tian, HP; Zander, T; Bardwell, JCA; Beckwith, J			Snapshots of DsbA in action: Detection of proteins in the process of oxidative folding	SCIENCE			English	Article							DISULFIDE-BOND-FORMATION; ESCHERICHIA-COLI; FORMATION INVIVO; RESPIRATORY-CHAIN; LIVING CELLS; THIOREDOXIN; CYSTEINES; SITE; IDENTIFICATION; ISOMERASE	DsbA, a thioredoxin superfamily member, introduces disulfide bonds into newly translocated proteins. This process is thought to occur via formation of mixed disulfide complexes between DsbA and its substrates. However, these complexes are difficult to detect, probably because of their short-lived nature. Here we show that it is possible to detect such covalent intermediates in vivo by a mutation in DsbA that alters cis proline-151. Further, this mutant allowed us to identify substrates of DsbA. Alteration of the cis proline, highly conserved among thioredoxin superfamily members, may be useful for the detection of substrates and intermediate complexes in other systems.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	jbeckwith@hms.harvard.edu	Kadokura, Hiroshi/AAE-1645-2019	Kadokura, Hiroshi/0000-0001-7308-7141	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057039, R01GM041883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57039, GM41883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; Frech C, 1996, EMBO J, V15, P392, DOI 10.1002/j.1460-2075.1996.tb00369.x; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; KADOKURA H, UNPUB; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; ORTENBERG R, UNPUB; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Richarme G, 1998, BIOCHEM BIOPH RES CO, V252, P156, DOI 10.1006/bbrc.1998.9591; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; Vinci F, 2002, PROTEIN SCI, V11, P1600, DOI 10.1110/ps.4960102; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	30	180	183	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					534	537		10.1126/science.1091724	http://dx.doi.org/10.1126/science.1091724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739460				2022-12-01	WOS:000188316400041
J	Cummings, DAT; Irizarry, RA; Huang, NE; Endy, TP; Nisalak, A; Ungchusak, K; Burke, DS				Cummings, DAT; Irizarry, RA; Huang, NE; Endy, TP; Nisalak, A; Ungchusak, K; Burke, DS			Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand	NATURE			English	Article							TIME-SERIES ANALYSIS; PARENTERAL INFECTION; AEDES-AEGYPTI; DISEASE; TEMPERATURE; DYNAMICS; VIRUSES; PREY	Dengue fever is a mosquito- borne virus that infects 50 - 100 million people each year(1). Of these infections, 200,000 - 500,000 occur as the severe, life- threatening form of the disease, dengue haemorrhagic fever ( DHF)(2). Large, unanticipated epidemics of DHF often overwhelm health systems(3). An understanding of the spatial - temporal pattern of DHF incidence would aid the allocation of resources to combat these epidemics. Here we examine the spatial - temporal dynamics of DHF incidence in a data set describing 850,000 infections occurring in 72 provinces of Thailand during the period 1983 to 1997. We use the method of empirical mode decomposition(4) to show the existence of a spatial - temporal travelling wave in the incidence of DHF. We observe this wave in a three- year periodic component of variance, which is thought to reflect host pathogen population dynamics(5,6). The wave emanates from Bangkok, the largest city in Thailand, moving radially at a speed of 148 km per month. This finding provides an important starting point for detecting and characterizing the key processes that contribute to the spatial - temporal dynamics of DHF in Thailand.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA; NASA, Goddard Space Flight Ctr, Lab Hydrospher Proc, Oceans & Ice Branch, Greenbelt, MD 20771 USA; USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand	Burke, DS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	dburke@jhsph.edu		/0000-0002-5704-8094				ANDERSON RM, 1984, J HYG-CAMBRIDGE, V93, P587, DOI 10.1017/S0022172400065177; Bacon P., 1985, POPULATION DYNAMICS; Bjornstad ON, 2002, SCIENCE, V298, P1020, DOI 10.1126/science.1075182; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Chareonsook O, 1999, EPIDEMIOL INFECT, V122, P161, DOI 10.1017/S0950268898001617; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; de Roos AM, 1998, THEOR POPUL BIOL, V53, P108, DOI 10.1006/tpbi.1997.1345; DeRoeck D, 2003, VACCINE, V22, P121, DOI 10.1016/S0264-410X(03)00533-4; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; GUBLER DJ, 1977, J MED ENTOMOL, V13, P469, DOI 10.1093/jmedent/13.4-5.469; GUBLER DJ, 1979, B WORLD HEALTH ORGAN, V57, P931; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; MOLLISON D, 1986, PHILOS T R SOC B, V314, P675, DOI 10.1098/rstb.1986.0080; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603; Sherratt JA, 2001, ECOL LETT, V4, P30, DOI 10.1046/j.1461-0248.2001.00193.x; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143	24	363	374	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2004	427	6972					344	347		10.1038/nature02225	http://dx.doi.org/10.1038/nature02225			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737166				2022-12-01	WOS:000188266200039
J	Orchard, JA; Ibbotson, RE; Davis, Z; Wiestner, A; Rosenwald, A; Thomas, PW; Hamblin, TJ; Staudt, LM; Oscier, DG				Orchard, JA; Ibbotson, RE; Davis, Z; Wiestner, A; Rosenwald, A; Thomas, PW; Hamblin, TJ; Staudt, LM; Oscier, DG			ZAP-70 expression and prognosis in chronic lymphocytic leukaemia	LANCET			English	Article							VARIABLE-REGION MUTATIONS; PROTEIN-TYROSINE KINASE; CD38 EXPRESSION; GENE-EXPRESSION; B-CELLS; PHENOTYPE	Background Chronic lymphocytic leukaemia (CLL) is a heterogeneous disease; many patients never need treatment, whereas some have poor outcomes. New treatments, which can induce complete remissions, allow patients with poor outlook to be treated while they are still asymptomatic. Whether or not the IgVH gene is mutated is the best predictor of clinical outcome, but this assay is unsuited to the routine laboratory. The gene coding for ZAP-70, a tyrosine kinase protein normally expressed in T and NK cells, has been shown by gene-expression profiling to be differentially expressed between patients with mutated and unmutated IgVH genes. We assessed whether ZAP-70 could be used as a prognostic marker in CLL. Methods We developed a flow cytometry assay for ZAP-70 protein expression and investigated its concordance with ZAP-70 mRNA expression, IgVH gene mutational status, and clinical outcome in 167 patients with CLL. Findings We showed high concordance between ZAP-70 protein expression and IgVH gene mutations. 108 patients (65%) had mutated IgVH genes and were ZAP-70 negative; 46 (28%) had unmutated IgVH genes and were ZAP-70 positive. Findings were discordant in 13 patients: six (4%) had mutated IgVH genes but were ZAP-70 positive, and seven (4%) had unmutated IgVH genes and were ZAP-70 negative. Expression of mRNA showed 97% concordance with ZAP-70 protein. Median survival was 24.4 years (95% CI 15.1-33.8) in ZAP-70 negative patients and 9.3 years (7.0-11.5) in those who were ZAP-70 positive (hazard ratio 5.5, 2.8-10.8). Interpretation ZAP-70 protein, which can be measured by flow cytometry in the general laboratory, is a reliable prognostic marker in CLL, equivalent to that of IgVH gene mutational status.	Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England; NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Poole Hosp, Dorset Res & Dev Support Unit, Poole, Dorset, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Poole Hospital	Oscier, DG (corresponding author), Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England.		Staudt, Louis/AAC-5324-2019	Thomas, Peter/0000-0003-2478-4324				Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armitage P., 1987, STAT METHODS MED RES; Byrd JC, 2000, SEMIN ONCOL, V27, P587; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chevallier P, 2002, BRIT J HAEMATOL, V116, P142, DOI 10.1046/j.0007-1048.2001.3205.x; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Geisler C, 1999, JNCI-J NATL CANCER I, V91, P861; Gurrieri C, 2002, J EXP MED, V196, P629, DOI 10.1084/jem.20011693; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kipps TJ, 2000, CURR OPIN HEMATOL, V7, P223, DOI 10.1097/00062752-200007000-00005; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; KONG GH, 1995, IMMUNITY, V2, P485, DOI 10.1016/1074-7613(95)90029-2; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lanham S, 2003, BLOOD, V101, P1087, DOI 10.1182/blood-2002-06-1822; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Schweighoffer E, 2003, IMMUNITY, V18, P523, DOI 10.1016/S1074-7613(03)00082-7; TALBOT D, 1989, TRANSPLANTATION, V47, P552, DOI 10.1097/00007890-198903000-00030; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Toyabe S, 2001, IMMUNOLOGY, V103, P164, DOI 10.1046/j.1365-2567.2001.01246.x; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306	30	442	467	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 10	2004	363	9403					105	111		10.1016/S0140-6736(03)15260-9	http://dx.doi.org/10.1016/S0140-6736(03)15260-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761WV	14726163				2022-12-01	WOS:000187939200007
J	Bastow, R; Mylne, JS; Lister, C; Lippman, Z; Martienssen, RA; Dean, C				Bastow, R; Mylne, JS; Lister, C; Lippman, Z; Martienssen, RA; Dean, C			Vernalization requires epigenetic silencing of FLC by histone methylation	NATURE			English	Article							FLOWERING LOCUS-C; MADS DOMAIN PROTEIN; METHYLTRANSFERASE ACTIVITY; LYSINE 9; ARABIDOPSIS; H3; GENE; REPRESSOR; COMPLEX; ROLES	To ensure flowering in favourable conditions, many plants flower only after an extended period of cold, namely winter. In Arabidopsis, the acceleration of flowering by prolonged cold, a process called vernalization, involves downregulation of the protein FLC, which would otherwise prevent flowering(1,2). This lowered FLC expression is maintained through subsequent development by the activity of VERNALIZATION (VRN) genes(3,4). VRN1 encodes a DNA-binding protein(4) whereas VRN2 encodes a homologue of one of the Polycomb group proteins, which maintain the silencing of genes during animal development(3). Here we show that vernalization causes changes in histone methylation in discrete domains within the FLC locus, increasing dimethylation of lysines 9 and 27 on histone H3. Such modifications identify silenced chromatin states in Drosophila and human cells(5-7). Dimethylation of H3 K27 was lost only in vrn2 mutants, but dimethylation of H3 K9 was absent from both vrn1 and vrn2, consistent with VRN1 functioning downstream of VRN2. The epigenetic memory of winter is thus mediated by a 'histone code' that specifies a silent chromatin state conserved between animals and plants.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Cold Spring Harbor Laboratory	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Mylne, Josh/GMX-4544-2022; Mylne, Joshua S/A-5581-2009	Mylne, Josh/0000-0003-4957-6388; Mylne, Joshua S/0000-0003-4957-6388; Lippman, Zachary/0000-0001-7668-9025				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Birve A, 2001, DEVELOPMENT, V128, P3371; BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandler J, 1996, PLANT J, V10, P637, DOI 10.1046/j.1365-313X.1996.10040637.x; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goodrich J, 2002, ANNU REV CELL DEV BI, V18, P707, DOI 10.1146/annurev.cellbio.18.040202.114836; Henderson IR, 2003, ANNU REV GENET, V37, P371, DOI 10.1146/annurev.genet.37.110801.142640; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007	29	670	737	11	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					164	167		10.1038/nature02269	http://dx.doi.org/10.1038/nature02269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712277				2022-12-01	WOS:000187863900037
J	Mempel, TR; Henrickson, SE; von Andrian, UH				Mempel, TR; Henrickson, SE; von Andrian, UH			T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases	NATURE			English	Article							IMMUNOLOGICAL SYNAPSE; ANTIGEN PRESENTATION; ACTIVATION; EXPRESSION; CHEMOKINE; INDUCTION	Primary T-cell responses in lymph nodes (LNs) require contact-dependent information exchange between T cells and dendritic cells (DCs). Because lymphocytes continually enter and leave normal LNs, the resident lymphocyte pool is composed of nonsynchronized cells with different dwell times that display heterogeneous behaviour in mouse LNs in vitro(1-3). Here we employ two-photon microscopy in vivo to study antigen-presenting DCs and naive T cells whose dwell time in LNs was synchronized. During the first 8 h after entering from the blood, T cells underwent multiple short encounters with DCs, progressively decreased their motility, and upregulated activation markers. During the subsequent 12 h T cells formed long-lasting stable conjugates with DCs and began to secrete interleukin-2 and interferon-gamma. On the second day, coinciding with the onset of proliferation, T cells resumed their rapid migration and short DC contacts. Thus, T-cell priming by DCs occurs in three successive stages: transient serial encounters during the first activation phase are followed by a second phase of stable contacts culminating in cytokine production, which makes a transition into a third phase of high motility and rapid proliferation.	Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008	Henrickson, Sarah/0000-0001-5569-4132	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2002, SCIENCE, V296, P1815, DOI 10.1126/science.296.5574.1815; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303	30	1263	1310	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					154	159		10.1038/nature02238	http://dx.doi.org/10.1038/nature02238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712275	Bronze			2022-12-01	WOS:000187863900035
J	Nambu, Y; Sugai, M; Gonda, H; Lee, CG; Katakai, T; Agata, Y; Yokota, Y; Shimizu, A				Nambu, Y; Sugai, M; Gonda, H; Lee, CG; Katakai, T; Agata, Y; Yokota, Y; Shimizu, A			Transcription-coupled events associating with immunoglobulin switch region chromatin	SCIENCE			English	Article							RNA EDITING ENZYME; ANTIBODY DIVERSIFICATION; V(D)J RECOMBINATION; ACCESSIBILITY CONTROL; HISTONE ACETYLATION; DNA DEAMINATION; AID; MECHANISM; INTERLEUKIN-4; HYPERMUTATION	Class switch recombination (CSR) at the antibody immunoglobulin locus is regulated by germline transcription (GLT) - coupled modi. cations in the accessibility of the switch region, where CSR takes place. Here we show that histone acetylation of switch regions is linked to CSR but that histone acetylation cannot alone promote CSR or GLT. Activation-induced cytidine deaminase (AID) specifically associates with the CSR target chromatin in a GLT-coupled manner, which may occur potentially by means of physical interaction between AID and the transcription machinery. These data indicate an important role of GLT in the regulation of chromatin accessibility, strongly suggesting that the target of AID is chromatin DNA. Our results give insights on the role of AID and the regulatory mechanism of CSR.	Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 068507, Japan; Alton Ochsner Med Fdn & Ochsner Clin, Cellular Immunol Lab, New Orleans, LA 70121 USA; Fukui Med Univ, Dept Biochem, Fukui 9101193, Japan	Kyoto University; Kyoto University; Ochsner Health System; University of Fukui	Sugai, M (corresponding author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.		Katakai, Tomoya/AAX-1434-2021	Nambu, Yukiko/0000-0001-6030-4530; Sugai, Manabu/0000-0003-1668-7647; Agata, Yasutoshi/0000-0001-9642-6994; Katakai, Tomoya/0000-0002-4290-7028				Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; GAUCHAT JF, 1992, INT IMMUNOL, V4, P397, DOI 10.1093/intimm/4.3.397; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAMBU Y, UNPUB; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Sugai M, 1998, NUCLEIC ACIDS RES, V26, P911, DOI 10.1093/nar/26.4.911; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	28	212	215	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2137	2140		10.1126/science.1092481	http://dx.doi.org/10.1126/science.1092481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684824				2022-12-01	WOS:000187385200049
J	Clyde, DE; Corado, MSG; Wu, XL; Pare, A; Papatsenko, D; Small, S				Clyde, DE; Corado, MSG; Wu, XL; Pare, A; Papatsenko, D; Small, S			A self-organizing system of repressor gradients establishes segmental complexity in Drosophila	NATURE			English	Article							PAIR-RULE STRIPES; BINDING-SITES; IN-VIVO; EMBRYO; GENE; EXPRESSION; MORPHOGEN; HUNCHBACK; KRUPPEL; ACTIVATORS	Gradients of regulatory factors are essential for establishing precise patterns of gene expression during development(1-3); however, it is not clear how patterning information in multiple gradients is integrated to generate complex body plans. Here we show that opposing gradients of two Drosophila transcriptional repressors, Hunchback (Hb) and Knirps (Kni), position several segments by differentially repressing two distinct regulatory regions (enhancers) of the pair-rule gene even-skipped (eve). Computational and in vivo analyses suggest that enhancer sensitivity to repression is controlled by the number and affinity of repressor-binding sites. Because the kni expression domain is positioned between two gradients of Hb, each enhancer directs expression of a pair of symmetrical stripes, one on each side of the kni domain. Thus, only two enhancers are required for the precise positioning of eight stripe borders (four stripes), or more than half of the whole eve pattern. Our results show that complex developmental expression patterns can be generated by simple repressor gradients. They also support the utility of computational analyses for defining and deciphering regulatory information contained in genomic DNA.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Small, S (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.		Papatsenko, Dmitri/G-7375-2016	Papatsenko, Dmitri/0000-0002-4390-5446				Andrioli LPM, 2002, DEVELOPMENT, V129, P4931; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fujioka M, 1999, DEVELOPMENT, V126, P2527; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; HOU XS, 1996, CELL, V85, P290; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kosman D, 1997, DEVELOPMENT, V124, P1343; KRAUT R, 1991, DEVELOPMENT, V111, P611; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Small S, 2000, METHOD ENZYMOL, V326, P146; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8	31	145	150	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					849	853		10.1038/nature02189	http://dx.doi.org/10.1038/nature02189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685241				2022-12-01	WOS:000187342000061
J	Arcury, TA; Quandt, SA				Arcury, TA; Quandt, SA			Pesticides at work and at home: exposure of migrant farmworkers	LANCET			English	Editorial Material									Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Arcury, TA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008739] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01-ES08739] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARR DB, 2003, ENV HLTH PERSPE 1104; *GOV ACC OFF, 2000, GAORCED0040; Lindell A. R., 2003, NATL PESTICIDE COMPE	3	33	39	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					2021	2021		10.1016/S0140-6736(03)15027-1	http://dx.doi.org/10.1016/S0140-6736(03)15027-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14686376				2022-12-01	WOS:000187210700029
J	Downey, M				Downey, M			The importance of being earnest	LANCET			English	Article									Amer Obes Assoc, Washington, DC 20037 USA		Downey, M (corresponding author), Amer Obes Assoc, Suite 300,1250 24th St NW, Washington, DC 20037 USA.								0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S42	S43		10.1016/S0140-6736(03)15072-6	http://dx.doi.org/10.1016/S0140-6736(03)15072-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698126				2022-12-01	WOS:000187790200022
J	Dhallan, R; Au, WC; Mattagajasingh, S; Emche, S; Bayliss, P; Damewood, M; Cronin, M; Chou, V; Mohr, M				Dhallan, R; Au, WC; Mattagajasingh, S; Emche, S; Bayliss, P; Damewood, M; Cronin, M; Chou, V; Mohr, M			Methods to increase the percentage of free fetal DNA recovered from the maternal circulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRENATAL-DIAGNOSIS; DOWNS-SYNDROME; PLASMA; SERUM; TRISOMY-18; BLOOD	Context Noninvasive prenatal diagnostic tests using free fetal DNA provide an alternative to invasive tests and their attendant risks; however, free fetal DNA exists in the maternal circulation at low percentages, which has hindered development of noninvasive tests. Objective To test the hypothesis that using formaldehyde to reduce cell lysis could increase the relative percentage of free fetal DNA in samples of maternal blood. Design, Setting, and Patients The first phase of the study was conducted from January through February 2002 at a single US clinical site; 2 samples of blood were collected from each of 10 pregnant women, and the percentage of free fetal DNA in formaldehyde-treated and untreated samples was determined. The second phase of the study was conducted from March 2002 through May 2003, and measured the percentage of free fetal DNA in 69 formaldehyde-treated samples of maternal blood obtained from a network of 27 US clinical sites in 16 states. Main Outcome Measure Percentage of free fetal DNA in samples of maternal blood. Results In the first phase of the study, the mean percentage of free fetal DNA in the untreated samples was 7.7% (range, 0.32%-40%), while the mean percentage of free fetal DNA in the formaldehyde-treated samples was 20.2% (range, 1.6%-40%) (P=.02 for difference). in the second phase, a median of 25% (range, 3.1% to >50%) free fetal DNA was obtained forthe 69 formaldehyde-treated maternal blood samples. Approximately 59% of the samples in this study had 25% or greater fetal DNA, and only 16% of the samples had less than 10% fetal DNA. In addition, 27.5% of the samples in this study had 50% or greater fetal DNA. Conclusion Addition of formaldehyde to maternal blood samples, coupled with careful processing protocols, increases the relative percentage of free fetal DNA, providing a foundation for development of noninvasive prenatal diagnostic tests to distinguish fetal DNA from maternal DNA in the maternal circulation.	Ravgen Inc, Columbia, MD 21045 USA; York Hosp, Dept Obstet & Gynecol, York, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Dhallan, R (corresponding author), Ravgen Inc, 9241 Rumsey Rd, Columbia, MD 21045 USA.	rdhallan@ravgen.com						Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; COX RA, 1976, BIOCHEM MED METAB B, V15, P126, DOI 10.1016/0006-2944(76)90039-9; d'Ercole C, 2003, CHILD NERV SYST, V19, P444, DOI 10.1007/s00381-003-0788-z; KAMM RC, 1972, CLIN CHEM, V18, P519; Lo YMD, 2000, CLIN CHEM, V46, P1903; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; LO YMD, 1989, LANCET, V2, P1363; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1999, CLIN CHEM, V45, P1747; Loncar J, 1995, Obstet Gynecol Surv, V50, P316, DOI 10.1097/00006254-199504000-00027; LOWRY DLB, 1995, FETAL DIAGN THER, V10, P286, DOI 10.1159/000264245; MACDONALD ML, 1991, OBSTET GYNECOL, V77, P63; Meier C, 2003, PRENATAL DIAG, V23, P443, DOI 10.1002/pd.614; Pertl B, 2001, OBSTET GYNECOL, V98, P483, DOI 10.1016/S0029-7844(01)01195-4; Poon LLM, 2000, LANCET, V356, P1819, DOI 10.1016/S0140-6736(00)03237-2; Samura O, 2001, CLIN CHEM, V47, P1622; Skinner Juliet, 2003, J Obstet Gynaecol, V23, P228; Summers AM, 2003, OBSTET GYNECOL, V101, P1301, DOI 10.1016/S0029-7844(03)00235-7; Verma L, 1998, LANCET, V352, P9, DOI 10.1016/S0140-6736(97)11090-X; WALKNOWSKA J, 1969, LANCET, V1, P1119; Wataganara T, 2003, HUM GENET, V112, P204, DOI 10.1007/s00439-002-0853-9	21	109	185	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2004	291	9					1114	1119		10.1001/jama.291.9.1114	http://dx.doi.org/10.1001/jama.291.9.1114			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780AQ	14996781	Bronze			2022-12-01	WOS:000189348900029
J	Warner, J				Warner, J			Risk of choking in mental illness	LANCET			English	Editorial Material							PSYCHIATRIC-PATIENTS; EXCESS MORTALITY; DEATH		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Psychiat, London W2 1PD, England	Imperial College London	Warner, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Psychiat, London W2 1PD, England.	j.warner@imperial.ac.uk						Appleby L, 2000, BRIT J PSYCHIAT, V176, P405, DOI 10.1192/bjp.176.5.405; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Corcoran E, 2003, IRISH J PSYCHOL MED, V20, P88, DOI 10.1017/S079096670000776X; Fioritti A, 1997, CAN J PSYCHIAT, V42, P515, DOI 10.1177/070674379704200509; GIACOTTO L, 1998, MINERVA PSYCHIAT, V39, P37; HAMMOND WA, 1883, TREATISE INSANITY IT, P724; Osborn DPJ, 2001, WESTERN J MED, V175, P329, DOI 10.1136/ewjm.175.5.329; REILLEY JG, 2002, BRIT J PSYCHIAT, V100, P515; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Ruschena D, 1998, BRIT J PSYCHIAT, V172, P331, DOI 10.1192/bjp.172.4.331; Ruschena D, 2003, BRIT J PSYCHIAT, V183, P446, DOI 10.1192/bjp.183.5.446	11	5	5	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 28	2004	363	9410					674	674		10.1016/S0140-6736(04)15664-X	http://dx.doi.org/10.1016/S0140-6736(04)15664-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	778XP	15001323				2022-12-01	WOS:000189266900006
J	Lindenmayer, DB; Foster, DR; Franklin, JF; Hunter, ML; Noss, RF; Schmiegelow, FA; Perry, D				Lindenmayer, DB; Foster, DR; Franklin, JF; Hunter, ML; Noss, RF; Schmiegelow, FA; Perry, D			Ecology - Salvage harvesting policies after natural disturbance	SCIENCE			English	Editorial Material							FORESTS		Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; Univ Maine, Dept Wildlife Ecol, Orono, ME 04469 USA; Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; Univ Hawaii, Kapaau, HI 96755 USA	Australian National University; Harvard University; University of Washington; University of Washington Seattle; University of Maine System; University of Maine Orono; State University System of Florida; University of Central Florida; University of Alberta; University of Hawaii System	Lindenmayer, DB (corresponding author), Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia.	davidl@cres.anu.edu.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088				Bradstock RA., 2002, FLAMMABLE AUSTR FIRE; *CAN COUNC FOR MIN, 2003, CAN WILDL FIR INF SY; *DEP SUST ENV, 2003, SALV HARV PRESCR 200; *FAO UN, 2001, STAT WORLDS FOR; Foster DR, 1997, BIOSCIENCE, V47, P437, DOI 10.2307/1313059; Franklin J.F., 2000, CONSERVATION BIOL PR, V1, P9, DOI DOI 10.1111/J.1526-4629.2000.TB00155.X; Gregory S.V., 1997, CREATING FORESTRY 21, P69; Hansen SB, 1983, THESIS U MAINE; Hoyt JS, 2002, CAN J FOREST RES, V32, P1881, DOI [10.1139/x02-109, 10.1139/X02-109]; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; KENNEDY P, 2003, GLOBE MAIL TORO 0905, P81; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer DB, 1997, CONSERV BIOL, V11, P1053, DOI 10.1046/j.1523-1739.1997.96150.x; Ough K., 1996, Australian Forestry, V59, P178; Pahl-Wostl C., 1995, DYNAMIC NATURE ECOSY; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Van Nieuwstadt MGL, 2001, CONSERV BIOL, V15, P1183, DOI 10.1046/j.1523-1739.2001.0150041183.x	17	204	213	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1303	1303		10.1126/science.1093438	http://dx.doi.org/10.1126/science.1093438			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988539				2022-12-01	WOS:000189238600025
J	Silva, GA; Czeisler, C; Niece, KL; Beniash, E; Harrington, DA; Kessler, JA; Stupp, SI				Silva, GA; Czeisler, C; Niece, KL; Beniash, E; Harrington, DA; Kessler, JA; Stupp, SI			Selective differentiation of neural progenitor cells by high-epitope density nanofibers	SCIENCE			English	Article							POLY(DL-LACTIC-CO-GLYCOLIC ACID) FOAMS; PEPTIDE-AMPHIPHILE NANOFIBERS; COLLAGEN-GAG MATRIX; SPINAL-CORD INJURY; STEM-CELLS; IN-VITRO; INJECTABLE ALGINATE; HIPPOCAMPAL-NEURONS; GENE-THERAPY; GROWTH	Neural progenitor cells were encapsulated in vitro within a three-dimensional network of nanofibers formed by self-assembly of peptide amphiphile molecules. The self-assembly is triggered by mixing cell suspensions in media with dilute aqueous solutions of the molecules, and cells survive the growth of the nanofibers around them. These nanofibers were designed to present to cells the neurite-promoting laminin epitope IKVAV at nearly van der Waals density. Relative to laminin or soluble peptide, the artificial nanofiber scaffold induced very rapid differentiation of cells into neurons, while discouraging the development of astrocytes. This rapid selective differentiation is linked to the amplification of bioactive epitope presentation to cells by the nanofibers.	Northwestern Univ, Inst Bioengn & Nanosci Adv Med, Chicago, IL 60611 USA; Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Dept Mat Sci & Engn, Chicago, IL 60611 USA; Northwestern Univ, Dept Chem, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Inst Bioengn & Nanosci Adv Med, Chicago, IL 60611 USA.	gsilva@ucsd.edu; s-stupp@northwestern.edu	Stupp, Samuel/B-6737-2009; Stupp, Samuel/AGV-1942-2022	Harrington, Daniel/0000-0003-2505-0349; Czeisler, Catherine/0000-0001-7895-6449	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034758, R01NS020013, R01NS020778] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34758, NS20778, NS20013] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499; ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3; Butler CE, 1999, BRIT J PLAST SURG, V52, P127, DOI 10.1054/bjps.1997.3047; Canaple L, 2002, J BIOMAT SCI-POLYM E, V13, P783, DOI 10.1163/156856202760197410; Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.3.CO;2-S; Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X; Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S; Chen ZJ, 2002, MOL CELL NEUROSCI, V20, P125, DOI 10.1006/mcne.2002.1102; Cornish T, 2002, MOL CELL NEUROSCI, V20, P140, DOI 10.1006/mcne.2002.1101; Costa S, 2002, GLIA, V37, P105, DOI 10.1002/glia.10015; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Hortelano G, 1996, BLOOD, V87, P5095, DOI 10.1182/blood.V87.12.5095.bloodjournal87125095; Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404; Kam L, 2001, BIOMATERIALS, V22, P1049, DOI 10.1016/S0142-9612(00)00352-5; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lauer L, 2002, BIOMATERIALS, V23, P3123, DOI 10.1016/S0142-9612(02)00056-X; Lavik Erin, 2002, Methods Mol Biol, V198, P89; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020; Matsuzawa M, 1996, INT J DEV NEUROSCI, V14, P283, DOI 10.1016/0736-5748(96)00014-7; Mehler MF, 1999, ARCH NEUROL-CHICAGO, V56, P780, DOI 10.1001/archneur.56.7.780; MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X; Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X; Nehrer S, 1997, J BIOMED MATER RES, V38, P95; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Orgill DP, 1998, PLAST RECONSTR SURG, V102, P423, DOI 10.1097/00006534-199808000-00020; Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204; Pincus DW, 1998, NEUROSURGERY, V42, P858, DOI 10.1097/00006123-199804000-00103; Powell SK, 2000, J NEUROSCI RES, V61, P302, DOI 10.1002/1097-4547(20000801)61:3<302::AID-JNR8>3.0.CO;2-G; Rabchevsky AG, 2001, ARCH NEUROL-CHICAGO, V58, P721, DOI 10.1001/archneur.58.5.721; Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287; Storch Alexander, 2002, Curr Opin Investig Drugs, V3, P774; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thiebaud P, 2002, BIOSENS BIOELECTRON, V17, P87, DOI 10.1016/S0956-5663(01)00279-2; WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K; Wheeler BC, 1999, J BIOMECH ENG-T ASME, V121, P73, DOI 10.1115/1.2798045; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Xu WM, 2001, FASEB J, V15, P213, DOI 10.1096/fj.01-0590fje; YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899; Yeung CK, 2001, NEUROSCI LETT, V301, P147, DOI 10.1016/S0304-3940(01)01628-7; Zhu G, 2000, J NEUROSCI RES, V59, P312, DOI 10.1002/(SICI)1097-4547(20000201)59:3<312::AID-JNR4>3.0.CO;2-A	46	1778	1887	6	568	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2004	303	5662					1352	1355		10.1126/science.1093783	http://dx.doi.org/10.1126/science.1093783			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14739465				2022-12-01	WOS:000189238600046
J	Ogawa, T; Nitta, R; Okada, Y; Hirokawa, N				Ogawa, T; Nitta, R; Okada, Y; Hirokawa, N			A common mechanism for microtubule destabilizers - M type kinesins stabilize curling of the protofilament using the class-specific neck and loops	CELL			English	Article							CENTROMERE-ASSOCIATED KINESIN; DYNEIN SUPERFAMILY PROTEINS; MOTOR PROTEIN; DEPOLYMERIZING ACTIVITY; ORGANELLE TRANSPORT; C-TERMINUS; K-LOOP; TUBULIN; DOMAIN; ATPASE	Unlike other kinesins, middle motor domain-type kinesins depolymerize the microtubule from its ends. To elucidate its mechanism, we solved the X-ray crystallographic structure of KIF2C, a murine member of this family. Three major class-specific features were identified. The class-specific N-terminal neck adopts a long and rigid helical structure extending out vertically into the interprotofilament groove. This structure explains its dual roles in targeting to the end of the microtubule and in destabilization of the lateral interaction of the protofilament. The loop L2 forms a unique finger-like structure, long and rigid enough to reach the next tubulin subunit to stabilize the peeling of the protofilament. The open conformation of the switch I loop could be reversed by the shift of the microtubule binding L8 loop, suggesting its role as the sensor to trigger ATP hydrolysis. Mutational analysis supports these structural implications.	Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Nitta, Ryo/Q-9958-2019; Nitta, Ryo/C-3727-2017; Okada, Yasushi/N-5067-2015; Tadayuki, Ogawa/P-5451-2018	Nitta, Ryo/0000-0002-6537-9272; Nitta, Ryo/0000-0002-6537-9272; Okada, Yasushi/0000-0003-2601-3689; Tadayuki, Ogawa/0000-0002-4627-0693				AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Inoue Y, 1997, P NATL ACAD SCI USA, V94, P7275, DOI 10.1073/pnas.94.14.7275; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kim AJ, 2000, J CELL SCI, V113, P3681; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Miki H, 2003, GENOME RES, V13, P1455, DOI 10.1101/gr.984503; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Moores CA, 2003, J CELL BIOL, V163, P963, DOI 10.1083/jcb.200304034; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Niederstrasser H, 2002, J MOL BIOL, V316, P817, DOI 10.1006/jmbi.2001.5360; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; REICHERT TM, 1998, P NATL ACAD SCI USA, V95, P3661; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; TAKEMURA R, 1992, J CELL SCI, V103, P953; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Watts NR, 2000, J CELL BIOL, V150, P349, DOI 10.1083/jcb.150.2.349; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	42	152	158	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					591	602		10.1016/S0092-8674(04)00129-1	http://dx.doi.org/10.1016/S0092-8674(04)00129-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980225	Bronze			2022-12-01	WOS:000189184200012
J	Sharp, D				Sharp, D			Butter-fingers	LANCET			English	Editorial Material							FLY BALLS; CATCH; FIELDER; RUN		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							FERRY G, 2001, OXFORD TODAY; McLeod P, 2003, NATURE, V426, P244, DOI 10.1038/426244a; McLeod P, 2002, J EXP PSYCHOL HUMAN, V28, P1499, DOI 10.1037//0096-1523.28.6.1499; McLeod P, 2001, J EXP PSYCHOL HUMAN, V27, P1347, DOI 10.1037/0096-1523.27.6.1347; Shaffer DM, 2003, J EXP PSYCHOL HUMAN, V29, P1244, DOI 10.1037/0096-1523.29.6.1244; Shaffer DM, 2002, J EXP PSYCHOL HUMAN, V28, P335, DOI 10.1037//0096-1523.28.2.335; TALLIS R, 2003, HAND PHILOS INQUIRY, P146	7	0	0	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 14	2004	363	9408					506	506		10.1016/S0140-6736(04)15577-3	http://dx.doi.org/10.1016/S0140-6736(04)15577-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774TA	14975610				2022-12-01	WOS:000188999900005
J	Valverde, F; Mouradov, A; Soppe, W; Ravenscroft, D; Samach, A; Coupland, G				Valverde, F; Mouradov, A; Soppe, W; Ravenscroft, D; Samach, A; Coupland, G			Photoreceptor regulation of CONSTANS protein in photoperiodic flowering	SCIENCE			English	Article							ARABIDOPSIS PHOTORECEPTORS; FLORAL INDUCTION; CIRCADIAN CLOCK; PHYTOCHROME-A; TIME; LIGHT; GENES; EXPRESSION; PLANTS; ROLES	Many plants flower in response to seasonal fluctuations in day length. The CONSTANS (CO) gene of Arabidopsis promotes flowering in long days. Flowering is induced when CO messenger RNA expression coincides with the exposure of plants to light. However, how this promotes CO activity is unknown. We show that light stabilizes nuclear CO protein in the evening, whereas in the morning or in darkness the protein is degraded by the proteasome. Photoreceptors regulate CO stability and act antagonistically to generate daily rhythms in CO abundance. This layer of regulation refines the circadian rhythm in CO messenger RNA and is central to the mechanism by which day length controls flowering.	Max Planck Inst Plant Breeding, D-50829 Cologne, Germany; Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel	Max Planck Society; Hebrew University of Jerusalem	Coupland, G (corresponding author), Max Planck Inst Plant Breeding, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de	Valverde, Federico/K-1248-2014; Rosa, Bruce/F-6393-2010; Coupland, George/AAP-8609-2020	Valverde, Federico/0000-0001-8063-0974; Coupland, George/0000-0001-6988-4172; Mouradov, Aidyn/0000-0003-2945-3751				BROWN JAM, 1971, PLANT PHYSIOL, V47, P393, DOI 10.1104/pp.47.3.393; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Garner WW, 1919, J AGRIC RES, V18, P0553; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	23	869	956	4	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1003	1006		10.1126/science.1091761	http://dx.doi.org/10.1126/science.1091761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963328	Green Published			2022-12-01	WOS:000188918000043
J	Kim, J; Dong, HL; Seabaugh, J; Newell, SW; Eberl, DD				Kim, J; Dong, HL; Seabaugh, J; Newell, SW; Eberl, DD			Role of microbes in the smectite-to-illite reaction	SCIENCE			English	Article							SOLE ELECTRON-ACCEPTOR; STRUCTURAL FE(III); SP-NOV; REDUCTION; GROWTH; NONTRONITES; CONVERSION; BENTONITES; MINERALS; ROCKS	Temperature, pressure, and time have been thought to control the smectite-to-illite (S-I) reaction, an important diagenetic process used for petroleum exploration. We demonstrated that microorganisms can promote the S-I reaction by dissolving smectite through reduction of structural Fe(III) at room temperature and 1 atmosphere within 14 days. This reaction typically requires conditions of 300degrees to 350degreesC, 100 megapascals, and 4 to 5 months in the absence of microbial activity. These results challenge the conventional concept of the S-I reaction and of reaction kinetic models.	USN, Res Lab, Seafloor Sci Branch, Stennis Space Ctr, MS 39529 USA; Miami Univ, Dept Geol, Oxford, OH 45056 USA; US Geol Survey, Boulder, CO 80303 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; University System of Ohio; Miami University; United States Department of the Interior; United States Geological Survey	Kim, J (corresponding author), USN, Res Lab, Seafloor Sci Branch, Stennis Space Ctr, MS 39529 USA.	jkim@nrlssc.navy.mil	Kim, Jinwook/AAO-7501-2020					BETHKE CM, 1986, CLAY CLAY MINER, V34, P136, DOI 10.1346/CCMN.1986.0340204; BOONE DR, 1995, INT J SYST BACTERIOL, V45, P441, DOI 10.1099/00207713-45-3-441; Brown KM, 2001, EARTH PLANET SC LETT, V194, P97, DOI 10.1016/S0012-821X(01)00546-5; BRUCE CH, 1984, AAPG BULL, V68, P673; BUCKLEY HA, 1978, MINERAL MAG, V42, P373, DOI 10.1180/minmag.1978.042.323.08; Dong HL, 1997, AM MINERAL, V82, P379; Dong HL, 2003, ENVIRON SCI TECHNOL, V37, P1268, DOI 10.1021/es020919d; Eberl DD, 1998, CLAY CLAY MINER, V46, P89, DOI 10.1346/CCMN.1998.0460110; Eberl DD, 1998, AM J SCI, V298, P499, DOI 10.2475/ajs.298.6.499; EBERL DD, 1996, 96171 USGS; ESLINGER E, 1979, CLAY CLAY MINER, V27, P327, DOI 10.1346/CCMN.1979.0270503; FREED RL, 1989, AAPG BULL, V73, P1223; GAUDETT E, 1966, CLAYS CLAY MINER, V13, P33; Kashefi K, 2002, APPL ENVIRON MICROB, V68, P1735, DOI 10.1128/AEM.68.4.1735-1742.2002; Keeling JL, 2000, CLAY CLAY MINER, V48, P537, DOI 10.1346/CCMN.2000.0480506; Kostka JE, 2002, APPL ENVIRON MICROB, V68, P6256, DOI 10.1128/AEM.68.12.6256-6262.2002; Kostka JE, 1996, CLAY CLAY MINER, V44, P522, DOI 10.1346/CCMN.1996.0440411; Lovley DR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P3; Masuda H, 2001, CLAY CLAY MINER, V49, P109, DOI 10.1346/CCMN.2001.0490201; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Pevear DR, 1999, P NATL ACAD SCI USA, V96, P3440, DOI 10.1073/pnas.96.7.3440; POLLASTRO RM, 1993, CLAY CLAY MINER, V41, P119, DOI 10.1346/CCMN.1993.0410202; Reed DW, 2002, APPL ENVIRON MICROB, V68, P3759, DOI 10.1128/AEM.68.8.3759-3770.2002; RUSSELL JD, 1979, CLAY CLAY MINER, V27, P63, DOI 10.1346/CCMN.1979.0270108; WARSHAW CM, 1957, THESIS PENNSYLVANIA; Weaver C.E., 2011, CHEM CLAY MINERALS	26	216	236	4	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2004	303	5659					830	832		10.1126/science.1093245	http://dx.doi.org/10.1126/science.1093245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764877				2022-12-01	WOS:000188753800055
J	Starace, DM; Bezanilla, F				Starace, DM; Bezanilla, F			A proton pore in a potassium channel voltage sensor reveals a focused electric field	NATURE			English	Article							SHAKER K+ CHANNEL; S4 SEGMENT; CHARGE MOVEMENT; GATING CHARGE; ION CHANNELS; INACTIVATION; FLUCTUATIONS; MUTAGENESIS; EXPRESSION; RESIDUES	Voltage-dependent potassium channels are essential for the generation of nerve impulses(1). Voltage sensitivity is conferred by charged residues located mainly in the fourth transmembrane segment (S4) of each of the four identical subunits that make up the channel. These charged segments relocate when the potential difference across the membrane changes(2,3), controlling the ability of the pore to conduct ions. In the crystal structure of the Aeropyrum pernix potassium channel KvAP(4), the S4 and part of the third (S3B) transmembrane alpha-helices are connected by a hairpin turn in an arrangement termed the 'voltage-sensor paddle'. This structure was proposed to move through the lipid bilayer during channel activation, transporting positive charges across a large fraction of the membrane(5). Here we show that replacing the first S4 arginine by histidine in the Shaker potassium channel creates a proton pore when the cell is hyperpolarized. Formation of this pore does not support the paddle model, as protons would not have access to a lipid-buried histidine. We conclude that, at hyperpolarized potentials, water and protons from the internal and external solutions must be separated by a narrow barrier in the channel protein that focuses the electric field to a small voltage-sensitive region.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bezanilla, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	Fbezanil@ucla.edu						Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; CONTI F, 1980, J PHYSIOL-LONDON, V308, P217, DOI 10.1113/jphysiol.1980.sp013469; ECOURSEY TE, 2003, PHYSIOL REV, V83, P475; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lee Y. W., 1960, STAT THEORY COMMUNIC; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Schumaker MF, 2000, BIOPHYS J, V79, P2840, DOI 10.1016/S0006-3495(00)76522-2; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Stefani E, 1998, METHOD ENZYMOL, V293, P300; STEVENS CF, 1972, BIOPHYS J, V12, P1028, DOI 10.1016/S0006-3495(72)86141-1; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448	30	315	324	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					548	553		10.1038/nature02270	http://dx.doi.org/10.1038/nature02270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765197				2022-12-01	WOS:000188721800043
J	van Dis, J				van Dis, J			Residency training and pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTETRICS; GYNECOLOGY; POLICIES		Univ Hawaii, Honolulu, HI 96822 USA	University of Hawaii System	van Dis, J (corresponding author), Univ Hawaii, Honolulu, HI 96822 USA.							*AM MED ASS, WOM RES SPEC 2002; *ASS AM MED COLL, 2002, WOM US AC MED STAT 2; Davis JL, 2001, OBSTET GYNECOL, V98, P1093, DOI 10.1016/S0029-7844(01)01605-2; ESKENAZI L, 1995, PLAST RECONSTR SURG, V95, P330, DOI 10.1097/00006534-199502000-00013; Finch SJ, 2003, ACAD MED, V78, P418, DOI 10.1097/00001888-200304000-00021; Gabbe SG, 2003, OBSTET GYNECOL, V102, P948, DOI 10.1016/S0029-7844(03)00856-1; Harris D L, 1990, J Am Med Womens Assoc (1972), V45, P127; Harris DL, 1990, J AM MED WOMEN ASSOC, V45, P131; KLEVAN JL, 1990, AM J DIS CHILD, V144, P767, DOI 10.1001/archpedi.1990.02150310035021; MANASTER BJ, 1995, ACAD RADIOL, V2, P804, DOI 10.1016/S1076-6332(05)80492-1; PHELAN ST, 1992, ACAD MED, V67, P408, DOI 10.1097/00001888-199206000-00014	11	10	10	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2004	291	5					636	636		10.1001/jama.291.5.636	http://dx.doi.org/10.1001/jama.291.5.636			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	769LC	14762048				2022-12-01	WOS:000188650700034
J	Chen, J; Muntner, P; Hamm, LL; Jones, DW; Batuman, V; Fonseca, V; Whelton, PK; He, J				Chen, J; Muntner, P; Hamm, LL; Jones, DW; Batuman, V; Fonseca, V; Whelton, PK; He, J			The metabolic syndrome and chronic kidney disease in US adults	ANNALS OF INTERNAL MEDICINE			English	Article							INSULIN-RESISTANCE SYNDROME; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; RENAL-DISEASE; SERUM CREATININE; BLOOD-PRESSURE; RISK; PROGRESSION; MORTALITY; PREVALENCE	Background: The metabolic syndrome is a common risk factor for cardiovascular disease. Objective: To examine the association between the metabolic syndrome and risk for chronic kidney disease and microalbuminuria. Design: Cross-sectional study. Setting: The Third National Health and Nutrition Examination Survey. Patients: Participants 20 years of age or older were studied in the chronic kidney disease (n = 6217) and microalbuminuria (n 6125) analyses. Measurements: The metabolic syndrome was defined as the presence of 3 or more of the following risk factors: elevated blood pressure, low high-density lipoprotein cholesterol level, high triglyceride level, elevated glucose level, and abdominal obesity. Chronic kidney disease was defined as a glomerular filtration rate less than 60 mL/min per 1.73 m(2), and microalbuminuria was defined as a urinary albumin-creatinine ratio of 30 to 300 mg/g. Results: The multivariate-adjusted odds ratios of chronic kidney disease and microalbuminuria in participants with the metabolic syndrome compared with participants without the metabolic syndrome were 2.60 (95% Cl, 1.68 to 4.03) and 1.89 (Cl, 1.34 to 2.67), respectively. Compared with participants with 0 or 1 component of the metabolic syndrome, participants with 2, 3, 4, and 5 components of chronic kidney disease had multivariate-adjusted odds ratios of 2.21 (Cl, 1.16 to 4.24), 3.38 (Cl, 1.48 to 7.69), 4.23 (Cl, 2.06 to 8.63), and 5.85 (Cl, 3.11 to 11.0), respectively. The corresponding multivariate-adjusted odds ratios of microalbuminuria for participants with 3, 4, and 5 components were 1.62 (Cl, 1.10 to 2.38), 2.45 (Cl, 1.55 to 3.85), and 3.19 (Cl, 1.96 to 5.19), respectively. Conclusions: These findings suggest that the metabolic syndrome might be an important factor in the cause of chronic kidney disease.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; Univ Mississippi, Sch Med, Jackson, MS 39216 USA	Tulane University; Tulane University; University of Mississippi	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave SL18, New Orleans, LA 70112 USA.	jhe@tulane.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Batuman, Vecihi/0000-0002-1800-9009	NICHD NIH HHS [K12 HD43451] Funding Source: Medline; NIDDK NIH HHS [U01 DK60963] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060963] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Hall JE, 1999, ANN NY ACAD SCI, V892, P91, DOI 10.1111/j.1749-6632.1999.tb07788.x; HE J, 1999, INT HDB HYPERTENSION; Hoehner CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015762.92814.85; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Iseki K, 1997, KIDNEY INT, pS169; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; National Institutes of Health,, 2001, NIH PUBL; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; PERNEGER TV, 1993, JAMA-J AM MED ASSOC, V269, P488, DOI 10.1001/jama.269.4.488; *US REN DAT SYST, 2002, USRDS 2002 ANN DAT R; Whelton PK, 1996, J HUM HYPERTENS, V10, P683; [No title captured]	29	1016	1078	0	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2004	140	3					167	174		10.7326/0003-4819-140-3-200402030-00007	http://dx.doi.org/10.7326/0003-4819-140-3-200402030-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770BZ	14757614				2022-12-01	WOS:000188704500002
J	Rendulic, S; Jagtap, P; Rosinus, A; Eppinger, M; Baar, C; Lanz, C; Keller, H; Lambert, C; Evans, KJ; Goesmann, A; Meyer, F; Sockett, RE; Schuster, SC				Rendulic, S; Jagtap, P; Rosinus, A; Eppinger, M; Baar, C; Lanz, C; Keller, H; Lambert, C; Evans, KJ; Goesmann, A; Meyer, F; Sockett, RE; Schuster, SC			A predator unmasked: Life cycle of Bdellovibrio bacteriovorus from a genomic perspective	SCIENCE			English	Article							ESCHERICHIA-COLI; PENETRATION; MEMBRANE; CELLS; 109J	Predatory bacteria remain molecularly enigmatic, despite their presence in many microbial communities. Here we report the complete genome of Bdellovibrio bacteriovorus HD100, a predatory Gram-negative bacterium that invades and consumes other Gram-negative bacteria. Its surprisingly large genome shows no evidence of recent gene transfer from its prey. A plethora of paralogous gene families coding for enzymes, such as hydrolases and transporters, are used throughout the life cycle of B. bacteriovorus for prey entry, prey killing, and the uptake of complex molecules.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England; Univ Bielefeld, Ctr Biotechnol, D-33594 Bielefeld, Germany	Max Planck Society; University of Nottingham; University of Bielefeld	Schuster, SC (corresponding author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	stephan.schuster@tuebingen.mpg.de	Lambert, Carey/AAY-9270-2020	Goesmann, Alexander/0000-0002-7086-2568; Meyer, Folker/0000-0003-1112-2284; Jagtap, Pratik/0000-0003-0984-0973; Lambert, Carey/0000-0002-1844-457X				Amiri H, 2003, J MOL EVOL, V56, P137, DOI 10.1007/s00239-002-2387-0; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; BURNHAM JC, 1968, J BACTERIOL, V96, P1366, DOI 10.1128/JB.96.4.1366-1381.1968; FACKRELL HB, 1973, CAN J MICROBIOL, V19, P659, DOI 10.1139/m73-107; Hasegawa H, 2003, FEMS MICROBIOL LETT, V223, P41, DOI 10.1016/S0378-1097(03)00327-6; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; Martin MO, 2002, J MOL MICROB BIOTECH, V4, P467; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; RITTENBERG SC, 1982, EXPT MICROBIAL ECOLO; RUBY EG, 1986, J BACTERIOL, V167, P1066, DOI 10.1128/jb.167.3.1066-1070.1986; SAIER MH, 1994, FEBS LETT, V337, P14, DOI 10.1016/0014-5793(94)80620-9; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Shilo M, 1969, Curr Top Microbiol Immunol, V50, P174; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; THOMASHOW LS, 1985, J BACTERIOL, V163, P1038, DOI 10.1128/JB.163.3.1038-1046.1985; THOMASHOW MF, 1978, J BACTERIOL, V135, P998, DOI 10.1128/JB.135.3.998-1007.1978; TUDOR JJ, 1990, J BACTERIOL, V172, P2421, DOI 10.1128/jb.172.5.2421-2426.1990; VARON M, 1980, ADV AQUATIC MICROBIO, V2	20	253	549	5	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					689	692		10.1126/science.1093027	http://dx.doi.org/10.1126/science.1093027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752164				2022-12-01	WOS:000188530800046
J	Kruit, MC; van Buchem, MA; Hofman, PAM; Bakkers, JTN; Terwindt, GM; Ferrari, MD; Launer, LJ				Kruit, MC; van Buchem, MA; Hofman, PAM; Bakkers, JTN; Terwindt, GM; Ferrari, MD; Launer, LJ			Migraine as a risk factor for subclinical brain lesions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; WHITE-MATTER; CARDIOVASCULAR HEALTH; ARTERIAL TERRITORIES; CLINICAL-FEATURES; ISCHEMIC STROKE; ELDERLY-PEOPLE; YOUNG-WOMEN; PREVALENCE; INFARCTS	Context Clinical series have suggested an increased prevalence of cerebral infarction and white matter lesions (WMLs) in migraine patients. It is not known whether these lesions are prevalent in the general migraine population. Objectives To compare the prevalence of brain infarcts and WMLs in migraine cases and controls from the general population and to identify migraine characteristics associated with these lesions. Design Cross-sectional, prevalence study of population-based sample of Dutch adults aged 30 to 60 years. Participants Randomly selected patients with migraine with aura (n=161), patients with migraine without aura (n=134), and controls (n=140), who were frequency matched to cases for age, sex, and place of residence. Nearly 50% of the cases had not been previously diagnosed by a physician. Main Outcome Measures Brain magnetic resonance images were evaluated for infarcts, by location and vascular supply territory, and for periventricular WMLs (PVWMLs) and deep WMLs (DWMLs). The odds ratios (ORs) and 95% confidence intervals (CIs) of these brain lesions compared with controls were examined by migraine subtype (with or without aura) and monthly attack frequency (<1 attack, &GE;1 attack), controlling for cardiovascular risk factors and use of vasoconstrictor migraine agents. All participants underwent a standard neurological examination. Results No participants reported a history of stroke or transient ischemic attack or had relevant abnormalities at standard neurological examination. We found no significant difference between patients with migraine and controls in overall infarct prevalence (8.1% vs 5.0%). However, in the cerebellar region of the posterior circulation territory, patients with migraine had a higher prevalence of infarct than controls (5.4% vs 0.7%; P=.02; adjusted OR, 7.1; 95% CI, 0.9-55). The adjusted OR for posterior infarct varied by migraine subtype and attack frequency. The adjusted OR was 13.7 (95% CI, 1.7-112) for patients with migraine with aura compared with controls. In patients with migraine with a frequency of attacks of 1 or more per month, the adjusted OR was 9.3 (95% CI, 1.1-76). The highest risk was in patients with migraine with aura with 1 attack or more per month (OR, 15.8; 95% CI, 1.8-140). Among women, the risk for high DWML load (top 20th percentile of the distribution of DWML load vs lower 80th percentile) was increased in patients with migraine compared with controls (OR, 2.1; 95% Cl, 1.0-4.1); this risk increased with attack frequency (highest in those with &GE;1 attack per month: OR, 2.6; 95% CI, 1.2-5.7) but was similar in patients with migraine with or without aura. In men, controls and patients with migraine did not differ in the prevalence of DWMLs. There was no association between severity of PVWMLs and migraine, irrespective of sex or migraine frequency or subtype. Conclusions. These population-based findings suggest that some patients with migraine with and without aura are at increased risk for subclinical lesions in certain brain areas.	Leiden Univ, Med Ctr, Dept Radiol, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2333 ZA Leiden, Netherlands; Acad Hosp Maastricht, Dept Radiol, Maastricht, Netherlands; Slingeland Hosp, Dept Radiol, Doetinchem, Netherlands; NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University Medical Centre (MUMC); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kruit, MC (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	m.c.kruit@lumc.nl	Ferrari, Michel D./ABE-3758-2021; Launer, Lenore J/A-8218-2010; Kruit, Mark C/K-2431-2012; van Buchem, Mark/AAC-9843-2022	Ferrari, Michel D./0000-0001-9691-9449; Kruit, Mark C/0000-0002-4319-834X; van Buchem, Mark/0000-0003-1881-1998; Dichgans, Martin/0000-0002-0654-387X	NATIONAL INSTITUTE ON AGING [ZIAAG007270, Z01AG007270] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander JA, 1996, AM J NEURORADIOL, V17, P1507; Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Bednarczyk EM, 1998, NEUROLOGY, V50, P1736, DOI 10.1212/WNL.50.6.1736; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Boer JMA, 1998, ATHEROSCLEROSIS, V136, P395, DOI 10.1016/S0021-9150(97)00231-1; BOGOUSSLAVSKY J, 1993, NEUROLOGY, V43, P1528, DOI 10.1212/WNL.43.8.1528; Bokura H, 1998, J NEUROL, V245, P116, DOI 10.1007/s004150050189; BURING JE, 1995, ARCH NEUROL-CHICAGO, V52, P129, DOI 10.1001/archneur.1995.00540260031012; CAPLAN LR, 1991, NEUROLOGY, V41, P55, DOI 10.1212/WNL.41.1.55; CAPLAN LR, 1996, POSTERIOR CIRCULATIO, P555; Carolei A, 1996, LANCET, V347, P1503, DOI 10.1016/S0140-6736(96)90669-8; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; Crassard I, 2001, CEPHALALGIA, V21, P630, DOI 10.1046/j.1468-2982.2001.00205.x; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; DEBENEDITTIS G, 1995, HEADACHE, V35, P264; del Rio MS, 1999, CEPHALALGIA, V19, P701, DOI 10.1046/j.1468-2982.1999.019008701.x; Donaghy M, 2002, J NEUROL NEUROSUR PS, V73, P747, DOI 10.1136/jnnp.73.6.747; Dreier JP, 2002, BRAIN, V125, P102, DOI 10.1093/brain/awf007; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Eggers AE, 2001, MED HYPOTHESES, V56, P360, DOI 10.1054/mehy.2000.1214; FAZEKAS F, 1992, HEADACHE, V32, P287, DOI 10.1111/j.1526-4610.1992.hed3206287.x; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Fujita S, 2002, ACTA NEUROL SCAND, V105, P445, DOI 10.1034/j.1600-0404.2002.01208.x; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; GOADSBY PJ, 1997, HEADACHE, P5; Goldberg MP, 2003, STROKE, V34, P330, DOI 10.1161/01.STR.0000054048.22626.B9; HoekstravanDalen RAH, 1996, J NEUROL, V243, P511, DOI 10.1007/BF00886872; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Merikangas KR, 1997, ARCH NEUROL-CHICAGO, V54, P362, DOI 10.1001/archneur.1997.00550160012009; Milhaud D, 2001, NEUROLOGY, V57, P1805, DOI 10.1212/WNL.57.10.1805; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PAVESE N, 1994, CEPHALALGIA, V14, P342, DOI 10.1046/j.1468-2982.1994.1405342.x; PESSIN MS, 1987, ANN NEUROL, V21, P290, DOI 10.1002/ana.410210311; Price T R, 1993, Ann Epidemiol, V3, P504; Sacco RL, 1997, NEUROLOGY S4, V49, P39; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; SPENCE JD, 1984, CAN MED ASSOC J, V131, P1457; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125; Tietjen GE, 2001, NEUROLOGY, V57, P334, DOI 10.1212/WNL.57.2.334; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Wilmshurst P, 2001, CLIN SCI, V100, P215, DOI 10.1042/CS20000231; 1988, CEPHALALGIA S7, V8, P1	47	660	693	0	32	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2004	291	4					427	434		10.1001/jama.291.4.427	http://dx.doi.org/10.1001/jama.291.4.427			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	767EF	14747499	Bronze			2022-12-01	WOS:000188426700027
J	Cooper, BG; Goller, F				Cooper, BG; Goller, F			Multimodal signals: Enhancement and constraint of song motor patterns by visual display	SCIENCE			English	Article							WINGBEAT; BIRDSONG	Many birds perform visual signals during their learned songs, but little is known about the interrelationship between visual and vocal displays. We show here that male brown-headed cowbirds (Molothrus ater) synchronize the most elaborate wing movements of their display with atypically long silent periods in their song, potentially avoiding adverse biomechanical effects on sound production. Furthermore, expiratory effort for song is significantly reduced when cowbirds perform their wing display. These results show a close integration between vocal and visual displays and suggest that constraints and synergistic interactions between the motor patterns of multimodal signals influence the evolution of birdsong.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Cooper, BG (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	cooper@biology.utah.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004390, F32DC005722] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC04390, DC05722] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLAN SE, 1994, J NEUROBIOL, V25, P1154, DOI 10.1002/neu.480250910; Beckers GJL, 2003, P NATL ACAD SCI USA, V100, P7372, DOI 10.1073/pnas.1232227100; Boggs DF, 1997, J EXP BIOL, V200, P1403; Boggs DF, 1997, J EXP BIOL, V200, P1413; Bradbury Jack W., 1998, pi; Dantzker MS, 1999, J EXP BIOL, V202, P2893; DUFTY AM, 1985, Z TIERPSYCHOL, V69, P177; EENS M, 1990, BIRD STUDY, V37, P48, DOI 10.1080/00063659009477038; Funk GD, 1997, J EXP BIOL, V200, P915; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; Goller F, 2001, P ROY SOC B-BIOL SCI, V268, P2301, DOI 10.1098/rspb.2001.1805; Hauser MD., 1996, EVOLUTION COMMUNICAT; HAVENWILEY R, 1975, SCIENCE, V190, P482; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Price JJ, 2002, EVOLUTION, V56, P1514; Suthers RA, 2002, P NATL ACAD SCI USA, V99, P5680, DOI 10.1073/pnas.042103199; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Suthers RA, 1997, CURR ORNITHOL, V14, P235; WEST MJ, 1986, J COMP PSYCHOL, V100, P296, DOI 10.1037/0735-7036.100.3.296; Wild JM, 1998, J NEUROBIOL, V36, P441, DOI 10.1002/(SICI)1097-4695(19980905)36:3<441::AID-NEU11>3.0.CO;2-E; Williams H, 2001, J EXP BIOL, V204, P3497	21	76	76	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					544	546		10.1126/science.1091099	http://dx.doi.org/10.1126/science.1091099			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739462				2022-12-01	WOS:000188316400044
J	Tanabe, K; Sakihama, N; Kaneko, A				Tanabe, K; Sakihama, N; Kaneko, A			Stable SNPs in malaria antigen genes in isolated populations	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; NATURAL-SELECTION		Osaka Inst Technol, Osaka 5358585, Japan; Karolinska Hosp, S-17276 Stockholm, Sweden; Tokyo Womens Med Univ, Tokyo 1628666, Japan	Osaka Institute of Technology; Karolinska Institutet; Karolinska University Hospital; Tokyo Women's Medical University	Tanabe, K (corresponding author), Osaka Inst Technol, Osaka 5358585, Japan.	kztanabe@ge.oit.ac.jp		, Akira/0000-0003-2411-3352				BOWDEN DK, 1982, MED J AUSTRALIA, V2, P561, DOI 10.5694/j.1326-5377.1982.tb132573.x; Escalante AA, 1998, GENETICS, V149, P189; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Maitland K, 2000, PARASITOLOGY, V120, P335, DOI 10.1017/S0031182099005612; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	6	34	36	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					493	493		10.1126/science.1092077	http://dx.doi.org/10.1126/science.1092077			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14739451				2022-12-01	WOS:000188316400029
J	Burton, DR; Desrosiers, RC; Doms, RW; Feinberg, MB; Gallo, RC; Hahn, B; Hoxie, JA; Hunter, E; Korber, B; Landay, A; Lederman, MM; Lieberman, J; McCune, JM; Moore, JP; Nathanson, N; Picker, L; Richman, D; Rinaldo, C; Stevenson, M; Watkins, DI; Wolinsky, SM; Zack, JA				Burton, DR; Desrosiers, RC; Doms, RW; Feinberg, MB; Gallo, RC; Hahn, B; Hoxie, JA; Hunter, E; Korber, B; Landay, A; Lederman, MM; Lieberman, J; McCune, JM; Moore, JP; Nathanson, N; Picker, L; Richman, D; Rinaldo, C; Stevenson, M; Watkins, DI; Wolinsky, SM; Zack, JA			Public health - A sound rationale needed for phase IIIHIV-1 vaccine trials	SCIENCE			English	Editorial Material							RECOMBINANT GP120; RESPONSES; TYPE-1; ADULTS		Scripps Res Inst, La Jolla, CA 92037 USA; Harvard Med Sch, Boston, MA USA; Univ Penn, Philadelphia, PA 19104 USA; Emory Univ, Atlanta, GA 30322 USA; Inst Human Virol, Baltimore, MD USA; Univ Alabama, Birmingham, AL USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Rush Med Coll, Chicago, IL 60612 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Gladstone Inst Virol & Immunol, San Francisco, CA USA; Cornell Univ, Weill Med Coll, New York, NY USA; Oregon Hlth & Sci Univ, Portland, OR USA; Univ Calif San Diego, San Diego, CA 92103 USA; San Diego Vet Affairs Healthcare Syst, San Diego, CA USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Univ Wisconsin, Madison, WI USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Calif Los Angeles, Los Angeles, CA USA	Scripps Research Institute; Harvard University; Harvard Medical School; University of Pennsylvania; Emory University; University System of Maryland; University of Maryland Baltimore; University of Alabama System; University of Alabama Birmingham; The Santa Fe Institute; Rush University; Case Western Reserve University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Cornell University; Oregon Health & Science University; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; University of California System; University of California Los Angeles	Burton, DR (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.		Lieberman, Judy/A-2717-2015; Wolinsky, Steven/B-2893-2012	Wolinsky, Steven/0000-0002-9625-6697; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887				Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; Cohen J, 2003, SCIENCE, V302, P1309; Cohen J, 2003, SCIENCE, V299, P1290, DOI 10.1126/science.299.5611.1290; Cohen J, 2002, SCIENCE, V295, P1616, DOI 10.1126/science.295.5560.1616; Cohen Jon, 2001, SHOTS DARK WAYWARD S; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Gorse GJ, 2001, VACCINE, V19, P1806, DOI 10.1016/S0264-410X(00)00378-9; Ratto-Kim S, 2003, JAIDS-J ACQ IMM DEF, V32, P9, DOI 10.1097/00126334-200301010-00003	8	101	103	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					316	316		10.1126/science.1094620	http://dx.doi.org/10.1126/science.1094620			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726576				2022-12-01	WOS:000188111800024
J	Hanada, K; Yewdell, JW; Yang, JC				Hanada, K; Yewdell, JW; Yang, JC			Immune recognition of a human renal cancer antigen through post-translational protein splicing	NATURE			English	Article							ENDOPLASMIC-RETICULUM; PROCESSING PATHWAY; CONCANAVALIN-A; LIGATION; CYTOSOL	Cytotoxic T lymphocytes (CTLs) detect and destroy cells displaying class I molecules of the major histocompatibility complex (MHC) that present oligopeptides derived from aberrant self or foreign proteins. Most class I peptide ligands are created from proteins that are degraded by proteasomes and transported, by the transporter associated with antigen processing, from the cytosol into the endoplasmic reticulum, where peptides bind MHC class I molecules and are conveyed to the cell surface(1). C2 CTLs, cloned from human CTLs infiltrating a renal cell carcinoma, kill cancer cells overexpressing fibroblast growth factor-5 (FGF-5)(2). Here we show that C2 cells recognize human leukocyte antigen-A3 MHC class I molecules presenting a nine-residue FGF-5 peptide generated by protein splicing. This process, previously described strictly in plants(3) and unicellular organisms(4), entails post-translational excision of a polypeptide segment followed by ligation of the newly liberated carboxyterminal and amino-terminal residues. The occurrence of protein splicing in vertebrates has important implications for the complexity of the vertebrate proteome and for the immune recognition of self and foreign peptides.	NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hanada, K (corresponding author), NCI, Surg Branch, NIH, 9000 Rockville Pike,Bldg 10,Room 2B42, Bethesda, MD 20892 USA.	khanada@nih.gov; jamesyang@mail.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Hanada, Ken-ichi/A-4642-2008; Hanada, Kenichi/L-2481-2013	Hanada, Kenichi/0000-0003-2959-1257	DIVISION OF BASIC SCIENCES - NCI [Z01BC010555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC006660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000653, Z01AI000653] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacik I, 1997, J EXP MED, V186, P479, DOI 10.1084/jem.186.4.479; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; Evans TC, 1999, J BIOL CHEM, V274, P3923, DOI 10.1074/jbc.274.7.3923; Hanada K, 2001, CANCER RES, V61, P5511; HUANG WM, 1988, SCIENCE, V239, P1005, DOI 10.1126/science.2830666; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; MIN W, 1994, NAT STRUCT BIOL, V1, P502, DOI 10.1038/nsb0894-502; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/S0092-8674(05)80090-X; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	13	238	252	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					252	256		10.1038/nature02240	http://dx.doi.org/10.1038/nature02240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724640				2022-12-01	WOS:000188068100045
J	Harris, H				Harris, H			Tumour suppression: Putting on the brakes	NATURE			English	Editorial Material									Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Harris, H (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.							CAVENEE W, 1989, RECESSIVE ONCOGENES; Harris H, 2003, DNA CELL BIOL, V22, P225, DOI 10.1089/104454903321908601; HARRIS H, 1985, J CELL SCI, V79, P83; HARRIS H, 1995, CELLS BODY, P211; Mechler B. M., 1994, LEGACY CELL FUSION, P183	5	52	54	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					201	201		10.1038/427201a	http://dx.doi.org/10.1038/427201a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724616				2022-12-01	WOS:000188068100023
J	Pang, XH; Zhu, ZH; Xu, FJ; Guo, JY; Gong, XH; Liu, DL; Liu, ZJ; Chin, DP; Feikin, DR				Pang, XH; Zhu, ZH; Xu, FJ; Guo, JY; Gong, XH; Liu, DL; Liu, ZJ; Chin, DP; Feikin, DR			Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYNDROME SARS	Context Beijing, China, experienced the world's largest outbreak of severe acute respiratory syndrome (SARS) beginning in March 2003, with the outbreak resolving rapidly, within 6 weeks of its peak in late April. Little is known about the control measures implemented during this outbreak. Objective To describe and evaluate the measures undertaken to control the SARS outbreak. Design, Setting, and Participants Data were reviewed from standardized surveillance forms from SARS cases (2521 probable cases) and their close contacts observed in Beijing between March 5, 2003, and May 29, 2003. Procedures implemented by health authorities were investigated through review of official documents and discussions with public health officials.' Main Outcome Measures Timeline of major control measures; number of cases and quarantined close contacts and attack rates, with changes in infection control measures, management, and triage of suspected cases; and time lag between illness onset and hospitalization with information dissemination. Results Healthcare worker training in use of personal protective equipment and management of patients with SARS and establishing fever clinics and designated SARS wards in hospitals predated the steepest decline in cases. During the outbreak, 30178 persons were quarantined. Among 2195 quarantined close contacts in 5 districts, the attack rate was 6.3 % (95% confidence interval [CI], 5.3 % -7.3 %), with a range of 15.4% (95% Cl, 11.5%-19.2%) among spouses to 0.36% (95% CI, 0%-0.77%) among work and school contacts. The attack rate among quarantined household members increased with age from 5.0% (95 % Cl, 0% -10.5%) in children younger than 10 years to 27.6% (95% Cl, 18.2%-37.0%) in adults aged 60 to 69 years. Among almost 14 million people screened for fever at the airport, train stations, and roadside checkpoints, only 12 were found to have probable SARS. The national and municipal governments held 13 press conferences about SARS. The time lag between illness onset and hospitalization decreased from a median of 5 to 6 days on or before April 20, 2003, the day the outbreak was announced to the public, to 2 days after April 20 (P<.001). Conclusions The rapid resolution of the SARS outbreak was multifactorial, involving improvements in management and triage in hospitals and communities of patients with suspected SARS and the dissemination of information to health care workers and the public.	CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; Beijing Municipal Hlth Bur, Beijing, Peoples R China; WHO, China Off, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; World Health Organization	Feikin, DR (corresponding author), CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop C23, Atlanta, GA 30333 USA.	drf0@cdc.gov						Ashraf H, 2003, LANCET, V361, P2212, DOI 10.1016/S0140-6736(03)13790-7; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P462; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P680; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P405; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; LIANG W, 2003, EMERG INFECT DIS; *MIN HLTH ED COMM, 2002, CHIN HLTH YB 2002, P514; PEIRIS JSM, LANCET; Twu SJ, 2003, EMERG INFECT DIS, V9, P718; *WHO, UPD 87 WHO CHANG LAS; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P181; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P137; World Health Organization, SUMM PROB SARS CAS O; [谢淑云 Xie Shuyun], 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P449; SARS CASE DISTRIBUTI	17	156	165	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2003	290	24					3215	3221		10.1001/jama.290.24.3215	http://dx.doi.org/10.1001/jama.290.24.3215			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756TR	14693874				2022-12-01	WOS:000187499300025
J	Diebold, SS; Kaisho, T; Hemmi, H; Akira, S; Sousa, CRE				Diebold, SS; Kaisho, T; Hemmi, H; Akira, S; Sousa, CRE			Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA	SCIENCE			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; INFLUENZA-VIRUS; CD8-ALPHA(+); ACTIVATION; PRECURSORS; REQUIRES; TLR7	Interferons (IFNs) are critical for protection from viral infection, but the pathways linking virus recognition to IFN induction remain poorly understood. Plasmacytoid dendritic cells produce vast amounts of IFN-alpha in response to the wild-type influenza virus. Here, we show that this requires endosomal recognition of influenza genomic RNA and signaling by means of Toll-like receptor 7 (TLR7) and MyD88. Single-stranded RNA (ssRNA) molecules of nonviral origin also induce TLR7-dependent production of inflammatory cytokines. These results identify ssRNA as a ligand for TLR7 and suggest that cells of the innate immune system sense endosomal ssRNA to detect infection by RNA viruses.	London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Japan Sci & Technol Corp, ERATO, Akira Innate Immun Project, Suita, Osaka 5650871, Japan	Cancer Research UK; Osaka University; RIKEN; Japan Science & Technology Agency (JST)	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England.	caetano@cancer.org.uk	Kaisho, Tsuneyasu/B-4130-2012; Yang, Chen/G-1379-2010; Reis e Sousa, Caetano/ABD-7322-2021; Akira, Shizuo/C-3134-2009; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119				Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; DIEBOLD S, UNPUB; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; KRUG A, 2003, BLOOD           1016, DOI DOI 10.1182/BLOOD-2003-08-2674; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Palmer P, 2000, VIROLOGY, V278, P86, DOI 10.1006/viro.2000.0627; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; 2003, WKLY EPIDEMIOL REC, V78, P39	28	2517	2798	7	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1529	1531		10.1126/science.1093616	http://dx.doi.org/10.1126/science.1093616			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	14976261				2022-12-01	WOS:000220000100046
J	Eggan, E; Baldwin, K; Tackett, M; Osborne, J; Gogos, J; Chess, A; Axel, R; Jaenisch, R				Eggan, E; Baldwin, K; Tackett, M; Osborne, J; Gogos, J; Chess, A; Axel, R; Jaenisch, R			Mice cloned from olfactory sensory neurons	NATURE			English	Article							END-JOINING PROTEINS; EMBRYONIC STEM-CELLS; RECEPTOR GENE; NUCLEAR TRANSPLANTATION; SOMATIC RECOMBINATION; MONOCLONAL-ANTIBODY; ODORANT RECEPTORS; TOPOGRAPHIC MAP; NERVOUS-SYSTEM; BASAL-CELLS	Cloning by nuclear transplantation has been successfully carried out in various mammals, including mice. Until now mice have not been cloned from post-mitotic cells such as neurons. Here, we have generated fertile mouse clones derived by transferring the nuclei of post-mitotic, olfactory sensory neurons into oocytes. These results indicate that the genome of a post-mitotic, terminally differentiated neuron can re-enter the cell cycle and be reprogrammed to a state of totipotency after nuclear transfer. Moreover, the pattern of odorant receptor gene expression and the organization of odorant receptor genes in cloned mice was indistinguishable from wild-type animals, indicating that irreversible changes to the DNA of olfactory neurons do not accompany receptor gene choice.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; Howard Hughes Medical Institute	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	achess@wi.mit.edu; jaenisch@wi.mit.edu		Baldwin, Kristin/0000-0002-6137-030X; Axel, Richard/0000-0002-3141-4076				BRACK C, 1978, CELL, V15, P1, DOI 10.1016/0092-8674(78)90078-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; Chun J, 1999, NEURON, V22, P7, DOI 10.1016/S0896-6273(00)80671-6; Chun J, 2001, ADV IMMUNOL, V77, P297, DOI 10.1016/S0065-2776(01)77020-4; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; Edelman Gerald M., 1989, REMEMBERED PRESENT B; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; GERDES J, 1984, J IMMUNOL, V133, P1710; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Goldstein BJ, 1996, J NEUROSCI, V16, P4005; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kratz E, 2002, TRENDS GENET, V18, P29, DOI 10.1016/S0168-9525(01)02579-3; NAGY A, 1990, DEVELOPMENT, V110, P815; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Ohta Y, 2000, ANN OTO RHINOL LARYN, V109, P1046, DOI 10.1177/000348940010901110; Osada T, 2002, CYTOGENET GENOME RES, V97, P7, DOI 10.1159/000064037; Qasba P, 1998, J NEUROSCI, V18, P227; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rossant J, 2002, NATURE, V415, P967, DOI 10.1038/415967a; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yagi T, 2003, GENES CELLS, V8, P1, DOI 10.1046/j.1365-2443.2003.00614.x; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	43	277	303	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					44	49		10.1038/nature02375	http://dx.doi.org/10.1038/nature02375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14990966				2022-12-01	WOS:000189363800029
J	Nateri, AS; Riera-Sans, L; Da Costa, C; Behrens, A				Nateri, AS; Riera-Sans, L; Da Costa, C; Behrens, A			The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling	SCIENCE			English	Article							F-BOX PROTEIN; C-JUN; CYCLIN-E; MICE LACKING; PHOSPHORYLATION; SYSTEM; GENE; SEL-10; SCF	Jun N-terminal kinases (JNKs) are essential for neuronal microtubule assembly and apoptosis. Phosphorylation of the activating protein 1 (AP1) transcription factor c-Jun, at multiple sites within its transactivation domain, is required for JNK-induced neurotoxicity. We report that in neurons the stability of c-Jun is regulated by the E3 ligase SCFFbw7, which ubiquitinates phosphorylated c-Jun and facilitates c-Jun degradation. Fbw7 depletion resulted in accumulation of phosphorylated c-Jun, stimulation of AP1 activity, and neuronal apoptosis. SCFFbw7 therefore antagonizes the apoptotic c-Jun-dependent effector arm of JNK signaling, allowing neurons to tolerate potentially neurotoxic JNK activity.	Canc Res UK, Mammalian Genet Lab, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Behrens, A (corresponding author), Canc Res UK, Mammalian Genet Lab, London Res Inst, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk		Behrens, Axel/0000-0002-1557-1143; Shams Nateri, Abdolrahman/0000-0002-6422-6813; Da Costa, Clive/0000-0002-0435-6747				Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Maruyama S, 2001, GENOMICS, V78, P214, DOI 10.1006/geno.2001.6658; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	22	301	313	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1374	1378		10.1126/science.1092880	http://dx.doi.org/10.1126/science.1092880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14739463				2022-12-01	WOS:000189238600053
J	Mecsas, J; Franklin, G; Kuziel, WA; Brubaker, RR; Falkow, S; Mosier, DE				Mecsas, J; Franklin, G; Kuziel, WA; Brubaker, RR; Falkow, S; Mosier, DE			CCR5 mutation and plague protection	NATURE			English	Editorial Material							RESISTANCE ALLELE; HIV-1 CORECEPTOR; INFECTION; PROGRESSION; ORIGIN; MICE; AIDS		Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Michigan State Univ, Dept Microbiol, E Lansing, MI 48824 USA	Stanford University; Scripps Research Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Michigan State University	Mecsas, J (corresponding author), Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	dmosier@scripps.edu						BUTLER T, 1989, T ROY SOC TROP MED H, V83, P458, DOI 10.1016/0035-9203(89)90246-0; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Libert F, 1998, HUM MOL GENET, V7, P399, DOI 10.1093/hmg/7.3.399; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Sato N, 1999, J IMMUNOL, V163, P5519; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Zhou YH, 1998, J IMMUNOL, V160, P4018	11	70	73	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					606	606		10.1038/427606a	http://dx.doi.org/10.1038/427606a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961112	Bronze			2022-12-01	WOS:000188875300032
J	Lynch, HT; Coronel, SM; Okimoto, R; Hampel, H; Sweet, K; Lynch, JF; Barrows, A; Wijnen, J; van der Klift, H; Franken, P; Wagner, A; Fodde, R; de la Chapelle, A				Lynch, HT; Coronel, SM; Okimoto, R; Hampel, H; Sweet, K; Lynch, JF; Barrows, A; Wijnen, J; van der Klift, H; Franken, P; Wagner, A; Fodde, R; de la Chapelle, A			A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLON-CANCER; FAMILIES; POPULATION; HNPCC; INDIVIDUALS; FREQUENCY; CARCINOMA; ORIGIN; BRCA1; RISK	Context Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is caused by mutations in the mismatch repair genes and confers an extraordinarily high risk of colorectal, endometrial, and other cancers. However, while carriers of these mutations should be identified, counseled, and offered clinical surveillance, at present the mutations are not tested for in mutation analyses. Objective To describe the prevalence of a large genomic deletion encompassing exons 1 to 6 of the MSH2 gene that is widespread in the US population as a result of a founder effect. Design, Setting, and Patients Ongoing genealogical, and historical study conducted to assess the origin and spread of an MSH2 mutation previously identified in 9 apparently unrelated families with putative HNPCC and living in widely different geographic locations in the United States. Main Outcome Measures Classification of family members as carriers or noncarriers of the MSH2 mutation; spread of the mutation across the continental United States. Results To date, 566 family members of the 9 probands have been identified to be at risk and counseled; 137 of these have been tested, and 61 carry the founder mutation. Three families have been genealogically shown to descend from a German immigrant family that arrived and first settled in Pennsylvania in the early 1700s. Movements of branches of the family from Pennsylvania through North Carolina, Alabama, Kentucky, Missouri, Iowa, Nebraska, Utah, Texas, and California have been documented, and carriers of the mutation have already been diagnosed in 14 states. In contrast, the deletion was not found among 407 European and Australian families with HNPCC. Conclusion The postulated high frequency and continent-wide geographic distribution of a cancer-predisposing founder mutation of the MSH2 gene in a large, outbred (as opposed to genetically isolated) population, and the ease with which the mutation can be detected, suggest that the routine testing of individuals at risk for HNPCC in the United States should include an assay for this mutation until more is learned about its occurrence.	Creighton Univ, Sch Med, Dept Prevent Med, Omaha, NE 68178 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Leiden Univ, Sylvius Lab, Dept Human Genet, Leiden, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands	Creighton University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Lynch, HT (corresponding author), Creighton Univ, Sch Med, Dept Prevent Med, 2500 Calif Plaza, Omaha, NE 68178 USA.	htlynch@creighton.edu	Fodde, Riccardo/AAW-9394-2021; Sweet, Kevin/E-4172-2011	Fodde, Riccardo/0000-0001-9839-4324; 	NCI NIH HHS [CA16058, 1U01 CA86389, CA67941] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA067941, U01CA086389, U01CA067941] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Burn J, 1998, P NUTR SOC, V57, P183, DOI 10.1079/PNS19980030; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Desai DC, 2000, J MED GENET, V37, P646, DOI 10.1136/jmg.37.9.646; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; FROGGATT NJ, 1995, LANCET, V345, P727, DOI 10.1016/S0140-6736(95)90900-1; Froggatt NJ, 1999, J MED GENET, V36, P97; GOODMAN RM, 1979, GENETIC DIS ASHKENAZ; Hutter P, 1996, J MED GENET, V33, P636, DOI 10.1136/jmg.33.8.636; *INT AG RES CANC, GLOB 2000 CANC INC P; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Lynch HT, 1999, J MED GENET, V36, P801; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; Moisio AL, 1996, AM J HUM GENET, V59, P1243; Nakagawa H, 2002, CANCER RES, V62, P4579; Nakagawa Hidewaki, 2003, Hum Mutat, V22, P258, DOI 10.1002/humu.9171; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; Reyes CM, 2002, CANCER, V95, P1848, DOI 10.1002/cncr.10910; RISINGER JI, 1993, CANCER RES, V53, P5100; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Vogelstein B., 1998, GENETIC BASIS HUMAN; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Wagner A, 2002, GENE CHROMOSOME CANC, V35, P49, DOI 10.1002/gcc.10094; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Wijnen J, 1996, AM J HUM GENET, V58, P300; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659	36	66	67	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2004	291	6					718	724		10.1001/jama.291.6.718	http://dx.doi.org/10.1001/jama.291.6.718			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AY	14871915	hybrid			2022-12-01	WOS:000188819200025
J	Kang, TM; Hilgemann, DW				Kang, TM; Hilgemann, DW			Multiple transport modes of the cardiac Na+/Ca2+ exchanger	NATURE			English	Article							SODIUM-CALCIUM EXCHANGE; PIG VENTRICULAR MYOCYTES; NA+-CA2+ EXCHANGE; MEMBRANE PATCHES; GUINEA-PIG; DYNAMIC PROPERTIES; STEADY-STATE; STOICHIOMETRY; ION; TRANSLOCATION	The cardiac Na+/Ca2+ exchanger(1) (NCX1; ref. 2) is a bi-directional Ca2+ transporter that contributes to the electrical activity of the heart(3,4). When, and if, Ca2+ is exported or imported depends on the Na+/Ca2+ exchange ratio(5). Whereas a ratio of 3:1 (Na+:Ca2+) has been indicated by Ca2+ flux equilibrium studies(6), a ratio closer to 4:1 has been indicated by exchange current reversal potentials(7,8). Here we show, using an ion-selective electrode technique(9) to quantify ion fluxes in giant patches(10), that ion flux ratios are approximately 3.2 for maximal transport in either direction. With Na+ and Ca2+ on both sides of the membrane, net current and Ca2+ flux can reverse at different membrane potentials, and inward current can be generated in the absence of cytoplasmic Ca2+, but not Na+. We propose that NCX1 can transport not only 1 Ca2+ or 3 Na+ ions, but also 1 Ca2+ with 1 Na+ ion at a low rate. Therefore, in addition to the major 3:1 transport mode, import of 1 Na+ with 1 Ca2+ defines a Na+-conducting mode that exports 1 Ca2+, and an electroneutral Ca2+ influx mode that exports 3 Na+. The two minor transport modes can potentially determine resting free Ca2+ and background inward current in heart.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Ctr Mol Med,Dept Physiol, Suwon 440746, South Korea	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Samsung; Sungkyunkwan University (SKKU)	Hilgemann, DW (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	donald.hilgemann@utsouthwestern.edu		Kang, Tong Mook/0000-0001-7404-9382				CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; DeFelice LJ, 1998, METHOD ENZYMOL, V296, P578; Dong H, 2002, BIOPHYS J, V82, P1943, DOI 10.1016/S0006-3495(02)75543-4; Fujioka Y, 2000, J PHYSIOL-LONDON, V523, P339, DOI 10.1111/j.1469-7793.2000.t01-2-00339.x; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; HILGEMANN DW, 1988, PROG BIOPHYS MOL BIO, V51, P1, DOI 10.1016/0079-6107(88)90009-0; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Hinata M, 2002, J PHYSIOL-LONDON, V545, P453, DOI 10.1113/jphysiol.2002.025866; Kang TM, 2002, ANN NY ACAD SCI, V976, P142; Kang TM, 2003, J GEN PHYSIOL, V121, P325, DOI 10.1085/jgp.200208777; Kappl M, 1996, BIOPHYS J, V71, P2473, DOI 10.1016/S0006-3495(96)79441-9; KIMURA J, 1987, J PHYSIOL-LONDON, V384, P199, DOI 10.1113/jphysiol.1987.sp016450; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; LYTTON J, 2002, P 4 INT C; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; MATSUOKA S, 1992, J GEN PHYSIOL, V100, P963, DOI 10.1085/jgp.100.6.963; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; NOBLE D, 1984, J PHYSIOL-LONDON, V353, P1; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; RAKOWSKI RF, 1989, J GEN PHYSIOL, V93, P903, DOI 10.1085/jgp.93.5.903; REEVES JP, 1984, J BIOL CHEM, V259, P7733; REEVES JP, 1983, J BIOL CHEM, V258, P3178; REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467; Robinson R. A., 2002, ELECTROLYTE SOLUTION; SMITH PJS, 1995, NATURE, V378, P645, DOI 10.1038/378645a0; Wang E, 2001, BIOPHYS J, V81, P3275, DOI 10.1016/S0006-3495(01)75961-9	29	118	126	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					544	548		10.1038/nature02271	http://dx.doi.org/10.1038/nature02271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765196				2022-12-01	WOS:000188721800042
J	Zheng, Y; Mellem, JE; Brockie, PJ; Madsen, DM; Maricq, AV				Zheng, Y; Mellem, JE; Brockie, PJ; Madsen, DM; Maricq, AV			SOL-1 is a CUB-domain protein required for GLR-1 glutamate receptor function in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; SEMAPHORIN-III; MUTATION; SUBUNIT; NEURONS; GENE; NEUROPILIN; CHANNEL; SYSTEM; MODULE	Ionotropic glutamate receptors (iGluRs) mediate most excitatory synaptic signalling between neurons. Binding of the neurotransmitter glutamate causes a conformational change in these receptors that gates open a transmembrane pore through which ions can pass. The gating of iGluRs is crucially dependent on a conserved amino acid that was first identified in the 'lurcher' ataxic mouse(1). Through a screen for modifiers of iGluR function in a transgenic strain of Caenorhabditis elegans expressing a GLR-1 subunit containing the lurcher mutation, we identify suppressor of lurcher (sol-1). This gene encodes a transmembrane protein that is predicted to contain four extracellular beta-barrel-forming domains known as CUB domains(2,3). SOL-1 and GLR-1 are colocalized at the cell surface and can be coimmunoprecipitated. By recording from neurons expressing GLR-1, we show that SOL-1 is an accessory protein that is selectively required for glutamate-gated currents. We propose that SOL-1 participates in the gating of non-NMDA (N-methyl-D-aspartate) iGluRs, thereby providing a previously unknown mechanism of regulation for this important class of neurotransmitter receptor.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9; Varela PF, 1997, J MOL BIOL, V274, P635, DOI 10.1006/jmbi.1997.1424; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	28	105	113	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					451	457		10.1038/nature02244	http://dx.doi.org/10.1038/nature02244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749834				2022-12-01	WOS:000188470500046
J	Miglioretti, DL; Rutter, CM; Geller, BM; Cutter, G; Barlow, WE; Rosenberg, R; Weaver, DL; Taplin, SH; Ballard-Barbash, R; Carney, PA; Yankaskas, BC; Kerlikowske, K				Miglioretti, DL; Rutter, CM; Geller, BM; Cutter, G; Barlow, WE; Rosenberg, R; Weaver, DL; Taplin, SH; Ballard-Barbash, R; Carney, PA; Yankaskas, BC; Kerlikowske, K			Effect of breast augmentation on the accuracy of mammography and cancer characteristics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCREENING MAMMOGRAPHY; UNITED-STATES; IMPLANTS; WOMEN; MAMMAPLASTY; DIAGNOSIS; SURVIVAL; PERFORMANCE; PROGNOSIS; DENSITY	Context Breast augmentation is not associated with an increased risk of breast cancer; however, implants may interfere with the detection of breast cancer thereby delaying cancer diagnosis in women with augmentation. Objective To determine whether mammography accuracy and tumor characteristics are different for women with and without augmentation. Design, Setting, and Participants A prospective cohort of 137 women with augmentation and 685 women without augmentation diagnosed with breast cancer between January 1, 1995, and October 15, 2002, matched (1:5) by age, race/ethnicity, previous mammography screening, and mammography registry, and 10533 women with augmentation and 974915 women without augmentation and without breast cancer among 7 mammography registries in Denver, Colo; Lebanon, NH; Albuquerque, NM; Chapel Hill, NC; San Francisco, Calif; Seattle, Wash; and Burlington, Vt. Main Outcome Measures Comparison between women with and without augmentation of mammography performance measures and cancer characteristics, including invasive carcinoma or ductal carcinoma in situ, tumor stage, nodal status, size, grade, and estrogen-receptor status. Results Among asymptomatic women, the sensitivity of screening mammography based on the final assessment was lower in women with breast augmentation vs women without (45.0% [95% confidence interval {CI}, 29.3%-61.5%] vs 66.8% [95% CI, 60.4%-72.8%]; P=.008), and specificity was slightly higher in women with augmentation (97.7% [95% CI, 97.4%-98.0%] vs 96.7% [95% CI, 96.6%-96.7%]; P<.001). Among symptomatic women, both sensitivity and specificity were lower for women with augmentation compared with women without but these differences were not significant. Tumors were of similar stage, size, estrogen-receptor status, and nodal status but tended to be lower grade (P=.052) for women with breast augmentation vs without. Conclusions Breast augmentation decreases the sensitivity of screening mammography among asymptomatic women but does not increase the false-positive rate. Despite the lower accuracy of mammography in women with augmentation, the prognostic characteristics of tumors are not influenced by augmentation.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Canc Res & Biostat, Seattle, WA USA; Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; Univ Nevada, Sch Med, Ctr Res Design & Stat Methods, Appl Res Facil, Reno, NV 89557 USA; Univ New Mexico, Hlth Sci Ctr, Dept Radiol, Albuquerque, NM 87131 USA; NCI, Appl Res Program, Dept Canc Control & Populat Sci, Bethesda, MD 20892 USA; Dartmouth Coll Sch Med, Dept Community & Family Med, Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; Univ Calif San Francisco, Dept Vet Affairs, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med & Epidemiol & Biostat, San Francisco, CA 94143 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; Cancer Research & Biostatistics; University of Vermont; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Dartmouth College; Norris Cotton Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miglioretti, DL (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	miglioretti.d@ghc.org	Rutter, Carolyn/AAZ-3677-2021; Cutter, Gary/AAY-5392-2021	Cutter, Gary/0000-0002-8455-980X	NATIONAL CANCER INSTITUTE [U01CA070040, U01CA063731, U01CA070013, U01CA086082, U01CA086076, U01CA063736, U01CA069976, U01CA063740] Funding Source: NIH RePORTER; NCI NIH HHS [U01CA63731, U01CA63736, U01CA63740, U01CA69976, U01CA70013, U01CA70040, U01CA86076, U01CA86082] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM SOC PLAST SURG, 2002 QUICK FACTS COS; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; BIRDSELL DC, 1993, PLAST RECONSTR SURG, V92, P795, DOI 10.1097/00006534-199392050-00003; BRIGHT RA, 1993, J LONG-TERM EFF MED, V3, P81; Brinton LA, 2000, CANCER CAUSE CONTROL, V11, P819, DOI 10.1023/A:1008941110816; Brinton LA, 1996, PLAST RECONSTR SURG, V97, P269, DOI 10.1097/00006534-199602000-00001; CAHAN AC, 1995, ANN SURG ONCOL, V2, P121, DOI 10.1007/BF02303626; CARLSON GW, 1993, PLAST RECONSTR SURG, V91, P837, DOI 10.1097/00006534-199304001-00014; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; CLARK CP, 1993, CANCER, V72, P2170, DOI 10.1002/1097-0142(19931001)72:7<2170::AID-CNCR2820720717>3.0.CO;2-1; COOK RR, 1995, J CLIN EPIDEMIOL, V48, P519, DOI 10.1016/0895-4356(94)00208-8; D'Orsi C. J., 1998, AM COLL RADIOLOGY AC; Deapen D, 2000, PLAST RECONSTR SURG, V105, P535, DOI 10.1097/00006534-200002000-00009; Deapen DM, 1997, PLAST RECONSTR SURG, V99, P1346, DOI 10.1097/00006534-199704001-00022; DOUGLAS KP, 1991, SOUTH MED J, V84, P49, DOI 10.1097/00007611-199101000-00013; EKLUND GW, 1988, AM J ROENTGENOL, V151, P469, DOI 10.2214/ajr.151.3.469; EKLUND GW, 1992, RADIOL CLIN N AM, V30, P21; Ernster VL, 2002, J NATL CANCER I, V94, P1546; FAJARDO LL, 1995, RADIOLOGY, V194, P859, DOI 10.1148/radiology.194.3.7862991; Garbers S, 1998, PLAST RECONSTR SURG, V101, P695, DOI 10.1097/00006534-199803000-00016; GUMUCIO CA, 1989, PLAST RECONSTR SURG, V84, P772, DOI 10.1097/00006534-198911000-00008; HANDEL N, 1992, JAMA-J AM MED ASSOC, V268, P1913, DOI 10.1001/jama.268.14.1913; HAYES H, 1988, PLAST RECONSTR SURG, V82, P1, DOI 10.1097/00006534-198882010-00001; Holmich LR, 2003, BRIT J CANCER, V88, P832, DOI 10.1038/sj.bjc.6600819; Hoshaw SJ, 2001, PLAST RECONSTR SURG, V107, P1393, DOI 10.1097/00006534-200105000-00012; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; LEIBMAN AJ, 1990, RADIOLOGY, V174, P195, DOI 10.1148/radiology.174.1.2152981; MOGELVANG LC, 1995, PLAST RECONSTR SURG, V95, P935, DOI 10.1097/00006534-199504000-00036; Muzaffar AR, 2002, PLAST RECONSTR SURG, V109, P742, DOI 10.1097/00006534-200202000-00049; Rosenberg RD, 2000, ACAD RADIOL, V7, P1058, DOI 10.1016/S1076-6332(00)80057-4; SCHIRBER S, 1993, SOUTHERN MED J, V86, P263, DOI 10.1097/00007611-199303000-00001; SILVERSTEIN MJ, 1992, EUR J CANCER, V28A, P635, DOI 10.1016/S0959-8049(05)80115-7; SILVERSTEIN MJ, 1990, PLAST RECONSTR SURG, V86, P1126, DOI 10.1097/00006534-199012000-00014; Skinner KA, 2001, ANN SURG ONCOL, V8, P138; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; 1997, AJCC CANC STAGING MA, P171	37	99	102	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2004	291	4					442	450		10.1001/jama.291.4.442	http://dx.doi.org/10.1001/jama.291.4.442			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	767EF	14747501	Bronze			2022-12-01	WOS:000188426700029
J	Jerome, KR; Corey, L				Jerome, KR; Corey, L			The danger within	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Jerome, KR (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.							Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991	2	19	21	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2004	350	4					411	412		10.1056/NEJMcibr032455	http://dx.doi.org/10.1056/NEJMcibr032455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765EU	14736935				2022-12-01	WOS:000188254800016
J	Stafford, RS; Furberg, CD; Finkelstein, SN; Cockburn, IM; Alehegn, T; Ma, J				Stafford, RS; Furberg, CD; Finkelstein, SN; Cockburn, IM; Alehegn, T; Ma, J			Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINES; PHYSICIANS; DOXAZOSIN	Context Research on factors that influence prescribing patterns and the extent of change produced by clinical trial findings is limited. Objective To examine the changes in prescribing of alpha-blockers for hypertension treatment before and after the April 2000 publication of the unfavorable Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) early termination involving the study's doxazosin mesylate arm. Changes in prescribing were considered in the context of other potential concurrent influences on medication use between 1996 and 2002, including changes in alpha-blocker drug prices, generic conversion, drug promotion, and competition. Design, Setting, and Patients Using 2 national pharmaceutical market research reports published by IMS HEALTH, alpha-blocker prescription orders reported in the National Prescription Audit-a random computerized sample of about 20000 of 29000 retail, independent, and mail order pharmacies and mass merchandise and discount houses-and office-based physician alpha-blocker prescribing patterns reported in the National Disease and Therapeutic Index-a random stratified sample of about 3500 physician offices-were tracked. Outcome Measures Trends in physician-reported use of alpha-blockers and alpha-blocker prescribing and dispensing by US pharmacies. Results There were steady increases in alpha-blocker new prescriptions, dispensed prescriptions, and physician drug use from 1996 through 1999. There was a moderate reversal in these trends following ALLHAT early termination and subsequent publications in early 2000. Between 1999 and 2002, new annual alpha-blocker prescription orders declined by 26% (from 5.15 million to 3.79 million), dispensed prescriptions by 22% (from 17.2 million to 13.4 million), and physician-reported drug use by 54% (from 2.26 million to 1.03 million). Other potential influences did not appear to have contributed significantly to this decline although cessation of alpha-blocker marketing may have hastened the decline. Conclusions Modest yet statistically significant declines in the use of doxazosin and other alpha-blockers coincided with the early termination of the ALLHAT doxazosin arm. Although physicians responded to this new evidence, strategies to augment the impact of clinical trials on clinical practice are warranted.	Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; MIT, Program Pharmaceut Ind, Cambridge, MA 02139 USA; Boston Univ, Sch Management, Boston, MA 02215 USA	Stanford University; Wake Forest University; Wake Forest Baptist Medical Center; Massachusetts Institute of Technology (MIT); Boston University	Stafford, RS (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	rstafford@stanford.edu	Cockburn, Iain M/G-9524-2013; Stafford, Randall/F-3974-2017	Cockburn, Iain M/0000-0003-2034-0187; Stafford, Randall/0000-0003-1805-1271	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013405] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS013405] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413; Cabana M, 1998, AM J MANAG CARE, V4, pS741; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; COLLINS R, 1991, BRIT HEART J, V66, P250; CONOVER WJ, 1980, PRACTICAL NONPARAMET, P94; DUNN DRF, 1981, B MED LIBR ASSOC, V69, P301; Frank RG, 1997, J ECON MANAGE STRAT, V6, P75, DOI 10.1162/105864097567039; FRIEDMAN L, 1983, CONTROL CLIN TRIALS, V4, P513, DOI 10.1016/0197-2456(83)90032-6; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Furberg CD, 2001, CURR CONTR TRIALS C, V2, P249, DOI 10.1186/CVM-2-6-249; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Guldal D, 2000, INT J HEALTH SERV, V30, P585, DOI 10.2190/GYW9-XUMQ-M3K2-T31C; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hogben M, 2002, OBSTET GYNECOL, V100, P801, DOI 10.1016/S0029-7844(02)02167-1; HURWITZ MA, 1988, J LAW ECON, V31, P299, DOI 10.1086/467158; *IMS HEALTH, 2001, NAT PRESCR AUD PLUS; *IMS HEALTH, 2002, NAT DIS THER IND DIA; Lacy CR, 2001, AM J CARDIOL, V87, P203, DOI 10.1016/S0002-9149(00)01317-5; LAMAS GA, 1992, NEW ENGL J MED, V327, P241, DOI 10.1056/NEJM199207233270405; Libby EN, 2002, ARCH INTERN MED, V162, P1893, DOI 10.1001/archinte.162.16.1893; Majumdar SR, 2001, J GEN INTERN MED, V16, P351, DOI 10.1046/j.1525-1497.2001.016006351.x; McCracken GH, 2001, AM J MANAG CARE, V7, pS183; Messerli F H, 2000, Curr Hypertens Rep, V2, P241, DOI 10.1007/s11906-000-0005-3; Messerli FH, 2001, J AM COLL CARDIOL, V38, P1295, DOI 10.1016/S0735-1097(01)01534-0; Mottur-Pilson C, 2001, Eff Clin Pract, V4, P207; *NAT I HLTH CAR MA, 1999, FACT AFF GROWTH PRES; *NAT I HLTH CAR MA, 2002, PRESCR DRUG EXP 2001; Nelson CR, 2000, HYPERTENSION, V36, P600, DOI 10.1161/01.HYP.36.4.600; *NIH, 2000, NHLBI STOPS PART STU; Pressel SL, 2001, CONTROL CLIN TRIALS, V22, P29, DOI 10.1016/S0197-2456(00)00109-4; REIFFEL JA, 1990, AM J CARDIOL, V66, P1262, DOI 10.1016/0002-9149(90)91115-M; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Zoorab Roger, 2002, J La State Med Soc, V154, P136	35	69	69	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2004	291	1					54	62		10.1001/jama.291.1.54	http://dx.doi.org/10.1001/jama.291.1.54			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760LX	14709576	Bronze			2022-12-01	WOS:000187836000019
J	Salazar-Martinez, E; Willett, WC; Ascherio, A; Manson, JE; Leitzmann, MF; Stampfer, MJ; Hu, FB				Salazar-Martinez, E; Willett, WC; Ascherio, A; Manson, JE; Leitzmann, MF; Stampfer, MJ; Hu, FB			Coffee consumption and risk for type 2 diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; GLUCOSE-TOLERANCE; CAFFEINE INGESTION; ENERGY-EXPENDITURE; DIETARY FIBER; DOUBLE-BLIND; WOMEN; HUMANS; METABOLISM; VOLUNTEERS	Background: in small, short-term studies, acute administration of caffeine decreases insulin sensitivity and impairs glucose tolerance. Objective: To examine the long-term relationship between consumption of coffee and other caffeinated beverages and incidence of type 2 diabetes mellitus. Design: Prospective cohort study. Setting: The Nurses' Health Study and Health Professionals' Follow-up Study. Participants: The authors followed 41934 men from 1986 to 1998 and 84 276 women from 1980 to 1998. These participants did not have diabetes, cancer, or cardiovascular disease at baseline. Measurements: Coffee consumption was assessed every 2 to 4 years through validated questionnaires. Results: The authors documented 1333 new cases of type 2 diabetes in men and 4085 new cases in women. The authors found an inverse association between coffee intake and type 2 diabetes after adjustment for age, body mass index, and other risk factors. The multivariate relative risks for diabetes according to regular coffee consumption categories (0, <1, I to 3, 4 to 5, or greater than or equal to6 cups per day) in men were 1.00, 0.98, 0.93, 0.71, and 0.46 (95% Cl, 0.26 to 0.82; P = 0.007 for trend), respectively. The corresponding multivariate relative risks in women were 1.00, 1.16, 0.99, 0.70, and 0.71 (Cl, 0.56 to 0.89; P < 0.001 for trend), respectively. For decaffeinated coffee, the multivariate relative risks comparing persons who drank 4 cups or more per day with nondrinkers were 0.74 (Cl, 0.48 to 1.12) for men and 0.85 (Cl, 0.61 to 1.17) for women. Total caffeine intake from coffee and other sources was associated with a statistically significantly lower risk for diabetes in both men and women. Conclusions: These data suggest that long-term coffee consumption is associated with a statistically significantly lower risk for type 2 diabetes.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Mexican Inst Social Secur, Cuernavaca, Morelos, Mexico	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Instituto Mexicano del Seguro Social	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013		NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969, CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASTRUP A, 1992, INT J OBESITY, V16, P269; ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759; Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023; BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671; BROWN CR, 1989, PHARMACOL BIOCHEM BE, V34, P565, DOI 10.1016/0091-3057(89)90559-5; CHERASKIN E, 1968, LANCET, V2, P689; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Cox DR., 1984, ANAL SURVIVAL DATA; Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5; DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44; FEINBERG LJ, 1968, METABOLISM, V17, P916, DOI 10.1016/0026-0495(68)90158-3; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559; Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; HARRIS M, 1979, DIABETES, V28, P1039; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364; LUNDSBERG LS, 1998, CAFFEINE, P199; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; Ryu S, 2001, J NUTR SCI VITAMINOL, V47, P139, DOI 10.3177/jnsv.47.139; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891; Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X	31	350	367	0	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2004	140	1					1	8		10.7326/0003-4819-140-1-200401060-00005	http://dx.doi.org/10.7326/0003-4819-140-1-200401060-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760VH	14706966	Green Published			2022-12-01	WOS:000187855600001
J	Muller-Navarra, DC; Brett, MT; Park, S; Chandra, S; Ballantyne, AP; Zorita, E; Goldman, CR				Muller-Navarra, DC; Brett, MT; Park, S; Chandra, S; Ballantyne, AP; Zorita, E; Goldman, CR			Unsaturated fatty acid content in seston and tropho-dynamic coupling in lakes	NATURE			English	Article							FOOD QUALITY; STOICHIOMETRIC CONSTRAINTS; COMMUNITY STRUCTURE; PELAGIC ECOSYSTEMS; LIMITATION; CONSUMER	Determining the factors that control food web interactions is a key issue in ecology(1,2). The empirical relationship between nutrient loading (total phosphorus) and phytoplankton standing stock (chlorophyll a) in lakes was described about 30 years ago(3) and is central for managing surface water quality. The efficiency with which biomass and energy are transferred through the food web and sustain the production of higher trophic levels (such as fish) declines with nutrient loading and system productivity(4,5), but the underlying mechanisms are poorly understood. Here we show that in seston (fine particles in water) during summer, specific omega3-polyunsaturated fatty acids (omega3-PUFAs), which are important for zooplankton(6-10), are significantly correlated to the trophic status of the lake. The omega3-PUFAs octadecatetraenoic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid, but not alpha-linolenic acid, decrease on a double-logarithmic scale with increasing total phosphorus. By combining the empirical relationship between EPA-to-carbon content and total phosphorus with functional models relating EPA-to-carbon content to the growth and egg production of daphnids(8), we predict secondary production for this key consumer. Thus, the decreasing efficiency in energy transfer with increasing lake productivity can be explained by differences in omega3-PUFA-associated food quality at the plant-animal interface.	Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; GKSS Forschungszentrum Geesthacht GmbH, Inst Coastal Res, D-21502 Geesthacht, Germany	University of California System; University of California Davis; University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Muller-Navarra, DC (corresponding author), Univ Hamburg, Inst Hydrobiol & Fishery Sci, D-22767 Hamburg, Germany.	doerthe.mueller-navarra@uni-hamburg.de	Brett, Michael T/A-2066-2010	Park, Sangkyu/0000-0003-3049-0728				Ahlgren G, 1997, FRESHWATER BIOL, V38, P555, DOI 10.1046/j.1365-2427.1997.00219.x; Ahlgren G., 1996, Ecology of Freshwater Fish, V5, P15; AHLGREN G, 1993, VERHANDLUNGEN INT VE, V25, P144; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brett MT, 1997, SCIENCE, V275, P384, DOI 10.1126/science.275.5298.384; CARPENTER SR, 1984, AM NAT, V124, P159, DOI 10.1086/284261; DeMott WR, 2002, ECOLOGY, V83, P3426, DOI 10.1890/0012-9658(2002)083[3426:SCVADT]2.0.CO;2; Elser JJ, 1998, ECOSYSTEMS, V1, P120, DOI 10.1007/s100219900009; GREENBERG AE, 1995, STANDARDS METHODS EX; GULATI RD, 1990, HYDROBIOLOGIA, V200; JONASDOTTIR SH, 1995, MAR ECOL PROG SER, V119, P87, DOI 10.3354/meps119087; KATTNER G, 1986, J CHROMATOGR, V361, P263, DOI 10.1016/S0021-9673(01)86914-4; Mardia KV, 1978, MULTIVARIATE ANAL; Marker A. F. H., 1980, ARCH HYDROBIOL S, V14, P52; Matson PA, 1992, SPECIAL FEATURE ECOL, V73; MCQUEEN DJ, 1986, CAN J FISH AQUAT SCI, V43, P1571, DOI 10.1139/f86-195; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; MULLERNAVARRA D, 1995, ARCH HYDROBIOL, V132, P297; MullerNavarra D, 1996, J PLANKTON RES, V18, P1137, DOI 10.1093/plankt/18.7.1137; Polis G.A., 1996, FOOD WEBS INTEGRATIO; Ravet JL, 2003, LIMNOL OCEANOGR, V48, P1938, DOI 10.4319/lo.2003.48.5.1938; SCHINDLER DW, 1987, CAN J FISH AQUAT SCI, V44, P6; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; STERNER RW, 2003, JECOLOGICAL STOICHIO; VOLLENWEIDER R A, 1976, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V33, P53; WANG KS, 1994, J APPL PHYCOL, V6, P415, DOI 10.1007/BF02182158	30	229	233	9	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2004	427	6969					69	72		10.1038/nature02210	http://dx.doi.org/10.1038/nature02210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702086				2022-12-01	WOS:000187710000035
J	Kvalsvig, A				Kvalsvig, A			Ask the elephant	LANCET			English	Article											Kvalsvig, A (corresponding author), 600 Makara Rd, Wellington, New Zealand.								0	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2079	2080		10.1016/S0140-6736(03)15105-7	http://dx.doi.org/10.1016/S0140-6736(03)15105-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697810				2022-12-01	WOS:000187429600024
J	Dennis, C				Dennis, C			Genomics - Compare and contrast	NATURE			English	News Item							SEQUENCES; REGIONS											Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858	8	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					750	751		10.1038/426750b	http://dx.doi.org/10.1038/426750b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685190	Bronze			2022-12-01	WOS:000187342000013
J	Ebrahim, S; Montaner, D; Lawlor, DA				Ebrahim, S; Montaner, D; Lawlor, DA			Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK; INSULIN-RESISTANCE; SOCIOECONOMIC CONDITIONS; DISEASE; MORTALITY; CORONARY; CIRCUMSTANCES; ASSOCIATION; PREDICTORS; PREVENTION	Objective To examine co-occurrence and clustering of risk factors used in the Framingham equation by social class in childhood and adult life. Design Cross sectional study. Setting 23 towns across England, Wales, and Scotland. Participants 2936 women aged 60-79 years. Main outcome measures Prevalence of risk factors (hypertension, obesity, smoking, left ventricular hypertrophy on electrocardiography, diabetes, and low concentration of high density cholesterol); ratios of observed to expected frequencies of clusters of risk factors. Results Risk factors were more common in women from manual social classes in either childhood or adult life, and the co-occurrence of three or four of these risk factors was greater among more disadvantaged groups. Within the four socioeconomic groups, these risk factors occur-red together more than would be expected from their individual frequency distributions, indicating that they were clustered. The extent of this clustering was similar in all four social class groups. Conclusions Clustering of risk factors included in the Framingham risk function occurs in all social class groups, but the lack of social patterning makes it unlikely that clustering is an explanation of socioeconomic inequalities in cardiovascular disease. As the proportion of women with co-occurrence of risk factors is greatest in those from manual social class in childhood, this measure of socioeconomic position might prove useful in risk prediction.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Ebrahim, S (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.	Shah.ebrahim@bristol.ac.uk	; Montaner, David/A-9362-2014	Lawlor, Debbie A/0000-0002-6793-2262; Montaner, David/0000-0002-2484-3278				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; Brunner E, 1999, J EPIDEMIOL COMMUN H, V53, P757, DOI 10.1136/jech.53.12.757; CRIQUI MH, 1980, PREV MED, V9, P525, DOI 10.1016/0091-7435(80)90047-X; ERENS B, 1999, HLTH SURVEY ENGLAND; Golden SH, 2002, DIABETES, V51, P3069, DOI 10.2337/diabetes.51.10.3069; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Hoeymans N, 1996, EUR HEART J, V17, P518; KAPLAN GA, 1990, BRIT MED J, V301, P1121, DOI 10.1136/bmj.301.6761.1121; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; LAWLOR DA, 2003, IN PRESS AM J PUBLIC; Liese AD, 1998, EPIDEMIOL REV, V20, P157, DOI 10.1093/oxfordjournals.epirev.a017978; LYNCH JW, 1994, LANCET, V343, P524, DOI 10.1016/S0140-6736(94)91468-0; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; MYERS L, 1995, AM J EPIDEMIOL, V142, P918, DOI 10.1093/oxfordjournals.aje.a117739; NOTKOLA V, 1985, SOC SCI MED, V21, P517, DOI 10.1016/0277-9536(85)90035-8; Office of Population Censuses and Surveys, 1980, CLASS OCC COD IND; Parsons TJ, 1999, INT J OBESITY, V23, pS1; RAITAKARI OT, 1994, J CLIN EPIDEMIOL, V47, P1085, DOI 10.1016/0895-4356(94)90094-9; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Smith GD, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P20; Smith GD, 1997, LANCET, V349, P284, DOI 10.1016/S0140-6736(05)64894-5; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P340, DOI 10.1136/jech.55.5.340; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wannamethee SG, 1996, LANCET, V348, P1259, DOI 10.1016/S0140-6736(96)02465-8; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P19, DOI 10.1093/oxfordjournals.aje.a113510; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Wood D, 1998, HEART, V80, pS1	30	61	65	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2004	328	7444					861	864		10.1136/bmj.38034.702836.55	http://dx.doi.org/10.1136/bmj.38034.702836.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15006898	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000220871400014
J	Choi, HK; Atkinson, K; Karlson, EW; Willett, W; Curhan, G				Choi, HK; Atkinson, K; Karlson, EW; Willett, W; Curhan, G			Purine-rich foods, dairy and protein intake, and the risk of gout in men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; URIC-ACID METABOLISM; FREQUENCY QUESTIONNAIRE; ELDERLY-MEN; WOMEN; SERUM; REPRODUCIBILITY; VALIDITY; HYPERURICEMIA; HEALTH	BACKGROUND: Various purine-rich foods and high protein intake have long been thought to be risk factors for gout. Similarly, the possibility that the consumption of dairy products has a role in protecting against gout has been raised by metabolic studies. We prospectively investigated the association of these dietary factors with new cases of gout. METHODS: Over a 12-year period, we prospectively examined the relationship between purported dietary risk factors and new cases of gout among 47,150 men who had no history of gout at base line. We used a supplementary questionnaire to ascertain whether participants met the American College of Rheumatology survey criteria for gout. Diet was assessed every four years by means of a food-frequency questionnaire. RESULTS: During the 12 years of the study, we documented 730 confirmed new cases of gout. The multivariate relative risk of gout among men in the highest quintile of meat intake, as compared with those in the lowest quintile, was 1.41 (95 percent confidence interval, 1.07 to 1.86; P for trend = 0.02), and the corresponding relative risk associated with seafood intake was 1.51 (95 percent confidence interval, 1.17 to 1.95; P for trend = 0.02). In contrast, the incidence of gout decreased with increasing intake of dairy products; the multivariate relative risk among men in the highest quintile, as compared with those in the lowest quintile, was 0.56 (95 percent confidence interval, 0.42 to 0.74; P for trend <0.001). The level of consumption of purine-rich vegetables and the total protein intake were not associated with an increased risk of gout. CONCLUSIONS: Higher levels of meat and seafood consumption are associated with an increased risk of gout, whereas a higher level of consumption of dairy products is associated with a decreased risk. Moderate intake of purine-rich vegetables or protein is not associated with an increased risk of gout.	Massachusetts Gen Hosp, Rheumatol Unit, Dept Med, Boston, MA 02114 USA; Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Choi, HK (corresponding author), Massachusetts Gen Hosp, Rheumatol Unit, Dept Med, Bulfinch 165,55 Fruit St, Boston, MA 02114 USA.	hchoi@partners.org			NCI NIH HHS [CA55075] Funding Source: Medline; NIDDK NIH HHS [DK58573] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; CLIFFORD AJ, 1976, J NUTR, V106, P435, DOI 10.1093/jn/106.3.435; CLIFFORD AJ, 1976, J NUTR, V106, P428, DOI 10.1093/jn/106.3.428; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Fam AG, 2002, J RHEUMATOL, V29, P1350; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; GARREL DR, 1991, AM J CLIN NUTR, V53, P665; GHADIRIAN P, 1995, EUR J EPIDEMIOL, V11, P275, DOI 10.1007/BF01719431; GIBSON T, 1980, ANN RHEUM DIS, V39, P417, DOI 10.1136/ard.39.5.417; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; GLYNN RJ, 1983, ARTHRITIS RHEUM-US, V26, P87, DOI 10.1002/art.1780260115; Griebsch A, 1974, Adv Exp Med Biol, V41, P443; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Kramer HM, 2002, AM J KIDNEY DIS, V40, P37, DOI 10.1053/ajkd.2002.33911; Lewis HB, 1918, J BIOL CHEM, V36, P1; LOENEN HMJA, 1990, J CLIN EPIDEMIOL, V43, P1297, DOI 10.1016/0895-4356(90)90095-7; Matzkies F, 1980, Adv Exp Med Biol, V122A, P227; NUGENT CHARLES A., 1965, ARTHRITIS RHEUM, V8, P671, DOI 10.1002/art.1780080427; Raiziss GW, 1914, J BIOL CHEM, V19, P473; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; ROUBENOFF R, 1990, RHEUM DIS CLIN N AM, V16, P539; Shadick NA, 2000, J RHEUMATOL, V27, P1708; SHARPE CR, 1984, CAN MED ASSOC J, V131, P563; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WASLIEN CI, 1968, AM J CLIN NUTR, V21, P892, DOI 10.1093/ajcn/21.9.892; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zollner N, 1974, Adv Exp Med Biol, V41, P435; ZOLLNER N, 1973, BIBL NUTR DIET, V19, P34	35	655	716	6	147	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2004	350	11					1093	1103		10.1056/NEJMoa035700	http://dx.doi.org/10.1056/NEJMoa035700			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801QJ	15014182				2022-12-01	WOS:000220110100006
J	Whitman, K; Starfield, AM; Quadling, HS; Packer, C				Whitman, K; Starfield, AM; Quadling, HS; Packer, C			Sustainable trophy hunting of African lions	NATURE			English	Article							COOPERATION; INFANTICIDE; MAMMALS; KINSHIP	In most species, sport hunting of male trophy animals can only reduce overall population size when the rate of removal of males is so high that females can no longer be impregnated(1). However, where males provide extensive paternal care, the removal of even a few individuals could harm the population as a whole(2,3). In species such as lions, excessive trophy hunting could theoretically cause male replacements (and associated infanticide(4,5)) to become sufficiently common to prevent cubs reaching adulthood. Here we simulate the population consequences of lion trophy hunting using a spatially explicit, individual-based, stochastic model parameterized with 40 years of demographic data from northern Tanzania. Although our simulations confirm that infanticide increases the risk of population extinction, trophy hunting could be sustained simply by hunting males above a minimum age threshold, and this strategy maximizes both the quantity and the quality of the long-term kill. We present a simple non-invasive technique for estimating lion age in populations lacking long-term records, and suggest that quotas would be unnecessary in any male-only trophy species where age determination could be reliably implemented.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	packer@cbs.umn.edu						BERTRAM BCR, 1975, J ZOOL, V177, P463; BYGOTT JD, 1979, NATURE, V282, P838; Caro TM, 1998, AFR J ECOL, V36, P321, DOI 10.1046/j.1365-2028.1998.00146.x; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Greene C, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P271; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Hillborn R., 1992, QUANTITATIVE FISHERI; LEADERWILLIAMS N, 1996, IUCN SPECIES SURVIVA, V14; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Packer C., 1988, P363; Packer C, 2001, SCIENCE, V293, P690, DOI 10.1126/science.1062320; PACKER C, 1983, ANIM BEHAV, V31, P334, DOI 10.1016/S0003-3472(83)80051-7; Packer C, 2000, AM ANTHROPOL, V102, P829, DOI 10.1525/aa.2000.102.4.829; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Quadling HS, 2002, S AFR J SCI, V98, P449; Schaller GB., 1972, SERENGETI LION; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Starfield A.M., 1981, P121; Sutherland WJ, 2001, WILDLIFE BIOL, V7, P131, DOI 10.2981/wlb.2001.017; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257	23	156	161	7	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2004	428	6979					175	178		10.1038/nature02395	http://dx.doi.org/10.1038/nature02395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	14990967				2022-12-01	WOS:000220103600047
J	Blandin, S; Shiao, SH; Moita, LF; Janse, CJ; Waters, AP; Kafatos, FC; Levashina, EA				Blandin, S; Shiao, SH; Moita, LF; Janse, CJ; Waters, AP; Kafatos, FC; Levashina, EA			Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae	CELL			English	Article							QUANTITATIVE TRAIT LOCI; IMMUNE-RESPONSE; MOSQUITO; EXPRESSION; STEPHENSI; GENES	Anopheles mosquitoes are major vectors of human malaria in Africa. Large variation exists in the ability of mosquitoes to serve as vectors and to transmit malaria parasites, but the molecular mechanisms that determine vectorial capacity remain poorly understood. We report that the hemocyte-specific complement-like protein TEP1 from the mosquito Anopheles gambiae binds to and mediates killing of midgut stages of the rodent malaria parasite Plasmodium, berghei. The dsRNA knockdown of TEP1 in adults completely abolishes melanotic refractoriness in a genetically selected refractory strain, Moreover, in susceptible mosquitoes this knockdown increases the number of developing parasites. Our results suggest that the TEP1-dependent parasite killing is followed by a TEP1-independent clearance of dead parasites by lysis and/or melanization. Further elucidation of the molecular mechanisms of TEP1-mediated parasite killing will be of great importance for our understanding of the principles of vectorial capacity in insects.	European Mol Biol Lab, D-69117 Heidelberg, Germany; CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France; Leiden Univ, Med Ctr, Dept Parasitol, NL-9600 RC Leiden, Netherlands	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Levashina, EA (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	e.levashina@ibmc.u-strasbg.fr	Blandin, Stephanie/I-2786-2016; Blandin, Stephanie/ABH-2267-2021; Moita, Luis F./L-1296-2013; Waters, Andy P/C-9377-2009; Moita, Luis/HCI-2793-2022	Blandin, Stephanie/0000-0003-4566-1200; Blandin, Stephanie/0000-0003-4566-1200; Moita, Luis F./0000-0003-0707-315X; Waters, Andy P/0000-0001-8900-2982; Moita, Luis/0000-0003-0707-315X; Levashina, Elena/0000-0003-4605-906X; Janse, Chris J/0000-0002-6410-6205; SHIAO, SHIN-HONG/0000-0002-7749-7807				Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Law SKA, 1997, PROTEIN SCI, V6, P263; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; MEIS JFGM, 1989, PARASITOL RES, V76, P13, DOI 10.1007/BF00931065; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; SIMONETTI AB, 1993, J EUKARYOT MICROBIOL, V40, P569, DOI 10.1111/j.1550-7408.1993.tb06109.x; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Thummel CS, 1992, DROS INF SERV, V71, P150; VARGAS L, 1949, CULICINE AEDINE MOSQ, P526; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	18	449	467	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					661	670		10.1016/S0092-8674(04)00173-4	http://dx.doi.org/10.1016/S0092-8674(04)00173-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006349	Bronze			2022-12-01	WOS:000221499700007
J	Nie, ZG; Schweitzer, P; Roberts, AJ; Madamba, SG; Moore, SD; Siggins, GR				Nie, ZG; Schweitzer, P; Roberts, AJ; Madamba, SG; Moore, SD; Siggins, GR			Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors	SCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ALCOHOL-DRINKING; OPIOID RECEPTOR; CENTRAL NUCLEUS; DRUG-ADDICTION; STRESS; ANXIETY; ACTIVATION; NEURONS; NEUROBIOLOGY	The central amygdala (CeA) plays a role in the relationship among stress, corticotropin-releasing factor (CRF), and alcohol abuse. In whole-cell recordings, both CRF and ethanol enhanced gamma-aminobutyric acid-mediated (GABAergic) neurotransmission in CeA neurons from wild-type and CRF2 receptor knockout mice, but not CRF1 receptor knockout mice. CRF1 (but not CRF2) receptor antagonists blocked both CRF and ethanol effects in wild-type mice. These data indicate that CRF1 receptors mediate ethanol enhancement of GABAergic synaptic transmission in the CeA, and they suggest a cellular mechanism underlying involvement of CRF in ethanol's behavioral and motivational effects.	Scripps Res Inst, Dept Neuropharmacol & Alcohol Res, La Jolla, CA 92037 USA; Duke Univ, Dept Psychiat, Durham, NC 27710 USA	Scripps Research Institute; Duke University	Siggins, GR (corresponding author), Scripps Res Inst, Dept Neuropharmacol & Alcohol Res, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	geobob@scripps.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA006420, R01AA010994, P60AA006420, R29AA010994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003665, R01DA013658] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA10994, AA06420] Funding Source: Medline; NIDA NIH HHS [DA13658, DA03665] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Blednov YA, 2003, J PHARMACOL EXP THER, V304, P30, DOI 10.1124/jpet.102.042960; Dautzenberg FM, 2002, TRENDS PHARMACOL SCI, V23, P71, DOI 10.1016/S0165-6147(02)01946-6; Day HEW, 1999, J COMP NEUROL, V413, P113; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; Hsin LW, 2002, BIOORGAN MED CHEM, V10, P175, DOI 10.1016/S0968-0896(01)00261-9; Koob GF, 2000, ANN NY ACAD SCI, V909, P170, DOI 10.1111/j.1749-6632.2000.tb06682.x; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; Krysiak R, 2000, POL J PHARMACOL, V52, P15; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; Liu X, 2002, J NEUROSCI, V22, P7856; McBride WJ, 2002, PHARMACOL BIOCHEM BE, V71, P509, DOI 10.1016/S0091-3057(01)00680-3; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; MOORE SP, UNPUB; Nie ZG, 2000, J PHARMACOL EXP THER, V293, P654; POHORECKY LA, 1990, ALCOHOL ALCOHOLISM, V25, P263, DOI 10.1093/oxfordjournals.alcalc.a045000; POHORECKY LA, 1991, ALCOHOL CLIN EXP RES, V15, P438, DOI 10.1111/j.1530-0277.1991.tb00543.x; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Roberto M, 2003, P NATL ACAD SCI USA, V100, P2053, DOI 10.1073/pnas.0437926100; Roberts AJ, 1996, ALCOHOL CLIN EXP RES, V20, P1289, DOI 10.1111/j.1530-0277.1996.tb01125.x; Ryabinin AE, 2002, ALCOHOL CLIN EXP RES, V26, P714; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Veinante P, 1997, NEUROREPORT, V8, P2985, DOI 10.1097/00001756-199709080-00035; Wand GS, 2002, NEUROPSYCHOPHARMACOL, V26, P106, DOI 10.1016/S0893-133X(01)00294-9	28	215	220	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1512	1514		10.1126/science.1092550	http://dx.doi.org/10.1126/science.1092550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001778				2022-12-01	WOS:000220000100040
J	Alter, DA; Iron, K; Austin, PC; Naylor, CD				Alter, DA; Iron, K; Austin, PC; Naylor, CD		SESAMI Study Grp	Socioeconomic status, service patterns, and perceptions of care among survivors of acute myocardial infarction in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; HEALTH-CARE; CARDIOVASCULAR-DISEASE; CARDIAC PROCEDURES; OUTCOMES; ACCESS; ATHEROSCLEROSIS; PREFERENCES; EDUCATION; INCOME	Context Some have argued that Canada's uniquely restrictive approach to private health insurance keeps the socioeconomic elite inside the public system so that their demands and influence elevate the standard of service for all Canadian citizens. The extent to which this theory is a valid representation of Canadian health care is unknown. Objectives To explore how patients with acute myocardial infarction from different socioeconomic backgrounds perceive their care in Canada's universal health care system and to correlate patients' backgrounds and perceptions with actual care received. Design, Setting, and Patients Prospective observational cohort study with follow-up telephone interviews of 2256 patients 30 days following acute myocardial infarction discharged from 53 hospitals across Ontario, Canada, between December 1999 and June 2002. Main Outcome Measures Postdischarge use of cardiac specialty services; satisfaction with care; willingness to pay directly for faster service or more choice; and mortality according to income and education, adjusted for age, sex, ethnicity, clinical factors, onsite angiography capacity at the admitting hospital, and rural-urban residence. Results Compared with patients in lower socioeconomic strata, more affluent or better educated patients were more likely to undergo coronary angiography (67.8% vs 52.8%; P<.001), receive cardiac rehabilitation (43.9% vs 25.6%; P<.001), or be followed up by a cardiologist (56.7% vs 47.8%; P<.001). Socioeconomic differences in cardiac care persisted after adjustment for confounders. Despite receiving more specialized services, patients with higher socioeconomic status were more likely to be dissatisfied with their access to specialty care (adjusted RR, 2.02; 95% confidence interval, 1.20-3.32) and to favor out-of-pocket payments for quicker access to a wider selection of treatment options (30% vs 15% for patients with household incomes of Can $60000 or higher vs less than Can $30000, respectively; P<.001). After adjusting for baseline characteristics, socioeconomic status was not significantly associated with mortality at 1 year following hospitalization for myocardial infarction. Conclusions Compared with those with lower incomes or less education, upper middle-class Canadians gain preferential access to services within the publicly funded health care system yet remain more likely to favor supplemental coverage or direct purchase of services.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evalut, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Deans Off, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Alter, DA (corresponding author), Inst Clin Evaluat Sci, 2075 Bayview Ave,G106, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca		Austin, Peter/0000-0003-3337-233X				Alter DA, 1998, ANN INTERN MED, V129, P567, DOI 10.7326/0003-4819-129-7-199810010-00011; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2003, AM HEART J, V146, P938, DOI 10.1016/S0002-8703(03)00449-6; Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; ALTER DA, 2003, PHARMACOECONOMICS OU, V3, P691; Anand SS, 2001, LANCET, V358, P1147, DOI 10.1016/S0140-6736(01)06255-9; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; BADGLEY RF, 1992, CANADIAN HLTH CARE S, P193; Choi BCK, 2001, DIABETOLOGIA, V44, P1221, DOI 10.1007/s001250100648; Dirnfeld V, 1996, CAN MED ASSOC J, V155, P407; Ganiats TG, 2000, MED DECIS MAKING, V20, P263, DOI 10.1177/0272989X0002000302; Hawker GA, 2002, ARTHRITIS RHEUM-US, V46, P3331, DOI 10.1002/art.10682; Klassen AC, 2002, AM J PUBLIC HEALTH, V92, P811, DOI 10.2105/AJPH.92.5.811; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; McIsaac W, 1997, J Health Serv Res Policy, V2, P94; *NAT POP HLTH SURV, 1997, STAT CAN; Naylor CD, 1999, HEALTH AFFAIR, V18, P9, DOI 10.1377/hlthaff.18.3.9; Ng E, 1993, Health Rep, V5, P179; Philbin EF, 2000, CIRCULATION, V102, P107; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Romanow R, 2002, BUILDING VALUES FUTU, P159; Ross CE, 1997, J HEALTH SOC BEHAV, V38, P275, DOI 10.2307/2955371; ROSS CK, 1993, MED CARE, V31, P1138, DOI 10.1097/00005650-199312000-00006; Schoen C, 2000, HEALTH POLICY, V51, P67, DOI 10.1016/S0168-8510(99)00084-6; *STAND COMM SOC AF, 2004, HLTH CAN FED ROL, V6; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; van Doorslaer E, 2000, J HEALTH ECON, V19, P553, DOI 10.1016/S0167-6296(00)00050-3; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; ZITNER D, 2002, 2 AIMS	29	108	108	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2004	291	9					1100	1107		10.1001/jama.291.9.1100	http://dx.doi.org/10.1001/jama.291.9.1100			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	780AQ	14996779	Bronze			2022-12-01	WOS:000189348900027
J	Halligan, SC; Gersh, BJ; Brown, RD; Rosales, AG; Munger, TM; Shen, WK; Hammill, SC; Friedman, PA				Halligan, SC; Gersh, BJ; Brown, RD; Rosales, AG; Munger, TM; Shen, WK; Hammill, SC; Friedman, PA			The natural history of lone atrial flutter	ANNALS OF INTERNAL MEDICINE			English	Article							FIBRILLATION	Background: The natural history of atrial flutter is not well defined. Objective: To report the risk for stroke, conversion to atrial fibrillation, and anticoagulation for lone atrial flutter. Design: Retrospective cohort analysis. Setting: A clinically based longitudinal study of inpatients and outpatients with atrial flutter. Patients: The authors compared the stroke rate in 59 patients with atrial flutter with rates in a sample in which age- and sex-specific ischemic cerebrovascular event rates were determined and in a sample of nonhypertensive patients with lone atrial fibrillation. The risk for developing atrial fibrillation after presenting with atrial flutter is also reported. Measurements: Electrocardiograms and clinical data were collected and reviewed for each study participant. Results: After adjustment for age and sex, patients with atrial flutter had a higher incidence of thromboembolic events than the sample control patients and patients with atrial fibrillation. Atrial fibrillation developed in 56% of patients with atrial flutter. Conclusions: Lone atrial flutter has a stroke risk at least as high as lone atrial fibrillation and carries a higher risk for subsequent development of atrial fibrillation than in the general population. Anticoagulation should be considered for all patients with atria[ flutter who are older than 65 years of age.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Friedman, PA (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.		Lavu, Madhav/A-9409-2013					[Anonymous], 2001, CIRCULATION, V104, P2118; BHANDARI AK, 1992, AM HEART J, V124, P381, DOI 10.1016/0002-8703(92)90601-Q; Biblo LA, 2001, AM J CARDIOL, V87, P346, DOI 10.1016/S0002-9149(00)01374-6; COSIO FG, 1993, AM J CARDIOL, V71, P705, DOI 10.1016/0002-9149(93)91014-9; Kopecky SL, 1999, ARCH INTERN MED, V159, P1118, DOI 10.1001/archinte.159.10.1118; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104	6	101	103	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2004	140	4					265	268		10.7326/0003-4819-140-4-200402170-00008	http://dx.doi.org/10.7326/0003-4819-140-4-200402170-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774GA	14970149				2022-12-01	WOS:000188970400004
J	Haig, E				Haig, E			A message from the gut	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Long Isl Internal Med Associates, Rockville Ctr, NY 11570 USA		Haig, E (corresponding author), Long Isl Internal Med Associates, Rockville Ctr, NY 11570 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2004	350	7					706	706		10.1056/NEJMicm030045	http://dx.doi.org/10.1056/NEJMicm030045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772YB	14960746				2022-12-01	WOS:000188869500011
J	Jablonski, D				Jablonski, D			Extinction: past and present	NATURE			English	Editorial Material							MASS EXTINCTIONS; LESSONS		Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Jablonski, D (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.							Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C	3	30	34	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 12	2004	427	6975					589	589		10.1038/427589a	http://dx.doi.org/10.1038/427589a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961099				2022-12-01	WOS:000188875300020
J	Petersen, KF; Dufour, S; Befroy, D; Garcia, R; Shulman, GI				Petersen, KF; Dufour, S; Befroy, D; Garcia, R; Shulman, GI			Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR-GAMMA COACTIVATOR-1; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; FREE FATTY-ACIDS; TRIGLYCERIDE CONTENT; GLUCOSE-TOLERANCE; MUSCLE; OBESITY; SENSITIVITY; MECHANISM	Background: Insulin resistance appears to be the best predictor of the development of diabetes in the children of patients with type 2 diabetes, but the mechanism responsible is unknown. Methods: We performed hyperinsulinemic-euglycemic clamp studies in combination with infusions of [6,6-(sup 2)H(sub 2)]glucose in healthy, young, lean, insulin-resistant offspring of patients with type 2 diabetes and insulin-sensitive control subjects matched for age, height, weight, and physical activity to assess the sensitivity of liver and muscle to insulin. Proton ((sup 1)H) magnetic resonance spectroscopy studies were performed to measure intramyocellular lipid and intrahepatic triglyceride content. Rates of whole-body and subcutaneous fat lipolysis were assessed by measuring the rates of [(sup 2)H(sub 5)]glycerol turnover in combination with microdialysis measurements of glycerol release from subcutaneous fat. We performed (sup 31)P magnetic resonance spectroscopy studies to assess the rates of mitochondrial oxidative-phosphorylation activity in muscle. Results: The insulin-stimulated rate of glucose uptake by muscle was approximately 60 percent lower in the insulin-resistant subjects than in the insulin-sensitive control subjects (P<0.001) and was associated with an increase of approximately 80 percent in the intramyocellular lipid content (P=0.005). This increase in intramyocellular lipid content was most likely attributable to mitochondrial dysfunction, as reflected by a reduction of approximately 30 percent in mitochondrial phosphorylation (P=0.01 for the comparison with controls), since there were no significant differences in systemic or localized rates of lipolysis or plasma concentrations of tumor necrosis factor (alpha), interleukin-6, resistin, or adiponectin. Conclusions: These data support the hypothesis that insulin resistance in the skeletal muscle of insulin-resistant offspring of patients with type 2 diabetes is associated with dysregulation of intramyocellular fatty acid metabolism, possibly because of an inherited defect in mitochondrial oxidative phosphorylation.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Box 208020,300 Cedar St,S269 CAB, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK049230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00125, M01 RR000125] Funding Source: Medline; NIA NIH HHS [R01 AG-23686, R01 AG023686-01A1, R01 AG023686-02, R01 AG023686] Funding Source: Medline; NIDDK NIH HHS [K23 DK-02347, R01 DK-49230, R01 DK-063192, P30 DK045735, R01 DK049230, P30 DK-45735] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DIAMOND MP, 1993, J REPROD MED, V38, P417; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Krssak M, 1999, DIABETOLOGIA, V42, P386; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Luft R, 1993, Lakartidningen, V90, P2770; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; MEYER RA, 1985, AM J PHYSIOL, V248, pC279, DOI 10.1152/ajpcell.1985.248.3.C279; MILES J, 1983, J LIPID RES, V24, P96; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller YL, 2003, DIABETES, V52, P895, DOI 10.2337/diabetes.52.3.895; Nyholm B, 1997, DIABETES, V46, P1822, DOI 10.2337/diabetes.46.11.1822; Pajvani Utpal B, 2003, Curr Diab Rep, V3, P207, DOI 10.1007/s11892-003-0065-2; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; VANDENBORNE K, 1995, AM J PHYSIOL-CELL PH, V268, pC869, DOI 10.1152/ajpcell.1995.268.4.C869; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	44	1359	1401	1	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2004	350	7					664	671		10.1056/NEJMoa031314	http://dx.doi.org/10.1056/NEJMoa031314			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772YB	14960743	Green Accepted			2022-12-01	WOS:000188869500007
J	Gouin, E; Egile, C; Dehoux, P; Villiers, V; Adams, J; Gertler, F; Li, R; Cossart, P				Gouin, E; Egile, C; Dehoux, P; Villiers, V; Adams, J; Gertler, F; Li, R; Cossart, P			The RickA protein of Rickettsia conorii activates the Arp2/3 complex	NATURE			English	Article							MONOCYTOGENES ACTA PROTEIN; LISTERIA-MONOCYTOGENES; FIBROBLAST MOTILITY; WASP/SCAR PROTEINS; ENA/VASP PROTEINS; POLYMERIZATION; WASP; NUCLEATION; CORTACTIN; FILAMENTS	Actin polymerization, the main driving force for cell locomotion, is also used by the bacteria Listeria and Shigella and vaccinia virus for intracellular and intercellular movements(1,2). Seminal studies have shown the key function of the Arp2/3 complex in nucleating actin and generating a branched array of actin filaments during membrane extension and pathogen movement(3). Arp2/3 requires activation by proteins such as the WASP-family proteins or ActA of Listeria. We previously reported that actin tails of Rickettsia conorii, another intracellular bacterium, unlike those of Listeria, Shigella or vaccinia, are made of long unbranched actin filaments apparently devoid of Arp2/3 (ref. 4). Here we identify a R. conorii surface protein, RickA, that activates Arp2/3 in vitro, although less efficiently than ActA. In infected cells, Arp2/3 is detected on the rickettsial surface but not in actin tails. When expressed in mammalian cells and targeted to the membrane, RickA induces filopodia. Thus RickA-induced actin polymerization, by generating long actin filaments reminiscent of those present in filopodia, has potential as a tool for studying filopodia formation.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Harvard Medical School; Cleveland Clinic Foundation; Massachusetts Institute of Technology (MIT)	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, 28 Rue Docteur Roux, F-75015 Paris, France.	pcossart@pasteur.fr	Adams, Josephine C/B-1121-2009	Adams, Josephine C/0000-0002-2225-4947				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; David V, 1998, J CELL SCI, V111, P2877; FRIEDERICH E, 1995, EMBO J, V14, P2731, DOI 10.1002/j.1460-2075.1995.tb07274.x; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Gouin E, 1999, J CELL SCI, V112, P1697; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lamarche N, 1996, BIOCHEM J, V320, P129, DOI 10.1042/bj3200129; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Van Kirk LS, 2000, INFECT IMMUN, V68, P4706, DOI 10.1128/IAI.68.8.4706-4713.2000; VanTroys M, 1996, EMBO J, V15, P201, DOI 10.1002/j.1460-2075.1996.tb00350.x; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8	29	194	200	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					457	461		10.1038/nature02318	http://dx.doi.org/10.1038/nature02318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749835				2022-12-01	WOS:000188470500047
J	Mennink-Kersten, MASH; Klont, RR; Warris, A; Op den Camp, HJM; Verweij, PE				Mennink-Kersten, MASH; Klont, RR; Warris, A; Op den Camp, HJM; Verweij, PE			Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection	LANCET			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INVASIVE ASPERGILLOSIS; CIRCULATING GALACTOMANNAN; PLATELIA(R) ASPERGILLUS; EARLY-DIAGNOSIS; INFANTS	A major difficulty with the detection of circulating galactomannan, a cell-wall polysaccharide released by Aspergillus sp during growth, in the serodiagnosis of invasive aspergillosis is the occurrence of false-positive ELISA results, especially in neonates and infants. On the basis of molecule similarity, we postulate that a lipotelchoic acid of Bifidobacterium sp can act as epitope for the monoclonal antibody used in the ELISA. The neonatal gut is heavily colonised with Bifidobacterium sp and these bacteria or their lipoteichoic acid might cause ELISA reactivity with serum after translocation because of immaturity of the intestinal mucosa. If our hypothesis is correct, we might find a method to discriminate between false-positive and true-positive ELISA results and thereby prevent unnecessary pre-emptive treatment of patients.	Univ Med Ctr Nijmegen, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands; Univ Nijmegen, Dept Microbiol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Mennink-Kersten, MASH (corresponding author), Univ Med Ctr Nijmegen, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Warris, Adilia/F-4882-2010; Verweij, P.E./H-8108-2014; Warris, A./L-4745-2015; Camp, Huub J.M. Op den/F-5114-2011	Verweij, P.E./0000-0002-8600-9860; Camp, Huub J.M. Op den/0000-0003-1990-9030; Warris, Adilia/0000-0001-6586-3358				Ansorg R, 1997, MYCOSES, V40, P353, DOI 10.1111/j.1439-0507.1997.tb00249.x; Denning DW, 2000, LANCET, V355, P423, DOI 10.1016/S0140-6736(00)82003-6; Duffy LC, 2000, J NUTR, V130, p432S, DOI 10.1093/jn/130.2.432S; FISCHER W, 1987, EUR J BIOCHEM, V165, P639, DOI 10.1111/j.1432-1033.1987.tb11488.x; HUSBY S, 1985, SCAND J IMMUNOL, V22, P83, DOI 10.1111/j.1365-3083.1985.tb01862.x; IWASAKI H, 1990, J BACTERIOL, V172, P845, DOI 10.1128/jb.172.2.845-852.1990; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Letscher-Bru V, 1998, J MYCOL MED, V8, P112; Locascio M, 2001, CAN J MICROBIOL, V47, P1048, DOI 10.1139/cjm-47-11-1048; Maertens J, 2002, J INFECT DIS, V186, P1297, DOI 10.1086/343804; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Naaber P, 2000, J MED MICROBIOL, V49, P431, DOI 10.1099/0022-1317-49-5-431; Requena T, 2002, APPL ENVIRON MICROB, V68, P2420, DOI 10.1128/AEM.68.5.2420-2427.2002; Rohrlich P, 1996, PEDIATR INFECT DIS J, V15, P232, DOI 10.1097/00006454-199603000-00011; Siemann M, 1998, MYCOSES, V41, P373, DOI 10.1111/j.1439-0507.1998.tb00356.x; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Sulahian A, 2001, CANCER-AM CANCER SOC, V91, P311, DOI 10.1002/1097-0142(20010115)91:2<311::AID-CNCR1003>3.0.CO;2-3; Swanink CMA, 1997, J CLIN MICROBIOL, V35, P257, DOI 10.1128/JCM.35.1.257-260.1997; WARRIS A, 2001, 41 INT C ANT AG CHEM, P387	20	87	101	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2004	363	9405					325	327		10.1016/S0140-6736(03)15393-7	http://dx.doi.org/10.1016/S0140-6736(03)15393-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766FQ	14751710				2022-12-01	WOS:000188361400028
J	Hall, IP				Hall, IP			The beta-agonist controversy revisited	LANCET			English	Editorial Material							ASTHMA; RECEPTORS		Univ Nottingham Hosp, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England	University of Nottingham	Hall, IP (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England.	ian.hall@nottingham.ac.uk		Hall, Ian/0000-0001-9933-3216				Beasley R, 1999, J ALLERGY CLIN IMMUN, V104, pS18, DOI 10.1016/S0091-6749(99)70270-8; Fenech A, 2002, BRIT J CLIN PHARMACO, V53, P3, DOI 10.1046/j.0306-5251.2001.01509.x; McGraw DW, 1999, J BIOL CHEM, V274, P32241, DOI 10.1074/jbc.274.45.32241; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; OCONNOR BJ, 1992, NEW ENGL J MED, V327, P1204, DOI 10.1056/NEJM199210223271704; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; VATHENEN AS, 1998, LANCET, V351, P554	7	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 17	2004	363	9404					183	184		10.1016/S0140-6736(03)15369-X	http://dx.doi.org/10.1016/S0140-6736(03)15369-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765AG	14738788				2022-12-01	WOS:000188243900005
J	Egea, PF; Shan, SO; Napetschnig, J; Savage, DF; Walter, P; Stroud, RM				Egea, PF; Shan, SO; Napetschnig, J; Savage, DF; Walter, P; Stroud, RM			Substrate twinning activates the signal recognition particle and its receptor	NATURE			English	Article							THERMUS-AQUATICUS FFH; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; CONSERVED GTPASE; NG DOMAIN; RIBOSOME; COMPLEX; BINDING	Signal sequences target proteins for secretion from cells or for integration into cell membranes. As nascent proteins emerge from the ribosome, signal sequences are recognized by the signal recognition particle (SRP), which subsequently associates with its receptor (SR). In this complex, the SRP and SR stimulate each other's GTPase activity, and GTP hydrolysis ensures unidirectional targeting of cargo through a translocation pore in the membrane. To define the mechanism of reciprocal activation, we determined the 1.9 Angstrom structure of the complex formed between these two GTPases. The two partners form a quasi-two-fold symmetrical heterodimer. Biochemical analysis supports the importance of the extensive interaction surface. Complex formation aligns the two GTP molecules in a symmetrical, composite active site, and the 3' OH groups are essential for association, reciprocal activation and catalysis. This unique circle of twinned interactions is severed twice on hydrolysis, leading to complex dissociation after cargo delivery.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute	Egea, PF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	pascal@mnsg.ucsf.edu; stroud@msg.ucsf.edu	Stroud, Rhonda M./C-5503-2008; Egea, Pascal Francois/AAI-2759-2020; Stroud, Rhonda/GQZ-0151-2022; egea, pascal/V-7662-2019	Stroud, Rhonda M./0000-0001-5242-8015; Stroud, Rhonda/0000-0001-5242-8015; egea, pascal/0000-0003-4432-8625				Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delano W. L., 2003, PYMOL MOL GENETICS G; FOCIA PJ, IN PRESS SCIENCE; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Montoya G, 2000, STRUCTURE, V8, P515, DOI 10.1016/S0969-2126(00)00131-3; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; MUELLER K, 1988, B SOC CHIM BELG, V97, P655; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan S, 2001, STRUCTURE, V9, P859, DOI 10.1016/S0969-2126(01)00641-4; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; PHILIPSSEN A, 2002, DINO VISUALIZING STR; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Ramirez UD, 2002, J MOL BIOL, V320, P783, DOI 10.1016/S0022-2836(02)00476-X; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Rinke-Appel J, 2002, RNA, V8, P612, DOI 10.1017/S1355838202020095; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Shepotinovskaya IV, 2002, BBA-PROTEIN STRUCT M, V1597, P107, DOI 10.1016/S0167-4838(02)00287-X; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Stroud RM, 1999, CURR OPIN STRUC BIOL, V9, P754, DOI 10.1016/S0959-440X(99)00040-8; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112	38	242	246	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					215	221		10.1038/nature02250	http://dx.doi.org/10.1038/nature02250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724630				2022-12-01	WOS:000188068100035
J	Chang, LY; Tsao, KC; Hsia, SH; Shih, SR; Huang, CG; Chan, WK; Hsu, KH; Fang, TY; Huang, YC; Lin, TY				Chang, LY; Tsao, KC; Hsia, SH; Shih, SR; Huang, CG; Chan, WK; Hsu, KH; Fang, TY; Huang, YC; Lin, TY			Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOUTH-DISEASE; PULMONARY-EDEMA; RISK-FACTORS; EPIDEMIC; FOOT; HAND; POLIOMYELITIS; SURVEILLANCE; SINGAPORE; OUTBREAK	Context Although enterovirus 71 has caused epidemics associated with significant morbidity and mortality, its transmission has not been thoroughly investigated. Objectives To investigate enterovirus 71 transmission and determine clinical outcomes within households. Design, Setting, and Participants Prospective family cohort study to investigate patients at a children's hospital in Taiwan and family members of these patients who had signs and symptoms suggestive of enterovirus 71 between February 2001 and August 2002. Patients and household members underwent clinical evaluations, virological studies, questionnaire-based interviews, and were followed up for 6 months. Main Outcome Measures Enterovirus 71 infection, defined as a positive viral culture from a throat or rectal swab, or the presence of IgM or a 4-fold increase in neutralizing antibody in serum; and clinical syndromes, defined as asymptomatic; uncomplicated symptomatic; and complicated; with unfavorable outcomes of sequelae or death. Results Ninety-four families (433 family members) had at least 1 family member with evidence of enterovirus 71 infection. The overall enterovirus 71 transmission rate to household contacts was 52% (176/339 household contacts). Transmission rates were 84% for siblings (70/83); 83%, cousins (19/23); 41%, parents (72/175); 28%, grandparents (10/36); and 26%, uncles and aunts (5/19). Of 183 infected children, 11 (6%) were asymptomatic and 133 (73%) had uncomplicated illnesses (hand, foot, and mouth disease, herpangina, nonspecific febrile illness, upper respiratory tract infection, enteritis, or viral exanthema). Twenty-one percent (39/183) experienced complicated syndromes including the central nervous system or cardiopulmonary failure. During the 6-month follow-up, 10 died and 13 had long-term sequelae consisting of dysfunction in swallowing, cranial nerve palsies, central hypoventilation, or limb weakness and atrophy. Age younger than 3 years was the most significant factor associated with an unfavorable outcome in children (P=.004). Among 87 infected adults, 46 (53%) were asymptomatic, 34 (39%) had nonspecific illnesses of fever, sore throat, or gastrointestinal discomfort, and 7 (8%) had hand, foot, and mouth disease. There were no complicated cases in adults. Conclusions Enterovirus 71 household transmission rates were high for children in Taiwan and severe disease with serious complications, sequelae, and death occurred frequently. in contrast, adults had a much lower rate of acquisition of the infection and much less adverse sequelae.	Chang Gung Univ, Chang Gung Childrens Hosp, Dept Pediat, Kweishan, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Kweishan, Taiwan; Chang Gung Mem Hosp, Clin Virol Lab, Kweishan, Taiwan; Chang Gung Univ, Dept Hlth Care Management, Kweishan, Taiwan; Chang Gung Univ, Lab Epidemiol, Sch Med Technol, Kweishan, Taiwan; Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Lin, TY (corresponding author), Chang Gung Univ, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, 5 Fu Hsing St, Taoyuan 333, Taiwan.		Shih, Shin-Ru/M-9711-2016	Shih, Shin-Ru/0000-0003-4874-401X; Chan, Wing-Kai/0000-0002-5328-548X; CHANG, LUAN-YIN/0000-0003-2632-1956; Hsu, Kuang-Hung/0000-0003-2642-7689				[Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P629; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Dolin R, 1999, NEW ENGL J MED, V341, P984, DOI 10.1056/NEJM199909233411309; GELFAND HM, 1957, AM J HYG, V65, P367, DOI 10.1093/oxfordjournals.aje.a119876; Grandien M, 1995, DIAGNOSTIC PROCEDURE, P279; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; KOGON A, 1969, AM J EPIDEMIOL, V89, P51, DOI 10.1093/oxfordjournals.aje.a120915; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; MORENS DM, 1991, TXB HUMAN VIROLOGY, P427; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SCHNURR D, 1992, P351; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Tsao KC, 2002, J MED VIROL, V68, P574, DOI 10.1002/jmv.10233; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	24	147	181	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2004	291	2					222	227		10.1001/jama.291.2.222	http://dx.doi.org/10.1001/jama.291.2.222			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762YZ	14722149				2022-12-01	WOS:000188040900031
J	Greenland, P; LaBree, L; Azen, SP; Doherty, TM; Detrano, RC				Greenland, P; LaBree, L; Azen, SP; Doherty, TM; Detrano, RC			Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAM COMPUTED-TOMOGRAPHY; C-REACTIVE PROTEIN; HEART-DISEASE; PROGNOSTIC VALUE; PLAQUE RUPTURE; EVENTS; CALCIFICATION; PREVENTION; PROFILE; PEOPLE	Context Guidelines advise that all adults undergo coronary heart disease (CHD) risk assessment to guide preventive treatment intensity. Although the Framingham Risk Score (FRS) is often recommended for this, it has been suggested that risk assessment may be improved by additional tests such as coronary artery calcium scoring (CACS). Objectives To determine whether CACS assessment combined with FIRS in asymptomatic adults provides prognostic information superior to either method alone and whether the combined approach can more accurately guide primary preventive strategies in patients with CHID risk factors. Design, Setting, and Participants Prospective observational population-based study, of 146 asymptomatic adults with coronary risk factors. Participants with at least 1 coronary risk factor (>45 years) underwent computed tomography (CT) examination, were screened between 1990-1992, were contacted yearly for up to 8.5 years after CT scan, and were assessed for CHID. This analysis included 1312 participants with CACS results; excluded were 269 participants with diabetes and 14 participants with either missing data or had a coronary event before CACS was performed. Main Outcome Measure Nonfatal myocardial infarction (MI) or CHID death. Results During a median of 7.0 years of follow-up, 84 patients experienced MI or CHID death; 70 patients died of any cause. There were 291 (28%) participants with an FRS of more than 20% and 221 (21%) with a CACS of more than 300. Compared with an FRS of less than 10%, an FIRS of more than 20% predicted the risk of MI or CHID death (hazard ratio [HR], 14.3; 95% confidence interval [CI]; 2.0-104; P=.009). Compared with a CACS of zero, a CACS of more than 300 was predictive (HR, 3.9; 95% CI, 2.1-7.3; P<.001). Across categories of FIRS, CACS was predictive of risk among patients with an FRS higher than 10% (P<.001) but not with an FIRS less than 10%. Conclusion These data support the hypothesis that high CACS can modify predicted risk obtained from FIRS alone, especially among patients in the intermediate-risk category in whom clinical decision making is most uncertain.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Stat Consultat & Res Ctr, Los Angeles, CA USA; Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA USA; Harbor UCLA Res & Educ Inst, Dept Med, Torrance, CA USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Southern California; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Detrano, RC (corresponding author), Harbor UCLA Med Ctr, Div Cardiol, Bldg RB-2,1135 W Carson St, Torrance, CA 90502 USA.	rdetrano@rei.edu	Greenland, Philip/ABD-5528-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063963] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alexopoulos D, 2003, AM HEART J, V145, P542, DOI 10.1067/mhj.2003.169; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Detrano RC, 1999, CIRCULATION, V99, P2633, DOI 10.1161/01.CIR.99.20.2633; Doherty TM, 1999, J AM COLL CARDIOL, V34, P787, DOI 10.1016/S0735-1097(99)00258-2; DOHERTY TM, 1994, CALCIFIED TISSUE INT, V54, P224, DOI 10.1007/BF00301683; Doherty TM, 1999, LANCET, V353, P41, DOI 10.1016/S0140-6736(05)74866-2; Doherty TM, 1999, AM HEART J, V137, P806, DOI 10.1016/S0002-8703(99)70403-5; Forrester JS, 2002, ANN INTERN MED, V137, P823, DOI 10.7326/0003-4819-137-10-200211190-00012; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Hawthorne V, 2002, HEART, V88, P222; Hecht H, 2003, CIRCULATION, V107, pE123, DOI 10.1161/01.CIR.0000071215.79943.0C; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; O'Malley PG, 2003, JAMA-J AM MED ASSOC, V289, P2215, DOI 10.1001/jama.289.17.2215; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; Park R, 2002, CIRCULATION, V106, P2073, DOI 10.1161/01.CIR.0000033819.29662.09; Qu WC, 2003, DIABETES CARE, V26, P905, DOI 10.2337/diacare.26.3.905; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Rupard EJ, 2002, MIL MED, V167, P211, DOI 10.1093/milmed/167.3.211; Secci A, 1997, CIRCULATION, V96, P1122, DOI 10.1161/01.CIR.96.4.1122; Shah PK, 2002, PROG CARDIOVASC DIS, V44, P357, DOI 10.1053/pcad.2002.123473; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Smith S C Jr, 2000, Circulation, V101, P111; Wang SJ, 1996, AM HEART J, V132, P550, DOI 10.1016/S0002-8703(96)90237-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 1996, AM J CARDIOL, V78, P1220, DOI 10.1016/S0002-9149(96)00599-1; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6	32	1330	1366	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2004	291	2					210	215		10.1001/jama.291.2.210	http://dx.doi.org/10.1001/jama.291.2.210			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762YZ	14722147				2022-12-01	WOS:000188040900029
J	Tong, S; Marjono, B; Brown, DA; Mulvey, S; Breit, SN; Manuelpillai, U; Wallace, EM				Tong, S; Marjono, B; Brown, DA; Mulvey, S; Breit, SN; Manuelpillai, U; Wallace, EM			Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage	LANCET			English	Article							PREGNANCY	Macrophage inhibitory cytokine 1 (MIC 1) is thought to have immunomodulatory actions favouring fetal viability. We measured serum concentrations of MIC 1 in asymptomatic women at 6-13 weeks' gestation who subsequently miscarried or who had already miscarried. MIC 1 concentrations in the miscarriage cohort (n=100), were a third of those who had ongoing pregnancies (n=197). Multiples of the median for miscarriage was 0.32 (95% CI 0.23-0.32) versus 1.00 (0.93-1.06) for ongoing pregnancies; p<0.0001. Concentrations were just as low 3 weeks before diagnosis as on the day of diagnosis. That MIC 1 serum concentrations seem to be low weeks before miscarriage suggests possible predictive and causative roles, as well as therapeutic potential.	Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia; Univ New S Wales, Sydney, NSW 2010, Australia	Monash University; St Vincents Hospital Sydney; University of New South Wales Sydney	Wallace, EM (corresponding author), Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, 246 Clayton Rd, Clayton, Vic 3168, Australia.		Wallace, Euan M/K-6774-2015	Wallace, Euan M/0000-0002-4506-5233; Tong, Stephen/0000-0002-2319-0586; Brown, David/0000-0003-1382-9419				Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Makhseed M, 2000, HUM REPROD, V15, P2011, DOI 10.1093/humrep/15.9.2011; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	5	70	76	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 10	2004	363	9403					129	130		10.1016/S0140-6736(03)15265-8	http://dx.doi.org/10.1016/S0140-6736(03)15265-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761WV	14726168				2022-12-01	WOS:000187939200012
J	Aizawa, H; Hu, SC; Bobb, K; Balakrishnan, K; Ince, G; Gurevich, I; Cowan, M; Ghosh, A				Aizawa, H; Hu, SC; Bobb, K; Balakrishnan, K; Ince, G; Gurevich, I; Cowan, M; Ghosh, A			Dendrite development regulated by CREST, a calcium-regulated transcriptional activator	SCIENCE			English	Article							SYNOVIAL SARCOMA TRANSLOCATION; CAM KINASE-IV; MEDIATED TRANSCRIPTION; CBP; PROTEIN; SYT; COACTIVATOR; SSX; P300	The lasting effects of neuronal activity on brain development involve calcium-dependent gene expression. Using a strategy called transactivator trap, we cloned a calcium-responsive transactivator called CREST (for calcium-responsive transactivator). CREST is a SYT-related nuclear protein that interacts with adenosine 3',5'-monophosphate (cAMP) response element binding protein (CREB)-binding protein (CBP) and is expressed in the developing brain. Mice that have a targeted disruption of the crest gene are viable but display defects in cortical and hippocampal dendrite development. Cortical neurons from crest mutant mice are compromised in calcium-dependent dendritic growth. Thus, calcium activation of CREST-mediated transcription helps regulate neuronal morphogenesis.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Balakrishnan, Karthik/0000-0001-8409-227X; Ince Dunn, Gulayse/0000-0003-1352-990X	NIMH NIH HHS [MH60598] Funding Source: Medline; NINDS NIH HHS [NS39993] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039993] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZAWA H, UNPUB; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hu S.-J., UNPUB; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Ptashne M., 1992, A GENETIC SWITCH; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	22	210	223	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					197	202		10.1126/science.1089845	http://dx.doi.org/10.1126/science.1089845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716005				2022-12-01	WOS:000187908500039
J	Lum, PY; Armour, CD; Stepaniants, SB; Cavet, G; Wolf, MK; Butler, JS; Hinshaw, JC; Garnier, P; Prestwich, GD; Leonardson, A; Garrett-Engele, P; Rush, CM; Bard, M; Schimmack, G; Phillips, JW; Roberts, CJ; Shoemaker, DD				Lum, PY; Armour, CD; Stepaniants, SB; Cavet, G; Wolf, MK; Butler, JS; Hinshaw, JC; Garnier, P; Prestwich, GD; Leonardson, A; Garrett-Engele, P; Rush, CM; Bard, M; Schimmack, G; Phillips, JW; Roberts, CJ; Shoemaker, DD			Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes	CELL			English	Article							CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; RIBOSOME BIOGENESIS; MOLECULAR-CLONING; PROTEIN; GENE; MOLSIDOMINE; 5-FLUOROURACIL; PROLIFERATION; MICROARRAYS	Modern medicine faces the challenge of developing safer and more effective therapies to treat human diseases. Many drugs currently in use were discovered without knowledge of their underlying molecular mechanisms. Understanding their biological targets and modes of action will be essential to design improved second-generation compounds. Here, we describe the use of a genome-wide pool of tagged heterozygotes to assess the cellular effects of 78 compounds in Saccharomyces cerevisiae. Specifically, lanosterol synthase in the sterol biosynthetic pathway was identified as a target of the antianginal drug molsi- domine, which may explain its cholesterol-lowering effects. Further, the rRNA processing exosome was identified as a potential target of the cell growth inhibitor 5-fluorouracil. This genome-wide screen validated previously characterized targets or helped identify potentially new modes of action for over half of the compounds tested, providing proof of this principle for analyzing the modes of action of clinically relevant compounds.	Rosetta Inpharmat LLC, Kirkland, WA 98034 USA; Merck & Co Inc, Rahway, NJ 07065 USA; Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, JP Wilmot Canc Ctr, Rochester, NY 14642 USA; Indiana Univ, Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA	Merck & Company; Merck & Company; University of Rochester; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Utah System of Higher Education; University of Utah	Lum, PY (corresponding author), Rosetta Inpharmat LLC, 12040 115th Ave NE, Kirkland, WA 98034 USA.	pek_lum@merck.com; shoemakd@stanford.alumni.org			NCI NIH HHS [R01 CA095913, CA95913] Funding Source: Medline; NIGMS NIH HHS [R01 GM059898, GM44836, GM59898, GM62104] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044836, R01GM059898, R01GM062104] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE I, 1995, P NATL ACAD SCI USA, V92, P9274, DOI 10.1073/pnas.92.20.9274; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BAL M, 1998, BIOCHEM BIOPH RES CO, V185, P323; BARNES G, 1984, MOL CELL BIOL, V4, P2381, DOI 10.1128/MCB.4.11.2381; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; CHASSOUX G, 1998, J CARDIOVASC PHA S11, V14, pS137; COREY EJ, 1994, P NATL ACAD SCI USA, V91, P2211, DOI 10.1073/pnas.91.6.2211; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; ENGELBRECHT C, 1984, BIOCHEM PHARMACOL, V33, P745, DOI 10.1016/0006-2952(84)90457-X; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Gilman A.G., 2001, GOODMAN GILMANS PHAR; GLAEVER G, 1999, NAT GENET, V21, P278; GRANZER E, 1984, ARZNEIMITTEL-FORSCH, V34-1, P191; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HUANG T, 1992, GENE, V121, P167, DOI 10.1016/0378-1119(92)90177-Q; Huels C, 2002, DRUG DISCOV TODAY, V7, pS119, DOI 10.1016/S1359-6446(02)02389-9; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MacBeath G, 2000, SCIENCE, V289, P1760; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Moebius FF, 1996, BIOCHEMISTRY-US, V35, P16871, DOI 10.1021/bi961996m; MONK BC, 1995, BBA-BIOMEMBRANES, V1239, P81, DOI 10.1016/0005-2736(95)00133-N; Nardese V, 1996, BIOCHEM BIOPH RES CO, V218, P273, DOI 10.1006/bbrc.1996.0048; NEFF NF, 1983, CELL, V33, P211, DOI 10.1016/0092-8674(83)90350-1; OCHS D, 1992, J BACTERIOL, V174, P298, DOI 10.1128/jb.174.1.298-302.1992; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; PARK JH, 1990, INT J GERIATR PSYCH, V5, P381, DOI 10.1002/gps.930050606; Patel O, 2003, MICROB DRUG RESIST, V9, P139, DOI 10.1089/107662903765826723; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pritchard DM, 1997, P NATL ACAD SCI USA, V94, P1795, DOI 10.1073/pnas.94.5.1795; REDEN J, 1990, BLOOD VESSELS, V27, P282; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; RITTBERG DAH, 1989, BIOCHEM CELL BIOL, V67, P352, DOI 10.1139/o89-055; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Service RF, 2000, SCIENCE, V289, P1673, DOI 10.1126/science.289.5485.1673; Soler F, 2000, J BIOENERG BIOMEMBR, V32, P133, DOI 10.1023/A:1005519312463; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; STOCKLEIN W, 1980, ANTIMICROB AGENTS CH, V18, P863, DOI 10.1128/AAC.18.6.863; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; SUN C, 1994, EMBO J, V13, P3127, DOI 10.1002/j.1460-2075.1994.tb06611.x; TANAYAMA S, 1974, XENOBIOTICA, V4, P175, DOI 10.3109/00498257409049357; TRUAN G, 1994, GENE, V142, P129; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Weir IE, 2003, CYTOM PART A, V54A, P109, DOI 10.1002/cyto.a.10054; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; WILSON ID, 1987, XENOBIOTICA, V17, P93, DOI 10.3109/00498258709047179; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YOSHIDA S, 1992, MOL GEN GENET, V231, P337, DOI 10.1007/BF00292700; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	68	366	388	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2004	116	1					121	137		10.1016/S0092-8674(03)01035-3	http://dx.doi.org/10.1016/S0092-8674(03)01035-3			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718172	Bronze			2022-12-01	WOS:000187960800014
J	Baksh, MM; Jaros, M; Groves, JT				Baksh, MM; Jaros, M; Groves, JT			Detection of molecular interactions at membrane surfaces through colloid phase transitions	NATURE			English	Article							MODEL SYSTEM; RESONANCE; GLASS	The molecular architecture of - and biochemical processes within - cell membranes play important roles in all living organisms, with many drugs and infectious disease agents targeting membranes. Experimental studies of biochemical reactions on membrane surfaces are challenging, as they require a membrane environment that is fluid ( like cell membranes) but nevertheless allows for the efficient detection and characterization of molecular interactions. One approach uses lipid membranes supported on solid substrates such as silica or polymers(1,2): although the membrane is trapped near the solid interface, it retains natural fluidity and biological functionality(3) and can be implanted with membrane proteins for functional studies(4). But the detection of molecular interactions involving membrane-bound species generally requires elaborate techniques, such as surface plasmon resonance(5) or total internal reflection fluorescence microscopy(6). Here we demonstrate that colloidal phase transitions of membrane-coated silica beads provide a simple and label-free method for monitoring molecular interactions on lipid membrane surfaces. By adjusting the lipid membrane composition and hence the pair interaction potential between the membrane-supporting silica beads, we poise our system near a phase transition so that small perturbations on the membrane surface induce dramatic changes in the macroscopic organization of the colloid. We expect that this approach, used here to probe with high sensitivity protein binding events at membrane surfaces, can be applied to study a broad range of cell membrane processes.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	JTGroves@lbl.gov						Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; BAYERL TM, 1990, BIOPHYS J, V58, P357, DOI 10.1016/S0006-3495(90)82382-1; Buranda T, 2003, LANGMUIR, V19, P1654, DOI 10.1021/la026405+; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Fang Y, 2002, J AM CHEM SOC, V124, P2394, DOI 10.1021/ja017346+; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2002, CURR OPIN DRUG DISC, V5, P606; Hoffman TL, 2000, P NATL ACAD SCI USA, V97, P11215, DOI 10.1073/pnas.190274097; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Ramos L, 1999, SCIENCE, V286, P2325, DOI 10.1126/science.286.5448.2325; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Wong AP, 2002, P NATL ACAD SCI USA, V99, P14147, DOI 10.1073/pnas.212392599; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o; Yethiraj A, 2003, NATURE, V421, P513, DOI 10.1038/nature01328	16	182	187	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					139	141		10.1038/nature02209	http://dx.doi.org/10.1038/nature02209			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712272				2022-12-01	WOS:000187863900031
J	Martin, MP; O'Neill, D				Martin, MP; O'Neill, D			Vascular higher-level gait disorders - a step in the right direction?	LANCET			English	Editorial Material							TRIAL		Adelaide & Meath Hosp Dublin, Trinity Coll Dublin, Dept Med Gerontol, Dublin 24, Ireland	Trinity College Dublin	Martin, MP (corresponding author), Adelaide & Meath Hosp Dublin, Trinity Coll Dublin, Dept Med Gerontol, Dublin 24, Ireland.		O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Alexander NB, 1996, CLIN GERIATR MED, V12, P689; Baezner H, 2001, CEREBROVASC DIS, V11, P235, DOI 10.1159/000047645; JANTRA P, 1992, ARCH PHYS MED REHAB, V73, P95; Kenny RA, 1996, SYNCOPE OLDER PATIEN; Liston R, 2003, AGE AGEING, V32, P252, DOI 10.1093/ageing/32.3.252; MEYER JS, 1986, JAMA-J AM MED ASSOC, V256, P2203, DOI 10.1001/jama.256.16.2203; Mickelborough Jane, 1997, Physiotherapy Theory and Practice, V13, P127; Nikolaus T, 2003, J AM GERIATR SOC, V51, P300, DOI 10.1046/j.1532-5415.2003.51102.x; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; SUDARSKY L, 1983, ARCH NEUROL-CHICAGO, V40, P740, DOI 10.1001/archneur.1983.04050110058009; WILKIESON CA, 1994, REV CLIN GERONTOL, V4, P31	11	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 3	2004	363	9402					8	8		10.1016/S0140-6736(03)15246-4	http://dx.doi.org/10.1016/S0140-6736(03)15246-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758YZ	14723986				2022-12-01	WOS:000187711300007
J	Pawlowski, WP; Golubovskaya, IN; Timofejeva, L; Meeley, RB; Sheridan, WF; Cande, WZ				Pawlowski, WP; Golubovskaya, IN; Timofejeva, L; Meeley, RB; Sheridan, WF; Cande, WZ			Coordination of meiotic recombination, pairing, and synapsis by PHS1	SCIENCE			English	Article							CHROMOSOME SYNAPSIS; HOMOLOGOUS CHROMOSOMES; MEIOSIS; PROTEIN; GENE; YEAST; DMC1; ARABIDOPSIS; MOUSE; PROGRESSION	Pairing, synapsis, and recombination are prerequisites for accurate chromosome segregation in meiosis. The phs1 gene in maize is required for pairing to occur between homologous chromosomes. In the phs1 mutant, homologous chromosome synapsis is completely replaced by synapsis between nonhomologous partners. The phs1 gene is also required for installation of the meiotic recombination machinery on chromosomes, as the mutant almost completely lacks chromosomal foci of the recombination protein RAD51. Thus, in the phs1 mutant, synapsis is uncoupled from recombination and pairing. The protein encoded by the phs1 gene likely acts in a multistep process to coordinate pairing, recombination, and synapsis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA; Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; DuPont; University of North Dakota Grand Forks	Pawlowski, WP (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.							Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Caryl AP, 2000, CHROMOSOMA, V109, P62, DOI 10.1007/s004120050413; DEJONG JH, 1991, GENOME, V34, P109, DOI 10.1139/g91-018; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Golubovskaya IN, 2002, GENETICS, V162, P1979; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; LOIDL J, 1991, CHROMOSOMA, V100, P221, DOI 10.1007/BF00344155; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Moens PB, 2002, J CELL SCI, V115, P1611; Nabeshima K, 2001, EMBO J, V20, P3871, DOI 10.1093/emboj/20.14.3871; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Schommer C, 2003, PLANT J, V36, P1, DOI 10.1046/j.1365-313X.2003.01850.x; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	24	109	123	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					89	92		10.1126/science.1091110	http://dx.doi.org/10.1126/science.1091110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704428				2022-12-01	WOS:000187710600040
J	Qin, L; Kudla, U; Roze, EHA; Goverse, A; Popeijus, H; Nieuwland, J; Overmars, H; Jones, JT; Schots, A; Smant, G; Bakker, J; Helder, J				Qin, L; Kudla, U; Roze, EHA; Goverse, A; Popeijus, H; Nieuwland, J; Overmars, H; Jones, JT; Schots, A; Smant, G; Bakker, J; Helder, J			Plant degradation: A nematode expansin acting on plants	NATURE			English	Editorial Material							CELL WALLS		Univ Wageningen & Res Ctr, Nematol Lab, Grad Sch Expt Plant Sci, NL-6709 PD Wageningen, Netherlands; Univ Wageningen & Res Ctr, Lab Mol Recognit & Antibody Technol, Grad Sch Expt Plant Sci, NL-6709 PD Wageningen, Netherlands; Catholic Univ Nijmegen, Grad Sch Expt Plant Sci, Dept Expt Bot, NL-6525 ED Nijmegen, Netherlands; Scottish Crop Res Inst, Plant Pathogen Interact Programme, Dundee DD2 5DA, Scotland	Wageningen University & Research; Wageningen University & Research; Radboud University Nijmegen; James Hutton Institute	Qin, L (corresponding author), Univ Wageningen & Res Ctr, Nematol Lab, Grad Sch Expt Plant Sci, NL-6709 PD Wageningen, Netherlands.	hans.helder@wur.nl	Schots, Arjen/ABF-8014-2020; Schots, Arjen/U-1839-2017	Schots, Arjen/0000-0002-6036-7088; Schots, Arjen/0000-0002-6036-7088; Jones, John/0000-0003-2074-0551				Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Davies M, 2000, S AFR J SURG, V38, P3; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Laine MJ, 2000, PHYSIOL MOL PLANT P, V57, P221, DOI 10.1006/pmpp.2000.0301; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Qin L, 2000, MOL PLANT MICROBE IN, V13, P830, DOI 10.1094/MPMI.2000.13.8.830; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Xu BZ, 2000, EUR J BIOCHEM, V267, P4970, DOI 10.1046/j.1432-1327.2000.01533.x	10	152	174	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					30	30		10.1038/427030a	http://dx.doi.org/10.1038/427030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702076	Bronze			2022-12-01	WOS:000187710000024
J	Tian, E; Zhan, FH; Walker, R; Rasmussen, E; Ma, YP; Barlogie, B; Shaughnessy, JD				Tian, E; Zhan, FH; Walker, R; Rasmussen, E; Ma, YP; Barlogie, B; Shaughnessy, JD			The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE MORPHOGENETIC PROTEIN-2; RECEPTOR-RELATED PROTEIN-5; GLOBAL GENE-EXPRESSION; STEM-CELL NICHE; OSTEOCLAST DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; QUANTITATIVE HISTOLOGY; MONOCLONAL GAMMOPATHY; LIGAND; OSTEOPROTEGERIN	Background: Myeloma cells may secrete factors that affect the function of osteoblasts, osteoclasts, or both. Methods: We subjected purified plasma cells from the bone marrow of patients with newly diagnosed multiple myeloma and control subjects to oligonucleotide microarray profiling and biochemical and immunohistochemical analyses to identify molecular determinants of osteolytic lesions. Results: We studied 45 control subjects, 36 patients with multiple myeloma in whom focal lesions of bone could not be detected by magnetic resonance imaging (MRI), and 137 patients in whom MRI detected such lesions. Different patterns of expression of 57 of approximately 10,000 genes from purified myeloma cells could be used to distinguish the two groups of patients (P<0.001). Permutation analysis, which adjusts the significance level to account for multiple comparisons in the data sets, showed that 4 of these 57 genes were significantly overexpressed by plasma cells from patients with focal lesions. One of these genes, dickkopf 1 (DKK1), and its corresponding protein (DKK1) were studied in detail because DKK1 is a secreted factor that has been linked to the function of osteoblasts. Immunohistochemical analysis of bone marrow-biopsy specimens showed that only myeloma cells contained detectable DKK1. Elevated DKK1 levels in bone marrow plasma and peripheral blood from patients with multiple myeloma correlated with the gene-expression patterns of DKK1 and were associated with the presence of focal bone lesions. Recombinant human DKK1 or bone marrow serum containing an elevated level of DKK1 inhibited the differentiation of osteoblast precursor cells in vitro. Conclusions: The production of DKK1, an inhibitor of osteoblast differentiation, by myeloma cells is associated with the presence of lytic bone lesions in patients with multiple myeloma.	Univ Arkansas Med Sci, Donna D & Donald M Lambert Lab Myeloma Genet, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Coll Med, Dept Radiol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Coll Med, Dept Pathol, Little Rock, AR 72205 USA; Canc Res & Biostat, Seattle, WA USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Cancer Research & Biostatistics	Shaughnessy, JD (corresponding author), Univ Arkansas Med Sci, Donna D & Donald M Lambert Lab Myeloma Genet, Myeloma Inst Res & Therapy, 4301 W Markham St 776, Little Rock, AR 72205 USA.			Zhan, Fenghuang/0000-0001-6208-1676	NCI NIH HHS [CA55819, CA97513] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA055819, R33CA097513] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; BARLOGIE B, IN PRESS BLOOD; BATAILLE R, 1990, BRIT J HAEMATOL, V76, P484, DOI 10.1111/j.1365-2141.1990.tb07904.x; BATAILLE R, 1986, BRIT J CANCER, V53, P805, DOI 10.1038/bjc.1986.136; BATAILLE R, 1991, J CLIN INVEST, V88, P62, DOI 10.1172/JCI115305; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KATAGIRI T, 1995, J CELL BIOL, V128, pA713; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; ROUX C, 1994, BONE, V15, P41, DOI 10.1016/8756-3282(94)90890-7; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Shaughnessy J, 2003, BLOOD, V101, P3849, DOI 10.1182/blood-2002-09-2873; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; VALENTINOPRAN A, 1982, BRIT J HAEMATOL, V52, P601, DOI 10.1111/j.1365-2141.1982.tb03936.x; Westfall P., 1993, RESAMPLING BASED MUL, P360; Yaccoby S, 2002, BLOOD, V100, p607A; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	1109	1220	0	59	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2003	349	26					2483	2494		10.1056/NEJMoa030847	http://dx.doi.org/10.1056/NEJMoa030847			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757BT	14695408				2022-12-01	WOS:000187529500003
J	Weitz, G				Weitz, G			Love and death in Wagner's Tristan und Isolde - an epic anticholinergic crisis	BRITISH MEDICAL JOURNAL			English	Article							NIGHTSHADE; INGESTION		Med Univ Schleswig Holstein, Dept Internal Med 1, D-23538 Lubeck, Germany	University of Kiel; Schleswig Holstein University Hospital	Weitz, G (corresponding author), Med Univ Schleswig Holstein, Dept Internal Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.							BETZ P, 1991, Archiv fuer Kriminologie, V188, P175; Carter AJ, 1996, BRIT MED J, V313, P1630, DOI 10.1136/bmj.313.7072.1630; Chessick RD, 1990, PSYCHOANALYTIC EXPLO, P465; COSMAN MP, 1983, ANNU REV NUTR, V3, P1, DOI 10.1146/annurev.nu.03.070183.000245; FUHNER H, 1926, ARCH EXP PATHOL PH, V111, P281; GEDIMAN HK, 1981, J AM PSYCHOANAL ASS, V29, P607, DOI 10.1177/000306518102900306; GOLDSMITH SR, 1968, J AMER MED ASSOC, V204, P169, DOI 10.1001/jama.204.2.169; GOWDY JM, 1972, J AMER MED ASSOC, V221, P585, DOI 10.1001/jama.221.6.585; HAULE J, 1990, DIVINE MADNESS ARCHE; HILL C, 1984, MUSIC REV, V45, P7; JACKSON S W, 1972, Journal of the History of Medicine and Allied Sciences, V27, P262; Karras DJ, 1996, AM J EMERG MED, V14, P478, DOI 10.1016/S0735-6757(96)90158-8; KNAPP R, 1984, MUS REV, V45, P10; MIKOLICH JR, 1975, ANN INTERN MED, V83, P321, DOI 10.7326/0003-4819-83-3-321; Muller JL, 1998, J TOXICOL-CLIN TOXIC, V36, P617, DOI 10.3109/15563659809028060; OBER PC, 1965, MONATSHEFTE DEUTSCHU, V57, P321; PAHLEN K, 1983, R WAGNER TRISTAN ISO; PIOMELLI D, 1994, HIST PHIL LIFE SCI, V16, P241; RICHEY J, 1994, MUS REV, V55, P97; SHAMPO MA, 1992, MAYO CLIN PROC, V67, P477, DOI 10.1016/S0025-6196(12)60396-6; Shannon M, 1999, J TOXICOL-CLIN TOXIC, V37, P709, DOI 10.1081/CLT-100102448; Volger Gisela, 1982, RAUSCH REALITAT DROG	22	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1469	1471		10.1136/bmj.327.7429.1469	http://dx.doi.org/10.1136/bmj.327.7429.1469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684652	Green Published			2022-12-01	WOS:000187562700023
J	Venter, H; Shilling, RA; Velamakanni, S; Balakrishnan, L; van Veen, HW				Venter, H; Shilling, RA; Velamakanni, S; Balakrishnan, L; van Veen, HW			An ABC transporter with a secondary-active multidrug translocator domain	NATURE			English	Article							P-GLYCOPROTEIN; FUNCTIONAL RECONSTITUTION; ANTIBIOTIC-RESISTANCE; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; INTRACELLULAR PH; DRUG TRANSPORT; BACTERIA; HOMOLOG; MSBA	Multidrug resistance, by which cells become resistant to multiple unrelated pharmaceuticals, is due to the extrusion of drugs from the cell's interior by active transporters such as the human multidrug resistance beta-glycoprotein(1). Two major classes of transporters mediate this extrusion(2,3). Primary-active transporters are dependent on ATP hydrolysis, whereas secondary-active transletters porters are driven by electrochemical ion gradients that exist across the plasma membrane. The ATP-binding cassette (ABC) transporter LmrA(4) is a primary drug transporter in Lactococcus lactis that can functionally substitute for P-glycoprotein in lung fibroblast cells(5). Here we have engineered a truncated LmrA protein that lacks the ATP-binding domain. Surprisingly, this truncated protein mediates a proton-ethidium symport reaction without the requirement for ATP. In other words, it functions as a secondary-active multidrug uptake system. These findings suggest that the evolutionary precursor of LmrA was a secondary-active substrate translocator that acquired an ATP-binding domain to enable primary-active multidrug efflux in L. lactis.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.		van Veen, Hendrik W./A-4162-2008; Venter, Rietie/E-4795-2013	van Veen, Hendrik W./0000-0002-9658-8077; Venter, Rietie/0000-0001-5569-7755				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; [Anonymous], [No title captured]; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Eytan GD, 1996, J BIOL CHEM, V271, P3172, DOI 10.1074/jbc.271.6.3172; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; Howard EM, 2003, BIOCHEMISTRY-US, V42, P3544, DOI 10.1021/bi026706i; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; KABACK HR, 1990, BACTERIA, V12, P151; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; Kuroda M, 1997, J BIOL CHEM, V272, P326; Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Putman M, 2000, MOL MICROBIOL, V36, P772, DOI 10.1046/j.1365-2958.2000.01871.x; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Santai CT, 1999, BIOCHEMISTRY-US, V38, P4227, DOI 10.1021/bi981930m; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; THIEBAUT F, 1990, J HISTOCHEM CYTOCHEM, V38, P685, DOI 10.1177/38.5.1692055; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; VANVEEN HW, 1993, J BIOL CHEM, V268, P19377; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668	26	96	98	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					866	870		10.1038/nature02173	http://dx.doi.org/10.1038/nature02173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685244				2022-12-01	WOS:000187342000065
J	Moller, C				Moller, C			Deafblindness: living with sensory deprivation	LANCET			English	Article									Sahlgrens Univ Hosp, Dept Audiol, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Moller, C (corresponding author), Sahlgrens Univ Hosp, Dept Audiol, S-41345 Gothenburg, Sweden.								0	34	35	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S46	S47						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698128				2022-12-01	WOS:000187790200024
J	Venter, JC; Remington, K; Heidelberg, JF; Halpern, AL; Rusch, D; Eisen, JA; Wu, DY; Paulsen, I; Nelson, KE; Nelson, W; Fouts, DE; Levy, S; Knap, AH; Lomas, MW; Nealson, K; White, O; Peterson, J; Hoffman, J; Parsons, R; Baden-Tillson, H; Pfannkoch, C; Rogers, YH; Smith, HO				Venter, JC; Remington, K; Heidelberg, JF; Halpern, AL; Rusch, D; Eisen, JA; Wu, DY; Paulsen, I; Nelson, KE; Nelson, W; Fouts, DE; Levy, S; Knap, AH; Lomas, MW; Nealson, K; White, O; Peterson, J; Hoffman, J; Parsons, R; Baden-Tillson, H; Pfannkoch, C; Rogers, YH; Smith, HO			Environmental genome shotgun sequencing of the Sargasso Sea	SCIENCE			English	Article							MARINE NITRIFYING BACTERIA; COMMUNITY STRUCTURE; DIVERSITY; PHOTOINHIBITION; PHOTOTROPHY; ABUNDANCE; NUMBER; OCEAN	We have applied "whole-genome shotgun sequencing" to microbial populations collected en masse on tangential flow and impact filters from seawater samples collected from the Sargasso Sea near Bermuda. A total of 1.045 billion base pairs of nonredundant sequence was generated, annotated, and analyzed to elucidate the gene content, diversity, and relative abundance of the organisms within these environmental samples. These data are estimated to derive from at least 1800 genomic species based on sequence relatedness, including 148 previously unknown bacterial phylotypes. We have identified over 1.2 million previously unknown genes represented in these samples, including more than 782 new rhodopsin-like photoreceptors. Variation in species present and stoichiometry suggests substantial oceanic microbial diversity.	Inst Biol Energy Alternat, Rockville, MD 20850 USA; Ctr Advancement Genom, Rockville, MD 20850 USA; Inst Genom Res, Rockville, MD 20850 USA; J Craig Venter Sci Fdn, Joint Technol Ctr, Rockville, MD 20850 USA; Univ So Calif, Los Angeles, CA 90089 USA; Bermuda Biol Stn Res Inc, St George GE01, Bermuda	J. Craig Venter Institute; J. Craig Venter Institute; J. Craig Venter Institute; J. Craig Venter Institute; University of Southern California	Venter, JC (corresponding author), Inst Biol Energy Alternat, 1901 Res Blvd, Rockville, MD 20850 USA.	jcventer@tcag.org	Parsons, Rachel J/B-1475-2016; WU, TAKLON/A-2827-2010; Eisen, Jonathan A./H-2706-2019; Paulsen, Ian T/K-3832-2012; Nelson, William C/E-9263-2016	Eisen, Jonathan A./0000-0002-0159-2197; Paulsen, Ian T/0000-0001-9015-9418; Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224; Lomas, Michael/0000-0003-1209-3753; Parsons, Rachel/0000-0003-3634-8220				ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; CHAO A, 1984, SCAND J STAT, V11, P265; CHRETIENNOTDINET MJ, 1995, PHYCOLOGIA, V34, P285, DOI 10.2216/i0031-8884-34-4-285.1; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Conte M, 1997, OCEANUS, V40, P15; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; delGiorgio PA, 1997, MICROBIAL ECOL, V34, P144; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Giovannoni S., 2000, P47; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P183, DOI 10.3354/meps141183; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P193, DOI 10.3354/meps141193; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hicks CL, 2000, AUST VET J, V78, P193, DOI 10.1111/j.1751-0813.2000.tb10593.x; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; KARLIN S, 1995, TRENDS GENET, V11, P283; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NEALSON KH, 2003, PROKARYOTES EVOLVING; PALENIK B, 1994, APPL ENVIRON MICROB, V60, P3212, DOI 10.1128/AEM.60.9.3212-3219.1994; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, DOI [10.1016/B978-0-08-030765-7.50010-6, DOI 10.1016/B978-0-08-030765-7.50010-6]; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Raymont J.E.G., 1980, PLANKTON PRODUCTIVIT; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Scanlan DJ, 1999, HYDROBIOLOGIA, V401, P149, DOI 10.1023/A:1003742528262; Scanlan DJ, 1997, APPL ENVIRON MICROB, V63, P2411, DOI 10.1128/AEM.63.6.2411-2420.1997; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X	40	2918	3173	21	755	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					66	74		10.1126/science.1093857	http://dx.doi.org/10.1126/science.1093857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15001713				2022-12-01	WOS:000220567900037
J	Logroscino, G; Kang, JH; Grodstein, F				Logroscino, G; Kang, JH; Grodstein, F			Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MELLITUS; INSULIN; POPULATION; HEALTH	Objective To examine the association of type 2 diabetes with baseline cognitive function and cognitive decline over two years of follow up, focusing on women living in the community and on the effects of treatments for diabetes. Design Nurses' health study in the United States. Two cognitive interview's were by carried out by telephone during 1995-2003. Participants 18 999 women aged 70-81 years who had been registered nurses completed the baseline interview; to date, 16 596 participants have completed follow up interviews after two years. Main outcome measures Cognitive assessments included telephone interview of cognitive status, immediate and delayed recalls of the East Boston memory test, test of verbal fluency, delayed recall of 10 word list, and digit span backwards. Global scores were calculated by averaging the results of all tests with z scores. Results After multivariate adjustment, women with type 2 diabetes performed worse on all cognitive tests than women without diabetes at baseline. For example, women with diabetes were at 25-35% increased odds of poor baseline score (defined as bottom 10% of the distribution) compared with women without diabetes on the telephone interview of cognitive status and the global composite score (odds ratios 1.34, 95% confidence interval 1.14 to 1.57, and 1.26,1.06 to 1.51, respectively). Odds of poor cognition were particularly high for women who had had diabetes for a long time (1.52,1.15 to 1.99, and 1.49, 1.11 to 2.00, respectively, for greater than or equal to 15 years' duration). In contrast, women with diabetes who were on oral hypoglycaemic agents performed similarly to women without diabetes (1.06 and 0.99), while women not using any medication had the greatest odds of poor performance (1.71,1.28 to 2.281, and 1.45,1.04 to 2.02) compared with women without diabetes. There was also a modest increase in odds of poor cognition among women using insulin treatment. All findings were similar when cognitive decline was examined over time. Conclusions Women with type 2 diabetes had increased odds of poor cognitive function and substantial cognitive decline. Use of oral hypoglycaemic therapy, however, may ameliorate risk.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Logroscino, G (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	glogrosc@hsph.harvard.edu	LOGROSCINO, GIANCARLO/K-5148-2016	LOGROSCINO, GIANCARLO/0000-0003-0423-3242	NCI NIH HHS [CA87969] Funding Source: Medline; NIA NIH HHS [AG15424] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015424] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Coker LH, 2003, J PSYCHOSOM RES, V54, P129, DOI 10.1016/S0022-3999(02)00523-8; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; KALMIJN S, 1995, DIABETOLOGIA, V38, P1096, DOI 10.1007/BF00402181; Kang JH, 2003, NEUROLOGY, V60, P1591; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Wu JH, 2003, ANN EPIDEMIOL, V13, P369, DOI 10.1016/S1047-2797(02)00464-7	14	138	163	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2004	328	7439					548	551		10.1136/bmj.37977.495729.EE	http://dx.doi.org/10.1136/bmj.37977.495729.EE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801JI	14980984	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000220091800017
J	Clavel, F; Hance, AJ				Clavel, F; Hance, AJ			Medical progress: HIV drug resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; HIGH-LEVEL RESISTANCE; REVERSE-TRANSCRIPTASE INHIBITORS; DYNAMICS IN-VIVO; PROTEASE INHIBITORS; CROSS-RESISTANCE; ANTIRETROVIRAL THERAPY; ZIDOVUDINE-RESISTANT; VIROLOGICAL FAILURE; HIV-1-INFECTED INDIVIDUALS		Hop Bichat Claude Bernard, INSERM, U552, IMEA,Unite Rech Antivirale, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Clavel, F (corresponding author), Hop Bichat Claude Bernard, INSERM, U552, IMEA,Unite Rech Antivirale, 46 Rue Henri Huchard, F-75018 Paris, France.	clavel@bichat.inserm.fr						Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Bleiber G, 2001, J VIROL, V75, P3291, DOI 10.1128/JVI.75.7.3291-3300.2001; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; BOYER PL, 1993, J VIROL, V67, P2412, DOI 10.1128/JVI.67.4.2412-2420.1993; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Chamberlain PP, 2002, J VIROL, V76, P10015, DOI 10.1128/JVI.76.19.10015-10019.2002; Charpentier C, 2002, ANTIVIR THER, V7, pS55; CHEN ZG, 1995, J BIOL CHEM, V270, P21433, DOI 10.1074/jbc.270.37.21942; Coakley EP, 2000, AIDS, V14, pF9, DOI 10.1097/00002030-200001280-00002; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; DeGruttola V, 2000, ANTIVIR THER, V5, P41; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Descamps D, 2000, JAMA-J AM MED ASSOC, V284, P1518; Descamps D, 1998, AIDS, V12, P1109; Descamps D, 1997, J VIROL, V71, P8893, DOI 10.1128/JVI.71.11.8893-8898.1997; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Doyon L, 1996, J VIROL, V70, P3763, DOI 10.1128/JVI.70.6.3763-3769.1996; Droz C, 2002, ANTIVIR THER, V7, pS146; Dulioust A, 1999, J VIROL, V73, P850, DOI 10.1128/JVI.73.1.850-854.1999; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; ERICE A, 1993, NEW ENGL J MED, V328, P1163, DOI 10.1056/NEJM199304223281605; ERICKSON J, 1994, ARCH VIROL, P19; Esnouf RM, 1997, P NATL ACAD SCI USA, V94, P3984, DOI 10.1073/pnas.94.8.3984; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hanna GJ, 2000, J INFECT DIS, V181, P904, DOI 10.1086/315329; Haubrich R, 2001, J ACQ IMMUN DEF SYND, V26, pS51, DOI 10.1097/00126334-200103011-00006; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hertogs K, 2000, AIDS, V14, P1203, DOI 10.1097/00002030-200006160-00018; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hong L, 2000, PROTEIN SCI, V9, P1898, DOI 10.1110/ps.9.10.1898; Hsiou Y, 2001, J MOL BIOL, V309, P437, DOI 10.1006/jmbi.2001.4648; *INT AIDS SOC US, 2002, HIV DRUG RES MUT; Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; KAPLAN AH, 1994, P NATL ACAD SCI USA, V91, P5597, DOI 10.1073/pnas.91.12.5597; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; Kilby JM, 2003, NEW ENGL J MED, V348, P2228, DOI 10.1056/NEJMra022812; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; Labrosse B, 2003, J VIROL, V77, P1610, DOI 10.1128/JVI.77.2.1610-1613.2003; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Miller V, 2001, ANTIVIR THER, V6, P25; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Picard V, 2001, J INFECT DIS, V184, P781, DOI 10.1086/323088; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; PRABUJEYABALAN MM, 2002, ANTIVIR THER, V7, pS36; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Ren J, 2001, J MOL BIOL, V312, P795, DOI 10.1006/jmbi.2001.4988; Resch W, 2001, P NATL ACAD SCI USA, V98, P176, DOI 10.1073/pnas.011511298; RICHMAN D, 2001, INT C ANT AG CHEM CH; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; RICHMAN DD, 1990, AM J MED, V88, pS8, DOI 10.1016/0002-9343(90)90414-9; Ridky TW, 1998, BIOCHEMISTRY-US, V37, P13835, DOI 10.1021/bi980612k; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354; Ross L, 2000, AIDS, V14, P813, DOI 10.1097/00002030-200005050-00007; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Schapiro JM, 1999, AIDS, V13, P359, DOI 10.1097/00002030-199902250-00008; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Shafer RW, 1998, ANN INTERN MED, V128, P906, DOI 10.7326/0003-4819-128-11-199806010-00008; Shafer RW, 1997, J VIROL, V71, P5441, DOI 10.1128/JVI.71.7.5441-5448.1997; Shafer RW, 1996, J INFECT DIS, V174, P448, DOI 10.1093/infdis/174.2.448; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Verhofstede C, 1999, AIDS, V13, P2541, DOI 10.1097/00002030-199912240-00007; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witvrouw M, 1999, AIDS, V13, P1477, DOI 10.1097/00002030-199908200-00006; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998; Zhang YM, 1997, J VIROL, V71, P6662, DOI 10.1128/JVI.71.9.6662-6670.1997	101	539	584	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2004	350	10					1023	1035		10.1056/NEJM2ra025195	http://dx.doi.org/10.1056/NEJM2ra025195			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780GH	14999114				2022-12-01	WOS:000189363600010
J	Kawahara, Y; Ito, K; Sun, H; Aizawa, H; Kanazawa, I; Kwak, S				Kawahara, Y; Ito, K; Sun, H; Aizawa, H; Kanazawa, I; Kwak, S			Glutamate receptors: RNA editing and death of motor neurons	NATURE			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; LOW RELATIVE ABUNDANCE; GLUR2 MESSENGER-RNA; MICE; LETHALITY; DEFICIENT; DISEASE; BRAIN; ADAR2		Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; Asahikawa Med Coll, Dept Internal Med 1, Asahikawa, Hokkaido 0788510, Japan; Japan Sci & Technol Corp, SORST, Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878502, Japan	University of Tokyo; Asahikawa Medical College; Japan Science & Technology Agency (JST); National Center for Neurology & Psychiatry - Japan	Kawahara, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kwak-tky@umin.ac.jp						AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Kawahara Y, 2003, EUR J NEUROSCI, V18, P23, DOI 10.1046/j.1460-9568.2003.02718.x; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S	10	416	438	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					801	801		10.1038/427801a	http://dx.doi.org/10.1038/427801a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985749	Bronze			2022-12-01	WOS:000189207500027
J	Stremlau, M; Owens, CM; Perron, MJ; Kiessling, M; Autissier, P; Sodroski, J				Stremlau, M; Owens, CM; Perron, MJ; Kiessling, M; Autissier, P; Sodroski, J			The cytoplasmic body component TRIM5 alpha restricts HIV-1 infection in Old World monkeys	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROMYELOCYTIC LEUKEMIA PROTEIN; SIMIAN CELLS; REVERSE TRANSCRIPTION; VIRAL REPLICATION; MOTIF PROTEIN; RING FINGER; ENTRY; RECRUITMENT; COMPLEXES	Host cell barriers to the early phase of immunodeficiency virus replication explain the current distribution of these viruses among human and non-human primate species(1-4). Human immunodeficiency virus type 1 (HIV-1), the cause of acquired immunodeficiency syndrome ( AIDS) in humans, efficiently enters the cells of Old World monkeys but encounters a block before reverse transcription(2-4). This species-specific restriction acts on the incoming HIV-1 capsid(5-7) and is mediated by a dominant repressive factor(7-9). Here we identify TRIM5alpha, a component of cytoplasmic bodies, as the blocking factor. HIV-1 infection is restricted more efficiently by rhesus monkey TRIM5alpha than by human TRIM5alpha. The simian immunodeficiency virus, which naturally infects Old World monkeys(10), is less susceptible to the TRIM5alpha-mediated block than is HIV-1, and this difference in susceptibility is due to the viral capsid. The early block to HIV-1 infection in monkey cells is relieved by interference with TRIM5alpha expression. Our studies identify TRIM5alpha as a species-specific mediator of innate cellular resistance to HIV-1 and reveal host cell components that modulate the uncoating of a retroviral capsid.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Dept Pathol, Div Aids, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Div Aids, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Dept Pathol, Div Aids, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu	Liu, FL/D-1795-2009					Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Dorfman T, 1996, J VIROL, V70, P5751, DOI 10.1128/JVI.70.9.5751-5757.1996; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Himathongkham S, 1996, VIROLOGY, V219, P485, DOI 10.1006/viro.1996.0276; Hofmann W, 1999, J VIROL, V73, P10020, DOI 10.1128/JVI.73.12.10020-10028.1999; KANKI PJ, 1985, SCIENCE, V230, P951, DOI 10.1126/science.2997923; Kootstra NA, 2003, P NATL ACAD SCI USA, V100, P1298, DOI 10.1073/pnas.0337541100; LaBonte JA, 2002, J EXP MED, V196, P431, DOI 10.1084/jem.20020468; LI J, 1992, J ACQ IMMUN DEF SYND, V5, P639; Marcello A, 2003, EMBO J, V22, P2156, DOI 10.1093/emboj/cdg205; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; OWENS CM, IN PRESS J VIROL; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rhodes DA, 2002, IMMUNOLOGY, V106, P246, DOI 10.1046/j.1365-2567.2002.01417.x; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; SHIBATA R, 1995, J GEN VIROL, V76, P2723, DOI 10.1099/0022-1317-76-11-2723; Toniato E, 2002, J BIOL CHEM, V277, P37315, DOI 10.1074/jbc.M205900200; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Xu LX, 2003, EXP CELL RES, V288, P84, DOI 10.1016/S0014-4827(03)00187-3	30	1453	1526	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					848	853		10.1038/nature02343	http://dx.doi.org/10.1038/nature02343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985764				2022-12-01	WOS:000189207500042
J	Keene, WE; Markum, AC; SAmadpour, M				Keene, WE; Markum, AC; SAmadpour, M			Outbreak of Pseudomonas aeruginosa infections caused by commercial piercing of upper ear cartilage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; PERICHONDRITIS; CHONDRITIS; HEPATITIS; PINNA	Context Sporadic infections following ear piercing are well documented, but common-source outbreaks are rarely recognized. Objective To investigate reports of auricular chondritis subsequent to commercial ear piercing. Design, Setting, and Subjects Outbreak investigation by Oregon public health agencies, including cohort study of persons pierced at a jewelry kiosk in August-September 2000, environmental sampling, and molecular subtyping of isolates. Confirmed cases had Pseudomonas aeruginosa cultured from ear wounds. Suspected cases had signs and symptoms of external ear infection, including drainage of pus or blood for at least 14 days. Main Outcome Measures Risk factors for infection and comparison of bacterial isolates by molecular subtyping. Results From 186 piercings in 118 individuals, we identified 7 confirmed P aeruginosa infections and 18 suspected infections. Confirmed cases were 10 to 19 years old. Most were initially treated with antibiotics ineffective against Pseudomonas. Four were hospitalized, 4 underwent incision and drainage surgeries (1 as an outpatient), and several were cosmetically deformed. Upper ear cartilage piercing was more likely to result in either confirmed or suspected infection than was lobe piercing (confirmed: RR undefined, P<.001; suspected: RR, 3.6; 95% confidence interval, 1.5-8.5). All persons with confirmed infections had their ear cartilage pierced With an open, spring-loaded piercing gun. Patient isolates were indistinguishable by molecular subtyping, and matching isolates were recovered from a disinfectant bottle and nearby sink. At least 1 worker admitted sometimes spraying the disinfectant on the ear studs before piercing. Conclusions Ear cartilage piercing is inherently more risky than lobe piercing. Clinicians should respond aggressively to potential auricular chondritis and consider Pseudomonas a possible cause pending culture results.	Oregon Dept Human Serv, Acute & Communicable Dis Program, Portland, OR 97232 USA; Klamath Cty Dept Publ Hlth, Klamath Falls, OR USA; Univ Washington, Sch Publ Hlth, Dept Environm Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Keene, WE (corresponding author), Oregon Dept Human Serv, Acute & Communicable Dis Program, 800 NE Oregon St,Suite 772, Portland, OR 97232 USA.	william.e.keene@state.or.us			ODCDC CDC HHS [U50/CCU011184] Funding Source: Medline	ODCDC CDC HHS		BIGGAR RJ, 1975, NEW YORK STATE J MED, V75, P1460; Braithwaite RL, 1999, J PUBLIC HEALTH POL, V20, P459, DOI 10.2307/3343131; Cicchetti S, 2002, BRIT J PLAST SURG, V55, P194, DOI 10.1054/bjps.2001.3799; CORTESE TA, 1971, AM FAM PHYSICIAN, V4, P66; CUMBERWORTH VL, 1990, BRIT J CLIN PRACT, V44, P512; FRANK MJ, 1976, JAMA-J AM MED ASSOC, V236, P2418, DOI 10.1001/jama.236.21.2418; Hanif J, 2001, BRIT MED J, V322, P906, DOI 10.1136/bmj.322.7291.906; Heal MR, 1999, ENVIRON INT, V25, P3, DOI 10.1016/S0160-4120(98)00092-0; JOHNSON CJ, 1974, JAMA-J AM MED ASSOC, V227, P1165, DOI 10.1001/jama.1974.03230230041022; Kent SE, 2001, BRIT MED J, V323, P400, DOI 10.1136/bmj.323.7309.400; Koenig LM, 1999, J GEN INTERN MED, V14, P379, DOI 10.1046/j.1525-1497.1999.00357.x; LEE J, 1960, JAMA-J AM MED ASSOC, V177, P708; More DR, 1999, PEDIATR EMERG CARE, V15, P189, DOI 10.1097/00006565-199906000-00007; ORTICOCHEA M, 1980, BRIT J PLAST SURG, V33, P38, DOI 10.1016/0007-1226(80)90049-1; Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164; SAMADPOUR M, 1993, J CLIN MICROBIOL, V31, P3179, DOI 10.1128/JCM.31.12.3179-3183.1993; Sanders D Y, 1971, Woman Physician, V26, P459; Simplot TC, 1998, AM J OTOLARYNG, V19, P305, DOI 10.1016/S0196-0709(98)90003-5; Staley R, 1997, PEDIATRICS, V99, P610, DOI 10.1542/peds.99.4.610; TURKELTAUB SH, 1990, ANN PLAS SURG, V24, P279, DOI 10.1097/00000637-199003000-00015; Tweeten SSM, 1998, CLIN INFECT DIS, V26, P735, DOI 10.1086/514586; VANSCIVER AE, 1969, J AMER MED ASSOC, V207, P2285, DOI 10.1001/jama.1969.03150250115028	22	40	42	2	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2004	291	8					981	985		10.1001/jama.291.8.981	http://dx.doi.org/10.1001/jama.291.8.981			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777MK	14982914				2022-12-01	WOS:000189182000026
J	Padera, TP; Stoll, BR; Tooredman, JB; Capen, D; di Tomaso, E; Jain, RK				Padera, TP; Stoll, BR; Tooredman, JB; Capen, D; di Tomaso, E; Jain, RK			Cancer cells compress intratumour vessels	NATURE			English	Editorial Material							SOLID TUMORS; PRESSURE		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Padera, TP (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Padera, Timothy/R-2982-2019	Jain, Rakesh K/0000-0001-7571-3548; Padera, Timothy/0000-0002-3453-9384				Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Arbiser JL, 1999, AM J PATHOL, V155, P723, DOI 10.1016/S0002-9440(10)65171-1; BOUCHER Y, 1992, CANCER RES, V52, P5110; Griffon-Etienne G, 1999, CANCER RES, V59, P3776; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; REINHOLD HS, 1971, EUR J CANCER, V7, P273, DOI 10.1016/0014-2964(71)90069-7; Schmid-Schonbein Geert W, 2003, Lymphat Res Biol, V1, P25, DOI 10.1089/15396850360495664	10	603	621	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					695	695		10.1038/427695a	http://dx.doi.org/10.1038/427695a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973470	Bronze			2022-12-01	WOS:000189026000028
J	Walley, T; Folino-Gallo, P; Schwabe, U; van Ganse, E				Walley, T; Folino-Gallo, P; Schwabe, U; van Ganse, E		EuroMedStat Grp	Variations and increase in use of statins across Europe: data from administrative databases	BRITISH MEDICAL JOURNAL			English	Article									Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England; CNR, IRPPS, I-00198 Rome, Italy; Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; Univ Lyon, Unite Pharmacoepidemiol, Lyon, France	University of Liverpool; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerche sulla Popolazione e le Politiche Sociali (IRPPS-CNR); Ruprecht Karls University Heidelberg	Walley, T (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England.	twalley@liv.ac.uk	VAN GANSE, Eric/D-5876-2015	VAN GANSE, Eric/0000-0002-7463-9187				*EUR MED STAT GROU, IN PRESS EUR J PUBLI; Larsen J, 2000, BRIT J CLIN PHARMACO, V49, P463, DOI 10.1046/j.1365-2125.2000.00192.x; Majeed A, 2000, J PUBLIC HEALTH MED, V22, P275, DOI 10.1093/pubmed/22.3.275; SUDLOW C, 2003, CLIN EVIDENCE, P166; WORLD HEALTH ORGANIZATION (WHO) REGIONAL OFFICE FOR EUROPE, 2003, EUR HLTH ALL DAT	5	99	103	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 14	2004	328	7436					385	386		10.1136/bmj.328.7436.385	http://dx.doi.org/10.1136/bmj.328.7436.385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775GA	14962875	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000189031300024
J	Engel, MS; Grimaldi, DA				Engel, MS; Grimaldi, DA			New light shed on the oldest insect	NATURE			English	Article							LAND ANIMALS; PHYLOGENY; RHYNIE	Insects are the most diverse lineage of all life in numbers of species, and ecologically they dominate terrestrial ecosystems. However, how and when this immense radiation of animals originated is unclear. Only a few fossils provide insight into the earliest stages of insect evolution, and among them are specimens in chert from Rhynie, Scotland's Old Red Sandstone (Pragian; about 396-407 million years ago(1)), which is only slightly younger than formations harbouring the earliest terrestrial faunas. The most well-known animal from Rhynie is the springtail Rhyniella praecursor (Entognatha; Collembola), long considered to be the oldest hexapod(2,3). For true insects (Ectognatha), the oldest records are two apparent wingless insects from later in the Devonian period of North America(4,5). Here we show, however, that a fragmentary fossil from Rhynie, Rhyniognatha hirsti, is not only the earliest true insect but may be relatively derived within basal Ectognatha. In fact, Rhyniognatha has derived characters shared with winged insects, suggesting that the origin of wings may have been earlier than previously believed. Regardless, Rhyniognatha indicates that insects originated in the Silurian period and were members of some of the earliest terrestrial faunas.	Univ Kansas, Museum Nat Hist, Div Entomol, Lawrence, KS 66045 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	University of Kansas; University of Kansas; American Museum of Natural History (AMNH)	Engel, MS (corresponding author), Univ Kansas, Museum Nat Hist, Div Entomol, Snow Hall,1460 Jayhawk Blvd, Lawrence, KS 66045 USA.	msengel@ku.edu	Engel, Michael S/C-5461-2012	Engel, Michael S/0000-0003-3067-077X				ALEGO TJ, 2001, PLANTS INVADE LAND, P213; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Carpenter F.M., 1992, TREATISE INVERTEBRAT; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Dudley R., 2000, BIOMECHANICS INSECT; EDWARDS D, 1995, NATURE, V377, P329, DOI 10.1038/377329a0; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gensel P.G., 1984, PLANT LIFE DEVONIAN; Grimaldi D, 2001, J PALEONTOL, V75, P1152, DOI 10.1666/0022-3360(2001)075<1152:IEHFHT>2.0.CO;2; Groning, 1996, ANN SOC GEOL BELG, V117, P47; Hasenfuss I, 2002, J ZOOL SYST EVOL RES, V40, P65, DOI 10.1046/j.1439-0469.2002.00180.x; Hennig W., 1981, INSECT PHYLOGENY; HIRST STANLEY, 1926, GEOL MAG [LONDON], V63, P69; JERAM AJ, 1990, SCIENCE, V250, P658, DOI 10.1126/science.250.4981.658; Kristensen N.P., 1991, P125; KUHNE WG, 1985, ENTOMOL GEN, V11, P91; Kukalova-Peck J., 1991, INSECTS AUSTR TXB ST, V1, P141; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; LABANDEIRA CC, 1988, SCIENCE, V242, P913, DOI 10.1126/science.242.4880.913; NOVACEK MJ, 1992, SYST BIOL, V41, P58, DOI 10.2307/2992506; Rasnitsyn A.P., 2002, HIST INSECTS, DOI [10.1007/0-306-47577-4, DOI 10.1007/0-306-47577-4]; RICE CM, 1995, J GEOL SOC LONDON, V152, P229, DOI 10.1144/gsjgs.152.2.0229; Scourfield DJ, 1940, NATURE, V145, P799, DOI 10.1038/145799a0; SHEAR WA, 1984, SCIENCE, V224, P492, DOI 10.1126/science.224.4648.492; Staniczek AH, 2000, ZOOL ANZ, V239, P147; TILLYARD R. J., 1928, TRANS ENT SOC LONDON, V76, P65; von Lieven AF, 2000, ZOOL ANZ, V239, P139; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; WHALLEY P, 1981, NATURE, V291, P317, DOI 10.1038/291317a0; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]	30	206	227	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					627	630		10.1038/nature02291	http://dx.doi.org/10.1038/nature02291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961119				2022-12-01	WOS:000188875300039
J	Osyczka, A; Moser, CC; Daldal, F; Dutton, PL				Osyczka, A; Moser, CC; Daldal, F; Dutton, PL			Reversible redox energy coupling in electron transfer chains	NATURE			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION; BC1 COMPLEX; RHODOBACTER-CAPSULATUS; DOMAIN MOVEMENT; UBIHYDROQUINONE OXIDATION; 2-ELECTRON TRANSFER; INHIBITOR BINDING; CRYSTAL-STRUCTURE	Reversibility is a common theme in respiratory and photosynthetic systems that couple electron transfer with a transmembrane proton gradient driving ATP production. This includes the intensely studied cytochrome bc(1), which catalyses electron transfer between quinone and cytochrome c. To understand how efficient reversible energy coupling works, here we have progressively inactivated individual cofactors comprising cytochrome bc(1). We have resolved millisecond reversibility in all electron-tunnelling steps and coupled proton exchanges, including charge-separating hydroquinone-quinone catalysis at the Q(o) site, which shows that redox equilibria are relevant on a catalytic timescale. Such rapid reversibility renders popular models based on a semiquinone in Q(o) site catalysis prone to short-circuit failure. Two mechanisms allow reversible function and safely relegate short-circuits to long-distance electron tunnelling on a timescale of seconds: conformational gating of semiquinone for both forward and reverse electron transfer, or concerted two-electron quinone redox chemistry that avoids the semiquinone intermediate altogether.	Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; Jagiellonian Univ, Fac Biotechnol, Krakow, Poland	University of Pennsylvania; University of Pennsylvania; Jagiellonian University	Dutton, PL (corresponding author), Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA.	dutton@mail.med.upenn.edu	Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Osyczka, Artur/0000-0002-1637-2365				ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; BERDEN JA, 1972, BIOCHIM BIOPHYS ACTA, V256, P199, DOI 10.1016/0005-2728(72)90053-9; Berry EA, 1999, BIOCHEM SOC T, V27, P565, DOI 10.1042/bst0270565; Boman P, 1999, J AM CHEM SOC, V121, P1558, DOI 10.1021/ja9831251; Brandt U, 1998, BBA-BIOENERGETICS, V1365, P261, DOI 10.1016/S0005-2728(98)00078-4; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; Brandt U, 1996, FEBS LETT, V387, P1, DOI 10.1016/0014-5793(96)00436-X; CHANCE B, 1961, J BIOL CHEM, V236, P1562; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3471, DOI 10.1074/jbc.M107974200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; Dutton PL, 2000, COENZYME Q OXIDATION, P65, DOI [10.1201/9781420036701.sec1b, DOI 10.1201/9781420036701.SEC1B]; Elbehti A, 2000, J BACTERIOL, V182, P3602, DOI 10.1128/JB.182.12.3602-3606.2000; Gileadi E, 2002, J ELECTROANAL CHEM, V532, P181, DOI 10.1016/S0022-0728(02)00766-0; GRAY KA, 1992, BIOCHEMISTRY-US, V31, P11864, DOI 10.1021/bi00162a027; Greaves MD, 1999, J AM CHEM SOC, V121, P266, DOI 10.1021/ja982451d; Guergova-Kuras M, 2000, BIOCHEMISTRY-US, V39, P7436, DOI 10.1021/bi992491+; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Klishin SS, 2002, BBA-BIOENERGETICS, V1553, P177, DOI 10.1016/S0005-2728(01)00250-X; KRAMER DM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P72, DOI 10.1016/0005-2728(93)90006-2; Lambert C, 2003, CHEMPHYSCHEM, V4, P877, DOI 10.1002/cphc.200300726; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; MIKI T, 1994, J BIOL CHEM, V269, P1827; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Nicholls D., 2002, BIOENERGETICS, V3; Osyczka A, 2001, BIOCHEMISTRY-US, V40, P14547, DOI 10.1021/bi011630w; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; RICH PR, 1982, FARADAY DISCUSS, V74, P349, DOI 10.1039/dc9827400349; ROBERTSON DE, 1986, J BIOL CHEM, V261, P584; Sadoski RC, 2000, BIOCHEMISTRY-US, V39, P4231, DOI 10.1021/bi000003o; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Trumpower BL, 2002, BBA-BIOENERGETICS, V1555, P166, DOI 10.1016/S0005-2728(02)00273-6; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; Yu CA, 2002, BBA-BIOENERGETICS, V1555, P65, DOI 10.1016/S0005-2728(02)00256-6; YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zusman LD, 1997, J PHYS CHEM A, V101, P4136, DOI 10.1021/jp970123e	49	211	219	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					607	612		10.1038/nature02242	http://dx.doi.org/10.1038/nature02242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961113				2022-12-01	WOS:000188875300033
J	Holmberg, L; Anderson, H				Holmberg, L; Anderson, H		HABITS Steering Data Monitoring Co	HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped	LANCET			English	Article							WOMEN	In the 1990s, two randomised clinical trials started in Scandinavia addressing whether hormone replacement therapy (HRT) is safe for women with previous breast cancer. We report the findings of the safety analysis in HABITS (hormonal replacement therapy after breast cancer-is it safe?), an open randomised clinical trial with allocation to either HRT or best treatment without hormones. The main endpoint was any new breast cancer event. All analyses were done according to intention-to-treat. Until September, 2003, 434 women were randomised; 345 had at least one follow-up report. After a median follow-up of 2.1 years, 26 women in the HRT group and seven in the non-HRT group had a new breast-cancer event. All women with an event in the HRT group and two of those in the non-HRT group were exposed to HRT and most women had their event when on treatment. We decided that these findings indicated an unacceptable risk for women exposed to HRT in the HABITS trial, and the trial was terminated on Dec 17, 2003.	Univ Hosp, Reg Oncol Ctr, SE-75185 Uppsala, Sweden; Lund Univ, Dept Canc Epidemiol, Lund, Sweden	Uppsala University; Uppsala University Hospital; Lund University	Holmberg, L (corresponding author), Univ Hosp, Reg Oncol Ctr, SE-75185 Uppsala, Sweden.	lars.holmberg@lul.se						Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Col NF, 2001, J CLIN ONCOL, V19, P2357, DOI 10.1200/JCO.2001.19.8.2357; O'Meara ES, 2001, JNCI-J NATL CANCER I, V93, P754, DOI 10.1093/jnci/93.10.754	5	341	353	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 7	2004	363	9407					453	455		10.1016/S0140-6736(04)15493-7	http://dx.doi.org/10.1016/S0140-6736(04)15493-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774RX	14962527				2022-12-01	WOS:000188999500013
J	Mumby, PJ; Edwards, AJ; Arias-Gonzalez, JE; Lindeman, KC; Blackwell, PG; Gall, A; Gorczynska, MI; Harborne, AR; Pescod, CL; Renken, H; Wabnitz, CCC; Llewellyn, G				Mumby, PJ; Edwards, AJ; Arias-Gonzalez, JE; Lindeman, KC; Blackwell, PG; Gall, A; Gorczynska, MI; Harborne, AR; Pescod, CL; Renken, H; Wabnitz, CCC; Llewellyn, G			Mangroves enhance the biomass of coral reef fish communities in the Caribbean	NATURE			English	Article							SEAGRASS BEDS; HABITATS; BAY	Mangrove forests are one of the world's most threatened tropical ecosystems with global loss exceeding 35% (ref. 1). Juvenile coral reef fish often inhabit mangroves(2-5), but the importance of these nurseries to reef fish population dynamics has not been quantified. Indeed, mangroves might be expected to have negligible influence on reef fish communities: juvenile fish can inhabit alternative habitats and fish populations may be regulated by other limiting factors such as larval supply or fishing(6). Here we show that mangroves are unexpectedly important, serving as an intermediate nursery habitat that may increase the survivorship of young fish. Mangroves in the Caribbean strongly influence the community structure of fish on neighbouring coral reefs. In addition, the biomass of several commercially important species is more than doubled when adult habitat is connected to mangroves. The largest herbivorous fish in the Atlantic, Scarus guacamaia, has a functional dependency on mangroves and has suffered local extinction after mangrove removal. Current rates of mangrove deforestation are likely to have severe deleterious consequences for the ecosystem function, fisheries productivity and resilience of reefs. Conservation efforts should protect connected corridors of mangroves, seagrass beds and coral reefs.	Univ Exeter, Sch Biol & Chem Sci, Marine Spatial Ecol Lab, Exeter EX4 4PS, Devon, England; Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; CINVESTAV, Unidad Merida, Dept Recursos Mar, Lab Ecol Ecosistemas Arrecifes Coralinos, Merida 97310, Yucatan, Mexico; Environm Def, Caribbean Field Off, Miami, FL 33186 USA; Univ Sheffield, Dept Probabil & Stat, Sheffield S3 7RH, S Yorkshire, England; Univ British Columbia, Lower Mall Res Stn, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; WWF US, Conservat Sci Program, Washington, DC 20037 USA	University of Exeter; Newcastle University - UK; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Sheffield; University of British Columbia; World Wildlife Fund	Mumby, PJ (corresponding author), Univ Exeter, Sch Biol & Chem Sci, Marine Spatial Ecol Lab, Prince Wales Rd, Exeter EX4 4PS, Devon, England.	p.j.mumby@exeter.ac.uk	Blackwell, Paul/F-2885-2017; Mumby, Peter/F-9914-2010; Edwards, Alasdair J/C-9558-2009; Harborne, Alastair R/F-6155-2013	Blackwell, Paul/0000-0002-3141-4914; Mumby, Peter/0000-0002-6297-9053; Edwards, Alasdair J/0000-0002-2979-7389; Harborne, Alastair R/0000-0002-6818-8615; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X; Wabnitz, Colette C.C./0000-0002-5076-9163; Lindeman, Ken/0000-0003-4098-4158				Bohnsack J., 1988, NMFSSEFC215 NAT OC A; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLARO R, 1993, CUBA AVICENNIA, V10, P60; GREENE LE, 1989, B MAR SCI, V44, P899; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; IUCN [International Union for Conservation of Nature], 2002, IUCN RED LIST THREAT; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Ley JA, 1999, ESTUAR COAST SHELF S, V48, P701, DOI 10.1006/ecss.1998.0459; Manly BFJ, 1992, DESIGN ANAL RES STUD; MCNEILL SE, 1994, BIODIVERS CONSERV, V3, P586, DOI 10.1007/BF00114203; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Ogden John C., 1997, P288; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Purdy EG, 2003, INT J EARTH SCI, V92, P532, DOI 10.1007/s00531-003-0324-0; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; ROOKER JR, 1991, B MAR SCI, V49, P684; SERAFY JE, B MAR SCI; Sullivan-Sealey K., 1999, SETTING GEOGRAPHIC P; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2	24	738	776	12	595	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					533	536		10.1038/nature02286	http://dx.doi.org/10.1038/nature02286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765193	Green Accepted			2022-12-01	WOS:000188721800039
J	Reiner, WG; Gearhart, JP				Reiner, WG; Gearhart, JP			Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENDER IDENTITY; DIETHYLSTILBESTROL DES; ANDROGENS; REASSIGNMENT; EXPERIENCE; BEHAVIOR; EXPOSURE; REVERSAL; CHILDREN; PENIS	BACKGROUND: Cloacal exstrophy is a rare, complex defect of the entire pelvis and its contents that occurs during embryogenesis and is associated with severe phallic inadequacy or phallic absence in genetic males. For about 25 years, neonatal assignment to female sex has been advocated for affected males to overcome the issue of phallic inadequacy, but data on outcome remain sparse. METHODS: We assessed all 16 genetic males in our cloacal-exstrophy clinic at the ages of 5 to 16 years. Fourteen underwent neonatal assignment to female sex socially, legally, and surgically; the parents of the remaining two refused to do so. Detailed questionnaires extensively evaluated the development of sexual role and identity, as defined by the subjects' persistent declarations of their sex. RESULTS: Eight of the 14 subjects assigned to female sex declared themselves male during the course of this study, whereas the 2 raised as males remained male. Subjects could be grouped according to their stated sexual identity. Five subjects were living as females; three were living with unclear sexual identity, although two of the three had declared themselves male; and eight were living as males, six of whom had reassigned themselves to male sex. All 16 subjects had moderate-to-marked interests and attitudes that were considered typical of males. Follow-up ranged from 34 to 98 months. CONCLUSIONS: Routine neonatal assignment of genetic males to female sex because of severe phallic inadequacy can result in unpredictable sexual identification. Clinical interventions in such children should be reexamined in the light of these findings.	Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Reiner, WG (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, WP 3150,920 SL Young Blvd, Oklahoma City, OK 73104 USA.				NIMH NIH HHS [K08 MH001777, 5 K08MH01777-02, K08 MH001777-05, K08 MH001777-04] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001777] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BATES JE, 1973, CHILD DEV, V44, P591; Berenbaum SA, 1997, PSYCHONEUROENDOCRINO, V22, P505, DOI 10.1016/S0306-4530(97)00049-8; Berenbaum SA, 2003, J CLIN ENDOCR METAB, V88, P1102, DOI 10.1210/jc.2002-020782; Berenbaum SA, 2000, J CLIN ENDOCR METAB, V85, P727, DOI 10.1210/jc.85.2.727; Bin-Abbas B, 1999, J PEDIATR-US, V134, P579, DOI 10.1016/S0022-3476(99)70244-1; Birnbacher R, 1999, J PEDIATR ENDOCR MET, V12, P687; Bradley SJ, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e9; Diamond M, 1997, ARCH PEDIAT ADOL MED, V151, P298, DOI 10.1001/archpedi.1997.02170400084015; Glassberg KI, 1999, J UROLOGY, V161, P1308, DOI 10.1016/S0022-5347(01)61676-8; GRELLERT EA, 1982, ARCH SEX BEHAV, V11, P451, DOI 10.1007/BF01542472; Grumbach MM, 2003, WILLIAMS TXB ENDOCRI, P842; Hendren WH, 1997, J UROLOGY, V157, P1469, DOI 10.1016/S0022-5347(01)65026-2; IMPERATOMCGINLEY J, 1979, NEW ENGL J MED, V300, P1233, DOI 10.1056/NEJM197905313002201; KLEIN AR, 1980, J ABNORM CHILD PSYCH, V8, P201, DOI 10.1007/BF00919064; LISH JD, 1992, ARCH SEX BEHAV, V21, P423, DOI 10.1007/BF01542268; LISH JD, 1991, J AM ACAD CHILD PSY, V30, P29, DOI 10.1097/00004583-199101000-00005; Lund DP, 2001, J PEDIATR SURG, V36, P68, DOI 10.1053/jpsu.2001.20009; Mathews R, 1998, J UROLOGY, V160, P2452, DOI 10.1016/S0022-5347(01)62209-2; Mathews RI, 1999, BJU INT, V84, P99; Mayer A, 1998, NEUROGENETICS, V1, P281, DOI 10.1007/s100480050042; Meyer-Bahlburg HFL, 1994, J PSYCHOL HUM SEX, V6, P19, DOI DOI 10.1300/J056v06n01_01; MEYERBAHLBURG HFL, 1984, ARCH SEX BEHAV, V13, P479, DOI 10.1007/BF01541431; MEYERBAHLBURG HFL, 1994, J ABNORM CHILD PSYCH, V22, P643, DOI 10.1007/BF02171993; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P301; MONEY J, 1975, ARCH SEX BEHAV, V4, P65, DOI 10.1007/BF01541887; Money J, 1994, SEX ERRORS BODY RELA, p[1, 60, 108]; Money J, 1972, MAN WOMAN BOY GIRL D, P311; Phoenix C. H., 1968, P33; Reiner WG, 1996, J AM ACAD CHILD PSY, V35, P799, DOI 10.1097/00004583-199606000-00020; Schober JM, 2002, J UROLOGY, V167, P300, DOI 10.1016/S0022-5347(05)65455-9; SKOOG SJ, 1989, J UROLOGY, V141, P589, DOI 10.1016/S0022-5347(17)40903-7; TANK ES, 1970, AM J SURG, V119, P95, DOI 10.1016/0002-9610(70)90018-8; Wilson JD, 1999, ENDOCR REV, V20, P726, DOI 10.1210/er.20.5.726; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	34	193	196	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2004	350	4					333	341		10.1056/NEJMoa022236	http://dx.doi.org/10.1056/NEJMoa022236			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765EU	14736925	Green Accepted			2022-12-01	WOS:000188254800005
J	Jorgensen, KJ; Gotzsche, PC				Jorgensen, KJ; Gotzsche, PC			Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAMMOGRAPHY; IMPACT; WOMEN	Objective To investigate whether information on mammographic screening presented on websites by interest groups is balanced, is independent of source of funding, and reflects recent findings. Design Cross sectional study using a checklist with 17 information items. Setting 27 websites in Scandinavian and English speaking countries. Results The 13 sites from advocacy groups and the 11 from governmental institutions all recommended mammographic screening, whereas the three from consumer organisations questioned screening (P = 0.0007). All the advocacy groups accepted industry funding, apparently without restrictions. In contrast the three consumer organisations acknowledged the risk of bias related to industry funding, and two of them did not accept such funding at all. Advocacy groups and governmental organisations favoured information items that shed positive light on screening. The major harms of screening, overdiagnosis and overtreatment, were mentioned by only four of these groups, but by all three sites from consumer organisations (P = 0.02). In addition, the chosen information was often misleading or erroneous. The selection of information items for websites did not reflect recent findings, apart from the consumer sites, which were much more balanced and comprehensive than other sites (median of 9 information items v 3 items, P = 0.03). Conclusions The information material provided by professional advocacy groups and governmental organisations is information poor and severely biased in favour of screening. Few websites live up to accepted standards for informed consent such as those stated in the General Medical Council's guidelines.	Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen O, Denmark.	pcg@cochrane.dk		Jorgensen, Karsten/0000-0001-8554-0388				ABE O, 1995, NEW ENGL J MED, V333, P1444; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Croft E, 2002, J FAM PRACTICE, V51, P858; Davey Heather M, 2002, Health Expect, V5, P330, DOI 10.1046/j.1369-6513.2002.00194.x; DOUEK M, 2003, BR J SURG S1, V90; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elwood M, 1998, NEW ZEAL MED J, V111, P180; *ET RAD, 1999, SCREEN RED; *EUR OP RES GROUP, 2003, EUR UN CIT SOURC INF; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; GOTZASCHE PC, IN PRESS INT J EPIDE; Gotzsche PC, 2002, LANCET, V360, P338, DOI 10.1016/S0140-6736(02)09524-7; Gotzsche PC, 2001, LANCET, V358, P2167, DOI 10.1016/S0140-6736(01)07198-7; Gotzsche PC, 2001, BRIT MED J, V323, P1131, DOI 10.1136/bmj.323.7321.1131a; GOTZSCHE PC, IN PRESS INT J EPIDE; Horton R, 2002, LANCET, V359, P441, DOI 10.1016/S0140-6736(02)07570-0; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; MATEAU TM, 2001, HLTH EXPECT, V4, P99; McNoe B, 1996, WOMENS EXPERIENCE OT; MILLER AB, 1993, AM J PREV MED, V9, P175, DOI 10.1016/S0749-3797(18)30734-7; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; *NHS, 2001, BREAST SCREEN FACTS; Nystrom L, 1996, J Med Screen, V3, P85; Nystrom L, 2002, LANCET, V360, P339, DOI 10.1016/S0140-6736(02)09527-2; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; NYSTROM L, 2002, LANCET, V360, P1178; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Olsen O, 2001, COCHRANE DB SYST REV, V4, P1877; OLSEN O, 2001, SYSTEMATIC REV SCREE; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Ries LAG, 2002, SEER CANC STAT REV 1; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Slaytor EK, 1998, BRIT MED J, V317, P263, DOI 10.1136/bmj.317.7153.263; Sundhedsstyrelsen. Statusrapport, 1997, TIDL OPSP BEH BRYSTK; Thornton H, 2000, LANCET, V356, P1033, DOI 10.1016/S0140-6736(05)72655-6; *US PREV SERV TASK, 2000, ANN INTERN MED, V137, P344; Wolf AMD, 1996, ARCH INTERN MED, V156, P1333, DOI 10.1001/archinte.156.12.1333	40	92	93	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2004	328	7432					148	151		10.1136/bmj.328.7432.148	http://dx.doi.org/10.1136/bmj.328.7432.148			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765CQ	14726344	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000188249900023
J	Dhugga, KS; Barreiro, R; Whitten, B; Stecca, K; Hazebroek, J; Randhawa, GS; Dolan, M; Kinney, AJ; Tomes, D; Nichols, S; Anderson, P				Dhugga, KS; Barreiro, R; Whitten, B; Stecca, K; Hazebroek, J; Randhawa, GS; Dolan, M; Kinney, AJ; Tomes, D; Nichols, S; Anderson, P			Guar seed beta-mannan synthase is a member of the cellulose synthase super gene family	SCIENCE			English	Article							HIGHER-PLANTS; GALACTOMANNAN BIOSYNTHESIS; ARABIDOPSIS; ENZYME; GALACTOSYLTRANSFERASE; IDENTIFICATION; PURIFICATION; SYNTHETASE; ENCODES; GROWTH	Genes for the enzymes that make plant cell wall hemicellulosic polysaccharides remain to be identified. We report here the isolation of a complementary DNA ( cDNA) clone encoding one such enzyme, mannan synthase (ManS), that makes the beta-1, 4-mannan backbone of galactomannan, a hemicellulosic storage polysaccharide in guar seed endosperm walls. The soybean somatic embryos expressing ManS cDNA contained high levels of ManS activities that localized to Golgi. Phylogenetically, ManS is closest to group A of the cellulose synthase-like (Csl) sequences from Arabidopsis and rice. Our results provide the biochemical proof for the involvement of the Csl genes in beta-glycan formation in plants.	Pioneer HiBred Int Inc, Crop Genet Res & Dev, Johnston, IA 50131 USA; Indian Inst Technol, Dept Biosci & Biotechnol, Roorkee 247667, Uttar Pradesh, India; DuPont Co Inc, Expt Stn, Crop Genet Res & Dev, Wilmington, DE 19880 USA; DuPont Co Inc, Expt Stn, Cent Res & Dev, Wilmington, DE 19880 USA	DuPont; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; DuPont; DuPont	Dhugga, KS (corresponding author), Pioneer HiBred Int Inc, Crop Genet Res & Dev, 7300 NW 62nd Ave, Johnston, IA 50131 USA.			Randhawa, Gursharn/0000-0003-1374-8360; Dhugga, Kanwarpal/0000-0003-2477-3422				Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Bacic A., 1988, BIOCH PLANTS, P297, DOI DOI 10.1016/B978-0-08-092615-5.50014-X; CUTLER S, 1997, CURR BIOL, V7, P108; DHUGGA KS, 1994, EUR J BIOCHEM, V220, P943, DOI 10.1111/j.1432-1033.1994.tb18698.x; EDWARDS M, 1992, PLANTA, V187, P67, DOI 10.1007/BF00201625; Edwards ME, 1999, PLANT J, V19, P691, DOI 10.1046/j.1365-313x.1999.00566.x; Faik A, 2002, P NATL ACAD SCI USA, V99, P7797, DOI 10.1073/pnas.102644799; Favery B, 2001, GENE DEV, V15, P79, DOI 10.1101/gad.188801; Goubet F, 2003, PLANT PHYSIOL, V131, P547, DOI 10.1104/pp.014555; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Joersbo M, 2001, MOL BREEDING, V7, P211, DOI 10.1023/A:1011375605835; KANG MS, 1984, J BIOL CHEM, V259, P4966; KOOIMAN P, 1971, CARBOHYD RES, V20, P329, DOI 10.1016/S0008-6215(00)81387-7; Kudlicka K, 1997, PLANT PHYSIOL, V115, P643, DOI 10.1104/pp.115.2.643; Maier H., 1993, IND GUMS POLYSACCHAR, P181, DOI DOI 10.1016/B978-0-08-092654-4.50012-7; MUJER CV, 1984, PHYTOCHEMISTRY, V33, P893; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; RAY PM, 1969, P NATL ACAD SCI USA, V64, P605, DOI 10.1073/pnas.64.2.605; REID JSG, 1995, PLANTA, V195, P489, DOI 10.1007/BF00195705; Reid JSG, 2003, PLANT PHYSIOL, V131, P1487, DOI 10.1104/pp.102.016840; REID JSG, 1992, BIOCHEM SOC T, V20, P23, DOI 10.1042/bst0200023; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Saxena IM, 1997, CELLULOSE, V4, P33, DOI 10.1023/A:1018411101036; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Wang X, 2001, PLANT PHYSIOL, V126, P575, DOI 10.1104/pp.126.2.575; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Whistler R.L., 1993, INTRO IND GUMS IND G, P1, DOI 10.1016/B978-0-08-092654-4.50005-X; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	29	258	284	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					363	366		10.1126/science.1090908	http://dx.doi.org/10.1126/science.1090908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726589				2022-12-01	WOS:000188111800041
J	Treanor, J				Treanor, J			Influenza vaccine - Outmaneuvering antigentic shift and drift	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		Univ Rochester, Med Ctr, Infect Dis Unit, Rochester, NY 14642 USA	University of Rochester	Treanor, J (corresponding author), Univ Rochester, Med Ctr, Infect Dis Unit, Rochester, NY 14642 USA.							Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Kilbourne ED, 1999, NAT MED, V5, P1119, DOI 10.1038/13436; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513	5	145	164	1	28	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2004	350	3					218	220		10.1056/NEJMp038238	http://dx.doi.org/10.1056/NEJMp038238			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763HF	14724300				2022-12-01	WOS:000188078400004
J	Liu, YL; Masson, JY; Shah, R; O'Regan, P; West, SC				Liu, YL; Masson, JY; Shah, R; O'Regan, P; West, SC			RAD51C is required for Holliday junction processing in mammalian cells	SCIENCE			English	Article							DNA-REPAIR PROTEINS; COMPLEX-FORMATION; IN-VITRO; RECOMBINATION; XRCC3; IDENTIFICATION; STABILITY; PARALOGS; BINDING; VIVO	During genetic recombination and the recombinational repair of chromosome breaks, DNA molecules become linked at points of strand exchange. Branch migration and resolution of these crossovers, or Holliday junctions (HJs), complete the recombination process. Here, we show that extracts from cells carrying mutations in the recombination/repair genes RAD51C or XRCC3 have reduced levels of HJ resolvase activity. Moreover, depletion of RAD51C from fractionated human extracts caused a loss of branch migration and resolution activity, but these functions were restored by complementation with a variety of RAD51 paralog complexes containing RAD51C. We conclude that the RAD51 paralogs are involved in HJ processing in human cells.	Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, S Mimms EN6 3LD, Herts, England	Cancer Research UK	West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, S Mimms, S Mimms EN6 3LD, Herts, England.			West, Stephen/0000-0001-8848-9418; Masson, Jean Yves/0000-0002-4403-7169				Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; BLEUYARD JY, IN PRESS EMBO J; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Braybrooke JP, 2003, J BIOL CHEM, V278, P48357, DOI 10.1074/jbc.M308838200; Brenneman MA, 2002, MOL CELL, V10, P387, DOI 10.1016/S1097-2765(02)00595-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; ELBOROUGH KM, 1988, NUCLEIC ACIDS RES, V16, P3603, DOI 10.1093/nar/16.9.3603; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Kurumizaka H, 2002, J BIOL CHEM, V277, P14315, DOI 10.1074/jbc.M105719200; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Liu Y., UNPUB; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200	25	245	258	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					243	246		10.1126/science.1093037	http://dx.doi.org/10.1126/science.1093037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716019				2022-12-01	WOS:000187908500053
J	Pecot, MY; Malhotra, V				Pecot, MY; Malhotra, V			Golgi membranes remain segregated from the endoplasmic reticulum during mitosis in mammalian cells	CELL			English	Article							HELA-CELLS; MITOTIC GOLGI; BREFELDIN-A; PROTEIN; FRAGMENTATION; COMPLEX; APPARATUS; INTERPHASE; VESICLES; DYNAMICS	What happens to organelles during mitosis, and how they are apportioned to each of the daughter cells, is not completely clear. We have devised a procedure to address whether Golgi membranes fuse with the Endoplasmic Reticulum (ER) during mitosis via the detection of interactions between ER and Golgi proteins. This procedure involves coexpressing an FKBP-tagged Golgi enzyme with an ER-retained protein fused to FRAP in COS cells. Since treatment with rapamycin induces a tight association between FKBP and FRAP, one would expect rapamycin to trap the FKBP-fused Golgi protein in the ER if it ever visits the ER during mitosis. However, after the doubly transfected cells progress through mitosis in the presence of rapamycin, we find the Golgi protein in the newly formed Golgi stacks and not in the ER. Based on these results, we conclude that Golgi membranes remain separate from the ER during mitosis in mammalian cells.	Univ Calif San Diego, Cell & Dev Biol Dept, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Cell & Dev Biol Dept, La Jolla, CA 92093 USA.	Malhotra@biomail.ucsd.edu	Malhotra, Vivek/O-9811-2014	Malhotra, Vivek/0000-0001-6198-7943				Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BURKE B, 1982, EMBO J, V1, P1621, DOI 10.1002/j.1460-2075.1982.tb01364.x; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FEATHERSTONE C, 1985, J CELL BIOL, V101, P2036, DOI 10.1083/jcb.101.6.2036; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Jesch SA, 2001, TRAFFIC, V2, P873, DOI 10.1034/j.1600-0854.2001.21203.x; Jokitalo E, 2001, J CELL BIOL, V154, P317, DOI 10.1083/jcb.200104073; Khalil H, 2003, INT IMMUNOL, V15, P1249, DOI 10.1093/intimm/dxg124; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; MAUL GG, 1970, CANCER RES, V30, P2326; Nebenfuhr A, 2001, TRENDS PLANT SCI, V6, P160, DOI 10.1016/S1360-1385(01)01891-X; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Puthenveedu MA, 2001, EXP CELL RES, V271, P22, DOI 10.1006/excr.2001.5367; ROBBINS E, 1964, J HISTOCHEM CYTOCHEM, V12, P704, DOI 10.1177/12.9.704; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SCHUTZE MP, 1994, EMBO J, V7, P1696; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; THYBERG J, 1992, J SUBMICR CYTOL PATH, V24, P495; Uchiyama K, 2003, J CELL BIOL, V161, P1067, DOI 10.1083/jcb.200303048; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; WIEDERRECHT G, 1991, P NATL ACAD SCI USA, V88, P1029, DOI 10.1073/pnas.88.3.1029; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	32	68	73	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 9	2004	116	1					99	107		10.1016/S0092-8674(03)01068-7	http://dx.doi.org/10.1016/S0092-8674(03)01068-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718170	Bronze			2022-12-01	WOS:000187960800012
J	Ruiz-Pesini, E; Mishmar, D; Brandon, M; Procaccio, V; Wallace, DC				Ruiz-Pesini, E; Mishmar, D; Brandon, M; Procaccio, V; Wallace, DC			Effects of purifying and adaptive selection on regional variation in human mtDNA	SCIENCE			English	Article							MITOCHONDRIAL-DNA; CYTOCHROME-B; DISEASE; LONGEVITY; POPULATION; HAPLOGROUPS; INHIBITION; UBIQUINOL; EVOLUTION; VARIANTS	A phylogenetic analysis of 1125 global human mitochondrial DNA (mtDNA) sequences permitted positioning of all nucleotide substitutions according to their order of occurrence. The relative frequency and amino acid conservation of internal branch replacement mutations was found to increase from tropical Africa to temperate Europe and arctic northeastern Siberia. Particularly highly conserved amino acid substitutions were found at the roots of multiple mtDNA lineages from higher latitudes. These same lineages correlate with increased propensity for energy deficiency diseases as well as longevity. Thus, specific mtDNA replacement mutations permitted our ancestors to adapt to more northern climates, and these same variants are influencing our health today.	Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Gen & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.		Mishmar, Dan/AAJ-6109-2020; Brandon, Marty C/A-1699-2009	Mishmar, Dan/0000-0003-3488-8792; procaccio, Vincent/0000-0002-1537-4684	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037167, R01NS021328, R01NS037167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64017] Funding Source: Medline; NIA NIH HHS [AG13154] Funding Source: Medline; NINDS NIH HHS [NS21328, NS37167] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Bonafe M, 2002, GENE, V286, P121, DOI 10.1016/S0378-1119(01)00812-5; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Brown MD, 1997, AM J HUM GENET, V60, P381; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DIRAGO JP, 1988, J BIOL CHEM, V263, P12564; Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474; Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Kalman B, 1996, J NEUROL SCI, V140, P75, DOI 10.1016/0022-510X(96)00112-8; Leonard WR, 2002, AM J HUM BIOL, V14, P609, DOI 10.1002/ajhb.10072; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Shinkarev VP, 2000, BIOCHEMISTRY-US, V39, P14232, DOI 10.1021/bi001179t; Templeton AR, 1996, GENETICS, V144, P1263; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4	26	610	632	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					223	226		10.1126/science.1088434	http://dx.doi.org/10.1126/science.1088434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716012				2022-12-01	WOS:000187908500046
J	Joliveau, E; Smith, J; Wolfe, J				Joliveau, E; Smith, J; Wolfe, J			Acoustics - Tuning of vocal tract resonance by sopranos	NATURE			English	Editorial Material							JAW		Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Joliveau, E (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	john.smith@unsw.edu.au		Wolfe, Joe/0000-0001-8030-0561				BERLIOZ H, 1882, GRAND TRAITE INSTRUM; DOWD A, 1997, LANG SPEECH, V41, P1; Epps J, 1997, MEAS SCI TECHNOL, V8, P1112, DOI 10.1088/0957-0233/8/10/012; Hollien H, 2000, J VOICE, V14, P287, DOI 10.1016/S0892-1997(00)80038-7; LINDBLOM BE, 1971, J ACOUST SOC AM, V50, P1166, DOI 10.1121/1.1912750; PANG T, 1973, SPEECH SOUNDS FEATUR; SUNDBERG J, 1975, ACUSTICA, V32, P89; Sundberg J, 1997, J VOICE, V11, P301, DOI 10.1016/S0892-1997(97)80008-2; Sundberg J., 1987, SCI SINGING VOICE; 1973, SPEECH SOUNDS FEATUR	10	59	61	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					116	116		10.1038/427116a	http://dx.doi.org/10.1038/427116a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712266				2022-12-01	WOS:000187863900025
J	Hersh, AL; Stefanick, ML; Stafford, RS				Hersh, AL; Stefanick, ML; Stafford, RS			National use of postmenopausal hormone therapy - Annual trends and response to recent evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; CALCIUM-CHANNEL BLOCKERS; HEALTH INITIATIVE MEMORY; CORONARY-HEART-DISEASE; REPLACEMENT THERAPY; CARDIOVASCULAR-DISEASE; UNITED-STATES; NONCONTRACEPTIVE ESTROGENS; PRIMARY PREVENTION	Context Postmenopausal hormone therapy use increased dramatically during the past 2 decades because of a prevailing belief in its health benefits. Recent evidence from randomized trials published in July 2002 demonstrated adverse cardiovascular disease events and other risks with hormone therapy in the form of oral estrogen combined with progestin. Objective To describe patterns of hormone therapy use from 1995 until July 2003, including the impact of recent evidence. Design, Setting, and Population Two databases were used to describe national trends in hormone therapy use from January 1995 to July 2003. The National Prescription Audit database provided data on the number of hormone therapy prescriptions filled by retail pharmacies and the National Disease and Therapeutic Index database provided data on patient visits to office-based physicians during which hormone therapy was prescribed. Main Outcome Measures Annual number of hormone therapy prescriptions and characteristics of visits to physicians during which hormone therapy was prescribed. Results Annual hormone therapy prescriptions increased from 58 million in 1995 to 90 million in 1999, representing approximately 15 million women per year, then remained stable through June 2002. Adoption of new oral estrogen/progestin combinations, primarily Prempro, accounted for most of this growth. Obstetrician/gynecologists provided more than 70% of hormone therapy prescriptions, and more than one third of patients were older than 60 years. Following the publication of trial results in July 2002, hormone therapy prescriptions declined in successive months. Relative to January-June 2002, prescriptions from January-June 2003 declined by 66% for Prempro and 33% for Premarin. Small increases were observed in vaginal formulations and in new prescriptions for low-dose Premarin. If prescription rates observed through July 2003 remain stable, a decline to 57 million prescriptions for 2003, similar to the rate in 1995, is projected. Conclusions Clinical practice responded rapidly to recent evidence of harms associated with hormone therapy. Since July 2002, many patients have discontinued hormone therapy or are tapering to lower doses.	Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Stanford, CA 94305 USA	Stanford University	Stafford, RS (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Stanford, CA 94305 USA.		Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013405] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007034] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS013405] Funding Source: Medline; NHLBI NIH HHS [5T32-HL07034] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ascott-Evans BH, 2003, ARCH INTERN MED, V163, P789, DOI 10.1001/archinte.163.7.789; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; Berg AO, 2002, ANN INTERN MED, V137, P834, DOI 10.7326/0003-4819-137-10-200211190-00013; BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Erblich J, 2000, PREV MED, V31, P714, DOI 10.1006/pmed.2000.0765; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; HEMMINKI E, 1988, AM J PUBLIC HEALTH, V78, P1478, DOI 10.2105/AJPH.78.11.1479; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441; Maclure M, 1998, LANCET, V352, P943, DOI 10.1016/S0140-6736(97)11390-3; Majumdar SR, 2001, J GEN INTERN MED, V16, P351, DOI 10.1046/j.1525-1497.2001.016006351.x; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P882, DOI 10.1001/jama.288.7.882; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Solomon CG, 2003, NEW ENGL J MED, V348, P579, DOI 10.1056/NEJMp030006; STAFFORD RS, IN PRESS ARCH INTERN; *US CENS BUR, RES POP EST US AG SE; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; *WHI, HRT UPD 2001; Whitlock EP, 1998, J WOMENS HEALTH, V7, P1017, DOI 10.1089/jwh.1998.7.1017; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F	31	728	738	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2004	291	1					47	53		10.1001/jama.291.1.47	http://dx.doi.org/10.1001/jama.291.1.47			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760LX	14709575				2022-12-01	WOS:000187836000018
J	Marsh, RL; Ellerby, DJ; Carr, JA; Henry, HT; Buchanan, CI				Marsh, RL; Ellerby, DJ; Carr, JA; Henry, HT; Buchanan, CI			Partitioning the energetics of walking and running: Swinging the limbs is expensive	SCIENCE			English	Article							GENERATING MUSCULAR FORCE; SKELETAL-MUSCLE; BLOOD-FLOW; TREADMILL EXERCISE; METABOLIC COST; RAT MUSCLES; CONTRACTION; LOCOMOTION; HYPEREMIA; PATTERNS	Explaining the energetics of walking and running has been difficult because the distribution of energy use among individual muscles has not been known. We estimated energy use by measuring blood flow to the hindlimb muscles in guinea fowl. Blood flow to skeletal muscles is controlled locally and varies directly with metabolic rate. We estimate that the swing-phase muscles consume 26% of the energy used by the limbs and the stance-phase muscles consume the remaining 74%, independent of speed. Thus, contrary to some previous suggestions, swinging the limbs requires an appreciable fraction of the energy used during terrestrial legged locomotion. Models integrating the energetics and mechanics of running will benefit from more detailed information on the distribution of energy use by the muscles.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Northeastern Univ, Dept Phys Therapy, Boston, MA 02115 USA	Northeastern University; Northeastern University	Marsh, RL (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA.	r.marsh@neu.edu	Ellerby, David/B-7975-2013	Ellerby, David/0000-0003-4045-0201; Marsh, Richard/0000-0002-4264-9890	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047337] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR47337] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altringham JD, 1999, J EXP BIOL, V202, P3397; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; ARMSTRONG RB, 1988, AM J CARDIOL, V62, pE9, DOI 10.1016/S0002-9149(88)80003-1; ARMSTRONG RB, 1986, J APPL PHYSIOL, V61, P683, DOI 10.1152/jappl.1986.61.2.683; ARMSTRONG RB, 1983, J PHYSIOL-LONDON, V344, P189, DOI 10.1113/jphysiol.1983.sp014933; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; CAVAGNA GA, 1977, AM J PHYSIOL, V233, P243; Ellerby DJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P695, DOI 10.1086/376430; ENGLISH AW, 1987, J MORPHOL, V191, P161, DOI 10.1002/jmor.1051910207; FEDAK MA, 1982, J EXP BIOL, V79, P23; Gatesy SM, 1999, J MORPHOL, V240, P127, DOI 10.1002/(SICI)1097-4687(199905)240:2<127::AID-JMOR4>3.0.CO;2-Q; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; GRUBB B, 1983, J EXP BIOL, V104, P193; Hedrick TL, 2003, J EXP BIOL, V206, P1363, DOI 10.1242/jeb.00272; Holloszy John O., 1998, Frontiers in Bioscience, V3, pD1011; Johnston RM, 1996, J COMP PHYSIOL A, V179, P169, DOI 10.1007/BF00222784; KLABUNDE RE, 1977, AM J PHYSIOL, V232, pH411, DOI 10.1152/ajpheart.1977.232.4.H411; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kram R, 2000, Exerc Sport Sci Rev, V28, P138; Laughlin MH, 2001, MED SCI SPORT EXER, V33, P81; LAUGHLIN MH, 1983, AM J PHYSIOL, V244, pH814, DOI 10.1152/ajpheart.1983.244.6.H814; Murrant CL, 2000, ACTA PHYSIOL SCAND, V168, P531, DOI 10.1046/j.1365-201x.2000.00706.x; MYERS MJ, 1985, J EXP BIOL, V116, P363; Roberts TJ, 1998, J EXP BIOL, V201, P2745; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; STEUDEL K, 1990, J EXP BIOL, V154, P287; TAYLOR CR, 1980, J EXP BIOL, V86, P9; TAYLOR CR, 1994, COMP VERTEBRATE EXER, P181; TYML K, 1986, MICROVASC RES, V32, P84, DOI 10.1016/0026-2862(86)90045-2; Vanden Berge JC., 1993, HDB AVIAN ANATOMY NO, P189	31	162	163	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					80	83		10.1126/science.1090704	http://dx.doi.org/10.1126/science.1090704			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704426				2022-12-01	WOS:000187710600037
J	Heil, F; Hemmi, H; Hochrein, H; Ampenberger, F; Kirschning, C; Akira, S; Lipford, G; Wagner, H; Bauer, S				Heil, F; Hemmi, H; Hochrein, H; Ampenberger, F; Kirschning, C; Akira, S; Lipford, G; Wagner, H; Bauer, S			Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; BACTERIAL-DNA; IN-VITRO; B-CELLS; ACTIVATION; ANTIGEN; RESPONSIVENESS; MATURATION; SUBFAMILY	Double-stranded ribonucleic acid (dsRNA) serves as a danger signal associated with viral infection and leads to stimulation of innate immune cells. In contrast, the immunostimulatory potential of single-stranded RNA (ssRNA) is poorly understood and innate immune receptors for ssRNA are unknown. We report that guanosine (G)- and uridine (U)-rich ssRNA oligonucleotides derived from human immunodeficiency virus-1 (HIV-1) stimulate dendritic cells (DC) and macrophages to secrete interferon-alpha and proinflammatory, as well as regulatory, cytokines. By using Toll-like receptor (TLR)-deficient mice and genetic complementation, we show that murine TLR7 and human TLR8 mediate species-specific recognition of GU-rich ssRNA. These data suggest that ssRNA represents a physiological ligand for TLR7 and TLR8.	Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, ERATO, Osaka 5650047, Japan; Coley Pharmaceut Grp Inc, Wellesley, MA 02481 USA	Technical University of Munich; Osaka University; Japan Science & Technology Agency (JST); Coley Pharmaceutical Group	Bauer, S (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Trogerstr 9, D-81675 Munich, Germany.	stefan.bauer@lrz.tum.de	Akira, Shizuo/C-3134-2009; Yang, Chen/G-1379-2010; Hochrein, Hubertus/L-3697-2013	Bauer, Stefan/0000-0002-8462-1845; Hochrein, Hubertus/0000-0001-9904-1934				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; HEIL F, UNPUB; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HEMMI H, UNPUB; HOET RM, 1992, J CLIN INVEST, V90, P1753, DOI 10.1172/JCI116049; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Koido S, 2000, J IMMUNOL, V165, P5713, DOI 10.4049/jimmunol.165.10.5713; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710	25	2782	3109	8	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1526	1529		10.1126/science.1093620	http://dx.doi.org/10.1126/science.1093620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	14976262				2022-12-01	WOS:000220000100045
J	Levy, J; Bres, C; Geurts, R; Chalhoub, B; Kulikova, O; Duc, G; Journet, EP; Ane, JM; Lauber, E; Bisseling, T; Denarie, J; Rosenberg, C; Debelle, F				Levy, J; Bres, C; Geurts, R; Chalhoub, B; Kulikova, O; Duc, G; Journet, EP; Ane, JM; Lauber, E; Bisseling, T; Denarie, J; Rosenberg, C; Debelle, F			A putative Ca2+ and calmodulin-dependent protein kinase required for bacterial and fungal symbioses	SCIENCE			English	Article							NOD FACTOR TRANSDUCTION; MEDICAGO-TRUNCATULA; CALCIUM SPIKING; NODULATION; GENE; RESPONSES; MUTANTS; SIGNAL; RECOGNITION; PERCEPTION	Legumes can enter into symbiotic relationships with both nitrogen-fixing bacteria ( rhizobia) and mycorrhizal fungi. Nodulation by rhizobia results from a signal transduction pathway induced in legume roots by rhizobial Nod factors. DMI3, a Medicago truncatula gene that acts immediately downstream of calcium spiking in this signaling pathway and is required for both nodulation and mycorrhizal infection, has high sequence similarity to genes encoding calcium and calmodulin-dependent protein kinases (CCaMKs). This indicates that calcium spiking is likely an essential component of the signaling cascade leading to nodule development and mycorrhizal infection, and sheds light on the biological role of plant CCaMKs.	INRA, CNRS, Lab Interact Plantes Micoorganismes, F-31326 Castanet Tolosan, France; Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands; INRA, Unite Rech Gen Vegetale, F-91057 Evry, France; INRA, Unite Rech Genet & Ecophysiol Legumineuses, F-21065 Dijon, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Wageningen University & Research; INRAE; INRAE	Debelle, F (corresponding author), INRA, CNRS, Lab Interact Plantes Micoorganismes, BP27, F-31326 Castanet Tolosan, France.	debelle@toulouse.inra.fr	Bisseling, Ton/A-2421-2013; Ané, Jean-Michel/G-5921-2010; Lauber, Emmanuelle/ABB-3077-2021; Journet, Etienne-Pascal/AAE-1573-2022; Journet, Etienne-Pascal/C-5878-2018; levy, julien G./I-9904-2019; Bres, Cecile/F-8305-2013	Ané, Jean-Michel/0000-0002-3128-9439; Lauber, Emmanuelle/0000-0001-5933-4476; Journet, Etienne-Pascal/0000-0003-1704-2998; Journet, Etienne-Pascal/0000-0003-1704-2998; levy, julien G./0000-0002-1422-2195; Bres, Cecile/0000-0001-6460-4637				Ane JM, 2002, MOL PLANT MICROBE IN, V15, P1108, DOI 10.1094/MPMI.2002.15.11.1108; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; DUC G, 1989, PLANT SCI, V60, P215, DOI 10.1016/0168-9452(89)90169-6; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; GianinazziPearson V, 1996, PLANT CELL, V8, P1871, DOI 10.1105/tpc.8.10.1871; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Oldroyd GED, 2001, PLANT J, V28, P191, DOI 10.1046/j.1365-313X.2001.01149.x; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; Poovaiah BW, 1999, PLANTA, V209, P161, DOI 10.1007/s004250050618; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Sathyanarayanan PV, 2002, EUR J BIOCHEM, V269, P2457, DOI 10.1046/j.1432-1033.2002.02904.x; Sathyanarayanan PV, 2001, J BIOL CHEM, V276, P32940, DOI 10.1074/jbc.M009648200; Schneider A, 2002, THEOR APPL GENET, V104, P1312, DOI 10.1007/s00122-002-0896-2; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Wang WY, 1999, J BIOL CHEM, V274, P12001, DOI 10.1074/jbc.274.17.12001; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004	28	531	571	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1361	1364		10.1126/science.1093038	http://dx.doi.org/10.1126/science.1093038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14963335				2022-12-01	WOS:000189238600049
J	Luo, LF; Yang, XP; Takihara, Y; Knoetgen, H; Kessel, M				Luo, LF; Yang, XP; Takihara, Y; Knoetgen, H; Kessel, M			The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions	NATURE			English	Article							DNA-REPLICATION; GENE-EXPRESSION; SEX COMB; PROTEIN; PROLIFERATION; BINDING; SPECIFICATION; PROGRESSION; REPRESSION; HOMOLOG	Embryonic development is tightly controlled. The clustered genes of the Hox family of homeobox proteins play an important part in regulating this development and also proliferation. They specify embryonic structures along the body axis, and are associated with normal and malignant cell growth(1-4). The cell-cycle regulator geminin controls replication by binding to the licensing factor Cdt1, and is involved in neural differentiation(5-7). Here, we show that murine geminin associates transiently with members of the Hox-repressing polycomb complex, with the chromatin of Hox regulatory DNA elements and with Hox proteins. Gain- and loss-of-function experiments in the chick neural tube demonstrate that geminin modulates the anterior boundary of Hoxb9 transcription, which suggests a polycomblike activity for geminin. The interaction between geminin and Hox proteins prevents Hox proteins from binding to DNA, inhibits Hox-dependent transcriptional activation of reporter and endogenous downstream target genes, and displaces Cdt1 from its complex with geminin. By establishing competitive regulation, geminin functions as a coordinator of developmental and proliferative control.	Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Res Grp Dev Biol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Mol Genet, D-37077 Gottingen, Germany; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Stem Cell Biol, Hiroshima 7348553, Japan	Max Planck Society; Max Planck Society; Hiroshima University	Kessel, M (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Res Grp Dev Biol, D-37077 Gottingen, Germany.	mkessel1@gwdg.de						Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Akasaka T, 1996, DEVELOPMENT, V122, P1513; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Care A, 1996, MOL CELL BIOL, V16, P4842; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Krosl J, 1998, ONCOGENE, V16, P3403, DOI 10.1038/sj.onc.1201883; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kulartz M, 2003, BIOCHEM BIOPH RES CO, V305, P412, DOI 10.1016/S0006-291X(03)00773-3; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Megason SG, 2002, DEVELOPMENT, V129, P2087; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; SEMENZA GL, 1995, BIOCHEM BIOPH RES CO, V209, P257, DOI 10.1006/bbrc.1995.1497; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tetsu O, 1998, IMMUNITY, V9, P439, DOI 10.1016/S1074-7613(00)80627-5; Thornhill S, 1997, PHYS WORLD, V10, P17; Tomotsune D, 1999, DIFFERENTIATION, V65, P229, DOI 10.1046/j.1432-0436.1999.6540229.x; Wohlschlegel JA, 2002, AM J PATHOL, V161, P267, DOI 10.1016/S0002-9440(10)64178-8; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309	29	180	181	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					749	753		10.1038/nature02305	http://dx.doi.org/10.1038/nature02305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973489	Green Published			2022-12-01	WOS:000189026000047
J	Ferrando, AA; Neuberg, DS; Dodge, RK; Paietta, E; Larson, RA; Wiernik, PH; Rowe, JM; Caligiuri, MA; Bloomfield, CD; Look, AT				Ferrando, AA; Neuberg, DS; Dodge, RK; Paietta, E; Larson, RA; Wiernik, PH; Rowe, JM; Caligiuri, MA; Bloomfield, CD; Look, AT			Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia	LANCET			English	Article								The activation of oncogenic transcription factors defines distinct molecular subsets of T-cell acute lymphoblastic leukaemia and has prognostic. relevance in children. We investigated the prognostic effect of the expression levels of eight oncogenic transcription factors-TLX1 (HOX11), TLX3 (HOX11L2), TAL1, TAL2, LYL1, OLIG2 (BHLHB1), LMO1, and LMO2-in 52 adults with T-cell acute lymphoblastic leukaemia. The leukaemia-specific survival rate for the 16 TLX1-positive patients was 88% (90% CI 73-100%), compared with 56% (42-70%) for all other cases (p=0.019). Only the TLX1 oncogene expression subgroup showed difference in leukaemia-specific survival. Our results suggest that overexpression of TLX1 confers a good outlook for adults with T-cell acute lymphoblastic leukaemia. Furthermore, our findings lead to questions about whether stem-cell transplantation in first remission is necessary for effective treatment of patients in the low-risk subgroup of patients with TLX1 oncogene expression.	Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA; Our Lady Mercy Med Ctr, Eastern Cooperat Oncol Grp, Bronx, NY USA; Duke Univ, Med Ctr, Canc & Leukemia Grp B, Durham, NC 27706 USA; Univ Chicago, Chicago, IL 60637 USA; Rambam Med Ctr, Dept Hematol & BMT, Haifa, Israel; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Duke University; University of Chicago; Rambam Health Care Campus; Technion Israel Institute of Technology; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Look, AT (corresponding author), Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St,Mayer 630, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Larson, Richard A./AAE-7223-2019	Larson, Richard A./0000-0001-9168-3203	NCI NIH HHS [CA77658, CA31946, CA23318, CA21115, CA101140, CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058, U10CA021115, U10CA077658, U10CA031946, U10CA023318, U10CA101140] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ferrando AA, 2000, SEMIN HEMATOL, V37, P381, DOI 10.1053/shem.2000.16447; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; FIERE D, 1993, J CLIN ONCOL, V11, P1990, DOI 10.1200/JCO.1993.11.10.1990; Gray R, 1988, ANN STAT, V16, P1140; Kees UR, 2003, LEUKEMIA, V17, P887, DOI 10.1038/sj.leu.2402892	5	106	114	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2004	363	9408					535	536		10.1016/S0140-6736(04)15542-6	http://dx.doi.org/10.1016/S0140-6736(04)15542-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TA	14975618				2022-12-01	WOS:000188999900013
J	Rasmussen, S; Chen, LH; Deamer, D; Krakauer, DC; Packard, NH; Stadler, PF; Bedau, MA				Rasmussen, S; Chen, LH; Deamer, D; Krakauer, DC; Packard, NH; Stadler, PF; Bedau, MA			Transitions from nonliving to living matter	SCIENCE			English	Editorial Material							LIFE		Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Argonne Natl Lab, Argonne, IL 60439 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Santa Fe Inst, Santa Fe, NM 87506 USA; Protolife Srl, Venice, Italy; Univ Leipzig, Leipzig, Germany; Reed Coll, Portland, OR 97202 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Santa Cruz; The Santa Fe Institute; Leipzig University; Reed College - Oregon	Rasmussen, S (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	steen@lanl.gov	Stadler, Peter F. F/L-7857-2015	Stadler, Peter F. F/0000-0002-5016-5191				Bedau MA, 2000, ARTIF LIFE, V6, P363, DOI 10.1162/106454600300103683; Eckardt LH, 2002, NATURE, V420, P286, DOI 10.1038/420286a; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Luisi PL, 2004, ORIGINS LIFE EVOL B, V34, P1, DOI 10.1023/B:ORIG.0000009999.54565.63; Pohorille A, 2002, TRENDS BIOTECHNOL, V20, P123, DOI 10.1016/S0167-7799(02)01909-1; Rasmussen S, 2003, ARTIF LIFE, V9, P269, DOI 10.1162/106454603322392479; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176	8	202	215	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					963	965		10.1126/science.1093669	http://dx.doi.org/10.1126/science.1093669			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963315				2022-12-01	WOS:000188918000029
J	Westover, KD; Bushnell, DA; Kornberg, RD				Westover, KD; Bushnell, DA; Kornberg, RD			Structural basis of transcription: Separation of RNA from DNA by RNA polymerase II	SCIENCE			English	Article							ELONGATION COMPLEX; RESOLUTION; STABILITY; HYBRID	The structure of an RNA polymerase II-transcribing complex has been determined in the posttranslocation state, with a vacancy at the growing end of the RNA-DNA hybrid helix. At the opposite end of the hybrid helix, the RNA separates from the template DNA. This separation of nucleic acid strands is brought about by interaction with a set of proteins loops in a strand/loop network. Formation of the network must occur in the transition from abortive initiation to promoter escape.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Westover, Ken/AAZ-1795-2020	Westover, Ken/0000-0003-3653-5923	NIGMS NIH HHS [GM49985] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; BUSHNELL DA, 2004, SCIENCE, V303; CHRISTOPHER JA, 1998, SPOCK; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Krapp S, 1998, NAT STRUCT BIOL, V5, P110, DOI 10.1038/nsb0298-110; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; TINTUT Y, 1995, GENE DEV, V9, P2305, DOI 10.1101/gad.9.18.2305; WESTOVER KD, UNPUB	12	208	214	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1014	1016		10.1126/science.1090839	http://dx.doi.org/10.1126/science.1090839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963331				2022-12-01	WOS:000188918000046
J	Cullen, T				Cullen, T			The chronicity of chronic disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												theresa.cullen@ihs.gov							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2004	291	6					671	672		10.1001/jama.291.6.671	http://dx.doi.org/10.1001/jama.291.6.671			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AY	14871900				2022-12-01	WOS:000188819200001
J	Palazzo, AF; Eng, CH; Schlaepfer, DD; Marcantonio, EE; Gundersen, GG				Palazzo, AF; Eng, CH; Schlaepfer, DD; Marcantonio, EE; Gundersen, GG			Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling	SCIENCE			English	Article							FOCAL ADHESION KINASE; DETYROSINATED GLU MICROTUBULES; TRANSFORMATION	Microtubule (MT) stabilization is regulated by the small guanosine triphosphate (GTP)-binding protein Rho and its effector, mammalian homolog of Diaphanous (mDia), in migrating cells, but factors responsible for localized stabilization at the leading edge are unknown. We report that integrin-mediated activation of focal adhesion kinase (FAK) at the leading edge is required for MT stabilization by the Rho-mDia signaling pathway in mouse fibroblasts. MT stabilization also involved FAK-regulated localization of a lipid raft marker, ganglioside G(M1), to the leading edge. The integrin-FAK signaling pathway may facilitate Rho-mDia signaling through G(M1), or through a specialized membrane domain containing G(M1), to stabilize MTs in the leading edge of migrating cells.	Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92307 USA	Columbia University; Columbia University; Columbia University; Scripps Research Institute	Gundersen, GG (corresponding author), Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, 630 W 168th St, New York, NY 10032 USA.	ggg1@columbia.edu	Palazzo, Alexander/B-1270-2013	Palazzo, Alexander/0000-0002-9700-1995	NCI NIH HHS [CA87038] Funding Source: Medline; NIGMS NIH HHS [GM 62939, GM 68695, GM 44585] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062939, R01GM044585] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CHAN PY, 1994, J BIOL CHEM, V269, P20567; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; ILLC D, 1995, NATURE, V377, P539; Infante AS, 2000, J CELL SCI, V113, P3907; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056	24	348	356	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					836	839		10.1126/science.1091325	http://dx.doi.org/10.1126/science.1091325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764879				2022-12-01	WOS:000188753800057
J	Li, T; Chang, CY; Jin, DY; Lin, PJ; Khvorova, A; Stafford, DW				Li, T; Chang, CY; Jin, DY; Lin, PJ; Khvorova, A; Stafford, DW			Identification of the gene for vitamin K epoxide reductase	NATURE			English	Article							DEPENDENT PROTEINS; WARFARIN; TARGET; EMBRYOPATHY; CARBOXYLASE; EXPRESSION; RESISTANCE; LOCUS; MICE	Vitamin K epoxide reductase (VKOR) is the target of warfarin, the most widely prescribed anticoagulant for thromboembolic disorders. Although estimated to prevent twenty strokes per induced bleeding episode(1), warfarin is under-used because of the difficulty of controlling dosage and the fear of inducing bleeding. Although identified in 1974 (ref. 2), the enzyme has yet to be purified or its gene identified. A positional cloning approach has become possible after the mapping of warfarin resistance to rat chromosome 1 (ref. 3) and of vitamin K-dependent protein deficiencies to the syntenic region of human chromosome 16 (ref. 4). Localization of VKOR to 190 genes within human chromosome 16p12-q21 narrowed the search to 13 genes encoding candidate transmembrane proteins, and we used short interfering RNA (siRNA) pools against individual genes to test their ability to inhibit VKOR activity in human cells. Here, we report the identification of the gene for VKOR based on specific inhibition of VKOR activity by a single siRNA pool. We confirmed that MGC11276 messenger RNA encodes VKOR through its expression in insect cells and sensitivity to warfarin. The expressed enzyme is 163 amino acids long, with at least one transmembrane domain. Identification of the VKOR gene extends our understanding of blood clotting, and should facilitate development of new anticoagulant drugs.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Dharmacon Inc, Lafayette, CO 80026 USA	University of North Carolina; University of North Carolina Chapel Hill	Stafford, DW (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	dws@email.unc.edu						BARR M, 1976, TERATOLOGY, V14, P129, DOI 10.1002/tera.1420140203; Bohley P, 1996, BIOL CHEM, V377, P425; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; CARLISLE TL, 1980, BIOCHEMISTRY-US, V19, P1161, DOI 10.1021/bi00547a019; DICE JF, 1975, P NATL ACAD SCI USA, V72, P3893, DOI 10.1073/pnas.72.10.3893; Fregin A, 2002, BLOOD, V100, P3229, DOI 10.1182/blood-2002-03-0698; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harborth J, 2001, J CELL SCI, V114, P4557; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Horton JD, 1999, AM FAM PHYSICIAN, V59, P635; HOWE AM, 1992, TERATOLOGY, V46, P379, DOI 10.1002/tera.1420460408; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; KHOVOROVA A, 2003, CELL, V115, P1; Kohn MH, 2000, BLOOD, V96, P1996, DOI 10.1182/blood.V96.5.1996.h8001996_1996_1998; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Li T, 2000, J BIOL CHEM, V275, P18291, DOI 10.1074/jbc.M001790200; Lin PJ, 2002, J BIOL CHEM, V277, P28584, DOI 10.1074/jbc.M202292200; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Presnell SR, 2002, THROMB HAEMOSTASIS, V87, P937, DOI 10.1055/s-0037-1613115; Scaringe SA, 2000, METHOD ENZYMOL, V317, P3; STEVENSON RE, 1980, JAMA-J AM MED ASSOC, V243, P1549, DOI 10.1001/jama.243.15.1549; THIJSSEN HHW, 1994, BIOCHEM J, V297, P277, DOI 10.1042/bj2970277; Tsaioun KI, 1999, NUTR REV, V57, P231, DOI 10.1111/j.1753-4887.1999.tb06950.x; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935; Zhang WL, 1996, J BIOL CHEM, V271, P18825, DOI 10.1074/jbc.271.31.18825; ZIMMERMA.A, 1974, BIOCHEM PHARMACOL, V23, P1033, DOI 10.1016/0006-2952(74)90002-1	30	537	575	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					541	544		10.1038/nature02254	http://dx.doi.org/10.1038/nature02254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765195				2022-12-01	WOS:000188721800041
J	Davies, P; Nwokoro, C; Leigh, M				Davies, P; Nwokoro, C; Leigh, M			Vaccinations against influenza and pneumococcus in children with diabetes: telephone questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article									Bedford Hosp NHS Trust, Dept Paediat, Bedford MK42 9DJ, England		Davies, P (corresponding author), Bedford Hosp NHS Trust, Dept Paediat, Bedford MK42 9DJ, England.	daviespatrick@hotmail.com	Nwokoro, Chinedu/A-1516-2013	Nwokoro, Chinedu/0000-0002-0355-7803				[Anonymous], IMM INF DIS; BOUTER KP, 1991, DIABETES RES CLIN PR, V12, P61, DOI 10.1016/0168-8227(91)90131-V; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; *PARK WAICHM, FREE CAS EV INFL VAC; FLU VACCINE REACTION	5	11	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 24	2004	328	7433					203	203		10.1136/bmj.328.7433.203	http://dx.doi.org/10.1136/bmj.328.7433.203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	769LU	14739188	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000188652200015
J	Focia, PJ; Shepotinovskaya, IV; Seidler, JA; Freymann, DM				Focia, PJ; Shepotinovskaya, IV; Seidler, JA; Freymann, DM			Heterodimeric GTPase core of the SRP targeting complex	SCIENCE			English	Article							SIGNAL-RECOGNITION PARTICLE; THERMUS-AQUATICUS FFH; CRYSTAL-STRUCTURE; NG DOMAIN; ENDOPLASMIC-RETICULUM; SEQUENCE RECOGNITION; CONSERVED GTPASE; STRUCTURAL BASIS; FTSY; BINDING	Two structurally homologous guanosine triphosphatase ( GTPase) domains interact directly during signal recognition particle (SRP)-mediated cotranslational targeting of proteins to the membrane. The 2.05 angstrom structure of a complex of the NG GTPase domains of Ffh and FtsY reveals a remarkably symmetric heterodimer sequestering a composite active site that contains two bound nucleotides. The structure explains the coordinate activation of the two GTPases. Conformational changes coupled to formation of their extensive interface may function allosterically to signal formation of the targeting complex to the signal-sequence binding site and the translocon. We propose that the complex represents a molecular "latch" and that its disengagement is regulated by completion of assembly of the GTPase active site.	Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Freymann, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, 303 E Chicago Ave, Chicago, IL 60611 USA.			Freymann, Douglas/0000-0002-5231-8841	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058500] Funding Source: NIH RePORTER; NCRR NIH HHS [RR07707, P41 RR007707] Funding Source: Medline; NIGMS NIH HHS [GM58500, R01 GM058500] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Cleverley RM, 2002, J BIOL CHEM, V277, P46763, DOI 10.1074/jbc.M207427200; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Focia PJ, 2004, PROTEINS, V54, P222, DOI 10.1002/prot.10598; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Freymann DM, 1999, NAT STRUCT BIOL, V6, P793, DOI 10.1038/11572; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lu Y, 2001, EMBO J, V20, P6724, DOI 10.1093/emboj/20.23.6724; LUTCKE H, 1992, EMBO J, V11, P1543, DOI 10.1002/j.1460-2075.1992.tb05199.x; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Montoya G, 2000, STRUCTURE, V8, P515, DOI 10.1016/S0969-2126(00)00131-3; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; Newitt JA, 1997, EUR J BIOCHEM, V245, P720, DOI 10.1111/j.1432-1033.1997.00720.x; Padmanabhan S, 2001, STRUCTURE, V9, P859, DOI 10.1016/S0969-2126(01)00641-4; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Ramirez UD, 2002, J MOL BIOL, V320, P783, DOI 10.1016/S0022-2836(02)00476-X; RAPIEJKO PJ, 1994, MOL BIOL CELL, V5, P887, DOI 10.1091/mbc.5.8.887; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shepotinovskaya IV, 2003, ACTA CRYSTALLOGR D, V59, P1834, DOI 10.1107/S0907444903016573; Shepotinovskaya IV, 2002, BBA-PROTEIN STRUCT M, V1597, P107, DOI 10.1016/S0167-4838(02)00287-X; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	34	217	218	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					373	377		10.1126/science.1090827	http://dx.doi.org/10.1126/science.1090827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726591	Green Accepted			2022-12-01	WOS:000188111800044
J	Dong, XP; Donoghue, PCJ; Cheng, H; Liu, JB				Dong, XP; Donoghue, PCJ; Cheng, H; Liu, JB			Fossil embryos from the Middle and Late Cambrian period of Hunan, South China	NATURE			English	Article								Comparative embryology is integral to uncovering the pattern and process of metazoan phylogeny(1), but it relies on the assumption that life histories of living taxa are representative of their antecedents. Fossil embryos provide a crucial test of this assumption and, potentially, insight into the evolution of development, but because discoveries so far(2-5) lack phylogenetic constraint, their significance is moot. Here we describe a collection of embryos from the Middle and Late Cambrian period (500 million years ago) of Hunan, south China, that preserves stages of development from cleavage to the pre-hatching embryo of a direct-developing animal comparable to living Scalidophora (phyla Priapulida, Kinorhyncha, Loricifera). The latest-stage embryos show affinity to the Lower Cambrian embryo Markuelia(3), whose life-history strategy contrasts both with the primitive condition inferred for metazoan phyla and with many proposed hypotheses of affinity(3,6), all of which prescribe indirect development. Phylogenetic tests based on these embryological data suggest a stem Scalidophora affinity. These discoveries corroborate, rather than contradict, the predictions of comparative embryology, providing direct historical support for the view that the life-history strategies of living taxa are representative of their stem lineages.	Peking Univ, Dept Geol, Beijing 100871, Peoples R China; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Peking University; University of Bristol; Peking University	Dong, XP (corresponding author), Peking Univ, Dept Geol, Beijing 100871, Peoples R China.	dongxp@pku.edu.cn; phil.donoghue@bristol.ac.uk	Donoghue, Philip/A-3873-2008; Dong, Xi-ping/N-5741-2014	Donoghue, Philip/0000-0003-3116-7463; Dong, Xi-ping/0000-0001-5917-7159				Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; Bohall PJ, 1997, INVERTEBR BIOL, V116, P26, DOI 10.2307/3226921; BRIGGS DEG, 1993, J GEOL SOC LONDON, V150, P1035, DOI 10.1144/gsjgs.150.6.1035; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 2003, SYST ASSOC SPEC VOL, P166; CRIMES TP, 1987, GEOL MAG, V124, P97; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Jenkins RJF, 2002, J GEOL SOC LONDON, V159, P645, DOI 10.1144/0016-764901-127; Kouchinsky A, 1999, GEOLOGY, V27, P609, DOI 10.1130/0091-7613(1999)027<0609:CLEAWT>2.3.CO;2; Lemburg C., 1999, ULTRASTRUKTURELLE UN; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; Morris SC, 1998, BIOESSAYS, V20, P676, DOI 10.1002/(SICI)1521-1878(199808)20:8<676::AID-BIES11>3.0.CO;2-W; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Schmidt-Rhaesa A, 1998, ZOOL ANZ, V236, P203; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; VOLKOV AK, 1983, POZDNIJ DOKEMBRIJ RA, P37; Wills MA, 1998, PALEOBIOLOGY, V24, P177; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; ZHANG XG, 1994, SCIENCE, V266, P637, DOI 10.1126/science.266.5185.637	20	98	125	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					237	240		10.1038/nature02215	http://dx.doi.org/10.1038/nature02215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724636				2022-12-01	WOS:000188068100041
J	Hallem, EA; Fox, AN; Zwiebel, LJ; Carlson, JR				Hallem, EA; Fox, AN; Zwiebel, LJ; Carlson, JR			Olfaction - Mosquito receptor for human-sweat odorant	NATURE			English	Editorial Material							ANOPHELES-GAMBIAE		Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Vanderbilt Univ, Dept Biol Sci, Program Dev Biol, Nashville, TN 37235 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37235 USA	Yale University; Vanderbilt University; Vanderbilt University	Hallem, EA (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Hallem, Elissa/0000-0003-0260-3174; Zwiebel, Laurence/0000-0001-6686-7289				Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Takken W, 1996, CIBA F SYMP, V200, P302; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; VALE GA, 1988, B ENTOMOL RES, V78, P293, DOI 10.1017/S0007485300013055	8	150	182	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					212	213		10.1038/427212a	http://dx.doi.org/10.1038/427212a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724626				2022-12-01	WOS:000188068100031
J	Kording, KP; Wolpert, DM				Kording, KP; Wolpert, DM			Bayesian integration in sensorimotor learning	NATURE			English	Article							UNCERTAINTY; INFORMATION; TRANSFORMATIONS; REPRESENTATION; DECISION; CONTEXT; CODES	When we learn a new motor skill, such as playing an approaching tennis ball, both our sensors and the task possess variability. Our sensors provide imperfect information about the ball's velocity, so we can only estimate it. Combining information from multiple modalities can reduce the error in this estimate(1-4). On a longer time scale, not all velocities are a priori equally probable, and over the course of a match there will be a probability distribution of velocities. According to bayesian theory(5,6), an optimal estimate results from combining information about the distribution of velocities-the prior-with evidence from sensory feedback. As uncertainty increases, when playing in fog or at dusk, the system should increasingly rely on prior knowledge. To use a bayesian strategy, the brain would need to represent the prior distribution and the level of uncertainty in the sensory feedback. Here we control the statistical variations of a new sensorimotor task and manipulate the uncertainty of the sensory feedback. We show that subjects internally represent both the statistical distribution of the task and their sensory uncertainty, combining them in a manner consistent with a performance-optimizing bayesian process(4,5). The central nervous system therefore employs probabilistic models during sensorimotor learning.	UCL, Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England	University of London; University College London	Kording, KP (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.	konrad@koerding.de	Kording, Konrad P/A-1233-2007; Ahmed, Shobi/AAE-4817-2022	Kording, Konrad P/0000-0001-8408-4499; Wolpert, Daniel/0000-0003-2011-2790				Basso MA, 1998, J NEUROSCI, V18, P7519; Bernardo J.M., 2009, BAYESIAN THEORY, V405; BERROU C, 1993, IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS 93 : TECHNICAL PROGRAM, CONFERENCE RECORD, VOLS 1-3, P1064, DOI 10.1109/ICC.1993.397441; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Lacquaniti F, 1998, EUR J NEUROSCI, V10, P195; Olshausen BA, 2000, ADV NEUR IN, V12, P841; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rao RPN, 1999, VISION RES, V39, P1963, DOI 10.1016/S0042-6989(98)00279-X; Sahani M, 2003, NEURAL COMPUT, V15, P2255, DOI 10.1162/089976603322362356; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Simoncelli EP, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL I, P379; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Vetter P, 2000, J NEUROPHYSIOL, V84, P1026, DOI 10.1152/jn.2000.84.2.1026; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8	30	1111	1119	6	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					244	247		10.1038/nature02169	http://dx.doi.org/10.1038/nature02169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724638				2022-12-01	WOS:000188068100043
J	Thomas, CD; Cameron, A; Green, RE; Bakkenes, M; Beaumont, LJ; Collingham, YC; Erasmus, BFN; de Siqueira, MF; Grainger, A; Hannah, L; Hughes, L; Huntley, B; van Jaarsveld, AS; Midgley, GF; Miles, L; Ortega-Huerta, MA; Peterson, AT; Phillips, OL; Williams, SE				Thomas, CD; Cameron, A; Green, RE; Bakkenes, M; Beaumont, LJ; Collingham, YC; Erasmus, BFN; de Siqueira, MF; Grainger, A; Hannah, L; Hughes, L; Huntley, B; van Jaarsveld, AS; Midgley, GF; Miles, L; Ortega-Huerta, MA; Peterson, AT; Phillips, OL; Williams, SE			Extinction risk from climate change	NATURE			English	Article							BIODIVERSITY; IMPACTS; DEFORESTATION; CO2; VULNERABILITY	Climate change over the past similar to30 years has produced numerous shifts in the distributions and abundances of species(1,2) and has been implicated in one species-level extinction(3). Using projections of species' distributions for future climate scenarios, we assess extinction risks for sample regions that cover some 20% of the Earth's terrestrial surface. Exploring three approaches in which the estimated probability of extinction shows a powerlaw relationship with geographical range size, we predict, on the basis of mid-range climate-warming scenarios for 2050, that 15 - 37% of species in our sample of regions and taxa will be 'committed to extinction'. When the average of the three methods and two dispersal scenarios is taken, minimal climate-warming scenarios produce lower projections of species committed to extinction (similar to18%) than mid-range (similar to24%) and maximum-change (similar to35%) scenarios. These estimates show the importance of rapid implementation of technologies to decrease greenhouse gas emissions and strategies for carbon sequestration.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Univ Witwatersrand, ZA-2050 Johannesburg, South Africa; Ctr Referencia Informacao Ambiental, BR-13083885 Campinas, SP, Brazil; Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Univ Stellenbosch, Dept Zool, ZA-7602 Stellenbosch, South Africa; Natl Bot Inst, Kirstenbosch Res Ctr, Climate Change Res Grp, ZA-7735 Cape Town, South Africa; Univ Nacl Autonoma Mexico, Inst Biol, Unidad Occidente, Mexico City 04510, DF, Mexico; Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; James Cook Univ N Queensland, Sch Trop Biol, Cooperat Res Ctr Trop Rainforest Ecol, Townsville, Qld 4811, Australia	University of Leeds; Royal Society for Protection of Birds; University of Cambridge; Netherlands National Institute for Public Health & the Environment; Macquarie University; Durham University; University of Witwatersrand; University of Leeds; Conservation International; Stellenbosch University; Universidad Nacional Autonoma de Mexico; University of Kansas; University of Kansas; James Cook University	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.	c.d.thomas@leeds.ac.uk	Cameron, Alison/D-3911-2009; Beaumont, Linda J/D-5499-2012; Erasmus, Barend/G-3411-2012; Phillips, Oliver L/A-1523-2011; Thomas, Chris D/A-1894-2012; de Siqueira, Marinez Ferreira/I-9205-2012; Fapesp, Biota/F-8655-2017; Williams, Stephen E/A-7250-2008; Peterson, A. Townsend/I-5697-2013; Midgley, Guy F./H-3585-2014; van Jaarsveld, Albert/H-5368-2013; Thomas, Chris D/A-1460-2014; Miles, Lera/C-7334-2009	Cameron, Alison/0000-0001-8236-7954; Beaumont, Linda J/0000-0001-6307-1680; Erasmus, Barend/0000-0003-1869-8091; Phillips, Oliver L/0000-0002-8993-6168; Thomas, Chris D/0000-0003-2822-1334; de Siqueira, Marinez Ferreira/0000-0002-6869-0293; Fapesp, Biota/0000-0002-9887-8449; Williams, Stephen E/0000-0002-2510-7408; Peterson, A. Townsend/0000-0003-0243-2379; Midgley, Guy F./0000-0001-8264-0869; Thomas, Chris D/0000-0003-2822-1334; Miles, Lera/0000-0003-0377-5904; Hughes, Lesley/0000-0003-0313-9780	Natural Environment Research Council [NE/B503384/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Baker RHA, 2000, AGR ECOSYST ENVIRON, V82, P57, DOI 10.1016/S0167-8809(00)00216-4; Bakkenes M, 2002, GLOBAL CHANGE BIOL, V8, P390, DOI 10.1046/j.1354-1013.2001.00467.x; Beaumont LJ, 2002, GLOBAL CHANGE BIOL, V8, P954, DOI 10.1046/j.1365-2486.2002.00490.x; BEERLING DJ, 1993, J BIOGEOGR, V20, P45, DOI 10.2307/2845738; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; IUCN Species Survival Commission, 2001, IUCN RED LIST CAT CR; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Overpeck J, 2003, GLO CH IGBP, P81; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Whittaker JB, 1999, EUR J ENTOMOL, V96, P149; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4	30	4710	5030	125	5442	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					145	148		10.1038/nature02121	http://dx.doi.org/10.1038/nature02121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712274	Green Accepted, Green Published			2022-12-01	WOS:000187863900033
J	Malone, CJ; Misner, L; Le Bot, N; Tsai, MC; Campbell, JM; Ahringer, J; White, JG				Malone, CJ; Misner, L; Le Bot, N; Tsai, MC; Campbell, JM; Ahringer, J; White, JG			The C-elegans hook protein, ZYG-12, mediates the essential attachment between the centrosome and nucleus	CELL			English	Article							LIGHT INTERMEDIATE CHAIN; CAENORHABDITIS-ELEGANS; CYTOPLASMIC DYNEIN; MITOTIC SPINDLE; MICROTUBULE ORGANIZATION; MEMBRANE-PROTEINS; GAMMA-TUBULIN; MIGRATION; DROSOPHILA; EMBRYOS	The centrosome and nucleus are intimately associated in most animal cells, yet the significance of this interaction is unknown. Mutations in the zyg-12 gene of Caenorhabditis elegans perturb the attachment of the centrosome to the nucleus, giving rise to aberrant spindles and ultimately, DNA segregation defects and lethality. These phenotypes indicate that the attachment is essential. ZYG-12 is a member of the Hook family of cytoskeletal linker proteins and localizes to both the nuclear envelope (via SUN-1) and centrosomes. ZYG-12 is able to bind the dynein subunit DLI-1 in a two-hybrid assay and is required for dynein localization to the nuclear envelope. Loss of dynein function causes a low percentage of defective centrosome/nuclei interactions in both Drosophila and Caenorhabditis elegans. We propose that dynein and ZYG-12 move the centrosomes toward the nucleus, followed by a ZYG-12/SUN-1-dependent anchorage.	Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Wellcome CRC Inst, Cambridge CB2 1QR, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Malone, CJ (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	cjmalone@facstaff.wisc.edu		Ahringer, Julie/0000-0002-7074-4051; Tsai, Miao-Chih/0000-0003-4471-4825; Le Bot, Nathalie/0000-0002-5258-2837	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052454] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM052454] Funding Source: Medline; Wellcome Trust [054523] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARONSON JF, 1971, J CELL BIOL, V51, P579, DOI 10.1083/jcb.51.2.579; BOMENS M, 1977, NATURE, V270, P80; BRENNER S, 1974, GENETICS, V77, P71; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; FRASER AG, 2000, BRIT J SOC PSYCHOL 4, V408, P325; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonzalez C, 1998, J CELL SCI, V111, P2697; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; HEDGECOCK EM, 1982, CELL, V30, P321, DOI 10.1016/0092-8674(82)90038-1; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jakubowski J, 1999, GENETICS, V153, P743; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Keating HH, 1998, J CELL SCI, V111, P3027; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kramer H, 1999, GENETICS, V151, P675; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; McDonald K, 1999, METH MOL B, V117, P77; NADEZHDINA ES, 1979, EUR J CELL BIOL, V19, P109; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Praitis V, 2001, GENETICS, V157, P1217; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; Raff JW, 1999, CURR BIOL, V9, pR708, DOI 10.1016/S0960-9822(99)80446-1; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2001, DEVELOPMENT, V128, P5039; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; Yoder JH, 2001, MOL BIOL CELL, V12, P2921, DOI 10.1091/mbc.12.10.2921; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	52	308	325	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2003	115	7					825	836		10.1016/S0092-8674(03)00985-1	http://dx.doi.org/10.1016/S0092-8674(03)00985-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697201	Bronze			2022-12-01	WOS:000187664700007
J	Johnston, RJ; Hobert, O				Johnston, RJ; Hobert, O			A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans	NATURE			English	Article							CHEMOSENSORY NEURONS; NERVOUS-SYSTEM; EXPRESSION; RNAS; LIM-6	How left/right functional asymmetry is layered on top of an anatomically symmetrical nervous system is poorly understood. In the nematode Caenorhabditis elegans, two morphologically bilateral taste receptor neurons, ASE left (ASEL) and ASE right (ASER), display a left/right asymmetrical expression pattern of putative chemoreceptor genes that correlates with a diversification of chemosensory specificities(1,2). Here we show that a previously undefined microRNA termed lsy-6 controls this neuronal left/right asymmetry of chemosensory receptor expression. lsy-6 mutants that we retrieved from a genetic screen for defects in neuronal left/right asymmetry display a loss of the ASEL-specific chemoreceptor expression profile with a concomitant gain of the ASER-specific profile. Alsy-6 reporter gene construct is expressed in less than ten neurons including ASEL, but not ASER. lsy-6 exerts its effects on ASEL through repression of cog-1, an Nkx-type homeobox gene, which contains a lsy-6 complementary site in its 30 untranslated region and that has been shown to control ASE-specific chemoreceptor expression profiles(3). lsy-6 is the first microRNA to our knowledge with a role in neuronal patterning, providing new insights into left/right axis formation.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854				Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 1999, DEVELOPMENT, V126, P1547; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yost HJ, 1998, DEV GENET, V23, P159; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	22	583	663	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					845	849		10.1038/nature02255	http://dx.doi.org/10.1038/nature02255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685240				2022-12-01	WOS:000187342000060
J	Caulford, P				Caulford, P			SARS: aftermath of an outbreak	LANCET			English	Article									Scarborough Gen Hosp, Family Med Serv, Scarborough, ON, Canada; Scarborough Gen Hosp, Community Serv, Scarborough, ON, Canada; Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada	Scarborough Hospital; Scarborough Hospital; University of Toronto	Caulford, P (corresponding author), Suite 207,3030 Lawrence Ave E, Scarborough, ON M1P 2T7, Canada.								0	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S2	S3		10.1016/S0140-6736(03)15052-0	http://dx.doi.org/10.1016/S0140-6736(03)15052-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698106	Green Published, Bronze			2022-12-01	WOS:000187790200002
J	Altman, D; Sweeney, HL; Spudich, JA				Altman, D; Sweeney, HL; Spudich, JA			The mechanism of myosin VI translocation an its load-induced anchoring	CELL			English	Article							ACTIN-BASED MOTOR; OPTICAL TWEEZERS; FORCE; MOLECULES; STEPS; PROCESSIVITY; MODEL	Myosin VI is thought to function as both a transporter and an anchor. While in vitro studies suggest possible mechanisms for processive stepping, a biochemical basis for anchoring has not been demonstrated. Using optical trapping, we observed myosin VI stepping against applied forces. Step size is not strongly affected by such loads. At saturating ATP, myosin VI kinetics shows little dependence on load until, at forces near stall, its stepping slows dramatically as load increases. At subsaturating ATP or in the presence of ADP, stepping kinetics is significantly inhibited by load. From our results, we propose a mechanism of myosin VI stepping that predicts a regulation through load of the motor's roles as transporter and anchor.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; University of Pennsylvania; Stanford University	Spudich, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	jspudich@stanford.edu	Sweeney, H Lee/F-1862-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33289, R01 GM033289] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAHLOUL A, IN PRESS P NATL ACAD; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Boal D., 2002, MECH CELL; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; Cramer LP, 2000, J CELL BIOL, V150, pF121, DOI 10.1083/jcb.150.6.F121; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Fisher ME, 1999, P NATL ACAD SCI USA, V96, P6597, DOI 10.1073/pnas.96.12.6597; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Howard J., 2001, MECH MOTOR PROTEINS; ISHIJIMA A, 1994, BIOCHEM BIOPH RES CO, V199, P1057, DOI 10.1006/bbrc.1994.1336; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Mathews C.K., 1996, BIOCHEMISTRY; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Rogat AD, 2002, J CELL SCI, V115, P4855, DOI 10.1242/jcs.00149; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; SHEETZ M, 1998, LASER TWEEZERS CELL; SHETERLINE P, 1994, PROTEIN PROFILE, V1, P1; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Stryer L, 1995, BIOCHEMISTRY; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Zhuang XW, 2003, CURR OPIN STRUC BIOL, V13, P88, DOI 10.1016/S0959-440X(03)00011-3	40	201	205	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					737	749		10.1016/S0092-8674(04)00211-9	http://dx.doi.org/10.1016/S0092-8674(04)00211-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006355	Bronze			2022-12-01	WOS:000221499700013
J	Kidner, CA; Martienssen, RA				Kidner, CA; Martienssen, RA			Spatially restricted microRNA directs leaf polarity through ARGONAUTE1	NATURE			English	Article							FILAMENTOUS-FLOWER; RNA INTERFERENCE; CELL FATE; ARABIDOPSIS; GENE; MERISTEM; PLANTS; ENCODES; PROTEIN; FAMILY	Gene regulation by RNA interference requires the functions of the PAZ domain protein Argonaute. In plants, mutations in ARGONAUTE1 (AGO1) are associated with distinctive developmental defects that suggest a role for microRNA (miRNA) in organ polarity. Potential targets of miRNA regulation are the homeodomain/leucine zipper genes PHABULOSA (PHB) and PHAVOLUTA (PHV)(1). These genes are expressed in a polar fashion in leaf primordia and are required for adaxial cell fate(2,3). Here we show that a 21-nucleotide miRNA that directs cleavage of PHB/PHV messenger RNA accumulates first in the embryonic meristem, and then in the abaxial domain of the developing leaf. miRNA distribution is disrupted by mutations in AGO1, indicating that AGO1 affects the regulation of miRNA. In addition, interactions between homeodomain/leucine zipper genes and an allelic series of ago1 indicate that miRNA acts as a signal to specify leaf polarity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org		Kidner, Catherine/0000-0001-6426-3000				Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen QY, 1999, DEVELOPMENT, V126, P2715; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Harris AN, 2001, DEVELOPMENT, V128, P2823; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lynn K, 1999, DEVELOPMENT, V126, P469; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799	30	390	450	6	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					81	84		10.1038/nature02366	http://dx.doi.org/10.1038/nature02366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999284				2022-12-01	WOS:000189363800039
J	Chen, J; de Felipe, KS; Clarke, M; Lu, H; Anderson, OR; Segal, G; Shuman, HA				Chen, J; de Felipe, KS; Clarke, M; Lu, H; Anderson, OR; Segal, G; Shuman, HA			Legionella effectors that promote nonlytic release from protozoa	SCIENCE			English	Article							LEGIONNAIRES-DISEASE; HUMAN-MONOCYTES; ACANTHAMOEBA-CASTELLANII; PNEUMOPHILA; CELLS; PHAGOSOME; DICTYOSTELIUM; SYSTEM; GROWTH; AMEBAS	Legionella pneumophila, the bacterial agent of legionnaires' disease, replicates intracellularly within a specialized vacuole of mammalian and protozoan host cells. Little is known about the specialized vacuole except that the Icm/Dot type IV secretion system is essential for its formation and maintenance. The Legionella genome database contains two open reading frames encoding polypeptides (LepA and LepB) with predicted coiled-coil regions and weak homology to SNAREs; these are delivered to host cells by an Icm/Dot - dependent mechanism. Analysis of mutant strains suggests that the Lep proteins may enable the Legionella to commandeer a protozoan exocytic pathway for dissemination of the pathogen.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA; Columbia Univ, Lamont Doherty Earth Observ, Dept Biol, Palisades, NY 10964 USA; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Columbia University; Columbia University; Oklahoma Medical Research Foundation; Columbia University; Tel Aviv University	Shuman, HA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	has7@columbia.edu	Segal, Gil/H-7987-2019	Segal, Gil/0000-0003-0392-253X; Chen, John/0000-0002-2318-1823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549] Funding Source: NIH RePORTER; NIAID NIH HHS [NIH-R01 AI23549] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Berk SG, 1998, APPL ENVIRON MICROB, V64, P279; BREIMAN RF, 1990, JAMA-J AM MED ASSOC, V263, P2924, DOI 10.1001/jama.263.21.2924; Clarke M, 2002, J CELL SCI, V115, P2893; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; DEFELIPE KS, UNPUB; Essig A, 1997, APPL ENVIRON MICROB, V63, P1396, DOI 10.1128/AEM.63.4.1396-1399.1997; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; HORWITZ MA, 1984, J CELL BIOL, V99, P1936, DOI 10.1083/jcb.99.6.1936; JEON KW, 1995, J EUKARYOT MICROBIOL, V42, P1, DOI 10.1111/j.1550-7408.1995.tb01532.x; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Maniak M, 2002, INT REV CYTOL, V221, P257; Molmeret M, 2002, MOL MICROBIOL, V43, P1139, DOI 10.1046/j.1365-2958.2002.02842.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; ROWBOTHAM TJ, 1986, ISRAEL J MED SCI, V22, P678; Segal G, 1999, MOL MICROBIOL, V33, P669, DOI 10.1046/j.1365-2958.1999.01512.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Sollner TH, 2002, DEV CELL, V2, P377, DOI 10.1016/S1534-5807(02)00161-2; Solomon JM, 2000, TRENDS MICROBIOL, V8, P478, DOI 10.1016/S0966-842X(00)01852-7; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873	26	228	242	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1358	1361		10.1126/science.1094226	http://dx.doi.org/10.1126/science.1094226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14988561				2022-12-01	WOS:000189238600048
J	Marston, AL; Tham, WH; Shah, H; Amon, A				Marston, AL; Tham, WH; Shah, H; Amon, A			A genome-wide screen identifies genes required for centromeric cohesion	SCIENCE			English	Article							SISTER-CHROMATID COHESION; MEI-S332	During meiosis, two chromosome segregation phases follow a single round of DNA replication. We identified factors required to establish this specialized cell cycle by examining meiotic chromosome segregation in a collection of yeast strains lacking all nonessential genes. This analysis revealed Sgo1, Chl4, and Iml3 to be important for retaining centromeric cohesin until the onset of anaphase II. Consistent with this role, Sgo1 localizes to centromeric regions but dissociates at the onset of anaphase II. The screen described here provides a comprehensive analysis of the genes required for the meiotic cell cycle and identifies three factors important for the stepwise loss of sister chromatid cohesion.	MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Ctr Canc Res, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu	Tham, Wai-Hong/L-3173-2018; Tham, Wai-Hong/P-6474-2019	Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699; Amon, Angelika/0000-0001-9837-0314; Marston, Adele/0000-0002-3596-9407	NIGMS NIH HHS [GM62207] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; KERREBROCK AW, 1992, GENETICS, V130, P827; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; MARSTON A, UNPUB; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8	18	214	221	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2004	303	5662					1367	1370		10.1126/science.1094220	http://dx.doi.org/10.1126/science.1094220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778JN	14752166				2022-12-01	WOS:000189238600051
J	Fukami, H; Budd, AF; Paulay, G; Sole-Cava, A; Chen, CLA; Iwao, K; Knowlton, N				Fukami, H; Budd, AF; Paulay, G; Sole-Cava, A; Chen, CLA; Iwao, K; Knowlton, N			Conventional taxonomy obscures deep divergence between Pacific and Atlantic corals	NATURE			English	Article							EVOLUTIONARY RELATIONSHIPS; MITOCHONDRIAL-DNA; SUBSTITUTIONS; REGION	Only 17% of 111 reef-building coral genera and none of the 18 coral families with reef-builders are considered endemic to the Atlantic, whereas the corresponding percentages for the Indowest Pacific are 76% and 39%(1,2). These figures depend on the assumption that genera and families spanning the two provinces belong to the same lineages ( that is, they are monophyletic). Here we show that this assumption is incorrect on the basis of analyses of mitochondrial and nuclear genes. Pervasive morphological convergence at the family level has obscured the evolutionary distinctiveness of Atlantic corals. Some Atlantic genera conventionally assigned to different families are more closely related to each other than they are to their respective Pacific 'congeners'. Nine of the 27 genera of reef-building Atlantic corals belong to this previously unrecognized lineage, which probably diverged over 34 million years ago. Although Pacific reefs have larger numbers of more narrowly distributed species, and therefore rank higher in biodiversity hotspot analyses(3), the deep evolutionary distinctiveness of many Atlantic corals should also be considered when setting conservation priorities.	Smithsonian Trop Res Inst, Naos Marine Lab, Balboa, Panama; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; Acad Sinica, Inst Zool, Taipei 115, Taiwan; Akajima Marine Sci Lab, Okinawa 9013311, Japan	Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Iowa; State University System of Florida; University of Florida; Universidade Federal do Rio de Janeiro; Academia Sinica - Taiwan	Knowlton, N (corresponding author), Smithsonian Trop Res Inst, Naos Marine Lab, Box 2072, Balboa, Panama.	nknowlton@ucsd.edu	Sole-Cava, Antonio M/G-4209-2011	Sole-Cava, Antonio M/0000-0003-0363-5821				Budd AF, 2000, CORAL REEFS, V19, P25, DOI 10.1007/s003380050222; Chen L, 2002, BIOORG MED CHEM LETT, V12, P137, DOI 10.1016/S0960-894X(01)00711-9; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lopez Jose V., 1997, P1613; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paulay Gustav, 1997, P298; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Romano SL, 2000, B MAR SCI, V67, P1043; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stolarski J, 2001, J PALEONTOL, V75, P1090, DOI 10.1666/0022-3360(2001)075<1090:TANSOE>2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; VAUGHAN TW, 1943, SPEC PAP GEOL SOC AM, V44, P1; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J. E. N., 1995, CORALS SPACE TIME; Veron JEN, 1996, CORAL REEFS, V15, P1; WALLACE CC, 2002, P 9 INT COR REEF S B, V1, P33; Wells J. W., 1964, Zoologische Mededeelingen Leiden, V39, P375; Williams ST, 2001, MOL PHYLOGENET EVOL, V20, P375, DOI 10.1006/mpev.2001.0976	24	242	260	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					832	835		10.1038/nature02339	http://dx.doi.org/10.1038/nature02339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985760				2022-12-01	WOS:000189207500038
J	Dian, BC; Clarkson, JR; Zwier, TS				Dian, BC; Clarkson, JR; Zwier, TS			Direct measurement of energy thresholds to conformational isomerization in tryptamine	SCIENCE			English	Article							RESOLVED ELECTRONIC SPECTROSCOPY; FLEXIBLE BIOMOLECULES; DYNAMICS; ACID; JET	Stimulated emission pumping (SEP)-hole filling spectroscopy and SEP-induced population transfer spectroscopy have been used to place narrow bounds on the energy thresholds for isomerization between individual reactant-product isomer pairs involving the seven conformational minima of tryptamine. The thresholds for isomerizing conformer A to all six other conformations divided into three groups at 750 wavenumbers (cm(-1)) (A-->B, F), 1000 cm(-1) [A-->C(2)], and 1280 to 1320 cm(-1) [A-->D, E, and C(1)]. The appearance of the first band and the absence of the band below it were used to place upper and lower bounds to the barrier heights for each process. The thresholds for A-->B and B-->A isomerizations were also combined to determine the relative energies of these two lowest energy minima. The combined data from all X-->Y isomerizations identify important isomerization pathways on the potential energy surface linking the minima.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zwier, TS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	zwier@purdue.edu						BURGI T, 1995, CHEM PHYS LETT, V246, P291, DOI 10.1016/0009-2614(95)01107-K; Carney JR, 2001, CHEM PHYS LETT, V341, P77, DOI 10.1016/S0009-2614(01)00464-X; Carney JR, 2000, J PHYS CHEM A, V104, P8677, DOI 10.1021/jp001433r; CONNELL LL, 1990, J PHYS CHEM-US, V94, P1229, DOI 10.1021/j100367a009; Dian BC, 2004, J CHEM PHYS, V120, P133, DOI 10.1063/1.1626540; DIAN BC, IN PRESS J CHEM PHYS; Ebata T, 2003, J CHEM PHYS, V119, P2947, DOI 10.1063/1.1596831; Evans DA, 2004, J CHEM PHYS, V120, P148, DOI 10.1063/1.1626541; Evans DA, 2003, J CHEM PHYS, V118, P3891, DOI 10.1063/1.1540099; Keske JC, 2000, ANNU REV PHYS CHEM, V51, P323, DOI 10.1146/annurev.physchem.51.1.323; KORTER TM, 2003, COMMUNICATION; Leitner DM, 2003, J PHYS CHEM A, V107, P10706, DOI 10.1021/jp0305180; PARK YD, 1986, J CHEM PHYS, V84, P6539, DOI 10.1063/1.450705; PHILIPS LA, 1988, J CHEM PHYS, V89, P85, DOI 10.1063/1.455464; Silva M, 2001, ANNU REV PHYS CHEM, V52, P811, DOI 10.1146/annurev.physchem.52.1.811; Wales DJ., 2003, ENERGY LANDSCAPES; WU YR, 1989, J CHEM PHYS, V91, P5278, DOI 10.1063/1.457573	17	148	148	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1169	1173		10.1126/science.1093731	http://dx.doi.org/10.1126/science.1093731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976308				2022-12-01	WOS:000189074700039
J	Pawlowska, TE; Taylor, JW				Pawlowska, TE; Taylor, JW			Organization of genetic variation in individuals of arbuscular mycorrhizal fungi	NATURE			English	Article							EVOLUTION; EXCHANGES; ORIGIN; DRIVE	Arbuscular mycorrhizal (AM) fungi (Glomeromycota) are thought to be the oldest group of asexual multicellular organisms. They colonize the roots of most land plants, where they facilitate mineral uptake from the soil in exchange for plant-assimilated carbon(1). Cells of AM fungi contain hundreds of nuclei. Unusual polymorphism of ribosomal DNA observed in individual spores of AM fungi inspired a hypothesis that heterokaryosis-that is, the coexistence of many dissimilar nuclei in cells-occurs throughout the AM fungal life history(2,3). Here we report a genetic approach to test the hypothesis of heterokaryosis in AM fungi. Our study of the transmission of polymorphic genetic markers in natural isolates of Glomus etunicatum, coupled with direct amplification of rDNA from microdissected nuclei by polymerase chain reaction, supports the alternative hypothesis of homokaryosis, in which nuclei populating AM fungal individuals are genetically uniform. Intrasporal rDNA polymorphism contained in each nucleus signals a relaxation of concerted evolution(4), a recombination-driven process that is responsible for homogenizing rDNA repeats(5). Polyploid organization of glomeromycotan genomes could accommodate intranuclear rDNA polymorphism and buffer these apparently asexual organisms against the effects of accumulating mutations.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Pawlowska, TE (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	tpawlows@nature.berkeley.edu						ARNHEIM N, 1982, P NATL ACAD SCI-BIOL, V79, P4677, DOI 10.1073/pnas.79.15.4677; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; BECARD G, 1993, PROTOPLASMA, V174, P62, DOI 10.1007/BF01404043; Bever JD, 1999, AM J BOT, V86, P1209, DOI 10.2307/2656768; Birky CW, 1996, GENETICS, V144, P427; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Giovannetti M, 2003, APPL ENVIRON MICROB, V69, P616, DOI 10.1128/AEM.69.1.616-624.2003; Hosny M, 1998, GENOME, V41, P422, DOI 10.1139/gen-41-3-422; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Klironomos JN, 1999, BIOL FERT SOILS, V29, P277, DOI 10.1007/s003740050553; KONDRASHOV AS, 1994, NATURE, V370, P213, DOI 10.1038/370213a0; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; MOGIE M, 1988, BIOL J LINN SOC, V35, P155, DOI 10.1111/j.1095-8312.1988.tb00463.x; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Redecker D, 1999, FUNGAL GENET BIOL, V28, P238, DOI 10.1006/fgbi.1999.1173; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; Schussler A, 1999, NEW PHYTOL, V144, P205, DOI 10.1046/j.1469-8137.1999.00526.x; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	25	166	179	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					733	737		10.1038/nature02290	http://dx.doi.org/10.1038/nature02290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973485				2022-12-01	WOS:000189026000043
J	Chipuk, JE; Kuwana, T; Bouchier-Hayes, L; Droin, NM; Newmeyer, D; Schuler, M; Green, DR				Chipuk, JE; Kuwana, T; Bouchier-Hayes, L; Droin, NM; Newmeyer, D; Schuler, M; Green, DR			Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis	SCIENCE			English	Article							CYTOCHROME-C RELEASE; TRANSCRIPTIONAL ACTIVATION; P53-DEPENDENT APOPTOSIS; CASPASE ACTIVATION; BCL-2; DEATH; PUMA; ABSENCE	The tumor suppressor p53 exerts its anti-neoplastic activity primarily through the induction of apoptosis. We found that cytosolic localization of endogenous wild-type or trans-activation-deficient p53 was necessary and sufficient for apoptosis. p53 directly activated the proapoptotic Bcl-2 protein Bax in the absence of other proteins to permeabilize mitochondria and engage the apoptotic program. p53 also released both proapoptotic multidomain proteins and BH3-only proteins [Proapoptotic Bcl-2 family proteins that share only the third Bcl-2 homology domain (BH3)] that were sequestered by Bcl-xL. The transcription-independent activation of Bax by p53 occurred with similar kinetics and concentrations to those produced by activated Bid. We propose that when p53 accumulates in the cytosol, it can function analogously to the BH3-only subset of proapoptotic Bcl-2 proteins to activate Bax and trigger apoptosis.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Mainz, Dept Med 3, D-55101 Mainz, Germany	La Jolla Institute for Immunology; Johannes Gutenberg University of Mainz	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	doug@liai.org	Green, Douglas R/N-8083-2018; Droin, Nathalie M/Y-5506-2018; Bouchier-Hayes, Lisa/T-9491-2019	Green, Douglas R/0000-0002-7332-1417; Droin, Nathalie M/0000-0002-6099-5324; Bouchier-Hayes, Lisa/0000-0003-3886-5977; Chipuk, Jerry Edward/0000-0002-1337-842X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047891, R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052735, R37GM052735] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40646, AI47891] Funding Source: Medline; NIGMS NIH HHS [GM52735] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; CHIPUK JE, UNPUB; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vater CA, 1996, ONCOGENE, V13, P739; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	30	1559	1648	10	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1010	1014		10.1126/science.1092734	http://dx.doi.org/10.1126/science.1092734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963330				2022-12-01	WOS:000188918000045
J	Kerns, JG; Cohen, JD; MacDonald, AW; Cho, RY; Stenger, VA; Carter, CS				Kerns, JG; Cohen, JD; MacDonald, AW; Cho, RY; Stenger, VA; Carter, CS			Anterior Cingulate conflict monitoring and adjustments in control	SCIENCE			English	Article							PREFRONTAL CORTEX; ERROR-DETECTION; BEHAVIOR	Conflict monitoring by the anterior cingulate cortex (ACC) has been posited to signal a need for greater cognitive control, producing neural and behavioral adjustments. However, the very occurrence of behavioral adjustments after conflict has been questioned, along with suggestions that there is no direct evidence of ACC conflict-related activity predicting subsequent neural or behavioral adjustments in control. Using the Stroop color-naming task and controlling for repetition effects, we demonstrate that ACC conflict-related activity predicts both greater prefrontal cortex activity and adjustments in behavior, supporting a role of ACC conflict monitoring in the engagement of cognitive control.	Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; Univ Calif Davis, Dept Psychiat, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Psychol, Sacramento, CA 95817 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Missouri System; University of Missouri Columbia; Princeton University; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis	Carter, CS (corresponding author), Univ Pittsburgh, Dept Psychiat, 3811 Ohara St, Pittsburgh, PA 15213 USA.	cameron.carter@ucdmc.ucdavis.edu	MacDonald, Angus/M-9855-2016; Cho, Raymond/P-3028-2014	MacDonald, Angus/0000-0003-4588-931X; Cho, Raymond/0000-0003-1331-1409				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; LAMING D, 1979, ACTA PSYCHOL, V43, P381, DOI 10.1016/0001-6918(79)90032-5; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V4, pCH1; POSNER MI, 1998, ATTENTIVE BRAIN, pCH17; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI [10.2307/1175262, DOI 10.2307/1175262]; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837	23	2181	2237	5	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1023	1026		10.1126/science.1089910	http://dx.doi.org/10.1126/science.1089910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963333				2022-12-01	WOS:000188918000049
J	Samba, E; Nkrumah, F; Leke, R				Samba, E; Nkrumah, F; Leke, R			Getting polio eradication back on track in Nigeria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Off Africa, Brazzaville, Rep Congo; Univ Ghana, Sch Med, Noguchi Mem Inst Med Res, Legon, Ghana; Univ Yaounde, Fac Med, Dept Immunol & Microbiol, Yaounde, Cameroon	World Health Organization; University of Ghana; University of Yaounde I	Samba, E (corresponding author), WHO, Off Africa, Brazzaville, Rep Congo.							Kapp D, 2003, LANCET, V362, P1631, DOI 10.1016/S0140-6736(03)14826-X; 2003, WKLY EPIDEMIOL REC, V78, P210	2	26	26	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2004	350	7					645	+		10.1056/NEJMp038210	http://dx.doi.org/10.1056/NEJMp038210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772YB	14960740				2022-12-01	WOS:000188869500004
J	Kang, JX; Wang, JD; Wu, L; Kang, ZB				Kang, JX; Wang, JD; Wu, L; Kang, ZB			Transgenic mice - Fat-1 mice convert n-6 to n-3 fatty acids	NATURE			English	Editorial Material							EXPRESSION; DESATURASE		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kang, JX (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	kang.jing@mgh.harvard.edu						Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Simopoulos AP, 2003, WORLD REV NUTR DIET, V92, P1; SIMOPOULOS AP, 1998, WORLD REV NUTR DIET, V83; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142	7	433	469	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					504	504		10.1038/427504a	http://dx.doi.org/10.1038/427504a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765186	Bronze			2022-12-01	WOS:000188721800031
J	Dickens, AF; Gelinas, Y; Masiello, CA; Wakeham, S; Hedges, JI				Dickens, AF; Gelinas, Y; Masiello, CA; Wakeham, S; Hedges, JI			Reburial of fossil organic carbon in marine sediments	NATURE			English	Article							BLACK CARBON; MATTER PRESERVATION; VARIABILITY; DEGRADATION; SEA	Marine sediments act as the ultimate sink for organic carbon, sequestering otherwise rapidly cycling carbon for geologic time-scales(1,2). Sedimentary organic carbon burial appears to be controlled by oxygen exposure time in situ(3,4), and much research has focused on understanding the mechanisms of preservation of organic carbon(5). In this context, combustion- derived black carbon has received attention as a form of refractory organic carbon that may be preferentially preserved in soils(6,7) and sediments(8,9). However, little is understood about the environmental roles, transport and distribution of black carbon. Here we apply isotopic analyses to graphitic black carbon samples isolated from pre- industrial marine and terrestrial sediments. We find that this material is terrestrially derived and almost entirely depleted of radiocarbon, suggesting that it is graphite weathered from rocks, rather than a combustion product. The widespread presence of fossil graphitic black carbon in sediments has therefore probably led to significant overestimates of burial of combustion-derived black carbon in marine sediments. It could be responsible for biasing radiocarbon dating of sedimentary organic carbon, and also reveals a closed loop in the carbon cycle. Depending on its susceptibility to oxidation, this recycled carbon may be locked away from the biologically mediated carbon cycle for many geologic cycles.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; Skidaway Inst Oceanog, Savannah, GA 31411 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Concordia University - Canada; California Institute of Technology; University of California System; University of California Santa Barbara; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Dickens, AF (corresponding author), Univ Washington, Sch Oceanog, Box 355351, Seattle, WA 98195 USA.	dickensa@u.washington.edu	Gélinas, Yves/K-4019-2013; Masiello, Caroline/A-2653-2011	Gélinas, Yves/0000-0001-5751-8378; Masiello, Caroline/0000-0003-2102-6229; Dickens, Angela/0000-0001-8433-5913				BERNER RA, 1989, PALAEOGEOGR PALAEOCL, V75, P97, DOI DOI 10.1016/0031-0182(89)90186-7; Blair NE, 2003, GEOCHIM COSMOCHIM AC, V67, P63, DOI 10.1016/S0016-7037(02)01043-8; CARPENTER R, 1987, GEOCHIM COSMOCHIM AC, V51, P1897, DOI 10.1016/0016-7037(87)90181-5; DRUFFEL ERM, 1984, EARTH PLANET SC LETT, V71, P205, DOI 10.1016/0012-821X(84)90087-6; Eglinton TI, 1997, SCIENCE, V277, P796, DOI 10.1126/science.277.5327.796; Eglinton TI, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000269; Gelinas Y, 2001, ENVIRON SCI TECHNOL, V35, P3519, DOI 10.1021/es010504c; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hedges JI, 1999, AM J SCI, V299, P529, DOI 10.2475/ajs.299.7-9.529; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HERRING JR, 1985, CARBON CYCLE ATMOSPH, P419; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; Masiello CA, 1998, SCIENCE, V280, P1911, DOI 10.1126/science.280.5371.1911; Middelburg JJ, 1999, MAR CHEM, V65, P245, DOI 10.1016/S0304-4203(99)00005-5; Petsch ST, 2000, ORG GEOCHEM, V31, P475, DOI 10.1016/S0146-6380(00)00014-0; Petsch ST, 2001, GEOCHIM COSMOCHIM AC, V65, P1867, DOI 10.1016/S0016-7037(01)00572-5; PRAHL FG, 1984, ESTUAR COAST SHELF S, V18, P703, DOI 10.1016/0272-7714(84)90040-4; SACKETT WM, 1974, SCIENCE, V185, P1045, DOI 10.1126/science.185.4156.1045; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; Schmidt MWI, 1999, EUR J SOIL SCI, V50, P351, DOI 10.1046/j.1365-2389.1999.00236.x; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Skjemstad JO, 1999, COMMUN SOIL SCI PLAN, V30, P2283, DOI 10.1080/00103629909370372; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Suman D.O., 1997, NATO ASI SERIES GLOB, P271, DOI [10.1007/978-3-642-59171-6_12, DOI 10.1007/978-3-642-59171-6_12]; VOGEL JS, 1987, RADIOCARBON, V29, P323; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; WAKEHAM SG, IN PRESS ENV SCI TEC; WEIS PL, 1981, GEOCHIM COSMOCHIM AC, V45, P2325, DOI 10.1016/0016-7037(81)90086-7	30	202	244	6	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					336	339		10.1038/nature02299	http://dx.doi.org/10.1038/nature02299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737163				2022-12-01	WOS:000188266200036
J	Harris, JE; Thun, MJ; Mondul, AM; Calle, EE				Harris, JE; Thun, MJ; Mondul, AM; Calle, EE			Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; FRENCH CASE-CONTROL; CARDIORESPIRATORY DISEASE; SMOKING-CESSATION; FILTER CIGARETTES; RISK FACTOR; SMOKERS; WOMEN; TOBACCO; MEN	Objective To assess the risk of lung cancer in smokers of medium tar filter cigarettes compared with smokers of low tar and very low tar cigarettes. Design Analysis of the association between the tar rating of the brand of cigarette smoked in 1982 and mortality from lung cancer over the next six years. Multivariate proportional hazards analyses used to assess hazard ratios, with adjustment for age at enrolment, race, educational level, marital status, blue collar employment, occupational exposure to asbestos, intake of vegetables, citrus fruits, and vitamins, and, in analyses of current and former smokers, for age when they started to smoke and number of cigarettes smoked per day. Setting Cancer prevention study H (CPS-II). Participants 364 239 men and 576 535 women, aged greater than or equal to 30 years, who had either never smoked, were former smokers, or were currently smoking a specific brand of cigarette when they were enrolled in the cancer prevention study. Main outcome measure Death from primary cancer of the lung among participants who had never smoked, former smokers, smokers of very low tar (less than or equal to 7 mg tar/cigarette) filter, low tar (8-14 mg) filter, high tar (greater than or equal to 22 mg) non-filter brands and medium tar conventional filter brands (15-21 mg). Results Irrespective of the tar level of their current brand, all current smokers had a far greater risk of lung cancer than people who had stopped smoking or had never smoked. Compared with smokers of medium tar (15-21 mg) filter cigarettes, risk was higher among men and women who smoked high tar (greater than or equal to 22 mg) non-filter brands (hazard ratio 1.44 95% confidence interval 1.20 to 1.73, and 1.64, 1.26 to 2.15, respectively). There was no difference in risk among men who smoked brands rated as very low tar (1.17, 0.95 to 1.45) or low tar (1.02, 0.90 to 1.16) compared with those who smoked medium tar brands. The same was seen for women (0.98, 0.80 to 1.21, and 0.95, 0.82 to 1.11, respectively). Conclusion The increase in lung cancer risk is similar in people who smoke medium tar cigarettes (15-21 mg), low tar cigarettes (8-14 mg), or very low tar cigarettes (less than or equal to 7 mg). Men and women who smoke non-filtered cigarettes with tar ratings greater than or equal to 22 mg have an even higher risk of lung cancer.	MIT, Dept Econ, Cambridge, MA 02139 USA; Amer Canc Soc, Atlanta, GA 30329 USA	Massachusetts Institute of Technology (MIT); American Cancer Society	Harris, JE (corresponding author), Massachusetts Gen Hosp, Internal Med Associates, Boston, MA 02114 USA.	jeharris@partners.org		Mondul, Alison/0000-0002-8843-1416				Agudo A, 2000, INT J CANCER, V88, P820, DOI 10.1002/1097-0215(20001201)88:5&lt;820::AID-IJC21&gt;3.0.CO;2-J; AGUDO A, 1994, INT J CANCER, V59, P165, DOI 10.1002/ijc.2910590204; ALDERSON MR, 1985, J EPIDEMIOL COMMUN H, V39, P286, DOI 10.1136/jech.39.4.286; Armadans-Gil L, 1999, INT J EPIDEMIOL, V28, P614, DOI 10.1093/ije/28.4.614; AUGUSTINE A, 1989, AM J PUBLIC HEALTH, V79, P188, DOI 10.2105/AJPH.79.2.188; BENHAMOU E, 1993, EUR J CANCER, V29A, P1778, DOI 10.1016/0959-8049(93)90124-X; BENHAMOU E, 1987, BRIT J CANCER, V55, P91, DOI 10.1038/bjc.1987.19; BENHAMOU E, 1989, BRIT J CANCER, V60, P601, DOI 10.1038/bjc.1989.322; BENHAMOU S, 1994, INT J EPIDEMIOL, V23, P437, DOI 10.1093/ije/23.3.437; BENHAMOU S, 1985, J NATL CANCER I, V74, P1169; BENOWITZ N, 2001, NCI SMOKING TOBACCO, V13, P39; BORLAND C, 1983, BRIT MED J, V287, P1583, DOI 10.1136/bmj.287.6405.1583; BROSS IDJ, 1968, AM J PUBLIC HEALTH N, V58, P1396, DOI 10.2105/AJPH.58.8.1396; BUFFLER PA, 1984, LUNG CANCER CAUSES P, P83; BURNS DR, 2001, NCI SMOKING TOBACCO, V13, P65; BURRIS DR, 2001, NATL CANCER I MONOGR, V13, P65; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; COX DR, 1972, J R STAT SOC B, V34, P187; DeStefani E, 1996, CANCER EPIDEM BIOMAR, V5, P515; Engeland A, 1996, CANCER CAUSE CONTROL, V7, P366, DOI 10.1007/BF00052943; Forey B., 2002, INT SMOKING STAT, V2nd ed; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; GARFINKEL L, 1988, CANCER RES, V48, P6951; GILLIS CR, 1988, J EPIDEMIOL COMMUN H, V42, P38, DOI 10.1136/jech.42.1.38; HAMMOND EC, 1976, ENVIRON RES, V12, P263, DOI 10.1016/0013-9351(76)90036-0; Harris JE, 2001, PUBLIC HEALTH REP, V116, P336, DOI 10.1093/phr/116.4.336; HAWTHORNE VM, 1978, J EPIDEMIOL COMMUN H, V32, P260, DOI 10.1136/jech.32.4.260; HIGENBOTTAM T, 1982, J EPIDEMIOL COMMUN H, V36, P113, DOI 10.1136/jech.36.2.113; HOFFMANN D, 1996, NCI SMOKING TOBACCO, V7, P15; HOFFMANN D, 1994, LUNG CANCER, P1; JOCKEL KH, 1992, INT J EPIDEMIOL, V21, P202, DOI 10.1093/ije/21.2.202; Kabat GC, 1996, LUNG CANCER, V15, P1, DOI 10.1016/0169-5002(95)00566-8; KAUFMAN DW, 1989, AM J EPIDEMIOL, V129, P703, DOI 10.1093/oxfordjournals.aje.a115185; Khuder SA, 1998, LUNG CANCER-J IASLC, V22, P15, DOI 10.1016/S0169-5002(98)00068-3; KIRYLUK S, 1989, NICOTINE SMOKING LOW; KOZLOWSKI LT, 2001, MON NCI, P13; KOZLOWSKI LT, 2001, MONOGRAPH USDHHS NAT, V13, P13; KULLER LH, 1991, PREV MED, V20, P638, DOI 10.1016/0091-7435(91)90060-H; KUNZE M, 1980, BANBURY REPORT, V3, P29; LANGE P, 1992, EUR RESPIR J, V5, P1111; LEE PN, 1981, J EPIDEMIOL COMMUN H, V35, P16, DOI 10.1136/jech.35.1.16; Lee PN, 2001, INHAL TOXICOL, V13, P951, DOI 10.1080/089583701753210353; LUBIN JH, 1984, INT J CANCER, V33, P569, DOI 10.1002/ijc.2910330504; LUBIN JH, 1984, BRIT MED J, V288, P1953, DOI 10.1136/bmj.288.6435.1953; Matos E, 1998, LUNG CANCER-J IASLC, V21, P155, DOI 10.1016/S0169-5002(98)00055-5; OCKENE JK, 1990, AM J PUBLIC HEALTH, V80, P954, DOI 10.2105/AJPH.80.8.954; PATHAK DR, 1986, JNCI-J NATL CANCER I, V76, P597, DOI 10.1093/jnci/76.4.597; PETITTI DB, 1985, J CHRON DIS, V38, P581, DOI 10.1016/0021-9681(85)90047-5; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; PEZZOTTO SM, 1993, CANCER CAUSE CONTROL, V4, P231; RIMINGTON J, 1981, ENVIRON RES, V24, P162, DOI 10.1016/0013-9351(81)90142-0; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; SIDNEY S, 1993, CANCER CAUSE CONTROL, V4, P3, DOI 10.1007/BF00051707; Simonato L, 2001, INT J CANCER, V91, P876, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1139>3.0.CO;2-7; Speizer FE, 1999, CANCER CAUSE CONTROL, V10, P475, DOI 10.1023/A:1008931526525; Stellman SD, 1997, CANCER-AM CANCER SOC, V80, P382, DOI 10.1002/(SICI)1097-0142(19970801)80:3<382::AID-CNCR5>3.0.CO;2-U; STELLMAN SD, 1986, JNCI-J NATL CANCER I, V76, P1057; TANG JL, 1995, BMJ-BRIT MED J, V311, P1530, DOI 10.1136/bmj.311.7019.1530; Thun MJ, 1997, PREV MED, V26, P422, DOI 10.1006/pmed.1997.0182; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Thun MJ, 2000, CANCER EPIDEM BIOMAR, V9, P861; TODD GF, 1978, J EPIDEMIOL COMMUN H, V32, P267, DOI 10.1136/jech.32.4.267; *US FED TRAD COMM, 2002, DOM MARK SHAR CIG TA; *US FED TRAD COMM, 1981, REP TAR NIC CARB MON; *USDA, 2002, TOB OUTL; *USDA EC RES SERV, 2002, TBS252 USDA EC RES S; VUTUC C, 1983, J NATL CANCER I, V71, P435; VUTUC C, 1982, PREV MED, V11, P713, DOI 10.1016/0091-7435(82)90033-0; WALD N, 1981, BRIT MED J, V282, P763, DOI 10.1136/bmj.282.6266.763; WILCOX HB, 1988, PREV MED, V17, P263, DOI 10.1016/0091-7435(88)90002-3; WYNDER EL, 1970, J AMER MED ASSOC, V213, P2221, DOI 10.1001/jama.213.13.2221; WYNDER EL, 1979, J NATL CANCER I, V62, P471, DOI 10.1093/jnci/62.3.471; WYNDER EL, 1988, CANCER, V62, P1223, DOI 10.1002/1097-0142(19880915)62:6<1223::AID-CNCR2820620630>3.0.CO;2-6; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; ZANG EA, 1992, CANCER, V70, P69, DOI 10.1002/1097-0142(19920701)70:1<69::AID-CNCR2820700112>3.0.CO;2-A	75	96	102	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2004	328	7431					72	76		10.1136/bmj.37936.585382.44	http://dx.doi.org/10.1136/bmj.37936.585382.44			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MP	14715602	Green Submitted, Green Published			2022-12-01	WOS:000187976400013
J	Si, K; Giustetto, M; Etkin, A; Hsu, R; Janisiewicz, AM; Miniaci, MC; Kim, JH; Zhu, HX; Kandel, ER				Si, K; Giustetto, M; Etkin, A; Hsu, R; Janisiewicz, AM; Miniaci, MC; Kim, JH; Zhu, HX; Kandel, ER			A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia	CELL			English	Article							XENOPUS OOCYTE MATURATION; ELEMENT-BINDING PROTEIN; CAMKII MESSENGER-RNA; DROSOPHILA ORB GENE; CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; S6 KINASE; EXPRESSION; PHOSPHORYLATION; POTENTIATION	Synapse-specific facilitation requires rapamycin-dependent local protein synthesis at the activated synapse. In Aplysia, rapamycin-dependent local protein synthesis serves two functions: (1) it provides a component of the mark at the activated synapse and thereby confers synapse specificity and (2) it stabilizes the synaptic growth associated with long-term facilitation. Here we report that a neuron-specific isoform of cytoplasmic polyadenylation element binding protein (CPEB) regulates this synaptic protein synthesis in an activity-dependent manner. Aplysia CPEB protein is upregulated locally at activated synapses, and it is needed not for the initiation but for the stable maintenance of long-term facilitation. We suggest that Aplysia CPEB is one of the stabilizing components of the synaptic mark.	Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Si, K (corresponding author), Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Howard Hughes Med Inst, 722 W 168th St, New York, NY 10032 USA.	ks560@columbia.edu; erk5@columbia.edu	Etkin, Amit/ABD-5761-2021; giustetto, maurizio/D-6606-2011	giustetto, maurizio/0000-0003-1323-4060; Miniaci, Maria/0000-0003-3844-0581				Bally-Cuif L, 1998, MECH DEVELOP, V77, P31, DOI 10.1016/S0925-4773(98)00109-9; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; DESGROSEILLERS L, 1994, BBA-GENE STRUCT EXPR, V1217, P322, DOI 10.1016/0167-4781(94)90293-3; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gebauer F, 1996, P NATL ACAD SCI USA, V93, P14602, DOI 10.1073/pnas.93.25.14602; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; LANTZ V, 1992, DEVELOPMENT, V115, P75; Liu JM, 2003, BRAIN RES, V959, P68, DOI 10.1016/S0006-8993(02)03729-0; Liu QR, 1997, J NEUROSCI, V17, P755; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Moccia R, 2003, J NEUROSCI, V23, P9409; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Reverte CG, 2003, DEV BIOL, V255, P383, DOI 10.1016/S0012-1606(02)00089-1; Salles FJ, 1999, METH MOL B, V118, P441; Schroeder KE, 1999, DEV BIOL, V214, P288, DOI 10.1006/dbio.1999.9426; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tan LH, 2001, DEVELOPMENT, V128, P1159; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; [No title captured]	43	321	332	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					893	904		10.1016/S0092-8674(03)01021-3	http://dx.doi.org/10.1016/S0092-8674(03)01021-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697206	Bronze			2022-12-01	WOS:000187664700012
J	Holbrook, A; Goldsmith, C				Holbrook, A; Goldsmith, C			Innovation and placebos in research: a new design of clinical trial	LANCET			English	Editorial Material							DISORDERS; ETHICS		St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada; McMaster Univ, Div Clin Pharmacol, Hamilton, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Holbrook, A (corresponding author), St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON L8N 1G6, Canada.		anand, amit/A-7222-2009					Amdur RJ, 2001, INT J CANCER, V96, P261, DOI 10.1002/ijc.1026; Charney DS, 2002, ARCH GEN PSYCHIAT, V59, P262, DOI 10.1001/archpsyc.59.3.262; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Fava M, 2003, PSYCHOTHER PSYCHOSOM, V72, P115, DOI 10.1159/000069738; Feinstein AR, 2002, J CLIN EPIDEMIOL, V55, P427, DOI 10.1016/S0895-4356(01)00495-4; GOLDSMITH CH, 2002, JOINT STAT M NEW YOR, P282; Huston P, 2001, NEW ENGL J MED, V345, P912, DOI 10.1056/NEJM200109203451210; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weijer C, 2002, CAN MED ASSOC J, V166, P603	10	3	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2036	2037		10.1016/S0140-6736(03)15147-1	http://dx.doi.org/10.1016/S0140-6736(03)15147-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697799				2022-12-01	WOS:000187429600004
J	Miranda, JJ				Miranda, JJ			TB and you and me ... personal reflections	LANCET			English	Article									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Miranda, JJ (corresponding author), UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England.		Miranda, J. Jaime/A-8482-2008	Miranda, J. Jaime/0000-0002-4738-5468					0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 20	2003	362	9401					2081	2082		10.1016/S0140-6736(03)15106-9	http://dx.doi.org/10.1016/S0140-6736(03)15106-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697811				2022-12-01	WOS:000187429600025
J	Wu, L; Hickson, ID				Wu, L; Hickson, ID			The Bloom's syndrome helicase suppresses crossing over during homologous recombination	NATURE			English	Article							SYNDROME GENE-PRODUCT; TOPOISOMERASE-III-ALPHA; STRAND-BREAK REPAIR; HOLLIDAY JUNCTION RESOLUTION; RECQ HELICASES; ESCHERICHIA-COLI; BRANCH MIGRATION; MAMMALIAN-CELLS; MEIOSIS; YEAST	Mutations in BLM, which encodes a RecQ helicase, give rise to Bloom's syndrome, a disorder associated with cancer predisposition and genomic instability(1). A defining feature of Bloom's syndrome is an elevated frequency of sister chromatid exchanges(2). These arise from crossing over of chromatid arms during homologous recombination, a ubiquitous process that exists to repair DNA double-stranded breaks and damaged replication forks. Whereas crossing over is required in meiosis, in mitotic cells it can be associated with detrimental loss of heterozygosity. BLM forms an evolutionarily conserved complex with human topoisomerase IIIalpha (hTOPO IIIalpha)(3,4), which can break and rejoin DNA to alter its topology. Inactivation of homologues of either protein leads to hyper-recombination in unicellular organisms(5). Here, we show that BLM and hTOPO IIIalpha together effect the resolution of a recombination intermediate containing a double Holliday junction. The mechanism, which we term double-junction dissolution, is distinct from classical Holliday junction resolution and prevents exchange of flanking sequences. Loss of such an activity explains many of the cellular phenotypes of Bloom's syndrome. These results have wider implications for our understanding of the process of homologous recombination and the mechanisms that exist to prevent tumorigenesis.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford	Hickson, ID (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK, Oxford OX3 9DS, England.		Hickson, Ian/AAJ-7548-2020					Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BENSON FE, 1994, J BIOL CHEM, V269, P5195; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Johnson FB, 2000, CANCER RES, V60, P1162; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2001, CELL MOL LIFE SCI, V58, P894, DOI 10.1007/PL00000909	28	846	861	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					870	874		10.1038/nature02253	http://dx.doi.org/10.1038/nature02253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685245				2022-12-01	WOS:000187342000066
J	't Jong, GW; Stricker, BHC; Sturkenboom, MCJM				't Jong, GW; Stricker, BHC; Sturkenboom, MCJM			Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Erasmus Univ, Med Ctr, Dept Med Informat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Sturkenboom, MCJM (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	m.sturkenboom@crasmusmc.nl						BRAUTIGAM M, 1995, BRIT MED J, V311, P919, DOI 10.1136/bmj.311.7010.919; Sheldon T, 2002, BRIT MED J, V325, P355, DOI 10.1136/bmj.325.7360.355; Vlug AE, 1999, METHOD INFORM MED, V38, P339	3	35	35	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					931	931		10.1136/bmj.38007.711481.F7	http://dx.doi.org/10.1136/bmj.38007.711481.F7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	14988148	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000220994400023
J	Jan, YW; Matter, M; Pai, JT; Chen, YL; Pilch, J; Komatsu, M; Ong, E; Fukuda, M; Ruoslahti, E				Jan, YW; Matter, M; Pai, JT; Chen, YL; Pilch, J; Komatsu, M; Ong, E; Fukuda, M; Ruoslahti, E			A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors	CELL			English	Article							FIBRONECTIN RECEPTOR; SIGNALING PATHWAY; EPITHELIAL-CELLS; ENDONUCLEASE-G; ANOIKIS; EXPRESSION; SURVIVAL; KINASE; ADHESION; BCL-2	A delicate balance of signals regulates cell survival. One set of these signals is derived from integrin-mediated cell adhesion to the extracellular matrix (ECM). Loss of cell attachment to the ECM causes apoptosis, a process known as anoikis. In searching for proteins involved in cell adhesion-dependent regulation of anoikis, we identified Bit1, a mitochondrial protein that is released into the cytoplasm during apoptosis. Cytoplasmic Bit1 forms a complex with AES, a small Groucho/transducin-like enhancer of split (TLE) protein, and induces cell death with characteristics of caspase-independent apoptosis. Cell attachment to fibronectin counteracts the apoptotic effect of Bit1 and AES. Increasing Bit1 expression enhances anoikis, while suppressing the expression reduces it. Thus, we have elucidated an integrin-controlled pathway that is, at least in part, responsible for the cell survival effects of cell-ECM interactions.	Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Burnham Inst, Program Mol Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, San Diego Branch, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Ruoslahti, E (corresponding author), Burnham Inst, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ruoslahti@burnham.org	Matter, Michelle/GSN-9703-2022; Pilch, Jan/AAJ-3614-2021; Pilch, Jan/AAM-1976-2020	Pilch, Jan/0000-0002-6427-5738; Matter, Michelle/0000-0002-5988-9663; Pilch, Jan/0000-0002-2682-4708; Komatsu, Masanobu/0000-0001-7548-137X	NCI NIH HHS [CA 30199, CA33000, CA79984, CA82713] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA079984, P01CA082713, R37CA033000, R01CA033000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633; BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; BROTHERICK I, 1994, CYTOMETRY, V16, P262, DOI 10.1002/cyto.990160311; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DEL PL, 1997, SCIENCE, V278, P687; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li GY, 1999, CANCER RES, V59, P6267; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; MALLO M, 1995, DEV DYNAM, V204, P338, DOI 10.1002/aja.1002040311; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; OBrien V, 1996, EXP CELL RES, V224, P208, DOI 10.1006/excr.1996.0130; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosas-Sandoval G, 2002, P NATL ACAD SCI USA, V99, P16707, DOI 10.1073/pnas.222659199; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Wang WF, 2002, DEV DYNAM, V224, P79, DOI 10.1002/dvdy.10089; Wang XD, 2001, GENE DEV, V15, P2922; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	47	130	148	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					751	762		10.1016/S0092-8674(04)00204-1	http://dx.doi.org/10.1016/S0092-8674(04)00204-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006356	Bronze			2022-12-01	WOS:000221499700014
J	Murase, K; Shiba, H; Iwano, M; Che, FS; Watanabe, M; Isogai, A; Takayama, S				Murase, K; Shiba, H; Iwano, M; Che, FS; Watanabe, M; Isogai, A; Takayama, S			A membrane-anchored protein kinase involved in Brassica self-incompatibility signaling	SCIENCE			English	Article							RECEPTOR KINASE; S-LOCUS; GENOMIC ORGANIZATION; PLANTS; GENE; POLLEN; DETERMINANT; CAMPESTRIS; MUTATION; OLERACEA	Self-incompatibility (SI) response in Brassica is initiated by haplotype-specific interactions between the pollen-borne ligand S locus protein 11/SCR and its stigmatic S receptor kinase, SRK. This binding induces autophosphorylation of SRK, which is then thought to trigger a signaling cascade that leads to self-pollen rejection. A recessive mutation of the modifier (m) gene eliminates the SI response in stigma. Positional cloning of M has revealed that it encodes a membrane-anchored cytoplasmic serine/threonine protein kinase, designated M locus protein kinase (MLPK). Transient expression of MLPK restores the ability of mm papilla cells to reject self-pollen, suggesting that MLPK is a positive mediator of Brassica SI signaling.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Nara Institute of Science & Technology; Iwate University	Takayama, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma 6300101, Japan.	takayama@bs.aist-nara.ac.jp	Isogai, Akira/O-8897-2017; Watanabe, Masao/N-1465-2019; Watanabe, Masao/E-6300-2011	Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149; Watanabe, Masao/0000-0002-9419-5149				Fukai E, 2001, MOL GENET GENOMICS, V265, P519, DOI 10.1007/s004380000440; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Ikeda S, 1997, SCIENCE, V276, P1564, DOI 10.1126/science.276.5318.1564; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Marin-Olivier M, 2000, PLANT J, V24, P231, DOI 10.1046/j.1365-313x.2000.00874.x; Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; MIYAKE Y, 1992, EUR J BIOCHEM, V210, P1, DOI 10.1111/j.1432-1033.1992.tb17383.x; Murase K., UNPUB; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2003, BIOSCI BIOTECH BIOCH, V67, P622, DOI 10.1271/bbb.67.622; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Suzuki G, 1999, GENETICS, V153, P391; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Takayama S, 2002, CURR OPIN PLANT BIOL, V5, P382, DOI 10.1016/S1369-5266(02)00284-4; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson GA, 2000, PROG LIPID RES, V39, P19, DOI 10.1016/S0163-7827(99)00014-4; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; [No title captured]	26	171	206	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1516	1519		10.1126/science.1093586	http://dx.doi.org/10.1126/science.1093586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001779				2022-12-01	WOS:000220000100042
J	Sigman, DM; Jaccard, SL; Haug, GH				Sigman, DM; Jaccard, SL; Haug, GH			Polar ocean stratification in a cold climate	NATURE			English	Article							SOUTHERN-OCEAN; NORTH-ATLANTIC; CYCLE; NITRATE; CARBON	The low-latitude ocean is strongly stratified by the warmth of its surface water. As a result, the great volume of the deep ocean has easiest access to the atmosphere through the polar surface ocean. In the modern polar ocean during the winter, the vertical distribution of temperature promotes overturning, with colder water over warmer, while the salinity distribution typically promotes stratification, with fresher water over saltier. However, the sensitivity of seawater density to temperature is reduced as temperature approaches the freezing point, with potential consequences for global ocean circulation under cold climates(1,2). Here we present deep-sea records of biogenic opal accumulation and sedimentary nitrogen isotopic composition from the Sub-arctic North Pacific Ocean and the Southern Ocean. These records indicate that vertical stratification increased in both northern and southern high latitudes 2.7 million years ago, when Northern Hemisphere glaciation intensified in association with global cooling during the late Pliocene epoch. We propose that the cooling caused this increased stratification by weakening the role of temperature in polar ocean density structure so as to reduce its opposition to the stratifying effect of the vertical salinity distribution. The shift towards stratification in the polar ocean 2.7 million years ago may have increased the quantity of carbon dioxide trapped in the abyss, amplifying the global cooling.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany	Princeton University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Sigman, DM (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	sigman@princeton.edu	Sigman, Daniel M/A-2649-2008; Jaccard, Samuel/G-3447-2014	Sigman, Daniel M/0000-0002-7923-1973; Jaccard, Samuel/0000-0002-5793-0896				Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Andreev A, 2002, DEEP-SEA RES PT II, V49, P5577, DOI 10.1016/S0967-0645(02)00200-X; BARKER PF, 1988, PALAEOGEOGR PALAEOCL, V67, P75, DOI 10.1016/0031-0182(88)90123-X; BOYLE EA, 1982, SCIENCE, V218, P784, DOI 10.1126/science.218.4574.784; BREWSTER NA, 1980, GEOL SOC AM BULL, V91, P337; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; BURCKLE LH, 1987, P ODP SCI RES, V113, P803; Conkright M., 2002, NOAA ATLAS NESDIS42; Diekmann B, 2003, SEDIMENTOLOGY, V50, P511, DOI 10.1046/j.1365-3091.2003.00562.x; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; FROELICH PN, 1991, P OCEAN DRILLING PRO, V0114; Gildor H, 2001, GEOPHYS RES LETT, V28, P2421, DOI 10.1029/2000GL012571; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; HILLENBRAND CD, 2001, P OCEAN DRILLING PRO, V0178; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; Martin F, 1996, GESTA, V35, P177, DOI 10.2307/767181; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Narita H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014320; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; REA DK, 1993, P ODP INIT REP, V145, P5; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sigman DM, 1999, GLOBAL BIOGEOCHEM CY, V13, P1149, DOI 10.1029/1999GB900038; Sigmon DE, 2002, DEEP-SEA RES PT II, V49, P1747, DOI 10.1016/S0967-0645(02)00010-3; TOGGWEILER JR, 2003, EOS S, V84; WANG WG, 2002, NETW MAG, V17, P10; WARREN BA, 1983, J MAR RES, V41, P327, DOI 10.1357/002224083788520207; Winton M, 1997, J CLIMATE, V10, P37, DOI 10.1175/1520-0442(1997)010<0037:TEOCCU>2.0.CO;2	30	189	197	8	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					59	63		10.1038/nature02357	http://dx.doi.org/10.1038/nature02357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999278	Green Submitted			2022-12-01	WOS:000189363800033
J	Mutsch, M; Zhou, WG; Rhodes, P; Bopp, M; Chen, RT; Linder, T; Spyr, C; Steffen, R				Mutsch, M; Zhou, WG; Rhodes, P; Bopp, M; Chen, RT; Linder, T; Spyr, C; Steffen, R			Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEAT-LABILE TOXIN; CASE SERIES; SAFETY; IMMUNOGENICITY; TRIVALENT; EFFICACY	BACKGROUND: After the introduction of an inactivated intranasal influenza vaccine that was used only in Switzerland, 46 cases of Bell's palsy were reported. METHODS: We conducted a matched case-control study and a case-series analysis. All primary care physicians, ear, nose, and throat specialists, and neurologists in German-speaking regions of Switzerland were requested to identify cases of Bell's palsy diagnosed in adults between October 1, 2000, and April 30, 2001. Each physician was invited to select three control patients for each patient with Bell's palsy, with matching according to age, date of the clinic visit, and physician. Vaccination information was provided by the physicians. RESULTS: A total of 773 patients with Bell's palsy were identified. Of the 412 (53.3 percent) who could be evaluated, 250 (60.7 percent) were enrolled and matched with 722 control patients; the other 162 patients had no controls. In the case-control study, we found that 68 patients with Bell's palsy (27.2 percent) and 8 controls (1.1 percent) had received the intranasal vaccine (P<0.001). In contrast to parenteral vaccines, the intranasal vaccine significantly increased the risk of Bell's palsy (adjusted odds ratio, 84.0; 95 percent confidence interval, 20.1 to 351.9). Even according to conservative assumptions, the relative risk of Bell's palsy was estimated to be 19 times the risk in the controls, corresponding to 13 excess cases per 10,000 vaccinees within 1 to 91 days after vaccination. In the case-series analysis, the period of highest risk was 31 to 60 days after vaccination. CONCLUSIONS: This study suggests a strong association between the inactivated intranasal influenza vaccine used in Switzerland and Bell's palsy. This vaccine is no longer in clinical use.	Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; Univ Zurich, Div Communicable Dis, WHO, Collaborating Ctr Travellers Hlth, CH-8006 Zurich, Switzerland; CDCP, Epidemiol Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; CDCP, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA USA; Kantonsspital Lucerne, Dept Otorhinolaryngol & Head & Neck Surg, Luzern, Switzerland; Berna Biotech, Bern, Switzerland	University of Zurich; University of Zurich; World Health Organization; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Lucerne Cantonal Hospital	Mutsch, M (corresponding author), Univ Zurich, Inst Social & Prevent Med, Sumatra Str 30, CH-8006 Zurich, Switzerland.	muetsch@ifspm.unizh.ch	Chen, Robert T/AIA-8164-2022; Linder, Thomas/ABH-6961-2020	Chen, Robert T/0000-0002-3094-8367; Bopp, Matthias/0000-0003-0766-3723; Mutsch, Margot/0000-0003-0620-5376				Adour KK, 1996, ANN OTO RHINOL LARYN, V105, P371, DOI 10.1177/000348949610500508; ANDERSON RN, 2000, NATL VITAL STAT REP, V50, P1; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; BRANDENBURG NA, 1993, NEUROEPIDEMIOLOGY, V12, P313, DOI 10.1159/000110333; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; De Diego JI, 1999, OTOLARYNG HEAD NECK, V120, P269, DOI 10.1016/S0194-5998(99)70418-3; di Valserra MDB, 2002, CLIN THER, V24, P100, DOI 10.1016/S0149-2918(02)85008-1; Ellenberg SS, 2001, PHARMACOEPIDEM DR S, V10, P411, DOI 10.1002/pds.616; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Gluck R, 2000, J INFECT DIS, V181, P1129, DOI 10.1086/315337; Gluck U, 1999, J VIROL, V73, P7780; Glueck R, 2001, VACCINE, V20, pS42, DOI 10.1016/S0264-410X(01)00292-4; Glueck R, 2001, ADV DRUG DELIVER REV, V51, P203, DOI 10.1016/S0169-409X(01)00174-0; GoncalvesCoelho TD, 1997, ARQ NEURO-PSIQUIAT, V55, P722, DOI 10.1590/S0004-282X1997000500007; Isaacson JE, 2002, OTOL NEUROTOL, V23, P589, DOI 10.1097/00129492-200207000-00031; Jacobson RM, 2001, VACCINE, V19, P2428, DOI 10.1016/S0264-410X(00)00467-9; KATUSIC SK, 1986, ANN NEUROL, V20, P622, DOI 10.1002/ana.410200511; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Marson AG, 2000, WESTERN J MED, V173, P266, DOI 10.1136/ewjm.173.4.266; McNeela EA, 2001, ADV DRUG DELIVER REV, V51, P43, DOI 10.1016/S0169-409X(01)00169-7; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; PAOLINO E, 1985, J NEUROL, V232, P363, DOI 10.1007/BF00313837; Papaevangelou V, 1999, PEDIATR INFECT DIS J, V18, P1024, DOI 10.1097/00006454-199911000-00022; PEITERSEN E, 1992, ACTA OTO-LARYNGOL, P122; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; Savettieri G, 1996, ACTA NEUROL SCAND, V94, P71, DOI 10.1111/j.1600-0404.1996.tb00043.x; TOVI F, 1986, European Journal of Epidemiology, V2, P228; YANAGIHARA N, 1984, ARCH OTOLARYNGOL, V110, P374; YANAGIHARA N, 1988, ANN OTO RHINOL LARYN, V97, P3, DOI 10.1177/00034894880976S301; Zurbriggen Rinaldo, 2003, Expert Rev Vaccines, V2, P295, DOI 10.1586/14760584.2.2.295; [No title captured]	33	610	647	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2004	350	9					896	903		10.1056/NEJMoa030595	http://dx.doi.org/10.1056/NEJMoa030595			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777UM	14985487	Green Accepted			2022-12-01	WOS:000189197300008
J	Csankovszki, G; McDonel, P; Meyer, BJ				Csankovszki, G; McDonel, P; Meyer, BJ			Recruitment and spreading of the C-elegans dosage compensation complex along X chromosomes	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; SEX-DETERMINATION; ROX GENES; RNA; SEGREGATION; MACHINERY; CHROMATIN; NEMATODE; PROTEINS	To achieve X-chromosome dosage compensation, organisms must distinguish X chromosomes from autosomes. We identified multiple, cis-acting regions that recruit the Caenorhabditis elegans dosage compensation complex (DCC) through a search for regions of X that bind the complex when detached from X. The DCC normally assembles along the entire X chromosome, but not all detached regions recruit the complex, despite having genes known to be dosage compensated on the native X. Thus, the DCC binds first to recruitment sites, then spreads to neighboring X regions to accomplish chromosome-wide gene repression. From a large chromosomal domain, we defined a 793-base pair fragment that functions in vivo as an X-recognition element to recruit the DCC.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	bjmeyer@uclink.berkeley.edu		Csankovszki, Gyorgyi/0000-0001-5918-034X; Meyer, Barbara/0000-0002-6530-4588	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030702, F32GM065007, R37GM030702] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37-GM30702, F32 GM065007, F32-GM065007, R01 GM030702] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERIB CC, 1994, GENETICS, V138, P1105; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; CSANKOVSZKI G, UNPUB; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Lieb JD, 2000, GENETICS, V156, P1603; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Meller VH, 2002, ADV GENET, V46, P1; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Oh K, 2003, GENE DEV, V17, P1334, DOI 10.1101/gad.1082003; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433	19	97	113	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1182	1185		10.1126/science.1092938	http://dx.doi.org/10.1126/science.1092938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976312				2022-12-01	WOS:000189074700043
J	Motta, MC; Divecha, N; Lemieux, M; Kamel, C; Chen, D; Gu, W; Bultsma, Y; McBurney, M; Guarente, L				Motta, MC; Divecha, N; Lemieux, M; Kamel, C; Chen, D; Gu, W; Bultsma, Y; McBurney, M; Guarente, L			Mammalian SIRT1 represses forkhead transcription factors	CELL			English	Article							PROTEIN-KINASE-B; PROMOTES CELL-SURVIVAL; CAENORHABDITIS-ELEGANS; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; FACTOR FKHR; FACTOR FOXO1; PHOSPHOENOLPYRUVATE CARBOXYKINASE; SIGNALING PATHWAY	The NAD-dependent deacetylase SIR2 and the forkhead transcription factor DAF-16 regulate lifespan in model organisms, such as yeast and C. elegans. Here we show that the mammalian SIR2 ortholog SIRT1 deacetylates and represses the activity of the forkhead transcription factor Foxo3a and other mammalian forkhead factors. This regulation appears to be in the opposite direction from the genetic interaction of SIR2 with forkhead in C. elegans. By restraining mammalian forkhead proteins, SIRT1 also reduces forkhead-dependent apoptosis. The inhibition of forkhead activity by SIRT1 parallels the effect of this deacetylase on the tumor suppressor p53. We speculate how down-regulating these two classes of damage-responsive mammalian factors may favor long lifespan under certain environmental conditions, such as calorie restriction.	MIT, Dept Biol, Cambridge, MA 02139 USA; Antoni Van Leeuwenhoek Ziekenhuis, Dept Cellular Biochem H3, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Univ Ottawa, Dept Med, Ottawa, ON K1H 1C4, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 1C4, Canada; Ottawa Reg Canc Ctr, Ottawa, ON K1H 1C4, Canada	Massachusetts Institute of Technology (MIT); Netherlands Cancer Institute; Columbia University; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu		divecha, nullin/0000-0001-9695-6039; Lemieux, Madeleine/0000-0001-6355-8691				Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Guarente L, 2000, GENE DEV, V14, P1021; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KAMEI Y, 2004, J LIPID RES, V1, P81; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nadal A, 2002, BIOCHEM J, V366, P289, DOI 10.1042/BJ20020598; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weindruch R., 1988, RETARDATION AGING DI; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000	64	1110	1178	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					551	563		10.1016/S0092-8674(04)00126-6	http://dx.doi.org/10.1016/S0092-8674(04)00126-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980222	Bronze, Green Published			2022-12-01	WOS:000189184200009
J	Liu, ZH; Herbert, TD				Liu, ZH; Herbert, TD			High-latitude influence on the eastern equatorial Pacific climate in the early Pleistocene epoch	NATURE			English	Article							SEA-SURFACE TEMPERATURE; OCEAN; ATLANTIC; CALIBRATION; INSOLATION; CYCLES	Many records of tropical sea surface temperature and marine productivity exhibit cycles of 23 kyr (orbital precession) and 100 kyr during the past 0.5 Myr (refs 1-5), whereas high-latitude sea surface temperature records display much more pronounced obliquity cycles at a period of about 41 kyr (ref. 6). Little is known, however, about tropical climate variability before the mid-Pleistocene transition about 900 kyr ago, which marks the change from a climate dominated by 41-kyr cycles(7) (when ice-age cycles and high-latitude sea surface temperature variations were dictated by changes in the Earth's obliquity(8,9)) to the more recent 100-kyr cycles of ice ages. Here we analyse alkenones from marine sediments in the eastern equatorial Pacific Ocean to reconstruct sea surface temperatures and marine productivity over the past 1.8 Myr. We find that both records are dominated by the 41-kyr	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Liu, ZH (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	Zhonghui_Liu@brown.edu	Liu, Zhonghui/D-3163-2009	Liu, Zhonghui/0000-0002-2168-8305				[Anonymous], [No title captured]; Beaufort L, 2001, SCIENCE, V293, P2440, DOI 10.1126/science.293.5539.2440; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; BLOEMENDAL J, 1989, NATURE, V342, P897, DOI 10.1038/342897a0; Budziak D, 2000, PALEOCEANOGRAPHY, V15, P307, DOI 10.1029/1999PA000433; Bush ABG, 1998, SCIENCE, V279, P1341, DOI 10.1126/science.279.5355.1341; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Emeis K.-C., 1995, P OCEAN DRILL PROGRA, V138, P605; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Herbert TD, 1998, PALEOCEANOGRAPHY, V13, P263, DOI 10.1029/98PA00069; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; LYLE MW, 1992, NATURE, V355, P812, DOI 10.1038/355812a0; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P839, DOI 10.2973/odp.proc.sr.138.160.1995; MOLFINO B, 1990, SCIENCE, V249, P766, DOI 10.1126/science.249.4970.766; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI DOI 10.1029/96E000259; PERKS H, 2002, PALEOCEANOGRAPHY, V17, P63; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Rostek F, 1997, DEEP-SEA RES PT II, V44, P1461, DOI 10.1016/S0967-0645(97)00008-8; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; RUDDIMAN WF, 1984, GEOL SOC AM BULL, V95, P381, DOI 10.1130/0016-7606(1984)95<381:ITRACR>2.0.CO;2; Schneider RR, 1996, SOUTH ATLANTIC, P527; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782	27	152	160	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					720	723		10.1038/nature02338	http://dx.doi.org/10.1038/nature02338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973481				2022-12-01	WOS:000189026000039
J	Peters, B; Whittall, T; Babaahmady, K; Gray, K; Vaughan, R; Lehner, T				Peters, B; Whittall, T; Babaahmady, K; Gray, K; Vaughan, R; Lehner, T			Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection	LANCET			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PRIMERS PCR-SSP; CLASS-I; LYMPHOCYTE-RESPONSES; VACCINE PROTECTION; RHESUS MACAQUES; SEX WORKERS; P27 ANTIGEN; T-CELLS; HLA	Background Unprotected sexual intercourse between regular heterosexual partners could elicit alloimmune responses that might be associated with inhibition of in-vitro HIV-1 infectivity. We investigated this hypothesis in people practising unprotected sex and those using protection. Methods We recruited 82 participants from an outpatient genitourinary medicine clinic. 29 monogamous heterosexual couples having unprotected sex; and 15 women and 10 men having condom protected or no sex. We used the mixed leucocyte reaction (MLR), stimulating one partner's peripheral blood mononuclear cells (PBMC) with the other partner's irradiated PBMC and compared the resulting response with control PBMC. We studied resistance to HIV-1 infection by challenging activated CD4-positive T cells with CCR5-binding and CXCR4-binding HIV-1 strains, and comparing the infectivity in participants having unprotected sex with those practising protected sex. We used the correlation coefficient to establish the significance of the relation between MLR and HIV-1 infectivity. Findings We recorded a significant increase in the stimulation indices in PBMC from women whose cells were stimulated with irradiated PBMC (2%, 10%, or 50%) from their regular partners. The mean with 10% partner's cells was 8.6 (SD 7.7), compared with those from unrelated cells (4.7 [3.9], p=0.009). Significant alloimmune responses were also seen in corresponding male partners, but only with 50% stimulating cells (p=0.013). Dose-dependent inhibition of activated CD4-positive T cells to HIV-1 infection with both binding strains was noted in vitro in women practising unprotected intercourse, compared with those having protected sex or having no sex for more than 1 year. Highly significant differences were found for CCR5 (p=0.0001) and for CXCR4 (p=0.001) strains of HIV-1 at all four virus-concentrations. Male partners also showed in-vitro inhibition of HIV-1 but this was less than that in women. Interpretation Unprotected sexual intercourse might result in alloimmunisation stimulated by HLA antigens in seminal or cervicovaginal fluid. Mucosal alloimmunisation may reduce infection by HIV-1, and the role of such immunisation in preventive and therapeutic vaccination should be investigated.	Guys Kings & St Thomas Hosp Med & Dent Sch, Dept Genitourinary Med, London SE1 9RT, England; Guys Kings & St Thomas Hosp Med & Dent Sch, Muscosal Immunol Unit, London SE1 9RT, England; Guys Kings & St Thomas Hosp Med & Dent Sch, Clin Transplantat Lab, London SE1 9RT, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Lehner, T (corresponding author), Guys Kings & St Thomas Hosp Med & Dent Sch, Dept Genitourinary Med, London SE1 9RT, England.	thomas.lehner@kcl.ac.uk		Gray, Kimberly/0000-0003-4594-3144; Whittall, Trevor/0000-0002-2189-3675				ARTHUR LO, 1995, J VIROL, V69, P3117, DOI 10.1128/JVI.69.5.3117-3124.1995; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Beyrer C, 1999, J INFECT DIS, V179, P59, DOI 10.1086/314556; Bruhl P, 1996, AIDS RES HUM RETROV, V12, P31, DOI 10.1089/aid.1996.12.31; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; CARLSON JR, 1990, AIDS RES HUM RETROV, V6, P1239, DOI 10.1089/aid.1990.6.1239; CELUM CL, 1994, ARCH INTERN MED, V154, P1129, DOI 10.1001/archinte.154.10.1129; CHAN WL, 1995, AIDS, V9, P223, DOI 10.1097/00002030-199509030-00002; Chaouat G, 2003, CLIN EXP IMMUNOL, V131, P393, DOI 10.1046/j.1365-2249.2003.02100.x; CLERICI M, 1993, EUR J IMMUNOL, V23, P2022, DOI 10.1002/eji.1830230845; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; Goh WC, 1999, J INFECT DIS, V179, P548, DOI 10.1086/314632; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; KIND C, 1995, EUR J PEDIATR, V154, P542, DOI 10.1007/s004310050339; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; Kristiansen TB, 2001, J IMMUNOL METHODS, V252, P147, DOI 10.1016/S0022-1759(01)00349-0; LANGLOIS AJ, 1992, SCIENCE, V255, P292, DOI 10.1126/science.1549775; LEHNER T, 1994, J IMMUNOL, V153, P1858; LEHNER T, 1994, J VIROL, V68, P1624, DOI 10.1128/JVI.68.3.1624-1632.1994; Lehner Thomas, 2000, AIDS Research and Human Retroviruses, V16, P309, DOI 10.1089/088922200309188; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; Martin-Villa JM, 1999, BIOL REPROD, V61, P1381, DOI 10.1095/biolreprod61.6.1381; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; OLERUP O, 1993, TISSUE ANTIGENS, V41, P119, DOI 10.1111/j.1399-0039.1993.tb01991.x; PINTO LA, 1995, J CLIN INVEST, V96, P867, DOI 10.1172/JCI118133; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; SHEARER GM, 1993, SCIENCE, V262, P161, DOI 10.1126/science.8211133; STOTT EJ, 1990, LANCET, V336, P1538, DOI 10.1016/0140-6736(90)93310-L; STOTT EJ, 1991, NATURE, V353, P393, DOI 10.1038/353393a0; STOTT EJ, 1995, BIOTECHNOLOGY AIDS, P151; Wang YF, 1999, NAT MED, V5, P1004, DOI 10.1038/12440; Wang YF, 1998, P NATL ACAD SCI USA, V95, P5223, DOI 10.1073/pnas.95.9.5223; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D	41	67	69	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2004	363	9408					518	524		10.1016/S0140-6736(04)15538-4	http://dx.doi.org/10.1016/S0140-6736(04)15538-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TA	14975614				2022-12-01	WOS:000188999900009
J	Bushnell, DA; Westover, KD; Davis, RE; Kornberg, RD				Bushnell, DA; Westover, KD; Davis, RE; Kornberg, RD			Structural basis of transcription: An RNA polymerase II-TFIIB cocrystal at 4.5 angstroms	SCIENCE			English	Article							START SITE SELECTION; N-TERMINAL REGION; PREINITIATION COMPLEX; FUNCTIONAL DOMAINS; ZINC RIBBON; SACCHAROMYCES-CEREVISIAE; PROTEIN INTERACTIONS; ANGSTROM RESOLUTION; ELONGATION COMPLEX; INITIATION COMPLEX	The structure of the general transcription factor IIB (TFIIB) in a complex with RNA polymerase II reveals three features crucial for transcription initiation: an N-terminal zinc ribbon domain of TFIIB that contacts the "dock" domain of the polymerase, near the path of RNA exit from a transcribing enzyme; a "finger" domain of TFIIB that is inserted into the polymerase active center; and a C-terminal domain, whose interaction with both the polymerase and with a TATA box-binding protein (TBP)-promoter DNA complex orients the DNA for unwinding and transcription. TFIIB stabilizes an early initiation complex, containing an incomplete RNA-DNA hybrid region. It may interact with the template strand, which sets the location of the transcription start site, and may interfere with RNA exit, which leads to abortive initiation or promoter escape. The trajectory of promoter DNA determined by the C-terminal domain of TFIIB traverses sites of interaction with TFIIE, TFIIF, and TFIIH, serving to de. ne their roles in the transcription initiation process.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Westover, Ken/AAZ-1795-2020	Westover, Ken/0000-0003-3653-5923	NIAID NIH HHS [AI21144] Funding Source: Medline; NIGMS NIH HHS [GM49985] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; Bell SD, 2000, J BIOL CHEM, V275, P12934, DOI 10.1074/jbc.275.17.12934; Bhargava P, 1999, J BIOL CHEM, V274, P26550, DOI 10.1074/jbc.274.37.26550; BLISKA JB, 1987, J MOL BIOL, V194, P205, DOI 10.1016/0022-2836(87)90369-X; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Chen HT, 2000, PROTEIN SCI, V9, P1743, DOI 10.1110/ps.9.9.1743; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; Fairley JA, 2002, MOL CELL BIOL, V22, P6697, DOI 10.1128/MCB.22.19.6697-6705.2002; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Hawkes NA, 1999, J BIOL CHEM, V274, P14337, DOI 10.1074/jbc.274.20.14337; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; PARVIN JD, 1994, J BIOL CHEM, V269, P18414; PINTO I, 1994, J BIOL CHEM, V269, P30569; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WESTOVER KD, 2004, SCIENCE, V303; YAMASHITA S, 1993, SCIENCE, V261, P463, DOI 10.1126/science.8332911; Zhang DY, 2002, NUCLEIC ACIDS RES, V30, P3078, DOI 10.1093/nar/gkf422; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	47	255	272	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					983	988		10.1126/science.1090838	http://dx.doi.org/10.1126/science.1090838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963322				2022-12-01	WOS:000188918000037
J	Check, E				Check, E			Retraction signals end of cell-biology debate	NATURE			English	News Item																		Chan SK, 2004, CELL, V116, P481, DOI 10.1016/S0092-8674(04)00122-9; Chan SK, 2002, CELL, V111, P265, DOI 10.1016/S0092-8674(02)01037-1	2	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					574	574		10.1038/427574a	http://dx.doi.org/10.1038/427574a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961082	Bronze			2022-12-01	WOS:000188875300004
J	Mauroy, B; Filoche, M; Weibel, ER; Sapoval, B				Mauroy, B; Filoche, M; Weibel, ER; Sapoval, B			An optimal bronchial tree may be dangerous	NATURE			English	Article							MODEL	The geometry and dimensions of branched structures such as blood vessels or airways are important factors in determining the efficiency of physiological processes. It has been shown that fractal trees can be space filling(1) and can ensure minimal dissipation(2-4). The bronchial tree of most mammalian lungs is a good example of an efficient distribution system with an approximate fractal structure(5,6). Here we present a study of the compatibility between physical optimization and physiological robustness in the design of the human bronchial tree. We show that this physical optimization is critical in the sense that small variations in the geometry can induce very large variations in the net air flux. Maximum physical efficiency therefore cannot be a sufficient criterion for the physiological design of bronchial trees. Rather, the design of bronchial trees must be provided with a safety factor and the capacity for regulating airway calibre. Paradoxically, our results suggest that bronchial malfunction related to asthma is a necessary consequence of the optimized efficiency of the tree structure.	Ecole Normale Super, Ctr Math & Leurs Applicat, F-94235 Cachan, France; Ecole Polytech, CNRS, Phys Mat Condensee Lab, F-91128 Palaiseau, France; Univ Bern, Dept Anat, CH-3000 Bern, Switzerland	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; University of Bern	Sapoval, B (corresponding author), Ecole Normale Super, Ctr Math & Leurs Applicat, F-94235 Cachan, France.	Bernard.Sapoval@polytechnique.fr	Weibel, Ewald R./K-3814-2019	FILOCHE, Marcel/0000-0001-8637-3016				Bejan A., 2000, SHAPE STRUCTURE ENG; Brown J., 2000, SCALING BIOL; Hess W, 1914, ARCH ANAT PHYSL, P1; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Mandelbrot B.B., 1977, FRACTAL GEOMETRY NAT; Mauroy B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148101; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; NELSON TR, 1988, IEEE T MED IMAGING, V7, P321, DOI 10.1109/42.14515; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Sapoval B, 2002, P NATL ACAD SCI USA, V99, P10411, DOI 10.1073/pnas.122352499; Sapoval B., 1997, UNIVERSALITES FRACTA; Weibel E R., 1984, PATHWAY OXYGEN; Weibel E. R., 1963, MORPHOMETRY HUMAN LU; Weibel ER, 2000, SYMMORPHOSIS; WEIBEL ER, 1997, LUNG SCI FDN, V1, P1061; WEST BJ, 1986, J APPL PHYSIOL, V60, P1089, DOI 10.1152/jappl.1986.60.3.1089; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilber RL, 2000, MED SCI SPORT EXER, V32, P732, DOI 10.1097/00005768-200004000-00003	19	194	203	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					633	636		10.1038/nature02287	http://dx.doi.org/10.1038/nature02287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961120				2022-12-01	WOS:000188875300041
J	Solomon, S				Solomon, S			The hole truth - What's news (and what's not) about the ozone hole.	NATURE			English	Editorial Material							CFC-11		NOAA, Aeron Lab, Boulder, CO 80305 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Solomon, S (corresponding author), NOAA, Aeron Lab, Boulder, CO 80305 USA.							Allen DR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017117; CAGIN S, 1993, EARTH SKY; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; McCulloch A, 2001, ATMOS ENVIRON, V35, P4387, DOI 10.1016/S1352-2310(01)00249-7; Montzka SA, 1999, NATURE, V398, P690, DOI 10.1038/19499; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; REVKIN AC, 2003, NY TIMES        1110; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; TABAZADEH A, 1993, SCIENCE, V260, P1082, DOI 10.1126/science.260.5111.1082; Walker SJ, 2000, J GEOPHYS RES-OCEANS, V105, P14285, DOI 10.1029/1999JC900273; *WORLD MET ORG, 1991, 25 WORLD MET ORG; *WORLD MET ORG, 1998, 25 WORLD MET ORG	12	35	37	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2004	427	6972					289	291		10.1038/427289a	http://dx.doi.org/10.1038/427289a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737143				2022-12-01	WOS:000188266200017
J	Jordt, SE; Bautista, DM; Chuang, HH; McKemy, DD; Zygmunt, PM; Hogestatt, ED; Meng, ID; Julius, D				Jordt, SE; Bautista, DM; Chuang, HH; McKemy, DD; Zygmunt, PM; Hogestatt, ED; Meng, ID; Julius, D			Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1	NATURE			English	Article							NEUROGENIC PLASMA EXTRAVASATION; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; PAIN PATHWAY; SUBSTANCE-P; ANANDAMIDE; THERMOSENSATION; INFLAMMATION; STIMULI; NEURONS	Wasabi, horseradish and mustard owe their pungency to isothiocyanate compounds. Topical application of mustard oil (allyl isothiocyanate) to the skin activates underlying sensory nerve endings, thereby producing pain, inflammation and robust hypersensitivity to thermal and mechanical stimuli(1,2). Despite their widespread use in both the kitchen and the laboratory, the molecular mechanism through which isothiocyanates mediate their effects remains unknown. Here we show that mustard oil depolarizes a subpopulation of primary sensory neurons that are also activated by capsaicin, the pungent ingredient in chilli peppers, and by Delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana. Both allyl isothiocyanate and THC mediate their excitatory effects by activating ANKTM1, a member of the transient receptor potential (TRP) ion channel family recently implicated in the detection of noxious cold(3,4). These findings identify a cellular and molecular target for the pungent action of mustard oils and support an emerging role for TRP channels as ionotropic cannabinoid receptors(5-8).	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Lund Hosp, Inst Lab Med, Dept Clin Pharmacol, SE-22185 Lund, Sweden	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Lund University; Skane University Hospital	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Zygmunt, Peter/0000-0002-5102-8199				Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Di Marzo V, 2001, TRENDS PHARMACOL SCI, V22, P346, DOI 10.1016/S0165-6147(00)01712-0; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; LOUIS SM, 1989, NEUROSCIENCE, V32, P581, DOI 10.1016/0306-4522(89)90281-9; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; PATACCHINI R, 1990, N-S ARCH PHARMACOL, V342, P72; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; RANG HP, 1994, TXB PAIN, P57; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Simons CT, 2003, CHEM SENSES, V28, P459, DOI 10.1093/chemse/28.6.459; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wall PD., 1999, TXB PAIN, V4th; Wilson RK, 2002, LIFE SCI, V71, P497, DOI 10.1016/S0024-3205(02)01708-3; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761; Zygmunt PM, 2002, J NEUROSCI, V22, P4720, DOI 10.1523/JNEUROSCI.22-11-04720.2002	29	1416	1498	2	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					260	265		10.1038/nature02282	http://dx.doi.org/10.1038/nature02282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14712238				2022-12-01	WOS:000188068100047
J	Si, K; Lindquist, S; Kandel, ER				Si, K; Lindquist, S; Kandel, ER			A neuronal isoform of the Aplysia CPEB has prion-like properties	CELL			English	Article							CHAPERONE PROTEIN HSP104; YEAST SUP35 PROTEIN; CYTOPLASMIC POLYADENYLATION; SACCHAROMYCES-CEREVISIAE; OOCYTE MATURATION; MESSENGER-RNA; URE3 PRION; PSI+ PRION; IN-VITRO; PROPAGATION	Prion proteins have the unusual capacity to fold into two functionally distinct conformations, one of which is self-perpetuating. When yeast prion proteins switch state, they produce heritable phenotypes. We report prion-like properties in a neuronal member of the CPEB family (cytoplasmic polyadenylation element binding protein), which regulates mRNA translation. Compared to other CPEB family members, the neuronal protein has an N-terminal extension that shares characteristics of yeast prion-determinants: a high glutamine content and predicted conformational flexibility. When fused to a reporter protein in yeast, this region confers upon it the epigenetic changes in state that characterize yeast prions. Full-length CPEB undergoes similar changes, but surprisingly it is the dominant, self-perpetuating prion-like form that has the greatest capacity to stimulate translation of CPEB-regulated mRNA. We hypothesize that conversion of CPEB to a prion-like state in stimulated synapses helps to maintain long-term synaptic changes associated with memory storage.	New York State Psychiat Inst & Hosp, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Si, K (corresponding author), New York State Psychiat Inst & Hosp, Coll Phys & Surg, Howard Hughes Med Inst, 722 W 168th St, New York, NY 10032 USA.	ks560@columbia.edu; erk5@columbia.edu						CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stumpf G, 1996, SCIENCE, V274, P1517, DOI 10.1126/science.274.5292.1517; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147	38	435	448	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2003	115	7					879	891		10.1016/S0092-8674(03)01020-1	http://dx.doi.org/10.1016/S0092-8674(03)01020-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	758RV	14697205	Bronze			2022-12-01	WOS:000187664700011
J	Steinbrook, R				Steinbrook, R			Surgery for severe obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*AM SOC BAR SURG, 2000, SAGES ASBS GUID LAP; *BLUE CROSS BLUE S, 2003, SPEC REP REL WEIGHT; *BLUE CROSS BLUE S, 2003, NEW TECHN BAR SURG M; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; GRUNDY SM, 1991, ANN INTERN MED, V115, P956	5	388	408	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2004	350	11					1075	1079		10.1056/NEJMp048029	http://dx.doi.org/10.1056/NEJMp048029			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801QJ	15014179				2022-12-01	WOS:000220110100003
J	Haile-Selassie, Y; Suwa, G; White, TD				Haile-Selassie, Y; Suwa, G; White, TD			Late Miocene teeth from Middle Awash, Ethiopia, and early hominid dental evolution	SCIENCE			English	Article							AUSTRALOPITHECUS; PALEOANTHROPOLOGY; PALEONTOLOGY; BEARING; GEOLOGY	Late Miocene fossil hominid teeth recovered from Ethiopia's Middle Awash are assigned to Ardipithecus kadabba. Their primitive morphology and wear pattern demonstrate that A. kadabba is distinct from Ardipithecus ramidus. These fossils suggest that the last common ancestor of apes and humans had a functionally honing canine-third premolar complex. Comparison with teeth of Sahelanthropus and Orrorin, the two other named late Miocene hominid genera, implies that these putative taxa are very similar to A. kadabba. It is therefore premature to posit extensive late Miocene hominid diversity on the basis of currently available samples.	Cleveland Museum Nat Hist, Cleveland, OH 44106 USA; Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Lab Human Evolutionary Studies, Berkeley, CA 94720 USA	Cleveland Museum of Natural History; University of Tokyo; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Haile-Selassie, Y (corresponding author), Cleveland Museum Nat Hist, 1 Wade Oval Dr, Cleveland, OH 44106 USA.	yhailese@cmnh.org						Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CONDE CJC, 2003, P NATL ACAD SCI USA, V100, P7684; de Bonis L., 1978, Annales de Paleontologie Vertebres, V64, P185; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; McHenry H.M., 1991, P133; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; SARMIENTO EE, 1987, AM J PHYS ANTHROPOL, V72, P250; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; White TD, 2002, CAM S BIO EVOL ANTHR, V33, P407; WHITE TD, 1995, NATURE, V375, P88, DOI 10.1038/375088a0; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058; Wolpoff MH, 2002, NATURE, V419, P581, DOI 10.1038/419581a; Wood B, 2002, NATURE, V418, P133, DOI 10.1038/418133a	24	143	147	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1503	1505		10.1126/science.1092978	http://dx.doi.org/10.1126/science.1092978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001775				2022-12-01	WOS:000220000100037
J	Rajagopalan, H; Jallepalli, PV; Rago, C; Velculescu, VE; Kinzler, KW; Vogelstein, B; Lengauer, C				Rajagopalan, H; Jallepalli, PV; Rago, C; Velculescu, VE; Kinzler, KW; Vogelstein, B; Lengauer, C			Inactivation of hCDC4 can cause chromosomal instability	NATURE			English	Article							CYCLIN-E; GENETIC INSTABILITY; COLORECTAL CANCERS; UBIQUITIN LIGASE; CELL-CYCLE; PHOSPHORYLATION; TUMORIGENESIS; ARCHIPELAGO; MUTATIONS; ONSET	Aneuploidy, an abnormal chromosome number, has been recognized as a hallmark of human cancer for nearly a century(1); however, the mechanisms responsible for this abnormality have remained elusive. Here we report the identification of mutations in hCDC4 (also known as Fbw7 or Archipelago) in both human colorectal cancers and their precursor lesions. We show that genetic inactivation of hCDC4, by means of targeted disruption of the gene in karyotypically stable colorectal cancer cells, results in a striking phenotype associated with micronuclei and chromosomal instability. This phenotype can be traced to a defect in the execution of metaphase and subsequent transmission of chromosomes, and is dependent on cyclin E-a protein that is regulated by hCDC4 (refs 2-4). Our data suggest that chromosomal instability is caused by specific genetic alterations in a large fraction of human cancers and can occur before malignant conversion.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Johns Hopkins Univ, Inst Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Johns Hopkins University	Lengauer, C (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	lengauer@jhmi.edu	Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X				Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bartek J, 2001, SCIENCE, V294, P66, DOI 10.1126/science.1066237; Boveri T, 1914, FRAGE ENTSTEHUNG MAL; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Goh PY, 1999, MOL CELL BIOL, V19, P5512; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pihan GA, 1998, CANCER RES, V58, P3974; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; SAVAGE JRK, 1989, MUTAT RES, V225, P171, DOI 10.1016/0165-7992(89)90115-2; Schwab M, 2001, NATURE, V413, P268, DOI 10.1038/35095157; Shih IM, 2001, CANCER RES, V61, P818; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P16910, DOI 10.1073/pnas.012679099; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	28	447	476	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					77	81		10.1038/nature02313	http://dx.doi.org/10.1038/nature02313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999283				2022-12-01	WOS:000189363800038
J	Halic, M; Becker, T; Pool, MR; Spahn, CMT; Grassucci, RA; Frank, J; Beckmann, R				Halic, M; Becker, T; Pool, MR; Spahn, CMT; Grassucci, RA; Frank, J; Beckmann, R			Structure of the signal recognition particle interacting with the elongation-arrested ribosome	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOME; 7SL RNA; ANGSTROM RESOLUTION; SACCHAROMYCES-CEREVISIAE; CRYOELECTRON MICROSCOPY; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; SECRETORY PROTEIN; CRYSTAL-STRUCTURE; 80S RIBOSOME	Cotranslational translocation of proteins across or into membranes is a vital process in all kingdoms of life. It requires that the translating ribosome be targeted to the membrane by the signal recognition particle (SRP), an evolutionarily conserved ribonucleoprotein particle. SRP recognizes signal sequences of nascent protein chains emerging from the ribosome. Subsequent binding of SRP leads to a pause in peptide elongation and to the ribosome docking to the membrane-bound SRP receptor. Here we present the structure of a targeting complex consisting of mammalian SRP bound to an active 80S ribosome carrying a signal sequence. This structure, solved to 12 Angstrom by cryo-electron microscopy, enables us to generate a molecular model of SRP in its functional conformation. The model shows how the S domain of SRP contacts the large ribosomal subunit at the nascent chain exit site to bind the signal sequence, and that the Alu domain reaches into the elongation-factor- binding site of the ribosome, explaining its elongation arrest activity.	Humboldt Univ, Univ Med Sch, Charite, Inst Biochem, D-10117 Berlin, Germany; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Humboldt Univ, Univ Med Sch, Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Manchester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Beckmann, R (corresponding author), Humboldt Univ, Univ Med Sch, Charite, Inst Biochem, Monbijoustr 2, D-10117 Berlin, Germany.	roland.beckmann@charite.de	Pool, Martin R./AAB-9181-2021; Halic, Mario/X-2163-2018	Pool, Martin R./0000-0003-3071-1535; 				ANDREAZZOLI M, 1991, EMBO J, V10, P767, DOI 10.1002/j.1460-2075.1991.tb08008.x; ANDREWS DW, 1987, EMBO J, V6, P3471, DOI 10.1002/j.1460-2075.1987.tb02671.x; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; BLOBEL G, 1971, BIOMEMBRANE, P193; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; Huang QJ, 2002, BIOCHEMISTRY-US, V41, P11362, DOI 10.1021/bi025765t; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; MARTOGLIO B, 1997, CELL BIOL LAB HDB, P265; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Padmanabhan S, 2001, STRUCTURE, V9, P859, DOI 10.1016/S0969-2126(01)00641-4; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Rinke-Appel J, 2002, RNA, V8, P612, DOI 10.1017/S1355838202020095; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Rosenblad MA, 2003, NUCLEIC ACIDS RES, V31, P363, DOI 10.1093/nar/gkg107; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SIEGEL V, 1988, P NATL ACAD SCI USA, V85, P1801, DOI 10.1073/pnas.85.6.1801; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; SPAHN C, IN PRESS EMBO J; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Thomas Y, 1997, NUCLEIC ACIDS RES, V25, P1920, DOI 10.1093/nar/25.10.1920; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; WALTER P, 1983, METHOD ENZYMOL, V96, P682; WALTER P, 1983, J CELL BIOL, V97, P1693, DOI 10.1083/jcb.97.6.1693; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Weichenrieder O, 2000, NATURE, V408, P167, DOI 10.1038/35041507; Wilson DN, 2002, CURR PROTEIN PEPT SC, V3, P1, DOI 10.2174/1389203023380846; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	50	320	330	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					808	814		10.1038/nature02342	http://dx.doi.org/10.1038/nature02342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985753				2022-12-01	WOS:000189207500031
J	Eaton, WW; Mortensen, PB; Agerbo, E; Byrne, M; Mors, O; Ewald, H				Eaton, WW; Mortensen, PB; Agerbo, E; Byrne, M; Mors, O; Ewald, H			Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers	BRITISH MEDICAL JOURNAL			English	Article									Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; Psychiat Hosp Aarhus, Inst Basic Psychiat Res, DK-8240 Risskov, Denmark	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aarhus University; Aarhus University	Eaton, WW (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway, Baltimore, MD 21205 USA.	weaton@jhsph.edu	Agerbo, Esben/A-2645-2012; Mortensen, Preben B/D-2358-2015	Agerbo, Esben/0000-0002-2849-524X; Mortensen, Preben B/0000-0002-5230-9865; Mors, Ole/0000-0002-5660-0393	PHS HHS [53188] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		DOHAN FC, 1966, ACTA PSYCHIAT SCAND, V42, P125, DOI 10.1111/j.1600-0447.1966.tb01920.x; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; SINGH MM, 1976, SCIENCE, V191, P191; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Zhong F, 1996, NAT GENET, V14, P329, DOI 10.1038/ng1196-329	5	70	71	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 21	2004	328	7437					438	439		10.1136/bmj.328.7437.438	http://dx.doi.org/10.1136/bmj.328.7437.438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777DV	14976100	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000189161000019
J	Poloniecki, J; Sismanidis, C; Bland, M; Jones, P				Poloniecki, J; Sismanidis, C; Bland, M; Jones, P			Retrospective cohort study of false alarm rates associated with a series of heart operations: the case for hospital mortality monitoring groups	BRITISH MEDICAL JOURNAL			English	Article								Objective To examine the efficacy of different methods of detecting a high death rate and determining whether an increase in deaths after heart transplantation could be explained by chance. Design Retrospective analysis of deaths after heart transplantation. Seven methods were used: mortality above national average, mortality excessively above national average, test of moving average mortality, test of number of consecutive deaths, sequential probability ratio test (SPRT), cusum with v-mask, and CRAM chart. The national average mortality was not available, and a rate of 15% was used instead as the benchmark. Setting Regional cardiothoracic unit. Participants All 371 patients who received a heart transplant in the programme, 1986-2000. Main outcome measures 30 day survival after transplantation. Results All methods provided evidence that the 30 day mortality had been high at some stage. The probability that the finding was a false positive depended on which test was used. At the end of the series the average mortality, sequential probability ratio, and cusum tests indicated a level of deaths higher than the benchmark while the remaining four tests yielded negative results. Conclusions If the decision to test for outlying mortality is made retrospectively, in the light of the data, it is not possible to determine the false positive rate. Prospective on-site mortality monitoring with the CRAM chart is recommended as this method can quantify the death rate and identify periods when an audit of cases is indicated, even when data from other hospitals are not available. A hospital mortality monitoring group can routinely monitor all deaths in the hospital, by specialty, using hospital episode statistics (HES) data and appropriate statistical methods.	St George Hosp, Sch Med, London SW17 0RE, England; St Georges Healthcare NHS Trust, London SW17 0QT, England	St Georges University London; St Georges University London	Poloniecki, J (corresponding author), St George Hosp, Sch Med, London SW17 0RE, England.	j.poloniecki@sghms.ac.uk						Anyanwu AC, 1999, EUR J CARDIO-THORAC, V16, P424, DOI 10.1016/S1010-7940(99)00238-9; BARNARD GA, 1959, J ROY STAT SOC B, V21, P239; BASSEVILLE M, 1993, DETECTION ABRUPT CHA; BOOTH J, 2000, SUNDAY TELEGRAP 1015; *BRIT TRANSPL SOC, 1998, STAND ORG TISS TRANS; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; Poloniecki J, 1998, BRIT MED J, V316, P1697, DOI 10.1136/bmj.316.7146.1697; Poloniecki J, 1998, BRIT MED J, V316, P1734, DOI 10.1136/bmj.316.7146.1734; *STAT OFF, 2003, DEATH CERT INV ENGL; Wald A, 1947, SEQUENTIAL ANAL	10	40	40	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 14	2004	328	7436					375	379		10.1136/bmj.37956.520567.44	http://dx.doi.org/10.1136/bmj.37956.520567.44			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775GA	14751918	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-01	WOS:000189031300018
J	Kennedy, S; Wang, D; Ruvkun, G				Kennedy, S; Wang, D; Ruvkun, G			A conserved siRNA-degrading RNase negatively regulates RNA interference in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; MESSENGER-RNA; GENETIC INTERFERENCE; ESCHERICHIA-COLI; PROTEIN; INDUCTION; INTERACTS; PATHWAY; DOMAIN; RDE-1	In many organisms, introducing double-stranded RNA (dsRNA) causes the degradation of messenger RNA that is homologous to the trigger dsRNA-a process known as RNA interference. The dsRNA is cleaved into short interfering RNAs (siRNAs), which hybridize to homologous mRNAs and induce their degradation(1). dsRNAs vary in their ability to trigger RNA interference: many mRNA-targeting dsRNAs show weak phenotypes, and nearly all mRNAs of the Caenorhabditis elegans nervous system are refractory to RNA interference(2-4). C. elegans eri-1 was identified in a genetic screen for mutants with enhanced sensitivity to dsRNAs. Here we show that eri-1 encodes an evolutionarily conserved protein with domains homologous to nucleic-acid-binding and exonuclease proteins. After exposure to dsRNA or siRNAs, animals with eri-1 mutations accumulate more siRNAs than do wild-type animals. C. elegans ERI-1 and its human orthologue degrade siRNAs in vitro. In the nematode worm, ERI-1 is predominantly cytoplasmic and is expressed most highly in the gonad and a subset of neurons, suggesting that ERI-1 siRNase activity suppresses RNA interference more intensely in these tissues. Thus, ERI-1 is a negative regulator that may normally function to limit the duration, cell-type specificity or endogenous functions of RNA interference.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Kennedy, Scott/0000-0002-7974-8155				Beitel GJ, 1995, GENE DEV, V9, P3149, DOI 10.1101/gad.9.24.3149; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	21	445	484	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					645	649		10.1038/nature02302	http://dx.doi.org/10.1038/nature02302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961122				2022-12-01	WOS:000188875300044
J	del Pozo, MA; Alderson, NB; Kiosses, WB; Chiang, HH; Anderson, RGW; Schwartz, MA				del Pozo, MA; Alderson, NB; Kiosses, WB; Chiang, HH; Anderson, RGW; Schwartz, MA			Integrins regulate Rac targeting by internalization of membrane domains	SCIENCE			English	Article							LIPID RAFTS; CHOLESTEROL; LOCALIZATION	Translocation of the small GTP-binding protein Rac1 to the cell plasma membrane is essential for activating downstream effectors and requires integrin-mediated adhesion of cells to extracellular matrix. We report that active Rac1 binds preferentially to low-density, cholesterol-rich membranes, and specificity is determined at least in part by membrane lipids. Cell detachment triggered internalization of plasma membrane cholesterol and lipid raft markers. Preventing internalization maintained Rac1 membrane targeting and effector activation in nonadherent cells. Regulation of lipid rafts by integrin signals may regulate the location of membrane domains such as lipid rafts and thereby control domain-specific signaling events in anchorage-dependent cells.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Ctr Nacl Invest Cardiovasc, Madrid, Spain; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biomed Engn, Mellon Prostate Canc Res, Inst & Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	Scripps Research Institute; Scripps Research Institute; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Virginia	del Pozo, MA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mdelpozo@scripps.edu	del Pozo, Miguel Angel/L-2861-2014	del Pozo, Miguel Angel/0000-0001-9077-391X; schwartz, martin/0000-0002-2071-1243	NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM52016, R01 GM47214] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016, R01GM047214] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grimmer S, 2002, J CELL SCI, V115, P2953; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Kumanogoh H, 2001, NEUROSCI RES, V39, P189, DOI 10.1016/S0168-0102(00)00211-X; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052	22	436	441	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					839	842		10.1126/science.1092571	http://dx.doi.org/10.1126/science.1092571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764880				2022-12-01	WOS:000188753800058
J	Chaimanee, Y; Suteethorn, V; Jintasakul, P; Vidthayanon, C; Marandat, B; Jaeger, JJ				Chaimanee, Y; Suteethorn, V; Jintasakul, P; Vidthayanon, C; Marandat, B; Jaeger, JJ			A new orang-utan relative from the Late Miocene of Thailand	NATURE			English	Article							MIDDLE MIOCENE; ANKARAPITHECUS-METEAI; BODY-WEIGHT; GREAT APE; PAKISTAN; NEOGENE; SHAPE	The fossil record of the living great apes is poor. New fossils from undocumented areas, particularly the equatorial forested habitats of extant hominoids, are therefore crucial for understanding their origins and evolution(1). Two main competing hypotheses have been proposed for orang-utan origins: dental similarities(2,3) support an origin from Lufengpithecus, a South Chinese(4) and Thai Middle Miocene hominoid(2); facial and palatal similarities(5) support an origin from Sivapithecus, a Miocene hominoid from the Siwaliks of Indo-Pakistan(4,6). However, materials other than teeth and faces do not support these hypotheses(7,8). Here we describe the lower jaw of a new hominoid from the Late Miocene of Thailand, Khoratpithecus piriyai gen. et sp. nov., which shares unique derived characters with orang-utans and supports a hypothesis of closer relationships with orang-utans than other known Miocene hominoids. It can therefore be considered as the closest known relative of orang-utans. Ancestors of this great ape were therefore evolving in Thailand under tropical conditions similar to those of today, in contrast with Southern China and Pakistan, where temperate(9) or more seasonal(10) climates appeared during the Late Miocene.	Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand; Rajabhat Inst Nakorn Ratchasima, Nakhon Ratchasima 30000, Thailand; Dept Fisheries, Museum & Aquarium Div, Bangkok 10900, Thailand; Univ Montpellier 2, CNRS, ISEM, F-34095 Montpellier, France	Department of Mineral Resources - Thailand; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Chaimanee, Y (corresponding author), Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand.	yaowalak@dmr.go.th		chaimanee, yaowalak/0000-0002-8432-3880				ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; Alpagut B, 1996, NATURE, V382, P349, DOI 10.1038/382349a0; BADGLEY C, 1988, NATL GEOGR RES, V4, P178; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; Begun DR, 1998, AM J PHYS ANTHROPOL, V105, P279, DOI 10.1002/(SICI)1096-8644(199803)105:3<279::AID-AJPA2>3.0.CO;2-N; Brown B., 1989, THESIS KENT STATE U; Brown Barbara, 1997, P153; Chaimanee Y, 2003, NATURE, V422, P61, DOI 10.1038/nature01449; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; DAEGLING DJ, 1993, AM J PHYS ANTHROPOL, V91, P505, DOI 10.1002/ajpa.1330910407; Daegling DJ, 2000, J HUM EVOL, V39, P107, DOI 10.1006/jhev.2000.0402; de Bonis L, 1977, Geobios Lyon, V10, P849, DOI 10.1016/S0016-6995(77)80081-8; GINGERICH PD, 1982, AM J PHYS ANTHROPOL, V58, P81, DOI 10.1002/ajpa.1330580110; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; Kelley J, 2002, CAM S BIO EVOL ANTHR, V33, P369; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; MCCROSSIN ML, 1993, P NATL ACAD SCI USA, V90, P1962, DOI 10.1073/pnas.90.5.1962; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; Pilbeam D, 1996, MOL PHYLOGENET EVOL, V5, P155, DOI 10.1006/mpev.1996.0010; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; PILBEAM D, 1990, NATURE, V348, P237, DOI 10.1038/348237a0; PILBEAM DR, 1980, POSTILLA, V181, P1; Schwartz Jeffrey H., 1997, P363; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Ward Steve, 1997, P269	27	65	70	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					439	441		10.1038/nature02245	http://dx.doi.org/10.1038/nature02245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749830				2022-12-01	WOS:000188470500042
J	Harris, RA; Washington, AE; Nease, RF; Kuppermann, M				Harris, RA; Washington, AE; Nease, RF; Kuppermann, M			Cost utility of prenatal diagnosis and the risk-based threshold	LANCET			English	Article							AGE-SPECIFIC RATES; CHORIONIC VILLUS; DOWN-SYNDROME; CHROMOSOME-ABNORMALITIES; REPRODUCTIVE-BEHAVIOR; ECONOMIC-EVALUATION; AMNIOCENTESIS; PREGNANCY; WOMEN; PREFERENCES	Background Prenatal testing guidelines recommend offering amniocentesis or chorionic villus sampling to women aged 35 years or older, or who have been found by screening to be at a similarly high risk of giving birth to an infant with Down's syndrome or another chromosomal abnormality. This threshold was chosen, in part, because 35 was the approximate age at which amniocentesis was cost beneficial when testing guidelines were developed in the USA in the 1970s. We aimed to assess the economic validity of thresholds based on age or risk for offering invasive prenatal diagnosis. Methods We did a cost-utility analysis of chorionic villus sampling and amniocentesis versus no invasive testing using data from randomised trials, case registries, and a utility assessment of 534 diverse pregnant women aged 16-47 years. Findings In the USA, compared with no diagnostic testing, amniocentesis costs less than US$15 000 per quality-adjusted life year gained for women of all ages and risk levels. The results do not depend on maternal age or risk of Down's syndrome-affected birth. The cost-utility ratio for any individual woman depends on her preferences for reassurance about the chromosomal status of her fetus, and, to a lesser extent, for miscarriage. Interpretation Prenatal diagnostic testing can be cost effective at any age or risk level. Current guidelines should be changed to offer testing to all pregnant women, not just those whose risk of carrying an affected fetus exceeds a specified threshold.	Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Effectiveness Res Ctr, San Francisco, CA 94143 USA; Washington Univ, Med Sch & Express Scripts, Dept Internal Med, Div Gen Med Sci,Lab Med Decis Sci, St Louis, MO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL)	Kuppermann, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 3333 Calif St,Suite 335, San Francisco, CA 94143 USA.	kuppermannm@obgyn.ucsf.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS007373] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001255] Funding Source: NIH RePORTER; AHRQ HHS [U01 HS07373] Funding Source: Medline; NHGRI NIH HHS [R01 HG01255] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		American College of Obstetricians and Gynecologists, 2001, Obstet Gynecol, V97, P1; Beazoglou T, 1998, PRENATAL DIAG, V18, P1241, DOI 10.1002/(SICI)1097-0223(199812)18:12<1241::AID-PD440>3.0.CO;2-M; BRANDENBURG H, 1992, CLIN GENET, V42, P149; BRANDENBURG H, 1992, PRENATAL DIAG, V12, P1031, DOI 10.1002/pd.1970121208; CONLEY R, 1975, PREVENTION GENETIC D; Dick PT, 1996, CAN MED ASSOC J, V154, P465; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Fryback DG, 1997, MED DECIS MAKING, V17, P276, DOI 10.1177/0272989X9701700303; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GRANT A, 1991, LANCET, V337, P1491; HADDOW JE, 1994, NEW ENGL J MED, V330, P1114, DOI 10.1056/NEJM199404213301603; HAGARD S, 1976, BRIT MED J, V1, P753, DOI 10.1136/bmj.1.6012.753; Hahn B., 1992, ANN EXPENSES SOURCES; Hahnemann JM, 1997, PRENATAL DIAG, V17, P801, DOI 10.1002/(SICI)1097-0223(199709)17:9<801::AID-PD153>3.0.CO;2-E; Harris RA, 2001, GENET TEST, V5, P23, DOI 10.1089/109065701750168644; *HEALTHC CONS AM, 1995, PHYS FEE COD GUID; HENSHAW SK, 1995, FAM PLANN PERSPECT, V27, P54, DOI 10.2307/2135905; Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123; HOOK EB, 1989, AM J HUM GENET, V45, P855; HOOK EB, 1989, AM J HUM GENET, V45, P474; HOOK EB, 1988, AM J HUM GENET, V42, P797; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; KULIEV AM, 1993, PRENATAL DIAG, V13, P197, DOI 10.1002/pd.1970130307; Kuppermann M, 2000, OBSTET GYNECOL, V96, P511, DOI 10.1016/S0029-7844(00)00969-8; Kuppermann M, 1999, PRENATAL DIAG, V19, P711, DOI 10.1002/(SICI)1097-0223(199908)19:8<711::AID-PD614>3.0.CO;2-V; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; LIPPMAN A, 1992, PRENATAL DIAG, V12, P385, DOI 10.1002/pd.1970120508; LUBS HA, 1972, ANTENATAL DIAGNOSIS, P17; *NAT I CHILD HLTH, 1979, ANT DIAGN REP CONS D; PAUKER SP, 1994, NEW ENGL J MED, V330, P1151, DOI 10.1056/NEJM199404213301610; Petrou S, 2001, HEALTH ECON, V10, P775, DOI 10.1002/hec.636; RHOADS GG, 1989, NEW ENGL J MED, V320, P609, DOI 10.1056/NEJM198903093201001; Seror V, 1998, HEALTH POLICY, V43, P83, DOI 10.1016/S0168-8510(97)00084-5; Shackley P, 1996, PRENATAL DIAG, V16, P389, DOI 10.1002/(SICI)1097-0223(199605)16:5<389::AID-PD870>3.0.CO;2-U; SICHERMAN N, 1995, FETAL DIAGN THER, V10, P157, DOI 10.1159/000264226; SIMPSON JL, 1987, JAMA-J AM MED ASSOC, V258, P2555, DOI 10.1001/jama.258.18.2555; TABOR A, 1986, LANCET, V1, P1287; Torrance G W, 1972, Health Serv Res, V7, P118; US Bureau of the Census, 1995, STAT ABSTR US; *US DEP HHS, 1995, NAT LIM CLIN LAB; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; VINCENT VA, 1991, SOUTHERN MED J, V84, P1210, DOI 10.1097/00007611-199110000-00012; WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188	44	88	91	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2004	363	9405					276	282		10.1016/S0140-6736(03)15385-8	http://dx.doi.org/10.1016/S0140-6736(03)15385-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766FQ	14751700				2022-12-01	WOS:000188361400009
J	Gibbons, DL; Vaney, MC; Roussel, A; Vigouroux, A; Reilly, B; Lepault, J; Kielian, M; Rey, FA				Gibbons, DL; Vaney, MC; Roussel, A; Vigouroux, A; Reilly, B; Lepault, J; Kielian, M; Rey, FA			Conformational change and protein protein interactions of the fusion protein of Semliki Forest virus	NATURE			English	Article							MEMBRANE-FUSION; INFLUENZA HEMAGGLUTININ; PORE FORMATION; CYTOPLASMIC TAIL; HEMIFUSION; CRYSTALLOGRAPHY; GLYCOPROTEIN; ACTIVATION; PATHWAY; ENTRY	Fusion of biological membranes is mediated by specific lipid- interacting proteins that induce the formation and expansion of an initial fusion pore. Here we report the crystal structure of the ectodomain of the Semliki Forest virus fusion glycoprotein E1 in its low- pH- induced trimeric form. E1 adopts a folded- back conformation that, in the final post- fusion form of the full- length protein, would bring the fusion peptide loop and the transmembrane anchor to the same end of a stable protein rod. The observed conformation of the fusion peptide loop is compatible with interactions only with the outer leaflet of the lipid bilayer. Crystal contacts between fusion peptide loops of adjacent E1 trimers, together with electron microscopy observations, suggest that in an early step of membrane fusion, an intermediate assembly of five trimers creates two opposing nipple- like deformations in the viral and target membranes, leading to formation of the fusion pore.	INRA, CNRS, UMR 2472 1157, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Yeshiva University; Albert Einstein College of Medicine	Kielian, M (corresponding author), INRA, CNRS, UMR 2472 1157, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	kielian@aecom.yu.edu; rey@vms.cnrs-gif.fr	Lepault, Jean/AAN-8859-2020; Rey, Felix/B-6497-2012	Kielian, Margaret/0000-0002-7395-4791; Rey, Felix/0000-0002-9953-7988				Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bagai S, 1996, J CELL BIOL, V135, P73, DOI 10.1083/jcb.135.1.73; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; BRESSANELLI S, IN PRESS EMBO J; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gaudin Y, 2000, J CELL BIOL, V150, P601, DOI 10.1083/jcb.150.3.601; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Gibbons DL, 2002, J VIROL, V76, P1194, DOI 10.1128/JVI.76.3.1194-1205.2002; GIBBONS DL, IN PRESS J VIROL; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Januszeski MM, 1997, J VIROL, V71, P3613, DOI 10.1128/JVI.71.5.3613-3619.1997; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kielian M, 2000, Subcell Biochem, V34, P409; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Markosyan RM, 2001, BIOPHYS J, V80, P812, DOI 10.1016/S0006-3495(01)76060-2; Markovic I, 2001, J CELL BIOL, V155, P833, DOI 10.1083/jcb.200103005; Melikyan GB, 2000, J VIROL, V74, P447, DOI 10.1128/JVI.74.1.447-455.2000; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROUSSEL A, 1991, SILICON GRAPHICS GEO; SCHLESINGER S, 2001, FIELDS VIROLOGY, P895; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002; Zimmerberg J, 1999, ADV DRUG DELIVER REV, V38, P197, DOI 10.1016/S0169-409X(99)00029-0	42	291	301	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					320	325		10.1038/nature02239	http://dx.doi.org/10.1038/nature02239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737160				2022-12-01	WOS:000188266200032
J	Schwartz, AB; Moran, DW; Reina, GA				Schwartz, AB; Moran, DW; Reina, GA			Differential representation of perception and action in the frontal cortex	SCIENCE			English	Article							PRIMATE MOTOR CORTEX; PREFRONTAL CORTEX; CORTICAL REPRESENTATION; NEURONAL POPULATION; MOVEMENT; DIRECTION; VISION; ADAPTATION; DISCHARGE; MONKEYS	A motor illusion was created to separate human subjects' perception of arm movement from their actual movement during figure drawing. Trajectories constructed from cortical activity recorded in monkeys performing the same task showed that the actual movement was represented in the primary motor cortex, whereas the visualized, presumably perceived, trajectories were found in the ventral premotor cortex. Perception and action representations can be differentially recognized in the brain and may be contained in separate structures.	Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15203 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; Washington Univ, Dept Neurobiol, St Louis, MO 63130 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL)	Schwartz, AB (corresponding author), Univ Pittsburgh, Dept Neurobiol, 3025 E Carson St, Pittsburgh, PA 15203 USA.			Reina, G Anthony/0000-0001-9623-9259	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026375] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS26375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHE J, 1994, CEREB CORTEX, V6, P590; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Averbeck BB, 2003, EXP BRAIN RES, V150, P127, DOI 10.1007/s00221-003-1416-6; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; CHAFEE MV, 2000, 30 ANN M SOC NEUR NE; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kurata K, 1999, J NEUROPHYSIOL, V81, P1927, DOI 10.1152/jn.1999.81.4.1927; Lashley K. S., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; Lebedev Mikhail A, 2002, Behav Cogn Neurosci Rev, V1, P108, DOI 10.1177/15382302001002002; LEE JH, 2001, 31 ANN M SOC NEUR SA; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Reina GA, 2003, HUM MOVEMENT SCI, V22, P137, DOI 10.1016/S0167-9457(02)00156-2; Reina GA, 2001, J NEUROPHYSIOL, V85, P2576, DOI 10.1152/jn.2001.85.6.2576; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Ungerleider L, 1982, ANAL VISUAL BEHAV, P549	26	100	101	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					380	383		10.1126/science.1087788	http://dx.doi.org/10.1126/science.1087788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726593				2022-12-01	WOS:000188111800046
J	Rodriguez-Navarro, S; Fischer, T; Luo, MJ; Antunez, O; Brettschneider, S; Lechner, J; Perez-Ortin, JE; Reed, R; Hurt, E				Rodriguez-Navarro, S; Fischer, T; Luo, MJ; Antunez, O; Brettschneider, S; Lechner, J; Perez-Ortin, JE; Reed, R; Hurt, E			Sus1, a functional component of the SAGA histone acetylase complex and the nuclear pore-associated mRNA export machinery	CELL			English	Article							HNRNP-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; COUPLING TRANSCRIPTION; POLY(A)(+) RNA; YEAST; INTERACTS; COACTIVATOR; YRA1P	Gene expression is a coordinated multistep process that begins with transcription and RNA processing in the nucleus followed by mRNA export to the cytoplasm for translation. Here we report the identification of a protein, Sus1, which functions in both transcription and mRNA export. Sus1 is a nuclear protein with a concentration at the nuclear pores. Biochemical analyses show that Sus1 interacts with SAGA, a large intranuclear histone acetylase complex involved in transcription initiation, and with the Sac3-Thp1 complex, which functions in mRNA export with specific nuclear pore proteins at the nuclear basket. DNA macroarray analysis revealed that Sus1 is required for transcription regulation. Moreover, chromatin immunoprecipitation showed that Sus1 is associated with the promoter of a SAGA-dependent gene during transcription activation. Finally, mRNA export is impaired in sus1 mutants. These data provide an unexpected connection between the SAGA histone acetylase complex and the mRNA export machinery.	Heidelberg Univ, Biochem Zentrum, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain; Univ Valencia, Serv Chips DNA SCSIE, Valencia, Spain	Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; University of Valencia; University of Valencia	Hurt, E (corresponding author), Heidelberg Univ, Biochem Zentrum, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz-uni-heidelberg.de	Fischer, Tamas/A-7729-2016; Pérez-Ortín, José E./K-8582-2014; Rodríguez-Navarro, Susana/B-5182-2014; Ed Hurt, Dr./AAE-8874-2019	Fischer, Tamas/0000-0002-7996-4042; Pérez-Ortín, José E./0000-0002-1992-513X; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Ed Hurt, Dr./0000-0002-4535-8255; Huch, Susanne/0000-0003-3956-7197				Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bauer A, 1996, J CELL SCI, V109, P1575; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Georgieva S, 2001, MOL CELL BIOL, V21, P5223, DOI 10.1128/MCB.21.15.5223-5231.2001; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Hauser NC, 1998, YEAST, V14, P1209, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1209::AID-YEA311>3.0.CO;2-N; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Jones AL, 2000, P NATL ACAD SCI USA, V97, P3224, DOI 10.1073/pnas.050432997; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lei EP, 2003, MOL BIOL CELL, V14, P836, DOI 10.1091/mbc.E02-08-0520; Lei EP, 2002, GENE DEV, V16, P2761, DOI 10.1101/gad.1032902; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Rodriguez-Navarro S, 2002, EMBO REP, V3, P438, DOI 10.1093/embo-reports/kvf091; Saleh A, 1998, J MOL BIOL, V282, P933, DOI 10.1006/jmbi.1998.2036; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	49	285	296	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2004	116	1					75	86		10.1016/S0092-8674(03)01025-0	http://dx.doi.org/10.1016/S0092-8674(03)01025-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718168	Green Submitted, Bronze			2022-12-01	WOS:000187960800010
J	Greene, MF; Ecker, JL				Greene, MF; Ecker, JL			Abortion, health, and the law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Greene, MF (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Annas GJ, 2001, NEW ENGL J MED, V344, P152, DOI 10.1056/NEJM200101113440220; Callaghan WM, 2003, OBSTET GYNECOL, V102, P1015, DOI 10.1016/S0029-7844(03)00740-3; Davison JM, 1999, MATERNAL FETAL MED, P873; Elam-Evans Laurie D., 2002, Morbidity and Mortality Weekly Report, V51, P1; ELAMEVANS LD, 2002, MMWR SURVEILL SUMM, V51, P11; Finer LB, 2003, PERSPECT SEX REPRO H, V35, P6, DOI 10.1111/j.1931-2393.2003.tb00079.x; Gleicher N, 1979, Obstet Gynecol Surv, V34, P721, DOI 10.1097/00006254-197910000-00001; HASKELL M, 1992, NAT AB FED RISK MAN, P27; KAFRISSEN ME, 1984, JAMA-J AM MED ASSOC, V251, P916; STOCKMAN F, 2003, BOSTON GLOBE    1023, pB3; Stubblefield Philip G., 2000, GYNECOLOGIC OBSTET R, p[1033, 1043]	11	10	10	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2004	350	2					184	186		10.1056/NEJMsb035739	http://dx.doi.org/10.1056/NEJMsb035739			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760WP	14711920				2022-12-01	WOS:000187858500016
J	Gobert, V; Gottar, M; Matskevich, AA; Rutschmann, S; Royet, J; Belvin, M; Hoffmann, JA; Ferrandon, D				Gobert, V; Gottar, M; Matskevich, AA; Rutschmann, S; Royet, J; Belvin, M; Hoffmann, JA; Ferrandon, D			Dual activation of the Drosophila Toll pathway by two pattern recognition receptors	SCIENCE			English	Article							GRAM-NEGATIVE BACTERIA; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; BINDING PROTEIN; SERINE-PROTEASE; HOST-DEFENSE; BOMBYX-MORI; BETA-1,3-GLUCAN; ANTIFUNGAL; MICROORGANISMS	The Toll-dependent defense against Gram-positive bacterial infections in Drosophila is mediated through the peptidoglycan recognition protein SA(PGRP-SA). A mutation termed osiris disrupts the Gram-negative binding protein 1 (GNBP1) gene and leads to compromised survival of mutant flies after Gram-positive infections, but not after fungal or Gram-negative bacterial challenge. Our results demonstrate that GNBP1 and PGRP-SA can jointly activate the Toll pathway. The potential for a combination of distinct proteins to mediate detection of infectious nonself in the fly will refine the concept of pattern recognition in insects.	CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, F-67084 Strasbourg, France; Exelixis Inc, San Francisco, CA 94083 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Exelixis, Inc.	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			FERRANDON, Dominique/0000-0001-7680-7773; Rutschmann, Sophie/0000-0003-3932-1162				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; GOBERT V, UNPUB; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; WEBER AN, 2003, NATURE IMMUNOL, V4, P494; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	26	289	303	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2126	2130		10.1126/science.1085432	http://dx.doi.org/10.1126/science.1085432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684822				2022-12-01	WOS:000187385200046
J	Johnson, JM; Castle, J; Garrett-Engele, P; Kan, ZY; Loerch, PM; Armour, CD; Santos, R; Schadt, EE; Stoughton, R; Shoemaker, DD				Johnson, JM; Castle, J; Garrett-Engele, P; Kan, ZY; Loerch, PM; Armour, CD; Santos, R; Schadt, EE; Stoughton, R; Shoemaker, DD			Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays	SCIENCE			English	Article							HUMAN GENES; TRANSCRIPTOME; EXPRESSION; DIVERSITY; BIOLOGY; ARRAYS	Alternative pre-messenger RNA (pre-mRNA) splicing plays important roles in development, physiology, and disease, and more than half of human genes are alternatively spliced. To understand the biological roles and regulation of alternative splicing across different tissues and stages of development, systematic methods are needed. Here, we demonstrate the use of microarrays to monitor splicing at every exon-exon junction in more than 10,000 multi-exon human genes in 52 tissues and cell lines. These genome-wide data provide experimental evidence and tissue distributions for thousands of known and novel alternative splicing events. Adding to previous studies, the results indicate that at least 74% of human multi-exon genes are alternatively spliced.	Merck & Co Inc, Rosetta Inpharmat LLC, Kirkland, WA 98034 USA	Merck & Company	Johnson, JM (corresponding author), Merck & Co Inc, Rosetta Inpharmat LLC, 115th Ave NE, Kirkland, WA 98034 USA.	jason_johnson@merck.com; shoemakd@stanfordalumni.org						Aboushadi N, 2000, BIOCHEMISTRY-US, V39, P237, DOI 10.1021/bi9916325; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egan J.P., 1975, SIGNAL DETECTION THE; Hu GK, 2001, GENOME RES, V11, P1237, DOI 10.1101/gr.165501; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303	20	1122	1206	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2141	2144		10.1126/science.1090100	http://dx.doi.org/10.1126/science.1090100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684825				2022-12-01	WOS:000187385200050
J	Cox, D; Meyers, E; Sinha, P				Cox, D; Meyers, E; Sinha, P			Contextually evoked object-specific responses in human visual cortex	SCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; NATURAL IMAGES; CORTICAL-CELLS; PERCEPTION; NEURONS; RECOGNITION; BRAIN; IDENTIFICATION; ATTENTION	Human visual recognition processes are remarkably robust and can function effectively even under highly degraded viewing conditions. Contextual information may play a critical role in such circumstances. Here, we provide neurophysiological evidence that contextual cues can elicit object-specific neural responses, which have hitherto been believed to be based on intrinsic cues alone. Specifically, we find that the "fusiform face area" (FFA) maintains its selectivity for faces without regard to whether the faces are defined intrinsically or contextually. This finding further elucidates the role of the FFA and reveals neural correlates of contextual processing in the service of robust object recognition.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sinha, P (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	psinha@mit.edu	Cox, David/C-4888-2008	Cox, David/0000-0002-2189-9743				Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Baddeley R, 1996, NATURE, V381, P560, DOI 10.1038/381560a0; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 1996, PERCEPTION, V25, P343, DOI 10.1068/p250343; Barlow H, 2001, BEHAV BRAIN SCI, V24, P602, DOI 10.1017/S0140525X01000024; Barlow H. B., 1961, CURRENT PROBLEMS ANI, P330; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Ganis G, 2003, COGNITIVE BRAIN RES, V16, P123, DOI 10.1016/S0926-6410(02)00244-6; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Puce A, 1996, J NEUROSCI, V16, P5205; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; WEBBER CJS, 1991, NETWORK-COMP NEURAL, V2, P169, DOI 10.1088/0954-898X/2/2/003; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	29	127	131	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2004	304	5667					115	117		10.1126/science.1093110	http://dx.doi.org/10.1126/science.1093110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808KL	15001712				2022-12-01	WOS:000220567900050
J	Almaas, E; Kovacs, B; Vicsek, T; Oltvai, ZN; Barabasi, AL				Almaas, E; Kovacs, B; Vicsek, T; Oltvai, ZN; Barabasi, AL			Global organization of metabolic fluxes in the bacterium Escherichia coli	NATURE			English	Article							DEFINITION	Cellular metabolism, the integrated interconversion of thousands of metabolic substrates through enzyme-catalysed biochemical reactions, is the most investigated complex intracellular web of molecular interactions. Although the topological organization of individual reactions into metabolic networks is well understood(1-4), the principles that govern their global functional use under different growth conditions raise many unanswered questions(5-7). By implementing a flux balance analysis(8-12) of the metabolism of Escherichia coli strain MG1655, here we show that network use is highly uneven. Whereas most metabolic reactions have low fluxes, the overall activity of the metabolism is dominated by several reactions with very high fluxes. E. coli responds to changes in growth conditions by reorganizing the rates of selected fluxes predominantly within this high-flux backbone. This behaviour probably represents a universal feature of metabolic activity in all cells, with potential implications for metabolic engineering.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Eotvos Lorand Univ, Biol Phys Dept, H-1117 Budapest, Hungary; Eotvos Lorand Univ, Res Grp HAS, H-1117 Budapest, Hungary; Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University of Notre Dame; Eotvos Lorand University; Eotvos Lorand University; Northwestern University	Barabasi, AL (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017; Vicsek, Tamas/A-3305-2009	Almaas, Eivind/0000-0002-9125-326X; Barabasi, Albert/0000-0002-4028-3522				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 2003, PHYSICA A, V319, P633, DOI 10.1016/S0378-4371(02)01382-1; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1016/S0378-1097(01)00407-4; Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heinrich R., 1996, REGULATION CELLULAR; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lovasz L, 1999, MATH PROGRAM, V86, P443, DOI 10.1007/s101070050099; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sauer U, 1999, J BACTERIOL, V181, P6679, DOI 10.1128/JB.181.21.6679-6688.1999; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; SMITH RL, 1984, OPER RES, V32, P1296, DOI 10.1287/opre.32.6.1296; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X	29	495	526	6	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					839	843		10.1038/nature02289	http://dx.doi.org/10.1038/nature02289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985762	Green Submitted			2022-12-01	WOS:000189207500040
J	Baptiste, N; Prives, C				Baptiste, N; Prives, C			p53 in the cytoplasm: A question of overkill?	CELL			English	Editorial Material							APOPTOSIS	The tumor suppressor p53 regulates cellular responses to stress by serving in the nucleus to regulate transcription of genes involved in processes including cell cycle arrest, DNA repair, and apoptosis. Nevertheless, recent papers show that p53 may have a separate cytoplasmic role in directly regulating the Bax-dependent mitochondrial pathway to cell death.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Baptiste, N (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.							Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; CHIPUK JE, 2004, IN PRESS SCIENCE; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	10	42	45	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2004	116	4					487	489		10.1016/S0092-8674(04)00164-3	http://dx.doi.org/10.1016/S0092-8674(04)00164-3			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980216	Bronze			2022-12-01	WOS:000189184200003
J	Faller, M; Niederweis, M; Schulz, GE				Faller, M; Niederweis, M; Schulz, GE			The structure of a mycobacterial outer-membrane channel	SCIENCE			English	Article							CELL-WALL; RHODOBACTER-CAPSULATUS; MYCOLIC ACIDS; PORIN; SMEGMATIS; ENVELOPE; PROTEIN; MSPA; ORGANIZATION; TUBERCULOSIS	Mycobacteria have low-permeability outer membranes that render them resistant to most antibiotics. Hydrophilic nutrients can enter by way of transmembrane-channel proteins called porins. An x-ray analysis of the main porin from Mycobacterium smegmatis, MspA, revealed a homooctameric goblet-like conformation with a single central channel. This is the first structure of a mycobacterial outermembrane protein. No structure-related protein was found in the Protein Data Bank. MspA contains two consecutive beta barrels with nonpolar outer surfaces that form a ribbon around the porin, which is too narrow to fit the thickness of the mycobacterial outer membrane in contemporary models.	Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, D-91058 Erlangen, Germany	University of Freiburg; University of Erlangen Nuremberg	Schulz, GE (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	schulz@bio.chemie.uni-freiburg.de						Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; BLEED D, 2001, GLOBAL TUBERCULOSIS; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dmitriev BA, 2000, INT J MED MICROBIOL, V290, P251; Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200; Fu LM, 2002, TUBERCULOSIS, V82, P85, DOI 10.1054/tube.2002.0328; Heinz C, 2003, J CHROMATOGR B, V790, P337, DOI 10.1016/S1570-0232(03)00130-2; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kartmann B, 1999, J BACTERIOL, V181, P6543, DOI 10.1128/JB.181.20.6543-6546.1999; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lambert PA, 2002, J APPL MICROBIOL, V92, p46S, DOI 10.1046/j.1365-2672.92.5s1.7.x; Lichtinger T, 1999, FEBS LETT, V454, P349, DOI 10.1016/S0014-5793(99)00844-3; LIU J, 1995, P NATL ACAD SCI USA, V92, P11254, DOI 10.1073/pnas.92.24.11254; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; MINNIKIN DE, 1991, RES MICROBIOL, V142, P423, DOI 10.1016/0923-2508(91)90114-p; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x; PAUL TR, 1992, J BACTERIOL, V174, P6508, DOI 10.1128/JB.174.20.6508-6517.1992; PITULLE C, 1992, INT J SYST BACTERIOL, V42, P337, DOI 10.1099/00207713-42-3-337; Rastogi N, 2001, REV SCI TECH OIE, V20, P21, DOI 10.20506/rst.20.1.1265; SCHILTZ E, 1991, EUR J BIOCHEM, V199, P587, DOI 10.1111/j.1432-1033.1991.tb16158.x; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; WEISS MS, 1991, FEBS LETT, V280, P379, DOI 10.1016/0014-5793(91)80336-2	30	257	296	6	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1189	1192		10.1126/science.1094114	http://dx.doi.org/10.1126/science.1094114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976314				2022-12-01	WOS:000189074700045
J	Vazquez, M; LaRussa, PS; Gershon, AA; Niccolai, LM; Muehlenbein, CE; Steinberg, SP; Shapiro, ED				Vazquez, M; LaRussa, PS; Gershon, AA; Niccolai, LM; Muehlenbein, CE; Steinberg, SP; Shapiro, ED			Effectiveness over time of varicella vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN	Context Reports of outbreaks of varicella in highly immunized groups have increased concern about the effectiveness of varicella vaccine. Objective To assess whether the effectiveness of varicella vaccine is affected either by time since vaccination or by age at the time of vaccination. Design Case-control study conducted from March 1997 through June 2003. Setting Twenty different group practices in southern Connecticut. Participants Case subjects, identified by active surveillance of all practices, consisted of 339 eligible children 13 months or older who were clinically diagnosed as having chickenpox and who also had a polymerase chain reaction (PCR) test result that was positive for varicella-zoster virus DNA. For each case subject, 2 controls were selected, matched by both age and pediatric practice. Main Outcome Measures The effectiveness of the vaccine, especially the effects of time since vaccination and age at the time of vaccination, adjusted for possible confounders. Results Although the adjusted overall effectiveness of the vaccine was 87% (95% confidence interval, 81%-91%; P<.001), there was a substantial difference in the vaccine's effectiveness in the first year after vaccination (97%) and in years 2 to 8 after vaccination (84%, P=.003). The vaccine's effectiveness in year 1 was substantially lower if the vaccine was administered at younger than 15 months (73%) than if it was administered at 15 months or older (99%, P=.01), although the difference in effectiveness overall for children immunized at younger than 15 months was not statistically significantly different than for those immunized at 15 months or older (81% vs 88%, P=.17). Most cases of chickenpox in vaccinees were mild. Conclusions Although varicella vaccine is effective, its effectiveness decreases significantly after 1 year, although most cases of breakthrough disease are mild. If administered at younger than 15 months, the vaccine's effectiveness was lower in the first year after vaccination, but the difference in effectiveness was not statistically significant for subsequent years.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Childrens Clin Res Ctr, New Haven, CT USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	Yale University; Yale University; Yale University; Columbia University	Shapiro, ED (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	Eugene.Shapiro@Yale.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024021, K24AI001703, R01AI041608] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR06022] Funding Source: Medline; NIAID NIH HHS [K24-AI01703, R01-AI 24021, R01-AI41608] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAMSON JH, 2001, COMPUTER PROGRAMS EP, P113; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; Breslow NE, 1980, STAT METHODS CANC RE; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Gershon AA, 2002, NEW ENGL J MED, V347, P1962, DOI 10.1056/NEJMe020138; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; *SAS I INC, 1999, SAS ONL VERS 8; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Verstraeten T, 2003, PEDIATRICS, V112, pE98, DOI 10.1542/peds.112.2.e98; WATSON B, 1995, CLIN INFECT DIS, V20, P316, DOI 10.1093/clinids/20.2.316; 2003, MMWR MORB MORTAL WKL, V52, P545	17	173	185	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2004	291	7					851	855		10.1001/jama.291.7.851	http://dx.doi.org/10.1001/jama.291.7.851			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TF	14970064				2022-12-01	WOS:000189000400023
J	Raithatha, N; Smith, RD				Raithatha, N; Smith, RD			Paying for statins	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; CHOLESTEROL; RISK		Univ E Anglia, Ctr Hlth, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Med Hlth Policy & Practice, Hlth Econ & Eth Grp, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Raithatha, N (corresponding author), Univ E Anglia, Ctr Hlth, Norwich NR4 7TJ, Norfolk, England.	N.Raithatha@uea.ac.uk		Smith, Richard/0000-0003-3837-6559				Beattie J, 1998, J RISK UNCERTAINTY, V17, P5, DOI 10.1023/A:1007711416843; *BRIT MED ASS ROYA, 2003, BRIT NAT FORM, P128; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; *DEP HLTH, 2003, FAIR ALL PERS YOU CH; *DEP HLTH, 2000, NAT SERV FRAM CORN H; Department of Health, 1999, SAV LIV OUR HLTH NAT; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Haq IU, 2001, HEART, V86, P289, DOI 10.1136/heart.86.3.289; Hulley SB, 2000, BRIT MED J, V321, P971, DOI 10.1136/bmj.321.7267.971; Jackson R, 2000, BMJ-BRIT MED J, V320, P659, DOI 10.1136/bmj.320.7236.659; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Marks D, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4290, DOI 10.3310/HTA4290]; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Rawls J., 1972, SOCIAL JUSTICE LIBER; TIMMINS N, 2001, FINANCIAL TIMES 0810	16	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2004	328	7436					400	402		10.1136/bmj.328.7436.400	http://dx.doi.org/10.1136/bmj.328.7436.400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	775GA	14962879	Green Published, Green Accepted			2022-12-01	WOS:000189031300032
J	Konishi, Y; Stegmuller, J; Matsuda, T; Bonni, S; Bonni, A				Konishi, Y; Stegmuller, J; Matsuda, T; Bonni, S; Bonni, A			Cdh1-APC controls axonal growth and patterning in the mammalian brain	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; RNA INTERFERENCE; IN-VIVO; UBIQUITIN; ELECTROPORATION; REQUIREMENT; REGULATOR; PROTEIN; CDC20; EMI1	The anaphase-promoting complex (APC) is highly expressed in postmitotic neurons, but its function in the nervous system was previously unknown. We report that the inhibition of Cdh1-APC in primary neurons specifically enhanced axonal growth. Cdh1 knockdown in cerebellar slice overlay assays and in the developing rat cerebellum in vivo revealed cell-autonomous abnormalities in layer-specific growth of granule neuron axons and parallel fiber patterning. Cdh1 RNA interference in neurons was also found to override the inhibitory influence of myelin on axonal growth. Thus, Cdh1-APC appears to play a role in regulating axonal growth and patterning in the developing brain that may also limit the growth of injured axons in the adult brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Calgary	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Holt, Janet E/B-2415-2013		NINDS NIH HHS [R01NS41021] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; KONISHI Y, UNPUB; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	23	306	317	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1026	1030		10.1126/science.1093712	http://dx.doi.org/10.1126/science.1093712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14716021	Green Submitted			2022-12-01	WOS:000188918000050
J	Boutros, M; Kiger, AA; Armknecht, S; Kerr, K; Hild, M; Koch, B; Haas, SA; Paro, R; Perrimon, N				Boutros, M; Kiger, AA; Armknecht, S; Kerr, K; Hild, M; Koch, B; Haas, SA; Paro, R; Perrimon, N		Heidelberg Fly Array Consortium	Genome-wide RNAi analysis of growth and viability in Drosophila cells	SCIENCE			English	Article							IDENTIFICATION; INTERFERENCE; PROTEIN; GENES	A crucial aim upon completion of whole genome sequences is the functional analysis of all predicted genes. We have applied a high-throughput RNA-interference (RNAi) screen of 19,470 double-stranded (ds) RNAs in cultured cells to characterize the function of nearly all (91%) predicted Drosophila genes in cell growth and viability. We found 438 dsRNAs that identified essential genes, among which 80% lacked mutant alleles. A quantitative assay of cell number was applied to identify genes of known and uncharacterized functions. In particular, we demonstrate a role for the homolog of a mammalian acute myeloid leukemia gene (AML1) in cell survival. Such a systematic screen for cell phenotypes, such as cell viability, can thus be effective in characterizing functionally related genes on a genome-wide scale.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg; Max Planck Society	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	perrimon@rascal.med.harvard.edu	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Perrimon, Norbert/0000-0001-7542-472X; Haas, Stefan/0000-0003-3418-3688	NIGMS NIH HHS [R01 GM078176] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078176] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; ECHALIER G, 1970, IN VITRO CELL DEV B, V6, P162; Frank LH, 1996, DEVELOPMENT, V122, P1343; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guo M, 1999, CURR OPIN CELL BIOL, V11, P745, DOI 10.1016/S0955-0674(99)00046-0; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hild M, 2004, GENOME BIOL, V5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	21	560	612	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					832	835		10.1126/science.1091266	http://dx.doi.org/10.1126/science.1091266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764878				2022-12-01	WOS:000188753800056
J	Matheny, SA; Chen, CY; Kortum, RL; Razidlo, GL; Lewis, RE; White, MA				Matheny, SA; Chen, CY; Kortum, RL; Razidlo, GL; Lewis, RE; White, MA			Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP	NATURE			English	Article							KINASE SUPPRESSOR; RNA INTERFERENCE; RAF-1 KINASE; ACTIVATION; SCAFFOLD; PHOSPHORYLATION; LOCALIZATION; TRANSDUCTION; KSR	The signal transduction cascade comprising Raf, mitogen-activated protein (MAP) kinase kinase (MEK) and MAP kinase is a Ras effector pathway that mediates diverse cellular responses to environmental cues and contributes to Ras-dependent oncogenic transformation. Here we report that the Ras effector protein Impedes Mitogenic signal Propagation (IMP) modulates sensitivity of the MAP kinase cascade to stimulus-dependent activation by limiting functional assembly of the core enzymatic components through the inactivation of KSR, a scaffold/adaptor protein that couples activated Raf to its substrate MEK1. IMP is a Ras-responsive E3 ubiquitin ligase that, on activation of Ras, is modified by auto-polyubiquitination, which releases the inhibition of Raf-MEK complex formation. Thus, Ras activates the MAP kinase cascade through simultaneous dual effector interactions: induction of Raf kinase activity and derepression of Raf-MEK complex formation. IMP depletion results in increased stimulus-dependent MEK activation without alterations in the timing or duration of the response. These observations suggest that IMP functions as a threshold modulator, controlling sensitivity of the cascade to stimulus and providing a mechanism to allow adaptive behaviour of the cascade in chronic or complex signalling environments.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Nebraska, Med Ctr, Dept Pathol, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Medical Center	White, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Lewis, Robert E./H-3404-2019	Razidlo, Gina/0000-0002-9042-2738				Brennan JA, 2002, J BIOL CHEM, V277, P5369, DOI 10.1074/jbc.M109875200; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	16	146	157	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2004	427	6971					256	260		10.1038/nature02237	http://dx.doi.org/10.1038/nature02237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763HE	14724641				2022-12-01	WOS:000188068100046
J	Schmidt, DN; Thierstein, HR; Bollmann, J; Schiebel, R				Schmidt, DN; Thierstein, HR; Bollmann, J; Schiebel, R			Abiotic forcing of plankton evolution in the Cenozoic	SCIENCE			English	Article							FORAMINIFERA; TRENDS; GRADUALISM; LINEAGE; RULE	We characterize the evolutionary radiation of planktic foraminifera by the test size distributions of entire assemblages in more than 500 Cenozoic marine sediment samples, including more than 1 million tests. Calibration of Holocene size patterns with environmental parameters and comparisons with Cenozoic paleoproxy data show a consistently positive correlation between test size and surface-water stratification intensity. We infer that the observed macroevolutionary increase in test size of planktic foraminifera through the Cenozoic was an adaptive response to intensifying surface-water strati. cation in low latitudes, which was driven by polar cooling.	ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; Univ Zurich, ETH Zentrum, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Schmidt, DN (corresponding author), Univ London, Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 OEX, Surrey, England.	d.schmidt@gl.rhul.ac.uk		Schiebel, Ralf/0000-0002-6252-7647; Schmidt, Daniela/0000-0001-8419-2721				ARNOLD AJ, 1983, PALEOBIOLOGY, V9, P390, DOI 10.1017/S0094837300007855; ARNOLD AJ, 1995, J PALEONTOL, V69, P203, DOI 10.1017/S0022336000034557; BOLLMANN J, IN PRESS IMAGE ANAL; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; CIFELLI R, 1969, SYST ZOOL, V18, P154, DOI 10.2307/2412601; DHONDT S, 1995, PALEOCEANOGRAPHY, V10, P123, DOI 10.1029/94PA02671; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; HECHT A D, 1976, Journal of Foraminiferal Research, V6, P295; Kaiho K, 1998, GEOLOGY, V26, P491, DOI 10.1130/0091-7613(1998)026<0491:GCFODS>2.3.CO;2; LIPPS JH, 1970, EVOLUTION, V24, P1, DOI 10.1111/j.1558-5646.1970.tb01737.x; LUTERBACHER H. P., 1964, RIV ITAL PALEONTOL STRATIGR, V70, P67; MacLeod KG, 2001, PALEOCEANOGRAPHY, V16, P133, DOI 10.1029/2000PA000514; MALMGREN BA, 1983, PALEOBIOLOGY, V9, P377, DOI 10.1017/S0094837300007843; Mulitza S, 1997, GEOLOGY, V25, P335, DOI 10.1130/0091-7613(1997)025<0335:PFAROP>2.3.CO;2; Norris RD, 1996, PALEOBIOLOGY, V22, P386, DOI 10.1017/S0094837300016341; NORRIS RD, 1991, PALEOBIOLOGY, V17, P388, DOI 10.1017/S0094837300010721; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; SCHMIDT DMZ, UNPUB; SCHMIDT DN, IN PRESS MAR MICROPA; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Stanley SM., 1998, MACROEVOLUTION PATTE; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; VINCENT E, 1981, SEA, V7, P1035; WEFER G, 1999, USE PROXIES PALEOCEA; Wei KY, 1986, PALEOCEANOGRAPHY, V1, P67, DOI 10.1029/PA001i001p00067; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	29	102	106	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2004	303	5655					207	210		10.1126/science.1090592	http://dx.doi.org/10.1126/science.1090592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716007				2022-12-01	WOS:000187908500041
J	Raad, I; Hanna, HA; Alakech, B; Chatzinikolaou, I; Johnson, MM; Tarrand, J				Raad, I; Hanna, HA; Alakech, B; Chatzinikolaou, I; Johnson, MM; Tarrand, J			Differential time to positivity: A useful method for diagnosing catheter-related bloodstream infections	ANNALS OF INTERNAL MEDICINE			English	Article							HUB-BLOOD; CULTURES; SEPSIS	Background: Catheter-related bloodstream infections are associated with recognized morbidity and mortality, especially in critically ill patients. Accurate diagnosis of such infections results in proper management of patients and in reducing unnecessary removal of catheters. Objective: To evaluate differential time to positivity as a method for diagnosing catheter-related bacteremias caused by both short-term and long-term use of central venous catheters. Design: Prospective study design. Setting: M.D. Anderson Cancer Center, Houston, Texas, a tertiary care cancer center. Patients: All patients, between September 1999 and November 2000, who had the same organism isolated from blood cultures drawn simultaneously through the central venous catheter and the peripheral vein. Measurements: Time necessary for the blood cultures from the central venous catheter and the peripheral vein to become positive, as well as other relevant patient information. Results: 191 bloodstream infections with positive simultaneous central venous catheter and peripheral vein blood cultures were included. One hundred eight patients had catheter-related bacteremias, and 83 had non-catheter-related bacteremias. Catheter-related bacteremias were more frequently caused by staphylococci and less likely to be associated with underlying hematologic malignant conditions, neutropenia, and longer duration of hospitalization. As a diagnostic tool for catheter-related bacteremia (using a composite definition reference standard according to the infectious Diseases Society of America guidelines), differential time to positivity of 120 minutes or more was associated with 81% sensitivity and 92% specificity for short-term catheters and 93% sensitivity and 75% specificity for long-term catheters. Conclusion: Differential time to positivity of 120 minutes or more is highly sensitive and specific for catheter-related bacteremia in patients who have short- and long-term catheters.	Univ Texas, MD Anderson Canc Ctr, Dept Informat Dis Infect Control & Employee Hlth, Unit 402, Houston, TX 77030 USA; Texas Tech Univ, Sch Med, Lubbock, TX 79409 USA	University of Texas System; UTMD Anderson Cancer Center; Texas Tech University System; Texas Tech University	Hanna, HA (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Informat Dis Infect Control & Employee Hlth, Unit 402, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hhanna@mdanderson.org	Chatzinikolaou, Yorgos/K-2593-2015					Blot F, 1998, J CLIN MICROBIOL, V36, P105, DOI 10.1128/JCM.36.1.105-109.1998; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; CAPDEVILA JA, 1992, EUR J CLIN MICROBIOL, V11, P403, DOI 10.1007/BF01961854; DORN GL, 1979, J CLIN MICROBIOL, V9, P391; FAN ST, 1989, EUR J CLIN MICROBIOL, V8, P142, DOI 10.1007/BF01963898; JARVIS WR, 1991, AM J MED, V91, pS185, DOI 10.1016/0002-9343(91)90367-7; Kluger DM, 1999, 39 INT C ANT AG CHEM; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; MAKI DG, 1998, HOSP INFECT, P689; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Mermel LA, 1998, 38 INT C ANT AG CHEM, P500; Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438; RAAD I, 1993, ARCH INTERN MED, V153, P1791, DOI 10.1001/archinte.153.15.1791; Rijnders BJA, 2001, CRIT CARE MED, V29, P1399, DOI 10.1097/00003246-200107000-00016; Seifert H, 2003, J CLIN MICROBIOL, V41, P118, DOI 10.1128/JCM.41.1.118-123.2003; SHERERTZ RJ, 1990, J CLIN MICROBIOL, V28, P76, DOI 10.1128/JCM.28.1.76-82.1990; Sherertz RJ, 1997, J CLIN MICROBIOL, V35, P641, DOI 10.1128/JCM.35.3.641-646.1997; WIDMER AF, 1992, ARCH INTERN MED, V152, P1299, DOI 10.1001/archinte.152.6.1299	18	220	232	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2004	140	1					18	25		10.7326/0003-4819-140-1-200401060-00007	http://dx.doi.org/10.7326/0003-4819-140-1-200401060-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760VH	14706968				2022-12-01	WOS:000187855600003
J	Furness, S; Connor, J; Robinson, E; Norton, R; Ameratunga, S; Jackson, R				Furness, S; Connor, J; Robinson, E; Norton, R; Ameratunga, S; Jackson, R			Car colour and risk of car crash injury: population based case control study	BRITISH MEDICAL JOURNAL			English	Article							DRIVER SLEEPINESS		Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia	University of Auckland; University of Sydney	Furness, S (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019, Auckland 1, New Zealand.			Connor, Jennie/0000-0002-3209-8693; Jackson, Rod/0000-0001-5914-6934; Ameratunga, Shanthi/0000-0001-8042-2251				Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, SLEEP, V24, P688, DOI 10.1093/sleep/24.6.688; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Lardelli-Claret P, 2002, EPIDEMIOLOGY, V13, P721, DOI 10.1097/00001648-200211000-00019; Peden M., 2002, INJURY CHART BOOK GR	5	11	12	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1455	1456		10.1136/bmj.327.7429.1455	http://dx.doi.org/10.1136/bmj.327.7429.1455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684646	Green Published			2022-12-01	WOS:000187562700017
J	Zahl, PH; Strand, H; Maehlen, J				Zahl, PH; Strand, H; Maehlen, J			Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAMMOGRAPHY	Objective To determine whether any increase in the incidence of breast cancer in women detected by mammography is compensated for by a drop in the incidence after age 69, years when women are no longer invited for screening. Design Population based cohort study of incidence of breast cancer during the introduction of nationwide screening programmes. Setting Norway and Sweden. Participants Ail women aged above 30 years (1.4 and 2.9 million, respectively, in 2000). Main outcome measures Changes in age specific incidence rates of invasive breast cancer associated with the introduction of the screening programmes. Results As a result of screening the recorded incidence of breast cancer in women aged 50-69 years increased by 54% in Norway and 45% in Sweden. There was no corresponding decline in incidence after the age of 69 years. Conclusions Without screening one third of all invasive breast cancers in the age group 50-69 years would not have been detected in the patients' lifetime. This level of overdiagnosis is larger than previously reported.	Ullevaal Univ Hosp, Dept Pathol, N-0407 Oslo, Norway; Norwegian Inst Publ Hlth, N-0403 Oslo, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH)	Maehlen, J (corresponding author), Ullevaal Univ Hosp, Dept Pathol, N-0407 Oslo, Norway.	jan.mahlen@ioks.uio.no		Strand, Bjorn Heine/0000-0003-4385-8886				BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; *CANC REG NORW, 2003, CANC NORW 2000; *CANC REG NORW, 2000, MAMM NORG EV PROV 19; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fletcher SW, 2003, NEW ENGL J MED, V348, P1672, DOI 10.1056/NEJMcp021804; Hakama M, 1999, J MED SCREEN, V6, P209, DOI 10.1136/jms.6.4.209; Harmer C, 1999, CANCER CAUSE CONTROL, V10, P333, DOI 10.1023/A:1008949819969; *HLTH COUNC NETH, 2002, PUBL HLTH COUNC NETH; *NAT BOARD HLTH WE, 2002, CANC INC SWED 2000; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Thornton H, 2003, BMJ-BRIT MED J, V327, P101, DOI 10.1136/bmj.327.7406.101; vandenAkkervanMarle ME, 1997, INT J CANCER, V73, P464, DOI 10.1002/(SICI)1097-0215(19971114)73:4<464::AID-IJC2>3.0.CO;2-Y	12	195	198	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					921	924		10.1136/bmj.38044.666157.63	http://dx.doi.org/10.1136/bmj.38044.666157.63			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15013948	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000220994400016
J	Wallsten, S				Wallsten, S			High-tech cluster bombs - Why successful biotech hubs are the exception, not the rule.	NATURE			English	Editorial Material									AEI Brookings Joint Ctr Regulatory Studies, Washington, DC 20036 USA; Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Wallsten, S (corresponding author), AEI Brookings Joint Ctr Regulatory Studies, 1150 17th St NW, Washington, DC 20036 USA.		Wallsten, Scott/ABF-2887-2021					Howard K, 2003, NATURE, V426, P689, DOI 10.1038/426689; JAFFE AB, 1989, AM ECON REV, V79, P957; Krugman P., 1991, GEOGRAPHY TRADE; Marshall A., 1920, IND TRADE; Wallsten S., 2004, DO SCI PARKS GENERAT; WILEN J, 2003, BALTIMORE BUSIN 0613; 2003, NATURE, V426, P4	7	6	6	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2004	428	6979					121	122		10.1038/428121a	http://dx.doi.org/10.1038/428121a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NW	15014470				2022-12-01	WOS:000220103600019
J	Smith, G; Bartlett, A; King, M				Smith, G; Bartlett, A; King, M			Treatments of homosexuality in Britain since the 1950s - an oral history: the experience of patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To investigate the circumstances since the 1950s in which people who were attracted to members of the same sex received treatments to change their sexual orientation, the referral pathway and the process of therapy, and its aftermath. Design A nationwide study based on qualitative interviews. Participants 29 people who had received treatments to change their sexual orientation in the United Kingdom and two relatives of former patients. Results Most participants had been distressed by their attraction to their own sex and people in whom they confided thought they needed treatment. Although some participants chose to undergo treatments instead of imprisonment or were encouraged through some form of medical coercion, most were responding to complex personal and social pressures that discouraged any expression of their sexuality. While many participants found happiness in same sex relationships after their treatment, most were left feeling emotionally distressed to some degree. Conclusion The definition of same sex attraction as an illness and the development of treatments to eradicate such attraction have had a negative long term impact on individuals.	UCL Royal Free & Univ Coll Sch Med, London NW3 2PF, England; St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England	University of London; University College London; St Georges University London	King, M (corresponding author), UCL Royal Free & Univ Coll Sch Med, Royal Free Campus, London NW3 2PF, England.	m.king@rfc.ucl.ac.uk	bartlett, annie/I-6651-2013; King, Michael B/D-7477-2011	bartlett, annie/0000-0002-5498-7141; King, Michael B/0000-0003-4715-7171				Bartlett A, 2001, BRIT J PSYCHIAT, V179, P545, DOI 10.1192/bjp.179.6.545; Davenport-Hines R., 1990, SEX DEATH PUNISHMENT; Foucault M, 1981, HIST SEXUALITY, VI; Hall Lesley, 2000, SEX GENDER SOCIAL CH; King M, 2004, BMJ-BRIT MED J, V328, P429, DOI 10.1136/bmj.37984.496725.EE; King M, 1999, BRIT J PSYCHIAT, V175, P106, DOI 10.1192/bjp.175.2.106; PORTER R, 1994, FACTS LIFE CREATION; Porter Roy., 1997, GREATEST BENEFIT MAN; Smith G, 2004, BMJ-BRIT MED J, V328, P427, DOI 10.1136/bmj.37984.442419.EE; Weeks J., 1990, COMING OUT HOMOSEXUA	10	56	58	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2004	328	7437					427	429		10.1136/bmj.37984.442419.EE	http://dx.doi.org/10.1136/bmj.37984.442419.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777DV	14751920	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000189161000014
J	Altmann, SW; Davis, HR; Zhu, LJ; Yao, XR; Hoos, LM; Tetzloff, G; Iyer, SPN; Maguire, M; Golovko, A; Zeng, M; Wang, LQ; Murgolo, N; Graziano, MP				Altmann, SW; Davis, HR; Zhu, LJ; Yao, XR; Hoos, LM; Tetzloff, G; Iyer, SPN; Maguire, M; Golovko, A; Zeng, M; Wang, LQ; Murgolo, N; Graziano, MP			Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption	SCIENCE			English	Article							DIETARY-CHOLESTEROL; 2-AZETIDINONE CLASS; GENE; IDENTIFICATION; MICE; INHIBITORS; METABOLISM; HYPERCHOLESTEROLEMIA; GLYCOPROTEIN; ACCUMULATION	Dietary cholesterol consumption and intestinal cholesterol absorption contribute to plasma cholesterol levels, a risk factor for coronary heart disease. The molecular mechanism of sterol uptake from the lumen of the small intestine is poorly defined. We show that Niemann-Pick C1 Like 1 (NPC1L1) protein plays a critical role in the absorption of intestinal cholesterol. NPC1L1 expression is enriched in the small intestine and is in the brush border membrane of enterocytes. Although otherwise phenotypically normal, NPC1L1-deficient mice exhibit a substantial reduction in absorbed cholesterol, which is unaffected by dietary supplementation of bile acids. Ezetimibe, a drug that inhibits cholesterol absorption, had no effect in NPC1L1 knockout mice, suggesting that NPC1L1 resides in an ezetimibe-sensitive pathway responsible for intestinal cholesterol absorption.	Schering Plough Corp, Res Inst, Dept Cardiovasc Endocrine Res, Kenilworth, NJ 07033 USA; Schering Plough Corp, Res Inst, Dept Discovery Technol, Kenilworth, NJ 07033 USA	Merck & Company; Schering Plough Corporation; Merck & Company; Schering Plough Corporation	Altmann, SW (corresponding author), Schering Plough Corp, Res Inst, Dept Cardiovasc Endocrine Res, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	scott.altmann@spcorp.com						Altmann SW, 2002, BBA-MOL CELL BIOL L, V1580, P77, DOI 10.1016/S1388-1981(01)00190-1; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BORGSTROM B, 1960, J CLIN INVEST, V39, P809, DOI 10.1172/JCI104100; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Burnett DA, 2002, BIOORG MED CHEM LETT, V12, P315, DOI 10.1016/S0960-894X(01)00752-1; Burnett DA, 2002, BIOORG MED CHEM LETT, V12, P311, DOI 10.1016/S0960-894X(01)00750-8; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHIN DJ, 1984, NATURE, V308, P613, DOI 10.1038/308613a0; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; GLOVER J, 1958, BRIT MED BULL, V14, P226, DOI 10.1093/oxfordjournals.bmb.a069688; GRUNDY SM, 1983, ANNU REV NUTR, V3, P71, DOI 10.1146/annurev.nu.03.070183.000443; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; PASTUSZYN A, 1987, J BIOL CHEM, V262, P13219; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Rosenblum SB, 1998, J MED CHEM, V41, P973, DOI 10.1021/jm970701f; Schoenheimer R, 1931, SCIENCE, V74, P579, DOI 10.1126/science.74.1928.579; Schulthess G, 1996, J LIPID RES, V37, P2405; Schwarz M, 1998, J LIPID RES, V39, P1833; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200	30	1267	1353	1	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2004	303	5661					1201	1204		10.1126/science.1093131	http://dx.doi.org/10.1126/science.1093131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976318				2022-12-01	WOS:000189074700049
J	Banerjee, RR; Rangwala, SM; Shapiro, JS; Rich, AS; Rhoades, B; Qi, Y; Wang, J; Rajala, MW; Pocai, A; Scherer, PE; Steppan, CM; Ahima, RS; Obici, S; Rossetti, L; Lazar, MA				Banerjee, RR; Rangwala, SM; Shapiro, JS; Rich, AS; Rhoades, B; Qi, Y; Wang, J; Rajala, MW; Pocai, A; Scherer, PE; Steppan, CM; Ahima, RS; Obici, S; Rossetti, L; Lazar, MA			Regulation of fasted blood glucose by resistin	SCIENCE			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; RECOMBINANT RESISTIN; ADIPOSE-TISSUE; EXPRESSION; GENE; OBESITY; ADIPOCYTE; INFLAMMATION; ASSOCIATION	The association between obesity and diabetes supports an endocrine role for the adipocyte in maintaining glucose homeostasis. Here we report that mice lacking the adipocyte hormone resistin exhibit low blood glucose levels after fasting, due to reduced hepatic glucose production. This is partly mediated by activation of adenosine monophosphate-activated protein kinase and decreased expression of gluconeogenic enzymes in the liver. The data thus support a physiological function for resistin in the maintenance of blood glucose during fasting. Remarkably, lack of resistin diminishes the increase in post-fast blood glucose normally associated with increased weight, suggesting a role for resistin in mediating hyperglycemia associated with obesity.	Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA; Albert Einstein Coll Med, Dept Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA	University of Pennsylvania; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, 611 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Banerjee, Ronadip/U-6649-2019; Ahima, Rexford/W-1394-2019; Lazar, Mitchell A/AAF-3738-2019; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392	NIDDK NIH HHS [P30 DK19525, P60 DK20541, P01 DK49210] Funding Source: Medline; NIGMS NIH HHS [NIH T32-GM008216] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, P01DK049210, P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Haugen F, 2001, FEBS LETT, V507, P105, DOI 10.1016/S0014-5793(01)02968-4; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hotamisligil GS, 2003, J CLIN INVEST, V111, P173, DOI 10.1172/JCI200317605; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Juan CC, 2003, J BIOTECHNOL, V103, P113, DOI 10.1016/S0168-1656(03)00099-3; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moon B, 2003, AM J PHYSIOL-ENDOC M, V285, pE106, DOI 10.1152/ajpendo.00457.2002; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Pizzuti A, 2002, J CLIN ENDOCR METAB, V87, P4403, DOI 10.1210/jc.2002-020096; Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Shojima N, 2002, DIABETES, V51, P1737, DOI 10.2337/diabetes.51.6.1737; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tan MS, 2003, J CLIN ENDOCR METAB, V88, P1258, DOI 10.1210/jc.2002-021453; Wang H, 2002, J CLIN ENDOCR METAB, V87, P2520, DOI 10.1210/jc.87.6.2520; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	38	563	604	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1195	1198		10.1126/science.1092341	http://dx.doi.org/10.1126/science.1092341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976316				2022-12-01	WOS:000189074700047
J	Rustom, A; Saffrich, R; Markovic, I; Walther, P; Gerdes, HH				Rustom, A; Saffrich, R; Markovic, I; Walther, P; Gerdes, HH			Nanotubular highways for intercellular organelle transport	SCIENCE			English	Article							MOVEMENT; VESICLE; CELL	Cell-to-cell communication is a crucial prerequisite for the development and maintenance of multicellular organisms. To date, diverse mechanisms of intercellular exchange of information have been documented, including chemical synapses, gap junctions, and plasmodesmata. Here, we describe highly sensitive nanotubular structures formed de novo between cells that create complex networks. These structures facilitate the selective transfer of membrane vesicles and organelles but seem to impede the flow of small molecules. Accordingly, we propose a novel biological principle of cell-to-cell interaction based on membrane continuity and intercellular transfer of organelles.	Heidelberg Univ, Inst Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany; Heidelberg Univ, Otto Meyerhoff Zentrum, D-69120 Heidelberg, Germany; Univ Belgrade, Fac Med, Inst Biochem, YU-11000 Belgrade, Serbia; Univ Ulm, Electron Microscopy Facil, D-89069 Ulm, Germany; Univ Bergen, Inst Biochem & Mol Biol, N-5009 Bergen, Norway	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Belgrade; Ulm University; University of Bergen	Gerdes, HH (corresponding author), Heidelberg Univ, Inst Neurobiol, Interdisciplinary Ctr Neurosci IZN, INF 364, D-69120 Heidelberg, Germany.	Hans-Hermann.Gerdes@ibmb.uib.no	Markovic, Ivanka/AAJ-1243-2020	Markovic, Ivanka/0000-0002-7961-3752; Saffrich, Rainer/0000-0002-0547-4550				Denzer K, 2000, J CELL SCI, V113, P3365; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Karlsson A, 2001, NATURE, V409, P150, DOI 10.1038/35051656; KUFFLER DP, 1990, J COMP NEUROL, V302, P729, DOI 10.1002/cne.903020405; Lucas WJ, 2001, NAT REV MOL CELL BIO, V2, P849, DOI 10.1038/35099096; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; PASTAN IH, 1981, SCIENCE, V214, P504, DOI 10.1126/science.6170111; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Scott G, 2002, J CELL SCI, V115, P1441	16	1200	1241	9	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1007	1010		10.1126/science.1093133	http://dx.doi.org/10.1126/science.1093133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963329				2022-12-01	WOS:000188918000044
J	Paulsson, J				Paulsson, J			Summing up the noise in gene networks	NATURE			English	Article							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; STOCHASTIC-MODEL; FLUCTUATIONS; REPLICATION; SENSITIVITY; MECHANISMS; EXPRESSION; CELLS	Ransom fluctuations in genetic networks are inevitable as chemical reactions are probabilistic and many genes, RNAs and proteins are present in low numbers per cell. Such 'noise' affects all life processes and has recently been measured using green protein (GFP). Two studies show that negative feedback suppresses noise, and three others identify the sources of in gene expression. Here I critically analyse these studies and present a simple equation that unifies and extends both the and biological perspectives.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Cambridge, Ctr Math Sci, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Princeton University; University of Cambridge	Paulsson, J (corresponding author), Princeton Univ, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.	J.Paulsson@damtp.cam.ac.uk						Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BERG OG, 1995, J THEOR BIOL, V173, P307, DOI 10.1006/jtbi.1995.0064; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Howard M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.128102; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KEIZER K, 1987, STAT THERMODYNAMICS; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Paulsson J, 2002, GENETICS, V161, P1373; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; RIGNEY DR, 1977, J THEOR BIOL, V69, P761, DOI 10.1016/0022-5193(77)90381-2; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SAVAGEAU MA, 1976, BIOCH SYSTEMS ANAL; Schroedinger E., 1944, WHAT IS LIFE; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SINGH UN, 1969, J THEOR BIOL, V25, P444, DOI 10.1016/S0022-5193(69)80032-9; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; VANKAMPER NG, 1992, STOCHASTIC PROCESSES; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Westerhoff H., 1987, THERMODYNAMICS CONTR; Xie XS, 2002, J CHEM PHYS, V117, P11024, DOI 10.1063/1.1521159; Zwanzig R., 2001, NONEQUILIBRIUM STAT	38	950	966	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					415	418		10.1038/nature02257	http://dx.doi.org/10.1038/nature02257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749823				2022-12-01	WOS:000188470500035
J	Liu, ZY; Moore, PH; Ma, H; Ackerman, CM; Ragiba, M; Yu, QY; Pearl, HM; Kim, MS; Charlton, JW; Stiles, JI; Zee, FT; Paterson, AH; Ming, R				Liu, ZY; Moore, PH; Ma, H; Ackerman, CM; Ragiba, M; Yu, QY; Pearl, HM; Kim, MS; Charlton, JW; Stiles, JI; Zee, FT; Paterson, AH; Ming, R			A primitive Y chromosome in papaya marks incipient sex chromosome evolution	NATURE			English	Article							GENOME; SEQUENCES; SILENE; GENE	Many diverse systems for sex determination have evolved in plants and animals(1-3). One involves physically distinct ( heteromorphic) sex chromosomes ( X and Y, or Z and W) that are homozygous in one sex ( usually female) and heterozygous in the other ( usually male). Sex chromosome evolution is thought to involve suppression of recombination around the sex determination genes, rendering permanently heterozygous a chromosomal region that may then accumulate deleterious recessive mutations by Muller's ratchet, and fix deleterious mutations by hitchhiking as nearby favourable mutations are selected on the Y chromosome(4,5). Over time, these processes may cause the Y chromosome to degenerate and to diverge from the X chromosome over much of its length; for example, only 5% of the human Y chromosome still shows X - Y recombination(6). Here we show that papaya contains a primitive Y chromosome, with a male-specific region that accounts for only about 10% of the chromosome but has undergone severe recombination suppression and DNA sequence degeneration. This finding provides direct evidence for the origin of sex chromosomes from autosomes.	Hawaii Agr Res Ctr, Aiea, HI 96701 USA; ARS, USDA, Pacific Basin Agr Res Ctr, Hilo, HI 96720 USA; Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; Integrated Coffee Technol Inc, Waialua, HI 96791 USA; Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University of Hawaii System; University System of Georgia; University of Georgia	Ming, R (corresponding author), Hawaii Agr Res Ctr, Aiea, HI 96701 USA.	rming@harc-hspa.com	; Yu, Qingyi/E-8899-2019	Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Yu, Qingyi/0000-0001-5393-5764				Bachtrog D, 2003, NAT GENET, V34, P215, DOI 10.1038/ng1164; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; CHIU CT, 2000, STUDY SEX INHERITANC; Deputy JC, 2002, THEOR APPL GENET, V106, P107, DOI 10.1007/s00122-002-0995-0; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; HOFMEYR J D J, 1967, Agronomia Tropical (Maracay), V17, P345; HOFMEYR J. D. J., 1938, Science Bulletin. Department of Agriculture and Forestry, Union of South Africa, V187; HOROVITZ S, 1967, AGRONOMIA TROPICAL, V17, P353; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lengerova M, 2003, GENETICS, V165, P935; MA H, IN PRESS GENETICS; Ming R, 2001, THEOR APPL GENET, V102, P892, DOI 10.1007/s001220000448; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; OHNO S, 1967, SEX CHROMOSOME SEX L; Okada S, 2001, P NATL ACAD SCI USA, V98, P9454, DOI 10.1073/pnas.171304798; RICE WR, 1987, GENETICS, V116, P161; Siroky J, 2001, CHROMOSOME RES, V9, P387, DOI 10.1023/A:1016783501674; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sondur SN, 1996, THEOR APPL GENET, V93, P547, DOI 10.1007/BF00417946; Storey, 1941, HAWAII AGR EXPT STAT, V87, P5; Storey W. B., 1976, Evolution of crop plants., P21; STOREY WB, 1953, J HERED, V44, P70, DOI 10.1093/oxfordjournals.jhered.a106358; STOREY WB, 1938, AM SOC HORT SCI P, V35, P83; TANKSLEY SD, 1988, P 18 STADL GEN S NEW, P157; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; WHITE MJD, 1973, INSECT REPROD, P57; Yang ZN, 2000, GENOME, V43, P412	30	280	314	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2004	427	6972					348	352		10.1038/nature02228	http://dx.doi.org/10.1038/nature02228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737167				2022-12-01	WOS:000188266200040
J	Tagami, H; Ray-Gallet, D; Almouzni, G; Nakatani, Y				Tagami, H; Ray-Gallet, D; Almouzni, G; Nakatani, Y			Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis	CELL			English	Article							VARIANT SYNTHESIS; CHROMATIN STATES; MESSENGER-RNA; HUMAN HOMOLOG; HUMAN ASF1; IN-VITRO; S-PHASE; REPLICATION; PROTEIN; CAF-1	Deposition of the major histone H3 (H3.1) is coupled to DNA synthesis during DNA replication and possibly DNA repair, whereas histone variant H3.3 serves as the replacement variant for the DNA-synthesis-independent deposition pathway. To address how histories H3.1 and H3.3 are deposited into chromatin through distinct pathways, we have purified deposition machineries for these histories. The H3.1 and H3.3 complexes contain distinct histone chaperones, CAF-1 and HIRA, that we show are necessary to mediate DNA-synthesis-dependent and -independent nucleosome assembly, respectively. Notably, these complexes possess one molecule each of H3.1/H3.3 and H4, suggesting that histories H3 and H4 exist as dimeric units that are important intermediates in nucleosome formation. This finding provides new insights into possible mechanisms for maintenance of epigenetic information after chromatin duplication.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; CNRS, UMR 218, Inst Curie, Sect Rech, F-75248 Paris 05, France	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	yoshihiro_nakatani@dfci.harvard.edu	Almouzni, Genevieve/ABG-1029-2021; Ray-Gallet, Dominique/A-9224-2019	Almouzni, Genevieve/0000-0001-5570-0723; 	NIGMS NIH HHS [GM065939-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065939] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Aho S, 2000, J CELL BIOL, V148, P1165, DOI 10.1083/jcb.148.6.1165; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; ALMOUZNI G, 1988, EMBO J, V7, P665, DOI 10.1002/j.1460-2075.1988.tb02861.x; ALMOUZNI G, 1998, CHROMATIN PRACTICAL, P195; BAXEVANIS AD, 1991, BIOCHEMISTRY-US, V30, P8817, DOI 10.1021/bi00100a013; Baxevanis AD, 1998, NUCLEIC ACIDS RES, V26, P372, DOI 10.1093/nar/26.1.372; BROWN DT, 1985, MOL CELL BIOL, V5, P2879, DOI 10.1128/MCB.5.11.2879; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; CUSICK ME, 1984, J MOL BIOL, V178, P249, DOI 10.1016/0022-2836(84)90143-8; FRANKLIN SG, 1977, NATURE, V266, P273, DOI 10.1038/266273a0; Gaillard PH, 1999, METH MOL B, V119, P231; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; GRUSS C, 1993, EMBO J, V12, P4533, DOI 10.1002/j.1460-2075.1993.tb06142.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaufman P.D., 2000, CHROMATIN STRUCTURE, P24; Krude T, 2001, CELL MOL LIFE SCI, V58, P665, DOI 10.1007/PL00000890; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Lorain S, 1996, GENOME RES, V6, P43, DOI 10.1101/gr.6.1.43; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; NAKATANI Y, 2004, IN PRESS METHODS ENZ, V370; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; RAYGELLET D, 2004, IN PRESS METHODS ENZ, V375; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Ridgway P, 2000, J CELL SCI, V113, P2647; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Utley RT, 1996, METHOD ENZYMOL, V274, P276; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Verreault A, 2000, GENE DEV, V14, P1430; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wolffe AP., 1998, CHROMATIN STRUCTURE; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; WUNSCH AM, 1987, DEV BIOL, V119, P94, DOI 10.1016/0012-1606(87)90210-7; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; ZWEIDLER A, 1984, HISTONE GENES STRUCT	52	948	985	3	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2004	116	1					51	61		10.1016/S0092-8674(03)01064-X	http://dx.doi.org/10.1016/S0092-8674(03)01064-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718166	Bronze			2022-12-01	WOS:000187960800008
J	Hubbuck, C				Hubbuck, C			Treatment of children with severe burns	LANCET			English	Article									Frenchay Hosp, Barbara Russell Childrens Unit, Bristol BS16 1LE, Avon, England		Hubbuck, C (corresponding author), Frenchay Hosp, Barbara Russell Childrens Unit, Bristol BS16 1LE, Avon, England.								0	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S44	S45		10.1016/S0140-6736(03)15073-8	http://dx.doi.org/10.1016/S0140-6736(03)15073-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698127				2022-12-01	WOS:000187790200023
J	Wells, S; Mullin, B; Norton, R; Langley, J; Connor, J; Lay-Yee, R; Jackson, R				Wells, S; Mullin, B; Norton, R; Langley, J; Connor, J; Lay-Yee, R; Jackson, R			Motorcycle rider conspicuity and crash related injury: case-control study	BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGIC FEATURES; COLLISION INJURIES; LAWS; RISK	Objective To investigate whether the risk of motorcycle crash related injuries is associated with the conspicuity of the driver or vehicle. Design Population based case-control study. Setting Auckland region of New Zealand from February 1993 to February 1996. Participants 463 motorcycle drivers (cases) involved in crashes leading to hospital treatment or death; 1233 motorcycle drivers (controls) recruited from randomly selected roadside survey sites. Main outcome measures Estimates of relative risk of motorcycle crash related injury and population attributable risk associated with conspicuity measures, including the use of reflective or fluorescent clothing, headlight operation, and colour of helmet, clothing, and motorcycle. Results Crash related injuries occurred mainly in urban zones with 50 km/h speed limit (66%), during the day (63%), and in fine weather (72%). After adjustment for potential confounders, drivers wearing any reflective or fluorescent clothing had a 37% lower risk (multivariate odds ratio 0.63, 95% confidence interval 0.42 to 0.94) than other drivers. Compared with wearing a black helmet, use of a white helmet was associated with a 24% lower risk (multivariate odds ratio 0.76, 0.57 to 0.99). Self reported light coloured helmet versus dark coloured helmet was associated with a 19% lower risk. Three quarters of motorcycle riders had their headlight turned on during the day, and this was associated with a 27% lower risk (multivariate odds ratio 0.73, 0.53 to 1.00). No association occurred between risk and the frontal colour of drivers' clothing or motorcycle. If these odds ratios are unconfounded, the population attributable risks are 33% for wearing no reflective or fluorescent clothing, 18% for a non-white helmet, 11% for a dark coloured helmet, and 7% for no daytime headlight operation. Conclusions Low conspicuity may increase the risk of motorcycle crash related injury. Increasing the use of reflective or fluorescent clothing, white or light coloured helmets, and daytime headlights are simple, cheap interventions that could considerably reduce motorcycle crash related injury and death.	Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; Univ Auckland, Sch Populat Hlth, Ctr Hlth Serv & Policy Res, Auckland 1, New Zealand; Univ Sydney, Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Otago, Injury Prevent Res Unit, Otago, New Zealand	University of Auckland; University of Auckland; University of Sydney; University of Otago	Wells, S (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019,Graften Rd, Auckland 1, New Zealand.	s.wells@auckland.ac.nz		Jackson, Rod/0000-0001-5914-6934; Connor, Jennie/0000-0002-3209-8693				Bijleveld F.D., 1997, EFFECTIVENESS DAYTIM; Bragg B. W, 1980, INT MOT SAF C WASH, V3, P1131; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hurt H, 1981, 805862 DOT HS NAT HI; Hurt H.H., 1981, MOTORCYCLE ACCIDENT, V2; Janoff M., 1971, HIGHWAY RES REC, V377, P53; KRAUS JF, 1976, ACCIDENT ANAL PREV, V8, P247, DOI 10.1016/0001-4575(76)90010-5; KRAUS JF, 1975, AM J EPIDEMIOL, V102, P74, DOI 10.1093/oxfordjournals.aje.a112136; KRAUS JF, 1975, AM J EPIDEMIOL, V102, P99, DOI 10.1093/oxfordjournals.aje.a112137; *LAND TRANSP SAF A, 1991, NZ HOUS TRAV SURV; Langley J, 2000, ACCIDENT ANAL PREV, V32, P659, DOI 10.1016/S0001-4575(99)00101-3; MULLER A, 1982, AM J PUBLIC HEALTH, V72, P1136, DOI 10.2105/AJPH.72.10.1136; MULLER A, 1984, ACCIDENT ANAL PREV, V16, P1, DOI 10.1016/0001-4575(84)90002-2; Mullin B, 2000, Inj Prev, V6, P32, DOI 10.1136/ip.6.1.32; Murray C. J. L., 1996, GLOBAL HLTH STAT COM; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Radin Umar R.S., 1995, J TRAFFIC MED, V23, P17; ROBERTSON LS, 1976, LAW SOC REV, V10, P467, DOI 10.2307/3053144; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; UMAR RSR, 1996, ACCIDENT ANAL PREV, V28, P325; Vaughan R. G, 1977, MOTORCYCLE CRASHES L; WILLIAMS MJ, 1979, ACCIDENT ANAL PREV, V11, P209, DOI 10.1016/0001-4575(79)90005-8; World Health Organization, 1980, INT CLASS DIS; ZADOR PL, 1985, AM J PUBLIC HEALTH, V75, P543, DOI 10.2105/AJPH.75.5.543	25	94	96	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					857	860A		10.1136/bmj.37984.574757.EE	http://dx.doi.org/10.1136/bmj.37984.574757.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812XE	14742349	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000220871400013
J	Dietrich, FS; Voegeli, S; Brachat, S; Lerch, A; Gates, K; Steiner, S; Mohr, C; Pohlmann, R; Luedi, P; Choi, SD; Wing, RA; Flavier, A; Gaffney, TD; Phillippsen, P				Dietrich, FS; Voegeli, S; Brachat, S; Lerch, A; Gates, K; Steiner, S; Mohr, C; Pohlmann, R; Luedi, P; Choi, SD; Wing, RA; Flavier, A; Gaffney, TD; Phillippsen, P			The Ashbya gossypii genome as a tool for mapping the ancient Saccharomyces cerevisiae genome	SCIENCE			English	Article							SEQUENCE; TRANSFORMATION; DUPLICATION; EVOLUTION; GENES	We have sequenced and annotated the genome of the filamentous ascomycete Ashbya gossypii. With a size of only 9.2 megabases, encoding 4718 protein-coding genes, it is the smallest genome of a free-living eukaryote yet characterized. More than 90% of A. gossypii genes show both homology and a particular pattern of synteny with Saccharomyces cerevisiae. Analysis of this pattern revealed 300 inversions and translocations that have occurred since divergence of these two species. It also provided compelling evidence that the evolution of S. cerevisiae included a whole genome duplication or fusion of two related species and showed, through inferred ancient gene orders, which of the duplicated genes lost one copy and which retained both copies.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Duke Univ, Med Ctr, Dept Microbiol & Mol Genet, Durham, NC 27710 USA; Syngenta Biotechnol Inc, Res Triangle Pk, NC 27709 USA; Clemson Univ, Dept Agron, Clemson, SC 29634 USA; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	University of Basel; Duke University; Syngenta; Clemson University; Clemson University	Phillippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.	Peter.philippsen@unibas.ch	Lerch, Anita/AAR-4467-2020; Wing, Rod A/Z-2885-2019	Lerch, Anita/0000-0003-3062-5901; Wing, Rod A/0000-0001-6633-6226; Lemire-Brachat, Sophie/0000-0002-3398-8225				Alberti-Segui C, 2001, J CELL SCI, V114, P975; AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826; Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; KELLIS M, 2004, IN PRESS NATURE; KNECHTLE P, 1993, MOL BIOL CELL, V14, P4140; LALO D, 1993, CR ACAD SCI III-VIE, V316, P367; Philippsen P, 1997, NATURE, V387, P93, DOI 10.1038/387s093; Stahmann KP, 2000, APPL MICROBIOL BIOT, V53, P509, DOI 10.1007/s002530051649; STEINER S, 1995, GENETICS, V140, P973; Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0; Wendland J, 2001, GENETICS, V157, P601; Wendland J, 1999, CURR GENET, V35, P618, DOI 10.1007/s002940050460; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z	20	503	1452	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					304	307		10.1126/science.1095781	http://dx.doi.org/10.1126/science.1095781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15001715				2022-12-01	WOS:000220719400051
J	Richards, M; Shipley, B; Fuhrer, R; Wadsworth, MEJ				Richards, M; Shipley, B; Fuhrer, R; Wadsworth, MEJ			Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AGE	Objective To examine die association between cognitive ability in childhood and mid-life cognitive decline in the normal population. Design Longitudinal, population based, birth cohort study. Participants 2058 men and women born in 1946. Main study measures Ability in childhood measured by AH4 and test of verbal comprehension at age 15 years. Ability in adulthood measured by the national adult reading test (NART) at age 53 years. Outcome measures were decline in memory (word list learning) and speed and concentration (timed visual search) from age 43 to 53 years. Results Ability in childhood was significantly and negatively associated with decline in memory (beta = 0.09, P = 0.005, for men; 0.10, P < 0.001, for women) and search speed (beta = 0.13, P < 0.001, for men; 0.08, P = 0.0 1, for women), independent of educational attainment, occupational social class, and a range of health indicators. The adult reading test was also significantly and negatively associated with decline in these outcomes (for memory beta = 0.21, P < 0.001, for men; 0.17, P < 0.001, for women; and for search speed beta = - 0.05 for men; 0.10, P = 0.008 for women) independent of educational attainment, social class, and childhood ability. Conclusions Ability in childhood can protect against cognitive decline in mid-life and beyond. Results for the adult reading test indicate that the protective effect of ability may also be acquired in adulthood.	UCL, MRC, Natl Survey Hlth & Dev, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada	University of London; University College London; McGill University	Richards, M (corresponding author), UCL, MRC, Natl Survey Hlth & Dev, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.richards@ucl.ac.uk		Richards, Marcus/0000-0001-9191-2192				Berger A, 2001, BMJ-BRIT MED J, V322, P203, DOI 10.1136/bmj.322.7280.203; Deary IJ, 1998, INTELLIGENCE, V26, P357, DOI 10.1016/S0160-2896(99)00005-7; Douglas JWB, 1964, HOME SCH; Heim AW, 1970, AH4 GROUP TEST INTEL; MORITZ DJ, 1995, AM J EPIDEMIOL, V141, P41, DOI 10.1093/oxfordjournals.aje.a117344; Nelson HE, 1991, NATL ADULT READING T; Pigeon DA, 1968, ALL OUR FUTURE; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; Rabbitt P, 2003, BRIT J PSYCHOL, V94, P63, DOI 10.1348/000712603762842101; Richards M, 2003, AM J PUBLIC HEALTH, V93, P994, DOI 10.2105/AJPH.93.6.994; Richards M, 2003, SOC SCI MED, V56, P785, DOI 10.1016/S0277-9536(02)00075-8; RUTTER M, 1985, J CHILD PSYCHOL PSYC, V26, P683, DOI 10.1111/j.1469-7610.1985.tb00584.x; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Wadsworth M. E. J., 1991, IMPRINT TIME CHILDHO; Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2; WADSWORTH MEJ, IN PRESS SOC SCI MED; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	21	122	123	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2004	328	7439					552	554B		10.1136/bmj.37972.513819.EE	http://dx.doi.org/10.1136/bmj.37972.513819.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801JI	14761906	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000220091800018
J	Brinkmann, V; Reichard, U; Goosmann, C; Fauler, B; Uhlemann, Y; Weiss, DS; Weinrauch, Y; Zychlinsky, A				Brinkmann, V; Reichard, U; Goosmann, C; Fauler, B; Uhlemann, Y; Weiss, DS; Weinrauch, Y; Zychlinsky, A			Neutrophil extracellular traps kill bacteria	SCIENCE			English	Article								Neutrophils engulf and kill bacteria when their antimicrobial granules fuse with the phagosome. Here, we describe that, upon activation, neutrophils release granule proteins and chromatin that together form extracellular fibers that bind Gram-positive and -negative bacteria. These neutrophil extracellular traps (NETs) degrade virulence factors and kill bacteria. NETs are abundant in vivo in experimental dysentery and spontaneous human appendicitis, two examples of acute inflammation. NETs appear to be a form of innate response that binds microorganisms, prevents them from spreading, and ensures a high local concentration of antimicrobial agents to degrade virulence factors and kill bacteria.	Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; Max Planck Inst Infect Biol, Microscopy Core Facil, D-10117 Berlin, Germany; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Max Planck Society; Max Planck Society; New York University	Zychlinsky, A (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Schumannstr 21-22, D-10117 Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009		NIAID NIH HHS [AI037720] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037720] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bainton DF, 1999, J IMMUNOL METHODS, V232, P153, DOI 10.1016/S0022-1759(99)00173-8; Balloy V, 2003, AM J RESP CELL MOL, V28, P746, DOI 10.1165/rcmb.2002-0119OC; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Elsbach P, 1992, INFLAMMATION BASIC P, P603; Elsbach Peter, 1994, Trends in Microbiology, V2, P324, DOI 10.1016/0966-842X(94)90449-9; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; HENSON PM, 1992, INFLAMMATION BASIC P, P511; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Junqueira LC., 1998, ALANGE MED BOOK BASI; Kim HS, 1996, BIOCHEM BIOPH RES CO, V229, P381, DOI 10.1006/bbrc.1996.1814; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; MALANSKI NA, 2002, BLOOD, V101, P1987; Movitz C, 2001, CELL BIOL INT, V25, P963, DOI 10.1006/cbir.2001.0760; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Salgame P, 1997, NUCLEIC ACIDS RES, V25, P680, DOI 10.1093/nar/25.3.680; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; ZHDAN-PUSHKINA S M, 1976, Mikrobiologiya, V45, P60	19	5649	5982	40	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1532	1535		10.1126/science.1092385	http://dx.doi.org/10.1126/science.1092385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001782				2022-12-01	WOS:000220000100047
J	Vajda, V; McLoughlin, S				Vajda, V; McLoughlin, S			Fungal proliferation at the Cretaceous-Tertiary boundary	SCIENCE			English	Article							EXTINCTION		Lund Univ, Geobiosphere Sci Ctr, SE-22362 Lund, Sweden; Queensland Univ Technol, Sch Nat Resource Sci, Brisbane, Qld 4001, Australia	Lund University; Queensland University of Technology (QUT)	Vajda, V (corresponding author), Lund Univ, Geobiosphere Sci Ctr, Solvegatan 12, SE-22362 Lund, Sweden.	vivi.vajda@geol.lu.se; s.mcloughlin@qut.edu.au	Vajda, Vivi/N-7693-2018	Vajda, Vivi/0000-0003-2987-5559				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; ELSIK W, COMMUNICATION; Nichols DJ, 2002, GEOL S AM S, P95; Pope KO, 1997, J GEOPHYS RES-PLANET, V102, P21645, DOI 10.1029/97JE01743; Sweet AR, 1999, CAN J EARTH SCI, V36, P743, DOI 10.1139/e98-061; Vajda V, 2001, SCIENCE, V294, P1700, DOI 10.1126/science.1064706; WOLFE JA, 2001, PALAEOBIOLOGY, V2, P232	8	94	102	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1489	1489		10.1126/science.1093807	http://dx.doi.org/10.1126/science.1093807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001770	Green Submitted			2022-12-01	WOS:000220000100032
J	Zhang, DK; Zhang, GL; Hayden, MS; Greenblatt, MB; Bussey, C; Flavell, RA; Ghosh, S				Zhang, DK; Zhang, GL; Hayden, MS; Greenblatt, MB; Bussey, C; Flavell, RA; Ghosh, S			A toll-like receptor that prevents infection by uropathogenic bacteria	SCIENCE			English	Article							ESCHERICHIA-COLI; URINARY-TRACT; RESPONSES; PATHOGENS; ACTIVATION	Toll-like receptors (TLRs) recognize molecular patterns displayed by microorganisms, and their subsequent activation leads to the transcription of appropriate host-defense genes. Here we report the cloning and characterization of a member of the mammalian TLR family, TLR11, that displays a distinct pattern of expression in macrophages and liver, kidney, and bladder epithelial cells. Cells expressing TLR11 fail to respond to known TLR ligands but instead respond specifically to uropathogenic bacteria. Mice lacking TLR11 are highly susceptible to infection of the kidneys by uropathogenic bacteria, indicating a potentially important role for TLR11 in preventing infection of internal organs of the urogenital system.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	sankar.ghosh@yale.edu	Zhang, Guolong/HCI-5587-2022; Hayden, Matthew/C-1263-2008; Zhang, Guolong/AAU-8197-2020	Zhang, Guolong/0000-0003-4781-5816	NIAID NIH HHS [R01-AI59440, R37-AI33443] Funding Source: Medline; NIGMS NIH HHS [GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI059440] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Guyer DM, 2001, J INFECT DIS, V183, pS32, DOI 10.1086/318854; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hedlund M, 1999, MOL MICROBIOL, V33, P693, DOI 10.1046/j.1365-2958.1999.01513.x; Johnson JR, 2001, J INFECT DIS, V184, P1556, DOI 10.1086/323891; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronald A, 2002, AM J MED, V113, p14S; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; ZHANG D, UNPUB	19	776	868	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR  5	2004	303	5663					1522	1526		10.1126/science.1094351	http://dx.doi.org/10.1126/science.1094351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	800AA	15001781				2022-12-01	WOS:000220000100044
J	Dinh, HT; Kuever, J; Mussmann, M; Hassel, AW; Stratmann, M; Widdel, F				Dinh, HT; Kuever, J; Mussmann, M; Hassel, AW; Stratmann, M; Widdel, F			Iron corrosion by novel anaerobic microorganisms	NATURE			English	Article							SULFATE-REDUCING BACTERIA; MILD-STEEL; CATHODIC HYDROGEN; METHANOGENESIS; IDENTIFICATION	Corrosion of iron presents a serious economic problem. Whereas aerobic corrosion is a chemical process(1), anaerobic corrosion is frequently linked to the activity of sulphate-reducing bacteria (SRB)(2-6). SRB are supposed to act upon iron primarily by produced hydrogen sulphide as a corrosive agent(3,5,7) and by consumption of 'cathodic hydrogen' formed on iron in contact with water(2-6,8). Among SRB, Desulfovibrio species - with their capacity to consume hydrogen effectively - are conventionally regarded as the main culprits of anaerobic corrosion(2-6,8-10); however, the underlying mechanisms are complex and insufficiently understood. Here we describe novel marine, corrosive types of SRB obtained via an isolation approach with metallic iron as the only electron donor. In particular, a Desulfobacterium-like isolate reduced sulphate with metallic iron much faster than conventional hydrogen-scavenging Desulfovibrio species, suggesting that the novel surface-attached cell type obtained electrons from metallic iron in a more direct manner than via free hydrogen. Similarly, a newly isolated Methanobacterium-like archaeon produced methane with iron faster than do known hydrogen-using methanogens, again suggesting a more direct access to electrons from iron than via hydrogen consumption.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Inst Mat Testing, D-28199 Bremen, Germany; Max Planck Inst Iron Res, D-40237 Dusseldorf, Germany	Max Planck Society; Max Planck Society	Widdel, F (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	fwiddel@mpi-bremen.de	Mussmann, Marc/A-8649-2017; Mussmann, Marc/AAA-6108-2021; Hassel, Achim Walter/C-3932-2009	Mussmann, Marc/0000-0003-3102-8703; , Marc/0000-0003-2785-2521				Appia-Ayme C, 1999, APPL ENVIRON MICROB, V65, P4781; BEECH IB, 1994, INT BIODETER BIODEGR, V34, P289, DOI 10.1016/0964-8305(94)90089-2; Bockris J.O., 1970, MODERN ELECTROCHEMIS, V2; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; BOOTH GH, 1968, CORROS SCI, V8, P583, DOI 10.1016/S0010-938X(68)80094-0; Cord-Ruwisch R, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P159; CORDRUWISCH R, 1986, APPL MICROBIOL BIOT, V25, P169, DOI 10.1007/BF00938942; COSTELLO JA, 1974, S AFR J SCI, V70, P202; DANIELS L, 1987, SCIENCE, V237, P509, DOI 10.1126/science.237.4814.509; Deckena S., 1992, BIOFOULING, V5, P287; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Hamilton WA, 2003, BIOFOULING, V19, P65, DOI 10.1080/0892701021000041078; HARDY JA, 1983, BRIT CORROS J, V18, P190, DOI 10.1179/000705983798273642; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; IVERSON WP, 1984, CURRENT PERSPECTIVES, P623; Laishley EJ, 2003, BIOCHEMISTRY AND PHYSIOLOGY OF ANAEROBIC BACTERIA, P252, DOI 10.1007/0-387-22731-8_18; LEE W, 1995, BIOFOULING, V8, P165, DOI 10.1080/08927019509378271; LUDWIG W, 2002, ARB SOFTWARE ENV SEQ; Manz W, 1998, FEMS MICROBIOL ECOL, V25, P43; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Pankhania I. P, 1988, Biofouling, V1, P27, DOI 10.1080/08927018809378094; PANKHANIA IP, 1986, J GEN MICROBIOL, V132, P3357; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Rabus R, 2000, PROKARYOTES EVOLVING; Schlegel HG, 1993, GEN MICROBIOLOGY, V7th; Uhlig H.H., 1985, CORROSION CORROSION; Van der Vlugt L.S., 1934, WATER-SUI, V18, P147; WIDDEL F, 1992, PROKARYOTES, V6, P3352; [No title captured]	29	494	520	21	355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					829	832		10.1038/nature02321	http://dx.doi.org/10.1038/nature02321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985759				2022-12-01	WOS:000189207500037
J	Nykjaer, A; Lee, R; Teng, KK; Jansen, P; Madsen, P; Nielsen, MS; Jacobsen, C; Kliemannel, M; Schwarz, E; Willnow, TE; Hempstead, BL; Petersen, CM				Nykjaer, A; Lee, R; Teng, KK; Jansen, P; Madsen, P; Nielsen, MS; Jacobsen, C; Kliemannel, M; Schwarz, E; Willnow, TE; Hempstead, BL; Petersen, CM			Sortilin is essential for proNGF-induced neuronal cell death	NATURE			English	Article							NERVE GROWTH-FACTOR; 100-KDA NEUROTENSIN RECEPTOR; P75 NEUROTROPHIN RECEPTOR; SYMPATHETIC NEURONS; BINDING; EXPRESSION; PROTEIN; INTERNALIZATION; DOMAINS; BRAIN	Sortilin(1) (similar to95 kDa) is a member of the recently discovered family of Vps10p-domain receptors(2,3), and is expressed in a variety of tissues, notably brain, spinal cord and muscle. It acts as a receptor for neurotensin(4,5), but predominates in regions of the nervous system that neither synthesize nor respond to this neuropeptide(6), suggesting that sortilin has additional roles. Sortilin is expressed during embryogenesis(7) in areas where nerve growth factor ( NGF) and its precursor, proNGF, have well-characterized effects(6,7). These neurotrophins can be released by neuronal tissues(8,9), and they regulate neuronal development through cell survival and cell death signalling. NGF regulates cell survival and cell death via binding to two different receptors, TrkA and p75(NTR) (ref. 10). In contrast, proNGF selectively induces apoptosis through p75(NTR) but not TrkA(11). However, not all p75(NTR)-expressing cells respond to proNGF, suggesting that additional membrane proteins are required for the induction of cell death. Here we report that proNGF creates a signalling complex by simultaneously binding to p75(NTR) and sortilin. Thus sortilin acts as a co-receptor and molecular switch governing the p75(NTR)-mediated pro-apoptotic signal induced by proNGF.	Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark; ReceptIcon Aps, DK-8000 Aarhus C, Denmark; Cornell Univ, Weill Med Coll, New York, NY 10021 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ Halle Wittenberg, Inst Biotechnol, D-06120 Halle An Der Saale, Germany	Aarhus University; Cornell University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Martin Luther University Halle Wittenberg	Nykjaer, A (corresponding author), Aarhus Univ, Dept Med Biochem, Ole Worms Alle 170, DK-8000 Aarhus C, Denmark.	an@biokemi.au.dk	Nielsen, Morten Schallburg/G-9498-2016	Nielsen, Morten Schallburg/0000-0001-9863-9694; Teng, Kenneth/0000-0002-9392-2172; Willnow, Thomas/0000-0001-9515-7921; Nykjaer, Anders/0000-0001-6422-6736; Madsen, Peder Sondergaard/0000-0002-8845-4802				Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Gargano N, 1997, J NEUROSCI RES, V50, P1; Hasan W, 2003, J NEUROBIOL, V57, P38, DOI 10.1002/neu.10250; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hermey G, 2003, J BIOL CHEM, V278, P7390, DOI 10.1074/jbc.M210851200; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mitsui C, 2001, J NEUROSCI RES, V66, P601, DOI 10.1002/jnr.10008; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Shonukan T, 2003, ONCOGENE, V22, P3616, DOI 10.1038/sj.onc.1206561; Wang JL, 2000, BIORESOURCE TECHNOL, V75, P157, DOI 10.1016/S0960-8524(00)00041-9	29	722	794	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2004	427	6977					843	848		10.1038/nature02319	http://dx.doi.org/10.1038/nature02319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777WU	14985763				2022-12-01	WOS:000189207500041
J	Chamberlain, JR; Schwarze, U; Wang, PR; Hirata, RK; Hankenson, KD; Pace, JM; Underwood, RA; Song, KM; Sussman, M; Byers, PH; Russell, DW				Chamberlain, JR; Schwarze, U; Wang, PR; Hirata, RK; Hankenson, KD; Pace, JM; Underwood, RA; Song, KM; Sussman, M; Byers, PH; Russell, DW			Gene targeting in stem cells from individuals with osteogenesis imperfecta	SCIENCE			English	Article							ADENOASSOCIATED VIRUS VECTORS; MARROW STROMAL CELLS; I COLLAGEN; NONHEMATOPOIETIC TISSUES; MESENCHYMAL CELLS; NULL-ALLELE; MUTATION; PROCOLLAGEN; SEQUENCES; MOSAICISM	Adult stem cells offer the potential to treat many diseases through a combination of ex vivo genetic manipulation and autologous transplantation. Mesenchymal stem cells (MSCs, also referred to as marrow stromal cells) are adult stem cells that can be isolated as proliferating, adherent cells from bones. MSCs can differentiate into multiple cell types present in several tissues, including bone, fat, cartilage, and muscle, making them ideal candidates for a variety of cell-based therapies. Here, we have used adeno-associated virus vectors to disrupt dominant-negative mutant COL1A1 collagen genes in MSCs from individuals with the brittle bone disorder osteogenesis imperfecta, demonstrating successful gene targeting in adult human stem cells.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Shriners Hosp Children, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seattle Children's Hospital	Russell, DW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	drussell@u.washington.edu	Hankenson, Kurt/ABI-1547-2020; Hankenson, Kurt/AFS-9417-2022	Hankenson, Kurt/0000-0001-6361-143X; Byers, Peter H./0000-0001-7786-7030				BONADIO J, 1985, J BIOL CHEM, V260, P1734; BYERS PH, 2000, METABOLIC MOL BASIS, P5241; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670; Edwards Matthew J., 1992, Human Mutation, V1, P47, DOI 10.1002/humu.1380010108; FEDARKO NS, 1992, J BONE MINER RES, V7, P921; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Inoue N, 1999, J VIROL, V73, P7376, DOI 10.1128/JVI.73.9.7376-7380.1999; Inoue N, 2001, MOL THER, V3, P526, DOI 10.1006/mthe.2001.0283; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PLOETZ C, 1991, J STRUCT BIOL, V106, P73, DOI 10.1016/1047-8477(91)90064-4; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; WILLING MC, 1992, AM J HUM GENET, V51, P508	21	211	259	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1198	1201		10.1126/science.1088757	http://dx.doi.org/10.1126/science.1088757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976317				2022-12-01	WOS:000189074700048
J	Terman, JR; Kolodkin, AL				Terman, JR; Kolodkin, AL			Nervy links protein kinase A to plexin-mediated semaphorin repulsion	SCIENCE			English	Article							GROWTH CONE GUIDANCE; DROSOPHILA; IDENTIFICATION	Cyclic nucleotides regulate axonal responses to a number of guidance cues through unknown molecular events. We report here that Drosophila nervy, a member of the myeloid translocation gene family of A kinase anchoring proteins (AKAPs), regulates repulsive axon guidance by linking the cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) to the Semaphorin 1a (Sema-1a) receptor Plexin A (PlexA). Nervy and PKA antagonize Sema-1a-PlexA-mediated repulsion, and the AKAP binding region of Nervy is critical for this effect. Thus, Nervy couples cAMP-PKA signaling to PlexA to regulate Sema-1a-mediated axonal repulsion, revealing a simple molecular mechanism that allows growing axons to integrate inputs from multiple guidance cues.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 1001 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu						Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Dontchev VD, 2002, J NEUROSCI, V22, P6659; FEINSTEIN PG, 1995, GENETICS, V140, P573; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fukuyama T, 2001, ONCOGENE, V20, P6225, DOI 10.1038/sj.onc.1204794; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Sacchi N, 1998, ONCOGENE, V16, P2609, DOI 10.1038/sj.onc.1201824; Schillace RV, 2002, J IMMUNOL, V168, P1590, DOI 10.4049/jimmunol.168.4.1590; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	19	79	79	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2004	303	5661					1204	1207		10.1126/science.1092121	http://dx.doi.org/10.1126/science.1092121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775RP	14976319				2022-12-01	WOS:000189074700050
J	Curran, LM; Trigg, SN; McDonald, AK; Astiani, D; Hardiono, YM; Siregar, P; Caniago, I; Kasischke, E				Curran, LM; Trigg, SN; McDonald, AK; Astiani, D; Hardiono, YM; Siregar, P; Caniago, I; Kasischke, E			Lowland forest loss in protected areas of Indonesian Borneo	SCIENCE			English	Article							DEFORESTATION; SCALE; PARKS	The ecology of Bornean rainforests is driven by El Nino-induced droughts that trigger synchronous fruiting among trees and bursts of faunal reproduction that sustain vertebrate populations. However, many of these species- and carbon-rich ecosystems have been destroyed by logging and conversion, which increasingly threaten protected areas. Our satellite, Geographic Information System, and field-based analyses show that from 1985 to 2001, Kalimantan's protected lowland forests declined by more than 56% (>29,000 square kilometers). Even uninhabited frontier parks are logged to supply international markets. "Protected" forests have become increasingly isolated and deforested and their buffer zones degraded. Preserving the ecological integrity of Kalimantan's rainforests requires immediate transnational management.	Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; Univ Maryland, Dept Geog, College Pk, MD 20742 USA; Univ Tanjungpura, Dept Forestry, Pontianak 780011, W Kalimantan, Indonesia; Jalan Abdurrachman Saleh, Pontianak 78124, W Kalimantan, Indonesia	Yale University; University System of Maryland; University of Maryland College Park; Universitas Tanjungpura	Curran, LM (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 205 Prospect St, New Haven, CT 06511 USA.	lisa.curran@yale.edu		Dwi, Astiani/0000-0002-1341-9201				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Barr C., 2002, WHICH WAY FORWARD PE, P191; Blundell Arthur G., 1996, Tropical Biodiversity, V3, P251; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; BUDIARTO T, 2003, INVESTIGASI AKTIVITA; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; HOLMES D, 2002, DEFORESTATION INDONE; *ITTO, 1996, ANN REV ASS WORLD TR; JOHNSON AM, UNPUB; Laidlaw RK, 2000, CONSERV BIOL, V14, P1639, DOI 10.1046/j.1523-1739.2000.99073.x; Laman Timothy G., 1996, Tropical Biodiversity, V3, P281; Lambert F.R., 2002, Forktail, V18, P127; LAWRENCE DC, 1995, CONSERV BIOL, V9, P76, DOI 10.1046/j.1523-1739.1995.09010076.x; Leighton M., 1983, TROPICAL RAIN FOREST, P181; Mackinnon K., 1996, ECOLOGY KALIMANTAN; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; NEPSTAD DC, UNPUB; ROSS ML, 2000, TIMBER BOOMS I BREAK; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; WONG ST, 1997, THESIS U MONTANA MIS	29	512	543	4	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2004	303	5660					1000	1003		10.1126/science.1091714	http://dx.doi.org/10.1126/science.1091714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773JJ	14963327				2022-12-01	WOS:000188918000042
J	Infante, PF; Newman, LS				Infante, PF; Newman, LS			Beryllium exposure and chronic beryllium disease	LANCET			English	Editorial Material							MACHINING PLANT; SENSITIZATION; SARCOIDOSIS; WORKERS		George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA; Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	George Washington University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Infante, PF (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.	pinfante@starpower.net		Infante, Peter/0000-0001-5350-0154				Department of Labor Semiannual Agenda of Regulations, 2000, FED REGISTER, V65, P74120; Fireman E, 2003, SARCOIDOSIS VASC DIF, V20, P144; HARDY HL, 1946, J IND HYG TOXICOL, V28, P197; Henneberger PK, 2001, INT ARCH OCC ENV HEA, V74, P167, DOI 10.1007/s004200100237; IARC (International Agency for Research on Cancer), 1993, IARC MON EV CARC RIS, V58, P41; Kelleher PC, 2001, J OCCUP ENVIRON MED, V43, P238, DOI 10.1097/00043764-200103000-00012; KREISS K, 1993, AM REV RESPIR DIS, V148, P985, DOI 10.1164/ajrccm/148.4_Pt_1.985; Kreiss K, 1997, OCCUP ENVIRON MED, V54, P605, DOI 10.1136/oem.54.8.605; KREISS K, 1993, J OCCUP ENVIRON MED, V35, P267; KREISS K, 1996, AM J IND MED, V30, P6; MROZ MM, 1991, J ALLERGY CLIN IMMUN, V88, P54, DOI 10.1016/0091-6749(91)90300-D; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Newman LS, 2001, J OCCUP ENVIRON MED, V43, P231, DOI 10.1097/00043764-200103000-00011; *OCC SAF HLTH ADM, 1975, FED REGISTER, V40, P48814; Richards B., 1978, WASH POST, pA1; RICHARDS B, 1978, WASHINGTON POST 0914, pA20; 1949, PROD ENG         SEP, P155; 1951, LANCET, V1, P1358	18	56	60	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 7	2004	363	9407					415	416		10.1016/S0140-6736(04)15523-2	http://dx.doi.org/10.1016/S0140-6736(04)15523-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774RX	14962519				2022-12-01	WOS:000188999500006
J	Vassilev, LT; Vu, BT; Graves, B; Carvajal, D; Podlaski, F; Filipovic, Z; Kong, N; Kammlott, U; Lukacs, C; Klein, C; Fotouhi, N; Liu, EA				Vassilev, LT; Vu, BT; Graves, B; Carvajal, D; Podlaski, F; Filipovic, Z; Kong, N; Kammlott, U; Lukacs, C; Klein, C; Fotouhi, N; Liu, EA			In vivo activation of the p53 pathway by small-molecule antagonists of MDM2	SCIENCE			English	Article							TUMOR; AMPLIFICATION; PROTEIN; GROWTH	MDM2 binds the p53 tumor suppressor protein with high affinity and negatively modulates its transcriptional activity and stability. Overexpression of MDM2, found in many human tumors, effectively impairs p53 function. Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy. Here, we identify potent and selective small-molecule antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes. These compounds bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.	Hoffmann La Roche Inc, Dept Discovery Oncol, Nutley, NJ 07110 USA; Hoffmann La Roche Inc, Roche Res Ctr, Dept Chem, Nutley, NJ 07110 USA; Roche Diagnost GmbH, Pharma Res, D-82372 Penzberg, Germany	Roche Holding; Roche Holding; Roche Holding	Vassilev, LT (corresponding author), Hoffmann La Roche Inc, Dept Discovery Oncol, 340 Kingsland St, Nutley, NJ 07110 USA.	lyubomir.vassilev@roche.com	Klein, Christian/G-1336-2010	Klein, Christian/0000-0001-7594-7280				Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen LH, 1998, P NATL ACAD SCI USA, V95, P195, DOI 10.1073/pnas.95.1.195; Chene P, 2000, J MOL BIOL, V299, P245, DOI 10.1006/jmbi.2000.3738; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lane DP, 1999, BRIT J CANCER, V80, P1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Tortora G, 2000, INT J CANCER, V88, P804, DOI 10.1002/1097-0215(20001201)88:5<804::AID-IJC19>3.0.CO;2-Z; VASSILEV LT, 2001, ANTI-CANCER DRUG DES, V13, P359; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang Ruiwen, 2003, Methods Mol Med, V85, P205	24	3573	3827	22	563	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					844	848		10.1126/science.1092472	http://dx.doi.org/10.1126/science.1092472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14704432				2022-12-01	WOS:000188753800060
J	Dong, CJ; Huang, FL; Deng, H; Schaffrath, C; Spencer, JB; O'Hagan, D; Naismith, JH				Dong, CJ; Huang, FL; Deng, H; Schaffrath, C; Spencer, JB; O'Hagan, D; Naismith, JH			Crystal structure and mechanism of a bacterial fluorinating enzyme	NATURE			English	Article							STREPTOMYCES-CATTLEYA; BIOSYNTHESIS; DATABASE; MOLECULES; CHEMISTRY; FAMILIES; PROGRAMS; MODELS; BONDS; ACID	Fluorine is the thirteenth most abundant element in the earth's crust, but fluoride concentrations in surface water are low and fluorinated metabolites are extremely rare(1,2). The fluoride ion is a potent nucleophile in its desolvated state, but is tightly hydrated in water and effectively inert. Low availability and a lack of chemical reactivity have largely excluded fluoride from biochemistry: in particular, fluorine's high redox potential precludes the haloperoxidase-type mechanism(3,4) used in the metabolic incorporation of chloride and bromide ions. But fluorinated chemicals are growing in industrial importance, with applications in pharmaceuticals, agrochemicals and materials products(5-7). Reactive fluorination reagents requiring specialist process technologies are needed in industry and, although biological catalysts for these processes are highly sought after, only one enzyme that can convert fluoride to organic fluorine has been described(8). Streptomyces cattleya can form carbon-fluorine bonds(9) and must therefore have evolved an enzyme able to overcome the chemical challenges of using aqueous fluoride. Here we report the sequence and three-dimensional structure of the first native fluorination enzyme, 5'-fluoro-5'-deoxyadenosine synthase, from this organism. Both substrate and products have been observed bound to the enzyme, enabling us to propose a nucleophilic substitution mechanism for this biological fluorination reaction.	Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of St Andrews; University of Cambridge	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	naismith@st-andrews.ac.uk	Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020; Deng, Hai/AAE-1758-2020	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Deng, Hai/0000-0002-0047-0622; O'Hagan, David/0000-0002-0510-5552	Biotechnology and Biological Sciences Research Council [BBS/B/04579] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Boutselakis H, 2003, NUCLEIC ACIDS RES, V31, P458, DOI 10.1093/nar/gkg065; Delano W. L., 2003, PYMOL MOL GENETICS G; DONG C, 2003, ACTA CRYSTALLOGR D, V60, P760; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Howard JAK, 1996, TETRAHEDRON, V52, P12613, DOI 10.1016/0040-4020(96)00749-1; Hutchinson J, 1997, TOP CURR CHEM, V193, P1; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Littlechild J, 1999, CURR OPIN CHEM BIOL, V3, P28, DOI 10.1016/S1367-5931(99)80006-4; MANN J, 1987, CHEM SOC REV, V16, P381, DOI 10.1039/cs9871600381; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; O'Hagan D, 1999, J FLUORINE CHEM, V100, P127, DOI 10.1016/S0022-1139(99)00201-8; O'Hagan D, 2003, J AM CHEM SOC, V125, P379, DOI 10.1021/ja026654k; SANADA M, 1986, J ANTIBIOT, V39, P259, DOI 10.7164/antibiotics.39.259; Sandford G, 2000, PHILOS T R SOC A, V358, P455, DOI 10.1098/rsta.2000.0541; Schaffrath C, 2003, FEBS LETT, V547, P111, DOI 10.1016/S0014-5793(03)00688-4; Schaffrath C, 2002, ANGEW CHEM INT EDIT, V41, P3913, DOI 10.1002/1521-3773(20021018)41:20<3913::AID-ANIE3913>3.0.CO;2-E; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; vanPee KH, 1996, ANNU REV MICROBIOL, V50, P375, DOI 10.1146/annurev.micro.50.1.375; Xu XH, 2003, J NAT PROD, V66, P285, DOI 10.1021/np020034f; Zechel DL, 2001, J AM CHEM SOC, V123, P4350, DOI 10.1021/ja005855q	31	235	243	8	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2004	427	6974					561	565		10.1038/nature02280	http://dx.doi.org/10.1038/nature02280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770KM	14765200				2022-12-01	WOS:000188721800046
J	Reed, KD; Melski, JW; Graham, MB; Regnery, RL; Sotir, MJ; Wegner, MV; Kazmierczak, JJ; Stratman, EJ; Li, Y; Fairley, JA; Swain, GR; Olson, VA; Sargent, EK; Kehl, SC; Frace, MA; Kline, R; Foldy, SL; Davis, JP; Damon, IK				Reed, KD; Melski, JW; Graham, MB; Regnery, RL; Sotir, MJ; Wegner, MV; Kazmierczak, JJ; Stratman, EJ; Li, Y; Fairley, JA; Swain, GR; Olson, VA; Sargent, EK; Kehl, SC; Frace, MA; Kline, R; Foldy, SL; Davis, JP; Damon, IK			The detection of monkeypox in humans in the Western Hemisphere	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; REEMERGENCE; CONGO	BACKGROUND: During May and June 2003, an outbreak of febrile illness with vesiculopustular eruptions occurred among persons in the midwestern United States who had had contact with ill pet prairie dogs obtained through a common distributor. Zoonotic transmission of a bacterial or viral pathogen was suspected. METHODS: We reviewed medical records, conducted interviews and examinations, and collected blood and tissue samples for analysis from 11 patients and one prairie dog. Histopathological and electron-microscopical examinations, microbiologic cultures, and molecular assays were performed to identify the etiologic agent. RESULTS: The initial Wisconsin cases evaluated in this outbreak occurred in five males and six females ranging in age from 3 to 43 years. All patients reported having direct contact with ill prairie dogs before experiencing a febrile illness with skin eruptions. We found immunohistochemical or ultrastructural evidence of poxvirus infection in skin-lesion tissue from four patients. Monkeypox virus was recovered in cell cultures of seven samples from patients and from the prairie dog. The virus was identified by detection of monkeypox-specific DNA sequences in tissues or isolates from six patients and the prairie dog. Epidemiologic investigation suggested that the prairie dogs had been exposed to at least one species of rodent recently imported into the United States from West Africa. CONCLUSIONS: Our investigation documents the isolation and identification of monkeypox virus from humans in the Western Hemisphere. Infection of humans was associated with direct contact with ill prairie dogs that were being kept or sold as pets.	Marshfield Clin Res Fdn, Clin Res Ctr, Marshfield, WI 54449 USA; Marshfield Clin Fdn Med Res & Educ, Dept Pathol, Marshfield, WI USA; Marshfield Clin Fdn Med Res & Educ, Dept Dermatol, Marshfield, WI USA; Med Coll Wisconsin, Div Infect Dis, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Family & Community Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; City Milwaukee Hlth Dept, Milwaukee, WI USA; Ctr Dis Control & Prevent, Poxvirus Sect, Off Director, Div Viral & Rickettsial Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Intelligence Serv, Atlanta, GA USA; Wisconsin Div Publ Hlth, Bur Communicable Dis, Madison, WI USA	Marshfield Clinic; Marshfield Clinic; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Reed, KD (corresponding author), Marshfield Clin Res Fdn, Clin Res Ctr, 1000 N Oak, Marshfield, WI 54449 USA.	reed.kurt@mcrf.mfldclin.edu		Fairley, Janet/0000-0002-8203-0486				Breman JG, 2000, EMERGING INFECTIONS 4, P45; *CDCP, 2003, UPD MULT OUTBR MONK; *CDCP, 2003, MONK REP CAS US DAT; *CDCP, 2003, INT GUID COLL DIAGN; *CDCP, 2003, INT GUID STAT LOC GO; DOANE FW, 1987, ELECT MICROSCOPY DIA, P87; ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4; Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Ibrahim MS, 2003, J CLIN MICROBIOL, V41, P3835, DOI 10.1128/JCM.41.8.3835-3839.2003; JEZEK Z, 1986, J INFECT DIS, V154, P551, DOI 10.1093/infdis/154.4.551; JEZEK Z, 1987, AM J EPIDEMIOL, V126, P1082, DOI 10.1093/oxfordjournals.aje.a114747; JEZEK Z, 1988, TROP GEOGR MED, V40, P73; JEZEK Z, 1987, J TROP MED HYG, V90, P31; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; LANDYL ID, 1972, B WORLD HEALTH ORGAN, V46, P593; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6; Meyer H, 1998, METH MOLEC MED, V12, P199; Mukinda VBK, 1997, LANCET, V349, P1449, DOI 10.1016/S0140-6736(05)63725-7; Pattyn SR, 2000, REV SCI TECH OIE, V19, P92, DOI 10.20506/rst.19.1.1207; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; *STAT IL EX DEP, 2003, EX ORD RESP ORTH OUT; *WI DEP HLTH FAM S, 2003, EM ORD; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; 2003, RESTRICTIONS AFRICAN; 2003, MMWR MORB MORTAL WKL, V52, P537	29	435	460	17	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2004	350	4					342	350		10.1056/NEJMoa032299	http://dx.doi.org/10.1056/NEJMoa032299			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765EU	14736926				2022-12-01	WOS:000188254800006
J	Rogers, GC; Rogers, SL; Schwimmer, TA; Ems-McClung, SC; Walczak, CE; Vale, RD; Scholey, JM; Sharp, DJ				Rogers, GC; Rogers, SL; Schwimmer, TA; Ems-McClung, SC; Walczak, CE; Vale, RD; Scholey, JM; Sharp, DJ			Two mitotic kinesins cooperate to drive sister chromatid separation during anaphase	NATURE			English	Article							CENTROMERE-ASSOCIATED KINESIN; MICROTUBULE FLUX; CHROMOSOME MOVEMENT; DYNAMICS; POLEWARD; SPINDLE; KINETOCHORE; PROTEIN; MITOSIS; XKCM1	During anaphase identical sister chromatids separate and move towards opposite poles of the mitotic spindle(1,2). In the spindle, kinetochore microtubules(3) have their plus ends embedded in the kinetochore and their minus ends at the spindle pole. Two models have been proposed to account for the movement of chromatids during anaphase. In the ' Pac- Man' model, kinetochores induce the depolymerization of kinetochore microtubules at their plus ends, which allows chromatids to move towards the pole by ' chewing up' microtubule tracks(4,5). In the 'poleward flux' model, kinetochores anchor kinetochore microtubules and chromatids are pulled towards the poles through the depolymerization of kinetochore microtubules at the minus ends(6). Here, we show that two functionally distinct microtubule- destabilizing KinI kinesin enzymes ( so named because they possess a kinesin- like ATPase domain positioned internally within the polypeptide) are responsible for normal chromatid- to- pole motion in Drosophila. One of them, KLP59C, is required to depolymerize kinetochore microtubules at their kinetochore- associated plus ends, thereby contributing to chromatid motility through a Pac- Man- based mechanism. The other, KLP10A, is required to depolymerize microtubules at their pole- associated minus ends, thereby moving chromatids by means of poleward flux.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; University of California System; University of California Davis; University of California System; University of California Davis	Sharp, DJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	dsharp@aecom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059618] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bousbaa H, 1997, J CELL SCI, V110, P1979; Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; Hunter AW, 2000, J CELL SCI, V113, P4379; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Maddox P, 2002, CURR BIOL, V12, P1670, DOI 10.1016/S0960-9822(02)01183-1; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; SULLIVAN W, 1993, DEVELOPMENT, V118, P1245; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; VALDESPEREZ PE, 1995, J THEOR BIOL, V175, P525, DOI 10.1006/jtbi.1995.0160; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	262	268	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					364	370		10.1038/nature02256	http://dx.doi.org/10.1038/nature02256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14681690				2022-12-01	WOS:000188266200044
J	Grant, VJ; Robinson, E; Muir, P				Grant, VJ; Robinson, E; Muir, P			Sex ratios in healthcare occupations: population based study	BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Fac Med & Hlth Sci, Dept Hlth Psychol, Auckland 1, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand	University of Auckland; University of Auckland	Grant, VJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Hlth Psychol, Private Bag 92019, Auckland 1, New Zealand.	vj.grant@auckland.ac.nz						deBeauvoir S., 1956, 2 SEX; Wootton BH, 1997, MON LABOR REV, V120, P15; 2001, NZ STAT	3	13	14	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 17	2004	328	7432					141	142		10.1136/bmj.328.7432.141	http://dx.doi.org/10.1136/bmj.328.7432.141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765CQ	14726342	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000188249900019
J	Robinson, NP; Dionne, I; Lundgren, M; Marsh, VL; Bernander, R; Bell, SD				Robinson, NP; Dionne, I; Lundgren, M; Marsh, VL; Bernander, R; Bell, SD			Identification of two origins of replication in the single chromosome of the Archaeon Sulfolobus solfataricus	CELL			English	Article							DNA-REPLICATION; RECOGNITION COMPLEX; HYPERTHERMOPHILIC ARCHAEON; PROTEIN; BINDING; INITIATION; XENOPUS; CYCLE; CHROMATIN; HELICASE	Eukaryotic chromosomes possess multiple origins of replication, whereas bacterial chromosomes are replicated from a single origin. The archaeon Pyrococcus abyssi also appears to have a single origin, suggesting a common rule for prokaryotes. However, in the current work, we describe the identification of two active origins of replication in the single chromosome of the hyperthermophilic archaeon Sulfolobus solfataricus. Further, we identify conserved sequence motifs within the origins that are recognized by a family of three Sulfolobus proteins that are homologous to the eukaryotic initiator proteins Orc1 and Cdc6. We demonstrate that the two origins are recognized by distinct subsets of these Orc1/Cdc6 homologs. These data, in conjunction with an analysis of the levels of the three Orc1/Cdc6 proteins in different growth phases and cell cycle stages, lead us to propose a model for the roles for these proteins in modulating origin activity.	Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 2XZ, England; Uppsala Univ, Evolutionary Biol Ctr, Dept Mol Evolut, SE-75236 Uppsala, Sweden	Uppsala University	Bell, SD (corresponding author), Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Hills Rd, Cambridge CB2 2XZ, England.	sb419@cam.ac.uk		Bell, Stephen/0000-0002-8474-6592; Robinson, Nick/0000-0002-6094-1924				Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Bell SD, 2000, J BIOL CHEM, V275, P31624, DOI 10.1074/jbc.M005422200; Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Benard M, 2001, MOL CELL, V7, P971, DOI 10.1016/S1097-2765(01)00237-4; Bernander R, 2000, TRENDS MICROBIOL, V8, P278, DOI 10.1016/S0966-842X(00)01760-1; Bernander R, 1997, J BACTERIOL, V179, P4963, DOI 10.1128/jb.179.16.4963-4969.1997; Berquist BR, 2003, J BACTERIOL, V185, P5959, DOI 10.1128/JB.185.20.5959-5966.2003; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Grabowski B, 2001, J BACTERIOL, V183, P5459, DOI 10.1128/JB.183.18.5459-5464.2001; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Maisnier-Patin S, 2002, MOL MICROBIOL, V45, P1443, DOI 10.1046/j.1365-2958.2002.03111.x; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Matsunaga F, 2001, P NATL ACAD SCI USA, V98, P11152, DOI 10.1073/pnas.191387498; Messer W, 2001, BIOCHIMIE, V83, P5, DOI 10.1016/S0300-9084(00)01216-5; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Napoli A, 1999, J BACTERIOL, V181, P1474, DOI 10.1128/JB.181.5.1474-1480.1999; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160; Zhang R, 2003, BIOCHEM BIOPH RES CO, V302, P728, DOI 10.1016/S0006-291X(03)00252-3	43	209	219	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2004	116	1					25	38		10.1016/S0092-8674(03)01034-1	http://dx.doi.org/10.1016/S0092-8674(03)01034-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718164	Bronze			2022-12-01	WOS:000187960800006
J	Raya, A; Kawakami, Y; Rodriguez-Esteban, C; Ibanes, M; Rasskin-Gutman, D; Rodriguez-Leon, J; Buscher, D; Feijo, J; Belmonte, JCI				Raya, A; Kawakami, Y; Rodriguez-Esteban, C; Ibanes, M; Rasskin-Gutman, D; Rodriguez-Leon, J; Buscher, D; Feijo, J; Belmonte, JCI			Notch activity acts as a sensor for extracellular calcium during vertebrate left-right determination	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; LUNATIC-FRINGE; SEGMENTATION CLOCK; PATTERN-FORMATION; NODAL EXPRESSION; CHICK-EMBRYO; GLYCOSYLTRANSFERASE; ESTABLISHMENT; INHIBITION; MECHANISMS	During vertebrate embryo development, the breaking of the initial bilateral symmetry is translated into asymmetric gene expression around the node and/or in the lateral plate mesoderm. The earliest conserved feature of this asymmetric gene expression cascade is the left-sided expression of Nodal, which depends on the activity of the Notch signalling pathway. Here we present a mathematical model describing the dynamics of the Notch signalling pathway during chick embryo gastrulation, which reveals a complex and highly robust genetic network that locally activates Notch on the left side of Hensen's node. We identify the source of the asymmetric activation of Notch as a transient accumulation of extracellular calcium, which in turn depends on left right differences in H+/K+-ATPase activity. Our results uncover a mechanism by which the Notch signalling pathway translates asymmetry in epigenetic factors into asymmetric gene expression around the node.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Inst Gulbenkian Ciencias, P-2780901 Oeiras, Portugal; Univ Lisbon, Fac Ciencias, Ctr Biotecnol Vegetal, P-1749016 Lisbon, Portugal	Salk Institute; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Leon, Joaquin Maria Rodriguez/C-6957-2013; Feijo, Jose A./ADM-0262-2022; Raya, Angel/E-6205-2010; Ibanes, Marta/A-7657-2008; Leon, Joaquin Maria Rodriguez/S-9814-2019	Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Feijo, Jose A./0000-0002-1100-5478; Raya, Angel/0000-0003-2189-9775; Ibanes, Marta/0000-0002-7913-7936; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Kawakami, Yasuhiko/0000-0002-0043-9705				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Bosenberg MW, 1993, CURR OPIN CELL BIOL, V5, P832, DOI 10.1016/0955-0674(93)90032-L; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Burdine RD, 2000, GENE DEV, V14, P763; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Esteban CR, 1999, NATURE, V401, P243, DOI 10.1038/45738; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gibson G, 2002, CURR BIOL, V12, pR347, DOI 10.1016/S0960-9822(02)00855-2; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; IZPISUABELMONTE JC, 1993, CELL, V74, P645, DOI 10.1016/0092-8674(93)90512-O; Jaffe LF, 1999, BIOESSAYS, V21, P657, DOI 10.1002/(SICI)1521-1878(199908)21:8<657::AID-BIES5>3.3.CO;2-B; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jouve C, 2002, DEVELOPMENT, V129, P1107; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mercola M, 2003, J CELL SCI, V116, P3251, DOI 10.1242/jcs.00668; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Murray JD, 1993, MATH BIOL, DOI [DOI 10.1007/978-3-662-08542-4, 10.1007/b98869, DOI 10.1007/B98869]; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Owen MR, 2000, DEV BIOL, V217, P54, DOI 10.1006/dbio.1999.9536; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; RANDHAWA MA, 1997, JRMC, V1, P6; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; STERN CD, 1995, DEV BIOL, V172, P192, DOI 10.1006/dbio.1995.0015; Stern CD, 2002, CURR BIOL, V12, pR802, DOI 10.1016/S0960-9822(02)01312-X; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Wagner MK, 2000, CURR BIOL, V10, pR149, DOI 10.1016/S0960-9822(00)00328-6; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	50	182	189	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					121	128		10.1038/nature02190	http://dx.doi.org/10.1038/nature02190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14712268				2022-12-01	WOS:000187863900027
J	Dwyer, JH; Allayee, H; Dwyer, KM; Fan, J; Wu, HY; Mar, R; Lusis, AJ; Mehrabian, M				Dwyer, JH; Allayee, H; Dwyer, KM; Fan, J; Wu, HY; Mar, R; Lusis, AJ; Mehrabian, M			Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYUNSATURATED FATTY-ACIDS; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; LEUKOTRIENE SYNTHESIS; DOCOSAHEXAENOIC ACID; EXPRESSION; GENE; EICOSANOIDS; RESPONSES; LIPOXINS	BACKGROUND: Leukotrienes are inflammatory mediators generated from arachidonic acid (polyunsaturated n-6 fatty acid) by the enzyme 5-lipoxygenase. Since atherosclerosis involves arterial inflammation, we hypothesized that a polymorphism in the 5-lipoxygenase gene promoter could relate to atherosclerosis in humans and that this effect could interact with the dietary intake of competing 5-lipoxygenase substrates. METHODS: We determined 5-lipoxygenase genotypes, carotid-artery intima-media thickness, and markers of inflammation in a randomly sampled cohort of 470 healthy, middle-aged women and men from the Los Angeles Atherosclerosis Study. Dietary arachidonic acid and marine n-3 fatty acids (including a competing 5-lipoxygenase substrate that reduces the production of inflammatory leukotrienes) were measured with the use of six 24-hour recalls of food intake. RESULTS: Variant 5-lipoxygenase genotypes (lacking the common allele) were found in 6.0 percent of the cohort. Mean (+/-SE) intima-media thickness adjusted for age, sex, height, and racial or ethnic group was increased by 80+/-19 microm (95 percent confidence interval, 43 to 116; P<0.001) among carriers of two variant alleles, as compared with carriers of the common (wild-type) allele. In multivariate analysis, the increase in intima-media thickness among carriers of two variant alleles (62 microm, P<0.001) was similar in this cohort to that associated with diabetes (64 microm, P=0.01), the strongest common cardiovascular risk factor. Increased dietary arachidonic acid significantly enhanced the apparent atherogenic effect of genotype, whereas increased dietary intake of n-3 fatty acids blunted the effect. Finally, the plasma level of C-reactive protein, a marker of inflammation, was increased by a factor of 2 among carriers of two variant alleles as compared with that among carriers of the common allele. CONCLUSIONS: Variant 5-lipoxygenase genotypes identify a subpopulation with increased atherosclerosis. The observed diet-gene interactions further suggest that dietary n-6 polyunsaturated fatty acids promote, whereas marine n-3 fatty acids inhibit, leukotriene-mediated inflammation that leads to atherosclerosis in this subpopulation.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California	Dwyer, JH (corresponding author), Keck Sch Med, 1000 S Fremont Ave,Unit 8, Alhambra, CA 91803 USA.	jimdwye@usc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049910, P01HL030568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-30568, HL-49910] Funding Source: Medline; NIGMS NIH HHS [5-T32-GM08243-15] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Allen S, 1998, CIRCULATION, V97, P2406, DOI 10.1161/01.CIR.97.24.2406; Andreotti F, 1999, Cardiologia, V44, P341; Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Cantwell MM, 2000, P NUTR SOC, V59, P187, DOI 10.1017/S0029665100000203; Cayatte AJ, 2000, ARTERIOSCL THROM VAS, V20, P1724, DOI 10.1161/01.ATV.20.7.1724; Cyrus T, 2001, CIRCULATION, V103, P2277; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drazen JM, 1999, NEW ENGL J MED, V340, P663; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Dwyer JH, 1998, ULTRASOUND MED BIOL, V24, P981, DOI 10.1016/S0301-5629(98)00069-6; Ferretti A, 1997, LIPIDS, V32, P435, DOI 10.1007/s11745-997-0057-5; FESKANICH D, 1989, COMPUT METH PROG BIO, V30, P47, DOI 10.1016/0169-2607(89)90122-3; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GOULET JL, 1994, P NATL ACAD SCI USA, V91, P12852, DOI 10.1073/pnas.91.26.12852; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; In KH, 1997, J CLIN INVEST, V99, P1130, DOI 10.1172/JCI119241; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Kelley DS, 1998, LIPIDS, V33, P125, DOI 10.1007/s11745-998-0187-9; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Koller M, 2003, CLIN NUTR, V22, P59, DOI 10.1054/clnu.2002.0592; LEE TH, 1988, CLIN SCI, V74, P467, DOI 10.1042/cs0740467; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; LI BY, 1994, J LIPID RES, V35, P1869; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lotzer K, 2003, ARTERIOSCL THROM VAS, V23, pE32, DOI 10.1161/01.ATV.0000082690.23131.CB; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Prescott SM, 2002, ARTERIOSCL THROM VAS, V22, P727, DOI 10.1161/01.ATV.0000016153.47693.B2; Radmark O, 2003, ARTERIOSCL THROM VAS, V23, P1140, DOI 10.1161/01.ATV.0000082460.58448.01; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sampson AP, 2000, THORAX, V55, pS28, DOI 10.1136/thorax.55.suppl_2.S28; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serhan CN, 1997, PROSTAG OTH LIPID M, V53, P107, DOI 10.1016/S0090-6980(97)00001-4; Serhan CN, 2000, AM J RESP CRIT CARE, V161, pS95, DOI 10.1164/ajrccm.161.supplement_1.ltta-19; Serio KJ, 2000, AM J RESP CELL MOL, V23, P234, DOI 10.1165/ajrcmb.23.2.4042; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; SPERLING RI, 1993, J CLIN INVEST, V91, P651, DOI 10.1172/JCI116245; Sun P, 2000, ARTERIOSCL THROM VAS, V20, P2005, DOI 10.1161/01.ATV.20.8.2005; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	50	487	529	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2004	350	1					29	37		10.1056/NEJMoa025079	http://dx.doi.org/10.1056/NEJMoa025079			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758PT	14702425				2022-12-01	WOS:000187659900007
J	Shi, YH; Lie, DC; Taupin, P; Nakashima, K; Ray, J; Yu, RT; Gage, FH; Evans, RM				Shi, YH; Lie, DC; Taupin, P; Nakashima, K; Ray, J; Yu, RT; Gage, FH; Evans, RM			Expression and function of orphan nuclear receptor TLX in adult neural stem cells	NATURE			English	Article							TAILLESS; BRAIN; NEUROGENESIS; COFACTOR; PROTEIN; SYSTEM; GENE; CNS	The finding of neurogenesis in the adult brain led to the discovery of adult neural stem cells(1). TLX was initially identified as an orphan nuclear receptor expressed in vertebrate forebrains(2) and is highly expressed in the adult brain(3). The brains of TLX-null mice have been reported to have no obvious defects during embryogenesis(4); however, mature mice suffer from retinopathies(5), severe limbic defects, aggressiveness, reduced copulation and progressively violent behaviour(4,6). Here we show that TLX maintains adult neural stem cells in an undifferentiated, proliferative state. We show that TLX-expressing cells isolated by fluorescence-activated cell sorting (FACS) from adult brains can proliferate, self-renew and differentiate into all neural cell types in vitro. By contrast, TLX-null cells isolated from adult mutant brains fail to proliferate. Reintroducing TLX into FACS-sorted TLX-null cells rescues their ability to proliferate and to self-renew. In vivo, TLX mutant mice show a loss of cell proliferation and reduced labelling of nestin in neurogenic areas in the adult brain. TLX can silence glia-specific expression of the astrocyte marker GFAP in neural stem cells, suggesting that transcriptional repression may be crucial in maintaining the undifferentiated state of these cells.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Modulat, Kumamoto 8600811, Japan	Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Kumamoto University	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019; Lie, Dieter Chichung/AAS-8604-2020; Lie, Dieter Chichung/S-7914-2017	Evans, Ronald/0000-0002-9986-5965; Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; Shi, Yanhong/0000-0002-3938-5839; Yu, Ruth/0000-0002-9527-9627				Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Chiang M.Y., 1997, REVERSE GENETIC ANAL; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lie DC, 2002, J NEUROSCI, V22, P6639; Misawa K, 2000, P NATL ACAD SCI USA, V97, P3062, DOI 10.1073/pnas.060489597; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Palmer TD, 1999, J NEUROSCI, V19, P8487; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897	19	319	338	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					78	83		10.1038/nature02211	http://dx.doi.org/10.1038/nature02211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702088				2022-12-01	WOS:000187710000038
J	Vigneron, N; Stroobant, V; Chapiro, J; Ooms, A; Degiovanni, G; Morel, S; van der Bruggen, P; Boon, T; Van den Eynde, BJ				Vigneron, N; Stroobant, V; Chapiro, J; Ooms, A; Degiovanni, G; Morel, S; van der Bruggen, P; Boon, T; Van den Eynde, BJ			An antigenic peptide produced by peptide splicing in the proteasome	SCIENCE			English	Article							CYTOLYTIC T-LYMPHOCYTES; INTRON SEQUENCE; CANCER ANTIGEN; HUMAN-MELANOMA; GENE; RECOGNITION; GENERATION; PROTEINS; CELLS	CD8 T lymphocytes recognize peptides of 8 to 10 amino acids presented by class 1 molecules of the major histocompatibility complex. Here, CD8 T lymphocytes were found to recognize a nonameric peptide on melanoma cells that comprises two noncontiguous segments of melanocytic glycoprotein gp100(PMEL17). The production of this peptide involves the excision of four amino acids and splicing of the fragments. This process was reproduced in vitro by incubating a precursor peptide of 13 amino acids with highly purified proteasomes. Splicing appears to occur by transpeptidation involving an acyl-enzyme intermediate. Our results reveal an unanticipated aspect of the proteasome function of producing antigenic peptides.	Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Univ Catholique Louvain, Cellular Genet Unit, B-1200 Brussels, Belgium; Univ Liege, Chirurg Expt Lab, B-4000 Liege, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; University of Liege	Van den Eynde, BJ (corresponding author), Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium.	benoit.vandeneynde@bru.licr.org						ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Engelhard VH, 2002, MOL IMMUNOL, V39, P127, DOI 10.1016/S0161-5890(02)00096-2; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Guilloux Y, 1996, J EXP MED, V183, P1173, DOI 10.1084/jem.183.3.1173; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; Morel S, 1999, INT J CANCER, V83, P755, DOI 10.1002/(SICI)1097-0215(19991210)83:6<755::AID-IJC10>3.0.CO;2-S; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131	14	246	264	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					587	590		10.1126/science.1095522	http://dx.doi.org/10.1126/science.1095522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	814LB	15001714				2022-12-01	WOS:000220975100049
J	Michels, KB; Ekbom, A				Michels, KB; Ekbom, A			Caloric restriction and incidence of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECREATIONAL PHYSICAL-ACTIVITY; EPIDERMAL-GROWTH-FACTOR; ANOREXIA-NERVOSA; BODY-SIZE; ENERGY RESTRICTION; DIFFERENT PERIODS; MAMMARY-TUMORS; UNITED-STATES; YOUNG-WOMEN; LONG-TERM	Context Restricting caloric intake is one of the most effective ways to extend lifespan and to reduce spontaneous tumor occurrence in experimental animals, but whether similar associations hold in humans has not been appropriately studied. Objective To determine whether caloric restriction in early life reduces the risk of invasive breast cancer. Design, Setting, and Participants Retrospective cohort study using data from the Swedish Inpatient Registry, the Swedish Cancer Registry, the Swedish Death Registry, and the Swedish Fertility Registry. Participants were 7303 Swedish women hospitalized for anorexia nervosa prior to age 40 years between 1965 and 1998. Women were excluded (n=31)if they were diagnosed with cancer prior to their first discharge from hospitalization for anorexia nervosa. Main Outcome Measure Incidence of invasive breast cancer. Results Compared with the Swedish general population, women hospitalized for anorexia nervosa prior to age 40 years had a 53% (95% confidence interval [CI], 3%-81%) lower incidence of breast cancer; nulliparous women with anorexia nervosa had a 23% (95% CI, 79% higher to 75% lower) lower incidence, and parous women with anorexia nervosa had a 76% (95 % CI, 13%-97%) lower incidence. Conclusions Severe caloric restriction in humans may confer protection from invasive breast cancer. Low caloric intake prior to first birth followed by a subsequent pregnancy appears to be associated with an even more pronounced reduction in risk.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Karolinska Inst, Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Karolinska University Hospital	Michels, KB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Obstet & Gynecol Epidemiol Ctr, 221 Longwood Ave, Boston, MA 02115 USA.	kmichels@rics.bwh.harvard.edu						Berkey CS, 1999, CANCER-AM CANCER SOC, V85, P2400, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2400::AID-CNCR15>3.0.CO;2-O; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BRUNING PF, 1995, INT J CANCER, V62, P266, DOI 10.1002/ijc.2910620306; Cleary MP, 2002, CANCER EPIDEM BIOMAR, V11, P836; Coates RJ, 1999, BRIT J CANCER, V81, P167, DOI 10.1038/sj.bjc.6690667; Dirx MJM, 2003, INT J CANCER, V106, P766, DOI 10.1002/ijc.11277; ENGELMAN RW, 1995, CANCER RES, V55, P1289; FERNANDES G, 1995, P NATL ACAD SCI USA, V92, P6494, DOI 10.1073/pnas.92.14.6494; Friedenreich CM, 2001, EUR J CANCER PREV, V10, P15, DOI 10.1097/00008469-200102000-00003; FRISCH RE, 1987, AM J CLIN NUTR, V45, P328, DOI 10.1093/ajcn/45.1.328; Gammon MD, 1998, AM J EPIDEMIOL, V147, P273; Gammon MD, 1998, JNCI-J NATL CANCER I, V90, P100, DOI 10.1093/jnci/90.2.100; Hall K., 1999, Journal of Endocrinological Investigation, V22, P48; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hilakivi-Clarke L, 2001, BRIT J CANCER, V85, P1680, DOI 10.1054/bjoc.2001.2109; KREIPE RE, 1989, AM J DIS CHILD, V143, P1322, DOI 10.1001/archpedi.1989.02150230080027; LEMARCHAND L, 1988, AM J EPIDEMIOL, V128, P137; Magnusson C, 1998, INT J CANCER, V76, P29, DOI 10.1002/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.0.CO;2-#; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Mellemkjaer L, 2001, CANCER CAUSE CONTROL, V12, P173, DOI 10.1023/A:1008974414116; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Michels KB, 2002, BREAST CANCER RES, V4, P58, DOI 10.1186/bcr423; MITTENDORF R, 1995, CANCER CAUSE CONTROL, V6, P347, DOI 10.1007/BF00051410; Munoz MT, 2002, EUR J ENDOCRINOL, V147, P275, DOI 10.1530/eje.0.1470275; Patel AV, 2003, CANCER CAUSE CONTROL, V14, P519, DOI 10.1023/A:1024895613663; Rockhill B, 1998, J NATL CANCER I, V90, P1155, DOI 10.1093/jnci/90.15.1155; ROSS MH, 1971, J NATL CANCER I, V47, P1095; Rous P, 1915, B JOHNS HOPKINS HOSP, V26, P146; RUGGERI BA, 1989, CANCER RES, V49, P4130; Spady TJ, 1999, J NUTR, V129, p587S, DOI 10.1093/jn/129.2.587S; *STAT SWED, 2002, 20025 SCB STAT SWED; SWANSON CA, 1988, CANCER RES, V48, P5363; *SWED CANC REG, 1993, CANC INC SWED 1990; TANNENBAUM A, 1953, CANCER RES, V13, P532; THEANDER S, 1985, J PSYCHIATR RES, V19, P493, DOI 10.1016/0022-3956(85)90059-7; THEANDER S, 1970, ACTA PSYCHIAT SCAND, P1; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Trentham-Dietz A, 2000, CANCER CAUSE CONTROL, V11, P533, DOI 10.1023/A:1008961931534; TRETLI S, 1989, INT J CANCER, V44, P23, DOI 10.1002/ijc.2910440105; Tretli S, 1996, CANCER CAUSE CONTROL, V7, P507, DOI 10.1007/BF00051882; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Visscher MB, 1942, SURGERY, V11, P48; World Health Organization, 2003, INTRO DRUG UTILIZATI; Zhu ZJ, 1999, MOL CARCINOGEN, V24, P241, DOI 10.1002/(SICI)1098-2744(199904)24:4<241::AID-MC1>3.0.CO;2-P	44	129	134	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2004	291	10					1226	1230		10.1001/jama.291.10.1226	http://dx.doi.org/10.1001/jama.291.10.1226			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800XV	15010444				2022-12-01	WOS:000220061900023
J	Raghavan, SC; Swanson, PC; Wu, XT; Hsieh, CL; Lieber, MR				Raghavan, SC; Swanson, PC; Wu, XT; Hsieh, CL; Lieber, MR			A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex	NATURE			English	Article							V(D)J RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; MECHANISM; DIVERSITY; NICKING; STEPS	The causes of spontaneous chromosomal translocations in somatic cells of biological organisms are largely unknown, although double-strand DNA breaks are required in all proposed mechanisms(1-5).(.) The most common chromosomal abnormality in human cancer is the reciprocal translocation between chromosomes 14 and 18 (t(14;18)), which occurs in follicular lymphomas. The break at the immunoglobulin heavy-chain locus on chromosome 14 is an interruption of the normal V(D)J recombination process. But the breakage on chromosome 18, at the Bcl-2 gene, occurs within a confined 150-base-pair region (the major breakpoint region or Mbr) for reasons that have remained enigmatic. We have reproduced key features of the translocation process on an episome that propagates in human cells. The RAG complex-which is the normal enzyme for DNA cleavage at V, D or J segments-nicks the Bcl-2 Mbr in vitro and in vivo in a manner that reflects the pattern of the chromosomal translocations; however, the Mbr is not a V(D)J recombination signal. Rather the Bcl-2 Mbr assumes a non-B-form DNA structure within the chromosomes of human cells at 20-30% of alleles. Purified DNA assuming this structure contains stable regions of single-strandedness, which correspond well to the translocation regions in patients. Hence, a stable non-B-DNA structure in the human genome appears to be the basis for the fragility of the Bcl-2 Mbr, and the RAG complex is able to cleave this structure.	Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Biol Sci, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; Creighton Univ, Sch Med, Dept Immunol & Med Microbiol, Omaha, NE 68178 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Creighton University	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Room 5428,1441 Eastlake Ave,MC91176, Los Angeles, CA 90033 USA.	lieber@usc.edu		Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; DALLAFAVERA R, 1993, CAUSES CONSEQUENCES, P313; Gauss GH, 1996, MOL CELL BIOL, V16, P258; GOUGH GW, 1986, EMBO J, V5, P191, DOI 10.1002/j.1460-2075.1986.tb04195.x; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber MR., 1993, CAUSES CONSEQUENCES, P239; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; Tevelev A, 2000, J BIOL CHEM, V275, P8341, DOI 10.1074/jbc.275.12.8341; TYCKO B, 1990, CANCER CELL-MON REV, V2, P1; Yu KF, 2000, MOL CELL BIOL, V20, P7914, DOI 10.1128/MCB.20.21.7914-7921.2000; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	18	190	196	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					88	93		10.1038/nature02355	http://dx.doi.org/10.1038/nature02355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999286	Bronze			2022-12-01	WOS:000189363800041
J	Iezzoni, LI; O'Day, BL; Killeen, M; Harker, H				Iezzoni, LI; O'Day, BL; Killeen, M; Harker, H			Communicating about health care: Observations from persons who are deaf or hard of hearing	ANNALS OF INTERNAL MEDICINE			English	Article							DISABLING CONDITIONS; QUALITY; PEOPLE; ACCESS; SATISFACTION; DISABILITIES; INTERPRETER; MANAGEMENT; ADULTS; WOMEN	Background: Achieving patient-centered care requires effective communication between physicians and patients. Persons who are deaf or hard of hearing face considerable barriers to communicating with physicians. Objective: To understand perceptions of health care experiences and suggestions for improving care among deaf or hard-of-hearing individuals. Design: 4 semistructured group interviews, 2 conducted in American Sign Language (for deaf individuals) and 2 using Communication Access Realtime Translation (for hard-of-hearing individuals). Men and women were interviewed separately. Tapes of interviews were transcribed verbatim for analysis. Setting: Greater Boston, Massachusetts, and Washington, DC, in 2001. Participants: 14 deaf adults (23 to 51 years of age) and 12 hard-of-hearing adults (30 to 74 years of age). Measurements: Commonly expressed themes or views organized around dimensions of communication. Results: concerns coalesced around 6 broad themes: conflicting views between physicians and patients about being deaf or hard of hearing; different perceptions about what constitutes effective communication (such as lip reading, writing notes, and sign language interpreter); medication safety and other risks posed by inadequate communication; communication problems during physical examinations and procedures; difficulties interacting with office staff, including in waiting rooms; and problems with telephone communication, such as lengthy message menus. Participants offered extensive suggestions for improvements, starting with clinicians' asking patients about their preferred communication approach. Having patients repeat critical health information (such as medication instructions) can identify potentially dangerous miscommunication. Conclusions: As the population ages, physicians will encounter many more persons with hearing limitations. Physicians are not reimbursed for making some accommodations, such as hiring sign language interpreters. However, ensuring effective communication is essential to safe, timely, efficient, and patient-centered care.	Harvard Univ, Thorndike Lab, Div Gen Med & Primary Care,Charles A Dana Res Inst, Beth Israel Deaconess Med Ctr,Med Sch,Dept Med, Boston, MA 02215 USA; Third Sector New England, Boston, MA USA; Cherry Engn Support Serv Inc, Mclean, VA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Iezzoni, LI (corresponding author), Harvard Univ, Thorndike Lab, Div Gen Med & Primary Care,Charles A Dana Res Inst, Beth Israel Deaconess Med Ctr,Med Sch,Dept Med, RO-137,330 Brookline Ave, Boston, MA 02215 USA.				AHRQ HHS [R01 HS10223-03] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010223] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Adams P F, 1995, Vital Health Stat 10, P1; Allen Barbara, 2002, HEC Forum, V14, P197, DOI 10.1023/A:1020508511133; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Baker DW, 1996, JAMA-J AM MED ASSOC, V275, P783, DOI 10.1001/jama.275.10.783; Barnett S, 1999, Fam Med, V31, P17; Barnett S, 2002, ACAD MED, V77, P694, DOI 10.1097/00001888-200207000-00009; Barnett S, 2002, HEALTH SERV RES, V37, P105; Barnett S, 2002, FAM MED, V34, P376; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Bogardus ST, 2003, JAMA-J AM MED ASSOC, V289, P1986, DOI 10.1001/jama.289.15.1986; Braddock D.L., 2001, HDB DISABILITY STUDI, P11, DOI DOI 10.4135/9781412976251; Burch S, 2001, NEW DISABILITY HIST, P214; EBERT DA, 1995, JAMA-J AM MED ASSOC, V273, P227; Edwards R.A.R., 2001, NEW DISABILITY HIST, P58; GILCHRIST VJ, 1993, SUCCESSFUL FOCUS GRO, P70; HARTYGOLDER B, 1996, J FLA MED ASSOC, V83, P573; Hines J, 2000, Nurs Stand, V14, P33; Iezzoni LI, 2002, INT J QUAL HEALTH C, V14, P369, DOI 10.1093/intqhc/14.5.369; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; IEZZONI LI, 2003, HS10223 AG HEALTHC R; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jackler RK, 2003, JAMA-J AM MED ASSOC, V289, P1557, DOI 10.1001/jama.289.12.1557; Kreuger RA, 1998, ANAL REPORTING FOCUS; Krueger R.A., 2009, FOCUS GROUPS PRACTIC; KULBACK SJ, 1995, JAMA-J AM MED ASSOC, V274, P795, DOI 10.1001/jama.1995.03530100034018; LOTKE M, 1995, ANN INTERN MED, V123, P54, DOI 10.7326/0003-4819-123-1-199507010-00008; MACKINNEY TG, 1995, J GEN INTERN MED, V10, P133, DOI 10.1007/BF02599667; MCEWEN E, 1988, J FAM PRACTICE, V26, P289; Miles M., 2019, QUALITATIVE DATA ANA, V4th; Morgan DL., 1993, SUCCESSFUL FOCUS GRO, P3, DOI [10.4135/9781483349008, DOI 10.4135/9781483349008.N1]; Munoz-Baell IM, 2000, J EPIDEMIOL COMMUN H, V54, P40, DOI 10.1136/jech.54.1.40; O'Day B., 2002, J DISABIL POLICY STU, V13, P9, DOI [10.1177/10442073020130010201, DOI 10.1177/10442073020130010201]; Ralston E, 1996, J Am Board Fam Pract, V9, P167; Rivadeneyra R, 2000, AM J MED, V108, P470, DOI 10.1016/S0002-9343(99)00445-3; ROCKOW K, 2001, WORKING DEAF HARD PA; Steinberg AG, 1998, AM J PSYCHIAT, V155, P982, DOI 10.1176/ajp.155.7.982; Ubido J, 2002, HEALTH SOC CARE COMM, V10, P247, DOI 10.1046/j.1365-2524.2002.00365.x; Weil E, 2002, JAMA-J AM MED ASSOC, V288, P1265, DOI 10.1001/jama.288.10.1265; Witte T N, 2000, J Am Board Fam Pract, V13, P17; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976; Zazove P, 1993, Arch Fam Med, V2, P745, DOI 10.1001/archfami.2.7.745; 1995, HOSP LAW NEWSL, V12, P1	43	184	193	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2004	140	5					356	362		10.7326/0003-4819-140-5-200403020-00011	http://dx.doi.org/10.7326/0003-4819-140-5-200403020-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	778NC	14996677				2022-12-01	WOS:000189246800005
J	Sanai, N; Tramontin, AD; Quinones-Hinojosa, A; Barbaro, NM; Gupta, N; Kunwar, S; Lawton, MT; McDermott, MW; Parsa, AT; Verdugo, JMG; Berger, MS; Alvarez-Buylla, A				Sanai, N; Tramontin, AD; Quinones-Hinojosa, A; Barbaro, NM; Gupta, N; Kunwar, S; Lawton, MT; McDermott, MW; Parsa, AT; Verdugo, JMG; Berger, MS; Alvarez-Buylla, A			Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration	NATURE			English	Article							SUBVENTRICULAR ZONE; PROGENITOR CELLS; OLFACTORY-BULB; MAMMALIAN BRAIN; NEUROGENESIS; FOREBRAIN; GENERATION; NEURONS; DIFFERENTIATION; IDENTIFICATION	The subventricular zone (SVZ) is a principal source of adult neural stem cells in the rodent brain, generating thousands of olfactory bulb neurons every day(1). If the adult human brain contains a comparable germinal region, this could have considerable implications for future neuroregenerative therapy. Stem cells have been isolated from the human brain(2-7), but the identity, organization and function of adult neural stem cells in the human SVZ are unknown. Here we describe a ribbon of SVZ astrocytes lining the lateral ventricles of the adult human brain that proliferate in vivo and behave as multipotent progenitor cells in vitro. This astrocytic ribbon has not been observed in other vertebrates studied. Unexpectedly, we find no evidence of chains of migrating neuroblasts in the SVZ or in the pathway to the olfactory bulb. Our work identifies SVZ astrocytes as neural stem cells in a niche of unique organization in the adult human brain.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dev Stem Cell Biol Program, San Francisco, CA 94143 USA; Univ Valencia, Inst Cavanilles, E-46100 Valencia, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Valencia	Sanai, N (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	nsanai@itsa.ucsf.edu; abuylla@itsa.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Bonfanti L, 1997, NEUROSCIENCE, V81, P489, DOI 10.1016/S0306-4522(97)00090-0; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Imura T, 2003, J NEUROSCI, V23, P2824; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Leel-Ossy L, 1998, Pathol Oncol Res, V4, P212; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Perez-Martin M, 2000, CELL TISSUE RES, V300, P11, DOI 10.1007/s004410000190; Pincus D W, 1997, Clin Neurosurg, V44, P17; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; SMITH KR, 1994, COMPUT MED IMAG GRAP, V18, P247, DOI 10.1016/0895-6111(94)90049-3; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a	30	985	1022	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					740	744		10.1038/nature02301	http://dx.doi.org/10.1038/nature02301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973487				2022-12-01	WOS:000189026000045
J	Kowalski, RG; Claassen, J; Kreiter, KT; Bates, JE; Ostapkovich, ND; Connolly, ES; Mayer, SA				Kowalski, RG; Claassen, J; Kreiter, KT; Bates, JE; Ostapkovich, ND; Connolly, ES; Mayer, SA			Initial misdiagnosis and outcome after subarachnoid hemorrhage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DELAYED DIAGNOSIS; INTRACRANIAL ANEURYSMS; HEADACHE; DEATH; MANAGEMENT; EMERGENCY; PITFALLS; CARE	Context Mortality and morbidity can be reduced if aneurysmal subarachnoid hemorrhage (SAH) is treated urgently. Objective To determine the association of initial misdiagnosis and outcome after SAH. Design, Setting, and Participants Inception cohort of 482 SAH patients admitted to a tertiary care urban hospital between August 1996 and August 2001. Main Outcome Measures Misdiagnosis was defined as failure to correctly diagnose SAH at a patient's initial contact with a medical professional. Functional outcome was assessed at 3 and 12 months with the modified Rankin Scale; quality of life (QOL), with the Sickness Impact Profile. Results Fifty-six patients (12%) were initially misdiagnosed, including 42 of 221 (19%) of those with normal mental status at first contact. Migraine or tension headache (36%) was the most common incorrect diagnosis, and failure to obtain a computed tomography (CT) scan was the most common diagnostic error (73%). Neurologic complications occurred in 22 patients (39%) before they were correctly diagnosed, including 12 patients (21%) who experienced rebleeding. Normal mental status, small SAH volume, and right-sided aneurysm location were independently associated with misdiagnosis. Among patients with normal mental status at first contact, misdiagnosis was associated with worse QOL at 3 months and an increased risk of death or severe disability at 12 months. Conclusions In this study, misdiagnosis of SAH occurred in 12% of patients and was associated with a smaller hemorrhage and normal mental status. Among individuals who initially present in good condition, misdiagnosis is associated with increased mortality and morbidity. A low threshold for CT scanning of patients with mild symptoms that are suggestive of SAH may reduce the frequency of misdiagnosis.	Columbia Univ Coll Phys & Surg, Inst Neurol, Div Stroke & Crit Care Neuro, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA	Columbia University; Columbia University	Mayer, SA (corresponding author), Columbia Univ Coll Phys & Surg, Inst Neurol, Div Stroke & Crit Care Neuro, 710 W 168th St,Unit 39, New York, NY 10032 USA.	sam14@columbia.edu	Claassen, Jan/AAA-5451-2020					ADAMS HP, 1980, JAMA-J AM MED ASSOC, V244, P794, DOI 10.1001/jama.244.8.794; BARTON CW, 1994, HEADACHE, V34, P91, DOI 10.1111/j.1526-4610.1994.hed3402091.x; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; CHAN BSH, 1991, MED J AUSTRALIA, V154, P509, DOI 10.5694/j.1326-5377.1991.tb119442.x; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Damiano AM, 1996, SICKNESS IMPACT PROF; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Fridriksson S, 2001, ACTA NEUROL SCAND, V103, P238; HIJDRA A, 1988, STROKE, V19, P1250, DOI 10.1161/01.STR.19.10.1250; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; KARCZ A, 1993, ANN EMERG MED, V22, P553, DOI 10.1016/S0196-0644(05)81941-9; KASSELL NF, 1985, STROKE, V16, P587, DOI 10.1161/01.STR.16.4.587; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Mayer PL, 1996, STROKE, V27, P1558, DOI 10.1161/01.STR.27.9.1558; MAYER SA, 2000, MERRITTS TXB NEUROLO, P260; Morgenstern LB, 1998, ANN EMERG MED, V32, P297; NeilDwyer G, 1997, J ROY COLL PHYS LOND, V31, P49; Ostapkovich N, 2001, ANN NEUROL, V50, pS78; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; SCHIEVINK WI, 1988, SURG NEUROL, V29, P367, DOI 10.1016/0090-3019(88)90045-6; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; Vannemreddy P, 2001, SOUTHERN MED J, V94, P1108, DOI 10.1097/00007611-200111000-00014; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VERMEULEN M, 1990, J NEUROL NEUROSUR PS, V53, P365, DOI 10.1136/jnnp.53.5.365	25	179	192	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2004	291	7					866	869		10.1001/jama.291.7.866	http://dx.doi.org/10.1001/jama.291.7.866			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TF	14970066	Bronze			2022-12-01	WOS:000189000400025
J	Johnston, SC; O'Meara, ES; Manolio, TA; Lefkowitz, D; O'Leary, DH; Goldstein, S; Carlson, MC; Fried, LP; Longstreth, WT				Johnston, SC; O'Meara, ES; Manolio, TA; Lefkowitz, D; O'Leary, DH; Goldstein, S; Carlson, MC; Fried, LP; Longstreth, WT			Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL IMPROVEMENT; CEREBRAL INFARCTION; DIABETES-MELLITUS; BRAIN INFARCTION; ELDERLY-PEOPLE; OLDER-ADULTS; MRI FINDINGS; RISK-FACTORS	Background: Whether carotid artery disease is a cause of cognitive impairment in persons who have not had stroke is unknown. If this is the case, diminished performance on the Modified Mini-Mental State Examination should be more common in persons with left carotid artery disease than in those with right carotid artery disease. Objective: To determine whether left carotid artery disease is associated with cognitive impairment. Design: Cross-sectional and cohort study. Setting: Four U.S. communities participating in the Cardiovascular Health Study. Patients: 4006 right-handed men and women 65 years of age or older without history of stroke, transient ischemic attack, or carotid endarterectomy. Measurements: internal carotid artery stenosis and intimamedia thickness of the common carotid artery were assessed by using duplex ultrasonography. Cognitive impairment was defined as a score less than 80 on the Modified Mini-Mental State Examination, and cognitive decline was defined as an average decrease of more than 1 point annually in Modified Mini-Mental State Examination score during up to 5 years of follow-up. Multivariate logistic regression models were used to estimate the risk for cognitive impairment and decline associated with left internal carotid artery stenosis and intima-media thickness, after adjustment for measures of right-sided disease and risk factors for vascular disease. Results: After adjustment for right-sided stenosis, high-grade (greater than or equal to75% narrowing of diameter) stenosis of the left internal carotid artery (32 patients) was associated with cognitive impairment (odds ratio, 6.7 [95% CI, 2.4 to 18.1] compared with no stenosis) and cognitive decline (odds ratio, 2.6 [CI, 1.1 to 6.3]). Intimamedia thickness of the left common carotid artery was associated with cognitive impairment and decline in univariate analysis, but this effect did not persist after adjustment. Conclusions: Cognitive impairment and decline are associated with asymptomatic high-grade stenosis of the left internal carotid artery. The persistence of the association after adjustment for right-sided stenosis indicates that the association is not due to underlying vascular risk factors or atherosclerosis in general.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Washington, Seattle, WA 98195 USA; NHLBI, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Tufts Univ, New England Med Ctr, Boston, MA 02111 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Wake Forest University; Tufts Medical Center; Tufts University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnston, SC (corresponding author), Univ Calif San Francisco, Dept Neurol, Box 0114,505 Parnassus Ave,M-798, San Francisco, CA 94143 USA.				NHLBI NIH HHS [N01-HC-85083, N01-HC-85086, N01-HC-85080, N01-HC-85082, N01-HC-35129, N01-HC-85079, N01-HC-15103, N01-HC-85085, N01-HC-85084, N01-HC-85081] Funding Source: Medline; NINDS NIH HHS [NS02254] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085081, N01HC085080, N01HC085086, N01HC085083, N01HC085084, N01HC085085, N01HC085082, N01HC085079, N01HC035129] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BROTT T, 1994, STROKE, V25, P1122, DOI 10.1161/01.STR.25.6.1122; BRYAN RN, 1994, AM J NEURORADIOL, V15, P1625; Caplan D., 1987, NEUROLINGUISTICS LIN; CASEY JE, 1989, J CLIN EXP NEUROPSYC, V11, P461, DOI 10.1080/01688638908400906; Cerhan JR, 1998, GERONTOLOGY, V44, P95, DOI 10.1159/000021991; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; De la Torre JC, 2000, ANN NY ACAD SCI, V903, P424, DOI 10.1111/j.1749-6632.2000.tb06394.x; DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; GREIFFENSTEIN MF, 1988, CORTEX, V24, P223, DOI 10.1016/S0010-9452(88)80031-5; Harrington F, 2000, HYPERTENSION, V36, P1079, DOI 10.1161/01.HYP.36.6.1079; HEMMINGSEN R, 1982, ACTA NEUROL SCAND, V66, P145, DOI 10.1111/j.1600-0404.1982.tb04512.x; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; JACOBS LA, 1983, SURGERY, V93, P683; KELLY MP, 1980, ARCH NEUROL-CHICAGO, V37, P743, DOI 10.1001/archneur.1980.00500610023002; KING GD, 1977, J CLIN PSYCHOL, V33, P215, DOI 10.1002/1097-4679(197701)33:1+<215::AID-JCLP2270330149>3.0.CO;2-D; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Manolio TA, 1999, ARTERIOSCL THROM VAS, V19, P356, DOI 10.1161/01.ATV.19.2.356; MATARAZZO R G, 1979, Journal of Clinical Neuropsychology, V1, P97, DOI 10.1080/01688637908414445; Melzer D, 1997, BRIT MED J, V315, P462, DOI 10.1136/bmj.315.7106.462; NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002; Neter J., 1990, APPL LINEAR STAT MOD; NORRIS JW, 1992, STROKE, V23, P483, DOI 10.1161/01.STR.23.4.483; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; PARKER JC, 1983, J CLIN NEUROPSYCHOL, V5, P345, DOI 10.1080/01688638308401182; Pettigrew LC, 2000, NEUROLOGY, V55, P30, DOI 10.1212/WNL.55.1.30; Price T R, 1993, Ann Epidemiol, V3, P504; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; Pullicino PM, 2001, NEUROLOGY, V57, P1945, DOI 10.1212/WNL.57.11.1945; Rao R, 2001, EUR NEUROL, V46, P63, DOI 10.1159/000050765; Rockwood K, 1997, ARCH NEUROL-CHICAGO, V54, P33, DOI 10.1001/archneur.1997.00550130019010; Rockwood K, 2000, NEUROLOGY, V54, P447, DOI 10.1212/WNL.54.2.447; SIRKKA A, 1992, ACTA NEUROL SCAND, V85, P58; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Smith A., 1982, SYMBOL DIGIT MODALIT; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; TIMSIT SG, 1992, STROKE, V23, P486, DOI 10.1161/01.STR.23.4.486; VANDENBURG W, 1985, PSYCHOL MED, V15, P341, DOI 10.1017/S003329170002362X; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	57	227	250	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2004	140	4					237	247		10.7326/0003-4819-140-4-200402170-00005	http://dx.doi.org/10.7326/0003-4819-140-4-200402170-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774GA	14970146				2022-12-01	WOS:000188970400001
J	Donnelly, CA				Donnelly, CA			Bovine spongiform encephalopathy in the United States - An epidemiologist's view	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CATTLE		Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Donnelly, CA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.			Donnelly, Christl/0000-0002-0195-2463				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; ANDERSON RM, 1997, NATURE, V384, P302; *DEFRA, 2003, BSE HOM; *DEP HLTH, 2004, MONTHL CREUTZF JAK D; Ferguson NM, 2003, P ROY SOC B-BIOL SCI, V270, P1579, DOI 10.1098/rspb.2003.2484	5	5	5	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2004	350	6					539	542		10.1056/NEJMp038005	http://dx.doi.org/10.1056/NEJMp038005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770FP	14762179				2022-12-01	WOS:000188712800003
J	Freedman, SD; Blanco, PG; Zaman, MM; Shea, JC; Ollero, M; Hopper, IK; Weed, DA; Gelrud, A; Regan, MM; Laposata, M; Alvarez, JG; O'Sullivan, BP				Freedman, SD; Blanco, PG; Zaman, MM; Shea, JC; Ollero, M; Hopper, IK; Weed, DA; Gelrud, A; Regan, MM; Laposata, M; Alvarez, JG; O'Sullivan, BP			Association of cystic fibrosis with abnormalities in fatty acid metabolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOCOSAHEXAENOIC ACID; ADIPOSE-TISSUE; CFTR(-/-) MICE; ION-TRANSPORT; GENE; INFLAMMATION; PANCREATITIS; MUTATIONS; DISEASE; CELLS	Background: Patients with cystic fibrosis have altered levels of plasma fatty acids. We previously demonstrated that arachidonic acid levels are increased and docosahexaenoic acid levels are decreased in affected tissues from cystic fibrosis-knockout mice. In this study we determined whether humans with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have a similar fatty acid defect in tissues expressing CFTR. Methods: Fatty acids from nasal- and rectal-biopsy specimens, nasal epithelial scrapings, and plasma were analyzed from 38 subjects with cystic fibrosis and compared with results in 13 obligate heterozygotes, 24 healthy controls, 11 subjects with inflammatory bowel disease, 9 subjects with upper respiratory tract infection, and 16 subjects with asthma. Results: The ratio of arachidonic to docosahexaenoic acid was increased in mucosal and submucosal nasal-biopsy specimens (P<0.001) and rectal-biopsy specimens (P=0.009) from subjects with cystic fibrosis and pancreatic sufficiency and subjects with cystic fibrosis and pancreatic insufficiency, as compared with values in healthy control subjects. In nasal tissue, this change reflected an increase in arachidonic acid levels and a decrease in docosahexaenoic acid levels. In cells from nasal mucosa, the ratio of arachidonic to docosahexaenoic acid was increased in subjects with cystic fibrosis (P<0.001), as compared with healthy controls, with values in obligate heterozygotes intermediate between these two groups (P<0.001). The ratio was not increased in subjects with inflammatory bowel disease. Subjects with asthma and those with upper respiratory tract infection had values intermediate between those in subjects with cystic fibrosis and those in healthy control subjects. Conclusions: These data indicate that alterations in fatty acids similar to those in cystic fibrosis-knockout mice are present in CFTR-expressing tissue from subjects with cystic fibrosis.	Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Div Lab Med, Boston, MA 02114 USA; Hosp San Rafael, Ctr Infertilidad Masculina Androgen, Inst Infertilidad Masculina, La Coruna, Spain; Univ Massachusetts, Sch Med, UMass Mem Hlth Care, Dept Pediat, Worcester, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester	Freedman, SD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Dana 552,330 Brookline Ave, Boston, MA 02215 USA.	sfreedma@caregroup.harvard.edu	Ollero, Mario/AAJ-3545-2020; Alvarez, Juan/GSD-7155-2022; Ollero, Mario/Q-6147-2018	Ollero, Mario/0000-0003-3590-706X	NCRR NIH HHS [RR 01032] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alasnier C, 2002, J NUTR BIOCHEM, V13, P337, DOI 10.1016/S0955-2863(02)00176-6; ALVAREZ JG, 1995, MOL REPROD DEV, V42, P334, DOI 10.1002/mrd.1080420311; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; BIGGEMANN B, 1988, SCAND J GASTROENTERO, V23, P135, DOI 10.3109/00365528809090234; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; CARLSTEDTDUKE J, 1986, P NATL ACAD SCI USA, V83, P9202, DOI 10.1073/pnas.83.23.9202; CHRISTOPHE AB, 1994, LIPIDS, V29, P569, DOI 10.1007/BF02536629; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; Durno C, 2002, GASTROENTEROLOGY, V123, P1857, DOI 10.1053/gast.2002.37042; Farrell PM, 1996, PEDIATRICS, V97, P524; FARRELL PM, 1985, PEDIATR RES, V19, P104, DOI 10.1203/00006450-198501000-00028; Freedman SD, 2002, J APPL PHYSIOL, V92, P2169, DOI 10.1152/japplphysiol.00927.2001; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GOLDSTEIN JL, 1988, AM J PHYSIOL, V254, pC719, DOI 10.1152/ajpcell.1988.254.5.C719; Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; Hollander M., 1999, NONPARAMETRIC STAT M, P202; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; HUBBARD VS, 1977, LANCET, V2, P1302; Kammouni W, 1997, INFECT IMMUN, V65, P5176, DOI 10.1128/IAI.65.12.5176-5183.1997; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; KUO PT, 1962, J PEDIATR-US, V60, P394, DOI 10.1016/S0022-3476(62)80065-1; KUTTY KM, 1979, CLIN BIOCHEM, V12, P98, DOI 10.1016/S0009-9120(79)80074-0; LAPOSATA M, 1995, AM J CLIN PATHOL, V104, P172; LLOYDSTILL JD, 1981, AM J CLIN NUTR, V34, P1; LONDON SJ, 1991, AM J CLIN NUTR, V54, P340, DOI 10.1093/ajcn/54.2.340; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Roulet M, 1997, EUR J PEDIATR, V156, P952, DOI 10.1007/s004310050750; RUBIN D, 1992, J LIPID RES, V33, P1431; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Strandvik B, 2001, J PEDIATR-US, V139, P650, DOI 10.1067/mpd.2001.118890; Tabary O, 1998, AM J PATHOL, V153, P921, DOI 10.1016/S0002-9440(10)65633-7; TAUSSIG LM, 1973, J PEDIATR-US, V82, P380, DOI 10.1016/S0022-3476(73)80110-6; Tzetis M, 2001, HUM GENET, V108, P216, DOI 10.1007/s004390100467; VEEZE HJ, 1991, GASTROENTEROLOGY, V101, P398, DOI 10.1016/0016-5085(91)90017-F; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607	44	298	307	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2004	350	6					560	569		10.1056/NEJMoa021218	http://dx.doi.org/10.1056/NEJMoa021218			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770FP	14762183	Bronze			2022-12-01	WOS:000188712800007
J	Reinhard, J; Srinivasan, MV; Zhang, SW				Reinhard, J; Srinivasan, MV; Zhang, SW			Olfaction: Scent-triggered navigation in honeybees	NATURE			English	Editorial Material									Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia	Australian National University	Reinhard, J (corresponding author), Australian Natl Univ, Res Sch Biol Sci, GPO Box 475, Canberra, ACT 2601, Australia.	reinhard@rsbs.anu.du.au	Zhang, Shaowu/C-9139-2009; Srinivasan, Mandyam V/G-5571-2010	Zhang, Shaowu/0000-0002-3551-5587; Muthukumarasamy, Srinivasan/0000-0002-2948-6206				Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; FREE JB, 1969, NATURE, V222, P778, DOI 10.1038/222778a0; Gould James L., 1993, P18; Jakobsen HB, 1995, J CHEM ECOL, V21, P1635, DOI 10.1007/BF02033666; Ribbands C. R., 1954, Proceedings of the Royal Entomological Society of London (A), V29, P141; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; von Frisch K, 1969, DANCE LANGUAGE ORIEN; WEHNER R, 1981, HDB SENSORY PHYSL, P288	8	117	124	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 29	2004	427	6973					411	411		10.1038/427411a	http://dx.doi.org/10.1038/427411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749818	Bronze			2022-12-01	WOS:000188470500030
J	Gupta, R; Irwin, A; Raviglione, MC; Kim, JY				Gupta, R; Irwin, A; Raviglione, MC; Kim, JY			Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis	LANCET			English	Article							HIV; HEALTH	The UN has launched an initiative to place 3 million people in developing countries on antiretroviral AIDS treatment by end 2005 (the 3 by 5 target). Lessons for HIV/AIDS treatment scale-up emerge from recent experience with multidrug-resistant tuberculosis. Expansion of treatment for multidrug-resistant tuberculosis through the multipartner mechanism known as the Green Light Committee (GLC) has enabled gains in areas relevant to 3 by 5, including policy development, drug procurement, rational use of drugs, and the strengthening of health systems. The successes of the GLC and the obstacles it has encountered provide insights for building sustainable HIV/AIDS treatment programmes.	WHO, Off Director Gen, CH-1211 Geneva, Switzerland; WHO, Evidence Informat & Policy Cluster, CH-1211 Geneva, Switzerland; WHO, Div Stop TB, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization; World Health Organization	Gupta, R (corresponding author), WHO, Off Director Gen, 20 Ave Appia, CH-1211 Geneva, Switzerland.	guptara@who.int		RAVIGLIONE, Mario/0000-0002-9331-2067; Gupta, Rajesh/0000-0002-3307-6541				ARNADOTTIR T, 2001, GUIDELINES ESTABLISH; Cullinan T, 2001, LANCET, V357, P1124, DOI 10.1016/S0140-6736(00)04268-9; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Flament-Saillour M, 1999, AM J RESP CRIT CARE, V160, P587, DOI 10.1164/ajrccm.160.2.9901012; FREEMAN P, 1999, PAN AM HLTH ORG REVO; Geerligs WA, 2000, INT J TUBERC LUNG D, V4, P758; Gupta R, 2003, INT J TUBERC LUNG D, V7, P410; Gupta R, 2002, INT J TUBERC LUNG D, V6, P651; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Gupta R, 2001, INT J TUBERC LUNG D, V5, P1078; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; MUKHERJEE J, 2003, ACCESS ANTIRETROVIRA; Mukherjee JS, 2003, BMJ-BRIT MED J, V327, P1104, DOI 10.1136/bmj.327.7423.1104; Narita M, 2001, CHEST, V120, P343, DOI 10.1378/chest.120.2.343; OKERO A, 2003, SCALING ANTIRETROVIR; [Organization WH World Health Organization Joint United Nations Programme on HIV/AIDS], 2003, TREAT 3 MILL 2005 MA; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; RABKIN M, 2003, SAVING MOTHERS SAVIN; RIEDMAN MA, 2003, LANCET, V361, P341; Riekstina V, 2003, INT J TUBERC LUNG D, V7, P903; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404; *U CAP TOWN DEP PU, 2003, ANT THER PRIM HLTH C; Viskum K, 1997, INT J TUBERC LUNG D, V1, P299; WHO, 1997, GUID MAN DRUG RES TU; *WHO, PREQ PROJ; *WHO, 2003, UNPUB M STOP TB WORK; WHO, 1997, TREATM TUB GUID NAT, V2; *WHO, WHO SAYS FAIL DEL AI; World Health Organization, 2002, SCAL ANT THER RES LT; World Health Organization, 2003, SCAL ANT THER RES LT; ZIMMERMAN R, 2003, WALL STREET J   0605	37	20	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2004	363	9405					320	324		10.1016/S0140-6736(03)15394-9	http://dx.doi.org/10.1016/S0140-6736(03)15394-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766FQ	14751708				2022-12-01	WOS:000188361400026
J	Harding, EJ; Paul, ES; Mendl, M				Harding, EJ; Paul, ES; Mendl, M			Animal behavior - Cognitive bias and affective state	NATURE			English	Editorial Material							DEPRESSION; INDICATOR; ANXIETY; REWARD		Univ Bristol, Ctr Behav Biol, Dept Vet Clin Sci, Langford BS40 5DU, England	University of Bristol	Harding, EJ (corresponding author), Univ Bristol, Ctr Behav Biol, Dept Vet Clin Sci, Langford House, Langford BS40 5DU, England.	mike.mendl@bris.ac.uk	Mendl, Michael T/D-7220-2016	Mendl, Michael T/0000-0002-5302-1871				Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; DAWKINS MS, 2001, COPING CHALLENGE WEL, P63; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Gotlib IH, 1998, BEHAV THER, V29, P603, DOI 10.1016/S0005-7894(98)80020-8; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; Nielsen BL, 1999, APPL ANIM BEHAV SCI, V63, P79, DOI 10.1016/S0168-1591(99)00003-9; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WRIGHT WF, 1992, ORGAN BEHAV HUM DEC, V52, P276, DOI 10.1016/0749-5978(92)90039-A; Zurita A, 2000, BEHAV BRAIN RES, V117, P163, DOI 10.1016/S0166-4328(00)00302-8	11	490	495	2	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2004	427	6972					312	312		10.1038/427312a	http://dx.doi.org/10.1038/427312a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765KE	14737158				2022-12-01	WOS:000188266200030
J	Modis, Y; Ogata, S; Clements, D; Harrison, SC				Modis, Y; Ogata, S; Clements, D; Harrison, SC			Structure of the dengue virus envelope protein after membrane fusion	NATURE			English	Article							BORNE ENCEPHALITIS-VIRUS; SEMLIKI-FOREST-VIRUS; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGE; GLYCOPROTEIN; DOMAIN; HEMIFUSION; PEPTIDE; BINDING; ENTRY	Dengue virus enters a host cell when the viral envelope glycoprotein, E, binds to a receptor and responds by conformational rearrangement to the reduced pH of an endosome. The conformational change induces fusion of viral and host- cell membranes. A three- dimensional structure of the soluble E ectodomain ( sE) in its trimeric, postfusion state reveals striking differences from the dimeric, prefusion form. The elongated trimer bears three ` fusion loops' at one end, to insert into the host- cell membrane. Their structure allows us to model directly how these fusion loops interact with a lipid bilayer. The protein folds back on itself, directing its carboxy terminus towards the fusion loops. We propose a fusion mechanism driven by essentially irreversible conformational changes in E and facilitated by fusion- loop insertion into the outer bilayer leaflet. Specific features of the folded- back structure suggest strategies for inhibiting flavivirus entry.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Hawaii Biotech Inc, Aiea, HI 96701 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Harrison, SC (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu		Modis, Yorgo/0000-0002-6084-0429				Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CECILIA D, 1991, VIROLOGY, V181, P70, DOI 10.1016/0042-6822(91)90471-M; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001; Dutch RE, 2001, J VIROL, V75, P5363, DOI 10.1128/JVI.75.11.5363-5369.2001; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; GAO GF, 1994, J GEN VIROL, V75, P609, DOI 10.1099/0022-1317-75-3-609; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HOLZMANN H, 1990, J VIROL, V64, P5156, DOI 10.1128/JVI.64.10.5156-5159.1990; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; IVY J, 1997, Patent No. 6165477; JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512; JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; LOBIGS M, 1990, VIROLOGY, V176, P587, DOI 10.1016/0042-6822(90)90029-Q; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Razinkov VI, 1999, BIOPHYS J, V77, P3144, DOI 10.1016/S0006-3495(99)77144-4; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WIMLEY WC, 1992, BIOCHEMISTRY-US, V31, P12813, DOI 10.1021/bi00166a015; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990	51	850	906	5	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					313	319		10.1038/nature02165	http://dx.doi.org/10.1038/nature02165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14737159				2022-12-01	WOS:000188266200031
J	Strang, J; Fortson, R				Strang, J; Fortson, R			Commentary: Supervised fixing rooms, supervised injectable maintenance clinics - understanding the difference	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Natl Addict Ctr, London SE5 8AF, England	University of London; King's College London	Strang, J (corresponding author), Kings Coll London, Natl Addict Ctr, London SE5 8AF, England.	johnstrang@iop.kcl.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				BURRELL I, 2000, INDEPENDENT     0120; *SEL COMM HOM AFF, 2002, 3 SEL COMM HOM AFF; van Beek I, 2003, J DRUG ISSUES, V33, P625, DOI 10.1177/002204260303300305; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310; Zador D, 2001, ADDICTION, V96, P547, DOI 10.1046/j.1360-0443.2001.9645473.x	5	14	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 10	2004	328	7431					102	103		10.1136/bmj.328.7431.102	http://dx.doi.org/10.1136/bmj.328.7431.102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MP	14715607	Green Published			2022-12-01	WOS:000187976400023
J	Schwartz, LM; Woloshin, S; Fowler, FJ; Welch, HG				Schwartz, LM; Woloshin, S; Fowler, FJ; Welch, HG			Enthusiasm for cancer screening in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MAMMOGRAPHY; HEALTH	Context Public health officials, physicians, and disease advocacy groups have worked hard to educate individuals living in the United States about the importance of cancer screening. Objective To determine the public's enthusiasm for early cancer detection. Design, Setting, and Participants Survey using a national telephone interview of adults selected by random digit dialing, conducted from December 2001 through July 2002. Five hundred individuals participated (women aged greater than or equal to40 years and men aged greater than or equal to50 years; without a history of cancer). Main Outcome Measures Responses to a survey with 5 modules: a general screening module (eg, value of early detection, total-body computed tomography); and 4 screening test modules: Papanicolaou test; mammography; prostate-specific antigen (PSA) test; and sigmoidoscopy or colonoscopy. Results Most adults (87%) believe routine cancer screening is almost always a good idea and that finding cancer early saves lives (74% said most or all the time). Less than one third believe that there will be a time when they will stop undergoing routine screening. A substantial proportion believe that an 80-year-old who chose not to be tested was irresponsible: ranging from 41% with regard to mammography to 32% for colonoscopy. Thirty-eight percent of respondents had experienced at least 1 false-positive screening test; more than 40% of these individuals characterized that experience as "very scary" or the "scariest time of my life." Yet, looking back, 98% were glad they had had the initial screening test. Most had a strong desire to know about the presence of cancer regardless of its implications: two thirds said they would want to be tested for cancer even if nothing could be done; and 56% said they would want to be tested for what is sometimes termed pseudodisease (cancers growing so slowly that they would never cause problems during the persons lifetime even if untreated). Seventy-three percent of respondents would prefer to receive a total-body computed tomographic scan instead of receiving $1000 in cash. Conclusions The public is enthusiastic about cancer screening. This commitment is not dampened by false-positive test results or the possibility that testing could lead to unnecessary treatment. This enthusiasm creates an environment ripe for the premature diffusion of technologies such as total-body computed tomographic scanning, placing the public at risk of overtesting and overtreatment.	VA Outcomes Grp, White River Jct, VT USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; Univ Massachusetts, Norris Cotton Canc Ctr, Boston, MA 02125 USA	VA Outcomes Group; Dartmouth College; University of Massachusetts System; University of Massachusetts Boston; Norris Cotton Cancer Center; University of Massachusetts System; University of Massachusetts Boston	Woloshin, S (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA.				NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER; NCI NIH HHS [CA91052-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM ASS PHYS MED, CT BOD SCANN NOT SCI; *AM ASS PUBL OP RE, STAND BEST PRACT STA; *AM CANC SOC, AM CANC SOC ISS NEW; *AM COLL RAD, ACR STAT CT SCREEN E; Black WC, 2000, J NATL CANCER I, V92, P1280, DOI 10.1093/jnci/92.16.1280; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; BRODY JE, 2002, NY TIMES        0924, pF7; *CDCP, 2002, BEH RISK FACT SURV S; Fletcher SW, 1997, NEW ENGL J MED, V336, P1180, DOI 10.1056/NEJM199704173361612; Frame PS, 2000, JAMA-J AM MED ASSOC, V284, P1980, DOI 10.1001/jama.284.15.1980; Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; HASS N, 2001, NY TIMES        0826, P1; Kolata G, 2002, N Y Times Web, P18; Kramer BS, 2000, HEMATOL ONCOL CLIN N, V14, P831, DOI 10.1016/S0889-8588(05)70314-2; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; Lerner Barron H, 2001, BREAST CANC WARS HOP; Linnan LA, 2001, PREV MED, V33, P606, DOI 10.1006/pmed.2001.0933; *NIH, 1997, BREAST CANC SCREEN W; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Ransohoff DF, 2002, AM J MED, V113, P663, DOI 10.1016/S0002-9343(02)01235-4; RUGGLES S, 1997, CENSUS 2000 DATA INT; Schwartz Lisa M., 1999, Journal of the National Cancer Institute Monographs, P124; *US BUR CENS, STAT ABSTR US TABL 1; *US FDA, WHOL BOD SCANN US CO; Welch HG, 2001, JAMA-J AM MED ASSOC, V285, P2776, DOI 10.1001/jama.285.21.2776; Wolfe SM, 2002, NEW ENGL J MED, V346, P524, DOI 10.1056/NEJM200202143460713; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112; 2003, CERVICAL CANC RECOMM	30	488	491	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2004	291	1					71	78		10.1001/jama.291.1.71	http://dx.doi.org/10.1001/jama.291.1.71			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760LX	14709578				2022-12-01	WOS:000187836000021
J	Hall, P; Adami, HO; Trichopoulos, D; Pedersen, NL; Lagiou, P; Ekbom, A; Ingvar, M; Lundell, M; Granath, F				Hall, P; Adami, HO; Trichopoulos, D; Pedersen, NL; Lagiou, P; Ekbom, A; Ingvar, M; Lundell, M; Granath, F			Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POOLED ANALYSIS; EXPOSURE; CHILDREN; IRRADIATION; TUMORS; RADIOTHERAPY; HEMANGIOMA; RADIUM; CANCER; RISK	Objective To determine whether exposure to low doses of ionising radiation in infancy affects cognitive function in adulthood. Design Population based cohort study. Setting Sweden. Participants 3094 men who had received radiation for cutaneous haemangioma before age 18 months during 1930-59. Main outcome measures Radiation dose to frontal and posterior parts of the brain, and association between dose and intellectual capacity at age 18 or 19 years based on cognitive tests (learning ability, logical reasoning, spatial recognition) and high school attendance. Results ne proportion of boys who attended high school decreased with increasing doses of radiation to both the frontal and the posterior parts of the brain from about 32% among those not exposed to around 17% in those who received >250 mGy. For the frontal dose, the multivariate odds ratio was 0.47 (95% confidence interval 0.26 to 0.85; P for trend 0.0003) and for the posterior dose it was 0.59 (0.23 to 1.47; 0.0005). A negative dose-response relation was also evident for the three cognitive tests for learning ability and logical reasoning but not for the test of spatial recognition. Conclusions Low doses of ionising radiation to the brain in infancy influence cognitive abilities in adulthood.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Harvard Ctr Canc Prevent, Dept Epidemiol, Boston, MA 02115 USA; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-10679 Athens, Greece; Karlinska Univ Hosp, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Karlinska Univ Hosp, Dept Hosp Phys, SE-17176 Stockholm, Sweden	Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Athens Medical School; National & Kapodistrian University of Athens	Hall, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.	Per.Hall@mep.ki.se		Ingvar, Martin/0000-0002-9041-5714				Anderson VA, 2000, BRIT J CANCER, V82, P255; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Carlstedt B, 2000, THESIS U GOTHENBURG; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; FOGARTY K, 1988, CLIN PEDIATR, V27, P524, DOI 10.1177/000992288802701102; Hall P, 1999, RADIAT RES, V152, P190, DOI 10.2307/3580093; HUSEN T, 1944, TULSKRIFT PSYKOLOGI, V43, P114; Kallen B, 1998, RADIAT RES, V149, P202, DOI 10.2307/3579931; Karlsson P, 1998, RADIAT RES, V150, P357, DOI 10.2307/3579984; KOLB B, 1990, FUNDAMENTALS HUMAN N, P412; LEITZ W, 2001, PATIENT DOSES XRAYS; LEITZ W, 2001, PATIENTS DOSES XRAYS; Lundell M, 1999, RADIAT RES, V151, P626, DOI 10.2307/3580039; LUNDELL M, 1995, ACTA ONCOL, V34, P727, DOI 10.3109/02841869509127179; LUNDELL M, 1994, RADIAT RES, V140, P327, DOI 10.2307/3579109; LUNDELL M, 1990, ACTA ONCOL, V29, P551, DOI 10.3109/02841869009090049; *NAT BOARD HLTH WE, 1982, REP STAT COORD; OTAKE M, 1984, BRIT J RADIOL, V57, P409, DOI 10.1259/0007-1285-57-677-409; Riva D, 2000, CHILD NERV SYST, V16, P751, DOI 10.1007/s003810000332; RON E, 1982, AM J EPIDEMIOL, V116, P149, DOI 10.1093/oxfordjournals.aje.a113389; Schull WJ, 1999, TERATOLOGY, V59, P222, DOI 10.1002/(SICI)1096-9926(199904)59:4<222::AID-TERA6>3.0.CO;2-M; Schull WJ, 1997, STEM CELLS, V15, P129; Schultz H. - D., 1997, EUROPA REGIONAL, V5, P2; Skowronska-Gardas A, 1999, MED PEDIATR ONCOL, V33, P572; UNSCEAR, 2000, SOURC EFF ION RAD; YOSHIMARU H, 1995, INT J RADIAT BIOL, V67, P359, DOI 10.1080/09553009514550411	26	229	238	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2004	328	7430					19	21		10.1136/bmj.328.7430.19	http://dx.doi.org/10.1136/bmj.328.7430.19			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761QG	14703539	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000187919000015
J	Klak, C; Reeves, G; Hedderson, T				Klak, C; Reeves, G; Hedderson, T			Unmatched tempo of evolution in Southern African semi-desert ice plants	NATURE			English	Article							DIVERSIFICATION RATES; AIZOACEAE	The Succulent Karoo is an arid region, situated along the west coast of southern Africa. Floristically this region is part of the Greater Cape Flora(1) and is considered one of the Earth's 25 biodiversity hotspots(2). Of about 5,000 species occurring in this region, more than 40% are endemic(3). Aizoaceae (ice plants) dominate the Succulent Karoo both in terms of species numbers (1,750 species in 127 genera) and density of coverage(3,4). Here we show that a well-supported clade within the Aizoaceae, representing 1,563 species almost exclusively endemic to southern Africa, has diversified very recently and very rapidly. The estimated age for this radiation lies between 3.8 and 8.7 million years (Myr) ago, yielding a per-lineage diversification rate of 0.77-1.75 per million years. Both the number of species involved and the tempo of evolution far surpass those of any previously postulated continental or island plant radiation(5-7). Diversification of the group is closely associated with the origin of several morphological features and one anatomical feature. Because species-poor clades lacking these features occur over a very similar distribution area, we propose that these characteristics are key innovations that facilitated this radiation.	Univ Cape Town, Dept Bot, Bolus Herbarium, ZA-7701 Rondebosch, South Africa; Natl Bot Inst Cape Town, Kirstenbosch Res Ctr, Leslie Hill Mol Systemat Lab, ZA-7735 Claremont, South Africa	University of Cape Town	Klak, C (corresponding author), Univ Cape Town, Dept Bot, Bolus Herbarium, ZA-7701 Rondebosch, South Africa.	klak@botzoo.uct.ac.za	Hedderson, Terry/AAD-8614-2021					Axelrod D. I., 1978, Biogeography and ecology of Southern Africa. Vol.1., P77; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Hendey QB., 1982, LANGEBAANWEG RECORD; HULBERT RC, 1993, PALEOBIOLOGY, V19, P216, DOI 10.1017/S0094837300015888; IHLENFELDT HD, 1994, ANNU REV ECOL SYST, V25, P521; JURGENS N, 1991, VEGETATIO, V97, P21; Jurgens N., 1986, MITT I ALLG BOT HAMB, V21, P129; Klak C, 2003, AM J BOT, V90, P1433, DOI 10.3732/ajb.90.10.1433; Landrum JV, 2001, PLANT SYST EVOL, V227, P49, DOI 10.1007/s006060170056; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Mauseth JD, 1995, J PLANT RES, V108, P517, DOI 10.1007/BF02344242; Mayhew PJ, 2002, P ROY SOC B-BIOL SCI, V269, P969, DOI 10.1098/rspb.2002.1957; McCune Amy R., 1997, P585; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Parolin P, 2001, FLORA, V196, P313; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schmiedel U, 1999, PLANT ECOL, V142, P57, DOI 10.1023/A:1009818210799; Scott L., 1997, P62; Scott L, 1995, QUATERNARY SCI REV, V14, P937, DOI 10.1016/0277-3791(95)00072-0; Swofford D.L., 1998, PAUP 4 0B2 PHYLOGENE; TANKARD AJ, 1978, J BIOGEOGR, V5, P319, DOI 10.2307/3038026; Ward J, 1990, MONOGRAPH TRANSVAAL, V7, P17; WARD JD, 1983, S AFR J SCI, V79, P175; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	30	242	251	0	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					63	65		10.1038/nature02243	http://dx.doi.org/10.1038/nature02243			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702084				2022-12-01	WOS:000187710000033
J	Arnold, P				Arnold, P			Why running is not for people	BRITISH MEDICAL JOURNAL			English	Article											Arnold, P (corresponding author), 202-170 Ocean St, Sydney, NSW 2027, Australia.							PORTER R, 2002, BLOOD GUTS SHORT HIS, P4	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1476	1476		10.1136/bmj.327.7429.1476	http://dx.doi.org/10.1136/bmj.327.7429.1476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684658	Green Published			2022-12-01	WOS:000187562700029
J	Mercereau-Puijalon, O				Mercereau-Puijalon, O			Antimalarial activity of artemisinins: identification of a novel target?	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; MALARIA; ERYTHROCYTES		Inst Pasteur, Unite Immunol Mol Parasites, CNRS, URA 2581, F-75724 Paris 15, France; Inst Pasteur Cambodge, Lab Epidemiol Mol, Phnom Penh, Cambodia	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Mercereau-Puijalon, O (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, CNRS, URA 2581, F-75724 Paris 15, France.	omp@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020					Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; Dow GS, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-4; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; ELLIS DS, 1985, ANN TROP MED PARASIT, V79, P367, DOI 10.1080/00034983.1985.11811933; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; GU HM, 1984, T ROY SOC TROP MED H, V78, P265, DOI 10.1016/0035-9203(84)90296-7; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; KIMURA M, 1993, J CELL SCI, V104, P1129; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Olliaro PL, 2001, TRENDS PARASITOL, V17, P122, DOI 10.1016/S1471-4922(00)01838-9; Varotti FP, 2003, CELL CALCIUM, V33, P137, DOI 10.1016/S0143-4160(02)00224-5; Vyas N, 2002, ANTIMICROB AGENTS CH, V46, P105, DOI 10.1128/AAC.46.1.105-109.2002	14	13	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2003	362	9401					2035	2036		10.1016/S0140-6736(03)15146-X	http://dx.doi.org/10.1016/S0140-6736(03)15146-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UJ	14697798				2022-12-01	WOS:000187429600003
J	Shann, F				Shann, F			Hypothermia for traumatic brain injury: how soon, how cold, and how long?	LANCET			English	Editorial Material							LOW INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; HYPERTENSION		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.		Shann, Frank/C-9510-2011					Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Colbourne F, 1998, STROKE, V29, P1967, DOI 10.1161/01.STR.29.9.1967; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; GADKARY CA, 2003, COCHRANE LIB; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; HIRAYAMA T, 1994, INTRACRANIAL PRESSUR, V9; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iida K, 2003, J NEUROSURG, V98, P793, DOI 10.3171/jns.2003.98.4.0793; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; LEROUX PD, 1991, CHILD NERV SYST, V7, P34, DOI 10.1007/BF00263831; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MEISSNER W, 1998, CRITICAL CARE MED S1, V26, pA82; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Yan Y, 2001, Chin J Traumatol, V4, P8; Zhang K, 2000, INNER MONGOLIA MED J, V32, P4	27	33	36	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1950	1951		10.1016/S0140-6736(03)15083-0	http://dx.doi.org/10.1016/S0140-6736(03)15083-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683651				2022-12-01	WOS:000187210700004
J	Ferreira, KN; Iverson, TM; Maghlaoui, K; Barber, J; Iwata, S				Ferreira, KN; Iverson, TM; Maghlaoui, K; Barber, J; Iwata, S			Architecture of the photosynthetic oxygen-evolving center	SCIENCE			English	Article							WATER-OXIDIZING COMPLEX; AMINO-ACID-RESIDUES; SITE-DIRECTED MUTAGENESIS; PRIMARY CHARGE SEPARATION; PRIMARY ELECTRON-DONOR; II REACTION-CENTER; PHOTOSYSTEM-II; BETA-CAROTENE; 3-DIMENSIONAL STRUCTURE; ANGSTROM RESOLUTION	Photosynthesis uses light energy to drive the oxidation of water at an oxygen-evolving catalytic site within photosystem II ( PSII). We report the structure of PSII of the cyanobacterium Thermosynechococcus elongatus at 3.5 angstrom resolution. We have assigned most of the amino acid residues of this 650-kilodalton dimeric multisubunit complex and refined the structure to reveal its molecular architecture. Consequently, we are able to describe details of the binding sites for cofactors and propose a structure of the oxygen-evolving center (OEC). The data strongly suggest that the OEC contains a cubane-like Mn3CaO4 cluster linked to a fourth Mn by a mono-mu-oxo bridge. The details of the surrounding coordination sphere of the metal cluster and the implications for a possible oxygen-evolving mechanism are discussed.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; ERATO, Japan Sci & Technol Corp, ATP Syst Project, Yokohama, Kanagawa 2260026, Japan; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England	Imperial College London; Japan Science & Technology Agency (JST); Imperial College London	Barber, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England.	j.barber@imperial.ac.uk; s.iwata@imperial.ac.uk			NIGMS NIH HHS [F32 GM068304-01, F32 GM068304] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068304] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JP, 1988, P NATL ACAD SCI USA, V85, P8487, DOI 10.1073/pnas.85.22.8487; [Anonymous], 1996, ADV PHOTOSYNTH; Baranov SV, 2000, BIOCHEMISTRY-US, V39, P6060, DOI 10.1021/bi992682c; Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; Barber J, 2001, J PHOTOCH PHOTOBIO A, V142, P97, DOI 10.1016/S1010-6030(01)00503-2; Barter LMC, 2003, P NATL ACAD SCI USA, V100, P946, DOI 10.1073/pnas.0136891100; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5859, DOI 10.1021/bi00017a017; de Weerd FL, 2002, BIOPHYS J, V82, P1586, DOI 10.1016/S0006-3495(02)75510-0; Debus RJ, 2001, BBA-BIOENERGETICS, V1503, P164, DOI 10.1016/S0005-2728(00)00221-8; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dekker JP, 2000, PHOTOSYNTH RES, V63, P195, DOI 10.1023/A:1006468024245; DEPAULA JC, 1986, J AM CHEM SOC, V108, P4002, DOI 10.1021/ja00274a025; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; Diner BA, 2001, BBA-BIOENERGETICS, V1503, P147, DOI 10.1016/S0005-2728(00)00220-6; Diner BA, 1991, CURR OPIN STRUC BIOL, V1, P546, DOI 10.1016/S0959-440X(05)80076-4; DURRANT JR, 1995, P NATL ACAD SCI USA, V92, P4798, DOI 10.1073/pnas.92.11.4798; Faller P, 2001, P NATL ACAD SCI USA, V98, P14368, DOI 10.1073/pnas.251382598; Faller P, 2001, BIOCHEMISTRY-US, V40, P6431, DOI 10.1021/bi0026021; Fromme P, 2002, PHILOS T R SOC B, V357, P1337, DOI 10.1098/rstb.2002.1143; GOVINDJEE, 1993, PHOTOSYNTHETIC REACT, V1, P357; Hankamer B, 2001, J STRUCT BIOL, V135, P262, DOI 10.1006/jsbi.2001.4405; Hanley J, 1999, BIOCHEMISTRY-US, V38, P8189, DOI 10.1021/bi990633u; Haumann M, 1999, BBA-BIOENERGETICS, V1411, P86, DOI 10.1016/S0005-2728(99)00042-0; Hienerwadel R, 1995, BIOCHEMISTRY-US, V34, P16288, DOI 10.1021/bi00050a008; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Knoepfle N, 1999, BIOCHEMISTRY-US, V38, P1582, DOI 10.1021/bi9821418; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; OETTMEIER W, 1992, TOPICS PHOTOSYNTHESI, V11, P349; Pecoraro VL, 1998, PURE APPL CHEM, V70, P925, DOI 10.1351/pac199870040925; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; Rosenberg C, 1999, BIOCHEMISTRY-US, V38, P15994, DOI 10.1021/bi991326r; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Siegbahn PEM, 2002, CURR OPIN CHEM BIOL, V6, P227, DOI 10.1016/S1367-5931(02)00312-5; Siegbahn PEM, 1999, J AM CHEM SOC, V121, P117, DOI 10.1021/ja982290d; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; TELFER A, 1991, BIOCHIM BIOPHYS ACTA, V1060, P106, DOI 10.1016/S0005-2728(05)80125-2; TELFER A, 1994, BIOCHEMISTRY-US, V33, P14469, DOI 10.1021/bi00252a013; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Tracewell CA, 2003, BIOCHEMISTRY-US, V42, P9127, DOI 10.1021/bi0345844; Tracewell CA, 2001, ARCH BIOCHEM BIOPHYS, V385, P61, DOI 10.1006/abbi.2000.2150; Tracewell CA, 2001, BIOCHEMISTRY-US, V40, P193, DOI 10.1021/bi001992o; VINCENT JB, 1987, INORG CHIM ACTA, V136, P41; Vrettos JS, 2001, BBA-BIOENERGETICS, V1503, P229, DOI 10.1016/S0005-2728(00)00214-0; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	2746	2834	20	973	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2004	303	5665					1831	1838		10.1126/science.1093087	http://dx.doi.org/10.1126/science.1093087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	804EI	14764885				2022-12-01	WOS:000220281600046
J	He, JF; Peng, GW; Min, J; Yu, DW; Liang, WJ; Zhang, SY; Xu, RH; Zheng, HY; Wu, XW; Xu, J; Wang, ZH; Fang, L; Zhang, X; Li, H; Yan, XG; Lu, JH; Hu, ZH; Huang, JC; Wan, ZY; Hou, JL; Lin, JY; Song, HD; Wang, SY; Zhou, XJ; Zhang, GW; Gu, BW; Zheng, HJ; Zhang, XL; He, M; Zheng, K; Wang, BF; Fu, G; Wang, XN; Chen, SJ; Chen, Z; Hao, P; Tang, H; Ren, SX; Zhong, Y; Guo, ZM; Liu, Q; Miao, YG; Kong, XY; He, WZ; Li, YX; Wu, CI; Zhao, GP; Chiu, RWK; Chim, SSC; Tong, YK; Chan, PKS; Tam, JS; Lo, YMD				He, JF; Peng, GW; Min, J; Yu, DW; Liang, WJ; Zhang, SY; Xu, RH; Zheng, HY; Wu, XW; Xu, J; Wang, ZH; Fang, L; Zhang, X; Li, H; Yan, XG; Lu, JH; Hu, ZH; Huang, JC; Wan, ZY; Hou, JL; Lin, JY; Song, HD; Wang, SY; Zhou, XJ; Zhang, GW; Gu, BW; Zheng, HJ; Zhang, XL; He, M; Zheng, K; Wang, BF; Fu, G; Wang, XN; Chen, SJ; Chen, Z; Hao, P; Tang, H; Ren, SX; Zhong, Y; Guo, ZM; Liu, Q; Miao, YG; Kong, XY; He, WZ; Li, YX; Wu, CI; Zhao, GP; Chiu, RWK; Chim, SSC; Tong, YK; Chan, PKS; Tam, JS; Lo, YMD		Chinese SARS Mol Epidemiology	Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China	SCIENCE			English	Article							ACUTE-RESPIRATORY-SYNDROME; GENOME SEQUENCE; AMOY GARDENS; OUTBREAK; VIRUS; IDENTIFICATION; VIRULENCE; MUTATION; HISTORY; RATES	Sixty-one SARS coronavirus genomic sequences derived from the early, middle, and late phases of the severe acute respiratory syndrome ( SARS) epidemic were analyzed together with two viral sequences from palm civets. Genotypes characteristic of each phase were discovered, and the earliest genotypes were similar to the animal SARS-like coronaviruses. Major deletions were observed in the Orf8 region of the genome, both at the start and the end of the epidemic. The neutral mutation rate of the viral genome was constant but the amino acid substitution rate of the coding sequences slowed during the course of the epidemic. The spike protein showed the strongest initial responses to positive selection pressures, followed by subsequent purifying selection and eventual stabilization.	Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Shanghai Med Univ 2, Ruijin Hosp, State Key Lab Med Genom Pole Sino Francais Rech S, Shanghai 200025, Peoples R China; Guangdong Ctr Dis Control & Prevent, Guangzhou 510300, Guangdong, Peoples R China; Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510120, Guangdong, Peoples R China; Chinese Acad Sci, Inst Zool, Beijing 100080, Peoples R China; Guangzhou Ctr Dis Control & Prevent, Guangzhou 510080, Guangdong, Peoples R China; Guangzhou Inst Resp Dis, Guangzhou 510120, Guangdong, Peoples R China; First Med Univ, Nanfang Hosp, Dept Infect Dis & Mol Immunol, Guangzhou 510515, Guangdong, Peoples R China; Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China; Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Hlth Sci Ctr, Inst Plant Physiol & Eocl,Bioinformat Ctr, Shanghai 200031, Peoples R China; Shanghai Ctr Bioinformat Technol, Shanghai 200235, Peoples R China; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Sun Yat Sen University; Chinese Academy of Sciences; Institute of Zoology, CAS; Southern Medical University - China; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chicago; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr Shanghai, 250 Bi Bo Rd,Zhang Jiang High Tech Pk, Shanghai 201203, Peoples R China.	gpzhao@ibs.ac.cn	Chan, Paul KS/J-9360-2013; Zhang, Shuyi/B-5117-2011; Hu, Zhihong/AAS-2215-2020; Chim, Stephen SC/O-6271-2016; Lo, Yuk Ming Dennis/D-4468-2011; Song, Huai-Dong/G-8961-2011	Chan, Paul KS/0000-0002-6360-4608; Hu, Zhihong/0000-0002-1560-0928; Chim, Stephen SC/0000-0002-2152-7050; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Hao, Pei/0000-0002-1498-7059; Zhao, Guo-Ping/0000-0002-7621-6620				Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P241; Chim SSC, 2003, LANCET, V362, P1807, DOI 10.1016/S0140-6736(03)14901-X; Chiu RWK, 2003, NEW ENGL J MED, V349, P1875, DOI 10.1056/NEJM200311063491923; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ewald PW, 1998, J URBAN HEALTH, V75, P480, DOI 10.1007/BF02427686; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAI MMC, 2001, FIELDS VIROLOGY, pCH35; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; LI WH, 1988, MOL BIOL EVOL, V5, P313; Luo ZL, 1999, J VIROL, V73, P8152, DOI 10.1128/JVI.73.10.8152-8159.1999; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; RASSCHAERT D, 1990, J GEN VIROL, V71, P2599, DOI 10.1099/0022-1317-71-11-2599; Rest JS, 2003, INFECT GENET EVOL, V3, P219, DOI 10.1016/j.meegid.2003.08.001; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Ruan YJ, 2003, LANCET, V361, P1779, DOI 10.1016/S0140-6736(03)13414-9; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Tsui SKW, 2003, NEW ENGL J MED, V349, P187, DOI 10.1056/NEJM200307103490216; Vogel G, 2003, SCIENCE, V300, P1062; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	26	433	462	8	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2004	303	5664					1666	1669		10.1126/science.1092002	http://dx.doi.org/10.1126/science.1092002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802GG	14752165				2022-12-01	WOS:000220151400043
J	Palacios, IM; Gatfield, D; St Johnston, D; Izaurralde, E				Palacios, IM; Gatfield, D; St Johnston, D; Izaurralde, E			An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay	NATURE			English	Article							INITIATION-FACTOR 4AIII; EXON JUNCTION COMPLEX; MAGO NASHI; DROSOPHILA-MELANOGASTER; PROTEIN; POSTERIOR; OOCYTE; TRANSLATION; COMPONENT; BINDING	The specification of both the germ line and abdomen in Drosophila depends on the localization of oskar messenger RNA to the posterior of the oocyte(1,2). This localization requires several transacting factors, including Barentsz and the Mago-Y14 heterodimer, which assemble with oskar mRNA into ribonucleoprotein particles (RNPs) and localize with it at the posterior pole(3-7). Although Barentsz localization in the germ line depends on Mago-Y14, no direct interaction between these proteins has been detected(5). Here, we demonstrate that the translation initiation factor eIF4AIII interacts with Barentsz and is a component of the oskar messenger RNP localization complex. Moreover, eIF4AIII interacts with Mago-Y14 and thus provides a molecular link between Barentsz and the heterodimer. The mammalian Mago (also known as Magoh)-Y14 heterodimer is a component of the exon junction complex(8-11). The exon junction complex is deposited on spliced mRNAs and functions in nonsense-mediated mRNA decay (NMD)(9,11-14), a surveillance mechanism that degrades mRNAs with premature translation-termination codons. We show that both Barentsz and eIF4AIII are essential for NMD in human cells. Thus, we have identified eIF4AIII and Barentsz as components of a conserved protein complex that is essential for mRNA localization in flies and NMD in mammals.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Cambridge; University of Cambridge; European Molecular Biology Laboratory (EMBL)	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	ds139@mole.bio.cam.ac.uk; izaurralde@embl-heidelberg.de	Palacios, Isabel/X-4807-2019; Izaurralde, Elisa/G-3239-2012; St Johnston, Daniel/C-9568-2009; Gatfield, David/C-2354-2011	Gatfield, David/0000-0001-5114-2824; Izaurralde, Elisa/0000-0001-7365-2649; St Johnston, Daniel/0000-0001-5582-3301				BAKER BS, 1991, GENETICS, V127, P125; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Chou TB, 1996, GENETICS, V144, P1673; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Li QY, 1999, MOL CELL BIOL, V19, P7336; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Macchi P, 2003, J NEUROSCI, V23, P5778; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr SE, 2001, GENE DEV, V15, P2886; Newmark PA, 1997, DEVELOPMENT, V124, P3197; SMITH RA, 1998, THESIS CAMBRIDGE U; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Weinstein DC, 1997, DEVELOPMENT, V124, P4235	28	287	296	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2004	427	6976					753	757		10.1038/nature02351	http://dx.doi.org/10.1038/nature02351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775DT	14973490				2022-12-01	WOS:000189026000048
J	Mallik, R; Carter, BC; Lex, SA; King, SJ; Gross, SP				Mallik, R; Carter, BC; Lex, SA; King, SJ; Gross, SP			Cytoplasmic dynein functions as a gear in response to load	NATURE			English	Article							HEAVY-CHAIN; OPTICAL TRAPS; KINESIN; ATP; FORCE; MOVEMENTS; DYNACTIN; PROTEIN; MYOSIN	Cytoskeletal molecular motors belonging to the kinesin and dynein families transport cargos (for example, messenger RNA, endosomes, virus) on polymerized linear structures called microtubules in the cel(l)1. These 'nanomachines' use energy obtained from ATP hydrolysis to generate force(2), and move in a step-like manner on microtubules. Dynein(3-5) has a complex and fundamentally different structure from other motor families. Thus, understanding dynein's force generation can yield new insight into the architecture and function of nanomachines. Here, we use an optical trap(6) to quantify motion of polystyrene beads driven along microtubules by single cytoplasmic dynein motors. Under no load, dynein moves predominantly with a mixture of 24-nm and 32-nm steps. When moving against load applied by an optical trap, dynein can decrease step size to 8 nm and produce force up to 1.1 pN. This correlation between step size and force production is consistent with a molecular gear mechanism. The ability to take smaller but more powerful strokes under load-that is, to shift gears-depends on the availability of ATP. We propose a model whereby the gear is downshifted through load-induced binding of ATP at secondary sites in the dynein head.	Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92612 USA; Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	University of California System; University of California Irvine; University of Missouri System; University of Missouri Kansas City	Gross, SP (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92612 USA.	sgross@uci.edu		mallik, roop/0000-0001-6820-6556				Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hackney DD, 1996, ANNU REV PHYSIOL, V58, P731; Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 2000, J CELL SCI, V113, P2521; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Neuwald AF, 1999, GENOME RES, V9, P27; Rice SE, 2003, METHOD ENZYMOL, V361, P112; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; SLOBODA RD, 1982, METHOD ENZYMOL, V85, P171; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945	30	385	390	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2004	427	6975					649	652		10.1038/nature02293	http://dx.doi.org/10.1038/nature02293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773AJ	14961123				2022-12-01	WOS:000188875300045
J	Wang, TJ; Larson, MG; Levy, D; Benjamin, EJ; Leip, EP; Omland, T; Wolf, PA; Vasan, RS				Wang, TJ; Larson, MG; Levy, D; Benjamin, EJ; Leip, EP; Omland, T; Wolf, PA; Vasan, RS			Plasma natriuretic peptide levels and the risk of cardiovascular events and death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; ATRIAL-FIBRILLATION; DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; SYSTOLIC DYSFUNCTION; PROGNOSTIC VALUE; MORTALITY; DISEASE; PREDICTION	Background: The natriuretic peptides are counterregulatory hormones involved in volume homeostasis and cardiovascular remodeling. The prognostic significance of plasma natriuretic peptide levels in apparently asymptomatic persons has not been established. Methods: We prospectively studied 3346 persons without heart failure. Using proportional-hazards regression, we examined the relations of plasma B-type natriuretic peptide and N-terminal pro-atrial natriuretic peptide to the risk of death from any cause, a first major cardiovascular event, heart failure, atrial fibrillation, stroke or transient ischemic attack, and coronary heart disease. Results: During a mean follow-up of 5.2 years, 119 participants died and 79 had a first cardiovascular event. After adjustment for cardiovascular risk factors, each increment of 1 SD in log B-type natriuretic peptide levels was associated with a 27 percent increase in the risk of death (P=0.009), a 28 percent increase in the risk of a first cardiovascular event (P=0.03), a 77 percent increase in the risk of heart failure (P<0.001), a 66 percent increase in the risk of atrial fibrillation (P<0.001), and a 53 percent increase in the risk of stroke or transient ischemic attack (P=0.002). Peptide levels were not significantly associated with the risk of coronary heart disease events. B-type natriuretic peptide values above the 80th percentile (20.0 pg per milliliter for men and 23.3 pg per milliliter for women) were associated with multivariable-adjusted hazard ratios of 1.62 for death (P=0.02), 1.76 for a first major cardiovascular event (P=0.03), 1.91 for atrial fibrillation (P=0.02), 1.99 for stroke or transient ischemic attack (P=0.02), and 3.07 for heart failure (P=0.002). Similar results were obtained for N-terminal pro-atrial natriuretic peptide. Conclusions: In this community-based sample, plasma natriuretic peptide levels predicted the risk of death and cardiovascular events after adjustment for traditional risk factors. Excess risk was apparent at natriuretic peptide levels well below current thresholds used to diagnose heart failure.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA; Boston Med Ctr, Cardiol Sect, Boston, MA USA; Boston Med Ctr, Dept Neurol, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Akershus Hosp, Dept Med, Oslo, Norway	Framingham Heart Study; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston Medical Center; Boston Medical Center; Boston University; University of Oslo	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,2, Framingham, MA 01702 USA.	vasan@fram.nhlbi.nih.gov	Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Wolf, Philip/0000-0002-3628-301X; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	NHLBI NIH HHS [K23-HL074077-01, K24-HL-04334, N01-HC-25195] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL074077, K24HL004334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Brunner F, 2001, CARDIOVASC RES, V51, P577, DOI 10.1016/S0008-6363(01)00283-8; COX DR, 1972, J R STAT SOC B, V34, P187; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; DAVIS KM, 1992, JAMA-J AM MED ASSOC, V267, P2625, DOI 10.1001/jama.267.19.2625; DAVIS KM, 1993, JAMA-J AM MED ASSOC, V269, P991; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Herring N, 2001, AM J PHYSIOL-HEART C, V281, pH2318, DOI 10.1152/ajpheart.2001.281.6.H2318; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION NAT; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Knight EL, 1998, J AM GERIATR SOC, V46, P453, DOI 10.1111/j.1532-5415.1998.tb02465.x; Kohno M, 1997, CIRC RES, V81, P585, DOI 10.1161/01.RES.81.4.585; Kook H, 2003, AM J PHYSIOL-HEART C, V284, pH1388, DOI 10.1152/ajpheart.00414.2002; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Molkentin JD, 2003, J CLIN INVEST, V111, P1275, DOI 10.1172/JCI200318389; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1264, DOI 10.1016/S0735-1097(03)00168-2; Morrow DA, 2003, J AM COLL CARDIOL, V41, P1853, DOI 10.1016/S0735-1097(03)00571-0; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9; Rossi A, 2000, J AM COLL CARDIOL, V35, P1256, DOI 10.1016/S0735-1097(00)00515-5; Rubattu S, 1999, CIRCULATION, V100, P1722, DOI 10.1161/01.CIR.100.16.1722; Rubattu S, 1999, CIRC RES, V85, P900; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; *SAS I INC, 1997, SAS STAT SOFTW CHANG, P871; Schirmer H, 1999, EUR HEART J, V20, P1439, DOI 10.1053/euhj.1999.1830; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; Ueda R, 2003, AM J MED, V114, P266, DOI 10.1016/S0002-9343(02)01525-5; van den Berg MP, 2002, EUR J HEART FAIL, V4, P255, DOI 10.1016/S1388-9842(01)00232-X; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wallen T, 1997, J INTERN MED, V241, P269, DOI 10.1046/j.1365-2796.1997.128149000.x; Wang TJ, 2003, ANN INTERN MED, V138, P907, DOI 10.7326/0003-4819-138-11-200306030-00012; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988	45	1141	1199	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2004	350	7					655	663		10.1056/NEJMoa031994	http://dx.doi.org/10.1056/NEJMoa031994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772YB	14960742				2022-12-01	WOS:000188869500006
J	Poremba, A; Malloy, M; Saunders, RC; Carson, RE; Herscovitch, P; Mishkin, M				Poremba, A; Malloy, M; Saunders, RC; Carson, RE; Herscovitch, P; Mishkin, M			Species-specific calls evoke asymmetric activity in the monkey's temporal poles	NATURE			English	Article							AUDITORY-CORTEX; VOCALIZATIONS; REPRESENTATION; PERCEPTION; MARMOSET; BRAIN	It has often been proposed that the vocal calls of monkeys are precursors of human speech, in part because they provide critical information to other members of the species who rely on them for survival and social interactions(1,2). Both behavioural and lesion studies suggest that monkeys, like humans, use the auditory system of the left hemisphere preferentially to process vocalizations(3,4). To investigate the pattern of neural activity that might underlie this particular form of functional asymmetry in monkeys, we measured local cerebral metabolic activity while the animals listened passively to species-specific calls compared with a variety of other classes of sound. Within the superior temporal gyrus, significantly greater metabolic activity occurred on the left side than on the right, only in the region of the temporal pole and only in response to monkey calls. This functional asymmetry was absent when these regions were separated by forebrain commissurotomy, suggesting that the perception of vocalizations elicits concurrent interhemispheric interactions that focus the auditory processing within a specialized area of one hemisphere.	Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; NIH, PET Dept, Ctr Clin, Bethesda, MD 20892 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Poremba, A (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	amy-poremba@uiowa.edu	Carson, Richard E/H-3250-2011	Carson, Richard E/0000-0002-9338-7966				Cheney D.L., 1990, MONKEYS SEE WORLD IN; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; George I, 2002, CR BIOL, V325, P197, DOI 10.1016/S1631-0691(02)01430-0; Ghazanfar AA, 2001, CURR OPIN NEUROBIOL, V11, P712, DOI 10.1016/S0959-4388(01)00274-4; GLASS I, 1983, HEARING RES, V9, P27, DOI 10.1016/0378-5955(83)90131-4; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; KEPPEL G, 1982, DESIGN ANAL RES HDB, pCH8; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; Netz J, 1999, EEG CL N SU, P137; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; PRELL CG, 2002, ANIM BEHAV, V63, P47; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Snowdon CT., 1982, PRIMATE COMMUNICATIO; Sokoloff L, 1996, DEV NEUROSCI-BASEL, V18, P343, DOI 10.1159/000111427; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yeterian EH, 1998, J COMP NEUROL, V399, P384	24	223	225	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					448	451		10.1038/nature02268	http://dx.doi.org/10.1038/nature02268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749833				2022-12-01	WOS:000188470500045
J	Dixon, J; Lewis, R; Rosen, R; Finlayson, B; Gray, D				Dixon, J; Lewis, R; Rosen, R; Finlayson, B; Gray, D			Can the NHS learn from US managed care organisations?	BRITISH MEDICAL JOURNAL			English	Article							KAISER-PERMANENTE; CHRONIC ILLNESS; UNITED-STATES; PHYSICIAN		Kings Fund, Hlth Policy, London W1G 0AN, England		Dixon, J (corresponding author), Kings Fund, Hlth Policy, London W1G 0AN, England.	jdixon@kingsfund.org.uk						*AUD COMM, 2002, INT SERV OLD PEOPL B, P24; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Budetti PP, 2002, HEALTH AFFAIR, V21, P203, DOI 10.1377/hlthaff.21.1.203; Casalino L, 2003, MILBANK Q, V81, P331, DOI 10.1111/1468-0009.t01-2-00056; *DEP HLTH, 2002, NAT SERV FRAM DIAB; *DEP HLTH, 2002, NHS PERF RAT IND JUL; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Department of Health, 1998, INF HLTH INF STRAT M; Druss BG, 2002, HEALTH AFFAIR, V21, P105, DOI 10.1377/hlthaff.21.4.105; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; HAGGAR T, 2003, HLTH SERVICES J  AUG; Ham C, 2003, BRIT MED J, V327, P1257, DOI 10.1136/bmj.327.7426.1257; *KINGS FUND, 2004, MAN CHRON DIS LESS 5; Lewis R, 2004, BMJ-BRIT MED J, V328, P220, DOI 10.1136/bmj.328.7433.220; LISK SF, 2000, EFFECTIVE CLIN PRACT; *NAT COMM QUAL ASS, HLTH PLAN EMPL DAT I; *NHS MOD AG, CHRON DIS MAN; RICHARDSON T, 2001, PERSONAL MED SERVICE; SEHKRI N, 2000, B WORLD HEALTH ORGAN, V78, P6; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; 2002, BMJ, V324, P1332	22	21	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 24	2004	328	7433					223	225		10.1136/bmj.328.7433.223	http://dx.doi.org/10.1136/bmj.328.7433.223			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	769LU	14739195	Green Published			2022-12-01	WOS:000188652200025
J	Green, M				Green, M			Motherhood - a potential killer	LANCET			English	Editorial Material												marinagr@iafrica.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2004	363	9405					311	311		10.1016/S0140-6736(03)15391-3	http://dx.doi.org/10.1016/S0140-6736(03)15391-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766FQ	14751706				2022-12-01	WOS:000188361400024
J	Webster, RG				Webster, RG			Wet markets - a continuing source of severe acute respiratory syndrome and influenza?	LANCET			English	Review							LIVE-BIRD MARKETS; AVIAN INFLUENZA; A VIRUSES; HONG-KONG; TRANSMISSION; GENE		St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org			NCI NIH HHS [P30 CA021765, CA-21765] Funding Source: Medline; NIAID NIH HHS [AI95357, N01AI95357] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Enserink M, 2003, SCIENCE, V302, P213; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; *INT SOC INF DIS, 2003, PROMED MAIL     1213; Ismael NF, 2000, DEV ARID REG RES SER, V1, P45; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Knipe D, 2001, FIELDS VIROLOGY, P1187; Lai M.M., 2001, FIELDS VIROLOGY; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Senior K, 2003, LANCET INFECT DIS, V3, P679, DOI 10.1016/S1473-3099(03)00815-6; Senne DA, 2003, AVIAN DIS, V47, P898, DOI 10.1637/0005-2086-47.s3.898; SENNE DA, 1992, P 3 INT S AV INFL RI; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Sims LD, 2003, AVIAN DIS, V47, P832, DOI 10.1637/0005-2086-47.s3.832; Trock SC, 2003, AVIAN DIS, V47, P1111, DOI 10.1637/0005-2086-47.s3.1111; van Kolfschooten F, 2003, LANCET, V361, P1444, DOI 10.1016/S0140-6736(03)13156-X; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2003, WHO DIS ALERT   0219	24	243	256	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2004	363	9404					234	236		10.1016/S0140-6736(03)15329-9	http://dx.doi.org/10.1016/S0140-6736(03)15329-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765AG	14738798	Green Published, Bronze			2022-12-01	WOS:000188243900024
J	Yamamoto, M; Saijoh, Y; Perea-Gomez, A; Shawlot, W; Behringer, RR; Ang, SL; Hamada, H; Meno, C				Yamamoto, M; Saijoh, Y; Perea-Gomez, A; Shawlot, W; Behringer, RR; Ang, SL; Hamada, H; Meno, C			Nodal antagonists regulate formation of the anteroposterior axis of the mouse embryo	NATURE			English	Article							NEURALIZING ACTIVITY; PRIMITIVE STREAK; XENOPUS EMBRYOS; CERBERUS-LIKE; EXPRESSION; ENDODERM; LEFTY-1; GENE; ESTABLISHMENT; INHIBITORS	Patterning of the mouse embryo along the anteroposterior axis during body plan development requires migration of the distal visceral endoderm (DVE) towards the future anterior side by a mechanism that has remained unknown. Here we show that Nodal signalling and the regionalization of its antagonists are required for normal migration of the DVE. Whereas Nodal signalling provides the driving force for DVE migration by stimulating the proliferation of visceral endoderm cells, the antagonists Lefty1 and Cerl determine the direction of migration by asymmetrically inhibiting Nodal activity on the future anterior side.	Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; Univ Strasbourg 1, IGBMC, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AA, England	Osaka University; Japan Science & Technology Agency (JST); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; UTMD Anderson Cancer Center; MRC National Institute for Medical Research	Hamada, H (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	hamada@fbs.osaka-u.ac.jp	yamamoto, masamichi/AAE-3273-2021; Hamada, Hiroshi/N-6374-2015	Hamada, Hiroshi/0000-0002-7196-5948; Perea-Gomez, Aitana/0000-0002-7788-038X; Saijoh, Yukio/0000-0002-7548-4789; Yamamoto, Masamichi/0000-0002-9088-8044	Medical Research Council [MC_U117570533] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belachew S, 2002, J NEUROSCI, V22, P8553; Belo JA, 2000, GENESIS, V26, P265, DOI 10.1002/(SICI)1526-968X(200004)26:4<265::AID-GENE80>3.0.CO;2-4; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Cheng AMS, 2000, DEVELOPMENT, V127, P1049; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; EYALGILADI H, 1994, ADV SPACE RES-SERIES, V14, P271, DOI 10.1016/0273-1177(94)90411-1; HAYASHI Y, 1988, J HISTOCHEM CYTOCHEM, V36, P511, DOI 10.1177/36.5.3282006; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Shawlot W, 2000, GENESIS, V26, P253, DOI 10.1002/(SICI)1526-968X(200004)26:4<253::AID-GENE60>3.3.CO;2-4; Simpson EH, 1999, DEV BIOL, V213, P202, DOI 10.1006/dbio.1999.9372; Skromne I, 2001, DEVELOPMENT, V128, P2915; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901	30	205	210	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2004	428	6981					387	392		10.1038/nature02418	http://dx.doi.org/10.1038/nature02418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805ZN	15004567				2022-12-01	WOS:000220404300032
J	Murshed, R; Douglas, RM; Ranmuthugala, G; Caldwell, B				Murshed, R; Douglas, RM; Ranmuthugala, G; Caldwell, B			Clinicians' roles in management of arsenicosis in Bangladesh: interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WATER		Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	Douglas, RM (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	bobdouglas@netspeed.com.au	Ranmuthugala, Geetha/P-5041-2019; Ranmuthugala, Geetha/F-5938-2012	Ranmuthugala, Geetha/0000-0002-4893-5775; Ranmuthugala, Geetha/0000-0002-4893-5775				British Geological Survey, ARS CONT GROUNDW; MacDonald R, 2001, BMJ-BRIT MED J, V322, P626, DOI 10.1136/bmj.322.7287.626; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093	3	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2004	328	7438					493	494		10.1136/bmj.328.7438.493	http://dx.doi.org/10.1136/bmj.328.7438.493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800BC	14988183	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000220002900020
J	Ford, N; Wilson, D; Bunjumnong, O; Angerer, TV				Ford, N; Wilson, D; Bunjumnong, O; Angerer, TV			The role of civil society in protecting public health over commercial interests: lessons from Thailand	LANCET			English	Editorial Material							MEDICINES		Med Sans Frontieres, Bangkok 10240, Thailand		Ford, N (corresponding author), Med Sans Frontieres, 522 Mooban Nakorn Thai,Ladphrao 101-1, Bangkok 10240, Thailand.	Nathan.Ford@London.msf.org		von Schoen-Angerer, Tido/0000-0003-3601-7480				BARSHEFSKY C, 2000, COMMUNICATION   0207; BHATIASEVI A, 2000, BANGKOK POST    0211; BHATIASEVI A, 1999, BANGKOK POST    1110; BHATIASEVI A, 2000, BANGKOK POST    0118; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; Boulet P., 2003, DRUG PATENTS SPOTLIG; BOULET P, 1999, ASSESSMENT SITUATION; CHASOMBAT S, 2003, 9 NAT AIDS SEM BANGK; CHITWARAKORN A, 2003, WHO BIR M SCAL UP HI; CORNISH WR, 1999, INTELLECTUAL PROPERT; Dukes MNG, 2002, LANCET, V360, P1682, DOI 10.1016/S0140-6736(02)11599-6; HECKLINGER RE, 1999, COMMUNICATION    NOV; KUANPOTH J, 2000, 3 S CURR ISS INT PRO; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; LIMPANANONT J, 2002, THAILAND IMPACT PRES, P41; LOVE J, 2000, COMMUNICATION   0122; MCGOWAN JJ, 1990, REV INFECT DIS, V12, pS513; PORAPAKKHAM Y, 1996, AIDSCAP POLICY WORKI; SAKBOON M, 2004, NATION BANGKOK  0117; SUPAKAKUNTI S, 1999, STUDY IMPLICATIONS W; ULLAH I, 1991, Patent No. 07733547; ULLAH I, 1992, Patent No. 07882204; ULLAH I, 1998, Patent No. 05245791; ULLAH I, 1999, Patent No. 5880106; ULLAH I, 1998, Patent No. 7600; ULLAH I, 1995, Patent No. 657337; VELASQUEZ G, 2000, WHO UNAIDS JOINT MIS; VIRAVAIDAYA M, 1995, P 3 INT C AIDS AS PA, P19; *WHO, 2001, IPCW305ADD3 WHO; *WHO, 2001, 5410 WHA WHO; Wilson D, 1999, LANCET, V354, P1893, DOI 10.1016/S0140-6736(99)06114-0; World Bank, 2000, THAIL RESP AIDS BUIL; 1995, P 3 INT C AIDS AS PA, P88; 2001, INTEGRATING INTELLEC, P51	34	34	34	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2004	363	9408					560	563		10.1016/S0140-6736(04)15545-1	http://dx.doi.org/10.1016/S0140-6736(04)15545-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TA	14975620				2022-12-01	WOS:000188999900024
J	Tong, AHY; Lesage, G; Bader, GD; Ding, HM; Xu, H; Xin, XF; Young, J; Berriz, GF; Brost, RL; Chang, M; Chen, YQ; Cheng, X; Chua, G; Friesen, H; Goldberg, DS; Haynes, J; Humphries, C; He, G; Hussein, S; Ke, LZ; Krogan, N; Li, ZJ; Levinson, JN; Lu, H; Menard, P; Munyana, C; Parsons, AB; Ryan, O; Tonikian, R; Roberts, T; Sdicu, AM; Shapiro, J; Sheikh, B; Suter, B; Wong, SL; Zhang, LV; Zhu, HW; Burd, CG; Munro, S; Sander, C; Rine, J; Greenblatt, J; Peter, M; Bretscher, A; Bell, G; Roth, FP; Brown, GW; Andrews, B; Bussey, H; Boone, C				Tong, AHY; Lesage, G; Bader, GD; Ding, HM; Xu, H; Xin, XF; Young, J; Berriz, GF; Brost, RL; Chang, M; Chen, YQ; Cheng, X; Chua, G; Friesen, H; Goldberg, DS; Haynes, J; Humphries, C; He, G; Hussein, S; Ke, LZ; Krogan, N; Li, ZJ; Levinson, JN; Lu, H; Menard, P; Munyana, C; Parsons, AB; Ryan, O; Tonikian, R; Roberts, T; Sdicu, AM; Shapiro, J; Sheikh, B; Suter, B; Wong, SL; Zhang, LV; Zhu, HW; Burd, CG; Munro, S; Sander, C; Rine, J; Greenblatt, J; Peter, M; Bretscher, A; Bell, G; Roth, FP; Brown, GW; Andrews, B; Bussey, H; Boone, C			Global mapping of the yeast genetic interaction network	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SMALL-WORLD; S-PHASE; BIOLOGY; DISEASE; COMPLEX	A genetic interaction network containing similar to1000 genes and similar to4000 interactions was mapped by crossing mutations in 132 different query genes into a set of similar to4700 viable gene yeast deletion mutants and scoring the double mutant progeny for fitness defects. Network connectivity was predictive of function because interactions often occurred among functionally related genes, and similar patterns of interactions tended to identify components of the same pathway. The genetic network exhibited dense local neighborhoods; therefore, the position of a gene on a partially mapped network is predictive of other genetic interactions. Because digenic interactions are common in yeast, similar networks may underlie the complex genetics associated with inherited phenotypes in other organisms.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland	University of Toronto; University of Toronto; McGill University; Memorial Sloan Kettering Cancer Center; University of Toronto; Cornell University; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of Pennsylvania; MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Andrews, B (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada.	brenda.andrews@utoronto.ca; howard.bussey@mcgill.ca; charlie.boone@utoronto.ca	Haynes, Jennifer/P-8565-2019; Sander, Chris/H-1452-2011; Xin, Xiaofeng/G-7736-2016; Bader, Gary/C-1176-2009; Chang, Michael/B-9279-2012; Roth, Frederick P/H-6308-2011; Shapiro, B. Jesse/U-9337-2019	Sander, Chris/0000-0001-6059-6270; Xin, Xiaofeng/0000-0002-2439-7183; Bader, Gary/0000-0003-0185-8861; Chang, Michael/0000-0002-1706-3337; Munro, Sean/0000-0001-6160-5773; Brown, Grant/0000-0002-9002-5003; Roth, Frederick/0000-0002-6628-649X; Roberts, Tania/0000-0001-9518-3011; Peter, Matthias/0000-0002-2160-6824; Menard, Patrice/0000-0001-8844-3727; Shapiro, B. Jesse/0000-0001-6819-8699; Burd, Christopher/0000-0003-1831-8706	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039066, R01GM061221] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39066, GM61221] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERRIZ GF, IN PRESS BIOINFORMAT; DOLINSKI K, SACCHAROMYCES GENOME; Foss EJ, 2001, GENETICS, V157, P567; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Hariharan IK, 2003, NEW ENGL J MED, V348, P2457, DOI 10.1056/NEJMon023158; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kamb A, 2003, J THEOR BIOL, V223, P205, DOI 10.1016/S0022-5193(03)00087-0; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; MAYER M, IN PRESS MOL BIOL CE; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Phillips PC, 1998, GENETICS, V150, P449; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	25	1519	1573	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2004	303	5659					808	813		10.1126/science.1091317	http://dx.doi.org/10.1126/science.1091317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770WF	14764870				2022-12-01	WOS:000188753800048
J	Erlinger, TP; Platz, EA; Rifai, N; Helzlsouer, KJ				Erlinger, TP; Platz, EA; Rifai, N; Helzlsouer, KJ			C-reactive protein and the risk of incident colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; RANDOMIZED-TRIAL; COLON-CANCER; MORTALITY; DISEASE; INFLAMMATION; SULINDAC; INTERLEUKIN-6; ASPIRIN; COUNT	Context Inflammation may play a role in the pathogenesis of colorectal cancer; however, epidemiological evidence supporting this hypothesis in average-risk persons is sparse. Objective To determine the risk of incident colon and rectal cancer associated with elevated baseline plasma concentrations of C-reactive protein (CRP). Design, Setting, and Participants Prospective, nested case-control study of a cohort of 22887 adults (>18 years and Washington County, Maryland, residents) enrolled between May and October 1989 and followed up through December 2000. A total of 172 colorectal cancer cases were identified through linkage with the Washington County and Maryland State Cancer registries. Up to 2 controls (n=342) were selected from the cohort for each case and matched by age, sex, race, and date of blood draw. Main Outcome Measure Odds ratio (OR) of incident colon and rectal cancer. Results Plasma CRP concentrations were higher among all colorectal cases combined than controls (median CRP, 2.44 vs 1.94 mg/L; P=.01). The highest concentration was found in persons who subsequently developed colon cancer vs matched controls (median CRP, 2.69 vs 1.97 mg/L; P<.001). Among rectal cancer cases, CRIP concentrations were not significantly different from controls (median CRP, 1.79 vs 1.81 mg/L; P=32). The risk of colon cancer was higher in persons in the highest vs lowest quartile of CRP (OR, 2.55; 95% confidence interval [CI], 1.34-4.88; P for trend =.002). in nonsmokers, the corresponding association was stronger (OR, 3.51; 95% Cl, 1.64-7.51; P for trend <.001). A 1 -SD increase in log CRP (1.02 mg/Q was associated with an increased risk of colon cancer after adjusting for potential confounders and excluding cases occurring within 2 years of baseline (OR, 1.35; 95% Cl, 1.05-1.74) or excluding those with late-stage colon cancer at the time of diagnosis (OR, 1.38; 95% Cl, 0.99-1.91). Conclusions Plasma CRP concentrations are elevated among persons who subsequently develop colon cancer. These data support the hypothesis that inflammation is a risk factor for the development of colon cancer in average-risk individuals.	Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Erlinger, TP (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Dept Med, 2024 E Monument,Suite 2-600, Baltimore, MD 21205 USA.	terlinge@jhmi.edu			NATIONAL CANCER INSTITUTE [U01CA086308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018033] Funding Source: NIH RePORTER; NCI NIH HHS [IU01 CA86308] Funding Source: Medline; NIA NIH HHS [IU01 AG18033] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAS I, 1985, CLIN CHIM ACTA, V153, P9, DOI 10.1016/0009-8981(85)90133-0; FRIEDMAN GD, 1991, AM J EPIDEMIOL, V133, P376, DOI 10.1093/oxfordjournals.aje.a115891; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Gussekloo J, 2000, ARTERIOSCL THROM VAS, V20, P1047, DOI 10.1161/01.ATV.20.4.1047; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; KO WF, 1994, J NATL CANCER I, V86, P1874, DOI 10.1093/jnci/86.24.1874; LABAYLE D, 1991, GASTROENTEROLOGY, V101, P635, DOI 10.1016/0016-5085(91)90519-Q; LADENHEIM J, 1995, GASTROENTEROLOGY, V108, P1083, DOI 10.1016/0016-5085(95)90206-6; LEVIN B, 1992, CANCER-AM CANCER SOC, V70, P1313, DOI 10.1002/1097-0142(19920901)70:3+<1313::AID-CNCR2820701518>3.0.CO;2-B; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Okada F, 2000, LAB INVEST, V80, P1617, DOI 10.1038/labinvest.3780172; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Rifai N, 1999, CLIN CHEM, V45, P2136; Rifai N, 2002, ANN INTERN MED, V136, P529, DOI 10.7326/0003-4819-136-7-200204020-00010; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; SoRelle Ruth, 2002, Circulation, V105, pE9071, DOI 10.1161/hc0502.106411; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tchernof A, 2002, CIRCULATION, V105, P564, DOI 10.1161/hc0502.103331; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Yano K, 2001, ARTERIOSCL THROM VAS, V21, P1065, DOI 10.1161/01.ATV.21.6.1065	24	417	434	1	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2004	291	5					585	590		10.1001/jama.291.5.585	http://dx.doi.org/10.1001/jama.291.5.585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	769LC	14762037	Bronze			2022-12-01	WOS:000188650700023
J	Baughn, AD; Malamy, MH				Baughn, AD; Malamy, MH			The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen	NATURE			English	Article							RESPIRATION; OXIDATION; REDUCTION; EVOLUTION; PROTEIN	Strict anaerobes cannot grow in the presence of greater than 5 muM dissolved oxygen(1). Despite this growth inhibition, many strict anaerobes of the Bacteroides class of eubacteria can survive in oxygenated environments until the partial pressure of O-2 (P-O2) is sufficiently reduced. For example, the periodontal pathogens Porphyromonas gingivalis and Tannerella forsythensis colonize subgingival plaques of mammals, whereas several other Bacteroides species colonize the gastrointestinal tract of animals. It has been suggested that pre-colonization of these sites by facultative anaerobes is essential for reduction of the P-O2 and subsequent colonization by strict anaerobes(2). However, this model is inconsistent with the observation that Bacteroides fragilis can colonize the colon in the absence of facultative anaerobes(3). Thus, this strict anaerobe may have a role in reduction of the environmental P-O2. Although some strictly anaerobic bacteria can consume oxygen through an integral membrane electron transport system(4), the physiological role of this system has not been established in these organisms. Here we demonstrate that B. fragilis encodes a cytochrome bd oxidase that is essential for O-2 consumption and is required, under some conditions, for the stimulation of growth in the presence of nanomolar concentrations of O-2. Furthermore, our data suggest that this property is conserved in many other organisms that have been described as strict anaerobes.	Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University	Malamy, MH (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.malamy@tufts.edu	Baughn, Anthony/ABB-7881-2020	Baughn, Anthony/0000-0003-1188-4238				Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; BAUGHN AD, 2003, MICROBIOLOGY, V149, P1503; Bocchetta M, 2000, J MOL EVOL, V50, P366, DOI 10.1007/s002399910040; BORNSIDE GH, 1976, P SOC EXP BIOL MED, V151, P437; CASTRESANA J, 1995, TRENDS BIOCHEM SCI, V20, P443, DOI 10.1016/S0968-0004(00)89098-2; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Di Giulio M, 2003, J THEOR BIOL, V221, P425, DOI 10.1006/jtbi.2003.3197; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Engelkirk P.G., 1992, PRINCIPLES PRACTICE; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; LEVITT MD, 1970, NEW ENGL J MED, V282, P1039, DOI 10.1056/NEJM197004302821814; MACY J, 1975, J BACTERIOL, V123, P436, DOI 10.1128/JB.123.2.436-442.1975; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; SCHMALFUSS H, 1925, BERICHTE DTSCH CHEM, V52, P71; Swofford DL, 2002, PHYLOGENETIC ANAL US; TALLY FP, 1982, J BACTERIOL, V151, P686, DOI 10.1128/JB.151.2.686-691.1982; Towe Kenneth M, 2002, Science, V295, P1419; WEISBURG WG, 1985, J BACTERIOL, V164, P230, DOI 10.1128/JB.164.1.230-236.1985	22	193	201	6	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					441	444		10.1038/nature02285	http://dx.doi.org/10.1038/nature02285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749831				2022-12-01	WOS:000188470500043
J	Selje, N; Simon, M; Brinkhoff, T				Selje, N; Simon, M; Brinkhoff, T			A newly discovered Roseobacter cluster in temperate and polar oceans	NATURE			English	Article							16S RIBOSOMAL-RNA; MARINE BACTERIOPLANKTON; COMMUNITY COMPOSITION; SAR11 CLUSTER; DIVERSITY; BACTERIA; IDENTIFICATION; GENES	Bacterioplankton phylotypes of alpha-Proteobacteria have been detected in various marine regions, but systematic biogeographical studies of their global distribution are missing. alpha-Proteobacteria comprise one of the largest fractions of heterotrophic marine bacteria(1,2) and include two clades, SAR11 and Roseobacter, which account for 26 and 16% of 16S ribosomal RNA gene clones retrieved from marine bacterioplankton(3). The SAR11 clade attracted much interest because related 16S rRNA gene clones were among the first groups of marine bacteria to be identified by cultivation-independent approaches(4) and appear to dominate subtropical surface bacterioplankton communities(5). Here we report on the global distribution of a newly discovered cluster affiliated to the Roseobacter clade, comprising only as-yet-uncultured phylotypes. Bacteria of this cluster occur from temperate to polar regions with highest abundance in the Southern Ocean, but not in tropical and subtropical regions. Between the south Atlantic subtropical front and Antarctica, we detected two distinct phylotypes, one north and one south of the polar front, indicating that two adjacent but different oceanic provinces allow the persistence of distinct but closely related phylotypes. These results suggest that the global distribution of major marine bacterioplankton components is related to oceanic water masses and controlled by their environmental and biogeochemical properties.	Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Simon, M (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, POB 2503, D-26111 Oldenburg, Germany.	m.simon@icbm.de						Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; Giovannoni S., 2000, P47; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Gosink JJ, 1997, SYST APPL MICROBIOL, V20, P356, DOI 10.1016/S0723-2020(97)80003-3; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; LONGHURST A, 1998, ECOLOGICAL GEOGRAPHY, P339; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993; Selje N, 2003, AQUAT MICROB ECOL, V30, P221, DOI 10.3354/ame030221; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Ward BB, 2002, APPL ENVIRON MICROB, V68, P4153, DOI 10.1128/AEM.68.8.4153-4157.2002; Zubkov MV, 2001, ENVIRON MICROBIOL, V3, P304, DOI 10.1046/j.1462-2920.2001.00196.x; [No title captured]	28	211	220	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2004	427	6973					445	448		10.1038/nature02272	http://dx.doi.org/10.1038/nature02272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	767UF	14749832				2022-12-01	WOS:000188470500044
J	Jacquemont, S; Hagerman, RJ; Leehey, MA; Hall, DA; Levine, RA; Brunberg, JA; Zhang, L; Jardini, T; Gane, LW; Harris, SW; Herman, K; Grigsby, J; Greco, CM; Berry-Kravis, E; Tassone, F; Hagerman, PJ				Jacquemont, S; Hagerman, RJ; Leehey, MA; Hall, DA; Levine, RA; Brunberg, JA; Zhang, L; Jardini, T; Gane, LW; Harris, SW; Herman, K; Grigsby, J; Greco, CM; Berry-Kravis, E; Tassone, F; Hagerman, PJ			Penetrance of the fragile X - Associated tremor/ataxia syndrome in a premutation carrier population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE RATING-SCALE; ESSENTIAL TREMOR; PARKINSONS-DISEASE; CGG REPEAT; FEMALE CARRIERS; COPIAH COUNTY; PREVALENCE; ALLELES; ATAXIA; CEREBELLAR	Context Premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene are frequent in the general population, with estimated prevalences of 1 per 259 females and 1 per 813 males. Several articles have recently described the presence of late-onset neurological symptoms in male carriers of premutation (FMR1) alleles. The main clinical features described in this newly identified syndrome are cerebellar ataxia and intention tremor. Additional documented symptoms include short-term memory loss, executive functional deficits, cognitive decline, parkinsonism, peripheral neuropathy, lower-limb proximal muscle weakness, and autonomic dysfunction. Objective To study the penetrance of the fragile X-associated tremor/ataxia syndrome (FXTAS) among premutation carriers. Design, Setting, and Participants Family-based study of 192 individuals (premutation carriers and controls) whose families belong to the Northern or Southern California Fragile X Associations. Data were collected (March 2002-April 2003) through a survey and a standardized neurological examination, which was videotaped and subsequently scored in a blinded fashion. Main Outcome Measures Penetrance of intention tremor and ataxia among adult carriers (aged greater than or equal to50 years) of premutation expansions of the FMR1 gene. Results Data from the survey of 192 individuals demonstrated an age-related penetrance of the combination of reported intention tremor and gait ataxia in male carriers (17%, 38%, 47%, and 75% [lower-bound estimates] for participants aged 50-59, 60-69, 70-79, and greater than or equal to80 years, respectively). The male carrier group had an age-adjusted 13-fold increased risk (95% confidence interval, 3.9-25.4; P=.003) of combined intention tremor and gait ataxia when compared with male controls. The clinical examination data from 93 individuals demonstrated that male carriers experienced more difficulties on each of 3 standardized neurological rating scales compared with controls (P<.05). Female carrier scores were also higher than those of female controls (P<.05) on 2 of the 3 neurological rating scales, but no participant was identified with probable or definite FXTAS. Conclusions The study demonstrates that older male carriers of premutation alleles of the FMR1 gene are at high risk of developing FXTAS. Since male premutation carriers are relatively common in the general population, older men with ataxia and intention tremor should be screened for the FMR1 mutation, especially if these signs are accompanied by parkinsonism, autonomic dysfunction, or cognitive decline, regardless of family history.	Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA; Univ Calif Davis, Sch Med, Dept Radiol, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Pathol, Davis, CA 95616 USA; Rush Presbyterian St Lukes Med Ctr, Dept Pediat, Chicago, IL 60612 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; California State University System; San Diego State University; University of California System; University of California Davis; University of California System; University of California Davis; Rush University	Hagerman, PJ (corresponding author), Univ Calif Davis, Sch Med, Dept Biol Chem, 1 Shields Ave, Davis, CA 95616 USA.	pjhagerman@ucdavis.edu	Jacquemont, Sebastien/AAS-5060-2021	Jacquemont, Sebastien/0000-0001-6838-8767	NICHD NIH HHS [HD 36071] Funding Source: Medline; NINDS NIH HHS [R01 NS044299, NS 43532] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044299, R01NS043532] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522; BHARUCHA NE, 1988, ARCH NEUROL-CHICAGO, V45, P907, DOI 10.1001/archneur.1988.00520320105023; Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371; DORN MB, 1994, J AM ACAD CHILD PSY, V33, P256, DOI 10.1097/00004583-199402000-00015; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FAHN S, 1998, PARKINSONS DIS MOVEM, P225; Franke P, 1998, PSYCHIAT RES, V80, P113, DOI 10.1016/S0165-1781(98)00055-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; HAERER AF, 1982, ARCH NEUROL-CHICAGO, V39, P750, DOI 10.1001/archneur.1982.00510240012003; Hagerman Paul J., 2003, Neurology, V60, pA469; Hagerman R.J., 2002, FRAGILE X SYNDROME D; Hagerman Randi J., 2003, Neurology, V60, pA331; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; HO SC, 1989, NEUROLOGY, V39, P1314, DOI 10.1212/WNL.39.10.1314; HOLM S, 1979, SCAND J STAT, V6, P65; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Johnston C, 2001, AM J MED GENET, V103, P314, DOI 10.1002/ajmg.1561.abs; Kis B, 2002, NEUROLOGY, V58, P1820, DOI 10.1212/WNL.58.12.1820; Leehey MA, 2002, MOVEMENT DISORD, V17, pS351; Leehey MA, 2003, ARCH NEUROL-CHICAGO, V60, P117, DOI 10.1001/archneur.60.1.117; Loesch DZ, 2002, J DEV BEHAV PEDIATR, V23, P416, DOI 10.1097/00004703-200212000-00004; Louis ED, 2000, MOVEMENT DISORD, V15, P516, DOI 10.1002/1531-8257(200005)15:3<516::AID-MDS1015>3.0.CO;2-J; LOUIS ED, 1995, ARCH NEUROL-CHICAGO, V52, P1201, DOI 10.1001/archneur.1995.00540360079019; Louis ED, 1999, ARCH NEUROL-CHICAGO, V56, P841, DOI 10.1001/archneur.56.7.841; Macpherson J, 2003, HUM GENET, V112, P619, DOI 10.1007/s00439-003-0939-z; Murray A, 1997, HUM MOL GENET, V6, P173, DOI 10.1093/hmg/6.2.173; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; RAJPUT AH, 1984, J NEUROL NEUROSUR PS, V47, P466, DOI 10.1136/jnnp.47.5.466; REISS AL, 1993, AM J HUM GENET, V52, P884; Riddle JE, 1998, AM J MENT RETARD, V102, P590; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; SCHOENBERG BS, 1985, NEUROLOGY, V35, P841, DOI 10.1212/WNL.35.6.841; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; SINGER C, 1994, MOVEMENT DISORD, V9, P193, DOI 10.1002/mds.870090212; Sobesky WE, 1996, AM J MED GENET, V64, P340, DOI 10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21>3.3.CO;2-K; Stebbins GT, 1999, MOVEMENT DISORD, V14, P585, DOI 10.1002/1531-8257(199907)14:4<585::AID-MDS1006>3.0.CO;2-3; Stebbins GT, 1998, MOVEMENT DISORD, V13, P633, DOI 10.1002/mds.870130404; TANDBERG E, 1995, MOVEMENT DISORD, V10, P541, DOI 10.1002/mds.870100503; Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.3.CO;2-W; TASSONE F, 2002, 8 INT FRAG X C JUL 1; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang Lin, 2003, Neurology, V60, pA470	55	452	462	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 28	2004	291	4					460	469		10.1001/jama.291.4.460	http://dx.doi.org/10.1001/jama.291.4.460			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	767EF	14747503	Bronze			2022-12-01	WOS:000188426700031
J	Galy, V; Gadal, O; Fromont-Racine, M; Romano, A; Jacquier, A; Nehrbass, U				Galy, V; Gadal, O; Fromont-Racine, M; Romano, A; Jacquier, A; Nehrbass, U			Nuclear retention of unspliced mRNAs in yeast is mediated by perinuclear Mlp1	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; COUPLING TRANSCRIPTION; QUALITY-CONTROL; PORE COMPLEX; PROTEINS; EXPORT; SITE; IDENTIFICATION; COMPONENT; DELETION	The molecular mechanism underlying the retention of intron-containing mRNAs in the nucleus is not understood. Here, we show that retention of intron-containing mRNAs in yeast is mediated by perinuclearly located Mlp1. Deletion of MLP1 impairs retention while having no effect on mRNA splicing. The Mlp1-dependent leakage of intron-containing RNAs is increased in presence of ts-prp18Delta, a splicing mutant. When overall pre-mRNA levels are increased by deletion of RRP6, a nuclear exosome component, MLP1 deletion augments leakage of only the intron-containing portion of mRNAs. Our data suggest, moreover, that Mlp1-dependent retention is mediated via the 5' splice site. Intriguingly, we found Mlp-proteins to be present only on sections of the NE adjacent to chromatin. We propose that at this confined site the perinuclear Mlp1 implements a quality control step prior to export, physically retaining faulty pre-mRNAs.	CNRS, URA 2582, Unite Biol Cellulaire Noyau, F-25724 Paris 15, France; Inst Pasteur, CNRS, URA 2171, Unite Genet Interact Macromol, F-25724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Jacquier, A (corresponding author), CNRS, URA 2582, Unite Biol Cellulaire Noyau, 25 Rue Docteur Roux, F-25724 Paris 15, France.	jacquier@pasteur.fr; nehrbass@pasteur.fr	Gadal, Olivier/A-4731-2008	Gadal, Olivier/0000-0001-9421-0831; Nehrbass, Ulf/0000-0002-7028-8076; JACQUIER, ALAIN/0000-0001-5707-9184; Fromont-Racine, Micheline/0000-0001-9906-0334				Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; HOROWITZ DS, 1993, MOL CELL BIOL, V13, P2959, DOI 10.1128/MCB.13.5.2959; Iborra FJ, 2000, J CELL SCI, V113, P291; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Long RM, 1995, RNA, V1, P1071; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Rain JC, 1997, EMBO J, V16, P1759, DOI 10.1093/emboj/16.7.1759; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; VIJAYRAGHAVAN U, 1990, MOL CELL BIOL, V10, P324, DOI 10.1128/MCB.10.1.324; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701	32	268	272	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 9	2004	116	1					63	73		10.1016/S0092-8674(03)01026-2	http://dx.doi.org/10.1016/S0092-8674(03)01026-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718167	Bronze			2022-12-01	WOS:000187960800009
J	Roe, SM; Ali, MMU; Meyer, P; Vaughan, CK; Panaretou, B; Piper, PW; Prodromou, C; Pearl, LH				Roe, SM; Ali, MMU; Meyer, P; Vaughan, CK; Panaretou, B; Piper, PW; Prodromou, C; Pearl, LH			The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37)	CELL			English	Article							N-TERMINAL DOMAIN; MOLECULAR CHAPERONE; ATPASE ACTIVITY; CLIENT PROTEIN; IN-VIVO; BINDING; CDC37; HYDROLYSIS; HEAT-SHOCK-PROTEIN-90; IDENTIFICATION	Recruitment of protein kinase clients to the Hsp90 chaperone involves the cochaperone p50(cdc37) acting as a scaffold, binding protein kinases via its N-terminal domain and Hsp90 via its C-terminal region. p50(cdc37) also has a regulatory activity, arresting Hsp90's ATPase cycle during client-protein loading. We have localized the binding site for p50(cdc37) to the N-terminal nucleotide binding domain of Hsp90 and determined the crystal structure of the Hsp90-p50(cdc37) core complex. Dimeric p50(cdc37) binds to surfaces of the Hsp90 N-domain implicated in ATP-dependent N-terminal dimerization and association with the middle segment of the chaperone. This interaction fixes the lid segment in an open conformation, inserts an arginine side chain into the ATP binding pocket to disable catalysis, and prevents trans-activating interaction of the N domains.	Inst Canc Res, Sect Struct Biol, Chester Beatty Labs, London SW3 6JB, England; Kings Coll London, Div Life Sci, London SE1 9NN, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of London; University College London	Prodromou, C (corresponding author), Inst Canc Res, Sect Struct Biol, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England.	chris.prodromou@icr.ac.uk; laurence.pearl@icr.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021; Meyer, Philippe/AAC-6038-2019	Prodromou, Chrisostomos/0000-0003-4320-1147; Meyer, Philippe/0000-0002-6220-0679; Pearl, Laurence/0000-0002-6910-1809; Roe, Mark/0000-0002-7371-9855; Piper, Peter William/0000-0003-4019-2329				An WG, 2000, CELL GROWTH DIFFER, V11, P355; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; BIJKMAKERS MJ, 2000, MOL BIOL CELL, V11, P1585; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Boudeau J, 2003, BIOCHEM J, V370, P849, DOI 10.1042/BJ20021813; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chavany C, 1996, J BIOL CHEM, V271, P4974; Dai K, 1996, J BIOL CHEM, V271, P22030, DOI 10.1074/jbc.271.36.22030; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Lange BMH, 2002, EMBO J, V21, P5364, DOI 10.1093/emboj/cdf531; Lee P, 2002, J CELL BIOL, V159, P1051, DOI 10.1083/jcb.200210121; LESLIE A, 1995, MOSFLM USERS GUIDE; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Mahony D, 1998, ONCOGENE, V16, P603, DOI 10.1038/sj.onc.1201570; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miyata Y, 2001, J BIOL CHEM, V276, P21841, DOI 10.1074/jbc.M010944200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl FMG, 2000, NUCLEIC ACIDS RES, V28, P277, DOI 10.1093/nar/28.1.277; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Perdew GH, 1997, BIOCHEMISTRY-US, V36, P3600, DOI 10.1021/bi9612529; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scholz GM, 2001, J BIOL CHEM, V276, P30971, DOI 10.1074/jbc.M103889200; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Tatebe H, 2003, MOL CELL BIOL, V23, P5132, DOI 10.1128/MCB.23.15.5132-5142.2003; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930	67	268	289	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2004	116	1					87	98		10.1016/S0092-8674(03)01027-4	http://dx.doi.org/10.1016/S0092-8674(03)01027-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	762FL	14718169	Bronze			2022-12-01	WOS:000187960800011
J	Muntner, P; Hamm, LL; Kusek, JW; Chen, J; Whelton, PK; He, J				Muntner, P; Hamm, LL; Kusek, JW; Chen, J; Whelton, PK; He, J			The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; 3RD NATIONAL-HEALTH; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; SERUM CREATININE; ARTERY-DISEASE; UNITED-STATES; MYOCARDIAL-INFARCTION	Background: Risk for coronary heart disease is high among patients with chronic kidney disease. Objective: To compare the prevalence of low apolipoprotein A1 levels and elevated apolipoprotein Ell, plasma fibrinogen, lipoprotein(a), homocysteine, and C-reactive protein levels by estimated glomerular filtration rate (GFR). Design: Cross-sectional study. Setting: Third National Health and Nutrition Examination survey. Participants: 12 547, 3180, and 744 persons with estimated GFRs of at least 90, 60 to 89, or less than 60 mL/min per 1.73 m(2), respectively, who were at least 18 years of age. Measurements: Chronic kidney disease was defined as an estimated GFR of less than 60 mL/min per 1.73 m(2) based on the abbreviated Modification of Diet in Renal Disease formula. Results: After standardization for age, race or ethnicity, and sex, lower estimated GFR (greater than or equal to90, 60 to 89, or <60 mL/min per 1.73 m 2) was associated with lower average levels of apolipoprotein A1 (1.44, 1.43, and 1.35 g/L) and higher levels of apolipoprotein B (1.03, 1.06, and 1.08 g/L), plasma fibrinogen (8.43, 8.44, and 9.53 mumol/L), homocysteine (8.5, 10.0, and 13.2 mumol/L), and C-reactive protein (3.0, 2.9, and 3.9 mg/L) (P < 0.05 for all values). The multivariate-adjusted odds ratios of an apolipoprotein A1 level of less than 1.2 g/L, a serum lipoprotein(a) level of at least 1.61 mumol/L (greater than or equal to45.3 mg/dL), a plasma fibrinogen level of at least 10.35 mumol/L, a serum homocysteine level of at least 15,mumol/L, and a C-reactive protein level of at least 10.0 mg/L for participants with chronic kidney disease compared with those with a GFR of at least 90 mL/min per 1.73 m(2) or greater were 1.92 (95% Cl, 1.02 to 3.63), 1.82 (Cl, 1.06 to 3.13), 1.74 (Cl, 1.35 to 2.24), 8.23 (Cl, 5.00 to 13.6), and 1.93 (Cl, 1.33 to 2.81), respectively. Conclusions: Levels of apolipoprotein A1 are decreased and levels of homocysteine, lipoprotein(a), fibrinogen, and C-reactive protein are increased among patients with chronic kidney disease.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave,SL18, New Orleans, LA 70118 USA.	jhe@tulane.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652	NCRR NIH HHS [P20 RR17659-01] Funding Source: Medline; NIDDK NIH HHS [U01 DK60963] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060963] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Bostom AG, 1996, ATHEROSCLEROSIS, V125, P91, DOI 10.1016/0021-9150(96)05865-0; Bostom AG, 1997, KIDNEY INT, V52, P10, DOI 10.1038/ki.1997.298; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Coresh J, 1998, J Am Soc Nephrol, V9, pS24; CRESSMAN MD, 1992, CIRCULATION, V86, P475, DOI 10.1161/01.CIR.86.2.475; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Dennis VW, 1996, KIDNEY INT, V50, pS11; DENTONS, 2019, 2019 CHIN DAT PROT C, P17; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; GOLDWASSER P, 1993, AM J KIDNEY DIS, V22, P215, DOI 10.1016/S0272-6386(12)70189-0; Grimm R H Jr, 1997, Kidney Int Suppl, V63, pS10; HAFFNER SM, 1992, J AM SOC NEPHROL, V3, P1156; Henning BF, 1999, NEPHRON, V83, P314, DOI 10.1159/000045423; Irish A, 1998, ATHEROSCLEROSIS, V137, P133, DOI 10.1016/S0021-9150(97)00273-6; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; *KDOQI WORK GROUP, 2002, AM J KIDNEY DIS, V39, pS46; Kovesdy CP, 2002, AM J KIDNEY DIS, V40, P899, DOI 10.1053/ajkd.2002.36319; Kronenberg F, 1999, J AM SOC NEPHROL, V10, P1027; KWITEROVICH PO, 1992, AM J CARDIOL, V69, P1015, DOI 10.1016/0002-9149(92)90856-T; Levey AS, 1998, AM J KIDNEY DIS, V32, pS5, DOI 10.1053/ajkd.1998.v32.pm9820463; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levinskii YV, 2000, INORG MATER+, V36, P24, DOI 10.1007/BF02758374; Longenecker JC, 2002, CIRCULATION, V106, P2812, DOI 10.1161/01.CIR.0000038946.91899.BB; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Reis SE, 2002, CIRCULATION, V105, P2826, DOI 10.1161/01.CIR.0000021597.63026.65; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Robinson K, 1996, CIRCULATION, V94, P2743, DOI 10.1161/01.CIR.94.11.2743; Samak MJ, 2002, CLIN NEPHROL, V57, P327; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Sechi LA, 1999, KIDNEY INT, V56, P1049, DOI 10.1046/j.1523-1755.1999.00621.x; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stein JH, 1997, ARCH INTERN MED, V157, P1170, DOI 10.1001/archinte.157.11.1170; Stenvinkel P, 1998, KIDNEY INT, V53, P1336, DOI 10.1046/j.1523-1755.1998.00880.x; Tamura T, 1996, J AM SOC NEPHROL, V7, P2414; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x; [No title captured]	48	312	322	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2004	140	1					9	17		10.7326/0003-4819-140-1-200401060-00006	http://dx.doi.org/10.7326/0003-4819-140-1-200401060-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760VH	14706967				2022-12-01	WOS:000187855600002
J	Aten, JA; Stap, J; Krawczyk, PM; van Oven, CH; Hoebe, RA; Essers, J; Kanaar, R				Aten, JA; Stap, J; Krawczyk, PM; van Oven, CH; Hoebe, RA; Essers, J; Kanaar, R			Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains	SCIENCE			English	Article							REPAIR; CHROMATIN; ABERRATIONS; COMPLEX; ALPHA; FOCI	Interactions between ends from different DNA double-strand breaks (DSBs) can produce tumorigenic chromosome translocations. Two theories for the juxtaposition of DSBs in translocations, the static "contact-first" and the dynamic "breakage-first" theory, differ fundamentally in their requirement for DSB mobility. To determine whether or not DSB-containing chromosome domains are mobile and can interact, we introduced linear tracks of DSBs in nuclei. We observed changes in track morphology within minutes after DSB induction, indicating movement of the domains. In a subpopulation of cells, the domains clustered. Juxtaposition of different DSB-containing chromosome domains through clustering, which was most extensive in G1 phase cells, suggests an adhesion process in which we implicate the Mre11 complex. Our results support the breakage-first theory to explain the origin of chromosomal translocations.	Erasmus MC Daniel den Hoed, Erasmus Med Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus MC Daniel den Hoed, Dept Radiat Oncol, NL-3000 DR Rotterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Ctr Microscopial Res, NL-1100 DE Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Kanaar, R (corresponding author), Erasmus MC Daniel den Hoed, Erasmus Med Ctr, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	r.kanaar@erasmusmc.nl						Anderson RM, 2002, P NATL ACAD SCI USA, V99, P12167, DOI 10.1073/pnas.182426799; BARENDSEN GW, 1962, NATURE, V193, P1153, DOI 10.1038/1931153a0; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Dianov GL, 2001, BIOESSAYS, V23, P745, DOI 10.1002/bies.1104; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Holley WR, 2002, RADIAT RES, V158, P568, DOI 10.1667/0033-7587(2002)158[0568:AMFICA]2.0.CO;2; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Ludwikow G, 2002, INT J RADIAT BIOL, V78, P239, DOI 10.1080/09553000110110086; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Savage JRK, 2000, SCIENCE, V290, P62, DOI 10.1126/science.290.5489.62; SAX K., 1941, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, V9, P93; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Serebrovsky AS, 1929, AM NAT, V63, P374, DOI 10.1086/280271; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Tashiro S, 1996, ONCOGENE, V12, P2165; Wyman C, 2002, CURR BIOL, V12, pR446, DOI 10.1016/S0960-9822(02)00941-7	23	372	386	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					92	95		10.1126/science.1088845	http://dx.doi.org/10.1126/science.1088845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704429				2022-12-01	WOS:000187710600041
J	Sarmiento, JL; Gruber, N; Brzezinski, MA; Dunne, JP				Sarmiento, JL; Gruber, N; Brzezinski, MA; Dunne, JP			High-latitude controls of thermocline nutrients and low latitude biological productivity	NATURE			English	Article							SOUTHERN-OCEAN; NORTH; SI; CYCLE; MODE	The ocean's biological pump strips nutrients out of the surface waters and exports them into the thermocline and deep waters. If there were no return path of nutrients from deep waters, the biological pump would eventually deplete the surface waters and thermocline of nutrients; surface biological productivity would plummet. Here we make use of the combined distributions of silicic acid and nitrate to trace the main nutrient return path from deep waters by upwelling in the Southern Ocean(1) and subsequent entrainment into subantarctic mode water. We show that the subantarctic mode water, which spreads throughout the entire Southern Hemisphere(2,3) and North Atlantic Ocean(3), is the main source of nutrients for the thermocline. We also find that an additional return path exists in the northwest corner of the Pacific Ocean, where enhanced vertical mixing, perhaps driven by tides(4), brings abyssal nutrients to the surface and supplies them to the thermocline of the North Pacific. Our analysis has important implications for our understanding of large-scale controls on the nature and magnitude of low-latitude biological productivity and its sensitivity to climate change.	Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90095 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA	Sarmiento, JL (corresponding author), Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA.	jls@princeton.edu	Dunne, John P/F-8086-2012; Gruber, Nicolas/B-7013-2009	Dunne, John P/0000-0002-8794-0489; Gruber, Nicolas/0000-0002-2085-2310				Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; Brzezinski MA, 2003, DEEP-SEA RES PT II, V50, P619, DOI 10.1016/S0967-0645(02)00587-8; Dugdale RC, 2002, DEEP-SEA RES PT II, V49, P2513, DOI 10.1016/S0967-0645(02)00046-2; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Gnanadesikan A, 2001, DEEP-SEA RES PT II, V49, P363; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hanawa K., 2001, INT GEOPHYS, VEds., P373, DOI [10.1016/S0074-6142(01)80129-7, DOI 10.1016/S0074-6142(01)80129-7]; KARA AB, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2000C000736; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Levitus S., 1998, WORLD OCEAN DATABASE, V1; McCartney M.S., 1977, VOYAGE DISCOVERY GEO, P103; McCartney MS, 1982, J MAR RES, V40, P427; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Nakamura T, 2000, J PHYS OCEANOGR, V30, P1601, DOI 10.1175/1520-0485(2000)030<1601:TGOLAU>2.0.CO;2; Pollard RT, 2002, DEEP-SEA RES PT II, V49, P3289, DOI 10.1016/S0967-0645(02)00084-X; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SARMIENTO JL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI DOI 10.1029/2002GB00191; Sigman DM, 1999, GLOBAL BIOGEOCHEM CY, V13, P1149, DOI 10.1029/1999GB900038; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P1005, DOI 10.1175/1520-0485(2001)031<1005:CRAMOA>2.0.CO;2; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; TALLEY LD, 1991, DEEP-SEA RES, V38, pS171, DOI 10.1016/S0198-0149(12)80009-4; Talley LD, 1997, J PHYS OCEANOGR, V27, P1795, DOI 10.1175/1520-0485(1997)027<1795:NPIWTI>2.0.CO;2; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; TOGGWEILER JR, 1993, GLOBAL CARBON CYCLE, P333; Tsunogai S, 2002, J OCEANOGR, V58, P245, DOI 10.1023/A:1015805607724; Yasuda I, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001037; Yasuda I, 2001, J GEOPHYS RES-OCEANS, V106, P6931, DOI 10.1029/1999JC000154	30	856	871	4	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					56	60		10.1038/nature02127	http://dx.doi.org/10.1038/nature02127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14702082				2022-12-01	WOS:000187710000031
J	Gostin, LO; Bayer, R; Fairchild, AL				Gostin, LO; Bayer, R; Fairchild, AL			Ethical and legal challenges posed by severe acute respiratory syndrome - Implications for the control of severe infectious disease threats	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; TERRORISM; EPIDEMIC; CARE; LAW	The appearance and spread of severe acute respiratory syndrome (SARS) on a global level raised vital legal and ethical issues. National and international responses to SARS have profound implications for 3 important ethical values:, privacy, liberty, and the duty to protect the public's health. This article examines, through legal and ethical lenses, various methods that countries used in reaction to the SARS outbreak: surveillance and contact tracing, isolation and quarantine, and travel restrictions. These responses, at least in some combination, succeeded in bringing the outbreak to an end. The article articulates a set of legal and ethical recommendations for responding to infectious disease threats, seeking to reconcile the tension between the public's health and individual rights to privacy, liberty, and freedom of movement. The ethical values that inform the recommendations include the precautionary principle, the least restrictive/intrusive alternative, justice, and transparency. Development of a set of legal and ethical recommendations becomes even more essential when, as was true with SARS and will undoubtedly be the case with future epidemics, scientific uncertainty is pervasive,and urgent public health action is required.	Georgetown Univ, Ctr Law, Ctr Law & Publ Hlth, Washington, DC 20001 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Columbia Univ, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, Joseph L Mailman Sch Publ Hlth, New York, NY USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Ctr Law & Publ Hlth, 600 New Jersey Ave NW, Washington, DC 20001 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				ALTMAN LK, 2003, NY TIMES        0428, pA1; [Anonymous], 1991, Law Med Health Care, V19, P247; [Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P226; [Anonymous], 1995, CONTROL COMMUNICABLE; Applegate JS, 2000, HUM ECOL RISK ASSESS, V6, P413, DOI 10.1080/10807030091124554; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; BAYER R, 1986, JAMA-J AM MED ASSOC, V256, P1768, DOI 10.1001/jama.256.13.1768; Bloom BR, 2003, SCIENCE, V300, P701, DOI 10.1126/science.300.5620.701; Bradsher K, 2003, NY TIMES, pA1; BRADSHER K, 2003, NY TIMES        0425, pA20; BROWN DL, 2003, WASHINGTON POST 0424, pA20; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P436; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P270; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P40; CHENG M, 2003, NEW YORK NEWSDA 0517, pA4; Cohn M. R., 2003, TORONTO STAR    0421, pAl; COOPER MH, 2003, CQ RES          0620; DONOVAN K, 2003, TORONTO STAR    0425, pA14; Feinberg J., 1987, MORAL LIMITS CRIMINA; Fidler DP, 2003, EMERG INFECT DIS, V9, P285, DOI 10.3201/eid0903.020336; FUJIWARA PI, TB CONTR NEW YORK CI; GARRETT L, 2003, NEWSDAY         0629, pA5; Gerberding JL, 2003, NEW ENGL J MED, V348, P2030, DOI 10.1056/NEJMe030067; Gostin LO, 1997, NEW ENGL J MED, V337, P1162, DOI 10.1056/NEJM199710163371611; Gostin LO, 2002, HEALTH AFFAIR, V21, P79, DOI 10.1377/hlthaff.21.6.79; Gostin LO, 2000, PUBLIC HLTH LAW POWE; *HARV U HLTH SERV, U ANN POL REG VIS SU; Kahn Joseph, 2003, NY TIMES        0701, pA; KRAUSS C, 2003, NY TIMES        0610, pA13; KUEPPER GJ, HONG KONG EXPERIENCE; LONG S, 2003, STRAITS TIMES S 0511; MARSHALL T, 2003, LOS ANGELES TIM 0428, P1; Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036; MAYNARD M, 2003, NY TIMES        0511, P5; MAYNARD M, 2003, NY TIMES        0511, P6; MCNEIL DG, 2003, NYT             0314, pA1; MORRIS J, 2000, RETHINKING RISK PREC, P1; MURPHY DE, 2003, NY TIMES, pA12; NAKASHIMA E, 2003, WASHINGTON POST 0501, pA11; PADDOCK R, 2003, LOS ANGELES TIM 0508, P1; PERL T, 2003, REPORT TORONTO ETHIC; Rider D., 2003, OTTAWA CITIZEN  0404, pA10; RIDER D, 2003, OTTAWA CITIZEN  0420, pA1; SHELDON P, 2003, NY TIMES        0507, pA10; Sorenson C., 2003, TORONTO STAR    0404; STERNBERG S, 2003, US TODAY        0424, pA1; *UN EC SOC COUNC, ECN419854 UN; WAYNE A, 2003, NY TIMES        0610, pF4; WHO, GUID MASS GATH HOST; *WHO, UPD 70 SING REM LIST; *WHO, UPD 58 1 GLOB CONS S; *WHO, UPD 95 CHRON TRAV RE; *WHO, CURR INT HLTH REG IH; WHO, CUM NUMB REP PROB CA; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P98; *WHO, CAS DEF SURV SEV AC; World Health Organization, REV INT HLTH REG SEV; World Health Organization, UPD 95 SARS CHRON SE; World Health Organization, 2003, SEV AC RESP SYNDR SA; World Health Organization (WHO), 2003, WKLY EPIDEMIOL REC, V78, P161; Wynia MK, 2002, SCIENCE, V296, P1613, DOI 10.1126/science.1072921; 1999, INT COVENANT CIVIL P; 2003, MMWR MORB MORTAL WKL, V52, P680; FREEDOM MOVEMENT TRA; SHELTERING PLACE; 2003, STRAITS TIMES S 0425; POLICE SYSTEM TRACKI	67	128	132	2	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2003	290	24					3229	3237		10.1001/jama.290.24.3229	http://dx.doi.org/10.1001/jama.290.24.3229			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756TR	14693876				2022-12-01	WOS:000187499300027
J	Buckling, A; Wills, MA; Colegrave, N				Buckling, A; Wills, MA; Colegrave, N			Adaptation limits diversification of experimental bacterial populations	SCIENCE			English	Article							EXPERIMENTAL EVOLUTION; GENETIC-POLYMORPHISM; PEAKS; DIVERSITY; FITNESS	Adaptation to a specific niche theoretically constrains a population's ability to subsequently diversify into other niches. We tested this theory using the bacterium Pseudomonas fluorescens, which diversifies into niche specialists when propagated in laboratory microcosms. Numerically dominant genotypes were allowed to diversify in isolation. As predicted, populations increased in fitness through time but showed a greatly decreased ability to diversify. Subsequent experiments demonstrated that niche generalists and reductions in intrinsic evolvability were not responsible for our data. These results show that niche specialization may come with a cost of reduced potential to diversify.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Bath; University of Edinburgh	Buckling, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssagjb@bath.ac.uk	Colegrave, Nick/F-3916-2010; Wills, Matthew Albion/AAE-1790-2019	Wills, Matthew/0000-0002-7344-7749; Buckling, Angus/0000-0003-1170-4604				Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bell G., 1997, SELECTION MECH EVOLU; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; FOBZHANSKY T, 1937, GENETICS ORIGIN SPEC; HEDRICK PW, 1976, ANNU REV ECOL SYST, V7, P1, DOI 10.1146/annurev.es.07.110176.000245; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Templeton A. R, 2000, EPISTASIS EVOLUTIONA; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Wade Michael J., 2000, P213; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wright S, 1931, GENETICS, V16, P0097	24	82	87	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2107	2109		10.1126/science.1088848	http://dx.doi.org/10.1126/science.1088848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684817	Green Submitted			2022-12-01	WOS:000187385200039
J	Ganesh, L; Burstein, E; Guha-Nijogi, A; Louder, MK; Mascola, JR; Klomp, LWJ; Wijmenga, C; Duckett, CS; Nabel, GJ				Ganesh, L; Burstein, E; Guha-Nijogi, A; Louder, MK; Mascola, JR; Klomp, LWJ; Wijmenga, C; Duckett, CS; Nabel, GJ			The gene product Murr1 restricts HIV-1 replication in resting CD4(+) lymphocytes	NATURE			English	Article							NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; UBIQUITINATION; ACTIVATION; ALPHA; TRANSCRIPTION; INFECTION; COMPLEX; PHOSPHORYLATION	Although human immunodeficiency virus-1 (HIV-1) infects quiescent and proliferating CD4(+) lymphocytes, the virus replicates poorly in resting T cells(1-6). Factors that block viral replication in these cells might help to prolong the asymptomatic phase of HIV infection(7); however, the molecular mechanisms that control this process are not fully understood. Here we show that Murr1, a gene product known previously for its involvement in copper regulation(8,9), inhibits HIV-1 growth in unstimulated CD4(+) T cells. This inhibition was mediated in part through its ability to inhibit basal and cytokine-stimulated nuclear factor (NF)-kappaB activity. Knockdown of Murr1 increased NF-kappaB activity and decreased IkappaB-alpha concentrations by facilitating phospho-IkappaB-alpha degradation by the proteasome. Murr1 was detected in CD4(+) T cells, and RNA-mediated interference of Murr1 in primary resting CD4(+) lymphocytes increased HIV-1 replication. Through its effects on the proteasome, Murr1 acts as a genetic restriction factor that inhibits HIV-1 replication in lymphocytes, which could contribute to the regulation of asymptomatic HIV infection and the progression of AIDS.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Med Ctr Utrecht, NL-3584 EA Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC-3005,40 Convent Dr, Bethesda, MD 20892 USA.		Burstein, Ezra/B-7247-2016; Wijmenga, Cisca/AAE-7719-2019; Mascola, John/AAI-7193-2021; Wijmenga, Cisca/D-2173-2009	Burstein, Ezra/0000-0003-4341-6367; Wijmenga, Cisca/0000-0002-5635-1614; Duckett, Colin/0000-0001-9413-2263				ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; RICHTER BW, 2000, SCI STKE; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	31	188	193	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2003	426	6968					853	857		10.1038/nature02171	http://dx.doi.org/10.1038/nature02171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685242	Green Published			2022-12-01	WOS:000187342000062
J	Hehenkamp, A; Hargreaves, S				Hehenkamp, A; Hargreaves, S			Tuberculosis treatment in complex emergencies: South Sudan	LANCET			English	Article									Med Sans Frontieres, London EC1N 8QX, England	Doctors Without Borders				Hargreaves, Sally/0000-0003-2974-4348					0	16	16	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2003	362			S			S30	S31		10.1016/S0140-6736(03)15066-0	http://dx.doi.org/10.1016/S0140-6736(03)15066-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	760BG	14698120				2022-12-01	WOS:000187790200016
J	Xu, YW; Moseley, JB; Sagot, I; Poy, F; Pellman, D; Goode, BL; Eck, MJ				Xu, YW; Moseley, JB; Sagot, I; Poy, F; Pellman, D; Goode, BL; Eck, MJ			Crystal structures of a formin homology-2 domain reveal a tethered dimer architecture	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; BINDING PROTEIN; CELL POLARITY; YEAST; NUCLEATION; PROFILIN; BNI1P; POLYMERIZATION	Formin proteins participate in a wide range of cytoskeletal processes in all eukaryotes. The defining feature of formins is a highly conserved similar to400 residue region, the Formin Homology-2 (FH2) domain, which has recently been found to nucleate actin filaments' Here we report crystal structures of the S. cerevesiae Bni1p FH2 domain. The mostly alpha-helical FH2 domain forms a unique "tethered dimer" in which two elongated actin binding heads are tied together at either end by an unusual lasso and linker structure. Biochemical and crystallographic observations indicate that the dimer is stable but flexible, with flexibility between the two halves of the dimer conferred by the linker segments. Although each half of the dimer is competent to interact with filament ends, the intact dimer is required for actin nucleation and processive capping. The tethered dimer architecture may allow formins to stair-step on the barbed end of an elongating nascent filament.	Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Hematol, Boston, MA 02115 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Brandeis University; Brandeis University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Pellman, D (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	David_Pellman@dfci.harvard.edu; eck@red.dfci.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063691, R01GM061345, R37GM061345] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61345, R01 GM061345, GM63691] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	36	274	278	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2004	116	5					711	723		10.1016/S0092-8674(04)00210-7	http://dx.doi.org/10.1016/S0092-8674(04)00210-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	821YQ	15006353	Bronze			2022-12-01	WOS:000221499700011
J	Wu, B; Ooi, TL; He, ZJJ				Wu, B; Ooi, TL; He, ZJJ			Perceiving distance accurately by a directional process of integrating ground information	NATURE			English	Article							VISUAL-PERCEPTION; MOTION; LOCATION; VISION; SLANT; SHAPE	By itself, the absolute distance of an object cannot be accurately judged beyond 2-3 m (refs 1-3). Yet, when it is viewed with reference to a flat terrain, humans accurately judge the absolute distance of the object up to 20 m, an ability that is important for various actions(4-8). Here we provide evidence that this is accomplished by integrating local patches of ground information into a global surface reference frame. We first show that restricting an observer's visual field of view to the local ground area around the target leads to distance underestimation, indicating that a relatively wide expanse of the ground surface is required for accurate distance judgement. Second, as proof of surface integration, we show that even with the restricted view, the observer can accurately judge absolute distance by scanning local patches of the ground surface, bit by bit, from near to far, but not in the reverse direction. This finding also reveals that the surface integration process uses the near-ground-surface information as a foundation for surface representation, and extrapolation to the far ground surface around the target for accurate absolute distance computation.	Penn Coll Optometry, Dept Basic Sci, Elkins Pk, PA 19027 USA; Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA	University of Louisville	He, ZJJ (corresponding author), Penn Coll Optometry, Dept Basic Sci, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	tlooi@pco.edu; zjhe@louisville.edu			NATIONAL EYE INSTITUTE [R01EY014821] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014821] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRAUNSTEIN ML, 1968, J EXP PSYCHOL, V78, P247, DOI 10.1037/h0026269; Dolezal H., 1982, LIVING WORLD TRANSFO; FREEMAN RB, 1965, PSYCHOL REV, V72, P501, DOI 10.1037/h0022614; Gibson J.J., 1950, PERCEPTION VISUAL WO, DOI DOI 10.2307/1419017; GIBSON JJ, 1952, J EXP PSYCHOL, V44, P11, DOI 10.1037/h0060729; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; GOGEL WC, 1979, VISION RES, V19, P1161, DOI 10.1016/0042-6989(79)90013-0; HAGEN MA, 1978, PERCEPT PSYCHOPHYS, V23, P326, DOI 10.3758/BF03199716; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; LAND MF, 1982, J EXP BIOL, V96, P427; Loomis JM, 1999, PERCEPT PSYCHOPHYS, V61, P397, DOI 10.3758/BF03211961; Loomis JM, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P21; Loomis JM, 2002, J EXP PSYCHOL HUMAN, V28, P1202, DOI 10.1037//0096-1523.28.5.1202; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; Loomis JM, 1996, CURR DIR PSYCHOL SCI, V5, P72, DOI 10.1111/1467-8721.ep10772783; Meng JC, 2001, PERCEPT PSYCHOPHYS, V63, P1, DOI 10.3758/BF03200497; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; RIESER JJ, 1990, PERCEPTION, V19, P675, DOI 10.1068/p190675; Sedgwick HA., 1986, HDB PERCEPTION HUMAN, P1; Sinai MJ, 1998, NATURE, V395, P497, DOI 10.1038/26747; THOMSON JA, 1983, J EXP PSYCHOL HUMAN, V9, P427, DOI 10.1037/0096-1523.9.3.427	22	190	195	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2004	428	6978					73	77		10.1038/nature02350	http://dx.doi.org/10.1038/nature02350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	780GK	14999282				2022-12-01	WOS:000189363800037
J	Cawley, S; Bekiranov, S; Ng, HH; Kapranov, P; Sekinger, EA; Kampa, D; Piccolboni, A; Sementchenko, V; Cheng, J; Williams, AJ; Wheeler, R; Wong, B; Drenkow, J; Yamanaka, M; Patel, S; Brubaker, S; Tammana, H; Helt, G; Struhl, K; Gingeras, TR				Cawley, S; Bekiranov, S; Ng, HH; Kapranov, P; Sekinger, EA; Kampa, D; Piccolboni, A; Sementchenko, V; Cheng, J; Williams, AJ; Wheeler, R; Wong, B; Drenkow, J; Yamanaka, M; Patel, S; Brubaker, S; Tammana, H; Helt, G; Struhl, K; Gingeras, TR			Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs	CELL			English	Article							GENOME-WIDE LOCATION; CAENORHABDITIS-ELEGANS; ANTISENSE RNA; SACCHAROMYCES-CEREVISIAE; TARGET GENES; XIST GENE; IDENTIFICATION; EXPRESSION; ALGORITHM; SEQUENCE	Using high-density oligonucleotide arrays representing essentially all nonrepetitive sequences on human chromosomes 21 and 22, we map the binding sites in vivo for three DNA binding transcription factors, Sp1, cMyc, and p53, in an unbiased manner. This mapping reveals an unexpectedly large number of transcription factor binding site (TFBS) regions, with a minimal estimate of 12,000 for Sp1, 25,000 for cMyc, and 1600 for p53 when extrapolated to the full genome. Only 22% of these TFBS regions are located at the 5' termini of protein-coding genes while 36% lie within or immediately 3' to well-characterized genes and are significantly correlated with noncoding RNAs. A significant number of these noncoding RNAs are regulated in response to retinoic acid, and overlapping pairs of protein-coding and noncoding RNAs are often coregulated. Thus, the human genome contains roughly comparable numbers of protein-coding and noncoding genes that are bound by common transcription factors and regulated by common environmental signals.	Affymetrix, Santa Clara, CA 95051 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Genome Inst Singapore, Singapore 138672, Singapore	Affymetrix; Harvard University; Harvard Medical School; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Gingeras, TR (corresponding author), Affymetrix, 3380 Cent Expressway, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com	Ng, Huck Hui/A-1135-2009	Gingeras, Thomas/0000-0001-9106-3573; Kapranov, Philipp/0000-0003-2647-4856	NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NIGMS NIH HHS [GM30186, GM53720] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM030186, R01GM053720] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Carmichael GG, 2003, NAT BIOTECHNOL, V21, P371, DOI 10.1038/nbt0403-371; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; DAMJANOV I, 1993, LAB INVEST, V68, P220; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Minc E, 1999, J BIOL CHEM, V274, P503, DOI 10.1074/jbc.274.1.503; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Patankar S, 2001, MOL BIOL CELL, V12, P3114, DOI 10.1091/mbc.12.10.3114; PLOUGASTEL B, 1993, GENOMICS, V18, P609, DOI 10.1016/S0888-7543(05)80363-5; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Sleutels F, 2002, ADV GENET, V46, P119; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	49	893	943	0	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2004	116	4					499	509		10.1016/S0092-8674(04)00127-8	http://dx.doi.org/10.1016/S0092-8674(04)00127-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	777NJ	14980218	Bronze			2022-12-01	WOS:000189184200005
J	Velicer, CM; Heckbert, SR; Lampe, JW; Potter, JD; Robertson, CA; Taplin, SH				Velicer, CM; Heckbert, SR; Lampe, JW; Potter, JD; Robertson, CA; Taplin, SH			Antibiotic use in relation to the risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLISM; VEGETABLES; ESTROGENS; INFECTIONS; EXPRESSION	Context Use of antibiotics may be associated with risk of breast cancer through effects on immune function, inflammation, and. metabolism of <LF>estrogen and phytochemicals; however, clinical data on the association between antibiotic use and risk of. breast cancer are sparse. Objective To examine the association between use of antibiotics and risk of breast cancer. Design, Setting, and Participants Case-control Study among 2266,women older than 19 years with primary, invasive breast cancer (cases) enrolled in a large, non-profit health plan for at least 1 year between January 1, 1993, and June 30, 2001, and 7953 randomly selected female health plan members (controls), frequency-matched to cases on age and length of enrollment. Cases were ascertained from the Surveillance, Epidemiology, and End Results cancer registry. Antibiotic use was ascertained from computerized pharmacy records. Main Outcome Measure Association between extent of antibiotic use and risk of breast cancer. Results Increasing cumulative-days of antibiotic. use were associated with increased risk of incident breast cancer, adjusted for age and length of enrollment. For categories of increasing use (0, 1-50, 51-100, 101-500, 501-1000, and greater than or equal to1001 days), odds ratios (95% confidence intervals) for breast <LF>cancer were 1.00 (reference), 1.45 (1.24-1.69), 1.53 (1.28-1.83), 1.68 (1.42-2.00), 2.14 (1.60-2.88),and 2.07 (1.48-2.89) (P<.001 for trend). Increased risk was observed in all antibiotic classes studied and in a subanalysis having breast cancer fatality as the outcome. Among women with the highest levels of tetracycline or macrolide use, risk of breast cancer was not elevated in those using these antibiotics exclusively for acne or rosacea (indications that could be risk factors for breast cancer due to altered hormone levels), compared with those using them exclusively for respiratory tract infections, adjusted for age and length. of enrollment (odds ratio, 0.91; 95% confidence interval, 0.44-1.87). Conclusions Use of antibiotics is associated with increased risk of incident and fatal breast cancer. It cannot be determined from this study whether antibiotic use is causally related to breast cancer, or whether indication for used overall weakened immune function, or other factors are pertinent underlying exposures. Although further studies are needed, these findings reinforce the need for prudent long-term use of antibiotics.	Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Dept Family Med, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Grp Hlth Cooperat Puget Sound, Dept Pharm, Seattle, WA 98121 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98104 USA; NCI, Appl Res Program, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Group Health Cooperative; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Heckbert, SR (corresponding author), Univ Washington, Dept Epidemiol, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	heckbert@u.washington.edu		Potter, John/0000-0001-5439-1500	NCI NIH HHS [T32CA09168, UO1CA63731] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA063731, T32CA009168] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLERCREUTZ H, 1976, J CLIN ENDOCR METAB, V43, P497, DOI 10.1210/jcem-43-3-497; Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; *AM CANC SOC, 2001, BREAST CANC FACTS FI; Attur MG, 1999, J IMMUNOL, V162, P3160; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Coogan PF, 1999, PREV MED, V29, P72, DOI 10.1006/pmed.1999.0518; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gonzales R, 2001, ANN INTERN MED, V134, P490, DOI 10.7326/0003-4819-134-6-200103200-00015; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Kilkkinen A, 2002, AM J EPIDEMIOL, V155, P472, DOI 10.1093/aje/155.5.472; Knekt P, 2000, BRIT J CANCER, V82, P1107, DOI 10.1054/bjoc.1999.1047; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Reed MJ, 2001, CLIN ENDOCRINOL, V54, P563, DOI 10.1046/j.1365-2265.2001.01276.x; Rowland I, 1999, BIOCHEM SOC T, V27, P304, DOI 10.1042/bst0270304; SAUNDERS KW, 2000, PHARMACOEPIDEM DR S, P247; SETCHELL KDR, 1981, LANCET, V2, P4; Shapiro TA, 1998, CANCER EPIDEM BIOMAR, V7, P1091; Shu XO, 2001, CANCER EPIDEM BIOMAR, V10, P483; Taplin SH, 1997, CANCER EPIDEM BIOMAR, V6, P625; Thompson LU, 1998, BAILLIERE CLIN ENDOC, V12, P691, DOI 10.1016/S0950-351X(98)80011-6; TIKKANEN MJ, 1973, BMJ-BRIT MED J, V2, P369, DOI 10.1136/bmj.2.5862.369; Velicer CM, 2003, CANCER CAUSE CONTROL, V14, P739, DOI 10.1023/A:1026323424792; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733	24	211	218	3	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2004	291	7					827	835		10.1001/jama.291.7.827	http://dx.doi.org/10.1001/jama.291.7.827			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774TF	14970061	Bronze			2022-12-01	WOS:000189000400020
J	Wong, TY; Klein, R; Sharrett, AR; Duncan, BB; Couper, DJ; Klein, BEK; Hubbard, LD; Nieto, FJ				Wong, TY; Klein, R; Sharrett, AR; Duncan, BB; Couper, DJ; Klein, BEK; Hubbard, LD; Nieto, FJ		Atherosclerosis Risk Communities S	Retinal arteriolar diameter and risk for hypertension	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; MICROVASCULAR ABNORMALITIES; BLOOD-PRESSURE; MICROCIRCULATION	Background: Narrowing of the small arterioles has been hypothesized to contribute to the pathogenesis of hypertension, but prospective clinical data are lacking. Objective: To examine the relation of retinal arteriolar narrowing to incident hypertension in healthy middle-aged persons. Design: Prospective cohort study. Setting: The population-based Atherosclerosis Risk in Communities Study, conducted in 4 U.S. communities. Participants: 5628 persons 49 to 73 years of age without preexisting hypertension. Measurements: Diameters of retinal vessels were measured from digitized retinal photographs. A summary arteriole-to-venule ratio was computed as an indicator of generalized arteriolar narrowing; a lower ratio indicated greater narrowing. Areas of focal arteriolar narrowing were defined from photographs by using a standard protocol. Incident hypertension, defined as systolic blood pressure of 140 mm Hg or higher, diastolic blood pressure of 90 mm Hg or higher, or use of anti hypertensive medication, was identified from the cohort. Results: After 3 years of follow-up, 811 (14.4%) persons had developed hypertension. The incidence of hypertension was higher in persons with lower arteriole-to-venule ratios (incidence of 8.9%, 12.3%, 13.7%, 14.3%, and 22.3%, comparing decreasing quintiles of the ratio) and in persons with focal arteriolar narrowing than in those without focal arteriolar narrowing (25.1% vs. 13.0%). After the authors controlled for the average systolic and diastolic blood pressures over the preceding 6 years, body mass index, waist-to-hip ratio, and other risk factors, the odds of developing hypertension were approximately 60% higher in persons with lower arteriole-to-venule ratios (odds ratio, 1.62 [95% Cl, 1.21 to 2.18] comparing lowest to highest quintile; P = 0.006 for trend) and focal arteriolar narrowing (odds ratio, 1.61 [CI, 1.27 to 2.04]; P < 0.001). Conclusions: smaller retinal arteriolar diameters are independently associated with incident hypertension, which suggests that arteriolar narrowing may be linked to the occurrence and development of hypertension.	Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Natl Univ Singapore, Singapore Eye Res Inst, Singapore, Singapore; Univ Wisconsin, Madison, WI USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; Univ N Carolina, Chapel Hill, NC USA	Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res Australia, 32 Gisborne St, Melbourne, Vic 3002, Australia.	ophwty@nus.edu.sg	Duncan, Bruce B/L-4140-2016; Wong, Tien Yin/AAC-9724-2020	Duncan, Bruce B/0000-0002-7491-2630; Wong, Tien Yin/0000-0002-8448-1264; Couper, David/0000-0002-4313-9235	NEI NIH HHS [EYO13939] Funding Source: Medline; NHLBI NIH HHS [N01-HC-55019, N01-HC-35125, N01-HC-55020, N01-HC-55021, N01-HC-35126, N01-HC-55022, N01-HC-55016, N01-HC-55018, N01-HC-55015] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055022, N01HC055015, N01HC055019, N01HC055020, N01HC035126, N01HC055016, N01HC035125, N01HC055021] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY013939] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Chobanian AV, 2001, NEW ENGL J MED, V345, P534, DOI 10.1056/NEJM200108163450709; DEVEREUX RB, 1990, ANN INTERN MED, V112, P157, DOI 10.7326/0003-4819-112-3-157; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; *JOINT NAT COMM PR, 1997, NIH PUBL; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Levy BI, 2001, CIRCULATION, V104, P735, DOI 10.1161/hc3101.091158; MULVANY MJ, 1991, HYPERTENSION, V18, P52, DOI 10.1161/01.HYP.18.3_Suppl.I52; *NAT HEART LUNG BL, 1988, ATH RISK COMM STUDY; NORRELUND H, 1994, HYPERTENSION, V24, P301, DOI 10.1161/01.HYP.24.3.301; Papastathopoulos KI, 1999, BRIT J OPHTHALMOL, V83, P285, DOI 10.1136/bjo.83.3.285; PAPP AC, 1989, THROMB HAEMOSTASIS, V61, P15; Pries AR, 1999, HYPERTENSION, V33, P153, DOI 10.1161/01.HYP.33.1.153; RIZZONI D, 1994, AM J HYPERTENS, V7, P193, DOI 10.1093/ajh/7.2.193; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; THYBO NK, 1995, HYPERTENSION, V25, P474, DOI 10.1161/01.HYP.25.4.474; VICAUT E, 1992, J HYPERTENS, V10, pS59, DOI 10.1097/00004872-199207005-00009; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X	22	247	254	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2004	140	4					248	255		10.7326/0003-4819-140-4-200402170-00006	http://dx.doi.org/10.7326/0003-4819-140-4-200402170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774GA	14970147				2022-12-01	WOS:000188970400002
J	Herzog, C; Sales, N; Etchegaray, N; Charbonnier, A; Freire, S; Dormont, D; Deslys, JP; Lasmezas, CI				Herzog, C; Sales, N; Etchegaray, N; Charbonnier, A; Freire, S; Dormont, D; Deslys, JP; Lasmezas, CI			Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; RESISTANT PRION PROTEIN; VARIANT CJD; BSE AGENT; TRANSMISSION; MICE; SCRAPIE; HEALTH; BLOOD; PATHOGENESIS	Background The disease-associated form of prion protein (Prp(res)) has been noted in lymphoreticular tissues in patients with variant Creutzfeldt-Jakob disease (vCJD). Thus, the disease could be transmitted iatrogenically by surgery or use of blood products. We aimed to assess transmissibility of the bovine spongiform encephalopathy (BSE) agent to primates by the intravenous route and study its tissue distribution compared with infection by the oral route. Methods Cynomolgus macaques were infected either intravenously or orally with brain homogenates from first-passage animals with BSE. They were clinically monitored for occurrence of neurological signs and killed humanely at the terminal stage of the disease. Brain, lymphoreticular tissues, digestive tract, and peripheral nerves were obtained and analysed by sandwich ELISA and immunohistochemistry for quantitative and qualitative assessment of their Prp(res) content. Findings Incubation periods after intravenous transmission of BSE were much shorter than after oral infection. We noted that Prp(res) was present in lymphoreticular tissues such as spleen and tonsils and in the entire gut from the duodenum to the rectum. In the gut, PrPres was present in Peyer's patches and in the enteric nervous system and nerve fibres of intestinal mucosa. Furthermore, Prp(res) was found in locomotor peripheral nerves and the autonomic nervous system. Amount of PrPres ranged from 0.02% to more than 10% of that recorded in brain. Distribution of Prp(res) was similar in animals infected by the intravenous or oral route. Interpretation Our findings suggest that the possible risk of vCJD linked to endoscopic procedures might be currently underestimated. Human iatrogenic vCJD cases infected intravenously raise the same public-health concerns as primary cases and need the same precautionary measures with respect to blood and tissue donations and surgical procedures.	Commissariat Energie Atom, Dept Rech Med, F-92265 Fontenay Aux Roses, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lasmezas, CI (corresponding author), Commissariat Energie Atom, Dept Rech Med, BP6, F-92265 Fontenay Aux Roses, France.	lasmezas@cea.fr						BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; Giaccone G, 2000, BRAIN PATHOL, V10, P31, DOI 10.1111/j.1750-3639.2000.tb00240.x; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Ironside JW, 2003, J THROMB HAEMOST, V1, P1479, DOI 10.1046/j.1538-7836.2003.00268.x; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Maignien T, 1999, J GEN VIROL, V80, P3035, DOI 10.1099/0022-1317-80-11-3035; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; van Duijn CM, 1998, LANCET, V351, P1081, DOI 10.1016/S0140-6736(97)09468-3; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	23	113	117	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2004	363	9407					422	428		10.1016/S0140-6736(04)15487-1	http://dx.doi.org/10.1016/S0140-6736(04)15487-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774RX	14962521				2022-12-01	WOS:000188999500008
J	Roberts, JP; Wolfe, RA; Bragg-Gresham, JL; Rush, SH; Wynn, JJ; Distant, DA; Ashby, VB; Held, PJ; Port, FK				Roberts, JP; Wolfe, RA; Bragg-Gresham, JL; Rush, SH; Wynn, JJ; Distant, DA; Ashby, VB; Held, PJ; Port, FK			The effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CADAVERIC RENAL-TRANSPLANTATION; RACIAL-DIFFERENCES; UNITED-STATES; ACCESS; IMPACT; RACE; GENDER; DONOR; SEX	Background: HLA typing and the time a patient has spent on the waiting list are the primary criteria used to allocate cadaveric kidneys for transplantation in the United States. Candidates with no HLA-A, B, and DR mismatches are given top priority, followed by candidates with the fewest mismatches at the HLA-B and DR loci; this policy contributes to a higher transplantation rate among whites than nonwhites. We hypothesized that changing this allocation policy would affect graft survival and the racial balance among transplant recipients. Methods: We estimated the relative rates of kidney transplantation according to race resulting from the current allocation policy and racial differences in HLA antigen profiles, using a Cox model for the time from placement on the waiting list to transplantation. Another model, also adjusted for HLA-B and DR antigen profiles, estimated the relative rates of kidney transplantation that would result if the distribution of these antigen profiles were identical among the racial and ethnic groups. We also investigated the effect of HLA matching on the risk of graft failure, using a Cox model for the time from the first transplantation to graft failure. The results of the two analyses were used to estimate the change in the racial balance of transplantation and graft-failure rates that would result from the elimination of HLA-B matching or HLA-B and DR matching as a means of assigning priority. Results: Eliminating the HLA-B matching as a priority while maintaining HLA-DR matching as a priority would decrease the number of transplantations among whites by 4.0 percent (166 fewer transplantations over a one-year period), whereas it would increase the number among nonwhites by 6.3 percent and increase the rate of graft loss by 2.0 percent. Conclusions: Removing HLA-B matching as a priority for the allocation of cadaveric kidneys could reduce the existing racial imbalance by increasing the number of transplantations among nonwhites, with only a small increase in the rate of graft loss.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Renal Res & Educ Assoc, Ann Arbor, MI USA; Med Coll Georgia, Augusta, GA 30912 USA; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Roberts, JP (corresponding author), Univ Calif San Francisco, Rm M896, San Francisco, CA 94143 USA.	robertsj@surgery.ucsf.edu		Wynn, James/0000-0001-5879-3400	PHS HHS [231-00-0116] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; ASHBY VB, 2001, AM J TRANSPLANTAT S1, V1, P357; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Bloembergen WE, 1997, AM J KIDNEY DIS, V30, P733, DOI 10.1016/S0272-6386(97)90076-7; Cecka J M, 2000, Clin Transpl, P1; EGGERS PW, 1988, NEW ENGL J MED, V318, P223, DOI 10.1056/NEJM198801283180406; GASTON RS, 1993, JAMA-J AM MED ASSOC, V270, P1352, DOI 10.1001/jama.270.11.1352; GAYLIN DS, 1993, JAMA-J AM MED ASSOC, V269, P603, DOI 10.1001/jama.269.5.603; HELD PJ, 1988, ARCH INTERN MED, V148, P2594, DOI 10.1001/archinte.148.12.2594; HELD PJ, 1994, NEW ENGL J MED, V331, P765, DOI 10.1056/NEJM199409223311203; *HLTH RES SERV ADM, 2002, 2001 ANN REP US ORG; HOSMER DW, 1999, APPL SURVIVAL ANAL R, P202; KJELLSTRAND CM, 1988, ARCH INTERN MED, V148, P1305; Narva A, 1996, BLOOD PURIFICAT, V14, P293, DOI 10.1159/000170276; OJO A, 1993, AM J KIDNEY DIS, V22, P835, DOI 10.1016/S0272-6386(12)70343-8; Schnitzler MA, 1999, NEW ENGL J MED, V341, P1440, DOI 10.1056/NEJM199911043411906; SOUCIE JM, 1992, AM J KIDNEY DIS, V19, P414, DOI 10.1016/S0272-6386(12)80947-4; Takemoto SK, 2000, NEW ENGL J MED, V343, P1078, DOI 10.1056/NEJM200010123431504; *UN NETW ORG SHAR, 2002, OPTN UNOS POL 3 5 OR; Webb R L, 1990, Clin Transpl, P75; Wolfe RA, 2000, AM J KIDNEY DIS, V36, P1025, DOI 10.1053/ajkd.2000.19106	22	117	118	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2004	350	6					545	551		10.1056/NEJMoa025056	http://dx.doi.org/10.1056/NEJMoa025056			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770FP	14762181				2022-12-01	WOS:000188712800005
J	Xie, LL; Miller, LM; Chatterjee, C; Averin, O; Kelleher, NL; van der Donk, WA				Xie, LL; Miller, LM; Chatterjee, C; Averin, O; Kelleher, NL; van der Donk, WA			Lacticin 481: In vitro reconstitution of lantibiotic synthetase activity	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; LACTOCOCCUS-LACTIS; NISIN BIOSYNTHESIS; EXPRESSION SYSTEM; GENE; PEPTIDE; LOCALIZATION; CONSTRUCTION; BACTERIOCIN; SEQUENCE	The lantibiotic lacticin 481 is synthesized on ribosomes as a prepeptide (LctA) and posttranslationally modified to its mature form. These modi. cations include dehydration of serines and threonines, followed by intramolecular addition of cysteines to the unsaturated amino acids, which generates cyclic thioethers. This process breaks eight chemical bonds and forms six newbonds and is catalyzed by one enzyme, LctM. We have characterized the in vitro activity of LctM, which completely processed a series of LctA mutants, displaying a permissive substrate specificity that holds promise for antibiotic engineering.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kelleher, NL (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	vddonk@uiuc.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071	NIGMS NIH HHS [GM 067725, GM58822] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067725, R01GM058822] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIERBAUM G, 1994, APPL ENVIRON MICROB, V60, P4332, DOI 10.1128/AEM.60.12.4332-4338.1994; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Chen P, 1998, APPL ENVIRON MICROB, V64, P2335; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kleinnijenhuis AJ, 2003, ANAL CHEM, V75, P3219, DOI 10.1021/ac0263770; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; LIU W, 1992, J BIOL CHEM, V267, P25078; McLafferty FW, 1999, SCIENCE, V284, P1289, DOI 10.1126/science.284.5418.1289; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Okeley NM, 2003, BIOCHEMISTRY-US, V42, P13613, DOI 10.1021/bi0354942; PIARD JC, 1993, J BIOL CHEM, V268, P16361; REIS M, 1994, APPL ENVIRON MICROB, V60, P2876, DOI 10.1128/AEM.60.8.2876-2883.1994; Rince A, 1997, APPL ENVIRON MICROB, V63, P4252; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; Szekat C, 2003, APPL ENVIRON MICROB, V69, P3777, DOI 10.1128/AEM.69.7.3777-3783.2003; vandenHooven HW, 1996, FEBS LETT, V391, P317, DOI 10.1016/0014-5793(96)00771-5; VANDERMEER JR, 1994, J BIOL CHEM, V269, P3555; XIE L, 2003, THESIS U ILLINOIS UR	25	200	211	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					679	681		10.1126/science.1092600	http://dx.doi.org/10.1126/science.1092600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14752162				2022-12-01	WOS:000188530800043
J	Saydah, SH; Fradkin, J; Cowie, CC				Saydah, SH; Fradkin, J; Cowie, CC			Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; UNITED-STATES; US ADULTS; PREVALENCE; CARE; HYPERTENSION; QUALITY; MANAGEMENT; MORTALITY	Context Control of blood glucose levels, blood pressure, and cholesterol levels is proven to reduce the risk of vascular disease among individuals with diabetes mellitus; however, the current state of control of these risk factors among individuals in the United States is uncertain. Objectives To examine 1999-2000 national data on control of risk factors for vascular disease among adults with previously diagnosed diabetes and to assess trends during the past decade. Design, Setting,and Participants Review of data from the Third National Health and Nutrition Examination Survey (NHANES III, conducted 1988-1994) and NHANES 1999-2000, cross-sectional surveys of a nationally representative sample of the non-institutionalized civilian US population. Participants were adults aged 20 years and older with previously diagnosed diabetes who participated in both the interview and examination in either NHANES III (n=1265) or NHANES 1999-2000 (n=441). Main Outcome Measures Levels of glycosylated hemoglobin (HbA(1c)), blood pressure, and total serum cholesterol in reference to target goals. Results Compared with NHANES III, participants with previously diagnosed diabetes in NHANES 1999-2000 were similar by age and sex, were less likely to be non-Hispanic white, were diagnosed at,an earlier age, had a higher body mass index, and were more likely to use insulin in combination with oral agents. In NHANES 19992000, only 37.0% of participants achieved the target goal of HbA(1c) level less than 7.0% and 37.2% of participants were above the recommended "take action" HbA(1c) level of greater than 8.0%; these percentages did not change significantly from NHANES III (P=.11 and P=.87, respectively). Only 35.8% of participants achieved the target of systolic blood pressure (SBP) less than 130 mm Hg and diastolic blood pressure (DBP) less than 80 mm Hg, and 40.4% had hypertensive blood pressure levels (SBP 140 or DBP 90 mm Hg). These percentages did not change significantly from NHANES III (P=.10 and P=.56, respectively). Over half (51.8%) of the participants in NHANES 1999-2000 had total cholesterol levels of 200 mg/dL or greater (vs 66.1% in NHANES III; P<.001). In total, only 7.3% (95% confidence interval, 2.8%-11.9%) of adults with diabetes in NHANES 1999-2000 attained recommended goals of HbA(1c) level less than 7%, blood pressure less than 130/80 mm Hg, and total cholesterol level less than 200 mg/dL (5.18 mmol/L). Conclusion Further public health efforts are needed to control risk factors for vascular disease among individuals with diagnosed diabetes.	NIDDKD, Diabet Epidemiol Program, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Cowie, CC (corresponding author), NIDDKD, Diabet Epidemiol Program, 6707 Democracy Blvd,Room 691,MSC 5460, Bethesda, MD 20892 USA.	cowiec@extra.niddk.nih.gov						American Diabetes Association, 2003, DIABETES CARE, V26, pS33, DOI DOI 10.2337/DIACARE.26.2007.S33; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark CM, 2001, DIABETES CARE, V24, P617, DOI 10.2337/diacare.24.4.617; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper ME, 2000, JAMA-J AM MED ASSOC, V283, P3177, DOI 10.1001/jama.283.24.3177; Cowie C. C., 2003, Morbidity and Mortality Weekly Report, V52, P833; Eastman RC, 1995, DIABETES AM, P339; Egede LE, 2002, ARCH INTERN MED, V162, P427, DOI 10.1001/archinte.162.4.427; Engel S, 2003, NEW ENGL J MED, V348, P2294; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; GABREL C, 2000, VITAL HLTH STAT, V146, P1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geiss LS, 2002, AM J PREV MED, V22, P42, DOI 10.1016/S0749-3797(01)00399-3; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; George PB, 2001, AM HEART J, V142, P857, DOI 10.1067/mhj.2001.119132; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GUNTER EW, 1997, LAB PROCEDURES USED; Haffner SM, 1998, DIABETES CARE, V21, P160, DOI 10.2337/diacare.21.1.160; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harris M, 1995, DIABETES AM, P1; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; JOHNSON C, 2002, ANAL APPROACHES CAVE; JONES A, 2002, VITAL HLTH STAT, V152, P1; Jorgenson WA, 2002, DIABETES EDUCATOR, V28, P989, DOI 10.1177/014572170202800613; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KLEIN R, 1995, DIABETES AM, P293; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; *NAT CTR HLTH STAT, NHANES CURR DAT FIL; *NAT CTR HLTH STAT, 1994, VIT HLTH STAT, V32, P3; *NAT CTR HLTH STAT, 1997, AN REP GUID 3 NAT HL; National Center for Health Statistics, NHANES 1999 2000 DAT; Petersen M, 2003, DIABETES CARE, V26, P917; PLEIS JR, 2003, VITAL HLTH STAT, V215, P28; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steinberg EP, 2003, NEW ENGL J MED, V348, P2681, DOI 10.1056/NEJMe030085; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Szklo M, 2000, EPIDEMIOLOGY BASICS, P265; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US DEP HHS, 1997, NAT HLTH NUTR EX SUR; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Wingard DL., 1995, DIABETES AM, P429	52	1003	1037	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2004	291	3					335	342		10.1001/jama.291.3.335	http://dx.doi.org/10.1001/jama.291.3.335			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764ZZ	14734596				2022-12-01	WOS:000188243100033
J	Gillespie, R				Gillespie, R			Community assembly through adaptive radiation in Hawaiian spiders	SCIENCE			English	Article							GENUS TETRAGNATHA; SPECIATION; COLONIZATION; EVOLUTION; ISLANDS	Communities arising through adaptive radiation are generally regarded as unique, with speciation and adaptation being quite different from immigration and ecological assortment. Here, I use the chronological arrangement of the Hawaiian Islands to visualize snapshots of evolutionary history and stages of community assembly. Analysis of an adaptive radiation of habitat-associated, polychromatic spiders shows that (i) species assembly is not random; (ii) within any community, similar sets of ecomorphs arise through both dispersal and evolution; and (iii) species assembly is dynamic with maximum species numbers in communities of intermediate age. The similar patterns of species accumulation through evolutionary and ecological processes suggest universal principles underlie community assembly.	Univ Calif Berkeley, Div Insect Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gillespie, R (corresponding author), Univ Calif Berkeley, Div Insect Biol, 201 Wellman Hall, Berkeley, CA 94720 USA.	gillespi@nature.berkeley.edu	Gillespie, Rosemary/AAF-4244-2019	Gillespie, Rosemary/0000-0003-0086-7424				Arthur W., 1987, NICHE COMPETITION EV; CHOWN SL, 1990, SYST ENTOMOL, V15, P283, DOI 10.1111/j.1365-3113.1990.tb00064.x; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Gillespie RG, 1999, J INSECT CONSERV, V3, P263, DOI 10.1023/A:1009654820519; Gillespie RG, 2002, J ARACHNOL, V30, P159, DOI 10.1636/0161-8202(2002)030[0159:HSOTGT]2.0.CO;2; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; GILLESPIE RG, 1991, J ARACHNOL, V19, P174; Gillespie Rosemary G., 1997, Pacific Science, V51, P380; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; Ruber L, 1999, P NATL ACAD SCI USA, V96, P10230, DOI 10.1073/pnas.96.18.10230; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Scott J. M., 1986, STUD AVIAN BIOL SER, V9, P431; SIMBERLOFF D, 1976, SCIENCE, V194, P572, DOI 10.1126/science.194.4265.572; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Wagner W.L., 1995, HAWAIIAN BIOGEOGRAPH; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E., 1999, ECOLOGICAL ASSEMBLY	21	438	448	0	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					356	359		10.1126/science.1091875	http://dx.doi.org/10.1126/science.1091875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14726588				2022-12-01	WOS:000188111800039
J	Crookes, WJ; Ding, LL; Huang, QL; Kimbell, JR; Horwitz, J; McFall-Ngai, MJ				Crookes, WJ; Ding, LL; Huang, QL; Kimbell, JR; Horwitz, J; McFall-Ngai, MJ			Reflectins: The unusual proteins of squid reflective tissues	SCIENCE			English	Article							PHYSIOLOGICAL COLOR-CHANGE; LOLLIGUNCULA-BREVIS; IRIDOPHORES; CEPHALOPODS; MORPHOLOGY; ORGAN	A family of unusual proteins is deposited in flat, structural platelets in reflective tissues of the squid Euprymna scolopes. These proteins, which we have named reflectins, are encoded by at least six genes in three subfamilies and have no reported homologs outside of squids. Reflectins possess five repeating domains, which are highly conserved among members of the family. The proteins have a very unusual composition, with four relatively rare residues (tyrosine, methionine, arginine, and tryptophan) comprising similar to57% of a reflectin, and several common residues (alanine, isoleucine, leucine, and lysine) occurring in none of the family members. These protein-based reflectors in squids provide a marked example of nanofabrication in animal systems.	Univ Hawaii Manoa, Pacific Biomed Res Ctr, Kewalo Marine Lab, Honolulu, HI 96813 USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Los Angeles	McFall-Ngai, MJ (corresponding author), Univ Hawaii Manoa, Pacific Biomed Res Ctr, Kewalo Marine Lab, 41 Ahui St, Honolulu, HI 96813 USA.				NATIONAL EYE INSTITUTE [R01EY003897] Funding Source: NIH RePORTER; NEI NIH HHS [NEI R01 EY3897] Funding Source: Medline; PHS HHS [R01 A150661] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARNOLD JM, 1974, BIOL BULL, V147, P522, DOI 10.2307/1540737; CLONEY RA, 1983, AM ZOOL, V23, P581, DOI 10.1093/icb/23.3.581; COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425; DENTON EJ, 1971, PROC R SOC SER B-BIO, V178, P43, DOI 10.1098/rspb.1971.0051; HANLON RT, 1990, CELL TISSUE RES, V259, P3, DOI 10.1007/BF00571424; Johnsen S, 2003, LIMNOL OCEANOGR, V48, P1277, DOI 10.4319/lo.2003.48.3.1277; Johnsen S, 2002, P ROY SOC B-BIOL SCI, V269, P243, DOI 10.1098/rspb.2001.1855; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; MONTGOMERY MK, 1992, J BIOL CHEM, V267, P20999; Steinberg-Yfrach G, 1998, NATURE, V392, P479, DOI 10.1038/33116; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; WEISS JL, 2002, CAC86921 NAT CTR BIO; Wise KJ, 2002, TRENDS BIOTECHNOL, V20, P387, DOI 10.1016/S0167-7799(02)02023-1; Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5	15	163	165	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2004	303	5655					235	238		10.1126/science.1091288	http://dx.doi.org/10.1126/science.1091288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716016				2022-12-01	WOS:000187908500050
J	Ricardo, A; Carrigan, MA; Olcott, AN; Benner, SA				Ricardo, A; Carrigan, MA; Olcott, AN; Benner, SA			Borate minerals stabilize ribose	SCIENCE			English	Article									Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ So Calif, Dept Geol, Los Angeles, CA 90089 USA	State University System of Florida; University of Florida; University of Southern California	Benner, SA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	sab@scinq.org	Olcott, Alison N./AAL-2020-2021	Olcott, Alison/0000-0002-6854-646X; Carrigan, Matthew/0000-0003-1459-2265				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; BRESLOW R, 1959, TETRAHEDRON LETT, P22; Hollis JM, 2001, ASTROPHYS J, V554, pL81, DOI 10.1086/320930; Kawakami T, 2001, J METAMORPH GEOL, V19, P61, DOI 10.1046/j.0263-4929.2000.00298.x; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; SHAPIRO R, 1988, ORIGINS LIFE EVOL B, V18, P71, DOI 10.1007/BF01808782	8	411	425	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2004	303	5655					196	196		10.1126/science.1092464	http://dx.doi.org/10.1126/science.1092464			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761KT	14716004				2022-12-01	WOS:000187908500038
J	Izard, T; Evans, G; Borgon, RA; Rush, CL; Bricogne, G; Bois, PRJ				Izard, T; Evans, G; Borgon, RA; Rush, CL; Bricogne, G; Bois, PRJ			Vinculin activation by talin through helical bundle conversion	NATURE			English	Article							ALPHA-CATENIN; BINDING-SITE; INTRAMOLECULAR ASSOCIATION; CRYSTAL-STRUCTURE; TAIL DOMAINS; ADHESION; PAXILLIN; KINASE; ACTIN; REGION	Vinculin is a conserved component and an essential regulator of both cell-cell (cadherin-mediated) and cell-matrix (integrin talin- mediated focal adhesions) junctions, and it anchors these adhesion complexes to the actin cytoskeleton by binding to talin in integrin complexes or to alpha-actinin in cadherin junctions(1-3). In its resting state, vinculin is held in a closed conformation through interactions between its head (Vh) and tail (Vt) domains(4-6). The binding of vinculin to focal adhesions requires its association with talin. Here we report the crystal structures of human vinculin in its inactive and talin- activated states. Talin binding induces marked conformational changes in Vh, creating a novel helical bundle structure, and this alteration actively displaces Vt from Vh. These results, as well as the ability of alpha-actinin to also bind to Vh and displace Vt from pre-existing Vh Vt complexes, support a model whereby Vh functions as a domain that undergoes marked structural changes that allow vinculin to direct cytoskeletal assembly in focal adhesions and adherens junctions. Notably, talin's effects on Vh structure establish helical bundle conversion as a signalling mechanism by which proteins direct cellular responses.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; Global Phasing Ltd, Cambridge CB3 0AX, England; Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Global Phasing Limited; University of Tennessee System; University of Tennessee Health Science Center	Izard, T (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	tina.izard@stjude.org	Evans, Gwyndaf/R-5524-2016	Evans, Gwyndaf/0000-0002-6079-2201; Borgon, Robert/0000-0002-5908-3395				Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; MCGREGOR A, 1994, BIOCHEM J, V301, P225, DOI 10.1042/bj3010225; Miller GJ, 2001, J BIOL CHEM, V276, P11729, DOI 10.1074/jbc.M008646200; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; WEISS EE, 1997, J CELL BIOL, V131, P755; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; WOOD CK, 1994, J CELL SCI, V107, P709; Xu WM, 1998, DEVELOPMENT, V125, P327; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Zamir E, 2001, J CELL SCI, V114, P3583	23	186	193	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 8	2004	427	6970					171	175		10.1038/nature02281	http://dx.doi.org/10.1038/nature02281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14702644				2022-12-01	WOS:000187863900039
J	Niittyla, T; Messerli, G; Trevisan, M; Chen, J; Smith, AM; Zeeman, SC				Niittyla, T; Messerli, G; Trevisan, M; Chen, J; Smith, AM; Zeeman, SC			A previously unknown maltose transporter essential for starch degradation in leaves	SCIENCE			English	Article							ARABIDOPSIS; BREAKDOWN; CARBON	A previously unknown maltose transporter is essential for the conversion of starch to sucrose in Arabidopsis leaves at night. The transporter was identified by isolating two allelic mutants with high starch levels and very high maltose, an intermediate of starch breakdown. The mutations affect a gene of previously unknown function, MEX1. We show that MEX1 is a maltose transporter that is unrelated to other sugar transporters. The severe mex1 phenotype demonstrates that MEX1 is the predominant route of carbohydrate export from chloroplasts at night. Homologous genes in plants including rice and potato indicate that maltose export is of widespread significance.	John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Bern; Academia Sinica - Taiwan	Smith, AM (corresponding author), John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England.	alison.smith@bbsrc.ac.uk	Smith, Steven M/G-7183-2015; Smith, Steven/HDM-9496-2022	Smith, Steven M/0000-0001-5661-9994; Zeeman, Samuel/0000-0002-2791-0915; Niittyla, Totte/0000-0001-8029-1503				Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Hausler RE, 1998, PLANTA, V204, P366, DOI 10.1007/s004250050268; RIESMEIER JW, 1993, P NATL ACAD SCI USA, V90, P6160, DOI 10.1073/pnas.90.13.6160; Rost S, 1996, BBA-GEN SUBJECTS, V1291, P221, DOI 10.1016/S0304-4165(96)00068-2; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Schleucher J, 1998, PLANT PHYSIOL, V118, P1439, DOI 10.1104/pp.118.4.1439; Servaites JC, 2002, J EXP BOT, V53, P1581, DOI 10.1093/jxb/erf009; Smith AM, 2003, J EXP BOT, V54, P577, DOI 10.1093/jxb/erg036; SMITH AM, 2002, J APPL GLYCOSCI, V50, P173; STITT M, 1981, PLANT PHYSIOL, V68, P755, DOI 10.1104/pp.68.3.755; Trethewey Richard N., 2000, VVolume 9, P205; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x	17	333	352	6	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					87	89		10.1126/science.1091811	http://dx.doi.org/10.1126/science.1091811			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704427				2022-12-01	WOS:000187710600039
J	Steel, GJ; Fullerton, DM; Tyson, JR; Stirling, CJ				Steel, GJ; Fullerton, DM; Tyson, JR; Stirling, CJ			Coordinated activation of Hsp70 chaperones	SCIENCE			English	Article							YEAST ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PROTEIN TRANSLOCATION; ATPASE ACTIVITY; KAR2P; BIP; PRECURSORS; COMPLEXES; HOMOLOG; BINDING	Hsp70s are a ubiquitous family of molecular chaperones involved in many cellular processes. Two Hsp70s, Lhs1p and Kar2p, are required for protein biogenesis in the yeast endoplasmic reticulum. Here, we found that Lhs1p and Kar2p specifically interacted to couple, and coordinately regulate, their respective activities. Lhs1p stimulated Kar2p by providing a specific nucleotide exchange activity, whereas Kar2p reciprocally activated the Lhs1p adenosine triphosphatase (ATPase). The two ATPase activities are coupled, and their coordinated regulation is essential for normal function in vivo.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.	colin.stirling@man.ac.uk						Baxter BK, 1996, MOL CELL BIOL, V16, P6444; Boisrame A, 1998, J BIOL CHEM, V273, P30903, DOI 10.1074/jbc.273.47.30903; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Craven RA, 1997, TRENDS CELL BIOL, V7, P277, DOI 10.1016/S0962-8924(97)01079-9; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Rassow J, 1997, TRENDS CELL BIOL, V7, P129, DOI 10.1016/S0962-8924(96)10056-8; Saris N, 1997, J CELL BIOL, V137, P813, DOI 10.1083/jcb.137.4.813; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	20	149	159	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					98	101		10.1126/science.1092287	http://dx.doi.org/10.1126/science.1092287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14704430				2022-12-01	WOS:000187710600043
J	Jiang, GQ; Kennedy, MJ; Christie-Blick, N				Jiang, GQ; Kennedy, MJ; Christie-Blick, N			Stable isotopic evidence for methane seeps in Neoproterozoic postglacial cap carbonates	NATURE			English	Article							GAS HYDRATE; EXCURSIONS; DEPOSITS; PRECIPITATION; DISSOCIATION; RECORD	The Earth's most severe glaciations are thought to have occurred about 600 million years ago, in the late Neoproterozoic era(1,2). A puzzling feature of glacial deposits from this interval is that they are overlain by 1-5-m-thick 'cap carbonates' (particulate deepwater marine carbonate rocks) associated with a prominent negative carbon isotope excursion(3-8). Cap carbonates have been controversially ascribed to the aftermath of almost complete shutdown of the ocean ecosystems for millions of years during such ice ages - the 'snowball Earth' hypothesis(4,5). Conversely, it has also been suggested that these carbonate rocks were the result of destabilization of methane hydrates during deglaciation and concomitant flooding of continental shelves and interior basins(3). The most compelling criticism of the latter 'methane hydrate' hypothesis has been the apparent lack of extreme isotopic variation in cap carbonates inferred locally to be associated with methane seeps. Here we report carbon isotopic and petrographic data from a Neoproterozoic postglacial cap carbonate in south China that provide direct evidence for methane-influenced processes during deglaciation. This evidence lends strong support to the hypothesis that methane hydrate destabilization contributed to the enigmatic cap carbonate deposition and strongly negative carbon isotopic anomalies following Neoproterozoic ice ages. This explanation requires less extreme environmental disturbance than that implied by the snowball Earth hypothesis(4,5).	Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Riverside; Columbia University; Columbia University	Jiang, GQ (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	ganqing@mail.ucr.edu	Jiang, Ganqing/GZM-7526-2022; Jiang, Ganqing/A-9557-2011; Jiang, Ganqing/AAX-7756-2020	Jiang, Ganqing/0000-0002-6627-2848; Jiang, Ganqing/0000-0002-6627-2848; Kennedy, Martin/0000-0002-1330-6864				Aiello IW, 2001, GEOLOGY, V29, P1111, DOI 10.1130/0091-7613(2001)029<1111:AAOOCS>2.0.CO;2; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Cavagna S, 1999, SEDIMENT GEOL, V126, P253, DOI 10.1016/S0037-0738(99)00044-5; CROWELL JC, 1999, MEM GEOL SOC AM, V192; Dickens G., 2003, GEOL SOC AM SPEC PAP, V369, P11, DOI [10.1130/0-8137-2369-8.11, DOI 10.1130/0-8137-2369-8.11]; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Gautier D. L., 1984, AAPG BULL, V37, P111; Greinert J, 2002, EARTH PLANET SC LETT, V203, P165, DOI 10.1016/S0012-821X(02)00830-0; Grotzinger JP, 1995, PALAIOS, V10, P578, DOI 10.2307/3515096; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, GEOLOGY, V30, P286, DOI 10.1130/0091-7613(2002)030<0286:APCCAI>2.0.CO;2; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; IRWIN H, 1977, NATURE, V269, P209, DOI 10.1038/269209a0; James NP, 2001, CAN J EARTH SCI, V38, P1229, DOI 10.1139/e01-046; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Kauffman EG, 1996, GEOLOGY, V24, P799, DOI 10.1130/0091-7613(1996)024<0799:WVOMRF>2.3.CO;2; Kennedy MJ, 2001, GEOLOGY, V29, P1135, DOI 10.1130/0091-7613(2001)029<1135:CICONG>2.0.CO;2; Kennedy MJ, 1996, J SEDIMENT RES, V66, P1050, DOI 10.2110/jsr.66.1050; Kennedy MJ, 2001, GEOLOGY, V29, P443, DOI 10.1130/0091-7613(2001)029<0443:APCCAI>2.0.CO;2; Kvenvolden KA, 1998, GEOL SOC SPEC PUBL, V137, P9, DOI 10.1144/GSL.SP.1998.137.01.02; Peckmann J, 2002, SEDIMENTOLOGY, V49, P855, DOI 10.1046/j.1365-3091.2002.00474.x; Sohl LE, 1999, GEOL SOC AM BULL, V111, P1120, DOI 10.1130/0016-7606(1999)111<1120:PPRIMC>2.3.CO;2; Stakes DS, 1999, MAR GEOL, V159, P93, DOI 10.1016/S0025-3227(98)00200-X; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318	26	286	366	7	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					822	826		10.1038/nature02201	http://dx.doi.org/10.1038/nature02201			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14685234	Green Published			2022-12-01	WOS:000187342000053
